Citrus Sinensis ID: 042383
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.847 | 0.289 | 0.509 | 8e-85 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.849 | 0.290 | 0.504 | 3e-84 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.824 | 0.281 | 0.494 | 8e-83 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.824 | 0.280 | 0.494 | 2e-82 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.818 | 0.303 | 0.480 | 3e-81 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.832 | 0.288 | 0.476 | 8e-81 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.813 | 0.283 | 0.486 | 4e-79 | |
| P85193 | 242 | Putative serine/threonine | N/A | no | 0.679 | 0.991 | 0.591 | 5e-79 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.841 | 0.291 | 0.465 | 7e-78 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.864 | 0.472 | 0.456 | 8e-74 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 314 bits (804), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 155/304 (50%), Positives = 214/304 (70%), Gaps = 5/304 (1%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
F+Y+ELKSAT F SNK+GEGGFG VYKG L DG VVAVK+LSV S+QG+ +F++E+ +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++++ H NLVKL+G C EG R++VY+Y+ N SL Q L G++ W+ R EI LG+
Sbjct: 742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT--LHLDWSTRYEICLGV 799
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
ARGL Y+HEE IVHRD+K SNILLD P+ISDFGL+KL+ + THISTRVAGT+G
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
YLAP+YA+ GHL K+D+Y+FGV+ L++V+G+ + E + YL+E AW +H +
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPG 341
L+D L +F+ EA R + + LLC Q +LRP MS V+ M++GDV+I D +PG
Sbjct: 920 ELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTS--KPG 976
Query: 342 LIND 345
++D
Sbjct: 977 YVSD 980
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 154/305 (50%), Positives = 211/305 (69%), Gaps = 5/305 (1%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
F+Y+ELKSAT F SNK+GEGGFG VYKGKL DG VAVK+LSV S+QG+ +F++E+
Sbjct: 680 TFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIV 739
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+++ + H NLVKL+G C EG R++VY+Y+ N SL Q L GE+ W+ R EI LG
Sbjct: 740 AISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEICLG 797
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+ARGL Y+HEE + IVHRD+K SNILLD PK+SDFGL+KL+ + THISTRVAGT+
Sbjct: 798 VARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTI 857
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280
GYLAP+YA+ GHL K+D+Y+FGV+ L++V+G+ + E + YL+E AW +H +
Sbjct: 858 GYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGRE 917
Query: 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEP 340
L+D L F+ E R + + LLC Q +LRP MS V+ M++GDV++ D +P
Sbjct: 918 VELIDHQLT-EFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTS--KP 974
Query: 341 GLIND 345
G + D
Sbjct: 975 GYLTD 979
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 8e-83, Method: Compositional matrix adjust.
Identities = 144/291 (49%), Positives = 207/291 (71%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
+F+ ++K ATN F NK+GEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++ + H NLVKL+G CIEG ++VY+Y++NNSL++ L G EK R W+ R ++ +G
Sbjct: 714 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIG 773
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
IA+GLAY+HEE + IVHRDIK +N+LLD + N KISDFGL+KL E+ THISTR+AGT+
Sbjct: 774 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTI 833
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280
GY+AP+YA+ G+L K+D+YSFGV+ L+IV+G++ ++ + YL++ A+ + L
Sbjct: 834 GYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSL 893
Query: 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331
LVDP L +FS EA+R L + LLC +LRP MS+V+ M+ G + +
Sbjct: 894 LELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 144/291 (49%), Positives = 207/291 (71%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
+F+ ++K ATN F NK+GEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 656 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 715
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++ + H NLVKL+G CIEG ++VY+Y++NNSL++ L G EK R W+ R +I +G
Sbjct: 716 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIG 775
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
IA+GLAY+HEE + IVHRDIK +N+LLD + N KISDFGL+KL ++ THISTR+AGT+
Sbjct: 776 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTI 835
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280
GY+AP+YA+ G+L K+D+YSFGV+ L+IV+G++ ++ + YL++ A+ + L
Sbjct: 836 GYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSL 895
Query: 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331
LVDP L +FS EA+R L + LLC +LRP MS+V+ M+ G + +
Sbjct: 896 LELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 139/289 (48%), Positives = 206/289 (71%)
Query: 39 INAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSE 98
I +FS ++K ATN F S+N++GEGGFG VYKGKL DGT++AVK LS SKQG +EF++E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668
Query: 99 VASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
+ ++ + H NLVKL+G C+EG ++VY++++NNSL++ L G ++ + + W RR+I
Sbjct: 669 IGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKIC 728
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+G+ARGLAY+HEE + IVHRDIK +N+LLD+ NPKISDFGL+KL ED THISTR+AG
Sbjct: 729 IGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG 788
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278
T GY+AP+YA+ GHL K+D+YSFG++ L+IV G++ + +YL++ + +
Sbjct: 789 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKN 848
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
L LVDP L ++ EA+ +++ ++C + RP MS V++M+ G
Sbjct: 849 NLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 140/294 (47%), Positives = 210/294 (71%)
Query: 39 INAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSE 98
I++FS ++K AT+ F +NK+GEGGFG V+KG + DGTV+AVK LS +SKQG +EF++E
Sbjct: 657 ISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNE 716
Query: 99 VASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
+A ++ + H +LVKL+G C+EG ++VY+Y++NNSL++ L G ++ + +W R++I
Sbjct: 717 IAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKIC 776
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+GIARGLAY+HEE + IVHRDIK +N+LLD+ NPKISDFGL+KL E+ THISTRVAG
Sbjct: 777 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAG 836
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278
T GY+AP+YA+ GHL K+D+YSFGV+ L+IV G++ + +YL++ + +
Sbjct: 837 TYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQN 896
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332
L +VDP L +++ EA+ +++G+LC RP MSTV+ M+ G ++
Sbjct: 897 TLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVN 950
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 140/288 (48%), Positives = 206/288 (71%), Gaps = 1/288 (0%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
F+ ++K+AT+ F + K+GEGGFGSVYKG+L +G ++AVK LS +S+QG +EF++E+
Sbjct: 665 TFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIG 724
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG-EEKNRAKFSWTARREIAL 159
++ + H NLVKL+G C+EG I+VY+Y++NN LS+ L G +E +R K W+ R++I L
Sbjct: 725 MISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFL 784
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT 219
GIA+GL ++HEE + IVHRDIK SN+LLD++ N KISDFGL+KL + THISTR+AGT
Sbjct: 785 GIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGT 844
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279
+GY+AP+YA+ G+L K+D+YSFGV+ L+IV+G++ +F YL++ A+ +
Sbjct: 845 IGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGS 904
Query: 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
L LVDP L ++S EA+ L V L+C +LRP MS V+ +I G
Sbjct: 905 LLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEG 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P85193|PK01_HELAN Putative serine/threonine-protein kinase (Fragment) OS=Helianthus annuus PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 146/247 (59%), Positives = 183/247 (74%), Gaps = 7/247 (2%)
Query: 1 MKFFFPLSRCFAWPSNFSAEDTVGANFFTKSGAKILKNINAFSYNELKSATNGFCSSNKV 60
MK FP +CF S +D V + K G + K FSY+ELK A +GF S NKV
Sbjct: 1 MKMCFPCLQCFCSTS----DDKVVVSKNDK-GGESGKKFRLFSYHELKVACDGFSSKNKV 55
Query: 61 GEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCI 118
GEGG G+VYKG+L DGT+VA+KVLSVE S +GE+EF+SE+A++++ HENLV LHG C+
Sbjct: 56 GEGGCGAVYKGRLTDGTMVAIKVLSVELESMRGEREFISEIAALSDAQHENLVNLHGCCV 115
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E R +VYDYM+NNSL+ LG E+NR F WT R+ + LG+A+ LAY+HEEI P IVH
Sbjct: 116 EEATRCLVYDYMENNSLAYQFLGREQNRNSFDWTKRKNVLLGVAKALAYLHEEINPHIVH 175
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RDIK SN+LLD NFNPK++DFGL++LF E +HISTRVAGTLGYL+P+YAVS L KSD
Sbjct: 176 RDIKASNVLLDHNFNPKVADFGLARLFQEGTSHISTRVAGTLGYLSPEYAVSERLTRKSD 235
Query: 239 IYSFGVL 245
+YSFGVL
Sbjct: 236 VYSFGVL 242
|
Helianthus annuus (taxid: 4232) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 140/301 (46%), Positives = 209/301 (69%), Gaps = 4/301 (1%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
FS+ +L++ATN F +NK+GEGGFGSV+KG+L DGT++AVK LS +S QG +EF++E+
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++ + H NLVKL+G C+E ++VY+YM+NNSL+ L G+ N K W AR++I +GI
Sbjct: 721 ISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQ--NSLKLDWAARQKICVGI 778
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
ARGL ++H+ +VHRDIK +N+LLD + N KISDFGL++L + THIST+VAGT+G
Sbjct: 779 ARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIG 838
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
Y+AP+YA+ G L K+D+YSFGV+ ++IV+G++ L+ A + T +
Sbjct: 839 YMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDIL 898
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPG 341
+VD ML G F+ +EAVR +KV L+C SLRP MS ++M+ G+++I + +PG
Sbjct: 899 EIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMS--DPG 956
Query: 342 L 342
+
Sbjct: 957 I 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 142/311 (45%), Positives = 202/311 (64%), Gaps = 6/311 (1%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
FSY L+ AT+ F NK+G+GG GSVYKG L +G VAVK L +KQ F +EV
Sbjct: 311 FSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNL 370
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++ + H+NLVKL G I GP ++VY+Y+ N SL L K+ +W R +I LG
Sbjct: 371 ISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF-VRKDVQPLNWAKRFKIILGT 429
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
A G+AY+HEE I+HRDIK SNILL+ +F P+I+DFGL++LFPED THIST +AGTLG
Sbjct: 430 AEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLG 489
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
Y+AP+Y V G L K+D+YSFGVL+++++TG+ F ++ G +++ W ++ T ++
Sbjct: 490 YMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGS--ILQSVWSLYRTSNVE 547
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPG 341
VDP+L NF+ EA R L++GLLCVQ RP MS V++M+ G ++I +P
Sbjct: 548 EAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKGSLEIHTPT---QPP 604
Query: 342 LINDIMDVKLR 352
+N V++R
Sbjct: 605 FLNPGSVVEMR 615
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | ||||||
| 224113013 | 345 | predicted protein [Populus trichocarpa] | 0.906 | 0.927 | 0.700 | 1e-131 | |
| 224097961 | 340 | predicted protein [Populus trichocarpa] | 0.898 | 0.932 | 0.701 | 1e-130 | |
| 225449074 | 449 | PREDICTED: probable LRR receptor-like se | 0.912 | 0.717 | 0.683 | 1e-128 | |
| 255577375 | 392 | ATP binding protein, putative [Ricinus c | 0.895 | 0.806 | 0.694 | 1e-127 | |
| 255557018 | 378 | ATP binding protein, putative [Ricinus c | 0.980 | 0.915 | 0.568 | 1e-116 | |
| 297741595 | 433 | unnamed protein product [Vitis vinifera] | 0.906 | 0.739 | 0.614 | 1e-113 | |
| 225439972 | 399 | PREDICTED: putative serine/threonine-pro | 0.906 | 0.802 | 0.614 | 1e-113 | |
| 449450984 | 364 | PREDICTED: putative serine/threonine-pro | 0.971 | 0.942 | 0.543 | 1e-106 | |
| 296086032 | 288 | unnamed protein product [Vitis vinifera] | 0.798 | 0.979 | 0.670 | 1e-104 | |
| 225462205 | 385 | PREDICTED: probable LRR receptor-like se | 0.895 | 0.820 | 0.558 | 1e-103 |
| >gi|224113013|ref|XP_002316361.1| predicted protein [Populus trichocarpa] gi|222865401|gb|EEF02532.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1223), Expect = e-131, Method: Compositional matrix adjust.
Identities = 225/321 (70%), Positives = 271/321 (84%), Gaps = 1/321 (0%)
Query: 31 SGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ 90
+G +IL+N++AFS++ELK ATNGF SSNK+GEGGFGSVYKG LQDG +VA+K+LS ESKQ
Sbjct: 4 TGLQILQNVHAFSFDELKVATNGFRSSNKIGEGGFGSVYKGVLQDGRIVAIKMLSAESKQ 63
Query: 91 GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFS 150
G +EFMSE+AS++NI HENLV LHGGCI+GPC+I+VYDYM+N SL+QTLLG E+NRA+F
Sbjct: 64 GHREFMSEIASVSNINHENLVNLHGGCIDGPCKILVYDYMENGSLAQTLLGGEENRARFG 123
Query: 151 WTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210
W RR I+LGIA+GLAYIHEEIKP IVHRDIK SNILLD+N PK+SDFGLSKLFPE+ T
Sbjct: 124 WETRRGISLGIAQGLAYIHEEIKPHIVHRDIKASNILLDKNLCPKVSDFGLSKLFPENFT 183
Query: 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
H+STRVAGTLGYLAP+YA+SG L K+D+YSFGVLLL+IV+G+ A FD ELGE+YLVEK
Sbjct: 184 HVSTRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLEIVSGRKATDFDPELGEHYLVEK 243
Query: 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330
AWEM+ D L LVDPML GNF G EAV F+KV LLCVQEK LRP MS I+M+ G++D
Sbjct: 244 AWEMYKADNLLKLVDPMLDGNFLGTEAVGFVKVALLCVQEKCGLRPSMSKAIKMMRGEID 303
Query: 331 IDDDVEIWEPGLINDIMDVKL 351
I + +I +PG I D MDVK+
Sbjct: 304 I-HNTQITQPGFIIDFMDVKI 323
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097961|ref|XP_002311099.1| predicted protein [Populus trichocarpa] gi|222850919|gb|EEE88466.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 223/318 (70%), Positives = 270/318 (84%), Gaps = 1/318 (0%)
Query: 34 KILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEK 93
++L+N++AFS+NELK ATNGF SSNK+GEGGFGSVYKG LQDG +VAVK+LS SKQG++
Sbjct: 2 QVLQNVHAFSFNELKVATNGFRSSNKIGEGGFGSVYKGILQDGRMVAVKMLSAGSKQGDR 61
Query: 94 EFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTA 153
EF+SE+AS++NI HENLVKLHGGCI+GP +I+VYDYM+N SL+QTLLG E+ RAKF W
Sbjct: 62 EFISEIASVSNINHENLVKLHGGCIDGPYKILVYDYMENGSLAQTLLGSEEKRAKFRWET 121
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213
RREI+LGIA+GLAYIHEEIKP IVHRDIK SNILLDQN PK+SDFGLSKLFPED TH+S
Sbjct: 122 RREISLGIAQGLAYIHEEIKPRIVHRDIKASNILLDQNLCPKVSDFGLSKLFPEDFTHVS 181
Query: 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273
TRVAGTLGYLAP+YA+SG L K+D+YSFGVLLLQI+ G+ AV FD ELGE+YLVEKAW+
Sbjct: 182 TRVAGTLGYLAPEYAISGRLTRKTDVYSFGVLLLQIICGRKAVDFDPELGEHYLVEKAWQ 241
Query: 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333
M+ TD L LVDPML +F EAV F+K+ LLCVQEK LRP MS I+M+ G++D+
Sbjct: 242 MYKTDNLLKLVDPMLNADFLETEAVGFVKIALLCVQEKCGLRPSMSMAIKMMRGEIDV-S 300
Query: 334 DVEIWEPGLINDIMDVKL 351
+++I +PG I DIMDVK+
Sbjct: 301 NMQITQPGFIIDIMDVKI 318
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225449074|ref|XP_002274408.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1193), Expect = e-128, Method: Compositional matrix adjust.
Identities = 220/322 (68%), Positives = 268/322 (83%)
Query: 30 KSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK 89
K G L+N +AF+YNE+K AT GF SS+K+G+GGFGSVYKG+LQDGTVVAVKVLS ESK
Sbjct: 107 KDGLPTLQNAHAFTYNEIKIATGGFRSSDKIGQGGFGSVYKGRLQDGTVVAVKVLSAESK 166
Query: 90 QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKF 149
QG++EFMSE+AS++NI HENLVKLHGGC+ G R++VYDYMQNNSLS TLL EK RAKF
Sbjct: 167 QGDREFMSEMASISNINHENLVKLHGGCVHGARRMLVYDYMQNNSLSHTLLRGEKRRAKF 226
Query: 150 SWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209
SW RREI LGIARGLAYIHE+I P +VHRDIK SNILLD +F PKISDFGLSKLF +I
Sbjct: 227 SWKTRREICLGIARGLAYIHEDITPHVVHRDIKASNILLDGDFTPKISDFGLSKLFYTNI 286
Query: 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE 269
THI+TRVAGTLGYLAP+YA+SGHL KSD+YSFGVL+L+IV+G+ A+ FD +LGE+YLV+
Sbjct: 287 THITTRVAGTLGYLAPEYALSGHLTRKSDVYSFGVLILEIVSGRTAIDFDLDLGEHYLVQ 346
Query: 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329
KAWE++ T KL LVDP++ G+ + EAVRFL+VGLLCVQEK RP++S + +++ D
Sbjct: 347 KAWELYKTKKLDQLVDPVMRGDITAKEAVRFLRVGLLCVQEKCDRRPKISKAMSLMSDDE 406
Query: 330 DIDDDVEIWEPGLINDIMDVKL 351
DD+ I +PG+I DIMDVKL
Sbjct: 407 INLDDLLISQPGIITDIMDVKL 428
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577375|ref|XP_002529567.1| ATP binding protein, putative [Ricinus communis] gi|223530943|gb|EEF32801.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 221/318 (69%), Positives = 268/318 (84%), Gaps = 2/318 (0%)
Query: 35 ILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKE 94
IL+N++AFSY ELK ATN F SNK+GEGGFGSVYKG L++G VAVKVLS ES+QG+KE
Sbjct: 54 ILQNVHAFSYRELKVATNSFHLSNKIGEGGFGSVYKGMLENGKFVAVKVLSAESRQGDKE 113
Query: 95 FMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR 154
F+SE+AS+++I HENLV LHG CI+GPCRI+VYDYM+N +L+Q LLG +K + KF W R
Sbjct: 114 FLSEIASLSSISHENLVILHGACIDGPCRILVYDYMENGNLAQILLGGDKIKRKFCWRVR 173
Query: 155 REIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
REI+LGIA GLA+IHEEIKP IVHRDIK SNILLDQNF PK+SDFGLSKLF ++ITHIST
Sbjct: 174 REISLGIAEGLAHIHEEIKPHIVHRDIKASNILLDQNFAPKVSDFGLSKLFADNITHIST 233
Query: 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274
RVAGTLGYLAP+YA+SGHL KSDIYSFGVLLL+IV+G+ AV FD ELGE++LVEKAWEM
Sbjct: 234 RVAGTLGYLAPEYAISGHLTRKSDIYSFGVLLLEIVSGRTAVDFDLELGEHFLVEKAWEM 293
Query: 275 HNTDKLQHLVDPMLCG-NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333
+ +KL HLVDPML G N EA+RFLKV LLCVQEK LRP++S ++M+ G+++I
Sbjct: 294 YKENKLVHLVDPMLNGNNLIEEEAIRFLKVALLCVQEKCGLRPKLSKAVKMMRGEINI-S 352
Query: 334 DVEIWEPGLINDIMDVKL 351
+EI +PGLIND M+VK+
Sbjct: 353 SIEISKPGLINDFMNVKI 370
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557018|ref|XP_002519542.1| ATP binding protein, putative [Ricinus communis] gi|223541405|gb|EEF42956.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/359 (56%), Positives = 281/359 (78%), Gaps = 13/359 (3%)
Query: 1 MKFFFPLSRCFAWPSNFSAEDTVGANFFTKSGAKILKNINAFSYNELKSATNGFCSSNKV 60
MKF S C ++P++ A T+ +G + N+ FS EL+ AT+ F SSNKV
Sbjct: 1 MKFHSCFSFCSSFPNSRPAISTIS------TGEQKHGNLQIFSSRELEIATHDFSSSNKV 54
Query: 61 GEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCI 118
GEG FGSVY G+L++G++VAVKVLSVE S +GE+EF+SE+A++++I HENLVKL G C+
Sbjct: 55 GEGAFGSVYMGQLKNGSIVAVKVLSVELESMRGEREFISELAALSDISHENLVKLQGCCV 114
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+G R +VYDYM+NNSL+QTLLG+E+NR KFSW ARR I+ G+ARGLAYIHEE+KP I+H
Sbjct: 115 DGANRYLVYDYMENNSLTQTLLGKEQNRMKFSWEARRNISFGVARGLAYIHEEVKPHILH 174
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RDIK SNILLD++F PK++DFGLS++ ++ +H+STRVAGTLGYLAP+YA+SGHL KSD
Sbjct: 175 RDIKASNILLDKDFTPKVADFGLSRILRDNTSHVSTRVAGTLGYLAPEYALSGHLTRKSD 234
Query: 239 IYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF----SG 294
+YSFGVLLL+I++G++AV FD ELGE++LV+KAWE +N +KL ++DP+L NF
Sbjct: 235 VYSFGVLLLEIISGRSAVDFDLELGEHFLVQKAWEAYNENKLLQIIDPILIMNFLEEEEE 294
Query: 295 NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPGLINDIMDVKLRY 353
+A+RFL VGLLCVQE + LRP+MST ++M+ ++DI D++I +PG ++++M VKL +
Sbjct: 295 EDALRFLIVGLLCVQEIAKLRPQMSTCVKMMVNEIDI-KDIQICQPGCVSNLMGVKLHH 352
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741595|emb|CBI32727.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1068), Expect = e-113, Method: Compositional matrix adjust.
Identities = 199/324 (61%), Positives = 257/324 (79%), Gaps = 4/324 (1%)
Query: 30 KSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE-- 87
++G + FSY ELK AT+ F SNK+GEGGFGSVYKG+L+DGT VAVKVLSVE
Sbjct: 62 ETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVKVLSVEIE 121
Query: 88 SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRA 147
S +GE+EF+SE++++ +I HENLV L G C+EG R +VYDYM+NNSL+QTLLG ++NR
Sbjct: 122 SMRGEREFVSELSALTDIKHENLVTLQGCCVEGASRFLVYDYMENNSLAQTLLGAKQNRM 181
Query: 148 KFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
+F W ARR I+LG+ RGLAY+HEE++P I+HRDIK +NILLDQN PKISDFGLSKLF +
Sbjct: 182 EFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISDFGLSKLFVD 241
Query: 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL 267
+HISTRVAGTLGYLAP+YA+SG L KSD+YSFGVLLL+I++G + V +D E GE+YL
Sbjct: 242 SRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEYDLEHGEHYL 301
Query: 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
VEKAWEM+ +KL LVDP L +F EA++FLKVGLLCVQE S LRPRMS ++M+
Sbjct: 302 VEKAWEMYTDNKLLQLVDPTL-KDFPEEEAIQFLKVGLLCVQEISGLRPRMSAAVKMLTN 360
Query: 328 DVDIDDDVEIWEPGLINDIMDVKL 351
++++ +DV I +PGL++D+ VK+
Sbjct: 361 EINV-NDVHISQPGLLSDLTAVKI 383
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439972|ref|XP_002281059.1| PREDICTED: putative serine/threonine-protein kinase [Vitis vinifera] gi|147770086|emb|CAN69887.1| hypothetical protein VITISV_005073 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-113, Method: Compositional matrix adjust.
Identities = 199/324 (61%), Positives = 257/324 (79%), Gaps = 4/324 (1%)
Query: 30 KSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE-- 87
++G + FSY ELK AT+ F SNK+GEGGFGSVYKG+L+DGT VAVKVLSVE
Sbjct: 28 ETGGNTSEKFQVFSYKELKIATDSFHPSNKIGEGGFGSVYKGQLRDGTTVAVKVLSVEIE 87
Query: 88 SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRA 147
S +GE+EF+SE++++ +I HENLV L G C+EG R +VYDYM+NNSL+QTLLG ++NR
Sbjct: 88 SMRGEREFVSELSALTDIKHENLVTLQGCCVEGASRFLVYDYMENNSLAQTLLGAKQNRM 147
Query: 148 KFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
+F W ARR I+LG+ RGLAY+HEE++P I+HRDIK +NILLDQN PKISDFGLSKLF +
Sbjct: 148 EFGWEARRGISLGVGRGLAYLHEEVQPHIIHRDIKAANILLDQNLAPKISDFGLSKLFVD 207
Query: 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL 267
+HISTRVAGTLGYLAP+YA+SG L KSD+YSFGVLLL+I++G + V +D E GE+YL
Sbjct: 208 SRSHISTRVAGTLGYLAPEYALSGRLTRKSDVYSFGVLLLEIISGHSVVEYDLEHGEHYL 267
Query: 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
VEKAWEM+ +KL LVDP L +F EA++FLKVGLLCVQE S LRPRMS ++M+
Sbjct: 268 VEKAWEMYTDNKLLQLVDPTL-KDFPEEEAIQFLKVGLLCVQEISGLRPRMSAAVKMLTN 326
Query: 328 DVDIDDDVEIWEPGLINDIMDVKL 351
++++ +DV I +PGL++D+ VK+
Sbjct: 327 EINV-NDVHISQPGLLSDLTAVKI 349
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450984|ref|XP_004143242.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] gi|449482501|ref|XP_004156301.1| PREDICTED: putative serine/threonine-protein kinase-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 391 bits (1005), Expect = e-106, Method: Compositional matrix adjust.
Identities = 192/353 (54%), Positives = 259/353 (73%), Gaps = 10/353 (2%)
Query: 1 MKFFFPLSRCFAWPSNFSAEDTVGANFFTKSGAKILKNINAFSYNELKSATNGFCSSNKV 60
MKF LS C PS+ + E + + + ++ +SYNELK ATNGF +NKV
Sbjct: 1 MKFRSLLSTCCYSPSSTAMESS-------RHDRQDSESFRVYSYNELKLATNGFSGANKV 53
Query: 61 GEGGFGSVYKGKLQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
GEGGFG+VYKG L+D +AVKVLS VES +GE+EF++E+ S++NI HENLV+L G +
Sbjct: 54 GEGGFGTVYKGWLRDDRKIAVKVLSIEVESMRGEREFIAELTSLSNIRHENLVELKGFYV 113
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+G R +VYDYM+NNSL+ L G +NR + W AR+EI +G+ARGLAY+HEE++P IVH
Sbjct: 114 DGSNRYLVYDYMENNSLAYVLQGVRENRMRLRWIARKEILIGVARGLAYLHEEVEPHIVH 173
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RDIK SNILLD NF PK++DFGL+KL E+ +H+STRVAGT+GYLAP+YAVSGHL KSD
Sbjct: 174 RDIKASNILLDHNFKPKVADFGLAKLLRENSSHVSTRVAGTIGYLAPEYAVSGHLTRKSD 233
Query: 239 IYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAV 298
+YSFGVLLL+IV+G+A V FD E GE++LV++ WE + ++L L+DP+L +F EAV
Sbjct: 234 VYSFGVLLLEIVSGRATVDFDLEHGEHHLVQRVWEHYKANELVKLIDPVLDIDFRKEEAV 293
Query: 299 RFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPGLINDIMDVKL 351
RF+K+GLLCVQE + RPRMS + M+ + D+++ I +P I D MD+K+
Sbjct: 294 RFMKIGLLCVQENPTKRPRMSLAVSMLIKETDLNEH-NISQPAHIIDFMDIKM 345
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296086032|emb|CBI31473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 385 bits (988), Expect = e-104, Method: Compositional matrix adjust.
Identities = 191/285 (67%), Positives = 226/285 (79%), Gaps = 3/285 (1%)
Query: 1 MKFFFPLSRCFAWPSNFSAEDTVGANFFTKSGAKILKNINAFSYNELKSATNGFCSSNKV 60
MKF S CF +PS+ D G KSG L+N +AF+YNE+K AT GF SS+K+
Sbjct: 1 MKFPLACSECF-YPSSDDLHDNNGGRVI-KSGLPTLQNAHAFTYNEIKIATGGFRSSDKI 58
Query: 61 GEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG 120
G+GGFGSVYKG+LQDGTVVAVKVLS ESKQG++EFMSE+AS++NI HENLVKLHGGC+ G
Sbjct: 59 GQGGFGSVYKGRLQDGTVVAVKVLSAESKQGDREFMSEMASISNINHENLVKLHGGCVHG 118
Query: 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRD 180
R++VYDYMQNNSLS TLL EK RAKFSW RREI LGIARGLAYIHE+I P +VHRD
Sbjct: 119 ARRMLVYDYMQNNSLSHTLLRGEKRRAKFSWKTRREICLGIARGLAYIHEDITPHVVHRD 178
Query: 181 IKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIY 240
IK SNILLD +F PKISDFGLSKLF +ITHI+TRVAGTLGYLAP+YA+SGHL KSD+Y
Sbjct: 179 IKASNILLDGDFTPKISDFGLSKLFYTNITHITTRVAGTLGYLAPEYALSGHLTRKSDVY 238
Query: 241 SFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW-EMHNTDKLQHLV 284
SFGVL+L+IV+G+ A+ FD +LGE+YLV+K HN H +
Sbjct: 239 SFGVLILEIVSGRTAIDFDLDLGEHYLVQKVTPTTHNPQPHSHAI 283
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462205|ref|XP_002268737.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430 [Vitis vinifera] gi|296082791|emb|CBI21796.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (981), Expect = e-103, Method: Compositional matrix adjust.
Identities = 177/317 (55%), Positives = 243/317 (76%), Gaps = 1/317 (0%)
Query: 36 LKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEF 95
+ N+ + Y ELK+AT+ F +NK+GEGGFGSVYKG+L+DGT+ A+KVL+ ESKQG +EF
Sbjct: 28 IHNVRLYMYKELKNATDDFSPANKIGEGGFGSVYKGRLKDGTIAAIKVLAAESKQGVREF 87
Query: 96 MSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR 155
++E+ ++NI HE LVKL+G C+E RI+VY++++NNSL+QTLLG + +FSW R
Sbjct: 88 LTEINVISNIEHEYLVKLYGCCVEANHRILVYNFLENNSLAQTLLGGGYSGMQFSWRTRS 147
Query: 156 EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215
I +G+ARGLA++HEE++P IVHRDIK SNILLD N NPKI+DFGL+KL P ++TH+STR
Sbjct: 148 RICIGVARGLAFLHEEVRPYIVHRDIKASNILLDGNLNPKIADFGLAKLIPSNMTHVSTR 207
Query: 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275
VAGT+GYLAP+YA+ G L K+DIYSFGVLL++IV G+ + +GE YL+E+ WE++
Sbjct: 208 VAGTIGYLAPEYAIRGQLTRKADIYSFGVLLVEIVCGRCNTNTRLPIGEQYLLERTWELY 267
Query: 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDV 335
+L LVD L G F EA RFLK+GLLC Q+ LRP MS+V++M+ G++D+D
Sbjct: 268 ERKELVGLVDESLNGAFDAEEACRFLKIGLLCTQDTPKLRPSMSSVVKMLIGEMDVDSRA 327
Query: 336 EIWEPGLINDIMDVKLR 352
I +PGLI+D MD+K+R
Sbjct: 328 -ITKPGLISDFMDLKIR 343
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 353 | ||||||
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.895 | 0.810 | 0.520 | 7.5e-89 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.866 | 0.778 | 0.491 | 3.7e-80 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.847 | 0.289 | 0.496 | 2.4e-76 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.813 | 0.277 | 0.501 | 3.9e-76 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.818 | 0.303 | 0.480 | 5e-76 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.847 | 0.285 | 0.480 | 1.3e-75 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.866 | 0.315 | 0.464 | 2.9e-71 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.804 | 0.263 | 0.484 | 1.5e-69 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.801 | 0.438 | 0.479 | 3.5e-68 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.827 | 0.412 | 0.473 | 1.9e-67 |
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 166/319 (52%), Positives = 235/319 (73%)
Query: 36 LKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEF 95
+ N+ + Y E++ AT+ F + NK+GEGGFGSVYKG L+DG + A+KVLS ES+QG KEF
Sbjct: 23 IDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIKVLSAESRQGVKEF 82
Query: 96 MSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLL--GEEKNRAKFSWTA 153
++E+ ++ I HENLVKL+G C+EG RI+VY++++NNSL +TLL G ++ +F W++
Sbjct: 83 LTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAGGYTRSGIQFDWSS 142
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213
R I +G+A+GLA++HEE++P I+HRDIK SNILLD+ +PKISDFGL++L P ++TH+S
Sbjct: 143 RANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFGLARLMPPNMTHVS 202
Query: 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273
TRVAGT+GYLAP+YAV G L K+DIYSFGVLL++IV+G++ + YL+E+AWE
Sbjct: 203 TRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRLPTEYQYLLERAWE 262
Query: 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGXXXXXX 333
++ ++L LVD L G F EA R+LK+GLLC Q+ LRP MSTV+ ++ G
Sbjct: 263 LYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMSTVVRLLTGEKDIDY 322
Query: 334 XXXXXXPGLINDIMDVKLR 352
PGLI+D MD+K+R
Sbjct: 323 KKISR-PGLISDFMDLKVR 340
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 153/311 (49%), Positives = 210/311 (67%)
Query: 38 NINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMS 97
N+ FSYN L+SAT+ F +N++G GG+G V+KG L+DGT VAVK LS ESKQG +EF++
Sbjct: 30 NVRVFSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLT 89
Query: 98 EVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI 157
E+ ++NI H NLVKL G CIEG RI+VY+Y++NNSL+ LLG W+ R I
Sbjct: 90 EINLISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAI 149
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA 217
+G A GLA++HEE++P +VHRDIK SNILLD NF+PKI DFGL+KLFP+++TH+STRVA
Sbjct: 150 CVGTASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVA 209
Query: 218 GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY--LVEKAWEMH 275
GT+GYLAP+YA+ G L K+D+YSFG+L+L++++G ++ G+ Y LVE W++
Sbjct: 210 GTVGYLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTR--AAFGDEYMVLVEWVWKLR 267
Query: 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGXXXXXXXX 335
+L VDP L F +E RF+KV L C Q + RP M V+EM+
Sbjct: 268 EERRLLECVDPELT-KFPADEVTRFIKVALFCTQAAAQKRPNMKQVMEMLRRKELNLNED 326
Query: 336 XXXXPGLINDI 346
PG+ +
Sbjct: 327 ALTEPGVYRGV 337
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 151/304 (49%), Positives = 208/304 (68%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
F+Y+ELKSAT F SNK+GEGGFG VYKG L DG VVAVK+LSV S+QG+ +F++E+ +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++++ H NLVKL+G C EG R++VY+Y+ N SL Q L G++ W+ R EI LG+
Sbjct: 742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT--LHLDWSTRYEICLGV 799
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
ARGL Y+HEE IVHRD+K SNILLD P+ISDFGL+KL+ + THISTRVAGT+G
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
YLAP+YA+ GHL K+D+Y+FGV+ L++V+G+ + E + YL+E AW +H +
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGXXXXXXXXXXXXPG 341
L+D L +F+ EA R + + LLC Q +LRP MS V+ M++G PG
Sbjct: 920 ELIDDKLT-DFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSK--PG 976
Query: 342 LIND 345
++D
Sbjct: 977 YVSD 980
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 144/287 (50%), Positives = 205/287 (71%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
+F+ ++K ATN F NK+GEGGFG VYKG L DG +AVK LS +SKQG +EF++E+
Sbjct: 654 SFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIG 713
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++ + H NLVKL+G CIEG ++VY+Y++NNSL++ L G EK R W+ R ++ +G
Sbjct: 714 MISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIG 773
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
IA+GLAY+HEE + IVHRDIK +N+LLD + N KISDFGL+KL E+ THISTR+AGT+
Sbjct: 774 IAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTI 833
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280
GY+AP+YA+ G+L K+D+YSFGV+ L+IV+G++ ++ + YL++ A+ + L
Sbjct: 834 GYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSL 893
Query: 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
LVDP L +FS EA+R L + LLC +LRP MS+V+ M+ G
Sbjct: 894 LELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQG 940
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 5.0e-76, P = 5.0e-76
Identities = 139/289 (48%), Positives = 206/289 (71%)
Query: 39 INAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSE 98
I +FS ++K ATN F S+N++GEGGFG VYKGKL DGT++AVK LS SKQG +EF++E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668
Query: 99 VASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
+ ++ + H NLVKL+G C+EG ++VY++++NNSL++ L G ++ + + W RR+I
Sbjct: 669 IGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKIC 728
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+G+ARGLAY+HEE + IVHRDIK +N+LLD+ NPKISDFGL+KL ED THISTR+AG
Sbjct: 729 IGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAG 788
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278
T GY+AP+YA+ GHL K+D+YSFG++ L+IV G++ + +YL++ + +
Sbjct: 789 TFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKN 848
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
L LVDP L ++ EA+ +++ ++C + RP MS V++M+ G
Sbjct: 849 NLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.3e-75, P = 1.3e-75
Identities = 146/304 (48%), Positives = 206/304 (67%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
F+Y+ELK+AT F SNK+GEGGFG+VYKG L DG VAVK LS+ S+QG+ +F++E+ +
Sbjct: 698 FTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEIIA 757
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++++ H NLVKL+G C EG R++VY+Y+ N SL Q L G++ W+ R EI LG+
Sbjct: 758 ISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKS--LHLDWSTRYEICLGV 815
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
ARGL Y+HEE I+HRD+K SNILLD PK+SDFGL+KL+ + THISTRVAGT+G
Sbjct: 816 ARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIG 875
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
YLAP+YA+ GHL K+D+Y+FGV+ L++V+G+ + E G+ YL+E AW +H ++
Sbjct: 876 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV 935
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGXXXXXXXXXXXXPG 341
L+D L ++ E R + + LLC Q +LRP MS V+ M++G PG
Sbjct: 936 ELIDDEL-SEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSGDAEVNDATSK--PG 992
Query: 342 LIND 345
+ D
Sbjct: 993 YLTD 996
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
Identities = 145/312 (46%), Positives = 210/312 (67%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
+FS +LK ATN F NK+GEGGFGSVYKG+L DGT++AVK LS +S QG KEF++E+
Sbjct: 627 SFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIG 686
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+A + H NLVKL+G C+E ++VY+Y++NN LS L ++ K W R +I LG
Sbjct: 687 MIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAG-RSCLKLEWGTRHKICLG 745
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
IARGLA++HE+ I+HRDIK +N+LLD++ N KISDFGL++L ++ +HI+TRVAGT+
Sbjct: 746 IARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGTI 805
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHF--DKELGEYYLVEKAWEMHNTD 278
GY+AP+YA+ GHL K+D+YSFGV+ ++IV+G++ + D E L++ A+ +
Sbjct: 806 GYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECC-VGLLDWAFVLQKKG 864
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGXXXXXXXXXXX 338
+ ++DP L G F EA R +KV LLC + S+LRP MS V++M+ G
Sbjct: 865 DIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEIEQIISD- 923
Query: 339 XPGLINDIMDVK 350
PG+ +D + K
Sbjct: 924 -PGVYSDNLHFK 934
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 710 (255.0 bits), Expect = 1.5e-69, P = 1.5e-69
Identities = 140/289 (48%), Positives = 203/289 (70%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA 100
+FS +LK AT+ F NK+GEGGFGSVYKG+L +GT++AVK LS +S QG KEF++E+
Sbjct: 664 SFSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIG 723
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+A + H NLVKL+G C+E ++VY+Y++NN L+ L G ++ K W R +I LG
Sbjct: 724 IIACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFG--RSGLKLDWRTRHKICLG 781
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
IARGLA++HE+ I+HRDIK +NILLD++ N KISDFGL++L +D +HI+TRVAGT+
Sbjct: 782 IARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTI 841
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHF--DKELGEYYLVEKAWEMHNTD 278
GY+AP+YA+ GHL K+D+YSFGV+ ++IV+G++ ++ D E L++ A+ +
Sbjct: 842 GYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECC-VGLLDWAFVLQKKG 900
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
++DP L G F EA R +KV LLC + +LRP MS V++M+ G
Sbjct: 901 AFDEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEG 949
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
Identities = 137/286 (47%), Positives = 191/286 (66%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
FSY L+ AT+ F NK+G+GG GSVYKG L +G VAVK L +KQ F +EV
Sbjct: 311 FSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNL 370
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++ + H+NLVKL G I GP ++VY+Y+ N SL L K+ +W R +I LG
Sbjct: 371 ISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF-VRKDVQPLNWAKRFKIILGT 429
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
A G+AY+HEE I+HRDIK SNILL+ +F P+I+DFGL++LFPED THIST +AGTLG
Sbjct: 430 AEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLG 489
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281
Y+AP+Y V G L K+D+YSFGVL+++++TG+ F ++ G +++ W ++ T ++
Sbjct: 490 YMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGS--ILQSVWSLYRTSNVE 547
Query: 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327
VDP+L NF+ EA R L++GLLCVQ RP MS V++M+ G
Sbjct: 548 EAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKG 593
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
Identities = 143/302 (47%), Positives = 198/302 (65%)
Query: 26 NFFTKSGAKILKNINA-FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVL 84
++ ++SG L N A FSY EL ATNGF N +GEGGFG VYKG L DG VVAVK L
Sbjct: 350 SYQSQSGG--LGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQL 407
Query: 85 SVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK 144
+ QG++EF +EV +++ I H +LV + G CI G R+++YDY+ NN L L GE
Sbjct: 408 KIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE-- 465
Query: 145 NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204
++ W R +IA G ARGLAY+HE+ P I+HRDIK SNILL+ NF+ ++SDFGL++L
Sbjct: 466 -KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARL 524
Query: 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264
+ THI+TRV GT GY+AP+YA SG L KSD++SFGV+LL+++TG+ V + LG+
Sbjct: 525 ALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGD 584
Query: 265 YYLVEKAWEM--H--NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMST 320
LVE A + H T++ L DP L GN+ +E R ++ CV+ ++ RPRM
Sbjct: 585 ESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQ 644
Query: 321 VI 322
++
Sbjct: 645 IV 646
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.X.2631.1 | hypothetical protein (320 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 353 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-20 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 8e-53
Identities = 74/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGGC 117
+GEGGFG+VY + + G VA+K++ E E + E+ + + H N+VKL+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ +V +Y + SL LL ++N K S I L I GL Y+H I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LL--KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 178 HRDIKPSNILLDQ-NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD-YAVSGHLNP 235
HRD+KP NILLD N K++DFGLSKL D + + T V GT Y+AP+ G+ +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 236 KSDIYSFGVLLLQI 249
KSDI+S GV+L ++
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-50
Identities = 74/245 (30%), Positives = 121/245 (49%), Gaps = 22/245 (8%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHG 115
K+G G FG+VYK K + G +VAVK+L S + ++ E+ + + H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ +V +Y + L L S ++IAL I RGL Y+H
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLF-DYLSRGG---PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD-YAVSGHLN 234
I+HRD+KP NILLD+N KI+DFGL+K + + ++T V GT Y+AP+
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---------WEMHNTDK-LQHLV 284
PK D++S GV+L +++TG+ + L + L+ + + + + + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 285 DPMLC 289
L
Sbjct: 238 KKCLN 242
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-48
Identities = 63/199 (31%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHG 115
K+GEG FG VY + + G +VA+KV+ + + ++E + E+ + + H N+V+L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ +V +Y + L L K R + S R I L Y+H +
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK---G 117
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
IVHRD+KP NILLD++ + K++DFGL++ + ++T V GT Y+AP+ +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 236 KSDIYSFGVLLLQIVTGQA 254
DI+S GV+L +++TG+
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 6e-46
Identities = 96/280 (34%), Positives = 133/280 (47%), Gaps = 41/280 (14%)
Query: 59 KVGEGGFGSVYKGKLQD-----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVK 112
K+GEG FG VYKGKL+ VAVK L + S+Q +EF+ E M + H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G C E IV +YM+ L L KNR K S + AL IARG+ Y+
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
K +HRD+ N L+ +N KISDFGLS+ +D + + ++AP+ G
Sbjct: 121 KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAWEMHNTDKLQHLVD------ 285
KSD++SFGVLL +I T LGE Y M N + L++L +
Sbjct: 180 FTSKSDVWSFGVLLWEIFT----------LGEQPY-----PGMSNEEVLEYLKNGYRLPQ 224
Query: 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
P C + + L C E RP S ++E++
Sbjct: 225 PPNC-----PPELY--DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-44
Identities = 86/290 (29%), Positives = 127/290 (43%), Gaps = 51/290 (17%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVL-SVESKQGEKEFMSEVASMANICHENLVK 112
K+GEG FG VYKGKL+ T VAVK L S++ K+F+ E M + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 113 LHGGCIEGPCRIIVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
L G C E +V +YM+ L + ++ S A+ IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG-----Y 222
+ + VHRD+ N L+ ++ KISDFGLS+ D+ T G +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLPIRW 173
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQ 281
+AP+ G KSD++SFGVLL +I T LG Y + N + L+
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPY-----PGLSNEEVLE 218
Query: 282 HLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+L P C ++ L C Q RP S ++E +
Sbjct: 219 YLRKGYRLPKPEYCP-------DELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 92/280 (32%), Positives = 130/280 (46%), Gaps = 40/280 (14%)
Query: 59 KVGEGGFGSVYKGKLQDG-----TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVK 112
K+GEG FG VYKG L+ VAVK L + S+Q +EF+ E M + H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G C E +IV +YM L L + + S + AL IARG+ Y+
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES-- 121
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
K +HRD+ N L+ +N KISDFGLS+ +D + + ++AP+ G
Sbjct: 122 KN-FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAWEMHNTDKLQHLVD------ 285
KSD++SFGVLL +I T LGE Y M N + L++L
Sbjct: 181 FTSKSDVWSFGVLLWEIFT----------LGEEPY-----PGMSNAEVLEYLKKGYRLPK 225
Query: 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
P C + K+ L C E RP S ++E++
Sbjct: 226 PPNC-----PPELY--KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 94/286 (32%), Positives = 129/286 (45%), Gaps = 52/286 (18%)
Query: 59 KVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
K+GEG FG VYKG L T VAVK L + + E+ EF+ E + M + H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G C +G IV +YM L L K+ K + ++AL IA+G+ Y+
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL-----APDY 227
K VHRD+ N L+ +N KISDFGLS+ DI G L AP+
Sbjct: 121 KN-FVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD 285
G KSD++SFGVLL +I T LGE Y M N + L+ L D
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT----------LGEQPY------PGMSNEEVLELLED 219
Query: 286 ------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
P C + + ++ L C RP S ++E +
Sbjct: 220 GYRLPRPENCP-----DELY--ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 58 NKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVKLH 114
+G G FGSVY +D G ++AVK + + E + E+ ++++ H N+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 115 GGCI--EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
G E I +Y+ SLS L K K R+ I GLAY+H
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSN- 120
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR-VAGTLGYLAPDYAVSG 231
IVHRDIK +NIL+D + K++DFG +K + T T V GT ++AP+
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 232 HLNPKSDIYSFGVLLLQIVTGQA 254
+DI+S G ++++ TG+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
F K+G+GGFG VYK + + G VA+KV+ +ESK+ +++ ++E+ + H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 113 LHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+G + IV ++ SL LL S A + + +GL Y+H
Sbjct: 62 YYG-SYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY--VCKELLKGLEYLHSN 117
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAPDYAV 229
I+HRDIK +NILL + K+ DFGLS ++ R + GT ++AP+
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSA----QLSDTKARNTMVGTPYWMAPEVIN 170
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQ 253
+ K+DI+S G+ +++ G+
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 16/198 (8%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKLHG 115
K+G G FG V+ G T VAVK L K G + F+ E M + H+ LV+L+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
C E IV +YM SL L E + + ++A IA G+AY+ +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---N 123
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI--THISTRVAGTLGYLAPDYAVSGHL 233
+HRD+ NIL+ +N KI+DFGL++L +D + + + AP+ A G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRF 181
Query: 234 NPKSDIYSFGVLLLQIVT 251
KSD++SFG+LL +IVT
Sbjct: 182 TIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 19/241 (7%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLH 114
K+GEG FG VY + D +VA+KVL+ + + + F+ E+ +A++ N+VKL+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+ +V +Y+ SL LL + + S + I I L Y+H +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHSK--- 120
Query: 175 SIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTR-----VAGTLGYLAPDYA 228
I+HRDIKP NILLD++ K+ DFGL+KL P+ + S GT GY+AP+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 229 ---VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285
+ + SDI+S G+ L +++TG +K K T L +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 286 P 286
P
Sbjct: 241 P 241
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-32
Identities = 59/198 (29%), Positives = 110/198 (55%), Gaps = 6/198 (3%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKL 113
F K+G G FG V++G ++ VA+K+L + +++F EV ++ + H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
C G I+ + M+ SL L + + + ++A +A G+AY+ E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSL-LAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
+ +HRD+ NIL+ ++ K++DFGL++L ED+ ++S+ + AP+ A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTF 181
Query: 234 NPKSDIYSFGVLLLQIVT 251
+ KSD++SFG+LL ++ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 57 SNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVKL 113
+ +G G FG VYKG L+ G VA+K +S+E + E K M E+ + N+ H N+VK
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA---RGLAYIHE 170
G I+ +Y +N SL Q + K F +A+ + +GLAY+HE
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQII----KKFGPFP---ESLVAVYVYQVLQGLAYLHE 117
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+ ++HRDIK +NIL ++ K++DFG++ + + V GT ++AP+
Sbjct: 118 Q---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPEVIEM 173
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+ SDI+S G +++++TG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSV-ESKQGEKEF-MSEVASMANICHENLVKLH 114
++G+G FG VY + DG + +K + + + E+E ++EV + + H N++K +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFS------WTARREIALGIARGLAYI 168
E IV +Y LSQ + ++K F W ++ L L Y+
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD-- 226
H I+HRDIKP NI L N K+ DFG+SK+ + T V GT YL+P+
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 227 ----YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
Y N KSDI+S G +L ++ T +
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 60 VGEGGFGSVYKGKL------QDGTVVAVKVLS-VESKQGEKEFMSEVASMANICHENLVK 112
+GEG FG V+ G+ D +VAVK L S K+F E + N HEN+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLL--GEEKNRAKFSWTARRE--------IALGIA 162
+G C EG I+V++YM++ L++ L G + K + E IA+ IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI-THISTRVAGT-- 219
G+ Y+ + VHRD+ N L+ + KI DFG+S+ D+ T RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 220 --LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ ++ P+ + +SD++SFGV+L +I T
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 62/193 (32%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G G FG V++G + T VAVK L + K+F++E M + H L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
IV + M+ SL + L G K ++A +A G+AY+ + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEAQ---NYIH 126
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N+L+ +N K++DFGL+++ EDI + + AP+ A+ + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 239 IYSFGVLLLQIVT 251
++SFG+LL +IVT
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 60 VGEGGFGSVYK-GKLQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG V K G + A+KVL + ++ + ++E ++ I H +VKLH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 116 GCIEGPCRII-------VYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIAR 163
V +Y L L EE RA+F + A EI L
Sbjct: 60 ------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE--RARF-YAA--EIVLA--- 105
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
L Y+H I++RD+KP NILLD + + K++DFGL+K + + +T GT YL
Sbjct: 106 -LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYL 160
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP+ + D +S GVLL +++TG+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 7/193 (3%)
Query: 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
++G G FG V+ G + VA+K + E E++F+ E M + H LV+L+G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
C E +V+++M++ LS L R KFS + L + G+AY+ ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESS---NV 121
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRD+ N L+ +N K+SDFG+++ +D ST + + +P+ + K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 237 SDIYSFGVLLLQI 249
SD++SFGVL+ ++
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 57 SNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVKL 113
NK+G G FG VY L G ++AVK + ++ + KE E+ + + H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+G + I +Y +L + L ++ R L + GLAY+H
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG---YLAPDY--- 227
IVHRDIKP+NI LD N K+ DFG + + T + V G Y+AP+
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 228 -AVSGHLNPKSDIYSFGVLLLQIVTG 252
GH +DI+S G ++L++ TG
Sbjct: 178 GKGKGHGR-AADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 57 SNKVGEGGFGSVYKGK---LQDGT--VVAVKVLSVES-KQGEKEFMSEVASMANICHENL 110
++GEG FG V + L D T VAVK L+ +Q +F E+ + + HEN+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 111 VKLHGGCIEGPCRI--IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
VK G C + R ++ +Y+ + SL L +++R + + + I +G+ Y+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG--YLAPD 226
+ +HRD+ NIL++ KISDFGL+K+ PED + + G + AP+
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVT 251
+ + SD++SFGV L ++ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 60 VGEGGFGSVYKGKLQ----DGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
+G G FG V +G+L+ VA+K L S ++ +F++E + M H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +I+ +YM+N SL + L +N KF+ + GIA G+ Y+ E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEM--- 125
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG--TLGYLAPDYAVSGH 232
+ VHRD+ NIL++ N K+SDFGLS+ ED T G + + AP+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
SD++SFG+++ ++++ GE Y W+M N D ++ + D
Sbjct: 185 FTSASDVWSFGIVMWEVMS----------YGERPY------WDMSNQDVIKAVEDGYRLP 228
Query: 286 -PMLC 289
PM C
Sbjct: 229 PPMDC 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 11/198 (5%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGG 116
+G+G G VYK + + G + A+K + V+ + K+ + E+ ++ + +VK +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ I IV +YM SL+ L K K IA I +GL Y+H +
Sbjct: 68 FYK-EGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKRH-- 120
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
I+HRDIKPSN+L++ KI+DFG+SK+ + +T V GT+ Y++P+ +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY 179
Query: 236 KSDIYSFGVLLLQIVTGQ 253
+DI+S G+ LL+ G+
Sbjct: 180 AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 73/222 (32%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 58 NKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+K+G G +G VY+G + VAVK L E +EF+ E A M I H NLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
C P I+ ++M +L L E NR + + +A I+ + Y+ K +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT---LGYLAPDYAVSGHL 233
+HRD+ N L+ +N K++DFGLS+L D T AG + + AP+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKF 182
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAWEM 274
+ KSD+++FGVLL +I T + + +L + Y L+EK + M
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM 224
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 33/213 (15%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLV 111
++GEG +G VYK + + G +VA+K + +E+ EKE + E+ + + H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIV 61
Query: 112 KLHGGCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+L I V++YM ++ L+ L + KF+ + + + GL Y+H
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHD-LTGLL---DSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST-RVAGTLGYLAP--- 225
I+HRDIK SNIL++ + K++DFGL++ + + + T RV TL Y P
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 226 ----DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
Y P+ D++S G +L ++ G+
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLVK 112
K+GEG +G VYK + + G +VA+K + +++ E+E + E++ + + H N+VK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVK 62
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L +V++Y + L + L +K S + I + RGLAY H
Sbjct: 63 LLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCHSH- 117
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
I+HRD+KP NIL++++ K++DFGL++ F + + V TL Y AP+ +
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174
Query: 233 L-NPKSDIYSFGVLLLQIVTGQA 254
+ DI+S G + +++TG+
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 68/194 (35%), Positives = 106/194 (54%), Gaps = 9/194 (4%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G+G FG V+ G T VA+K L + E F+ E M + HE LV+L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E P IV +YM SL L GE + ++A IA G+AY+ + + VH
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVE---RMNYVH 125
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-TLGYLAPDYAVSGHLNPKS 237
RD++ +NIL+ +N K++DFGL++L ED + + + A + + AP+ A+ G KS
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 238 DIYSFGVLLLQIVT 251
D++SFG+LL ++ T
Sbjct: 185 DVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 24/290 (8%)
Query: 37 KNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFM 96
K + + N++ S+ N + G G+ YKGK ++ + E
Sbjct: 678 KVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPS 731
Query: 97 SEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE 156
SE+A M + H N+VKL G C ++++Y++ +LS+ L SW RR+
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRK 784
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216
IA+GIA+ L ++H P++V ++ P I++D P + L L D +
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842
Query: 217 AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMH 275
Y+AP+ + + KSDIY FG++L++++TG++ D E G + +VE A +
Sbjct: 843 ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA--DAEFGVHGSIVEWARYCY 896
Query: 276 NTDKLQHLVDPMLCGNFS--GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
+ L +DP + G+ S NE V + + L C + RP + V++
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 62/199 (31%), Positives = 112/199 (56%), Gaps = 15/199 (7%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE-KEFMSEVASMANICH---ENLVKLH 114
+G G +G+VY+GK + G VVA+K++++++ + + EVA ++ + N+ K +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G ++GP I+ +Y + S+ +TL+ K+ RE+ + L YIH K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIH---KV 120
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL- 233
++HRDIK +NIL+ N K+ DFG++ L ++ + ST V GT ++AP+ G
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYY 179
Query: 234 NPKSDIYSFGVLLLQIVTG 252
+ K+DI+S G+ + ++ TG
Sbjct: 180 DTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 75/280 (26%), Positives = 136/280 (48%), Gaps = 40/280 (14%)
Query: 60 VGEGGFGSVYKGKLQ----DGTVVAVKVLSV-ESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V++G L+ VA+K L +++ ++F+SE + M H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +I+ +YM+N +L + L + +FS + GIA G+ Y+ +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDM--- 126
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG--YLAPDYAVSGH 232
+ VHRD+ NIL++ N K+SDFGLS++ +D T G + + AP+
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD------P 286
SD++SFG+++ ++++ GE W+M N + ++ + D P
Sbjct: 187 FTSASDVWSFGIVMWEVMS----------FGE----RPYWDMSNHEVMKAINDGFRLPAP 232
Query: 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
M C + AV L L C Q+ + RPR ++ +++
Sbjct: 233 MDCPS-----AVYQLM--LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 9/203 (4%)
Query: 53 GFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVES-KQGEKE-FMSEVASMANICHEN 109
F K+G+G +GSVYK K L D A+K + + S Q E+E ++E+ +A++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ ++G IV +Y LS+ + +K R I + + RGL +H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
E+ I+HRD+K +NILL N KI D G+SK+ +++ GT Y+AP+
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWK 174
Query: 230 SGHLNPKSDIYSFGVLLLQIVTG 252
+ KSDI+S G LL ++ T
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 69/196 (35%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLHG 115
K+G G FG V+ G T VA+K L KQG F++E M + H LV+L+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ P II +YM+N SL L E K + ++A IA G+A+I E K
Sbjct: 69 VVTQEPIYIIT-EYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFI--ERKNY 123
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
I HRD++ +NIL+ + KI+DFGL++L ++ + + AP+ G
Sbjct: 124 I-HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 236 KSDIYSFGVLLLQIVT 251
KSD++SFG+LL +IVT
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 9/194 (4%)
Query: 60 VGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE 119
+G G FG V+ GK + VA+K++ E E +F+ E M + H NLV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 120 -GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
P IV +YM N L L + + K ++ + + Y+ +H
Sbjct: 71 QRPIF-IVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIH 123
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N L+ ++ K+SDFGL++ +D S + + P+ + KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 239 IYSFGVLLLQIVTG 252
++SFGVL+ ++ +
Sbjct: 184 VWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQG-EKEFMSEVASMANICHEN 109
+++GEG GSV K +L G + A+K ++ + +K+ + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 110 LVKLHGGCI-EGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
+VK +G + E I I +Y + SL +K + +IA + +GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
+H I+HRDIKPSNILL + K+ DFG+S E + ++ GT Y+AP+
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPER 174
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTG 252
+ SD++S G+ LL++
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 43/224 (19%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSV-----ESKQG----EKEFMSEVASMANICHEN 109
+GEG F +V K + A+K+L E K EKE ++ + H
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG-----HPG 63
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
++KL+ + + V +Y N L Q + + R A I L Y+
Sbjct: 64 IIKLYY-TFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALEYL 118
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA----------- 217
H + I+HRD+KP NILLD++ + KI+DFG +K+ + + S +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 218 --------GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
GT Y++P+ SD+++ G ++ Q++TG+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 34/274 (12%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVLSV-----ESKQGEKEFMSEVASMANICHENLVKL 113
+G G FGSVY+G L DG AVK +S+ ++ K+ E+A ++ + H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G E I + + SL++ L K F R I GL Y+H+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GH 232
+ VHRDIK +NIL+D N K++DFG++K E S G+ ++AP+ G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGG 178
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292
+DI+S G +L++ TG+ + V +++ + +L + D +
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP------WSQLEGVAAVFKIGRSKELPPIPDHL----- 227
Query: 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+EA F+ L C+Q SLRP T E++
Sbjct: 228 -SDEAKDFI---LKCLQRDPSLRP---TAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 59 KVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
++GEG FG V+ + QD +VAVK L S K+F E + N+ HE++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQ---------TLLGEEKNRAKFSWTARREIALGIAR 163
+G C+EG I+V++YM++ L++ L+ E A+ + + IA IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTLGY 222
G+ Y+ + VHRD+ N L+ +N KI DFG+S+ ++ D + + +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ P+ + +SD++S GV+L +I T
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 11/190 (5%)
Query: 60 VGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE 119
+G+G FG V G + G VAVK L +S + F++E + M + H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHR 179
G IV +YM SL L + RA + + AL + G+ Y+ E+ + VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 180 DIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDI 239
D+ N+L+ ++ K+SDFGL+K S ++ + + AP+ + KSD+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 240 YSFGVLLLQI 249
+SFG+LL +I
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG--EKEFMSEVASMANICHENLVKLHG 115
++GEG G V+K K + G VA+K +++ +G + + E+ ++ H +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
G ++V +YM + LS+ +L +E + + +G+AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSE-VLRDE--ERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
I+HRD+KP+N+L+ + KI+DFGL++LF E+ + + T Y AP
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 58 NKVGEGGFGSVYKGKLQ--DGTV--VAVKVLSVE-SKQGEKEFMSEVASMANICHENLVK 112
++G G FGSV KG G VAVK L E G+KEF+ E + MA + H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G C +G ++V + L + L K R + + +E+A +A G+AY+ E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYL-ESK 114
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT--LGYLAPDYAVS 230
VHRD+ N+LL KISDFG+S+ + AG L + AP+
Sbjct: 115 H--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 231 GHLNPKSDIYSFGVLLLQIVT 251
G + KSD++S+GV L + +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 73/280 (26%), Positives = 129/280 (46%), Gaps = 40/280 (14%)
Query: 60 VGEGGFGSVYKGKLQ----DGTVVAVKVLSV-ESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V G+L+ VA+K L +++ ++F+SE + M H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +IV +YM+N SL L K+ +F+ + GIA G+ Y+ +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLSDM--- 125
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG--YLAPDYAVSGH 232
VHRD+ NIL++ N K+SDFGLS++ +D T G + + AP+
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ------HLVDP 286
SD++S+G+++ ++++ Y WEM N D ++ L P
Sbjct: 186 FTSASDVWSYGIVMWEVMS--------------YGERPYWEMSNQDVIKAIEEGYRLPAP 231
Query: 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
M C ++ L C Q+ + RP+ ++ +++
Sbjct: 232 MDC-------PAALHQLMLDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 40/271 (14%)
Query: 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKLHG 115
++G G G V K + G ++AVK + +E + K+ + E+ + +V +G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 116 GCI-EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE-----IALGIARGLAYIH 169
G I + +YM SL + L K E IA+ + +GL Y+H
Sbjct: 67 AFYNNGDISICM-EYMDGGSLDKIL--------KEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
E+ K I+HRD+KPSNIL++ K+ DFG+S + + ++ GT Y+AP+
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQ 172
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD---P 286
+ KSDI+S G+ L+++ TG+ Y E + LQ++V+ P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFP----------YPPENDPPDGIFELLQYIVNEPPP 222
Query: 287 ML-CGNFSGNEAVRFLKVGLLCVQEKSSLRP 316
L G FS + F+ LC+ + RP
Sbjct: 223 RLPSGKFSP-DFQDFVN---LCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-EVASMANICHENLVKLHG 115
+G G VY L + VA+K + +E Q + + EV +M+ H N+VK +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE--IAL---GIARGLAYIHE 170
+ G +V Y+ SL + ++ + E IA + +GL Y+H
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIM------KSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF--PEDITHIS-TRVAGTLGYLAPDY 227
+HRDIK NILL ++ + KI+DFG+S D T GT ++AP+
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 228 AVSGH-LNPKSDIYSFGVLLLQIVTGQAAVH 257
H + K+DI+SFG+ +++ TG A
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-24
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVES-KQGEKEFM-SEVASMANICHENLVKLH 114
+G+G FG+V K + DG ++ K + + + EK+ + SEV + + H N+V+ +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 115 GGCIEGPCRII------VYDYMQNNS---LSQTLLGEEKNRAKFSWTARREIALGIARGL 165
RII +Y M+ L+Q + +K R I + L
Sbjct: 66 D-------RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 166 AYIHEEIKPS--IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
H P ++HRD+KP+NI LD N N K+ DFGL+K+ D + T V GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+P+ + KSDI+S G L+ ++
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-24
Identities = 71/284 (25%), Positives = 131/284 (46%), Gaps = 46/284 (16%)
Query: 60 VGEGGFGSVYKGKLQ----DGTVVAVKVLSV-ESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V +G+L+ VA+K L +++ ++F+SE + M H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +I+ ++M+N +L L +N +F+ + GIA G+ Y+ E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM--- 125
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG------YLAPDYA 228
+ VHRD+ NIL++ N K+SDFGLS+ +D + + +LG + AP+
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAI 183
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ------H 282
SD++S+G+++ ++++ GE W+M N D +
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS----------YGE----RPYWDMSNQDVINAIEQDYR 229
Query: 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
L PM C ++ L C Q+ + RP+ ++ ++
Sbjct: 230 LPPPMDC-------PTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-24
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
+ + K+GEG G VYK G VA+K + + + E E+ M + H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVD 79
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA---LGIARGLAYIH 169
+ + G +V +YM SL+ + +N + + +IA + +GL Y+H
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDII---TQNFVRMN---EPQIAYVCREVLQGLEYLH 133
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+++HRDIK NILL ++ + K++DFG + ++ + ++ V GT ++AP+ +
Sbjct: 134 ---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE-VI 188
Query: 230 SGHL-NPKSDIYSFGVLLLQIVTGQ 253
PK DI+S G++ +++ G+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G G FG V+ G T VAVK L + E F+ E M + H+ LV+L+
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E P I+ +YM SL L E K ++A +A G+AYI + + +H
Sbjct: 72 EEPIYIVT-EYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIE---RMNYIH 125
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-TLGYLAPDYAVSGHLNPKS 237
RD++ +NIL+ KI+DFGL++L ED + + + A + + AP+ A+ G KS
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 238 DIYSFGVLLLQIVT 251
D++SFG+LL ++VT
Sbjct: 185 DVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 60 VGEGGFGSVYKGKL------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVK 112
+G+G FG V++ + + T+VAVK+L E S + +F E A MA H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTL------------------LGEEKNRAKFSWTAR 154
L G C G ++++YM L++ L N S T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 155 REIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHIS 213
IA +A G+AY+ E VHRD+ N L+ +N KI+DFGLS ++ D S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
A + ++ P+ +SD++++GV+L +I
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-23
Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGGC 117
K+G+G FG VYKG L+ T VAVK K F+ E + H N+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
++ IV + + SL T L ++KNR +++L A G+ Y+ E K I
Sbjct: 62 VQKQPIYIVMELVPGGSL-LTFLRKKKNRLTVK--KLLQMSLDAAAGMEYL--ESKNCI- 115
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT----LGYLAPDYAVSGHL 233
HRD+ N L+ +N KISDFG+S+ E+ I T G + + AP+ G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 234 NPKSDIYSFGVLLLQIVTG 252
+SD++S+G+LL + +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 70/239 (29%), Positives = 117/239 (48%), Gaps = 23/239 (9%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G G FG V+ T VAVK + S E F++E M + H+ LVKLH
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVT 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ P II ++M SL L +E ++ + + IA G+A+I + + +H
Sbjct: 72 KEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIE---QRNYIH 125
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-TLGYLAPDYAVSGHLNPKS 237
RD++ +NIL+ + KI+DFGL+++ ED + + A + + AP+ G KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 238 DIYSFGVLLLQIVT-------GQAAVHFDKELGEYYLVEKAWEMHNTDKL-QHLVDPML 288
D++SFG+LL++IVT G + + L E+ + M + + L + M+
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL------ERGYRMPRPENCPEELYNIMM 237
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G+G FG V+ G T VA+K L + E F+ E M + H+ LV L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E P IV ++M SL L +E + ++A IA G+AYI + + +H
Sbjct: 72 EEPI-YIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-TLGYLAPDYAVSGHLNPKS 237
RD++ +NIL+ N KI+DFGL++L ED + + + A + + AP+ A+ G KS
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 238 DIYSFGVLLLQIVT 251
D++SFG+LL ++VT
Sbjct: 185 DVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
+G+G +G VY + L +A+K + + + E+A + + H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG-----IARGLAYIHEEIK 173
E I + + SLS L R+K+ E + I GL Y+H+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127
Query: 174 PSIVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTRVAGTLGYLAP---DYAV 229
IVHRDIK N+L++ KISDFG SK I + GTL Y+AP D
Sbjct: 128 -QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGP 185
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264
G+ +DI+S G ++++ TG+ ELGE
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFI---ELGE 216
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 59 KVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
++GEG FG V+ + QD +VAVK L S+ ++F E + + H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLL-----------GEEKNRAKFSWTARREIALGI 161
+G C EG ++V++YM++ L++ L GE+ + + IA I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTL 220
A G+ Y+ VHRD+ N L+ Q KI DFG+S+ ++ D + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
++ P+ + +SDI+SFGV+L +I T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 59 KVGEGGFGSVYKGK------LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
++GEG FG V+ + +D +VAVK L + K+F E + N+ HE++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGE------------EKNRAKFSWTARREIALG 160
+G C +G I+V++YM++ L++ L + + + + IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGT 219
IA G+ Y+ + VHRD+ N L+ N KI DFG+S+ ++ D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ ++ P+ + +SD++SFGV+L +I T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 28/207 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS--EVASMANI-CHENLVKLH 114
++G+G FGSVY + + G +VA+K + + E E M+ EV S+ + H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
E V++YM+ N L Q L +++ FS + R I I +GLA+IH K
Sbjct: 65 EVFRENDELYFVFEYMEGN-LYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI-------THISTRVAGTLGYLAPDY 227
HRD+KP N+L+ KI+DFGL++ +I ++STR Y AP+
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 228 AV-SGHLNPKSDIYSFGVLLLQIVTGQ 253
+ S + DI++ G ++ ++ T +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENL 110
+ K+GEG +G VYK + G +VA+K + + ES+ K + E+ + + H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIARGL 165
+KL +V+++M + Q L E ++ + +GL
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKS---------YLYQLLQGL 111
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
A+ H I+HRD+KP N+L++ K++DFGL++ F + + V T Y AP
Sbjct: 112 AFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAP 167
Query: 226 DYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV 268
+ + + DI+S G + ++++ + E+ + + +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-22
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
K+G G FG V+ G + T VAVK L + + F+ E M + H+ LV+L+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVT 71
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ I+ +YM SL L +E + + + IA G+AYI + + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIE---RKNYIH 126
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD++ +N+L+ ++ KI+DFGL+++ ++ + + AP+ G KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 239 IYSFGVLLLQIVT 251
++SFG+LL +IVT
Sbjct: 187 VWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 7e-22
Identities = 83/290 (28%), Positives = 135/290 (46%), Gaps = 59/290 (20%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGE-KEFMSEV-ASM-ANICHENLVKLHG 115
+G G FG+V K + GT++AVK + + E K + ++ M ++ C +VK +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC-PYIVKFYG 70
Query: 116 GCI-EGPCRI--------------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
EG C I VY+ + + + + +LG+ IA+
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK--------------IAVA 115
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+ L Y+ EE+K I+HRD+KPSNILLD+N N K+ DFG+S + I TR AG
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCR 171
Query: 221 GYLAPDYAVSGHLNP---KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277
Y+AP+ + +SD++S G+ L ++ TG+ + K W
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP--YPK-----------W-NSVF 217
Query: 278 DKLQHLV--DPMLCGNFSGNE-AVRFLKVGLLCVQEKSSLRPRMSTVIEM 324
D+L +V DP + N E + F+ LC+ + S RP+ ++E
Sbjct: 218 DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
++G G FG V GK + VA+K++ E E EF+ E M + HE LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ IV +YM N L L ++ +F + E+ + G+AY+ + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N L+D K+SDFGLS+ +D S + + P+ + + KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 239 IYSFGVLLLQIVT 251
+++FGVL+ ++ +
Sbjct: 184 VWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 60 VGEGGFGSVYKGKL-QDGTV---VAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKL 113
+GEG FGSV +G+L QD VAVK + ++ + +EF+SE A M + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 114 HGGCIEG------PCRIIVYDYMQNNSLSQTLLGE--EKNRAKFSWTARREIALGIARGL 165
G C E P +++ +M++ L LL K + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDI---THISTRVAGTLG 221
Y+ + +HRD+ N +L ++ ++DFGLS K++ D I+ +
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PVK 180
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQ 253
++A + KSD+++FGV + +I T GQ
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVK--VLSVESKQGEKEFMS-------EVASMANICHEN 109
+G G FGSVY G G ++AVK L S + S E+A + + HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+V+ G ++ I +Y+ S+ LL N F T R I +GL Y+H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV-AALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA-----GTLGYLA 224
I+HRDIK +NIL+D KISDFG+SK + T A G++ ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 225 PDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
P+ K+DI+S G L+++++TG
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 60 VGEGGFGSVYKGK---LQDGT--VVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLH 114
+G+G FGSV + LQD T VVAVK L + + ++F E+ + ++ H+N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 115 GGCIEGPCRI---IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
G C R +V +Y+ SL L +K+R + A I +G+ Y+ +
Sbjct: 72 GVCY-SAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT--LGYLAPDYAV 229
VHRD+ NIL++ KI DFGL+K+ P+D + R G + + AP+
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
+ SD++SFGV+L ++ T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+GEG +GSVYK + G VVA+KV+ VE +E + E++ + +VK +G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 118 IEGPCRIIVYDYMQNNSLS------QTLLGEEKNRAKFSWTARREIAL---GIARGLAYI 168
+ IV +Y S+S L EE EIA +GL Y+
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE------------EIAAILYQTLKGLEYL 115
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H +HRDIK NILL++ K++DFG+S + + +T V GT ++AP+
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVI 171
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTG 252
N K+DI+S G+ +++ G
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-21
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 22/281 (7%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLVKLHGGC 117
+G G GSV K K + GTV+A KV+ + +K K+ + E+ M +V +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ + ++M SL + K +IA+ + GL Y++ + I+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRDIKPSNIL++ K+ DFG+S E I I+ GT Y++P+ G KS
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD---PMLCGNFSG 294
D++S G+ ++++ G+ F + + M D LQ +V P L +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDD----GQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 295 NEAVRFLKVGLLCVQEK----SSLRPRMSTVIEMINGDVDI 331
+ F+ LL + L + + +VD+
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-21
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 58 NKVGEGGFGSVYKG----------KLQDGTVVAVKVL-SVESKQGEKEFMSEVASMANIC 106
+G G FG VY+G +LQ VAVK L S+Q E +F+ E M+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQ----VAVKTLPESCSEQDESDFLMEALIMSKFN 67
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAK--FSWTARR--EIALGIA 162
H+N+V+L G E R I+ + M L ++ L E + R + S T + A +A
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSK-LFPEDITHISTRVA 217
+G Y+ E +HRDI N LL P KI+DFG+++ ++ R
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 218 GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
+ ++ P+ + G K+D++SFGVLL +I
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-21
Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 22/267 (8%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
++G G FG V+ GK + VA+K ++ E E++F+ E M + H LV+L+G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ IV ++M+N L L + + K S + + G+ Y+ + S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N L+ K+SDFG+++ +D S+ + + P+ + KSD
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 239 IYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAV 298
++SFGVL+ ++ T + + F+K+ Y +VE L P L
Sbjct: 184 VWSFGVLMWEVFT-EGKMPFEKK-SNYEVVEMISRGF------RLYRPKLASMT------ 229
Query: 299 RFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+V C EK RP + ++ I
Sbjct: 230 -VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 60 VGEGGFGSVYKGKL------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVK 112
+GEG FG VYKG+L T VA+K L + ++EF E M+++ H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE------------IALG 160
L G C + ++++Y+ + L + L+ + + + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL-FPEDITHISTRVAGT 219
IA G+ Y+ VHRD+ N L+ + KISDFGLS+ + D + ++
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
+ ++ P+ + G +SDI+SFGV+L +I
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 60 VGEGGFGSVYKG------KLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANI-CHENLV 111
+G+G FG VY+G K + T VA+K ++ + E+ EF++E + M CH ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLG---EEKNRAKFSWTARREI---ALGIARGL 165
+L G G ++V + M L L E +N ++ A IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTLGYLA 224
AY+ + VHRD+ N ++ ++ KI DFG+++ ++ D + + ++A
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 225 PDYAVSGHLNPKSDIYSFGVLLLQIVT 251
P+ G KSD++SFGV+L ++ T
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 69/245 (28%), Positives = 124/245 (50%), Gaps = 38/245 (15%)
Query: 22 TVGANFFTKSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVA 80
+ ++ + S A A S +EL+ N++G G G+VYK + G + A
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 81 VKVLSVESKQG-EKEFMSEVASMANICHENLVKLH-----GGCIEGPCRIIVYDYMQNNS 134
+KV+ + ++ E+ + ++ H N+VK H G I+ ++ ++M S
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ-----VLLEFMDGGS 158
Query: 135 LSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194
L T + +E+ A ++A I G+AY+H + IVHRDIKPSN+L++ N
Sbjct: 159 LEGTHIADEQFLA--------DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNV 207
Query: 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP------KSDIYSFGVLLLQ 248
KI+DFG+S++ + + ++ V GT+ Y++P+ ++ LN DI+S GV +L+
Sbjct: 208 KIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 249 IVTGQ 253
G+
Sbjct: 266 FYLGR 270
|
Length = 353 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 14/217 (6%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
+GEG FG+V +G+ G VAVK + + + F+ E A M + H+NLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
I V + M +L L + RA S + +L +A G+ Y+ + +VH
Sbjct: 70 HNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ NIL+ ++ K+SDFGL+++ + + V T AP+ + KSD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 239 IYSFGVLLLQIVTGQAAVHFDKELGEYY-LVEKAWEM 274
++S+GVLL ++ + A + L E VEK + M
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 35/211 (16%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLV 111
K+GEG + VYK + + G +VA+K + + ++ K+ ++ E+ + + H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 112 KLHGGCIEGPCRIIVYDYMQ--------NNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
L +V+++M+ + S+ T + K S+ L R
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTP-ADIK-----SYM------LMTLR 113
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
GL Y+H I+HRD+KP+N+L+ + K++DFGL++ F ++ +V T Y
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 224 APDYAV-SGHLNPKSDIYSFGV----LLLQI 249
AP+ + H D++S G LLL++
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 40/211 (18%)
Query: 61 GEGGFGSVYKG--KLQDGTV---VAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLH 114
G G FG+VYKG + V VA+KVL E+ + KE + E MA++ H ++V+L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 115 GGCIEGPCRII--------VYDYMQNNSL---SQTLLGEEKNRAKFSWTARREIALGIAR 163
G C+ ++I + DY++N+ SQ LL +W + IA+
Sbjct: 76 GICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL---------NW------CVQIAK 120
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG---TL 220
G++Y+ E+ +VHRD+ N+L+ + KI+DFGL+KL D G +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPI 175
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
++A + + KSD++S+GV + +++T
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 66/254 (25%), Positives = 113/254 (44%), Gaps = 23/254 (9%)
Query: 51 TNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSV----ESKQGEKEFMSEVASMANI 105
F K+G+G F VYK L DG VVA+K + + ++K + + E+ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59
Query: 106 CHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGL 165
H N++K IE IV + LS+ + +K + + + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
++H + I+HRDIKP+N+ + K+ D GL + F T + V GT Y++P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDK----------ELGEYYLVEKAWEMH 275
+ N KSDI+S G LL ++ Q+ + DK E +Y + H
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD---H 232
Query: 276 NTDKLQHLVDPMLC 289
+++L+ LV +
Sbjct: 233 YSEELRDLVSRCIN 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 60 VGEGGFGSVYKGK------LQDGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVK 112
+GEG FG V K T VAVK+L + E ++ +SE + + H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTL----------LGEEKNRAKFSWTARREIALG-- 160
L+G C + +++ +Y + SL L LG + NR E AL
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 161 --------IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITH 211
I+RG+ Y+ E +VHRD+ N+L+ + KISDFGLS+ ++ ED
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
++ + ++A + +SD++SFGVLL +IVT
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 58 NKVGEGGFGSVYKG-KLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLH 114
NK+G+G FG V+K + D V A+K + + +++ +E + E +A + +++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
++ IV +Y +N L + L + R + I GLA++H
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR--FFIQILLGLAHLH---SK 120
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
I+HRDIK N+ LD N KI D G++KL D T+ + + GT YL+P+ N
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 235 PKSDIYSFGVLLLQIVTGQ 253
KSD+++ GV+L + TG+
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-20
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 11/201 (5%)
Query: 54 FCSSNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH-ENLV 111
F +G+G FG VYK + VVA+KV+ +E + E E + + + C +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
K +G ++G I+ +Y S L K T I + GL Y+HEE
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLEYLHEE 117
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
K +HRDIK +NILL + + K++DFG+S ++ +T V GT ++AP+
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQS 173
Query: 232 HLNPKSDIYSFGVLLLQIVTG 252
+ K+DI+S G+ +++ G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 60 VGEGGFGSVYKGKLQDG--TVVAVKVLSV---ESKQGEKEFMSEVASMANIC-------- 106
+G G FG VYK + ++ ++A+K ++V + ++E + + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
H N+V+ + +E IV D ++ L + ++ + +F+ I + + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
Y+H+E + IVHRD+ P+NI+L ++ I+DFGL+K + T V GT+ Y P+
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTILYSCPE 183
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257
+ K+D+++FG +L Q+ T Q +
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 74/258 (28%), Positives = 121/258 (46%), Gaps = 31/258 (12%)
Query: 59 KVGEGGFGSVY----------------KGKLQDGTV-VAVKVLSV-ESKQGEKEFMSEVA 100
K+GEG FG V+ + D V VAVKVL S ++F+ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTL---LGEEKNRAKFSWTARRE- 156
++ + N+ +L G C P ++ +YM+N L+Q L + E A S +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 157 ---IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHI 212
+A IA G+ Y+ E + VHRD+ N L+ +N+ KI+DFG+S+ L+ D +
Sbjct: 132 LLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272
R + ++A + + G KSD+++FGV L +I+T ++ L + ++E A
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQVIENAG 247
Query: 273 EMHNTDKLQ-HLVDPMLC 289
D Q +L P C
Sbjct: 248 HFFRDDGRQIYLPRPPNC 265
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-20
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 60 VGEGGFGSVYKGKLQD----GT---VVAVKVLSVESKQGEK-EFMSEVASMANICHENLV 111
+G G FG VY+G D G+ VAVK L + EK EF+ E M+N H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNR---AKFSWTARREIALGIARGLAYI 168
KL G C+ + I+ + M+ L L R + +I L +A+G Y+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 169 HEEIKPSIVHRDIKPSNILL-----DQNFNPKISDFGLSK-LFPEDITHISTRVAGTLGY 222
+ +HRD+ N L+ D + KI DFGL++ ++ D + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+AP+ + G +SD++SFGVL+ +I+T
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 57/199 (28%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEF-MSEVASMANICHENLVKLHGG 116
K+GEG + +VYKG+ + G +VA+K + +++++G + E++ M + HEN+V+LH
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
++V++YM + + + R + + +G+A+ HE +
Sbjct: 67 IHTENKLMLVFEYMDKDL--KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRD+KP N+L+++ K++DFGL++ F + S V TL Y APD +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 237 S-DIYSFGVLLLQIVTGQA 254
S DI+S G ++ +++TG+
Sbjct: 181 SIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-20
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
G G +G V K + + GT++AVK + +V S++ ++ M SM ++ V +G
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69
Query: 118 I-EGPCRIIVYDYMQ--NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
EG V+ M+ + SL + +IA+ I + L Y+H ++
Sbjct: 70 FREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS- 124
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
++HRD+KPSN+L+++N K+ DFG+S + + T AG Y+AP+ ++ LN
Sbjct: 125 -VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPE-RINPELN 180
Query: 235 P-----KSDIYSFGVLLLQIVTG 252
KSD++S G+ ++++ TG
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
++G G +G VYK + + G +VA+KV+ +E + E++ + H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR----GLAYIHEEI 172
+ IV +Y SL + R S +IA + R GLAY+HE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIY---QVTRGPLS---ELQIAY-VCRETLKGLAYLHETG 121
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVA--GTLGYLAPDYA- 228
K +HRDIK +NILL ++ + K++DFG+S +T I+ R + GT ++AP+ A
Sbjct: 122 K---IHRDIKGANILLTEDGDVKLADFGVSAQ----LTATIAKRKSFIGTPYWMAPEVAA 174
Query: 229 --VSGHLNPKSDIYSFGVLLLQIVTGQ 253
G + K DI++ G+ +++ Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 53 GFCSSNKVGEGGFGSVYKGKLQDGTV-----VAVKVLSVESKQGEKEFM-SEVASMANIC 106
S+ + EG FG ++ G L D V VK + + + + + E + +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 107 HENLVKLHGGCIEGPCR-IIVYDYMQNNSLSQTL----LGEEKNRAKFSWTARREIALGI 161
H+N++ + CIE ++Y YM +L L LGE N S +A+ I
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTL 220
A G++Y+H K ++H+DI N ++D+ KI+D LS+ LFP D + +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
++A + V+ + SD++SFGVLL +++T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHG 115
VGEG +G V K + + G +VA+K S + + +K + EV + + HEN+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+V++Y++ L E + A R + + +AY H +
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SGHLN 234
I+HRDIKP NIL+ ++ K+ DFG ++ T T Y AP+ V +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271
D+++ G ++ +++ G+ D ++ + YL++K
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 61/188 (32%), Positives = 98/188 (52%), Gaps = 7/188 (3%)
Query: 60 VGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLHGGCI 118
+G+G FG V+KG L+D T VAVK + Q K +F+SE + H N+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ IV + + + L ++K+ K + AL A G+AY+ + + +H
Sbjct: 63 QRQPIYIVMELVPGGDF-LSFLRKKKDELKTKQLVK--FALDAAAGMAYLESK---NCIH 116
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N L+ +N KISDFG+S+ + I S + + AP+ G + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 239 IYSFGVLL 246
++S+G+LL
Sbjct: 177 VWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-19
Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 37/261 (14%)
Query: 59 KVGEGGFGSVY-----------------KGKLQDGTVVAVKVLSVES-KQGEKEFMSEVA 100
K+GEG FG V+ +VAVK+L ++ K +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLL-------GEEKNRAKFSWTA 153
M+ + N+++L CI ++ +YM+N L+Q L E+ + S++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHI 212
+A IA G+ Y+ + VHRD+ N L+ +N+ KI+DFG+S+ L+ D I
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT---GQAAVHFDKELGEYYLVE 269
R + +++ + + G SD+++FGV L +I+T Q E ++E
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE----QVIE 244
Query: 270 KAWEMHNTDKLQ-HLVDPMLC 289
E Q +L P LC
Sbjct: 245 NTGEFFRDQGRQVYLPKPALC 265
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 59 KVGEGGFGSVY----KGKL---------QDG--TVVAVKVLSVE-SKQGEKEFMSEVASM 102
K+GEG FG V+ +G DG +VAVK+L + +K +F+ E+ M
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 103 ANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKF---------SWTA 153
+ + + N+++L G C+ ++ +YM+N L+Q L + + + F S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ-FLSQREIESTFTHANNIPSVSIAN 130
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHI 212
+A+ IA G+ Y+ + VHRD+ N L+ ++ KI+DFG+S+ L+ D I
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
R + ++A + + G SD+++FGV L ++ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 60 VGEGGFGSVYKGKL-QDGTV--VAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLH 114
+GEG FGSV +G+L QD ++ VAVK + + ++ ++F+SE M H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 115 GGCIEG------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIAL--GIARGLA 166
G C++ P +++ +M++ L LL + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LGYLAP 225
Y+ + S +HRD+ N +L++N N ++DFGLSK + R+A + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVT-GQ 253
+ KSD++SFGV + +I T GQ
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 63 GGFGSVYKG-KLQDGTVVAVKVLS---------VESKQGEKEFMSE-----VASM-ANIC 106
G +G V+ K G + A+KV+ V+ E++ +S+ V + +
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
+ L+ +V +Y+ L+ +LL +N R I L
Sbjct: 64 GKK--NLY----------LVMEYLPGGDLA-SLL---ENVGSLDEDVARIYIAEIVLALE 107
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-------LFPEDITHISTRVAGT 219
Y+H I+HRD+KP NIL+D N + K++DFGLSK + D R+ GT
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
Y+AP+ + + D +S G +L + + G
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 35/208 (16%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G GGFG V K++ A+K + VE+ Q ++ SE + H +VKL+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 115 GGCIEGPCRIIV---YDYMQNNSLSQTLLGEE-----KNRAKFS-WTARREIALGIARGL 165
R Y YM L + LG E ++R F +TAR IA +
Sbjct: 60 --------RTFKDKKYIYM----LMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAF 106
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTLGYLA 224
Y+H I++RD+KP N+LLD N K+ DFG +K L T T GT Y+A
Sbjct: 107 EYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVA 160
Query: 225 PDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
P+ ++ + D +S G+LL +++TG
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-19
Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 59 KVGEGGFGSVYKG----KLQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKL 113
+GEG FG VY+G + VAVK + +E F+ E M H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI--ALGIARGLAYIHEE 171
G E P I+ M+ L + L K+S I + ++ LAY+ +
Sbjct: 73 IGVITENPVWIV----MELAPLGE--LRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
VHRDI N+L+ K+ DFGLS+ ++ + +++ + ++AP+
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 232 HLNPKSDIYSFGVLLLQI 249
SD++ FGV + +I
Sbjct: 184 RFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 13/197 (6%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG V + +D + A+K ++ K + ++E + + H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ +V D + L L + KFS + I L Y+H +
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---G 120
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
I+HRDIKP NILLD+ + I+DF ++ D ++T +GT GY+AP+ +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSV 178
Query: 236 KSDIYSFGVLLLQIVTG 252
D +S GV + + G
Sbjct: 179 AVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 7e-19
Identities = 77/301 (25%), Positives = 133/301 (44%), Gaps = 52/301 (17%)
Query: 59 KVGEGGFGSVY--------------------KGKLQDGTVVAVKVLSVE-SKQGEKEFMS 97
K+GEG FG V+ KG+ +VAVK+L + +K +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDFLK 68
Query: 98 EVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQ-----TLLGEEKNRAK---- 148
EV ++ + N+++L G C++ ++ +YM+N L+Q L +E+N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 149 ------FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202
S+++ +AL IA G+ Y+ + VHRD+ N L+ +N KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 203 K-LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
+ L+ D I R + ++A + + G SD+++FGV L +I+ + E
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG-E 244
Query: 262 LGEYYLVEKAWEMHNTDKLQ-HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMST 320
L + ++E A E Q +L P C ++ L C RP S
Sbjct: 245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ-------GLYELMLQCWSRDCRERPSFSD 297
Query: 321 V 321
+
Sbjct: 298 I 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-19
Identities = 65/250 (26%), Positives = 114/250 (45%), Gaps = 19/250 (7%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVK---VLSVESKQGEKEFMSEVASMANICHEN 109
F K+G G F VY+ L DG VA+K + + + + + E+ + + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++K + IE IV + LS+ + +K + + + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
++HRDIKP+N+ + K+ D GL + F T + V GT Y++P+
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM--------HNTDKLQ 281
N KSDI+S G LL ++ Q+ + DK + Y L +K + H +++L+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 282 HLVDPMLCGN 291
LV+ +C N
Sbjct: 239 QLVN--MCIN 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 59 KVGEGGFGSVYKG--KLQDGTV--VAVKVLSVESKQG-EKEFMSEVASMANICHENLVKL 113
K+G+G FG V +G G V VAVK L + +F+ E A M ++ HENL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+G + P + V + SL L + F + + A+ IA G+ Y+ +
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-- 116
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST----RVAGTLGYLAPDYAV 229
+HRD+ NILL + KI DFGL + P++ H +V + AP+
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLR 173
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
+ + SD++ FGV L ++ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-19
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 38/283 (13%)
Query: 59 KVGEGGFGSVYKGKL-----QDGTVVAVKVLS-VESKQGEKEFMSEVASMANICHENLVK 112
++GE FG +YKG L +VA+K L + + Q EF E + MA + H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLL-----------GEEKNRAKFSWTARR--EIAL 159
L G + ++++Y+ L + L+ +E K S IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAG 218
IA G+ Y+ VH+D+ NIL+ + + KISD GLS+ ++ D + +
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278
+ ++ P+ + G + SDI+SFGV+L +I F L YY +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI--------FSFGLQPYYGFSNQEVIEMVR 240
Query: 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321
K Q L C R + C QE S RPR +
Sbjct: 241 KRQLLPCSEDC-------PPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 51/196 (26%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+GEG G V ++ G +VAVK + + +Q + +EV M + HEN+V+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ G +V ++++ +L+ + N + + + L + + L+ +H + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ---GVI 138
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRDIK +ILL + K+SDFG +++ + V GT ++AP+ P+
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 238 DIYSFGVLLLQIVTGQ 253
DI+S G++++++V G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVE--SKQGEKEFMS---EVASMANICHENLVKL 113
+G+G FG VY D G +AVK + + S + +KE + E+ + N+ HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 114 HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+G C+ + I +YM S+ L K + T R+ I G+ Y+H +
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSNM 124
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE---DITHISTRVAGTLGYLAPDYAV 229
IVHRDIK +NIL D N K+ DFG SK T + + V GT +++P+ +
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE-VI 179
Query: 230 SGH-LNPKSDIYSFGVLLLQIVT 251
SG K+D++S G +++++T
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 32/269 (11%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLS-VESKQGEKE-----FMSEVASMANICHENLVK 112
+G G F S Y+ + ++ GT++AVK ++ V + E+E E+ MA + H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ G E + ++M S+S L F + RGL+Y+HE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN- 122
Query: 173 KPSIVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDIT---HISTRVAGTLGYLAPDYA 228
I+HRD+K +N+L+D +I+DFG + T ++ GT+ ++AP+
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK-AWEMHNTDKLQHLVDPM 287
D++S G +++++ T + + +K L+ K A +HL
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL---- 236
Query: 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRP 316
+ +R V L C++ + RP
Sbjct: 237 -------SPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVL-SVESKQGEK 93
AF + L+ T +G G FG V+ K + T+V VK L + + +
Sbjct: 1 AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53
Query: 94 EFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLL----GEEKNRAK- 148
EF E+ + H+N+V+L G C E ++ +Y L Q L +EK +
Sbjct: 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113
Query: 149 FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208
S + + IA G+ ++ VHRD+ N L+ K+S LSK
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ L +LAP+ + KSD++SFGVL+ ++ T
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-18
Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 58 NKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+GEG G V G VAVK + + +Q + +EV M + H N+V+++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 117 CIEGPCRIIVYDYMQNNSL----SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ G +V ++++ +L + T + EE+ + L + + L+++H +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---------VCLAVLKALSFLHAQ- 134
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
++HRDIK +ILL + K+SDFG +++ + V GT ++AP+
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLP 191
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDK 260
+ DI+S G++++++V G+ +F++
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP-YFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-18
Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 60 VGEGGFGSVYKGKLQDG----TVVAVKVLS-VESKQGEKEFMSEVASMANICHENLVKLH 114
+G+G FG VY G L D AVK L+ + + ++F+ E M + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 115 GGCI--EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG--IARGLAYIHE 170
G C+ EG ++V YM++ L + E N T + I G +A+G+ Y+
Sbjct: 63 GICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNP-----TVKDLIGFGLQVAKGMEYLAS 116
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTL--GYLAPDY 227
+ VHRD+ N +LD++F K++DFGL++ ++ ++ + L ++A +
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT 251
+ KSD++SFGVLL +++T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 24/207 (11%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLV 111
N++GEG +G VY+ + G +VA+K + +++ E++ + E+ + N+ H N+V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---ERDGIPISSLREITLLLNLRHPNIV 69
Query: 112 KLH----GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
+L G ++ +V +Y + + L+ L + FS + + + L + RGL Y
Sbjct: 70 ELKEVVVGKHLDSI--FLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
+HE I+HRD+K SN+LL KI+DFGL++ + ++ +V TL Y AP+
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPEL 179
Query: 228 AVSGHLNPKS-DIYSFGVLLLQIVTGQ 253
+ + D+++ G +L +++ +
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 9e-18
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 33/268 (12%)
Query: 54 FCSSNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV- 111
F ++G+G FG V+KG + VVA+K++ +E + E E + + ++ + C V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
K +G ++G I+ +Y+ S L + + + T +EI +GL Y+H E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-TMLKEIL----KGLDYLHSE 120
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
K +HRDIK +N+LL + + K++DFG++ + +T V GT ++AP+
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD---PML 288
+ K+DI+S G+ +++ G+ +MH L + P L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNS---------------DMHPMRVLFLIPKNNPPTL 221
Query: 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRP 316
G FS F + C+ + S RP
Sbjct: 222 TGEFSKP----FKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 53/292 (18%)
Query: 60 VGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGE-KEFMSEVASMANIC-HENLV 111
+GEG FG V K + + VAVK+L ++ + + + +SE+ M I H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 112 KLHGGCI-EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI------------A 158
L G C EGP ++V +Y + +L L S R A
Sbjct: 80 NLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+ARG+ ++ + +HRD+ N+L+ ++ KI+DFGL++ DI HI
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191
Query: 219 TLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272
T G L AP+ +SD++SFGVLL +I T G G Y
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG----------GSPYPGIPVE 241
Query: 273 EMHNTDKLQHLVD-PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
E+ K + ++ P C E + C E S RP ++E
Sbjct: 242 ELFKLLKEGYRMEKPQNC----TQELYHLM---RDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 76/294 (25%), Positives = 134/294 (45%), Gaps = 50/294 (17%)
Query: 59 KVGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGEK-EFMSEVASM-ANICHENL 110
++G+G FG VY+G +D T VAVK ++ + E+ EF++E + M CH ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HV 71
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG----EEKNRAKFSWTARREIALG--IARG 164
V+L G +G ++V + M + L L E N + T + I + IA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG--- 221
+AY++ + VHRD+ N ++ +F KI DFG+++ DI G G
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 222 --YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE-MHNTD 278
++AP+ G SD++SFGV+L +I + L E+ ++ + N
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 229
Query: 279 KLQHLVDPMLCGNF---SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329
L+ ++D G + N R + +C Q +RP ++ ++ D+
Sbjct: 230 VLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 13/191 (6%)
Query: 60 VGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE 119
+G+G FG V G + G VAVK +++ + F++E + M + H NLV+L G +E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 120 GPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ IV +YM SL L + R+ + +L + + Y+ + VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSD 238
RD+ N+L+ ++ K+SDFGL+K + + + + AP+ + KSD
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 239 IYSFGVLLLQI 249
++SFG+LL +I
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 46/277 (16%)
Query: 60 VGEGGFGSVYKGKLQ----DGTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKL 113
+G G FG + +G L+ VA+ L KQ + F++E ++ H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVRL 71
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G G +IV +YM N +L L K+ + + G+A G+ Y+ E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM-- 126
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED-ITHISTRVAGTLGYL--APDYAVS 230
VH+ + +L++ + KIS F ED I T ++G L AP+
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD----- 285
H + SD++SFG+++ ++++ GE W+M D ++ + D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS----------YGE----RPYWDMSGQDVIKAVEDGFRLP 228
Query: 286 -PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321
P C N ++ L C Q++ RPR S +
Sbjct: 229 APRNCPNL-------LHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 18/200 (9%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+GEG G V + + G VAVK++ + +Q + +EV M + H+N+V+++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 118 IEGPCRIIVYDYMQNNSL----SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ G ++ +++Q +L SQT L EE+ + + + L Y+H +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---------VCESVLQALCYLHSQ-- 136
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
++HRDIK +ILL + K+SDFG +D+ + V GT ++AP+
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPY 194
Query: 234 NPKSDIYSFGVLLLQIVTGQ 253
+ DI+S G++++++V G+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS------EVASMANICHENLVK 112
+G G G VYK + + G V+AVK + + G KE +V ++ C +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDC-PYIVK 78
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAK--FSWTARREIALGIARGLAYIHE 170
+G I I + M T L + R + ++ + I + L Y+ E
Sbjct: 79 CYGYFITDSDVFICMELMS------TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
K ++HRD+KPSNILLD + N K+ DFG+S + TR AG Y+AP+
Sbjct: 133 --KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDP 188
Query: 231 GHLNPK----SDIYSFGVLLLQIVTGQ 253
NPK +D++S G+ L+++ TGQ
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 54 FCSSNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLV 111
F ++G+G FG VYKG + VVA+K++ +E + E E E+ ++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+ +G ++G I+ +Y+ S + LL + T REI +GL Y+H E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREIL----KGLDYLHSE 120
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
K +HRDIK +N+LL + + K++DFG++ + +T V GT ++AP+
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ K+DI+S G+ +++ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 60 VGEGGFGSV--YK-GKLQDGT--VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKL 113
+GEG FG V Y DGT +VAVK L E +Q + E+ + + HEN+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 114 HGGCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
G C E + + + +Y+ SL L + N A+ A++ I G+AY+H +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-----ICEGMAYLHSQ 126
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT--LGYLAPDYAV 229
+HRD+ N+LLD + KI DFGL+K PE + R G + + A +
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
+ SD++SFGV L +++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLHG 115
+K+GEG + +V+KG+ + +VA+K + +E ++G + EV+ + N+ H N+V LH
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIARGLAYIHE 170
C +V++Y+ ++ L Q L L N F + + RGL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQ--------LLRGLSYCHK 121
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV- 229
I+HRD+KP N+L+++ K++DFGL++ S V TL Y PD +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQ 253
S + D++ G +L ++ TG+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 60 VGEGGFGS--VYKGKLQDGTVVAVKV-LSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+G+G FG +Y+ D VV +V L+ S++ ++ ++E+ ++ + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
++ +I +Y +L ++ ++ F I ++YIH+ I
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKA---GI 122
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRDIK NI L + K+ DFG+SK+ + + T V GT Y++P+ N K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 237 SDIYSFGVLLLQIVT 251
SDI++ G +L +++T
Sbjct: 182 SDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 5e-17
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V + + G A+K+LS V+ KQ + ++E + +I H LV L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +V +Y+ L L + +F R A + L Y+H
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLHSL--- 120
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR---VAGTLGYLAPDYAVS- 230
IV+RD+KP N+LLD + KI+DFG +K + R + GT YLAP+ +S
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEIILSK 173
Query: 231 GHLNPKSDIYSFGVLLLQIVTG 252
G+ D ++ G+L+ +++ G
Sbjct: 174 GY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLVK 112
K+GEG +G VYK + G +VA+K + +E+ E E + E++ + + H N+V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVR 62
Query: 113 LHGGCIEGPCRIIVYDYM------QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
L +V++++ +S T L + + + + +G+A
Sbjct: 63 LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-SYLYQ--------LLQGIA 113
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF--P-EDITHISTRVAGTLGYL 223
Y H ++HRD+KP N+L+D+ K++DFGL++ F P TH V TL Y
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYR 166
Query: 224 APDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266
AP+ + + DI+S G + ++V + D E+ + +
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 51/196 (26%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 59 KVGEGGFGSV-YKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+GEG G V + G VAVK + + +Q + +EV M + HEN+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ G +V ++++ +L+ + N + + + L + R L+Y+H + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---GVI 140
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRDIK +ILL + K+SDFG +++ + V GT ++AP+ +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 238 DIYSFGVLLLQIVTGQ 253
DI+S G+++++++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ---GEKEF---MSEVASMANICHENLV 111
+G+G +G+VY G G ++AVK + +++ EKE+ EV + ++ H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+ G C++ I +++ S+S L + I G+AY+H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSK---LFPEDITH--ISTRVAGTLGYLAPD 226
+VHRDIK +N++L N K+ DFG ++ TH + + GT ++AP+
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
KSDI+S G + ++ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 73/241 (30%), Positives = 121/241 (50%), Gaps = 29/241 (12%)
Query: 40 NAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEK-EFMS 97
A SY L+ K+GEG + +VYKG + +G +VA+KV+S+++++G +
Sbjct: 3 AATSYLNLE----------KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR 52
Query: 98 EVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI 157
E + + + H N+V LH V++YM + L+Q ++ ++ R
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYN---VRLF 108
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL--SKLFPEDITHISTR 215
+ RGLAYIH + I+HRD+KP N+L+ K++DFGL +K P T+ S
Sbjct: 109 MFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEV 164
Query: 216 VAGTLGYLAPDYAVSGHLNPKS--DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273
V TL Y PD + G + S DI+ G + ++++ GQ A F + +EK W
Sbjct: 165 V--TLWYRPPD-VLLGATDYSSALDIWGAGCIFIEMLQGQPA--FPGVSDVFEQLEKIWT 219
Query: 274 M 274
+
Sbjct: 220 V 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 6e-17
Identities = 56/225 (24%), Positives = 111/225 (49%), Gaps = 12/225 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G G+V+ + G VA+K ++++ + ++ ++E+ M + + N+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ G +V +Y+ SL+ + + A+ + R + + L ++H ++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRDIK N+LL + + K++DFG + + ST V GT ++AP+ PK
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK--AWEMHNTDKL 280
DI+S G++ +++V G+ + L YL+ E+ N +KL
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHG 115
VGEG +G V K K ++ G +VA+K S + K +K M E+ + + HENLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGE-EKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+V++++ + T+L + EK + R+ I RG+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDH-----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLF--PEDITHISTRVAGTLGYLAPDYAVSGH 232
+I+HRDIKP NIL+ Q+ K+ DFG ++ P ++ T T Y AP+ V
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY---TDYVATRWYRAPELLVGDT 176
Query: 233 LNPKS-DIYSFGVLLLQIVTGQ 253
++ DI++ G L+ +++TG+
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 7e-17
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH-ENLVKLHGGC 117
VG G +G VYKG+ ++ G + A+KV+ V + E+E E+ + H N+ +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 118 IE-GPCRI-----IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
I+ P + +V ++ S++ + + N K W A I I RGL+++H+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
++HRDIK N+LL +N K+ DFG+S + +T + GT ++AP+ ++
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE-VIAC 185
Query: 232 HLNP------KSDIYSFGVLLLQIVTG 252
NP KSD++S G+ +++ G
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLHGG 116
K+GEG + +VYKGK + +G +VA+KV+ ++ ++G + E + + + H N+V LH
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+V++Y+ + L Q + +K+ + + RGL+YIH+ I
Sbjct: 72 IHTKETLTLVFEYVHTD-LCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 177 VHRDIKPSNILLDQNFNPKISDFGL--SKLFPEDITHISTRVAGTLGYLAPDYAV-SGHL 233
+HRD+KP N+L+ K++DFGL +K P +H + TL Y PD + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 234 NPKSDIYSFGVLLLQIVTGQAA 255
+ D++ G + ++++ G AA
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 74 QDGTVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLHGGCIEGPCRII-VYDY 129
G VA+K+L ++ + E + F E A A + H N+V L P + V++Y
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL- 188
+ +L + L + A T R + L + LA H + IVHRD+KP NI++
Sbjct: 61 VPGRTLREVLAADGALPA--GETGR--LMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 189 --DQNFNPKISDFGLSKLFP----EDITHIS--TRVAGTLGYLAPDYAVSGHLNPKSDIY 240
+ K+ DFG+ L P D+ ++ T V GT Y AP+ + P SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 241 SFGVLLLQIVTGQAAV 256
++G++ L+ +TGQ V
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 60 VGEGGFGSV-YKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANI-------CHEN 109
+G G G+V ++ DG AVKV+ +E S+ + +EV + N CHE+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARR-EIALGIARGLAY 167
K E I +V DY L Q E K+RAK + T R E L + L
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQ----EIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPD 226
+H ++HRDIK +NILL N K+ DFG SK++ ++ + GT Y+AP+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVT 251
+ K+D++S GVLL +++T
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 50/195 (25%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE 119
G+G FG VYK + + G A K++ +ES++ ++FM E+ ++ H N+V L+
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHR 179
I+ ++ +L +L E+ + R + + L ++H ++HR
Sbjct: 74 ENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 180 DIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-----SGHLN 234
D+K NILL + + K++DFG+S + T + GT ++AP+ +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 235 PKSDIYSFGVLLLQI 249
K+DI+S G+ L+++
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 54/210 (25%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKE----------FMSEVASMANICHE 108
+G+G +G VY + G ++AVK + + + + SE+ ++ ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 109 NLVKLHGGCIEGPCRIIVY-DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
N+V+ + G + ++ +Y+ S+ L + +F R + GLAY
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI--THISTRVAGTLGYLAP 225
+H I+HRD+K N+L+D + KISDFG+SK +DI + + G++ ++AP
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAP 179
Query: 226 DYAVSGH--LNPKSDIYSFGVLLLQIVTGQ 253
+ S + K DI+S G ++L++ G+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 54 FCSSNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV- 111
F K+G+G FG V+KG + VVA+K++ +E + E E + + ++ + C V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
K +G ++ I+ +Y+ S L + + + T REI +GL Y+H E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-TILREIL----KGLDYLHSE 120
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS-TRVAGTLGYLAPDYAVS 230
K +HRDIK +N+LL ++ K++DFG++ + T I GT ++AP+
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQ 175
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+ K+DI+S G+ +++ G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 4e-16
Identities = 56/225 (24%), Positives = 109/225 (48%), Gaps = 12/225 (5%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G G+VY + G VA+K ++++ + ++ ++E+ M + N+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ G +V +Y+ SL+ + + + + R + + L ++H ++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRDIK NILL + + K++DFG + + ST V GT ++AP+ PK
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK--AWEMHNTDKL 280
DI+S G++ +++V G+ + L YL+ E+ N ++L
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 33/205 (16%)
Query: 57 SNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE-SKQGEKEFM-SEVASMANIC---HENL 110
++GEG +G+VYK + L G VA+K + V S++G E+A + + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EKNRAKF----------SWTARREIA 158
V+L + + + L TL+ E +++ A + T + +
Sbjct: 64 VRL---------LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD-LM 113
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+ RG+ ++H IVHRD+KP NIL+ + KI+DFGL++++ ++ T V
Sbjct: 114 RQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVV 168
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFG 243
TL Y AP+ + D++S G
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVG 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKE-F----MSEVASMANICHENLVK 112
K+GEG FG VYK +++ G VVA+K + + + EK+ F + E+ + + H N+V
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVP 71
Query: 113 LHGGCIEGP--------CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
L +E P +V YM ++ LS L E K + + + L + G
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLL---ENPSVKLTESQIKCYMLQLLEG 127
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210
+ Y+HE I+HRDIK +NIL+D KI+DFGL++ +
Sbjct: 128 INYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 67/203 (33%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVES---KQGEKEFMSEVASM-ANICHENLVKLH 114
+G+G FG V K DG AVKVL ++ K+ +K M+E + N+ H LV LH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEE---KNRAKFSWTARREIALGIARGLAYIHEE 171
V DY+ L L E + RA+F A IA L Y+H
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLHSL 115
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAGTLGYLAPDYAV 229
+I++RD+KP NILLD + ++DFGL K E I H T GT YLAP+
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 230 SGHLNPKSDIYSFGVLLLQIVTG 252
+ D + G +L +++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 57 SNKVGEGGFGSVYKG------KLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANI-CHE 108
S ++G+G FG VY+G K + T VA+K ++ + E+ EF++E + M CH
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH- 69
Query: 109 NLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG----EEKNRAKFSWTARREIALG--IA 162
++V+L G +G +++ + M L L E N + + ++ I + IA
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG- 221
G+AY++ VHRD+ N ++ ++F KI DFG+++ DI G G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 182
Query: 222 ----YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+++P+ G SD++SFGV+L +I T
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE+ ++E + L K+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNE--------KKILEKVS- 51
Query: 116 GCIEGPCRIIV---YDYMQNNSLS--QTLL--GEEK------NRAKFSWTARREIALGIA 162
R IV Y + + L TL+ G+ K F A I
Sbjct: 52 ------SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII 105
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
GL ++H+ IV+RD+KP N+LLD + N +ISD GL+ AGT GY
Sbjct: 106 CGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGY 160
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+AP+ + D ++ G L +++ G++
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-16
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 60 VGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKL 113
+GEG FG V + G VAVK L ES + E+ + N+ HEN+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 114 HGGCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
G C E I + +++ + SL + L +N+ K + + + A+ I +G+ Y+
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAPDYAV 229
VHRD+ N+L++ KI DFGL+K D + + + + + + AP+ +
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
SD++SFGV L +++T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHE-NLVKLHGGC 117
VG G +G VYKG+ ++ G + A+KV+ V + E+E E+ + H N+ +G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 118 IE-GPC-----RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
I+ P +V ++ S++ + + N K W A I I RGLA++H
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
++HRDIK N+LL +N K+ DFG+S + +T + GT ++AP+ ++
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE-VIAC 195
Query: 232 HLNP------KSDIYSFGVLLLQIVTG 252
NP +SDI+S G+ +++ G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 8e-16
Identities = 54/226 (23%), Positives = 111/226 (49%), Gaps = 14/226 (6%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G G+VY + G VA++ ++++ + ++ ++E+ M + N+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ G +V +Y+ SL+ + + + + R + + L ++H ++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 178 HRDIKPSNILLDQNFNPKISDFGL-SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
HRDIK NILL + + K++DFG +++ PE + + GT ++AP+ PK
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 237 SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK--AWEMHNTDKL 280
DI+S G++ ++++ G+ + L YL+ E+ N +KL
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 60 VGEGGFGSVYK------GKLQDGTVVAVKVLSVESKQGEKE-FMSEVASMANI-CHENLV 111
+G G FG V + K VAVK+L + E+E MSE+ M+++ HEN+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKF-SWTARREIALGIARGLAYIHE 170
L G C G +++ +Y L L + R F + + +A+G+A++
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL---RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-----TLGYLAP 225
+ + +HRD+ N+LL KI DFGL++ DI + S V + ++AP
Sbjct: 160 K---NCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ + +SD++S+G+LL +I +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 29/231 (12%)
Query: 58 NKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLV 111
++GEG +G VYK + +D G +VA+K + +++ EKE + E+ + + H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLNHRNIV 69
Query: 112 KLHGGCIEGPCRI----------IVYDYMQNNSLSQTLLG-EEKNRAKFSWTARREIALG 160
L + + +V++YM ++ L+G E FS +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQ 124
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+ GL Y H K + +HRDIK SNILL+ K++DFGL++L+ + + T TL
Sbjct: 125 LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 221 GYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
Y P+ + P D++S G +L ++ T + ++EL + L+ +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 60 VGEGGFGSVY--KGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
VG G FG V+ + K D +V +K + VE +K +E + + H N+++ +
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+E +IV +Y +L++ + +++ + + I L ++H ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTKL--- 121
Query: 176 IVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
I+HRD+K NILLD++ KI DFG+SK+ + T V GT Y++P+ N
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYT-VVGTPCYISPELCEGKPYN 179
Query: 235 PKSDIYSFGVLLLQIVT 251
KSDI++ G +L ++ +
Sbjct: 180 QKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSV--ESKQGEKEFMS---EVASMANICHENLVKL 113
+G+G FG VY D G +AVK + ES + KE + E+ + N+ HE +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 114 HGGCIEGPCRI--IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+G + R I ++M S+ L K+ + R+ I G++Y+H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST---RVAGTLGYLAPDYA 228
+ IVHRDIK +NIL D N K+ DFG SK + I T V GT +++P+
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 229 VSGHLNPKSDIYSFGVLLLQIVT 251
K+DI+S G +++++T
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 59 KVGEGGFG-SVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
K+GEG FG ++ +DG +K +++ S + +E EVA ++N+ H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEE----KNRAKFSWTARREIALGIARGLAYIHEE 171
E IV DY + L + + + W + I L ++H+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVHDR 120
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
I+HRDIK NI L ++ K+ DFG++++ + T + GT YL+P+ +
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 232 HLNPKSDIYSFGVLLLQIVT 251
N KSDI++ G +L ++ T
Sbjct: 177 PYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 60 VGEGGFGSVY--------KGKLQDGTVVAVKVLSVESKQGE-KEFMSEVASMANIC-HEN 109
+GEG FG V K K ++ VAVK+L ++ + + + +SE+ M I H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR------------EI 157
++ L G C + ++ +Y +L + L ++S+ R
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA 217
+ARG+ Y+ + +HRD+ N+L+ +N KI+DFGL++ D+ +I
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 218 GTLG-----YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G ++AP+ +SD++SFGVL+ +I T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 60 VGEGGFGSVYKG--KLQDGTV--VAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKL 113
+G+G FGSV + K +DG+ VAVK+L + S +EF+ E A M H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 114 HGGCIEG------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR--EIALGIARGL 165
G + P +++ +M++ L LL F+ + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLA 224
Y+ + + +HRD+ N +L++N ++DFGLS K++ D + +LA
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 225 PDYAVSGHLNPKSDIYSFGVLLLQIVT-GQ 253
+ SD+++FGV + +I+T GQ
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLVKLHGG 116
++G G G V K + + G ++A K++ +E K + + E+ + +V +G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
I ++M SL Q L K + ++++ + RGLAY+ E K I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQI 125
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRD+KPSNIL++ K+ DFG+S I ++ GT Y++P+ H + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 237 SDIYSFGVLLLQIVTGQ 253
SDI+S G+ L+++ G+
Sbjct: 183 SDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 13/194 (6%)
Query: 59 KVGEGGFGSVYKG--KLQDGTV-VAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
++G G FG V KG K++ + VA+KVL E+++ + E M E M + + +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G C E ++V + L++ L +K+ S E+ ++ G+ Y+ +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNK-FLSGKKDEITVSNVV--ELMHQVSMGMKYLEGK--- 114
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT--LGYLAPDYAVSGH 232
+ VHRD+ N+LL KISDFGLSK D ++ R AG L + AP+
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 233 LNPKSDIYSFGVLL 246
+ +SD++S+G+ +
Sbjct: 175 FSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVL---SVESKQGEKEFMSEVASMANICHE-NLVKLH 114
+ +G FGSVY K G A+KVL + +K +E A M + KL+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 115 GGCIEGPCRIIVYDYMQNN---SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+V +Y+ SL +TL G ++ AK + A E+ LG+ +H+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIA--EVVLGVE----DLHQR 116
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
I+HRDIKP N+L+DQ + K++DFGLS+ + + GT YLAP+ +
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGV 168
Query: 232 HLNPKSDIYSFGVLLLQIVTG 252
+ SD +S G ++ + + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 30/204 (14%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGC 117
+GEG +G VYK + + G +VA+K++ + + E+E E + H N+ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 118 IEGPCRI------IVYDYMQNNS---LSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
I+ +V + S L + L ++ R K W A I RGLAY+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--ILRETLRGLAYL 129
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR---VAGTLGYLAP 225
HE ++HRDIK NILL +N K+ DFG+S + R GT ++AP
Sbjct: 130 HEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPYWMAP 182
Query: 226 -----DYAVSGHLNPKSDIYSFGV 244
D + +SD++S G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 59 KVGEGGFGSVY--KGKLQDGTVVAVKVLSVESKQGEKEF-MSEVASMANICHENLVKLHG 115
K+GEG FG +Y K K V ++ + EKE EV +A + H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 116 GCIEGPCRIIVYDY------MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
E IV +Y M+ + + +L E SW + I+ GL +IH
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------ISLGLKHIH 118
Query: 170 EEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
+ I+HRDIK NI L +N K+ DFG+++ D ++ GT YL+P+
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEIC 174
Query: 229 VSGHLNPKSDIYSFGVLLLQIVT 251
+ N K+DI+S G +L ++ T
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 42/128 (32%), Positives = 69/128 (53%), Gaps = 9/128 (7%)
Query: 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPS 184
I ++M SL Q L K + +I++ + RGL Y+ E+ K I+HRD+KPS
Sbjct: 76 ICMEHMDGGSLDQVL----KKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPS 129
Query: 185 NILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGV 244
NIL++ K+ DFG+S + I ++ GT Y++P+ H +SDI+S G+
Sbjct: 130 NILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 245 LLLQIVTG 252
L+++ G
Sbjct: 187 SLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 42/231 (18%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVK--VLSVESKQGEKEFMSEVASMANICHENLV---- 111
K+GEG +G V+K + ++ G +VA+K V S + +K + E+ + + H NLV
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 112 ------KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE-EKNRAKFSWTARREIALGIARG 164
KLH +V++Y T+L E EKN ++I +
Sbjct: 68 VFRRKRKLH----------LVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF---PEDIT-HISTRVAGTL 220
+ + H K + +HRD+KP NIL+ + K+ DFG +++ +D T +++TR
Sbjct: 113 VNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR----- 164
Query: 221 GYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
Y AP+ V P D+++ G + +++TGQ ++ + YL+ K
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 32/208 (15%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVLSVESK-QGEKEF-MSEVASMANICHENLVKLHG 115
K+GEG +G+V+K K ++ +VA+K + ++ +G + E+ + + H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL-- 64
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGE--EKNRAKFSWTARREIALGIA--------RGL 165
YD + ++ TL+ E +++ K+ + +I I +GL
Sbjct: 65 -----------YDVLHSDK-KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
A+ H +++HRD+KP N+L+++N K++DFGL++ F + S V TL Y P
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPP 168
Query: 226 DYAVSGHLNPKS-DIYSFGVLLLQIVTG 252
D L S D++S G + ++
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGEKEFMS---EVASMANICHENLVK 112
+G G +G VYK K + DG A+K + +Q S E+A + + HEN+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 113 LHGGCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
L +E + + ++DY +++ + R + + + I G+ Y+H
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 171 EIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLFPEDITHIST--RVAGTLGYLA 224
++HRD+KP+NIL+ KI D GL++LF + ++ V T+ Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183
Query: 225 PDYAV-SGHLNPKSDIYSFGVLLLQIVT 251
P+ + + H DI++ G + +++T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 60 VGEGGFGSVY--------KGKLQDGTVVAVKVLSVESKQGE-KEFMSEVASMANIC-HEN 109
+GEG FG V K K T VAVK+L ++ + + + +SE+ M I H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 110 LVKLHGGCIE-GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR------------E 156
++ L G C + GP +IV +Y +L + L ++ + +
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216
A +ARG+ Y+ + +HRD+ N+L+ ++ KI+DFGL++ DI HI
Sbjct: 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197
Query: 217 AGTLG-----YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G ++AP+ +SD++SFGVLL +I T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 63/227 (27%), Positives = 113/227 (49%), Gaps = 16/227 (7%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFM-SEVASMANICHENLVKLHGG 116
K+G+G G+VY + G VA+K +++ +Q +KE + +E+ M H N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ G +V +Y+ SL+ + + + + R + L ++H +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLHSN---QV 136
Query: 177 VHRDIKPSNILLDQNFNPKISDFGL-SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
+HRDIK NILL + + K++DFG +++ PE + ST V GT ++AP+ P
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK--AWEMHNTDKL 280
K DI+S G++ +++V G+ + L YL+ E+ N +KL
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 59 KVGEGGFGSVYKG--KLQDGTVVAVKV-LSVESKQGEKEFMSEVASMANICHENLVKLHG 115
K+GEG +G VYK ++ + T+ K+ L E + + E++ + + H N+V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR--REIALGIARGLAYIHEEIK 173
+V++Y L L + F+ R + I RG+AY H
Sbjct: 69 VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 174 PSIVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SG 231
++HRD+KP N+L+D+ N K++DFGL++ F + + V TL Y AP+ + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSR 179
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266
H + DI+S G + ++V + D E+ E +
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 28/242 (11%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSE--VASMANICHENLVKL 113
+G GGFG VY + D G + A+K L ++ KQGE ++E + S+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 114 HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
P ++ + D M L L FS R A I GL ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG- 231
+V+RD+KP+NILLD++ + +ISD GL+ F + H S GT GY+AP+ G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291
+ +D +S G +L +++ G + + K + H D++ + L +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP----------FRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 292 FS 293
FS
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 59/232 (25%), Positives = 113/232 (48%), Gaps = 26/232 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLVK 112
K+GEG +G VYKG+ + G +VA+K + +ES E+E + E++ + + H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES---EEEGVPSTAIREISLLKELQHPNIVC 63
Query: 113 LHGGCIEGPCRIIVYDYMQ---NNSLSQTLLGE--EKNRAKFSWTARREIALGIARGLAY 167
L ++ ++++++ L G+ + K S+ + I +G+ +
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK-SYLYQ------ILQGILF 116
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
H ++HRD+KP N+L+D K++DFGL++ F + + T TL Y AP+
Sbjct: 117 CHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172
Query: 228 AV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278
+ S + DI+S G + ++ T + H D E+ + + + + D
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 17/248 (6%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVK---VLSVESKQGEKEFMSEVASMANICHEN 109
F K+G G F VY+ L D VA+K + + + ++ + E+ + + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++K IE IV + LSQ + +K + + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
++HRDIKP+N+ + K+ D GL + F T + V GT Y++P+
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM--------HNTDKLQ 281
N KSDI+S G LL ++ Q+ + DK + + L +K + H ++KL+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 282 HLVDPMLC 289
LV +
Sbjct: 239 ELVSMCIY 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSE--VASMANICHENLVKL 113
+G GGFG VY + D G + A+K L ++ KQGE ++E + S+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 114 HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
P ++ + D M L L FS R A I GL ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG- 231
+V+RD+KP+NILLD++ + +ISD GL+ F + H S GT GY+AP+ G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 232 HLNPKSDIYSFGVLLLQIVTGQA 254
+ +D +S G +L +++ G +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 39/236 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKV--LSVESKQGEKEFMSEVASMANICHENLVKLHG 115
K+GEG +G VYK + G VVA+K L E++ + E++ + + H N+VKL
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKF-SWTARREIALGIAR--------GL 165
I ++ +V+++ L Q L KF + I L + + GL
Sbjct: 67 -VIHTENKLYLVFEF-----LHQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
A+ H ++HRD+KP N+L++ K++DFGL++ F + + V TL Y AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 226 DYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV--------EKAW 272
+ + + + DI+S G + ++VT +A D E+ + + + E W
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 60 VGEGGFGSV----YKGKLQDGTVVAVKVL---------SVESKQGEKEFMSEVASMANIC 106
+G+G FG V KG + AVKVL VE EK ++
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK----- 54
Query: 107 HENLVKLHGGCIEGPCRI-IVYDYMQNNSLS---QTLLGEEKNRAKFSWTARREIALGIA 162
H L +LH C + R+ V +Y+ L Q ++ RA+F A I
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-------YAAEIV 106
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRV-AGTL 220
GL ++HE I++RD+K N+LLD + KI+DFG+ K E I ++T GT
Sbjct: 107 LGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTP 160
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
Y+AP+ P D ++ GVLL +++ GQ+ D E
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE ++E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTL--LGE---EKNRAKFSWTARREIALGIARGLAYIHE 170
+V M L + +GE E+ RA F A I GL +H+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICCGLEDLHQ 120
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
E IV+RD+KP NILLD + + +ISD GL+ PE T I RV GT+GY+AP+ +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKN 175
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQA 254
D ++ G LL +++ GQ+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVK----VLSVESKQGEKEFMSEVASMANICHENLVKL 113
++G G FG V+ G+L+ D T VAVK L + K +F+ E + H N+V+L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 58
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C + IV + +Q T L E R K + + A G+ Y+ +
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVKELIQ--MVENAAAGMEYLESK-- 113
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT----LGYLAPDYAV 229
+HRD+ N L+ + KISDFG+S+ E+ + G + + AP+
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 230 SGHLNPKSDIYSFGVLL 246
G + +SD++SFG+LL
Sbjct: 170 YGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 30/207 (14%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-F----MSEVASMANICHENLV 111
N++ EG +G VY+ + + G +VA+K L +E EKE F + E+ + + H N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIV 67
Query: 112 KLH----GGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
+ G ++ +I +V +Y++++ ++L+ E + F + + + L + G+A
Sbjct: 68 TVKEVVVGSNLD---KIYMVMEYVEHDL--KSLM--ETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
++H+ I+HRD+K SN+LL+ KI DFGL++ + + T++ TL Y AP+
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYRAPE 176
Query: 227 YAVS-GHLNPKSDIYS----FGVLLLQ 248
+ + D++S F LL +
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 58 NKVGEGGFGSVYKG--KLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
K+GEG + +V+KG KL + +VA+K + +E ++G + EV+ + ++ H N+V LH
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+V++Y+ + L Q + + S + I RGLAY H +
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SGHL 233
++HRD+KP N+L+++ K++DFGL++ S V TL Y PD + S
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 234 NPKSDIYSFGVLLLQIVTGQ 253
+ + D++ G + ++ +G+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVK--VLSVESKQGEKEFMSEVASMANICHEN-LVKLH 114
K+GEG +G VYK + G +VA+K L ++ + + E++ + + +V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 115 GGCIEG-------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
+E P +V++Y+ ++ + + +G+A+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
H K ++HRD+KP N+L+D+ KI+D GL + F + + + TL Y AP+
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPE 181
Query: 227 YAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262
+ S H + DI+S G + ++ Q D EL
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 58 NKVGEGGFGSVYKG--KLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
+K+GEG + +VYKG KL D +VA+K + +E ++G + EV+ + ++ H N+V LH
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTL--LGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+V++Y+ + L Q L G N + + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNV-----KLFLFQLLRGLNYCHRR- 123
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SG 231
++HRD+KP N+L+++ K++DFGL++ S V TL Y PD + S
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGST 180
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ + D++ G + ++ TG+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 46 ELKSATNGFCSSNKVGEGGFGSVYK-GKLQDGTVVAVKVLSVESKQG-EKEFMSEVASMA 103
ELK + F +++G G G V+K G ++A K++ +E K + + E+ +
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 104 NICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
+V +G I ++M SL Q L K + ++++ + +
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIK 114
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
GL Y+ E K I+HRD+KPSNIL++ K+ DFG+S I ++ GT Y+
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 169
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+P+ H + +SDI+S G+ L+++ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVL---SVESKQGEKEFMSEVASM-ANICHENLVKLH 114
+G+G FG V K + DG+ AVKVL ++ K+ + M+E + N+ H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
V DY+ L L E F R A +A + Y+H
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSL--- 115
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLAPDYAVSGH 232
+I++RD+KP NILLD + ++DFGL K + PE+ T + GT YLAP+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEP 172
Query: 233 LNPKSDIYSFGVLLLQIVTG 252
+ D + G +L +++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 15/195 (7%)
Query: 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQG--EKEFMSEVASMANICHENLVKL 113
++G G FG+V KG + VAVK+L ++ + E + E M + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C E ++V + + L++ L +KN+ + E+ ++ G+ Y+ E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNK-HVTEKNITELVHQVSMGMKYLEET-- 114
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT--LGYLAPDYAVSG 231
+ VHRD+ N+LL KISDFGLSK D + + G + + AP+
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 232 HLNPKSDIYSFGVLL 246
+ KSD++SFGVL+
Sbjct: 174 KFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 67/203 (33%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVL---SVESKQGEKEFMSEV-ASMANICHENLVKLH 114
+G+G FG V + + + AVKVL ++ K+ EK MSE + N+ H LV LH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEE---KNRAKFSWTARREIALGIARGLAYIHEE 171
V DY+ L L E + RA+F A IA L Y+H
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-------YAAEIASALGYLHSL 115
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAGTLGYLAPDYAV 229
+IV+RD+KP NILLD + ++DFGL K E+I H T GT YLAP+
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 230 SGHLNPKSDIYSFGVLLLQIVTG 252
+ D + G +L +++ G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLHGG 116
K+GEG + +VYKG+ + G +VA+K + +E ++G + E + + ++ H N+V LH
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+V++Y+ + L Q + + S R + RGLAY H + +
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYM---DDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRV 124
Query: 177 VHRDIKPSNILLDQNFNPKISDFGL--SKLFPEDITHISTRVAGTLGYLAPDYAV-SGHL 233
+HRD+KP N+L+ + K++DFGL +K P + + TL Y PD + S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 234 NPKSDIYSFGVLLLQIVTGQAA 255
+ D++ G + ++ TG+
Sbjct: 182 STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 60 VGEGGFGSVYKGK-LQDGTVV----AVKVLS-VESKQGEKEFMSEVASMANICHENLVKL 113
+G G FG+VYKG + +G V A+K+L+ + EFM E MA++ H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKN---RAKFSWTARREIALGIARGLAYIHE 170
G C+ P +V M + L + + N + +W + IA+G+ Y+ E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LGYLAPDYAV 229
+VHRD+ N+L+ + KI+DFGL++L D + + ++A +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
+SD++S+GV + +++T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 36/210 (17%)
Query: 60 VGEGGFGSVY---KGKLQD-GTVVAVKVL-----SVESKQGEKEFMSEVASMANICHENL 110
+G+G FG V+ K D G + A+KVL V + K E +A + H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHPFI 60
Query: 111 VKLHGGC-IEGPCRIIVYDYMQNNS----LSQTLLGEEKNRAKFSWTARREIALGIARGL 165
VKLH EG +I+ D+++ LS+ ++ E++ KF E+AL L
Sbjct: 61 VKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEED-VKFYLA---ELALA----L 111
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--GTLGYL 223
++H I++RD+KP NILLD+ + K++DFGLSK E I H + GT+ Y+
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 165
Query: 224 APDYA-VSGHLNPKSDIYSFGVLLLQIVTG 252
AP+ GH +D +SFGVL+ +++TG
Sbjct: 166 APEVVNRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 54/200 (27%), Positives = 108/200 (54%), Gaps = 19/200 (9%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G+G FG VYK K ++ G + A KV+ +S++ +++M E+ +A H +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 118 I-EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+G I++ ++ ++ +L E +R + + I + L Y+H I
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIML--ELDRG-LTEPQIQVICRQMLEALQYLHSM---KI 131
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--GTLGYLAPDYAVSGHL- 233
+HRD+K N+LL + + K++DFG+S +++ + R + GT ++AP+ + +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 234 ----NPKSDIYSFGVLLLQI 249
+ K+DI+S G+ L+++
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 48/199 (24%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 60 VGEGGFGSVYKG---KLQDGTVVAVKVLSVESKQGEKEFMS---EVASMANICHENLVKL 113
+G G FG+V+KG D + V + +++ + G + F + +M ++ H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C G +V SL + ++R + IA+G+ Y+ E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTLGYLAPDYAVSGH 232
+VHR++ NILL + +I+DFG++ L+P+D + + + ++A + + G
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 233 LNPKSDIYSFGVLLLQIVT 251
+SD++S+GV + ++++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 60 VGEGGFGSVYKGK-LQDG----TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKL 113
+G G FG+VYKG + DG VA+KVL S + KE + E MA + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 114 HGGCIEGPCRII--------VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGL 165
G C+ +++ + DY++ N ++ +W + IA+G+
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQ------IAKGM 122
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG---TLGY 222
+Y+ EE++ +VHRD+ N+L+ + KI+DFGL++L DI G + +
Sbjct: 123 SYL-EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKW 177
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+A + + +SD++S+GV + +++T
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVL--SVESKQGEKEFMSEVASMANICH 107
TN + VG G FG V + Q G VA+K + + K E+ + ++ H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR-------EIALG 160
EN++ L I + +++ LLG + +R T+R
Sbjct: 69 ENIISL--------SDIFISP-LEDIYFVTELLGTDLHRL---LTSRPLEKQFIQYFLYQ 116
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGT 219
I RGL Y+H +VHRD+KPSNIL+++N + KI DFGL+++ +T ++STR
Sbjct: 117 ILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--- 170
Query: 220 LGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQ 253
Y AP+ ++ + + DI+S G + +++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 32/204 (15%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G G G+VYK L ++AVKV+ ++ + + +K+ MSE+ + ++ +G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 118 -IEGPCRI-IVYDYMQNNSLS------QTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+E RI I ++M SL + +LG IA+ + +GL Y+
Sbjct: 69 FVEN--RISICTEFMDGGSLDVYRKIPEHVLGR--------------IAVAVVKGLTYLW 112
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
I+HRD+KPSN+L++ K+ DFG+S + I+ GT Y+AP+
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERIS 166
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQ 253
SD++S G+ +++ G+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVA---VKVLSVESKQGEK-EFMSEVASMANICHENLVKL 113
+++G G FG V G+ G A VK L + E+ F+ EV + H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWT-ARREIALGIARGLAYIHEEI 172
G CIE ++V ++ L L A+ + + +A +A GL ++H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLAPDYAVSG 231
+ +H D+ N L + + KI D+GL+ + +PED A L +LAP+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 232 HLN-------PKSDIYSFGVLLLQIVT 251
+ KS+I+S GV + ++ T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 36/210 (17%)
Query: 60 VGEGGFGSVYKGK-LQDG----TVVAVKVL-SVESKQGEKEFMSEVASMANICHENLVKL 113
+G G FG+VYKG + +G VA+K L S + KE + E MA++ + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 114 HGGCIEGPCRII--------VYDYM---QNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
G C+ ++I + DY+ ++N SQ LL +W + IA
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL---------NWCVQ------IA 119
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LG 221
+G+ Y+ E +VHRD+ N+L+ + KI+DFGL+KL D +
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
++A + + +SD++S+GV + +++T
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGG 116
VG G +G V G VA+K LS +S K E+ + ++ HEN++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL--- 79
Query: 117 CIEGPCRIIVY------DYMQNNSLSQTLLGEEKNR----AKFSWTARREIALGIARGLA 166
+ V+ + Q+ L L+G + N K S + + I RGL
Sbjct: 80 -------LDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLK 132
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAP 225
YIH I+HRD+KPSNI ++++ KI DFGL++ +++T +++TR Y AP
Sbjct: 133 YIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184
Query: 226 DYAVS-GHLNPKSDIYSFGVLLLQIVTGQ 253
+ ++ H N DI+S G ++ +++TG+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVLSV--ESKQGEKEFMS---EVASMANICHENLVKL 113
+G+G FG VY + G +A K + ES + KE + E+ + N+ HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 114 HGGCIEGPCR---IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
+G C+ I +YM S+ L K + + R+ I G++Y+H
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST---RVAGTLGYLAPDY 227
+ IVHRDIK +NIL D N K+ DFG SK + I T V GT +++P+
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEV 180
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT 251
K+D++S G +++++T
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 60 VGEGGFGSVY--------KGKLQDGTVVAVKVLSVESKQGE-KEFMSEVASMANIC-HEN 109
+GEG FG V K K VAVK+L ++ + + +SE+ M I H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR------------EI 157
++ L G C + ++ +Y +L + L +S+ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA 217
A +ARG+ Y+ + +HRD+ N+L+ ++ KI+DFGL++ D+ +I
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKK 192
Query: 218 GTLG-----YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G ++AP+ +SD++SFGVLL +I T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVV--AVKVL-SVESKQGEKEFMSEVASMANICHE-NLVKLH 114
+GEG FG V K +++ DG + A+K + SK ++F E+ + + H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 115 GGC---------IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI---ALGIA 162
G C IE + D+++ + + +T + S + +++ A +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
RG+ Y+ ++ +HRD+ NIL+ +N+ KI+DFGLS+ +++ V T+G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVY-----VKKTMGR 172
Query: 223 LAPDYAVSGHLN-----PKSDIYSFGVLLLQIVT 251
L + LN SD++S+GVLL +IV+
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVV--AVKVL-SVESKQGEKEFMSEVASMANIC-HENLVKLH 114
+GEG FG V + ++ DG + A+K+L S+ ++F E+ + + H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 115 GGC---------IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI---ALGIA 162
G C IE + D+++ + + +T K S +++ A +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
G+ Y+ E+ +HRD+ N+L+ +N KI+DFGLS+ E++ V T+G
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVY-----VKKTMGR 179
Query: 223 LAPDYAVSGHLN-----PKSDIYSFGVLLLQIVT 251
L + LN KSD++SFGVLL +IV+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGG 116
+G G +G V + G VA+K +S + K + E+ + ++ HEN++ L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLD- 66
Query: 117 CIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
I P IV + M+ + L + + K+ + + I RGL Y+H
Sbjct: 67 -ILRPPSPEDFNDVYIVTELMETD-LHKVI----KSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211
+++HRD+KPSNIL++ N + KI DFGL++ D
Sbjct: 121 SA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 59 KVGEGGFGSVY-----KGKLQDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
++G+G FG+VY K ++ V ++ E E + E ++ + H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
H +E I+ +Y + L L + S E + + G+ Y+H+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR- 125
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
I+HRD+K NI L N KI DFG+S+L ++T GT Y++P+
Sbjct: 126 --RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALKHQG 181
Query: 233 LNPKSDIYSFGVLLLQI 249
+ KSDI+S G +L ++
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 60 VGEGGFGSVYKG-KLQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGG 116
VG G +GSV + G VAVK LS +S K E+ + ++ HEN++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 83
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNR----AKFSWTARREIALGIARGLAYIHEEI 172
+ P R + + L L+G + N K + + + I RGL YIH
Sbjct: 84 -VFTPAR--SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS-- 138
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSG 231
I+HRD+KPSN+ ++++ KI DFGL++ +++T +++TR Y AP+ ++
Sbjct: 139 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 232 -HLNPKSDIYSFGVLLLQIVTGQ 253
H N DI+S G ++ +++TG+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 16/199 (8%)
Query: 66 GSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125
G +Y K+ + K + E + E++ + + LV LH +
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAFQTDTKLHL 82
Query: 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185
+ DY+ L L R +F + + I L ++H K I++RDIK N
Sbjct: 83 ILDYINGGELFTHL----SQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLEN 135
Query: 186 ILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSF 242
ILLD N + ++DFGLSK F ED + GT+ Y+APD GH + D +S
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH-DKAVDWWSM 194
Query: 243 GVLLLQIVTGQAAVHFDKE 261
GVL+ +++TG + D E
Sbjct: 195 GVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE ++E + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLL-----GEEKNRAKFSWTARREIALGIARGLAYIHE 170
+V M L + G E+ RA F A I GL +H
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-------YAAEILCGLEDLHR 120
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
E + V+RD+KP NILLD + +ISD GL+ PE I RV GT+GY+AP+ +
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTVGYMAPEVLNN 175
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
D + G L+ +++ GQ+ KE
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+VG G +G VYK L G + AVK++ +E E+ + H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 118 IEGPCRIIVYDYMQNNSLSQTL-LGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ I +Y SL + + + ++ R + +GLAY+H + K
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV---SGHL 233
+HRDIK +NILL N + K++DFG++ I + + GT ++AP+ A +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 234 NPKSDIYSFGVLLLQI 249
N DI++ G+ +++
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 5e-13
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHEN 109
F ++G G FG+VY + ++ VVA+K +S KQ ++ + EV + I H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ G + +V +Y S S L +K + A I G +GLAY+H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLH 142
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+++HRDIK NILL + K++DFG + I + GT ++AP+ +
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSAS-----IASPANSFVGTPYWMAPEVIL 194
Query: 230 S---GHLNPKSDIYSFGVLLLQI 249
+ G + K D++S G+ +++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 52/218 (23%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVL-----SVESKQGEKEFMSEVASMANIC-HENL 110
K+GEG F V K + + G A+K + S+E + + E+ ++ + H N+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNI 60
Query: 111 VKLH-------GGCIEGPCRII---VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++L G + ++ +Y+ ++ + L E++ + + +
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVK-SYMYQ-------- 108
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG-----LSKL-FPEDITHIST 214
+ + L ++H + I HRDIKP NIL+ + K++DFG SK + E +IST
Sbjct: 109 LLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YIST 161
Query: 215 RVAGTLGYLAPD-YAVSGHLNPKSDIYSFGVLLLQIVT 251
R Y AP+ G+ PK DI++ G + +I++
Sbjct: 162 R-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSV---------ESKQGEKEFMSEVASMANICHEN 109
VG G FG V+ + + A+KV+++ + EK + EV+ H
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPF 62
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+++L + ++ +Y+ L L +N +FS + A I L Y+H
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+ IV+RD+KP NILLD+ + K++DFG +K + + + GT YLAP+
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQ 171
Query: 230 S-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266
S GH N D ++ G+L+ +++ G FD Y
Sbjct: 172 SKGH-NKAVDWWALGILIYEMLVGYPPF-FDDNPFGIY 207
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G +G VYK + + G + A+KV+ +E + E+ M + H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 118 IEGPCRIIVYDYMQNNSLSQTL-LGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ I ++ SL + + ++ ++ +R + +GL Y+H + K
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK--- 127
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV---SGHL 233
+HRDIK +NILL N + K++DFG+S I + + GT ++AP+ A G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGY 186
Query: 234 NPKSDIYSFGVLLLQI 249
N DI++ G+ +++
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEV-ASMANICHENLVKLH 114
+G+G FG V K + DG AVKVL V +++ +K M+E + N+ H LV LH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEE---KNRAKFSWTARREIALGIARGLAYIHEE 171
V D++ L L E + RA+F A IA L Y+H
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF-------YAAEIASALGYLHS- 114
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH--ISTRVAGTLGYLAPDYAV 229
+IV+RD+KP NILLD + ++DFGL K E I +T GT YLAP+
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 230 SGHLNPKSDIYSFGVLLLQIVTG 252
+ D + G +L +++ G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 60 VGEGGFGSVYKGKL-QDGTVV--AVKVLS-VESKQGEKEFMSEVASMANIC-HENLVKLH 114
+GEG FG V K ++ +DG + A+K + SK ++F E+ + + H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 115 GGC---------IEGPCRIIVYDYMQNNSLSQT---LLGEEKNRAKFSWTARREIALGIA 162
G C IE + D+++ + + +T + S A +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
RG+ Y+ ++ +HRD+ NIL+ +N+ KI+DFGLS+ V T+G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 184
Query: 223 LAPDYAVSGHLN-----PKSDIYSFGVLLLQIVT 251
L + LN SD++S+GVLL +IV+
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHEN 109
F ++G G FG+VY + +++ VVA+K +S KQ ++ + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ G + +V +Y S S L +K + A + G +GLAY+H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH 132
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+++HRD+K NILL + K+ DFG + I + GT ++AP+ +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANXFVGTPYWMAPEVIL 184
Query: 230 S---GHLNPKSDIYSFGVLLLQI 249
+ G + K D++S G+ +++
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 54 FCSSNKVGEGGFGSVYKG-KLQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENL 110
+ S +VG G +GSV + G VA+K LS +S+ K E+ + ++ HEN+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 111 VKLHGGCIEGPCRIIVYD------YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
+ L D YMQ + Q ++G + K + + + G
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL--QKIMGHPLSEDKVQYLVYQML-----CG 129
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYL 223
L YIH I+HRD+KP N+ ++++ KI DFGL++ ++T ++ TR Y
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181
Query: 224 APDYAVSG-HLNPKSDIYSFGVLLLQIVTGQ 253
AP+ ++ H N DI+S G ++ +++TG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 35/191 (18%)
Query: 57 SNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENL 110
K+G+G FG V+K + + +VA+K + +E+ EKE E+ + + HEN+
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENV 73
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLL----------GEEKNRA-KFSWTARREIAL 159
V L IE CR N L G N+ KF+ + +++
Sbjct: 74 VNL----IE-ICRTKAT--PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP----EDITHISTR 215
+ GL YIH I+HRD+K +NIL+ ++ K++DFGL++ F + R
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 216 VAGTLGYLAPD 226
V TL Y P+
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 50/208 (24%), Positives = 77/208 (37%), Gaps = 32/208 (15%)
Query: 53 GFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGE--KEFMSEVASMANICHENL 110
G C + + K K T+VAVK ++++S E K E+ + + H N+
Sbjct: 7 GKCFED----LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAK--FSWTARREIALGIARGLAYI 168
+ I +V M S L K A I + L YI
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDF---------GLSKLFPEDITHISTRVAGT 219
H + +HR +K S+ILL + +S G + D S +
Sbjct: 118 HSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN--- 171
Query: 220 LGYLAP---DYAVSGHLNPKSDIYSFGV 244
L +L+P + G+ N KSDIYS G+
Sbjct: 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 52/197 (26%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G+G FG VYK + ++ G + A KV+ +S++ +++M E+ +A+ H N+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
I+ ++ ++ +L E+ + R + L Y+HE I+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV--SGHLNP 235
HRD+K NIL + + K++DFG+S I + + GT ++AP+ + + P
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 236 ---KSDIYSFGVLLLQI 249
K+D++S G+ L+++
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 65/220 (29%), Positives = 87/220 (39%), Gaps = 40/220 (18%)
Query: 61 GEGGFGSV----YKGKLQDGTVVAVKVL---------SVESKQGEKEFMSEVASMANICH 107
G G FG V YK G + A+K L VES EK S H
Sbjct: 8 GRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSER---H 61
Query: 108 ENLVKLHGGCIEGPCRI-IVYDYMQNNSLS---QTLLGEEKNRAKFSWTARREIALGIAR 163
LV L C + + V +Y L T + E RA F A +
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-RAVF-------YAACVVL 112
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAGTLG 221
GL Y+HE IV+RD+K N+LLD KI+DFGL K E + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPE 166
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
+LAP+ D + GVL+ +++ G++ D E
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 43/275 (15%)
Query: 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHE----NLVK 112
+++G+G +GSVYK + G +A+K + +E + + +++ +I H+ +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK---FNQIIMELDILHKAVSPYIVD 63
Query: 113 LHGG-CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+G IEG + +YM SL + L R I + +GL ++ EE
Sbjct: 64 FYGAFFIEG-AVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
+I+HRD+KP+N+L++ N K+ DFG+S + ++ G Y+AP+ SG
Sbjct: 122 H--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSG 176
Query: 232 HLNP------KSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLV 284
N +SD++S G+ +L++ LG Y Y E + +L +V
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMA-----------LGRYPYPPETYANIFA--QLSAIV 223
Query: 285 D---PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP 316
D P L +S +A F+ C+ + + RP
Sbjct: 224 DGDPPTLPSGYSD-DAQDFVA---KCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 10/214 (4%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHGG 116
VGEG +G V K + ++ +VA+K S E+++ ++ + E+ + + EN+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+V++Y++ N L LL E N ++ I + + IH K I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGV-----PPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
VHRDIKP N+L+ N K+ DFG ++ E T T Y +P+ +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 237 SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
D++S G +L ++ GQ + E+ + + ++K
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVK 112
+G G FG V K + G A+K L ++ KQ + E + + + H +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPFIVN 82
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIH 169
+ + + +++ L L + + AKF + A E+ L Y+H
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-YHA--ELVLA----FEYLH 135
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+ I++RD+KP N+LLD + K++DFG +K P+ + + GT YLAP+
Sbjct: 136 SK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQ 188
Query: 230 S-GHLNPKSDIYSFGVLLLQIVTG 252
S GH D ++ GVLL + + G
Sbjct: 189 SKGH-GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 54 FCSSNKVGEGGFGSVY-KGKLQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHEN 109
F +++G G FG+VY VVAVK +S KQ ++ + EV + + H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ G ++ +V +Y S S L +K + A I G +GLAY+H
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLH 138
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+++HRDIK NILL + K++DFG + + + GT ++AP+ +
Sbjct: 139 SH---NMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVIL 190
Query: 230 S---GHLNPKSDIYSFGVLLLQI 249
+ G + K D++S G+ +++
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 36/265 (13%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
+ +G G G V+ D VAVK + + Q K + E+ + + H+N+VK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 113 LHGGCIEGPCRI--------------IVYDYMQN---NSLSQTLLGEEKNRAKFSWTARR 155
++ + IV +YM+ N L Q L EE R
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-------- 118
Query: 156 EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFPEDITHIST 214
+ RGL YIH +++HRD+KP+N+ ++ + KI DFGL+++ +H
Sbjct: 119 -FMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 215 RVAGTLG--YLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271
G + Y +P +S + D+++ G + +++TG+ EL + L+ ++
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 272 WEM-HNTDKLQHL-VDPMLCGNFSG 294
+ D+ + L V P N G
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGG 259
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 60 VGEGGFGSVYKGKL-QDGTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V +L + G + AVKVL VE EK +S + H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HPF 57
Query: 110 LVKLHGGCIEGPCRII-VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
L +L+ C + P R+ V +++ L + +K+R +F R A I L ++
Sbjct: 58 LTQLYC-CFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFL 112
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH--ISTRVAGTLGYLAPD 226
H++ I++RD+K N+LLD + K++DFG+ K E I + ++ GT Y+AP+
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPE 166
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
P D ++ GVLL +++ G A + E
Sbjct: 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVE--SKQGEKEFMS---EVASMANICHENLVKL 113
+G G FG VY D G +AVK + + S++ KE + E+ + N+ H+ +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 114 HGGCIEGPCR---IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
+G C+ P I +YM S+ L K + R I +G++Y+H
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST---RVAGTLGYLAPDY 227
+ IVHRDIK +NIL D N K+ DFG SK + I T V GT +++P+
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEV 180
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT 251
K+D++S +++++T
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 61 GEGGFGSVY----KGKLQDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHEN-LV 111
G G +G V+ G G + A+KVL V+ + + +E + + LV
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
LH ++ DY+ L L R F+ + R I L ++H
Sbjct: 69 TLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH-- 122
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY---A 228
+ I++RDIK NILLD + ++DFGLSK F + + GT+ Y+AP+
Sbjct: 123 -QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTG 252
GH + D +S GVL +++TG
Sbjct: 182 SGGH-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 60 VGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV 111
+G+G F ++KG ++ T V +KVL + + F + M+ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+G C+ G I+V +Y++ SL T L + KN SW + E+A +A L ++ ++
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLD-TYLKKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 172 IKPSIVHRDIKPSNILL-----DQNFNP---KISDFGLS-KLFPEDITHISTRVAGTLGY 222
+ H ++ N+LL + NP K+SD G+S + P++I + R+ +
Sbjct: 120 ---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERIP----W 170
Query: 223 LAPD-YAVSGHLNPKSDIYSFGVLLLQIVTG 252
+ P+ +L+ +D +SFG L +I +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 60 VGEGGFGSVYKGKLQDGT--VVAVKVL---------SVESKQGEKEFMSEVASMANICHE 108
+G+G FG V +L+ GT V A+KVL V+ EK ++ A H
Sbjct: 3 LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-----HP 56
Query: 109 NLVKLHGGCIEGPCRII-VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
L LH C + R+ V +Y+ L + +++R KF R A + L +
Sbjct: 57 FLTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTLALMF 111
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH--ISTRVAGTLGYLAP 225
+H +++RD+K NILLD + K++DFG+ K E I + +T GT Y+AP
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAP 165
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
+ P D ++ GVL+ +++ GQ D E
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 60 VGEGGFGSV---YKGKLQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLH 114
VG G +GSV Y +L+ VAVK LS +S + E+ + ++ HEN++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNR-AKFSWTARREIALGI---ARGLAYIHE 170
+ P I + L L+G + N K + + I RGL YIH
Sbjct: 81 D--VFTPATSI--ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAV 229
I+HRD+KPSN+ ++++ +I DFGL++ +++T +++TR Y AP+ +
Sbjct: 137 ---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIML 188
Query: 230 SG-HLNPKSDIYSFGVLLLQIVTGQA 254
+ H N DI+S G ++ +++ G+A
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 60 VGEGGFGS--VYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
VGEG FG + + D ++ +S ++ E +A + H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES- 66
Query: 118 IEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAK-FSWTARREIALGIARGLAYIHEEIKPS 175
E + IV +Y L Q + + R K F + + + G+ +IHE+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
++HRDIK NI L QN K+ DFG ++L + T V GT Y+ P+ + N
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 236 KSDIYSFGVLLLQIVT 251
KSDI+S G +L ++ T
Sbjct: 180 KSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 60 VGEGGFGSVYKGKLQDGT----VVAVKVLS----VESKQGEKEFMSEVASMANICHENLV 111
+G+GG+G V++ + G + A+KVL V +++ +E + + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEE---KNRAKFSWTARREIALGIARGLAYI 168
L G ++ +Y+ L L E ++ A F + EI+L L ++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---EISLA----LEHL 116
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLAPD 226
H + I++RD+KP NILLD + K++DFGL K + +TH GT+ Y+AP+
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170
Query: 227 YAV-SGHLNPKSDIYSFGVLLLQIVTGQ 253
+ SGH D +S G L+ ++TG
Sbjct: 171 ILMRSGH-GKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 60 VGEGGFGSVYKGKL-------QDGTV-VAVKVLSVESKQGE-KEFMSEVASMANIC-HEN 109
+GEG FG V + + D TV VAVK+L + + + +SE+ M I H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 110 LVKLHGGCI-EGPCRIIVYDYMQNNSLSQTLL------------GEEKNRAKFSWTARRE 156
++ L G C EGP +IV +Y +L + L + + S+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216
A +ARG+ Y+ +HRD+ N+L+ ++ KI+DFGL++ DI +
Sbjct: 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTS 194
Query: 217 AGTL--GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
G L ++AP+ +SD++SFG+L+ +I T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE ++E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLL-----GEEKNRAKFSWTARREIALGIARGLAYIHE 170
+V M L + G ++ RA F A I GL +H
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITCGLEDLHR 120
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
E IV+RD+KP NILLD + +ISD GL+ PE T I RV GT+GY+AP+ +
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKN 175
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
D + G L+ +++ G++ KE
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 25/220 (11%)
Query: 60 VGEGGFGSVYKGKLQDG-TVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLHG 115
+G G FG V KL++ V A+K+L+ E F E + N ++ + LH
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNR-----AKFSWTARREIALGIARGLAYIHE 170
+ +V DY L TLL + ++R A+F + A IA+ L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARF-YLAEMVIAIDSVHQLHY--- 123
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
VHRDIKP NIL+D N + +++DFG ED T S+ GT Y++P+ +
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 231 -----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY 265
G P+ D +S GV + +++ G+ + + + Y
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQ-----GEKEFMSEVASMANICHEN 109
+G+G FG VY+ + +D + A+KVLS V K+ GE+ + V ++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNIL--VRTLLDES-PF 57
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE---EKNRAKFSWTARREIALGIARGLA 166
+V L +V DYM L L E ++RAKF + A +AL
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF-YIAELVLAL------E 110
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLA 224
++H+ IV+RD+KP NILLD + + DFGLSK L T+ GT YLA
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLA 164
Query: 225 PDYAVSGHLNPKS-DIYSFGVLLLQIVTG 252
P+ + K D +S GVL+ ++ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE ++E + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLL-----GEEKNRAKFSWTARREIALGIARGLAYIHE 170
+V M L + G ++ RA F A + GL +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-------YAAELCCGLEDLQR 120
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
E IV+RD+KP NILLD + +ISD GL+ PE T + RV GT+GY+AP+ +
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
D + G L+ +++ GQ+ KE
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVK-VLSVESKQGEKEF-------------MSEVASM 102
+GEG +G V K G +VA+K V +E + + E+ M
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 103 ANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
I HEN++ L +EG +V D M ++ L + + + + + + + I L I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQIL 129
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT------------ 210
GL +H K +HRD+ P+NI ++ KI+DFGL++ +
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 211 --HISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQA 254
++++V TL Y AP+ + + + D++S G + +++TG+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 38/98 (38%), Positives = 58/98 (59%), Gaps = 12/98 (12%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR----- 215
I RGL YIH +++HRD+KPSN+LL+ N + KI DFGL+++ D H T
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEY 169
Query: 216 VAGTLGYLAPDYAVSGHLNPKS-DIYSFGVLLLQIVTG 252
VA T Y AP+ ++ K+ DI+S G +L ++++
Sbjct: 170 VA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 45/213 (21%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLH 114
+VG+GG+G V+ K +D G +VA+K + + + ++E + E LVKL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL- 66
Query: 115 GGCIEGPCRIIVYDYMQNNSLS-----------QTLLGE----EKNRAKFSWTARREIAL 159
+Y + + L +TLL ++ A+F
Sbjct: 67 -----------LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY--------- 106
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT 219
+A + + +HRD+KP N L+D + + K++DFGLSK I + V G+
Sbjct: 107 -MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGS 161
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
Y+AP+ + D +S G +L + + G
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 41/114 (35%), Positives = 61/114 (53%), Gaps = 4/114 (3%)
Query: 148 KFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
+F R A I GL ++H K I++RD+K N+LLD++ + KI+DFG+ K
Sbjct: 92 RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148
Query: 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
ST GT Y+AP+ N D +SFGVLL +++ GQ+ H + E
Sbjct: 149 GEGKAST-FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 19/193 (9%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-EK--EFMSEVASMANICHENLVKLH 114
++G G FG+VY + ++ VVA+K +S KQ EK + + EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + +V +Y S S L +K + A I G +GLAY+H +
Sbjct: 82 GCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHER- 136
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS---G 231
+HRDIK NILL + K++DFG + L + + GT ++AP+ ++ G
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 232 HLNPKSDIYSFGV 244
+ K D++S G+
Sbjct: 190 QYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 59 KVGEGGFGSVYKGKLQDG---TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLH 114
++G G FG V G++ G V VK L V S Q + +F+ E ++ H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR----REIALGIARGLAYIHE 170
G C E ++V ++ L L R T + +A IA GL ++H
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL---RSCRKAELMTPDPTTLQRMACEIALGLLHLH- 117
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL-FPEDITHISTRVAGTLGYLAPDYAV 229
K + +H D+ N LL + KI D+GLS + ED ++ L ++AP+
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 230 SGHLN-------PKSDIYSFGVLLLQI 249
H N +S+++S GV + ++
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V+ +L+ A+K L VE EK +S H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-----HPF 57
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLS---QTLLGEEKNRAKFSWTARREIALGIARGLA 166
L L+ V +Y+ L Q+ + RA F A I GL
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-------YAAEIICGLQ 110
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI--THISTRVAGTLGYLA 224
++H + IV+RD+K NILLD + + KI+DFG+ K E++ + GT Y+A
Sbjct: 111 FLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIA 164
Query: 225 PDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257
P+ + N D +SFGVLL +++ GQ+ H
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 64/296 (21%), Positives = 112/296 (37%), Gaps = 90/296 (30%)
Query: 52 NGFCSSNKVGEGGFGSVY--KGKLQDGTVVAVKVLS----VESKQ-----GEKEFMSEVA 100
+ F +G G FG V+ + K G V A+KVL ++ Q E++ +++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 101 SMANICHENLVKLHGGCIEGPCRI-------IVYDYMQNNSLSQTLLGE----EKNRAKF 149
S +VKL+ +V +YM L LL + A+F
Sbjct: 60 SPW------IVKLY-------YSFQDEEHLYLVMEYMPGGDL-MNLLIRKDVFPEETARF 105
Query: 150 SWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK------ 203
+ A E+ L + +H K +HRDIKP NIL+D + + K++DFGL K
Sbjct: 106 -YIA--ELVLALD----SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 204 ------------LFPEDIT----------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYS 241
LF +++ + GT Y+AP+ + D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
Query: 242 FGVLLLQIVTGQAA-------------VHFDKELGEYYLVEKAWEMHNTDKLQHLV 284
GV+L +++ G +++ + L + + D + L+
Sbjct: 216 LGVILYEMLYGFPPFYSDTLQETYNKIINWKESL--RFPPDPPVSPEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDG-TVVAVKVLSVESKQGEKEFM-----SEVA---SMANICHE 108
++GEG +G V+K + L++G VA+K + V Q +E M EVA + H
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 109 NLVKLHGGCIEGPCR-----IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
N+V+L C +V++++ + L+ L ++ +++ + R
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQLLR 121
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
GL ++H +VHRD+KP NIL+ + K++DFGL++++ T V TL Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYR 176
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQI 249
AP+ + D++S G + ++
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTR 215
A IA GL ++H I++RD+K N++LD + KI+DFG+ K +F T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT--- 160
Query: 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
GT Y+AP+ D ++FGVLL +++ GQ FD E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP--FDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 23/181 (12%)
Query: 79 VAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQT 138
V +KVL + F + M+ + H +L +HG C+ G I+V +++++ L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-V 105
Query: 139 LLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL-----LDQNFN 193
L +EK R +W + +A +A L+Y+ ++ ++VH ++ NIL L + +
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS 160
Query: 194 P--KISDFGLSKLFPEDITHIS--TRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQ 248
P K+SD G+S T +S RV + ++AP+ G L+ +D +SFG LL+
Sbjct: 161 PFIKLSDPGVS------FTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLE 213
Query: 249 I 249
I
Sbjct: 214 I 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVA---VKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
++G G FG V ++ T VA VK L + E+ EF+ + + H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G C+E ++V++Y + L L E+ +R + +A IA G+ ++H K
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLAPDYAVSGH- 232
+ +H D+ N L + K+ D+G+ + ED L +LAP+ H
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 233 ------LNPKSDIYSFGVLLLQI 249
S++++ GV L ++
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
I RGL Y+H I+HRDIKP N+L++ N KI DFGL+++ D + T+ T
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 221 GYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQ 253
Y AP+ + S H DI+S G + +++ +
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 53/232 (22%)
Query: 59 KVGEGGFGSVYKGKLQD---GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVK 112
+G+GG G VY D VA+K + E+ +K F+ E A++ H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 113 LHGGCIEGPCRIIVYDYM----------------QNNSLSQTLLGEEKNRAKFSWTARRE 156
++ C +G VY M Q SLS+ L EK S A
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKEL--AEKT----SVGAFLS 117
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG--LSKLFPED------ 208
I I + Y+H + ++HRD+KP NILL I D+G + K E+
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 209 -----ITH----ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
I + I ++ GT Y+AP+ + + +DIY+ GV+L Q++T
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 89 KQGEKE-FMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRA 147
K G++ +E + I H ++++L G + Y N + +L K
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKG----------TFTY---NKFTCLILPRYKTDL 169
Query: 148 KFSWTARREIAL--------GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199
A+R IA+ + R + Y+HE I+HRDIK NI ++ + + DF
Sbjct: 170 YCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF 226
Query: 200 GLSKLFPEDITHISTRV---AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAV 256
G + FP DI + + AGT+ AP+ P DI+S G++L ++ T ++
Sbjct: 227 G-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
Query: 257 HFDKE 261
F+K+
Sbjct: 284 -FEKD 287
|
Length = 391 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 25/75 (33%), Positives = 43/75 (57%), Gaps = 6/75 (8%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL---FPEDITHISTRVA 217
+ RGL YIH +++HRD+KPSN+L++++ +I DFG+++ P + + T
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 218 GTLGYLAPDYAVSGH 232
T Y AP+ +S
Sbjct: 173 ATRWYRAPELLLSLP 187
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEF--MSEVA---SMANICHENLVK 112
++G G +G+VYK + G VA+K + V++ + + EVA + H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR-----------REIALGI 161
L C + TL+ E ++ ++ + +++
Sbjct: 67 LMDVCATS---------RTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
RGL ++H IVHRD+KP NIL+ K++DFGL++++ + T V TL
Sbjct: 118 LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLW 172
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
Y AP+ + D++S G + ++
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V ++++ G + A K L ++ K GEK + E + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLL-----GEEKNRAKFSWTARREIALGIARGLAYIHE 170
+V M L + G E R ++A+ I G+ ++H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH-YSAQ------ITCGILHLHS 113
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
IV+RD+KP N+LLD N ++SD GL+ + T T+ AGT GY+AP+
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKE 168
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
+ D ++ G + ++V G+ KE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L+ ++ ++G + M E +A + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 116 G-------CI------EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
C+ G R +Y+ + N G + RA F +TA+ I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP------GFPEPRACF-YTAQ------II 107
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
GL ++H+ I++RD+KP N+LLD + N +ISD GL+ + + + AGT G+
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGF 163
Query: 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIV 250
+AP+ + D ++ GV L +++
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGG 116
+G G +G V K + VA+K ++ +++ K + E+ + ++ HEN++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71
Query: 117 CIEGPCR------IIVYDYM-----QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGL 165
+ P R IVY+ M Q SQTL + + + RGL
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ----------LLRGL 121
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
YIH +++HRD+KPSN+LL+ N + KI DFGL++ E ++ V T Y AP
Sbjct: 122 KYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
Query: 226 DYAVSGHLNPKS-DIYSFGVLLLQIVTGQ 253
+ ++ + D++S G + +++ +
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 10/139 (7%)
Query: 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPS 184
++ DY+ + L R FS R + I L ++H K IV+RDIK
Sbjct: 82 LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLE 134
Query: 185 NILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY--AVSGHLNPKSDIYSF 242
NILLD + ++DFGLSK F + + GT+ Y+AP+ GH D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGH-GKAVDWWSL 193
Query: 243 GVLLLQIVTGQAAVHFDKE 261
G+L+ +++TG + + E
Sbjct: 194 GILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMS---EVASMANICHENLVKLHG 115
KVG G +G VYK K +DG K +++ +G MS E+A + + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 116 GCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRA-----KFSWTARREIALGIARGLAYI 168
+ R + ++DY +++ L + ++A + + + + I G+ Y+
Sbjct: 66 VFLSHSDRKVWLLFDYAEHD-LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 169 HEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGLSKLFPEDITHIS--TRVAGTLGY 222
H ++HRD+KP+NIL+ + KI+D G ++LF + ++ V T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 223 LAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
AP+ + H DI++ G + +++T + H +E
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 60 VGEGGFGSV-YKGKLQDGTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHGG 116
VG G +G+V + G VA+K L +S+ K E+ + ++ HEN++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+D+ T LG+ K S + + + +GL YIH I
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGI 139
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSG-HLN 234
+HRD+KP N+ ++++ KI DFGL++ ++T ++ TR Y AP+ ++ H
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYT 194
Query: 235 PKSDIYSFGVLLLQIVTGQ 253
DI+S G ++ +++TG+
Sbjct: 195 QTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMS---EVASMANICHENLVKLHG 115
KVG G +G VYK K +DG + +++ +G MS E+A + + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 116 GCIEGPCRII--VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY-----I 168
+ R + ++DY +++ L + + +RA + ++ G+ + L Y I
Sbjct: 66 VFLSHADRKVWLLFDYAEHD-LWHII---KFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 169 HEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGLSKLFPEDITHIS--TRVAGTLGY 222
H ++HRD+KP+NIL+ + KI+D G ++LF + ++ V T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 223 LAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
AP+ + H DI++ G + +++T + H +E
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 59 KVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLV 111
++GE FG VYKG L + VA+K L +++ +EF E + + H N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR------------EIAL 159
L G + +++ Y ++ L + L+ + S + I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL-SKLFPEDITHISTRVAG 218
IA G+ ++ +VH+D+ N+L+ N KISD GL +++ D +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ +++P+ + G + SDI+S+GV+L ++ +
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 60 VGEGGFGSVYKGKLQDGTVV----AVKVLSVESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG V + + +D + ++ + S+ ++E +A + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEE 171
+ P ++ +V ++ L L E + +RA+F +TA AL +H+
Sbjct: 61 S-FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF-YTAELLCAL------ENLHKF 112
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
++++RD+KP NILLD + + DFGL KL +D +T GT YLAP+ + G
Sbjct: 113 ---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPEL-LLG 167
Query: 232 HLNPKS-DIYSFGVLLLQIVTGQAAVHFDKELGEYY 266
H K+ D ++ GVLL +++TG +D+ + E Y
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP-FYDENVNEMY 202
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 61 GEGGFGSVYKGKLQ-------DGTVVAVKVLSVESKQGEKEFMS--EVAS-MANICHENL 110
G+G F ++YKG L+ G V V+ ++ ++ E AS M+ + H++L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
VKL+G C+ I+V +Y++ L L EKN W + ++A +A L Y+ E
Sbjct: 64 VKLYGVCVRDE-NIMVEEYVKFGPLD-VFLHREKNNVSLHW--KLDVAKQLASALHYL-E 118
Query: 171 EIKPSIVHRDIKPSNILL---DQNFNP----KISDFGLSKLFPEDITHISTRVAGTLGYL 223
+ K +VH ++ NIL+ N K+SD G+ P + RV + ++
Sbjct: 119 DKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVE-RIPWI 171
Query: 224 APDYAVSGHLNPKS--DIYSFGVLLLQI 249
AP+ +G + D +SFG LL+I
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 34/100 (34%), Positives = 59/100 (59%), Gaps = 8/100 (8%)
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI--THISTRVAGTLG 221
GL ++H + I++RD+K N++LD++ + KI+DFG+ K E++ + ++ GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPD 161
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
Y+AP+ D +SFGVLL +++ GQ+ H D E
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 35/252 (13%)
Query: 36 LKNINAF---------SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDG-TVVAVKVLS 85
KNI+ F +L+ F +G G FG V + + V A+K+LS
Sbjct: 18 NKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS 77
Query: 86 VES--KQGEKEFM-SEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE 142
K+ + F E MA+ E +V+LH + +V +YM L L+
Sbjct: 78 KFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSN 136
Query: 143 ----EKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198
EK A+F +TA E+ L L IH +HRD+KP N+LLD++ + K++D
Sbjct: 137 YDIPEK-WARF-YTA--EVVLA----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 199 FGLS-KLFPEDITHISTRVAGTLGYLAPDY----AVSGHLNPKSDIYSFGVLLLQIVTGQ 253
FG K+ + T V GT Y++P+ G+ + D +S GV L +++ G
Sbjct: 186 FGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
Query: 254 AAVHFDKELGEY 265
+ D +G Y
Sbjct: 245 TPFYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 53 GFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHEN 109
+C VG+G +G V + DG +K L++ S++ K E ++ + H N
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+V + IV + + L L +E+ E + IA L Y+
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
HE+ I+HRD+K N+ L + K+ D G++++ E+ +++ + GT Y++P+
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELF 174
Query: 229 VSGHLNPKSDIYSFGVLLLQIVT 251
+ N KSD+++ G + ++ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 60 VGEGGFGSVYKGKLQDGT-VVAVKVLSVES--KQGEKE-FMSEVASMANICHENLVKLHG 115
+G G FG V K++ + A+K+L+ K+ E F E + N + + LH
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNR-----AKFSWTARREIALGIARGLAYIHE 170
+ +V DY L TLL + ++R A+F IA + IH
Sbjct: 69 AFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY----------IAEMVLAIHS 117
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+ VHRDIKP N+LLD N + +++DFG +D T S+ GT Y++P+ +
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 231 -----GHLNPKSDIYSFGVLLLQIVTGQ 253
G P+ D +S GV + +++ G+
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 39/168 (23%)
Query: 98 EVASMANICHENLVKLHGGCIEGPCRIIV--------YDYMQNNS----LSQTLLGEEKN 145
E + N+ H +++++ + G +V Y Y+ S + Q L+ E++
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQ- 165
Query: 146 RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL- 204
I GL Y+H + I+HRD+K NI ++ I D G ++
Sbjct: 166 ---------------ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207
Query: 205 --FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIV 250
P + +AGT+ AP+ N K+DI+S G++L +++
Sbjct: 208 VVAPAFLG-----LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 60 VGEGGFGSVYK-GKLQDGTVVAVKVLSVESKQGEKEFMSE---VASMANICHENLVKLHG 115
+G+G +G VYK +DG++ AVK+L S E E +E + S+ N H N+VK +G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPN--HPNVVKFYG 86
Query: 116 ------GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+ G +++ + S+++ + G + I G GL ++H
Sbjct: 87 MFYKADKLVGGQLWLVL-ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
I+HRD+K +NILL K+ DFG+S +T V GT ++AP+
Sbjct: 146 NN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 201
Query: 230 SGH-----LNPKSDIYSFGVLLLQIVTG 252
+ + D++S G+ +++ G
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 35/95 (36%), Positives = 51/95 (53%), Gaps = 7/95 (7%)
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL-FPEDITHIS-TRVAGTL 220
R L YIH ++ HRD+KP NIL + + KI DFGL+++ F + T I T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 221 GYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQ 253
Y AP+ S P DI+S G + +++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 34/111 (30%), Positives = 60/111 (54%), Gaps = 18/111 (16%)
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE------ 207
+R I + + L YIH +++HRD+KPSNILL+ + K++DFGL++ E
Sbjct: 109 KRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 208 --DIT-HISTRVAGTLGYLAPDYAVSGHLNPKS-DIYSFGVLLLQIVTGQA 254
+T +++TR Y AP+ + K D++S G +L +++ G+
Sbjct: 166 NPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G G + V +L+ + + A+KV+ ++ Q EK + +S +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-----NPF 57
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
LV LH C + R+ +V +Y+ L + ++ R K R A I L ++
Sbjct: 58 LVGLHS-CFQTTSRLFLVIEYVNGGDL---MFHMQRQR-KLPEEHARFYAAEICIALNFL 112
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLAPD 226
HE I++RD+K N+LLD + + K++D+G+ K L P D T + GT Y+AP+
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE 166
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
D ++ GVL+ +++ G++
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G G + V +L+ + A+KV+ ++ Q EK + ++ H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 57
Query: 110 LVKLHGGCIEGPCRII-VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
LV LH C + R+ V +Y+ L + + K + + EI+L L Y+
Sbjct: 58 LVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYL 112
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLAPD 226
HE I++RD+K N+LLD + K++D+G+ K L P D T + GT Y+AP+
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPE 166
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
D ++ GVL+ +++ G++
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLS---------VESKQGEKEFMSEVASMA 103
F +G+G FG V + + + A+K+L VE EK ++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-- 59
Query: 104 NICHENLVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
L +LH C + R+ V +Y+ L + + KF A I+
Sbjct: 60 ---PPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEIS 111
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV-AGTLG 221
GL ++H I++RD+K N++LD + KI+DFG+ K + ++TR GT
Sbjct: 112 VGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPD 166
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
Y+AP+ D +++GVLL +++ GQ FD E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP--FDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVES--KQGEKE-FMSEVASMANICHENLVKLHG 115
+G G FG V K+++ G V A+K+L+ K+ E F E + N + LH
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNR-----AKFSWTARREIALGIARGLAYIHE 170
+ +V DY L TLL + ++R A+F + A +A+ L Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARF-YLAEMVLAIDSVHQLGY--- 123
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY--A 228
VHRDIKP N+LLD+N + +++DFG D T S GT Y++P+ A
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 229 V---SGHLNPKSDIYSFGVLLLQIVTGQ 253
+ G P+ D +S GV + +++ G+
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 60 VGEGGFGSVYKGKLQDG-TVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G G FG V + + V A+K+LS + + F E MA +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEE--KNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ +V +YM L + + + AKF +TA +AL +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-YTAEVVLALDAIHSMG------- 162
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLAPDYAVS-- 230
++HRD+KP N+LLD++ + K++DFG K+ + T V GT Y++P+ S
Sbjct: 163 --LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 231 --GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY 265
G+ + D +S GV L +++ G + D +G Y
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY 256
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 9/98 (9%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT----HISTRV 216
I GL YIH +++HRD+KP N+L++ + KI DFGL++ F E+ ++ V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 217 AGTLGYLAPDYAVSGHLNPKS-DIYSFGVLLLQIVTGQ 253
A T Y AP+ +S K+ D++S G +L +++ +
Sbjct: 171 A-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 37/106 (34%), Positives = 61/106 (57%), Gaps = 10/106 (9%)
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI-THISTRV 216
A IA GL ++H + I++RD+K N++LD + KI+DFG+ K E++ ++T+
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160
Query: 217 -AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261
GT Y+AP+ D ++FGVLL +++ GQA F+ E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP--FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 45/180 (25%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLAPDYAVS----G 231
+HRD+KP N+LLD++ + K++DFG K+ E + T V GT Y++P+ S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV---EKAWEMHNTDKLQHLVDPML 288
+ + D +S GV L +++ G + D +G Y + + + + + + ++
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282
Query: 289 CGNFSGNEAVRFLKVGLLCVQEK----------SSLRPRMSTVIEMINGDVDID--DDVE 336
C F + VR + G+ ++ +LR ++ V+ ++ D+D DD+E
Sbjct: 283 CA-FLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAG 218
I L Y+H +V+RD+K N++LD++ + KI+DFGL K E I+ +T G
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
T YLAP+ D + GV++ +++ G+
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI---STRVA 217
+ARG+ ++ +HRD+ NILL +N KI DFGL++ +D ++ S R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 218 GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
L ++AP+ +SD++SFGVLL +I +
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-08
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG V + + G A+K+L E +K ++E + N H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
V +Y+ L L E FS R I L Y+H
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSG---K 115
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAGTLGYLAPDYAVSGHL 233
IV+RD+K N++LD++ + KI+DFGL K E IT +T GT YLAP+
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 234 NPKSDIYSFGVLLLQIVTGQ 253
D + GV++ +++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-T 219
+A+G+ ++ +HRD+ NILL +N KI DFGL++ +D ++ A
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAA----VHFDKEL 262
L ++AP+ +SD++SFGVLL +I + A+ V D+E
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 51/219 (23%)
Query: 60 VGEGGFGSVYKGKLQDGT-VVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G G + V +L+ + A+KV+ ++ Q EK E AS H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVF-ETASN----HPF 57
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIAR 163
LV LH C + R+ V +++ L Q L EE A+F ++A EI+L
Sbjct: 58 LVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA--- 108
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLG 221
L ++HE I++RD+K N+LLD + K++D+G+ K + P D T + GT
Sbjct: 109 -LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPN 161
Query: 222 YLAP------DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
Y+AP DY S D ++ GVL+ +++ G++
Sbjct: 162 YIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
VHRDIKP N+L+D+ + K++DFG + + S GT Y+AP+ + + + K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 237 S------DIYSFGVLLLQIVTGQAAVHFD 259
D +S GV+ +++ G++ H
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 61 GEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEF---MSEVASMANICHENLVKLHGG 116
G+G G V+ +L+ G + A+KVL + + ++E +A + H L L+
Sbjct: 10 GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYAS 69
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+V DY L + L + + S R A + L Y+H I
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALEYLHLL---GI 124
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKL------FPEDITHISTRVA------------- 217
V+RD+KP NILL ++ + +SDF LSK +R +
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 218 ---------GTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTG 252
GT Y+AP+ GH D ++ G+LL +++ G
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 4/95 (4%)
Query: 158 ALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA 217
+ +ARG+ ++ +HRD+ NILL +N KI DFGL++ +D ++ A
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 218 G-TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
L ++AP+ +SD++SFGVLL +I +
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAG 218
I L Y+H +V+RDIK N++LD++ + KI+DFGL K E I+ +T G
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
T YLAP+ D + GV++ +++ G+
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 5/175 (2%)
Query: 78 VVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQ 137
VVA V+ + +Q SE+ +A H +VK +++ +Y L++
Sbjct: 96 VVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK 154
Query: 138 TLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197
+ K F + I L +H ++HRD+K +NI L K+
Sbjct: 155 QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLG 211
Query: 198 DFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
DFG SK + + ++ +++ GT YLAP+ + K+D++S GV+L +++T
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 3/105 (2%)
Query: 149 FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208
FS R I L Y+H E ++V+RD+K N++LD++ + KI+DFGL K +D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 149
Query: 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+ T GT YLAP+ D + GV++ +++ G+
Sbjct: 150 GATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 62/264 (23%)
Query: 60 VGEGGFGSVY-KGKLQDGTVVAVKVL---SVESKQGEKEFMSEVASMANICHENLVKLHG 115
+G G FG V K+ + A+K L V + +E +A +E +VKL+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGE---EKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ V DY+ + L+ E++ A+F + A E+ I +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-YIA--ELTCAIE----SVH--- 118
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGL----------------------SKLFPEDIT 210
K +HRDIKP NIL+D++ + K++DFGL S E+ +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 211 HISTR--------------------VAGTLGYLAPD-YAVSGHLNPKSDIYSFGVLLLQI 249
I + GT Y+AP+ +G+ D +S GV+L ++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEM 237
Query: 250 VTGQAAVHFDKELGEYYLVEKAWE 273
+ GQ D V WE
Sbjct: 238 LVGQPPFLADTPAETQLKV-INWE 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 4e-07
Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 30/242 (12%)
Query: 44 YNELKSATNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVES-KQGEK-EFMSEVA 100
Y++ +S N + K+G G FG V+ K + K +S K+ EK + + EV
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 101 SMANICHENLVKLHGGCIEGPCR--IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
M + H+N+V+ + + I+ ++ LS+ + K K A +I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 159 LGIARGLAYIHE-EIKPS---IVHRDIKPSNILLD-------------QNFN----PKIS 197
+ LAY H + P+ ++HRD+KP NI L N N KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 198 DFGLSKLFPEDITHISTRVAGTLGYLAPDYAV--SGHLNPKSDIYSFGVLLLQIVTGQAA 255
DFGLSK I ++ GT Y +P+ + + + KSD+++ G ++ ++ +G+
Sbjct: 185 DFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 256 VH 257
H
Sbjct: 243 FH 244
|
Length = 1021 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 60 VGEGGFGSVYKGKLQDGTV--VAVKVLS----VESKQGEKEFMSEVASMANICHENLVKL 113
+G G FG V ++ VA+K ++ KQ + F SE + I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+G + +V +++ L + +F ++ A + I E ++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFP----NDVGCFYAAQIVLIFEYLQ 148
Query: 174 P-SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR---VAGTLGYLAPDYAV 229
+IV+RD+KP N+LLD++ K++DFG +K+ + TR + GT Y+AP+ +
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEYIAPEILL 201
Query: 230 SGHLNPKSDIYSFGVLLLQIVTG 252
+ +D ++ G+ + +I+ G
Sbjct: 202 NVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 54/227 (23%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 48 KSATNGFCSSNKVGEGGFGSVYKGKLQDGT-VVAVKVLSVESKQGEKEFMSEVASMANIC 106
+S + N +G G FG VY+ D + VA+K + + + +E + M N+
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 107 HENLVKL----HGGCIEGPCRII------------VYDYMQNNSLSQTLLGEEKNRAKFS 150
H N++ L + C + + I V+ YM++ + +N
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA---------RNNHALP 168
Query: 151 WTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP-KISDFGLSKLF---P 206
+ + + R LAYIH + I HRD+KP N+L+D N + K+ DFG +K
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225
Query: 207 EDITHISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTG 252
+++I +R Y AP+ + + + D++S G ++ +++ G
Sbjct: 226 RSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT------HIS--TR- 215
L Y+H IVHRD+KP N+L+ + K++DFGLSK+ +T HI TR
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 216 -----VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
V GT Y+AP+ + D ++ G++L + + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 12/96 (12%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-- 218
+ARG+ ++ + + VHRD+ N+LL Q KI DFGL++ DI H S V+
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 219 ---TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ ++AP+ SD++S+G+LL +I +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 21/46 (45%), Positives = 25/46 (54%), Gaps = 7/46 (15%)
Query: 167 YIHEEI-------KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205
YI E I K +HRDIKP N+LLD + K+SDFGL
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 43/196 (21%), Positives = 89/196 (45%), Gaps = 22/196 (11%)
Query: 67 SVYKGKLQDGTVVAVKVL---SVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG--- 120
S+YKG + V ++ K +E+ ++ I N++K++G I+
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 121 -PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-KPSIVH 178
P ++ +Y L + +L +EK+ S+ + ++A+ +GL +++ KP +
Sbjct: 94 LPRLSLILEYCTRGYL-REVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---Y 146
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA--VSGHLNPK 236
+++ + L+ +N+ KI GL K+ ++ + + Y + + K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 237 SDIYSFGVLLLQIVTG 252
DIYS GV+L +I TG
Sbjct: 203 DDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 21/155 (13%)
Query: 60 VGEGGFGSV-YKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN----LVKLH 114
+G+G FG V K G + A+K L ++S+ +K+ ++ V + ++ E+ +V L+
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR----EIALGIARGLAYIHE 170
+ ++ +++ L L+ FS R E L I +H
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEA----VH- 118
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205
K +HRDIKP NIL+D+ + K+SDFGLS F
Sbjct: 119 --KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 47/238 (19%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--- 109
F S +G G FG V + +D G V A+K+L ++ EKE + + + +I E
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSL 61
Query: 110 -LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+VK+ + ++ +++ + L+ ++ E IA + I
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-------LTEEETQFYIAETVLAI 114
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL----------------SKLFPEDIT-- 210
+ +HRDIKP N+LLD + K+SDFGL + P D T
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 211 ----------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
++ GT Y+AP+ + N D +S GV++ +++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 73/283 (25%), Positives = 110/283 (38%), Gaps = 80/283 (28%)
Query: 54 FCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEKE-FMSEVA------ 100
F K+GEG FG VYK L ++G V K ++ G E +M+E
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA----TEYGAVEIWMNERVRRACPN 189
Query: 101 SMANICHENLVKLHGGCIEGPCRIIV---------YDYMQNN----SLSQTLLGEEKNRA 147
S A+ + L + + +V D MQ+ ++ LLG+ ++
Sbjct: 190 SCADFVYGFLEPVSSK--KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 148 KFSWTARRE------IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISD 198
K RE I I L +H IVHRD+KP NI+ + +F KI D
Sbjct: 248 K---GLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSF--KIID 299
Query: 199 FGLSKLFPEDITHIST------RVAGTLGYL-------APDYAVSGHLNP---------K 236
G + I +I R A Y+ AP V+ L+P +
Sbjct: 300 LGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359
Query: 237 SDIYSFGVLLLQIV-----TGQAAVHFDKELGE--YYLVEKAW 272
DIYS G++ LQ+ + + F+++L Y LV AW
Sbjct: 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLV--AW 400
|
Length = 566 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 76 GTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM--- 130
GT+V V++ +E+ E K +EV H N++ G ++ +M
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ 190
NSL +T E + A I G RGL Y+H+ +HR+IK S+IL+
Sbjct: 85 SANSLLKTYFPEGMSEALI-----GNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136
Query: 191 NFNPKISDFGLSKLFP-----------EDITHISTRVAGTLGYLAPDYA---VSGHLNPK 236
+ +S GLS L+ D ST V L +L+P+ + G+ N K
Sbjct: 137 DGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGY-NVK 190
Query: 237 SDIYSFGVLLLQIVTGQ 253
SDIYS G+ ++ TG+
Sbjct: 191 SDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
G+ ++H I+HRD+KPSNI++ + KI DFGL++ + + T T Y
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYR 189
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTG----QAAVHFDK 260
AP+ + DI+S G ++ ++V G Q H D+
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 10/97 (10%)
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTR 215
I + LAY+H I+HRD+K NI LD+ N + DFG + KL T
Sbjct: 190 IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 216 VAGTLGYLAPDYAVSGHLNP---KSDIYSFGVLLLQI 249
+GTL +P+ L+P K+DI+S G++L ++
Sbjct: 247 WSGTLETNSPELLA---LDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 21/53 (39%), Positives = 33/53 (62%), Gaps = 4/53 (7%)
Query: 152 TARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204
A + I+ +A L Y+H I+HRD+KP N+L+ + K++DFGLSK+
Sbjct: 105 MAVKYIS-EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 53/238 (22%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--- 109
F S +G G FG V + +D G + A+K+L ++ EKE ++ + + +I E
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEADGA 61
Query: 110 -LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+VK+ + ++ +++ + L+ ++ + IA + I
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-------LSEEATQFYIAETVLAI 114
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL--------SKLFPEDITH--------- 211
+ +HRDIKP N+LLD + K+SDFGL F ++TH
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 212 -----------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG 252
++ GT Y+AP+ + N D +S GV++ +++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT- 219
+A G+ ++ + + VHRD+ N+L+ + KI DFGL++ D +IS G+
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 220 ---LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
L ++AP+ + SD++SFG+LL +I T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 60 VGEGGFGSVYK-GKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-----HENLVKL 113
+G+G +G V+K ++G+ AVK+L E E+ + NI H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-----EIEAEYNILKALSDHPNVVKF 80
Query: 114 HG-----GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+G G +V + S++ + G K + I GL ++
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY- 227
H +HRD+K +NILL K+ DFG+S +T V GT ++AP+
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 196
Query: 228 ----AVSGHLNPKSDIYSFGVLLLQIVTG 252
+ + + D++S G+ +++ G
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 102 MANICHENLVKLHGGCIEGP-CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
M + + N +KL+ + +++ DY+++ L L K K S ++I
Sbjct: 65 MKD--NPNFIKLYY-SVTTLKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQ 117
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTRVAGT 219
+ L +H K +I+H DIK N+L D+ + D+GL K I + GT
Sbjct: 118 LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGT 169
Query: 220 LGYLAPDYAVSGHLNPKS-DIYSFGVLLLQIVTGQAAVH-FDKELGEYYLVEK 270
L Y +P+ + GH S D ++ GVL +++TG+ H F ++ E +E
Sbjct: 170 LDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGK---HPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
G+ ++H I+HRD+KPSNI++ + KI DFGL++ + + T T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIV 250
AP+ + DI+S G ++ ++V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
G+ ++H I+HRD+KPSNI++ + KI DFGL++ + + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP+ + DI+S G ++ +++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-- 218
+A+G++++ + + +HRD+ NILL KI DFGL++ DI + S V
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR----DIRNDSNYVVKGN 275
Query: 219 ---TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
+ ++AP+ + +SD++S+G+LL +I
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 58/250 (23%), Positives = 94/250 (37%), Gaps = 57/250 (22%)
Query: 54 FCSSNKVGEGGFGSV-YKGKLQDGTVVAVKVL---SVESKQGEKEFMSEVASMANICHEN 109
F +G G FG V K+ + A+K L V ++ +E +A +E
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+VKL+ + V DY+ + L+ E + E+ L I +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES----VH 118
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF---------------------PED 208
K +HRDIKP NIL+D + + K++DFGL F P D
Sbjct: 119 ---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 209 I----------------------TH---ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFG 243
+ H ++ + GT Y+AP+ + D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 244 VLLLQIVTGQ 253
V+L +++ GQ
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 97 SEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR-- 154
+E+ ++ + HEN++K IE R YM L + A F W R
Sbjct: 212 NEILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEA-FDWKDRPL 265
Query: 155 ----REIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210
R I + + YIH++ ++HRDIK NI L+ + + DFG + F ++
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT 251
GT+ +P+ +DI+S G++LL +++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT---HISTRVAGTL 220
G+ ++H I+HRD+KPSNI++ + KI DFGL++ ++ TR
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
Y AP+ + DI+S G ++ +++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 32/99 (32%), Positives = 45/99 (45%), Gaps = 23/99 (23%)
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL--------SKLFPEDITHISTRVAG 218
YIH E I+HRDIK N+L++ + + DFG S F I AG
Sbjct: 275 YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI-------AG 324
Query: 219 TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257
T+ AP+ P DI+S G+++ +AAVH
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIF-----EAAVH 358
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 12/94 (12%)
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG-- 218
+A+G+ ++ + + +HRD+ N+LL KI DFGL++ DI + S V
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR----DIMNDSNYVVKGN 273
Query: 219 ---TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQI 249
+ ++AP+ +SD++S+G+LL +I
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 5e-04
Identities = 32/162 (19%), Positives = 62/162 (38%), Gaps = 18/162 (11%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV--KLHGG 116
+ G VY +D V +K+ K ++E EVA + + + L K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
++ ++++ +L + E+++ IA +A LA +H+ +
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVL 110
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPE--DITHISTRV 216
H D+ P NIL+D I D+ + P D+
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAALLFN 152
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 17/33 (51%), Positives = 24/33 (72%)
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205
K +HRDIKP NIL+D++ + K++DFGL F
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 35/264 (13%)
Query: 60 VGEGGFGSVYKGKLQDGT-------------VVAVKVLSVESKQGEKEFMSEVASMANIC 106
+G G +Y G L V +KVL + F + M +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
H+++V L+G C+ I+V ++++ L L + + + ++A +A L+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 167 YIHEEIKPSIVHRDIKPSNILL-----DQNFNP--KISDFGLSKLFPEDITHISTR-VAG 218
Y+ ++ +VH ++ NILL D P K+SD G+ IT +S +
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSRQECVE 170
Query: 219 TLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277
+ ++AP+ S +L+ +D +SFG L +I DK L E + M T
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230
Query: 278 DKLQHLVDPML-CGNFSGNEAVRF 300
+ L D M C N+ N+ F
Sbjct: 231 PSCKELADLMTHCMNYDPNQRPFF 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 53/216 (24%), Positives = 83/216 (38%), Gaps = 37/216 (17%)
Query: 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVA--------------SMAN 104
+G GGFG VY+ + D + V +E+ + E M + ++ N
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 105 ICHENLVKLHGGCIEGPCRI----IVYD--YMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
I H + K +G CR+ I+ + + + + + K K I
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK-------NIM 132
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA- 217
+ L YIHE I H DIKP NI++D N I D+G++ F HI
Sbjct: 133 KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189
Query: 218 -----GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQ 248
GTL Y D + + D+ S G +L+
Sbjct: 190 KDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 8/78 (10%)
Query: 60 VGEGGFGSVYK------GKLQDGTVVAVKVLSVESKQGEKE-FMSEVASMANIC-HENLV 111
+G G FG V + GK + VAVK+L + E+E MSE+ ++++ H+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 112 KLHGGCIEGPCRIIVYDY 129
L G C G +++ +Y
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 21/156 (13%)
Query: 106 CHENLVKLHGGCIEGPCRIIVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALG 160
C N+V LH + +V + + L + EE + W A +AL
Sbjct: 43 CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALD 99
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+H E IV RD+ P+NILLD + +++ F ++ A
Sbjct: 100 A------LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWS----EVEDSCDGEAVEN 146
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAV 256
Y AP+ D +S G +L +++TG+ V
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.16 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.15 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.1 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.09 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.75 | |
| PLN02236 | 344 | choline kinase | 97.51 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.48 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.43 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.35 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.34 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.29 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.04 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.03 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.0 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.98 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.82 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.63 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.39 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.15 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.72 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=381.36 Aligned_cols=291 Identities=51% Similarity=0.856 Sum_probs=252.8
Q ss_pred cCccCCHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeE
Q 042383 38 NINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117 (353)
Q Consensus 38 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 117 (353)
....|++.++..++++|.....||+|+||+||+|...+|+.||||.+.........+|.+|+.++.+++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998899999987754433145699999999999999999999999
Q ss_pred ecCC-ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 118 IEGP-CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 118 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.+.+ ..++|+||++.|+|.+.+...... +++|..+.+|+.++|.||+|||+.+...|+|||||+.|||+|++.++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9999 499999999999999999643222 8999999999999999999999988778999999999999999999999
Q ss_pred eeccCCccCCC-CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 197 SDFGLSKLFPE-DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 197 ~Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
+|||+++..+. ........ .||.+|+|||++..+..+.++||||||+++.||+||+.+...........+..|.....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999976654 22211111 79999999999999999999999999999999999998887655444445777777777
Q ss_pred cccccccccCcccC-CCCCh-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 276 NTDKLQHLVDPMLC-GNFSG-NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 276 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
....+..++|+.+. ..+.. ....++..+..+|++.+|++||+|.+|++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 77789999999987 55664 6788899999999999999999999999999766554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=357.05 Aligned_cols=283 Identities=24% Similarity=0.368 Sum_probs=229.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeee-eEecCCc-eEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG-GCIEGPC-RIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv 126 (353)
.+|++.++||+|.||+||++.. .+|..+|.|.++.. +......+..|+.+|++|+|||||++++ .|.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4578889999999999999985 47999999998854 3444567889999999999999999998 5555444 8999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||+|.+|+|.+.+...+..++.+++..+|+++.|++.||.++|+.. +..+.||||||.||+++.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999988888899999999999999999999999832 234999999999999999999999999999988
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
..... ......|||.||+||.+...+|+.+|||||+||++|||+..++||.+++ -+.+..++.+..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~KI~qgd---------- 244 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCKKIEQGD---------- 244 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHHHHHcCC----------
Confidence 75433 3445789999999999999999999999999999999999999998763 233333333221
Q ss_pred cccCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC-CCCCCccccCCccccccccccc
Q 042383 286 PMLCGNFS-GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV-DIDDDVEIWEPGLINDIMDVKL 351 (353)
Q Consensus 286 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~-~~~~~~~~~~~~~~~~~~~~~~ 351 (353)
. +..+ ...+..+..||..|+.+||+.||+...+++.+.... .-+--+..|.+.+..++++++.
T Consensus 245 --~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~~~s~~~~~~~~~l~~~Enel~~ 309 (375)
T KOG0591|consen 245 --Y-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELDGESFQLHRFGARLFEDENELGV 309 (375)
T ss_pred --C-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhcccchhHhHHHHhhhhhhhhhhh
Confidence 1 1223 445778999999999999999999655555554422 2222234577888888877654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=382.18 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=215.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+|...+.||+|+|+.||.+++ .+|..||+|++... .....+.+.+|+++.++|+|||||+++++|+|.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 78999999999853 4455677899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|+|..++|..++ +.+++++|.+++.++.||+.||.|||++ +|+|||||..|+|++++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999998 4678999999999999999999999999 999999999999999999999999999998764
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
+ .....+.+|||.|.|||++....++..+||||+|||+|.||.|++||....-.+.+..+.....
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-------------- 235 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-------------- 235 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc--------------
Confidence 3 2345668999999999999999999999999999999999999999986654444433322111
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...+....+||.++|+.||.+|||+++|+.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122233456779999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=367.11 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=209.2
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-------hcHHHHHHHHHHHHhcCCCCceeeeeeEec
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-------QGEKEFMSEVASMANICHENLVKLHGGCIE 119 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 119 (353)
+...+.|.+.+.||+|+||.|-+|..+ +|+.||||+++.... .....+.+|+++|++++|||||+++++|++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 346678999999999999999999754 799999999974311 122346799999999999999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC---CCeEE
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN---FNPKI 196 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl 196 (353)
.+..|+||||++||+|.+.+. .++.+.+..-+.+++|++.|+.|||+. ||+||||||+|||++.+ ..+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred CCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence 999999999999999999994 455678888899999999999999999 99999999999999765 78999
Q ss_pred eeccCCccCCCCCccccccccCCcCccCccccccCCC---CccccchhHHHHHHHHHhCCCCCCCCcccc-hhhHHHHHH
Q 042383 197 SDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL---NPKSDIYSFGVLLLQIVTGQAAVHFDKELG-EYYLVEKAW 272 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~ 272 (353)
+|||+|+... ....+.+.+|||.|.|||++.+... ..+.|+||+||+||-+++|.+||....... ....+....
T Consensus 321 tDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~ 398 (475)
T KOG0615|consen 321 TDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR 398 (475)
T ss_pred cccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc
Confidence 9999999875 3566788999999999999987753 347899999999999999999998655433 211111111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... +..-.+..++..+||.+||..||++|||+.|+|+
T Consensus 399 y~f~-------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 399 YAFG-------------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccc-------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111 1222344678899999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=357.01 Aligned_cols=266 Identities=27% Similarity=0.417 Sum_probs=220.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-eEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC-RIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~ 129 (353)
+.+..+.||+|..|+||++.++ +++.+|+|++... .....+++.+|++++++.+||+||++++.|..+.. ..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 5566789999999999999977 6889999999654 44556889999999999999999999999999984 9999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++|||.+.+ ...+.++|.....++.+|++||.|||+ . +|+||||||.|+||+..|.|||||||.+....+.
T Consensus 160 MDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998 344779999999999999999999996 6 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcc--cchhhHHHHHHhhccccccccccCc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE--LGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
....+.||..|||||.+.+..|+.++||||||++++|+++|+.||....+ ...+.+... +++.
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~~ 297 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVDE 297 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------HhcC
Confidence 45668899999999999999999999999999999999999999976521 112222211 2221
Q ss_pred ccCCCCCh-HHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCCccccCCc
Q 042383 287 MLCGNFSG-NEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDDDVEIWEPG 341 (353)
Q Consensus 287 ~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~~~~~~ 341 (353)
.. +.++. .++.++..++..||+.||.+|||+.++++ ++++....+-+++.|.-.
T Consensus 298 pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~ 354 (364)
T KOG0581|consen 298 PP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRK 354 (364)
T ss_pred CC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHH
Confidence 11 23333 36778999999999999999999999986 566666666556655443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=355.63 Aligned_cols=206 Identities=28% Similarity=0.522 Sum_probs=186.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
...+|.+.+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++.+++..++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3578999999999999999999976 6899999999866 566778889999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC------CCeEEeecc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN------FNPKISDFG 200 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~------~~~kl~Dfg 200 (353)
||||+||+|.+++ ...+.+++..++.++.||+.||++||++ +||||||||+|||++.+ ..+||+|||
T Consensus 88 MEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999999 5566899999999999999999999999 99999999999999764 568999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccch
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~ 264 (353)
+|+.+.. .....+.+|+|-|||||++..+.|+.|+|+||+|+++|++++|..||......+.
T Consensus 161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 9998864 3445678999999999999999999999999999999999999999986554433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=365.07 Aligned_cols=256 Identities=32% Similarity=0.478 Sum_probs=214.0
Q ss_pred CCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecCC-ceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEGP-CRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~ 130 (353)
..+.+.||+|+||+||++.++....||+|++...... ..+.+.+|+.+|.+++|||||+++|++.+.. .+++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999985444999999854322 2568999999999999999999999999988 799999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCCCCCeEECCCC-CeEEeeccCCccCCCC
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS-IVHRDIKPSNILLDQNF-NPKISDFGLSKLFPED 208 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~-i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~ 208 (353)
++|+|.+++... ....+++..+..++.||+.||.|||+. + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999543 467899999999999999999999999 8 99999999999999997 9999999999876532
Q ss_pred CccccccccCCcCccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 209 ITHISTRVAGTLGYLAPDYAV--SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
. .......||+.|||||++. ...++.|+||||||+++|||+||..||......... ......
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~---------------~~v~~~ 261 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA---------------SAVVVG 261 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH---------------HHHHhc
Confidence 2 2233367999999999999 568999999999999999999999999866541111 111122
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
..+...+..++..+..++.+||+.||..||++.+++..|+.+..
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 23344455578889999999999999999999999999997765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=346.84 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=206.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.++||+|+||+|+.++.+ +++.+|+|+++.. .....+....|..+|..++||+||+++-.|++...+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999865 6899999999854 23345678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|+||+.||.|.-.| ++.+.+++..+..++..|+.||.|||+. +|+||||||+|||+|.+|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999 6678899999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
-.. .....+.+||+.|+|||++.+.+|+.++|.||||+++|||++|.+||...+-...+..+...
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-------------- 240 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-------------- 240 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC--------------
Confidence 322 23345589999999999999999999999999999999999999999876643333222111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
. ....+.-...+.++++.++|+.||++|.-
T Consensus 241 -k-~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 241 -K-LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -c-CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 1 11222224566889999999999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=360.66 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=220.5
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
+..+.||+|-||.||.|.++....||+|.++.. ....+.+.+|+.+|++|+|++||+++++|..+...+||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 457889999999999999998879999999854 4445678899999999999999999999999989999999999999
Q ss_pred hhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccc
Q 042383 135 LSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214 (353)
Q Consensus 135 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 214 (353)
|.++|.. ..+..++..+.+.++.|||+|++||+++ ++|||||..+||||+++..+||+|||+|+...++......
T Consensus 288 Ll~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 288 LLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred HHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 9999954 3567899999999999999999999999 9999999999999999999999999999966655555555
Q ss_pred cccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
...-+.-|.|||.+..+.++.||||||||++||||+| |+.|+......+-.. .++...+-..+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----------------~le~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----------------LLERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----------------HHhccCcCCCC
Confidence 5556778999999999999999999999999999999 888876555433322 23333444556
Q ss_pred hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
..|+..+.+++..||+.+|++|||++.+...|++.....
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 667889999999999999999999999999998876543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=324.73 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=212.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
+.|+...++|+|+||+||+++++ +|+-||||.+... +..-.+-..+|+..|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888899999999999999977 6999999998633 23334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
||+. ++.+-+ +.....++.+.+..+++|++.|+.|+|++ +++||||||+||||+.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHEL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9987 454444 24566789999999999999999999999 999999999999999999999999999998865
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc--------cc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT--------DK 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~ 279 (353)
.....+.+..|..|+|||.+.+ ..|+...|||++||++.||++|++.|.+.++.+..+.+.....-..+ ..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 3444556778999999999887 68999999999999999999999999998887777766654321111 11
Q ss_pred -cccccCc------ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 -LQHLVDP------MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 -~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+.-+ .+...++ ....-+.+++..||+.||.+|++.++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000001 1111111 22446889999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=321.61 Aligned_cols=238 Identities=27% Similarity=0.362 Sum_probs=207.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|+..+.||.|+||.|.+++.+ +|..+|+|++... ...+.+...+|..+|+.+.||+++++++.|.+.+..++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3478899999999999999999976 6889999999854 23455677899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||.+||.|..++ +..+++++..++.++.||+.||+|||+. +|++|||||+|||+|.+|++|++|||.|...
T Consensus 122 vmeyv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 122 VMEYVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEeccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999999 6678899999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. ...+.+|||.|+|||++...+++.++|.|+||+++|||+.|.+||...+....+..+. .
T Consensus 195 ~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~---------------~ 255 (355)
T KOG0616|consen 195 SG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL---------------E 255 (355)
T ss_pred cC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH---------------h
Confidence 43 3567899999999999999999999999999999999999999999877644443222 1
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLR 315 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 315 (353)
.. -.++.-....+.+|+...|+.|-.+|
T Consensus 256 ~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Cc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 12444445668899999999999988
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=344.88 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=215.7
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcC-CCCceeeeeeEecCC-ceE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANIC-HENLVKLHGGCIEGP-CRI 124 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 124 (353)
...++|.+.++||.|+||.||+|+.. +|..||||.++..-. ...-.-.+|+..|++++ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45688999999999999999999854 688999999875422 22334468999999998 999999999999988 999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+|||||+. +|++.+.. .+..|++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+-
T Consensus 87 fVfE~Md~-NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhhh-hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 99999965 99999953 378899999999999999999999999 999999999999999999999999999996
Q ss_pred CCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc-
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH- 282 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 282 (353)
... ....+.+..|..|+|||++.. +.|+.+.|+|++|||++|+.+-++.|-+.++.++...+-..........+.+
T Consensus 160 v~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 160 VRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 543 344566788999999998775 5689999999999999999999999998887666554443332222221111
Q ss_pred -----ccC---cccC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 283 -----LVD---PMLC----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 283 -----~~~---~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+. +... ..+-+..+.+..+++.+|++|||.+|||+.+.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 0000 12223467889999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=343.13 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=212.8
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
.....+|..++.||.|+|++|++|+.+ +++.||||++.... ....+-+..|-++|.+| +||.|++++-.|.|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 334578999999999999999999865 68999999987441 12224466788899999 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
+|+|+||+++|+|.++| ...+.|++...+.++.+|+.||+|||+. |||||||||+|||++++++++|+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999 5568899999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc------------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHH
Q 042383 203 KLFPEDITH------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 203 ~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 270 (353)
..++..... ....+.||..|.+||++..+..++.+|+|+||||+|+|+.|.+||...++.-.+..+..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 887532221 11347899999999999999999999999999999999999999998776544433332
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. =.+++..++...+||.+.|-.||++|+|.++|-+
T Consensus 302 l~-----------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 302 LD-----------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred hc-----------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 21 1233344466889999999999999999988865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=343.98 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=209.4
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc----Ch-hcHHHHHHHHHHHHhcC-CCCceeeeeeEecCC
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE----SK-QGEKEFMSEVASMANIC-HENLVKLHGGCIEGP 121 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 121 (353)
...++|.+.+.||+|+||+|+.|.+. ++..||+|++... .. ...+.+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 35678999999999999999999754 6899999977653 11 23456778999999998 999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeecc
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFG 200 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg 200 (353)
..++||||+.||+|.+++ ...+++.+..+..++.|+++|++|+|+. ||+||||||+|++++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i----~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYI----VNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHH----HHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999 4467899999999999999999999999 99999999999999999 999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGH-LN-PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...+....+..
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----------- 234 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----------- 234 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence 999874 2344556789999999999999977 75 789999999999999999999987443222211
Q ss_pred ccccccCcccCCCCChHH-HHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNE-AVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
+....+ .++... +.++..|+.+||..||.+|+|+.+|+
T Consensus 235 ----i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 ----IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111100 111112 56788999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=334.24 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=207.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC--ceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP--CRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 127 (353)
..+|...+.||+|+||+||++... +|...|+|.+...+....+.+.+|+.+|.+++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777889999999999999866 48899999988664444677899999999999999999999754444 689999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~ 206 (353)
||+++|+|.+++.. .++++++..+..+..||++||.|||++ |++||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999943 222799999999999999999999999 9999999999999999 7999999999998765
Q ss_pred C--CCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 E--DITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~--~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
. ..........||+.|+|||++..+ ...+++|||||||++.||+||.+||... ........++ ..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~i---g~------- 237 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLI---GR------- 237 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHH---hc-------
Confidence 3 222234457899999999999863 3445999999999999999999999753 1111111111 11
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
....+.++...+....+++.+|++.+|+.|||+.++|+.---..+.
T Consensus 238 --~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 238 --EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred --cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1111244445567788999999999999999999999865554433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=337.07 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=219.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 125 (353)
.+.|+.+++||+|+||.||+|++ .+|+.||+|.++... ........+|+.+|++|+||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 35677889999999999999985 479999999998765 44557788999999999999999999988766 68999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|+|||+. +|.-++. ...-.|++.+++.++.||+.||+|+|+. +++|||||..|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 8888772 3355799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc--c
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ--H 282 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 282 (353)
........+....|..|+|||++.+. .|+.+.|+||+|||+.||+.|++.|.+..+.++...+.+.........+. .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 77666656667789999999998875 69999999999999999999999999999888887777665444443333 1
Q ss_pred ccC-cccC--CCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVD-PMLC--GNFS-------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~-~~~~--~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.. ..+. ..+. ...+...++|+..+|..||.+|.|+.++|+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110 0001 1111 112445778999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=310.12 Aligned_cols=265 Identities=20% Similarity=0.318 Sum_probs=219.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.+|...++||+|.||.||+|++ ++|+.||||.++..... ......+|+..|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 47999999999865322 23567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++. +|...+. .+...++...++.++.++++|++|+|++ .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 8998884 4567899999999999999999999999 9999999999999999999999999999988755
Q ss_pred CccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC--
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD-- 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 285 (353)
...... ...|..|+|||.+.|. .|+...|+||.|||+.||+-|.+.|.+.++.++...+-.+...+..+.+..+..
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 433322 3568889999988875 699999999999999999999999888888777777666655555444433221
Q ss_pred ---------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 286 ---------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 286 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......-+.+.....+|+.+++..||.+|+|+.|.++.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111223445667999999999999999999999864
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=309.15 Aligned_cols=267 Identities=22% Similarity=0.297 Sum_probs=218.6
Q ss_pred HhccCCCCCCeeeeeCceEEEEEE-eCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-----
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC----- 122 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 122 (353)
...++|++.+.||+|||+-||+++ ..++..+|+|.+......+.+...+|++..++++|||+++++++...+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456889999999999999999998 44688899999998888888999999999999999999999987765444
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.|++++|...|||.+.+......+..+++.+++.|+.+|++||.+||+. ...+.||||||.||++++.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999977766777899999999999999999999998 113999999999999999999999999999
Q ss_pred ccCCCCCcccc--------ccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 203 KLFPEDITHIS--------TRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 203 ~~~~~~~~~~~--------~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
+...-...... ....+|..|+|||.+.-+ ..+.++|||||||++|.|+.|..||...-+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 87653222211 123578899999988744 568899999999999999999999973221
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
......-.+....+...-.+..++.+.+++++||++||.+||++.+++..+++..
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111112223333333333447889999999999999999999999999988754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=327.09 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=214.1
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
...+.|++..+||.|..++||+|++. .++.||||++..+... ..+.+.+|+..++.++||||++++..|..+..+++|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 35678999999999999999999854 6899999999976433 358899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|.||.+||+.+.+...- ...++|..+..+++++++||.|||.+ |.+|||||+.||||+++|.|||+|||.+-.+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999996543 34599999999999999999999999 99999999999999999999999999876554
Q ss_pred CCCcc---ccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 207 EDITH---ISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 207 ~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
..... ...+..||++|+|||++.. .+|+.|+||||||++..||.+|+.||....+........ ..... .
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp--~-- 251 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPP--T-- 251 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCC--C--
Confidence 33221 1145689999999999654 479999999999999999999999998666543321111 01000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
.....+..+-.......+++++..||+.||.+|||++++++ +++..+
T Consensus 252 -~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 252 -LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred -cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 00111111111223447999999999999999999999975 444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=338.97 Aligned_cols=249 Identities=23% Similarity=0.417 Sum_probs=215.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
..|....+||+|+.|.||.+.. .+++.||+|++........+.+.+|+.+|+..+|+|||.+++.|...+..+.||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5677888999999999999974 468889999999877777788999999999999999999999998889999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+||+|.|.+ ....++|.++..++.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999998 334599999999999999999999999 999999999999999999999999999988766544
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
...+..|||.|||||+.....|+++.||||||++++||+.|++||.+.++....+++..... ..-
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~--------------P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT--------------PKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC--------------CCc
Confidence 33557899999999999999999999999999999999999999987665544433322111 111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...+..|.+++.+||+.|+.+|+++.|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 233344677999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=332.63 Aligned_cols=274 Identities=19% Similarity=0.260 Sum_probs=217.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++++.||+|+||.||+|+.+ +|..+|+|+++.. ...+.+.+..|-.+|....+|.||+++-.|.+.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4588999999999999999999865 6999999999855 34556788899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||++||++..+| ...+.+++..+..++.+++.|+..||+. |++||||||+|+|||..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999 6778999999999999999999999999 9999999999999999999999999998533
Q ss_pred CC-----------------------CCc----ccc-------------------ccccCCcCccCccccccCCCCccccc
Q 042383 206 PE-----------------------DIT----HIS-------------------TRVAGTLGYLAPDYAVSGHLNPKSDI 239 (353)
Q Consensus 206 ~~-----------------------~~~----~~~-------------------~~~~g~~~y~aPE~~~~~~~~~~~Dv 239 (353)
.. ... ... ....|||-|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 000 000 01469999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC--
Q 042383 240 YSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-- 317 (353)
Q Consensus 240 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-- 317 (353)
||||||+||||.|.+||...+..+.+..+..-..... .........+..+||.+||. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999998887766654433221111 11111223678899999999 9999975
Q ss_pred -HHHHHH--HhcCCC--CCCCCccccCCcccc
Q 042383 318 -MSTVIE--MINGDV--DIDDDVEIWEPGLIN 344 (353)
Q Consensus 318 -~~evl~--~L~~~~--~~~~~~~~~~~~~~~ 344 (353)
++||-+ .++++. .+..+.+.+.|.+..
T Consensus 438 G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 438 GAEEIKKHPFFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred cHHHHhcCCccccCCcchhhcCCCCCCCCCCC
Confidence 555533 233332 222333455555443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=343.84 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=218.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.+-|++++.||.|+.|.|-+|++. +|+.+|||++... +......+.+|+.+|+.+.|||++++++++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356889999999999999999865 7999999999865 233446788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
.||++||.|++++ -.++++++.++.+++.||+.|+.|+|.. +||||||||+|+|++..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 9999999999999 5678999999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
. ...-.+.+|+|.|++||++.+..| +.++||||+|+|||.||+|+.||.+++- ..+..+.....
T Consensus 164 ~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G~---------- 228 (786)
T KOG0588|consen 164 P--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRGV---------- 228 (786)
T ss_pred C--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcCc----------
Confidence 3 445577899999999999999987 5799999999999999999999983332 22222222111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCCcccc
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDDDVEIW 338 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~~~ 338 (353)
-+.+...+.+..+|+.+||.+||++|.|++||++ +|.+-..++.+-..+
T Consensus 229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~ 279 (786)
T KOG0588|consen 229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLR 279 (786)
T ss_pred ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcC
Confidence 1122333556788999999999999999999988 466666666643333
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=337.94 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=204.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC-
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEG- 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 120 (353)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346899999999999999999974 235679999987443 23346788999999999 899999999988764
Q ss_pred CceEEEEEcCCCCChhhhhhhccc--------------------------------------------------------
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK-------------------------------------------------------- 144 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~-------------------------------------------------------- 144 (353)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999998854211
Q ss_pred --cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-ccccccCCcC
Q 042383 145 --NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLG 221 (353)
Q Consensus 145 --~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~ 221 (353)
...++++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 023578889999999999999999999 9999999999999999999999999999865332211 1222345678
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHH
Q 042383 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRF 300 (353)
Q Consensus 222 y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 300 (353)
|+|||++.+..++.++|||||||++|||++ |..||.......... ... .... ....+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~--~~~---~~~~----------~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC--QRL---KDGT----------RMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHH---hcCC----------CCCCCCCCCHHH
Confidence 999999999999999999999999999997 999997644322111 000 0000 011122335678
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 301 LKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 301 ~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.+++.+||+.||++|||+.||++.|++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=329.17 Aligned_cols=249 Identities=22% Similarity=0.408 Sum_probs=215.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
...|+..+.||+|.||.||+|.+. +++.||+|++..+. ....+.+.+|+.+|.+++++||.++++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777789999999999999865 68899999999774 4445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
||.||++.+.+ .....+++..+..++++++.|+.|||+. +.+|||||+.||++..+|.+||+|||++-.....
T Consensus 92 y~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999 5556669999999999999999999999 9999999999999999999999999999877655
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.... .++.|||.|||||++.+..|+.++||||||++++||++|.+|+....+. ++.-++-+..
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~ 227 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSA 227 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCC
Confidence 4444 6688999999999999889999999999999999999999999754442 2222233333
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+.+.......+.+++..||+.||+.|||+.++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 34455566677999999999999999999999974
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=325.62 Aligned_cols=265 Identities=21% Similarity=0.315 Sum_probs=205.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999976 57889999987542 2334567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++++++.... .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987665443 2345789999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---------ccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---------TDK 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~ 279 (353)
.........|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........ ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 33333345689999999999988999999999999999999999999986554332222211110000 000
Q ss_pred cccccCcccC------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLC------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+... .......+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0111223557999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.82 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=210.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+. +....+.+.+|+++++.++||||+.+++.|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 6889999998754 34455789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.| +|..++ ...+.++++.+..++.+++.||.|||+. +|+|||+||.|||++.++++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9988 999999 6678899999999999999999999999 9999999999999999999999999999987653
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
+.......|||-|||||+..+..|+..+|+||+||++||+++|++||....-. .++...+
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------------------~Lv~~I~ 213 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------------------QLVKSIL 213 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------------------HHHHHHh
Confidence 34445678999999999999999999999999999999999999999743321 1111111
Q ss_pred CC--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CG--NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
++ ..+......+..++...|..||.+|.|-.+++.
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11 233455677999999999999999999998864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=331.88 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=216.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-eEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC-RIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 126 (353)
.++|.+++++|+|+||.++.++++ +++.+++|.+.... ....+...+|+.++++++|||||.+.+.|++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367999999999999999999866 57889999998653 3334577899999999999999999999999888 9999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|+||+||++.+.+... ++.-++++.+..|+.|++.|+.|||+. +|+|||||+.|||++.++.|+|+|||+++.+.
T Consensus 83 m~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999543 357799999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+... ++.++.+ .
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~------------~ 221 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINR------------G 221 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhh------------c
Confidence 653 24455789999999999999999999999999999999999999998655422 2222211 1
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.....+.....++..+|..|++.+|..||++.++|..
T Consensus 222 -~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1244566667889999999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=325.80 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999876 68899999987432 233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ ...+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999998 3456789999999999999999999999 999999999999999999999999999886543
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .... ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~---~i~~----~~-------- 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE---KILA----GK-------- 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----CC--------
Confidence 2 223568999999999999899999999999999999999999997654322111 1100 00
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIEM 324 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~~ 324 (353)
..++......+.+++.+||+.||.+||+ ++++++.
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122223556889999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.40 Aligned_cols=246 Identities=19% Similarity=0.263 Sum_probs=199.6
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc---HHHHHHHHHHHHhcCCCCceeeeeeEec----CCceEEEEEcC
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG---EKEFMSEVASMANICHENLVKLHGGCIE----GPCRIIVYDYM 130 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 130 (353)
..||+|+++.||+|... |+.||+|.++...... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999984 8899999987543322 4667899999999999999999999876 45688999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|.+++. ....+++.....++.|++.||.+||+. .+++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999983 445789999999999999999999973 288899999999999999999999999988654321
Q ss_pred cccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 211 HISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
....++..|+|||++.+ ..++.++|||||||++|+|++|..||...+....... . .....
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~---i------------~~~~~ 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---I------------INKNN 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH---H------------HhcCC
Confidence 23457889999999876 6789999999999999999999999975543211111 0 00011
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11223345677999999999999999999999999998654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=329.47 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=206.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999976 58899999987442 223456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999998 3456789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.... ..+...
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK---------ETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc---------ccccCC
Confidence 2234568999999999999999999999999999999999999997654432221111100 000000
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.........+..+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000012335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=319.72 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=202.3
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.|++.+.||+|+||+||++... +|+.||+|.+.... ......+.+|+.++.+++|++|+++.+++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 78999999987432 2233457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+.+.. .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999888743 2334689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||............... ... .
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~----------~ 220 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR---VKE----------D 220 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH---hhc----------c
Confidence 2 123356899999999999999999999999999999999999999865432221111100 000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
...++...+..+.+|+.+||+.||++||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01222334567889999999999999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=329.45 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=202.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367899999999999999999876 68899999987432 23345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+.+++|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999998 3456789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... ....|++.|+|||++.+..++.++|||||||++|+|++|..||........+ ..... .
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~----~-------- 230 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---EKILA----G-------- 230 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH---HHHhc----C--------
Confidence 322 2356899999999999999999999999999999999999999755432211 11110 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
. ..++...+..+.+++.+||+.||.+||+ ++++++
T Consensus 231 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 231 R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0112223456889999999999999997 677763
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=319.60 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=204.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC-----------------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCcee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD-----------------GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVK 112 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 112 (353)
.++|++.+.||+|+||.||+|.+++ +..||+|++.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678999999999999999997532 3469999987543 334567889999999999999999
Q ss_pred eeeeEecCCceEEEEEcCCCCChhhhhhhccc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 042383 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK---------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177 (353)
Q Consensus 113 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~ 177 (353)
+++++.+.+..++||||+.+++|.+++..... ....+++..+..++.||+.||.|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999998854211 123578889999999999999999999 999
Q ss_pred EcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh--CCC
Q 042383 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT--GQA 254 (353)
Q Consensus 178 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~ 254 (353)
|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976533221 12233445778999999988899999999999999999987 556
Q ss_pred CCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 255 AVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 255 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
||........ ............. ......++.++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7764432211 1111111111000 00011223345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.63 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=203.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357999999999999999999865 688999999875432 233567789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 89888732 234578999999999999999999999 9999999999999999999999999998765332
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc-----
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH----- 282 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 282 (353)
.. ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+................+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 21 1233467889999998865 5689999999999999999999999976654433332222211111111111
Q ss_pred ----ccCcccCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 ----LVDPMLCG----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ----~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111000 011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=348.18 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=217.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.+-...+.||+|.||.||+|+.. +...||||.++..... ...+|.+|++++..++|||||+++|+|.+++.+|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34456789999999999999743 3467999999976555 6789999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccc------c----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 125 IVYDYMQNNSLSQTLLGEEK------N----RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~------~----~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
+|+|||..|+|.++|..... . ..+++..+.+.++.|||.|+.||-++ .+|||||..+|+||+++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999954321 1 23489999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccC-CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHH
Q 042383 195 KISDFGLSKLF-PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 195 kl~Dfg~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 272 (353)
||+|||+++.. ..+.........-+.+|||||.+..+.++.+|||||+||+|||+++ |..|+..-...+-
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV-------- 714 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV-------- 714 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH--------
Confidence 99999999844 2333333334455779999999999999999999999999999999 8899875443222
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
+..+.+..+ -..+..++.++..|+..||+.+|++||++.||-..|+......
T Consensus 715 -------Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 -------IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -------HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 222222222 4566777899999999999999999999999999998765443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=317.94 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=211.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
...+|++.+.||+|+||.|-+|.. ..|+.||||.|+.. +..+.-.+.+|++++..|+||||+.++.+|++.+..+|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 357899999999999999999975 68999999999854 44555678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||..+|.|++++ ...+.+++.++..++.||.+|+.|+|.+ +++|||||.+|||+|.++++|++|||++..+
T Consensus 131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999 6788999999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.. ....++++|+|-|.+||++.+.+| ++..|-||||++||-|..|..||.+.+.... +..+.
T Consensus 204 ~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---vrQIs------------ 266 (668)
T KOG0611|consen 204 AD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---VRQIS------------ 266 (668)
T ss_pred cc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---HHHhh------------
Confidence 54 455678999999999999999887 5889999999999999999999986654221 11111
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..... .++.+....-||++||-.||++|.|+.+|...
T Consensus 267 ~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 267 RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111 11222335567889999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=325.50 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=197.8
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||+|..+ +|+.||+|++.... ......+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68899999987432 233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 213 (353)
+|.+.+ .....+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHL----SRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999888 3456789999999999999999999999 9999999999999999999999999998753221 1222
Q ss_pred ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... .. ... ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---~~----~~~----------~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---IL----MEE----------IRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH---HH----cCC----------CCCC
Confidence 345689999999999999999999999999999999999999975443211111 00 000 1122
Q ss_pred hHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...+..+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 33456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.38 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=206.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999876 68889999987553 3344678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++ .....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVL----KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999998 3445689999999999999999999985 16999999999999999999999999998765332
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc-cc--------
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT-DK-------- 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-------- 279 (353)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....... ..... ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPR 232 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcc
Confidence 22335689999999999999999999999999999999999999965443211100000 00000 00
Q ss_pred ------------------------cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 ------------------------LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+.............+..+.+|+.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000112345679999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=333.42 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=209.4
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
.....++|.+.++||+|.||+|+++..+ +++.+|||+++.. ..++.+....|..++... +||+++.++.+|...+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3445688999999999999999999866 6889999999865 445567778888888877 5999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
+.|+||||+.||++... ...+.+++..+..++..|+.||.|||++ +|+|||||.+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~-----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH-----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEE-----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 99999999999995544 3557899999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
++-.-. ......+++|||.|+|||++.+..|+.+.|.|||||++|||+.|+.||.++++++.+..+..
T Consensus 515 cKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------- 582 (694)
T KOG0694|consen 515 CKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------- 582 (694)
T ss_pred ccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------
Confidence 984321 23356779999999999999999999999999999999999999999998887655432211
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
+. ..++...+.+...++.++|..+|++|.-.
T Consensus 583 ---d~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ---DE---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CC---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 22444556778889999999999999865
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=316.67 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=205.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|++.+.||+|+||.||+|..+ .+..||+|.++... ......+.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 35689999988553 3334578899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999998842 235789999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
............++..|+|||.+.+..++.++|||||||++|++++ |..||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~~----------- 223 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---KAVED----------- 223 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHHHC-----------
Confidence 3221111122334678999999999999999999999999999875 99999755432211 11100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
......+...+..+.+++.+||+.+|.+|||+++|++.|++.
T Consensus 224 --~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 --GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122334566789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.59 Aligned_cols=260 Identities=21% Similarity=0.360 Sum_probs=204.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.+.||+|+||+||+|.+ .++..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999963 245689999987432 33446788999999999 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc----------------------------------------------------------
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK---------------------------------------------------------- 144 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 144 (353)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998853211
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 145 -------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 145 -------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 113578899999999999999999999 9999999999999999999999999999865433221
Q ss_pred -ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 212 -ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 212 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.......... .... . ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~--~~~~----~---------~~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY--KMIK----E---------GYR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH--HHHH----h---------Ccc
Confidence 1122334567999999999999999999999999999998 888886543221111 0000 0 000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111122245789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=312.68 Aligned_cols=276 Identities=22% Similarity=0.308 Sum_probs=220.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEee--ccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-----CC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHGGCIE-----GP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 121 (353)
....|...+.||+|++|.|+.+.++ +|+.||+|.+. ..+....++..+|+.+|+.++|+||+.+.+++.- -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456667899999999999999865 78999999988 5677788899999999999999999999998764 45
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..|+|+|+|+ .+|.+.+ ..+..+++..+..+++|++.||.|+|+. +++||||||.|++++.++.+|++|||+
T Consensus 100 DvYiV~elMe-tDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHh-hHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 6799999994 4899988 4556699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCC-CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPED-ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|+..... .....+.+..|..|+|||++.. ..|+.+.||||+|||+.||++|++.|.+.+...+..++.........+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987543 1233356778999999998764 5799999999999999999999999999887777766665443333222
Q ss_pred ccccc--------Ccc---cCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH-----HhcCCCCCCC
Q 042383 280 LQHLV--------DPM---LCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE-----MINGDVDIDD 333 (353)
Q Consensus 280 ~~~~~--------~~~---~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~-----~L~~~~~~~~ 333 (353)
+..+- ... .... .-+...+..++|+.+||..||.+|+|++|.|+ .+.+..+-|.
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~ 324 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPV 324 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCC
Confidence 22221 111 0111 11234566889999999999999999999964 4555555553
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=313.74 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=208.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998878889999876433 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999998432 345688899999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ........ .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~-------------~ 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRGY-------------R 222 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcCC-------------C
Confidence 22223345678999999988889999999999999999998 9999865432211 11111100 0
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.......+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11112234668899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=312.38 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.+.||+|+||.||++..+++..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999887778999987633 3334678889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.++........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999998842 234689999999999999999999999 9999999999999999999999999998865433222
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..... ....... ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~---~~i~~~~-------------~~ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV---EMISRGF-------------RL 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHCCC-------------CC
Confidence 2222335568999999988889999999999999999999 89998755432221 1111100 00
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
..+...+..+.+++.+||+.+|++|||++++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=323.55 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=200.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc----ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCce
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE----SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 123 (353)
+|++.+.||+|+||+||+++.. +++.||+|++... .....+.+..|+.++..+ +||+|+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999752 5789999998743 122335677899999999 599999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998 3456789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..............||+.|+|||++.+. .++.++|||||||++|+|++|..||............... ...
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--ILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--Hhc------
Confidence 6543333333446789999999998865 4788999999999999999999999754332221111110 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
.....+...+..+.+++.+||+.||++|| +++++++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00122233456688999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=312.59 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=209.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----ceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP-----CRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 124 (353)
.-.|.-.+++|+|+||.||.|... +++.||||..-.+.. --.+|+.+|+.++|||||++.-+|.... +..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345677889999999999999865 578999998754332 2347999999999999999998886322 445
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeeccCCc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSK 203 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~ 203 (353)
+||||++. +|.+.+......+..++...++-+..||++||.|||+. +||||||||.|+|+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999987 99999976656678899999999999999999999998 99999999999999875 899999999999
Q ss_pred cCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....+... ..+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+...+...+-+....+..+.+..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 88655444 345678899999988865 799999999999999999999999998777666665555443333222222
Q ss_pred cc-------CcccC-----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LV-------DPMLC-----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~-------~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+- .+.+. .-+....+++..+|+.++|+.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 11111 1134455678999999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=315.91 Aligned_cols=259 Identities=25% Similarity=0.343 Sum_probs=208.4
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------------hcHHHHHHHHHHHHhcCCCC
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------------QGEKEFMSEVASMANICHEN 109 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ 109 (353)
.+-....+.|++.+.||+|.||.|-+|... +++.||||++..... ...+...+|+.+|++++|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 333445688999999999999999999865 689999999973211 12357889999999999999
Q ss_pred ceeeeeeEec--CCceEEEEEcCCCCChhhhhhhccccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 110 LVKLHGGCIE--GPCRIIVYDYMQNNSLSQTLLGEEKNRAK-FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 110 iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~-l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
||+++.+..+ .+..|+|+|||..|.+... ...++ +++.+++.++.+++.||+|||.+ +|+||||||.|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL 241 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL 241 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence 9999999875 4578999999998877543 34455 99999999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCC----ccccccccCCcCccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCC
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDI----THISTRVAGTLGYLAPDYAVSGH----LNPKSDIYSFGVLLLQIVTGQAAVHF 258 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~pf~~ 258 (353)
|++++|++||+|||.+..+.... ........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||..
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 99999999999999998774321 11223367999999999887643 35789999999999999999999986
Q ss_pred CcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 259 DKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
....+.+ .+++...+.-.-.++..+.+.+||+++|+.||++|.+..+|....-
T Consensus 322 ~~~~~l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 DFELELF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred chHHHHH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 6554433 2233333333333456778999999999999999999999876543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=337.29 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-C-CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-D-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 44899999999999999999754 3 678999987665555556778899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++|+|.+.+........++++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998865444566799999999999999999999999 99999999999999999999999999998764432
Q ss_pred c-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 T-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ..... ...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~---~~~~~----~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM---QQVLY----GKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CCC--------
Confidence 2 1233456899999999999999999999999999999999999999754432111 11100 000
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112233456899999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=330.17 Aligned_cols=260 Identities=21% Similarity=0.362 Sum_probs=204.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.+ +|+||+++++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457899999999999999998742 24579999997543 33345688999999999 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc----------------------------------------------------------
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK---------------------------------------------------------- 144 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 144 (353)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998843210
Q ss_pred --------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-cccc
Q 042383 145 --------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTR 215 (353)
Q Consensus 145 --------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 215 (353)
...++++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 123578899999999999999999999 9999999999999999999999999998765432211 1122
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCCh
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSG 294 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (353)
..++..|+|||++.+..++.++|||||||++|+|++ |..||............ .. .......+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~---~~------------~~~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM---VK------------RGYQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH---HH------------cccCccCCC
Confidence 335667999999998899999999999999999997 99999754332211110 00 000111111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 295 NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 295 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2246789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=325.16 Aligned_cols=246 Identities=22% Similarity=0.284 Sum_probs=202.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-C-CcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-D-GTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|.+.+.||+|+||.||+|.++ + +..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 467999999999999999999854 2 368999998643 22334567889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999998 3456789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+.. ...
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~---i~~------------ 242 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK---ILE------------ 242 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH---Hhc------------
Confidence 432 2345689999999999988899999999999999999999999986543221111 110
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIEM 324 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 324 (353)
.. ..++...+..+.+++.+||+.+|++|+ +++++++.
T Consensus 243 ~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 243 GI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 011222345578999999999999995 89888764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=329.01 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=205.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999976 68999999987432 234467888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999983 336799999999999999999999998 999999999999999999999999999986644
Q ss_pred CC----------------------------ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 042383 208 DI----------------------------THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFD 259 (353)
Q Consensus 208 ~~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~ 259 (353)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456899999999999999999999999999999999999999765
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-MSTVIEM 324 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~ 324 (353)
........+ .... ..+........+..+.+++.+||+ +|.+||+ ++++++.
T Consensus 234 ~~~~~~~~i---~~~~----------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKI---INWK----------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHH---hccC----------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 532221111 0000 000001111135678899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=320.07 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=194.6
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||+|+||+||+|... +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 5888999998743 233446678899999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+++. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99983 456789999999999999999999999 99999999999999999999999999987543221 22234
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..||+.|+|||++.+..++.++|||||||++|+|++|..||......... .... .. ...++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~---~~~~------------~~--~~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY---RKIL------------QE--PLRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH---HHHH------------cC--CCCCCCc
Confidence 56899999999999999999999999999999999999999754322111 1110 00 0122233
Q ss_pred HHHHHHHHHhhccCCCCCCCCCH---HHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRM---STVIE 323 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~---~evl~ 323 (353)
.+..+.+++.+||+.||++||++ .+++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 45678899999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=313.12 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=212.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
..+|++.++||.|++|+||+|...++..+++|++..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688999999999999999998888999999998766656678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++... ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999432 345689999999999999999999999 999999999999999999999999999976643322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. .....++..|+|||.+....++.++||||||+++|+|++ |..||......+...... . ...
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~-------------~~~ 222 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A-------------GYR 222 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h-------------CCc
Confidence 2 123345678999999988899999999999999999998 899986544222111110 0 011
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+..+.+++.+||+.+|.+|||++++++.|+++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122334456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=320.26 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=196.5
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999865 6899999998754 2233456678999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 213 (353)
+|..++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 998887 3445789999999999999999999999 99999999999999999999999999987532211 122
Q ss_pred ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...+........ . ... ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~---~----~~~----------~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---L----MEE----------IRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---h----cCC----------CCCC
Confidence 3356899999999999999999999999999999999999999754432211110 0 000 1122
Q ss_pred hHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...+..+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23356688999999999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.19 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=197.7
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6889999998743 2233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 213 (353)
+|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 998888 3445789999999999999999999999 99999999999999999999999999987533221 122
Q ss_pred ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .. ... ...++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~---~~----~~~----------~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LI----LME----------DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH---Hh----ccC----------CccCC
Confidence 34568999999999999999999999999999999999999997544321111 00 000 01122
Q ss_pred hHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIEM 324 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 324 (353)
...+..+.+++.+||+.||++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 33456688999999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=311.48 Aligned_cols=255 Identities=27% Similarity=0.378 Sum_probs=207.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.+|.+.+.||+|++|.||+|..+ +++.+|+|.+... ......+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999865 5888999988743 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999998843 2345689999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+........ . ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~-------------~~~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E-------------KGYR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H-------------CCCC
Confidence 22222334567999999998999999999999999999998 88998654322111110 0 0111
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 222333456799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=326.89 Aligned_cols=260 Identities=21% Similarity=0.299 Sum_probs=207.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-C-----CCceeeeeeEecCCceEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-H-----ENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~l 125 (353)
+|.+.+.||+|+||.|.+|.+. +++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788999999999999999854 7999999999843 444556678999999996 4 389999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC--CCCeEEeeccCCc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ--NFNPKISDFGLSK 203 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~ 203 (353)
|+|.+.. +|+++++. .+..+++...++.++.||+.||.+||+. +|||+||||+|||+.. ...+||+|||.++
T Consensus 266 VfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999965 99999954 4556799999999999999999999999 9999999999999964 3479999999999
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc------
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT------ 277 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 277 (353)
...... ..+..+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+....+......+..
T Consensus 340 ~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 340 FESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 764432 2566788999999999999999999999999999999999999888877666544433211110
Q ss_pred cccccccC--------------------------------cccCC--------CCChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 278 DKLQHLVD--------------------------------PMLCG--------NFSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 278 ~~~~~~~~--------------------------------~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
.....+++ ....+ .........+.+++++||++||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000111 00001 112244567899999999999999999
Q ss_pred HHHHHH
Q 042383 318 MSTVIE 323 (353)
Q Consensus 318 ~~evl~ 323 (353)
+.+.++
T Consensus 496 p~qal~ 501 (586)
T KOG0667|consen 496 PAQALN 501 (586)
T ss_pred HHHHhc
Confidence 999976
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.70 Aligned_cols=264 Identities=21% Similarity=0.354 Sum_probs=198.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC--CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhc---CCCCceeeeeeEe-----c
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ--DGTVVAVKVLSVES--KQGEKEFMSEVASMANI---CHENLVKLHGGCI-----E 119 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 119 (353)
++|++.+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46789999987542 22234556677777665 6999999999875 3
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
....++||||++ ++|.+++.. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 489888843 2334689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|++...... .......|++.|+|||.+.+..++.++|||||||++|+|++|.+||......+....+...........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 999765432 223345689999999999888999999999999999999999999987655433322221111111111
Q ss_pred ccc---ccCcccC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQH---LVDPMLC-------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~---~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.. +....+. ....+..+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100 0000000 0111223566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=323.78 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=200.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----CceE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----PCRI 124 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 124 (353)
+|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999865 6899999998743 223345678999999999999999999987543 2479
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+. ++|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVI----KANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHH----HhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 5898888 3455799999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCc--cccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc---
Q 042383 205 FPEDIT--HISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT--- 277 (353)
Q Consensus 205 ~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 277 (353)
...... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.........
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 12234568999999998875 67899999999999999999999999765433222111111000000
Q ss_pred -----cccccccCcc---cCCCC---ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCC
Q 042383 278 -----DKLQHLVDPM---LCGNF---SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDV 329 (353)
Q Consensus 278 -----~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~ 329 (353)
......+... ....+ .+..+..+.+++.+||+.||++|||++|+++. +++..
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0000000000 00000 01224567899999999999999999999853 44433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.79 Aligned_cols=239 Identities=27% Similarity=0.428 Sum_probs=204.3
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChh
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLS 136 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 136 (353)
++=||.|+.|.||+|+.. ++.||||.++. .-..++.-|++|+||||+.+.|+|....++|||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 456999999999999987 67799998762 1235788999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccc
Q 042383 137 QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216 (353)
Q Consensus 137 ~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 216 (353)
..| +...++.......|..+|+.|++|||.+ .|||||||.-||||+.+..|||+|||-++...+..+. -.+
T Consensus 201 ~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MSF 271 (904)
T KOG4721|consen 201 EVL----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MSF 271 (904)
T ss_pred HHH----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hhh
Confidence 999 6677899999999999999999999999 9999999999999999999999999998866543222 236
Q ss_pred cCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHH
Q 042383 217 AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNE 296 (353)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
.||..|||||++.+.+.+.|.|||||||+||||+||..||.+-+... .+..+=...+.-..+..+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCcccccCcccC
Confidence 79999999999999999999999999999999999999997544321 111111223344566777
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 297 AVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 297 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
+..|.-|+++||+..|..||+|++|+..|.=
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 8889999999999999999999999998853
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.52 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=207.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|++|.||+|..++++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999998777889999987433 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++... ....+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999998432 234689999999999999999999999 999999999999999999999999999987653222
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
........+..|+|||.+.+..++.++||||||+++|+|++ |+.||......... ..... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~-------------~~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQVDQ-------------GYR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHc-------------CCC
Confidence 11122223457999999998899999999999999999999 99998654322111 11100 001
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
...+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11222345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.04 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=207.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD------GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998542 2579999887443 334467889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 125 IVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
++|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999854321 115688999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
.++|+|||++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~---~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---EM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH
Confidence 99999999987653221 122233456788999999988899999999999999999998 99998754432111 11
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.. . ......+...+.++.+|+.+||+.||.+||++++|++.|++
T Consensus 239 i~----~---------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR----S---------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----c---------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 10 0 11112234456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=336.62 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=215.7
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCC-cEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeee-Eec------
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDG-TVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGG-CIE------ 119 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~------ 119 (353)
....+++|.+.|.+|||+.||+|....+ ..+|+|.+-..+....+.+.+|+.++++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788899999999999999997755 999999988778888899999999999996 9999999993 221
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
.-.++|+||||.||.|-|++.... ...|++.++++|+.++++|+.+||.. +..|+|||||-+||||+.+++.|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 124679999999999999995443 34499999999999999999999987 556999999999999999999999999
Q ss_pred cCCccCCCCCccc--------cccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHH
Q 042383 200 GLSKLFPEDITHI--------STRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV 268 (353)
Q Consensus 200 g~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~ 268 (353)
|.+.-.-...... .-...-|+.|+|||++. +...++|+|||+|||+||-|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 9986332111110 01134589999999764 67889999999999999999999999985432
Q ss_pred HHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 269 EKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
..|++..+.-.-.+.....|..||+.||+.||.+||++-+|++.+..+...+.
T Consensus 264 ------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 264 ------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 23444444434446778899999999999999999999999999988877665
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.82 Aligned_cols=264 Identities=22% Similarity=0.370 Sum_probs=203.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 68889999887542 3344678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++ ...+.+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999998 3445689999999999999999999974 17999999999999999999999999998755332
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc-----c-----
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT-----D----- 278 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~----- 278 (353)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..................... .
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 123356889999999999888999999999999999999999999754331111000000000000 0
Q ss_pred ---------------ccccccCcccC---CCC-ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 ---------------KLQHLVDPMLC---GNF-SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ---------------~~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+.+.... ... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000000 000 1123456889999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.15 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=199.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 688999999875432 223456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++ ++|.+++. .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 57877773 2345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchh-hHHHHHHhhccccccc-----
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQ----- 281 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~----- 281 (353)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....+.... ..............+.
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 1 12233567899999998865 45788999999999999999999999764332111 1111110000000000
Q ss_pred -cccCcccCCCCC---------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 -HLVDPMLCGNFS---------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 -~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...........+ ......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000 011245779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=327.78 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=203.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999875 6889999998742 22334557789999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++|+|.+++. ...+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999883 23588999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccCCcCccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSG----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+.. ..... .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i~~~~--~--- 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---IMDHK--N--- 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH---HHcCC--C---
Confidence 43322233446789999999988653 378899999999999999999999986554222111 11000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIEM 324 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 324 (353)
.+........+..+.+++.+||+.+|++ |||++++++.
T Consensus 265 -----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0000011123567889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=302.21 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=211.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 126 (353)
+.|+.+..|++|+||.||+|+++ +++.||+|.++.+. ..-.-...+|+.+|.+.+|||||.+-.+.+. -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56788899999999999999966 68899999998543 1222456799999999999999999987763 4568999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
||||+. +|...+.. -..+|...+++.++.|++.|++|||++ .|+|||||+.|+|++..|.+|++|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 88888832 346899999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
..... .+...-|..|+|||.+.+. .|+.+.|+||+|||+.||+++.+.|.+..+.++...+......+....+..+..
T Consensus 229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 65333 4456679999999998875 699999999999999999999999999888777766655443333222221111
Q ss_pred --------------cccCCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 --------------PMLCGNFSGN-EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 --------------~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...+... ..+.-.+|+..+|..||++|.|+.|.|+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1112222222 3466778999999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.42 Aligned_cols=259 Identities=18% Similarity=0.228 Sum_probs=198.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+|.+.+.||+|+||.||+|.+. +++.||+|... ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999865 68899999653 23467899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+. ++|..++ .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYL----AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 95 5888887 3345689999999999999999999999 99999999999999999999999999997543322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccch-----hhHHHHHHhhcc-c------
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-----YYLVEKAWEMHN-T------ 277 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~-~------ 277 (353)
........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..+......... .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2233446799999999999999999999999999999999999988754332110 000000000000 0
Q ss_pred --ccccccc---------CcccCCCC--ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 278 --DKLQHLV---------DPMLCGNF--SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 278 --~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+.... .+...... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00000000 0123567889999999999999999999984
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=326.93 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 68899999997432 233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999983 445799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc-------------------------------------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHH
Q 042383 208 DITH-------------------------------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIV 250 (353)
Q Consensus 208 ~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (353)
.... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999999999999999999999999999
Q ss_pred hCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 042383 251 TGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR---MSTVIE 323 (353)
Q Consensus 251 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~ 323 (353)
+|..||...+....... ..... . .+........+..+.+++.+|+. +|.+|++ ++++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~---i~~~~--~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRK---IINWK--E--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHH---HHcCC--C--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999976543222111 10000 0 00000001224567888999996 9999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=309.22 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=210.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999865 6889999987642 2333456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865444556789999999999999999999999 999999999999999999999999999887643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .......... .
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~------------~ 224 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQC------------D 224 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcC------------C
Confidence 3221 123457889999999988889999999999999999999999986543211 1111111100 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+......+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=313.24 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=207.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888999999999999999753 2478999998755443 457889999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhcc----------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEE----------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~----------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
++||||+++++|.+++.... .....+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999985431 2235688999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHH
Q 042383 194 PKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 271 (353)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---ECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHH
Confidence 99999999875432211 11223345778999999999999999999999999999998 99998754432211 111
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
. ... ....+...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 238 ~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 T----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 000 011122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=323.46 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|.+.+.||+|+||+||++... +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 68899999998542 234456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999842 235799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccCCcCccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAV------SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||........... .... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---i~~~---~--- 225 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN---IMNF---Q--- 225 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH---HHcC---C---
Confidence 3333333456899999999887 45678899999999999999999999975543222111 1000 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+........+..+.+|+.+||+ +|.+|||++++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 226 ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000001112235668889999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.22 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
...++|++.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999976 5889999998642 2233456778999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999883 23589999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccCCcCccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGH----LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
.............||+.|+|||++.+.. ++.++||||+||++|+|++|..||...+.......+ .. ...
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i---~~---~~~- 264 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI---MD---HKN- 264 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---CCc-
Confidence 6443332334567999999999987643 788999999999999999999999765432221111 00 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIEM 324 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 324 (353)
.+........+..+.+++.+||..++.+ |||+.|+++.
T Consensus 265 ------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000011123456778888999865544 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.09 Aligned_cols=264 Identities=25% Similarity=0.413 Sum_probs=211.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|.+.+.||+|+||+||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999742 34568999987666566678899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 125 IVYDYMQNNSLSQTLLGEE---------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999985332 1223589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHh
Q 042383 196 ISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
|+|||.+........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .......
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i~~ 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECITQ 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc
Confidence 999999886543221 11223345678999999998899999999999999999998 888886443221 1111111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
... ...+...+..+.+++.+||+.||.+|||+.++++.|+++...+.
T Consensus 238 ----~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 238 ----GRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred ----CCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000 01111234568999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.46 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=209.6
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
.+.....++|.+.+.||+|+||+||+|+.. +|+.||+|++... .......+.+|+..+..++|+|+++++..+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 334445689999999999999999999864 6899999998754 3344466788999999999999999988765432
Q ss_pred --------ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 122 --------CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 122 --------~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 36799999999999999865545567899999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 194 PKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~---~~~~ 258 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM---HKTL 258 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHh
Confidence 9999999998654322 22234467899999999999999999999999999999999999999754321111 1110
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
... ....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 259 ----~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 ----AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ----cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 011233445678999999999999999999999763
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=323.45 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=197.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.|++++.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999865 68899999997532 2344678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++++||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999983 445789999999999999999999999 9999999999999999999999999997543110
Q ss_pred Cc----------------------------------------------cccccccCCcCccCccccccCCCCccccchhH
Q 042383 209 IT----------------------------------------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSF 242 (353)
Q Consensus 209 ~~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 242 (353)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhh--ccCCCCCCCCCHHH
Q 042383 243 GVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLL--CVQEKSSLRPRMST 320 (353)
Q Consensus 243 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~e 320 (353)
||++|+|++|..||...........+. . ... .+........+.++.+++.+ |+..++..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~---~---~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVI---N---WEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHH---c---ccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999997654322211110 0 000 00000111224567788877 55666667999999
Q ss_pred HHHH
Q 042383 321 VIEM 324 (353)
Q Consensus 321 vl~~ 324 (353)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=301.60 Aligned_cols=272 Identities=21% Similarity=0.332 Sum_probs=214.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCC-ceeeeeeEecCC------
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHEN-LVKLHGGCIEGP------ 121 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------ 121 (353)
..|...++||+|+||+||+|+.+ +|+.||+|.++.... .......+|+.+|++++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999865 789999999987644 24466789999999999999 999999999877
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++|+||++. +|..++.........++...++.++.||+.||+|||++ +|+||||||+||+|+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 89999854332224677899999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
|+.+...... .....+|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+.+....+-..........+
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 9966533222 3446678899999999987 7899999999999999999999999988876555555544444433333
Q ss_pred ccccC-----cccC-C----CCCh---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 042383 281 QHLVD-----PMLC-G----NFSG---NEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGD 328 (353)
Q Consensus 281 ~~~~~-----~~~~-~----~~~~---~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 328 (353)
..... ..+. . .+.. .......+++.+||+.+|.+|.|++..++. +..+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 32221 0010 0 1111 112467889999999999999999999886 5544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=308.10 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=203.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.+.||+|++|+||++...++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999988777779999887433 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||.+.........
T Consensus 83 ~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999998843 233689999999999999999999999 9999999999999999999999999998765433222
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~~-------------~~~ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKVSQG-------------LRL 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHhcC-------------CCC
Confidence 2222335667999999988889999999999999999998 9999864442211 1111100 001
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
..+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123567899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=307.70 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
.+|++.+.||+|++|.||++.++++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578889999999999999998777789999886332 234567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++.. ....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999843 234689999999999999999999999 9999999999999999999999999998765432222
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ...... ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~-------------~~~ 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSAG-------------YRL 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHcC-------------CcC
Confidence 2222233457999999998899999999999999999999 78888654332111 111100 011
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 122234667999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=290.69 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=212.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++++.||+|.||.||.|+.+ ++--||+|++..+ ......++.+|+++-..|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3478999999999999999999865 6778999998744 23345778999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
++||...|+|...+.. .....+++...+.++.|++.|+.|+|.. +++||||||+|+|++..+.+|++|||.+-..
T Consensus 100 ilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999942 3556799999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
+ .....+.+||.-|.|||...+..++...|+|++|++.||++.|.+||......+.+..+.+..
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------------- 238 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------------- 238 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-------------
Confidence 3 334456889999999999999999999999999999999999999998766544443332211
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
-.++...+....++|.+|+..+|.+|.+..|++.
T Consensus 239 ----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 ----LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1122333556889999999999999999999875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=307.06 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=204.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|++|.||+|..+++..+|+|.+..... ....+.+|+.++++++|+|++++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 467899999999999999999988888899999874332 34578899999999999999999998764 5678999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999843 2234689999999999999999999999 999999999999999999999999999986644322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.... ...... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~-------------~~~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQVER-------------GYR 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHHc-------------CCC
Confidence 22222335567999999988889999999999999999999 8888865432211 111100 011
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
...+...+..+.+++.+||+.+|++|||++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12233345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=316.12 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=195.9
Q ss_pred CeeeeeCceEEEEEEe----CCCcEEEEEEeeccC----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKL----QDGTVVAVKVLSVES----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 257889999987431 22334567899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+.+ ...+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999988 3456788999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..... .... ...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~---~~~~------------~~~-- 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI---DKIL------------KGK-- 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH---HHHH------------cCC--
Confidence 1223356899999999999888999999999999999999999999755432111 1110 000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...+...+..+.+++.+||+.+|++|| +++++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112223356688999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=306.95 Aligned_cols=255 Identities=27% Similarity=0.387 Sum_probs=206.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|++.++||+|+||.||+|..++++.+|+|.+.... .....+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 356799999999999999999998888999999887433 34467889999999999999999999875 4568999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+.+++|.+++.. .....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999998843 2345789999999999999999999998 99999999999999999999999999997665322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........++..|+|||.+.+..++.++||||||+++|++++ |..||...+..... ..... ..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~-------------~~ 220 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI---QNLER-------------GY 220 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHHc-------------CC
Confidence 222223345678999999998889999999999999999999 99999754422111 11100 00
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
....+...+.++.+++.+||+.+|++|||++++++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111122234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=323.49 Aligned_cols=268 Identities=25% Similarity=0.454 Sum_probs=212.1
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
++..+..+...+...||+|.||+||+|+|-. .||||++... +.+..+.|.+|+.++++-+|.||+-+.|++.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4444455666788999999999999999763 4999999866 45566899999999999999999999999998876
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.||..+|+|.+|+.++... ...|.......|+.||++|+.|||.+ +|||+|||..|||+.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 9999999999999999543 35688899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-CccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 203 KLFPED-ITHISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 203 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
.....- .........|...|+|||++.. .+|++.+||||||+++|||++|..||.....+.....+. +....+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG---rG~l~p 612 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG---RGYLMP 612 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec---ccccCc
Confidence 754311 1111223457788999999874 468999999999999999999999998322211111000 000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC-CCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD-IDD 333 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~-~~~ 333 (353)
+. ......++.++.+|+..||..++++||++.+|+..|+.... ++.
T Consensus 613 d~---------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk 659 (678)
T KOG0193|consen 613 DL---------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK 659 (678)
T ss_pred cc---------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence 00 11234457789999999999999999999999998888776 544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=320.19 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=196.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|+..+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999865 68999999986443 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+.. ..++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 356778889999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 210 THISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ......|+..|+|||++.. ...+.++|||||||++|+|++|..||.................
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 290 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----------- 290 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----------
Confidence 1 1233568999999998743 2345689999999999999999999974332211111111100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 291 --~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 --SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00112223345679999999999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.03 Aligned_cols=242 Identities=23% Similarity=0.293 Sum_probs=196.5
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 6889999999753 2233456678999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
+|..++ .....+++..+..++.||+.||.|||+ . +++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 999887 345578999999999999999999997 6 999999999999999999999999999875332211 2
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ .... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~----------~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE----------IRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC----------CCC
Confidence 23356899999999999999999999999999999999999999754432111110 0000 112
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIEM 324 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 324 (353)
+...+..+.+++.+||+.||++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 223355688999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=309.03 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=201.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
+|++.+.||+|+||+||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999865 68899999987432 2223456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+.+.. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988743 2335689999999999999999999999 9999999999999999999999999998865432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. .....|++.|+|||++.+..++.++||||+||++|+|++|..||............. ..... .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~----------~ 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE----------D 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh----------c
Confidence 21 223468899999999998889999999999999999999999997644322111111 00000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...++...+..+.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0122333456688999999999999999 7888855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=310.68 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=205.4
Q ss_pred cCC-CCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--Cc
Q 042383 52 NGF-CSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PC 122 (353)
Q Consensus 52 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 122 (353)
++| ++.+.||+|+||+||++.. .++..||+|++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 444 8899999999999988653 357789999987543 23456788999999999999999999987653 45
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.+++|||+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 789999999999999883 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 203 KLFPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 203 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ............+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTVVRL 233 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccchhhh
Confidence 876543221 1122335667999999988889999999999999999999999986543211000 0000000001111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+.......+...+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1122222222334445678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=306.54 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=205.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.+.||+|+||+||+|.+.. ...||+|.+.... ......+.+|+.+++.++||||+++++.+.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998642 4579999887543 33446788899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++.. ....+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999843 234789999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 207 EDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 207 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~~---------- 224 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAVEDG---------- 224 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHHHcC----------
Confidence 222211 112334578999999998899999999999999999998 9999864432211 1111100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.....+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=308.59 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||+|+||+||++... +++.+|+|.+..... ...+.+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 688999999874322 2235567899999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+.+.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 888754434556799999999999999999999999 999999999999999999999999999876543322 2233
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||............. . .+.... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~--------~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---Q--------RILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---H--------hhcccC--CCCccc
Confidence 568999999999999999999999999999999999999997544321111000 0 000000 112233
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
.+..+.+++.+||+.||++|| |++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456788999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.43 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=198.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|.+.+.||+|+||+||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999865 6889999998643 2233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999983 456789999999999999999999999 999999999999999999999999999864321
Q ss_pred CCcc----------------------------------------------ccccccCCcCccCccccccCCCCccccchh
Q 042383 208 DITH----------------------------------------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYS 241 (353)
Q Consensus 208 ~~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 241 (353)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCC---CCH
Q 042383 242 FGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLR---PRM 318 (353)
Q Consensus 242 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~ 318 (353)
|||++|+|++|..||........+..+ .... . .+.-......+..+.+++.+||. +|.+| +|+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i---~~~~---------~-~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKI---INWR---------E-TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHH---HccC---------C-ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999999765442222111 1000 0 00000001124568889999997 66665 599
Q ss_pred HHHHHH
Q 042383 319 STVIEM 324 (353)
Q Consensus 319 ~evl~~ 324 (353)
.++++.
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=323.52 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=206.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESK-QGEKEFMSEVASMANIC-HENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 122 (353)
.++|.+.+.||+|+||+||+|.+. .+..||+|++..... ...+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568999999999999999999753 134699999875433 33467889999999996 9999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc----------------------------------------------------------
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK---------------------------------------------------------- 144 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~---------------------------------------------------------- 144 (353)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988854211
Q ss_pred ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC
Q 042383 145 ----------------------------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ 190 (353)
Q Consensus 145 ----------------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~ 190 (353)
....+++..+..++.||+.||.|||+. +++|+||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 113578889999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHH
Q 042383 191 NFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLV 268 (353)
Q Consensus 191 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 268 (353)
++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 999999999998765432221 1222346778999999998899999999999999999997 889986433221111
Q ss_pred HHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 269 EKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.... . ......+...+..+.+++.+||+.+|++|||+.+|.+.|+...
T Consensus 351 ~~~~----~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NKIK----S---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHh----c---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0000 0 0111122334567899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=316.19 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=215.2
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh---cHHHHHHHHHHHHhcC-CCCceeeeeeEecCCce
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ---GEKEFMSEVASMANIC-HENLVKLHGGCIEGPCR 123 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 123 (353)
.....|++.+.||+|.||.||+++.+ +|+.+|+|++...... ....+.+|+.+|+++. ||||+.+.++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 35678999999999999999999976 5999999999865332 3468899999999998 99999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC----CCCeEEeec
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ----NFNPKISDF 199 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~----~~~~kl~Df 199 (353)
++|||++.||.|.+.+... .+++..+..++.|++.|+.|||+. |++||||||+|+|+.. ++.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999544 399999999999999999999999 9999999999999953 357999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||....+......+.....
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------ 255 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------ 255 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence 99998765 4455668999999999999999999999999999999999999999998776555442221100
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+....-+.......+++..|+..||.+|+|+.++|+.
T Consensus 256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12222223346778899999999999999999999993
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=306.55 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=204.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.++||+|++|+||+|.+.++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35799999999999999999988766779999987432 234578899999999999999999998754 5578999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++... ....+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999998432 234678999999999999999999999 999999999999999999999999999986654332
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......++..|+|||...+..++.++||||||+++|+|++ |..||......... ..... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~---~~~~~-------------~~~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVER-------------GYR 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH---HHHhc-------------CCC
Confidence 22223445678999999988899999999999999999999 78888654322111 11100 001
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=320.58 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=196.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 68899999987432 223356788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ ...+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999998 3456799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC
Q 042383 208 DIT----------------------------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253 (353)
Q Consensus 208 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~ 253 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 042383 254 AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQ--EKSSLRPRMSTVIEM 324 (353)
Q Consensus 254 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~evl~~ 324 (353)
.||......+....+. ... .. + .+.... .....+.+++.+++. .++..||+++||++.
T Consensus 234 ~Pf~~~~~~~~~~~i~---~~~--~~---~---~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVM---NWK--ET---L---IFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHH---cCc--Cc---c---cCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997654332221111 000 00 0 000000 123456677766443 233456899999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=313.59 Aligned_cols=240 Identities=25% Similarity=0.336 Sum_probs=191.7
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +++.||+|+++... .........|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58889999987432 22334455666666654 899999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHI----QSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999888 3445799999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~---~i~~----~----------~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD---SILN----D----------RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHc----C----------CCCC
Confidence 334568999999999999899999999999999999999999997654322111 1100 0 0112
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMS-TVI 322 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl 322 (353)
+...+..+.+++.+||+.+|++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223345678999999999999999976 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=315.89 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=194.7
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHH---HhcCCCCceeeeeeEecCCceEEE
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASM---ANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999865 68899999987432 22334566666555 456799999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|...+. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988772 34689999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. ........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+...... .... .
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~---~i~~------------~ 216 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---SIVN------------D 216 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh------------C
Confidence 21 122234668999999999999999999999999999999999999997654322111 1000 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
. ...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 112223356688999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.91 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=211.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|++|.||+|... +|+.||+|.++.. .......+.+|+.++++++|+|++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999976 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.........+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998865444556789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... . .
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~--------~- 223 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE----K--------C- 223 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhh----c--------C-
Confidence 3221 22345788899999998888999999999999999999999998644321 111111100 0 0
Q ss_pred cCCCCCh-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 288 LCGNFSG-NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 288 ~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....+. ..+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0111112 34567889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=314.85 Aligned_cols=246 Identities=23% Similarity=0.286 Sum_probs=197.8
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCC-CCceeeeeeEecCCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICH-ENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 127 (353)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|..++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999866 5788999998743 22344567788999998865 56888999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHI----QQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999888 3456789999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .....
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~i~~~------------- 216 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---SIMEH------------- 216 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHHcC-------------
Confidence 11 12234568999999999999999999999999999999999999997554322211 11100
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM-----STVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 323 (353)
...++...+..+.+++.+||+.||.+|++. +++++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011222335668899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=324.26 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=201.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----ceE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP-----CRI 124 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 124 (353)
+|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999864 6899999988643 2334467889999999999999999999998776 789
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+|+||+. ++|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKII----VSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 4788777 3456799999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc---
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL--- 280 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 280 (353)
.............+++.|+|||.+.+. .++.++||||+||++|+|++|+.||...+.......+...........+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543333333345678899999988774 4789999999999999999999999766543322222111000000000
Q ss_pred -----ccccCcccC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 281 -----QHLVDPMLC-------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 281 -----~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...... .........++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 0112223567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=325.16 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=198.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999865 68899999986432 223456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ ...+.+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLL----IRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999998 3456789999999999999999999999 999999999999999999999999999753210
Q ss_pred CC------------------------------------------ccccccccCCcCccCccccccCCCCccccchhHHHH
Q 042383 208 DI------------------------------------------THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVL 245 (353)
Q Consensus 208 ~~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~i 245 (353)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC---CHHHHH
Q 042383 246 LLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP---RMSTVI 322 (353)
Q Consensus 246 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl 322 (353)
+|+|++|..||...........+ .... ..+........+..+.+++.+|+ .+|.+|+ |+.+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i---~~~~----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKV---INWE----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHH---hccC----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999999765533221111 0000 00000111123455777888876 5999999 888887
Q ss_pred HH
Q 042383 323 EM 324 (353)
Q Consensus 323 ~~ 324 (353)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.40 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=203.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999864 6889999998866555556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++ ....++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999988 3445789999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
. ......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+..... .. ... .+..+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~-~~~---~~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LM-SKS---NFQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------ee-ecC---CCCCC
Confidence 1 122345788999999874 3457789999999999999999999986433221110 00 000 00000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
.. ......+..+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 11122356789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=297.98 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=207.8
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.+.+.|.+-+.||+|.|+.|+++.+. +|+.+|+|++... +..+.+.+.+|+.+.+.|+||||+++.+.+.+....|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 35678888899999999999999754 6888999988743 34466788999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeeccCC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFGLS 202 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~ 202 (353)
|+|++.|++|..-|.. +..+++..+...+.||+.||.|.|.+ +|||||+||+|+++.+ ..-+||+|||++
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999877743 25679999999999999999999999 9999999999999943 445999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..... ...-....|||+|+|||++...+|+..+|||+.|++||-|+.|.+||.+.++...+..+.....-.+++.
T Consensus 161 i~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~--- 235 (355)
T KOG0033|consen 161 IEVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE--- 235 (355)
T ss_pred EEeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc---
Confidence 98763 3333457899999999999999999999999999999999999999997665444433222111111111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
=+...++..+|+++||..||.+|.|+.|.|.
T Consensus 236 ----------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 236 ----------WDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----------cCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1122456789999999999999999998764
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.17 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|.+.+.||+|++|.||.+... ++..+|+|.+.... ......+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 68899999887432 1123567889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|+||+++++|.+.+ .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999988 3445689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCcccc--ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDITHIS--TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIAT------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H---HHhc-------
Confidence 43221111 2345778999999999988999999999999999999999998754322111 0 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 222 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 --QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001122333445678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=305.13 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=208.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|.+.+.||+|++|+||+|..+++..+|+|.+... ....+.+.+|+.++++++|+|++++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 35789999999999999999999887788999988743 33456788999999999999999999999998999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. .....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999843 2235689999999999999999999999 99999999999999999999999999988765422
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........++..|+|||.+.+..++.++|+||||+++|++++ |+.||....... ........ .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~-------------~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVERG-------------Y 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC-------------C
Confidence 222222334568999999998889999999999999999998 999986443211 11111110 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
....+...+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111122235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=322.46 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=195.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999865 68899999987432 2334578889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999883 345789999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------ccccccccCCcCccCccccccCCCCccccchhH
Q 042383 209 I----------------------------------------------THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSF 242 (353)
Q Consensus 209 ~----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 242 (353)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000112468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC---HH
Q 042383 243 GVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR---MS 319 (353)
Q Consensus 243 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ 319 (353)
||++|+|++|..||...+.......+ .... ...........+..+.+++.+|+ .+|++|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i---~~~~----------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKV---INWQ----------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHH---HccC----------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999765432221111 0000 00000011122455777777766 49999997 88
Q ss_pred HHHH
Q 042383 320 TVIE 323 (353)
Q Consensus 320 evl~ 323 (353)
++++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=321.20 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=202.7
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
++....++|++.+.||+|+||.||++..+ +++.+|+|++... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999876 6889999998642 2233455778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++|+|.+++. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999883 23588999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGH----LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
+...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+....+..+ ...
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH------HcC
Confidence 9876543333334567999999999987543 788999999999999999999999865442222111 000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIEM 324 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 324 (353)
... +........+..+.+++.+||...+.+ ||+++++++.
T Consensus 263 ~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 000 000111233556888999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=303.42 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=207.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.|++.+.||.|.-|+||+++.+ ++..+|+|++.... .....++..|-+||+.++||.++.++..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 56788999999999999999976 46899999998553 233356778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||+||+|..+.+ ++..+.+++..++.++..++.||+|||.. |||+|||||+||||-++|++.|+||.++..+..
T Consensus 157 eyCpGGdL~~Lrq--kQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ--KQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHh--hCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999998874 45677899999999999999999999999 999999999999999999999999988754421
Q ss_pred C---------------------------------Cc----------------------cccccccCCcCccCccccccCC
Q 042383 208 D---------------------------------IT----------------------HISTRVAGTLGYLAPDYAVSGH 232 (353)
Q Consensus 208 ~---------------------------------~~----------------------~~~~~~~g~~~y~aPE~~~~~~ 232 (353)
. .. ..+.-+.||-+|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 00 0111256899999999999999
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCC
Q 042383 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKS 312 (353)
Q Consensus 233 ~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 312 (353)
.+.+.|.|+||+++|||+.|..||.+.+..+.... ++.+-+.-...+..+..+.+||++.|-.||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999998776544432 222222222222456778999999999999
Q ss_pred CCCCC----HHHHH
Q 042383 313 SLRPR----MSTVI 322 (353)
Q Consensus 313 ~~RPt----~~evl 322 (353)
++|.- +.||-
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99998 77764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=309.73 Aligned_cols=249 Identities=33% Similarity=0.518 Sum_probs=194.3
Q ss_pred CCCeeeeeCceEEEEEEeC-----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 56 SSNKVGEGGFGSVYKGKLQ-----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|+..+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999866 3578999999654 334467899999999999999999999999988889999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC-
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED- 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~- 208 (353)
+++|+|.+++... ....+++..+..++.||+.||.|||+. +++|++|+++||++++++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999432 346789999999999999999999999 9999999999999999999999999999876322
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.............|+|||.+.+..++.++||||||+++|||++ |..||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~~~~~~------------- 221 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIEKLKQG------------- 221 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHHHHHTT-------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc-------------
Confidence 1122233456778999999999999999999999999999999 67887654321 111111111
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
.....+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112233456688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.90 Aligned_cols=272 Identities=24% Similarity=0.322 Sum_probs=204.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-----CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-----DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 123 (353)
..+|++.+.||+|+||+||++... ++..||+|.+........+.+.+|+.+++.++||||+++.+++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357889999999999999999742 578899999886666666788999999999999999999997643 4568
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++|+||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999842 235689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITHI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..++.......................+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 765432211 111223446999999988889999999999999999999887764332110000000000000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+............+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111122233456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=327.50 Aligned_cols=264 Identities=19% Similarity=0.276 Sum_probs=198.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG-------- 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------- 120 (353)
..++|++.+.||+|+||+||+|... +++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999875 68899999886332 2335799999999999999998876432
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeec
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDF 199 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Df 199 (353)
...++||||+++ +|.+++.........+++..++.++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 78877755545667899999999999999999999999 999999999999998664 6999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+.........+
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9998664322 22335679999999988764 68999999999999999999999998655433322221111100000
Q ss_pred c-------cccc-----cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 K-------LQHL-----VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~-------~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ...+ ....+...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 0000 0001111122234567899999999999999999999973
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=314.03 Aligned_cols=236 Identities=23% Similarity=0.333 Sum_probs=191.6
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|+.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999987432 23345567788888776 699999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++ .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 9999888 3446799999999999999999999999 99999999999999999999999999987542221 12
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~i~----~~~----------~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---AIL----NDE----------VVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH---HHh----cCC----------CCC
Confidence 234568999999999998899999999999999999999999997654322211 110 000 011
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
+...+..+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22235568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.91 Aligned_cols=248 Identities=19% Similarity=0.275 Sum_probs=194.9
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 68899999998532 23345677899999888 799999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++ ...+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 g~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9998887 3446799999999999999999999999 9999999999999999999999999998743221 112
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc--hhhHHHHHHhhccccccccccCcccCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG--EYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....||+.|+|||++.+..++.++|+|||||++|+|++|..||....... ............ .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~--~ 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCC--C
Confidence 234678999999999999999999999999999999999999996432111 000000111100 1110 1
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPR------MSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt------~~evl~ 323 (353)
..+...+..+.+++.+||+.||.+||| ++++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122233556889999999999999998 567753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=313.86 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=195.1
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345567788888866 799999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999888 3445789999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+...... .... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~---~i~~---~~-----------~~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE---SILH---DD-----------VLY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH---HHHc---CC-----------CCC
Confidence 234568999999999999899999999999999999999999997655322211 1110 00 011
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRP-------RMSTVIEM 324 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~~ 324 (353)
+...+..+.+++.+||+.||++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 222345688999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=303.15 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=203.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.+.||+|++|.||+|....+..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 5688999999999999999998776779999876432 334667889999999999999999998764 56789999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999998432 234588999999999999999999999 9999999999999999999999999999866433222
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||...+..++.++||||||+++|+|++ |..||......... ...... ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~-------------~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVERG-------------YRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcC-------------CCC
Confidence 2222345678999999988889999999999999999999 88998754332111 111000 001
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=309.90 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=210.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999743 345689998876666666788999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 126 VYDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999985432 1234589999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHH
Q 042383 194 PKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 271 (353)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH
Confidence 99999999876543221 12233456788999999999999999999999999999999 9999865443211 1111
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
..... ...+...+..+.+++.+||+.+|++|||+++|++.|+++...
T Consensus 239 ----~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 ----TQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----hCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11110 111222356788999999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=317.61 Aligned_cols=238 Identities=23% Similarity=0.305 Sum_probs=193.7
Q ss_pred CeeeeeCceEEEEEEe----CCCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 58 NKVGEGGFGSVYKGKL----QDGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
+.||+|+||.||+++. .+|+.+|+|++..... .....+..|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999975322 233456789999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999988 3445789999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...... .... .. ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~---~i~~------------~~--~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---MILK------------AK--LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH---HHHc------------CC--CC
Confidence 2234568999999999998889999999999999999999999997544321111 1100 00 11
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMST 320 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~~e 320 (353)
.+...+..+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22233566889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.86 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=203.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|++|.||+|.+. ++..||+|.+... .......+.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 2567999988643 23344568899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhcccc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKN------RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~------~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998542211 23467888999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhh
Q 042383 197 SDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH--
Confidence 999998755432221 1122345678999999998899999999999999999999 68888654322111 1000
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.... ...+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 236 --~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 --EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000 11122335678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.87 Aligned_cols=243 Identities=20% Similarity=0.297 Sum_probs=191.4
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +++.+|+|++... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999998753 223345677888888777 799999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|..++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 9998887 3456799999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc--hhhHHHHHHhhccccccccccCcccCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG--EYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ............ .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~--~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCC--C
Confidence 234578999999999999999999999999999999999999995321110 000001111110 0100 1
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
.++...+..+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2233345668899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=316.55 Aligned_cols=262 Identities=24% Similarity=0.375 Sum_probs=204.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEec-CC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIE-GP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 121 (353)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457999999999999999999632 35789999987442 23345678899999999 79999999998764 45
Q ss_pred ceEEEEEcCCCCChhhhhhhcccc--------------------------------------------------------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKN-------------------------------------------------------- 145 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------------------------- 145 (353)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988532110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCcc
Q 042383 146 -RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYL 223 (353)
Q Consensus 146 -~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~ 223 (353)
..++++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++......... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 23689999999999999999999999 9999999999999999999999999999865432221 122234567899
Q ss_pred CccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHH
Q 042383 224 APDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLK 302 (353)
Q Consensus 224 aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (353)
|||++.+..++.++|||||||++|+|++ |..||......+... ...... .....+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC------RRLKEG---------TRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH------HHHhcc---------CCCCCCccCCHHHHH
Confidence 9999999999999999999999999998 999987543222110 000000 001112233467899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 303 VGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 303 li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
++.+||+.+|++||++.||++.|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.64 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=197.2
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
+.||+|+||+||+|... +++.+|+|.+... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999865 6889999987643 234456788999999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc-c
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS-T 214 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 214 (353)
.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+........... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 998832 234689999999999999999999999 999999999999999999999999999875443211111 1
Q ss_pred cccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 215 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
....+..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ... .......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~---~~~-------------~~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE---AIE-------------QGVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH---HHH-------------cCCCCCCc
Confidence 1123456999999998889999999999999999998 888886433211110 000 01111222
Q ss_pred hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.53 Aligned_cols=262 Identities=29% Similarity=0.397 Sum_probs=212.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC--C---cEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD--G---TVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
..++..+.++||+|.||.||+|+.+. + ..||+|..... ......++.+|+.++++++|||||+++|+.....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 45666778999999999999998542 2 23899998853 4666788999999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++|||+|.||+|.++|.. +...++..+...++.+.+.||+|||++ +++||||-.+|+|++.++.+|++|||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred ccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999942 333699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
++.... .........-+..|+|||.+....++.++|||||||++||+++ |..||......+.. .+
T Consensus 309 s~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~k---------- 374 (474)
T KOG0194|consen 309 SRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AK---------- 374 (474)
T ss_pred ccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HH----------
Confidence 886541 1111111234678999999999999999999999999999999 88898765543211 11
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
+.........+...+..+..++.+||..+|++||||.++.+.|+.+.....
T Consensus 375 --I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 375 --IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 111122233334557778888889999999999999999999888775544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.79 Aligned_cols=252 Identities=30% Similarity=0.438 Sum_probs=202.9
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHH--HHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEK--EFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
|++++.||+|+||+||++... +++.+|+|++......... ...+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999976 5678999999866544332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++. ....+++..++.++.||+.||.+||+. +++|+||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999993 566789999999999999999999999 999999999999999999999999999976422 22
Q ss_pred cccccccCCcCccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......++..|+|||++. +...+.++||||||+++|+|++|..||.........................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-------- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------
Confidence 2334466889999999998 7889999999999999999999999998663222222222211111100000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+.+++.+||+.||++|||+.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001277999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.78 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=209.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|++|.||++... +++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47888999999999999999864 7889999987643 2233457888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864444456789999999999999999999999 999999999999999999999999999876643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........ ... .
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~---------~~~---~ 224 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI---------EQC---D 224 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhh---------hcC---C
Confidence 3221 22346788999999998888999999999999999999999998643321 11111110 000 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.........+..+.+++.+||+.+|++|||+.+|++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00111123466799999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.70 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=214.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC--Cc----EEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD--GT----VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
...+..+.||+|.||.||.|...+ |. .||+|.+... +......|.+|..+++.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345667899999999999998552 43 4899988755 4555688999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 125 IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
|++|||+||+|..+|...+. ....++......++.|||+|+.||+++ ++|||||..+|+|++....+|++|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999954322 145688999999999999999999999 999999999999999999999999999
Q ss_pred Cc-cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SK-LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~-~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|+ .+..+.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+..+-......
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~--------- 919 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE--------- 919 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---------
Confidence 99 333333443343345678999999999999999999999999999999 8899876654332221111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.. +-+.+..++..+.+++..||+.+|++||++..|++.+..+...
T Consensus 920 ------gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 ------GG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ------CC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11 2344566788899999999999999999999999988777643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=293.21 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=207.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhc-CCCCceeeeeeEec
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------QGEKEFMSEVASMANI-CHENLVKLHGGCIE 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 119 (353)
+-..|...+.||+|..++|-++.++ +|...|+|++..... .-.+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456777888999999999998755 688899998874311 1124456799999999 69999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
+...++|+|.|+.|.|.|++ ...-.++++...+++.|++.|++|||.. +||||||||+|||++++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999 6677899999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVS------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
|.++....+ ..-...+|||+|+|||.+.. .+|+...|+|++|+|+|.|+.|.+||.-..+.-....+.....
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 999987653 34456899999999998874 3578889999999999999999999986665544444433322
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...++.+. +.+....+||.+||+.||.+|.|++|+|.
T Consensus 246 qF~speWa-------------dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 QFRSPEWA-------------DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccCCcchh-------------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22222222 22445778999999999999999999975
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=309.81 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=208.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|++|.||++... ....+|+|.+... .......+.+|+.++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4567889999999999999999854 2367999988753 233445688999999999 7999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
..+++|||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999985421 2345789999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhH
Q 042383 190 QNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYL 267 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~ 267 (353)
.++.+||+|||.++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999876432211 1222334668999999988899999999999999999998 8899865432211111
Q ss_pred HHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. . .......+...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 247 ~-------~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 L-------K---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------H---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 0 00111222334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.43 Aligned_cols=241 Identities=23% Similarity=0.285 Sum_probs=194.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999866 57899999987532 22334566777888777 5899999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQI----QQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999888 3445789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... ..... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~---~i~~~------------~ 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIMEH------------N 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH---HHHhC------------C
Confidence 11 12234568999999999999999999999999999999999999997654322211 11110 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
..++...+.++.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11222335678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.94 Aligned_cols=242 Identities=27% Similarity=0.319 Sum_probs=191.3
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHH-HHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEV-ASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999987432 12223344444 456778999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~ 152 (325)
T cd05602 81 GELFYHL----QRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGT 152 (325)
T ss_pred CcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCC
Confidence 9999988 3456788999999999999999999999 9999999999999999999999999998754322 122
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~----~~----------~~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---ILN----KP----------LQL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH---HHh----CC----------cCC
Confidence 3345689999999999999999999999999999999999999975543222111 100 00 111
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+..+..+.+++.+||+.+|.+||++.+.+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 22335568899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.41 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=202.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|.+.+.||+|+||+||+|..+ +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999865 678899999875432 2334677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 976 78877732 334588999999999999999999999 99999999999999999999999999987643322
Q ss_pred ccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC---
Q 042383 210 THISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD--- 285 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 285 (353)
.. .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+................+..+..
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 21 223457889999998865 4688999999999999999999999976654333322222111111111100000
Q ss_pred ------cccCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 ------PMLCG----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.... ...+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 011223556889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.72 Aligned_cols=241 Identities=25% Similarity=0.331 Sum_probs=195.1
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999998532 23345567888888887 699999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ .....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~L~~~~----~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHI----QRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 9999888 3445799999999999999999999999 99999999999999999999999999986532211 12
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..... .... .. . ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~~i~----~~--------~--~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---QSIL----ED--------E--VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---HHHH----cC--------C--CCC
Confidence 23356899999999999999999999999999999999999999755432111 1110 00 0 111
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRM-----STVIE 323 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 323 (353)
+...+..+.+++.+||+.||++|||+ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 22335678899999999999999999 87765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.60 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=192.3
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +++.||+|+++... .........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 22334556677777764 899999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
|+|.+++ .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 9999988 3445789999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... ... .. . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---~i~----~~------~----~~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ---SIR----MD------N----PCY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH---HHH----hC------C----CCC
Confidence 233568999999999999899999999999999999999999997554321111 110 00 0 111
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMS-TVIE 323 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 323 (353)
+......+.+++.+||+.||++||++. ++++
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=311.46 Aligned_cols=240 Identities=24% Similarity=0.325 Sum_probs=192.5
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||.||+|..+ +|+.||+|+++... .........|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 68899999987532 22334566777777755 899999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|..++ .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...... ...
T Consensus 81 g~L~~~i----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 9999888 3446789999999999999999999999 9999999999999999999999999998743211 122
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ..... . ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~~~~~----~----------~~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---ESIRV----D----------TPHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----C----------CCCC
Confidence 33466899999999999999999999999999999999999999755432111 11100 0 0111
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMS-TVI 322 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~-evl 322 (353)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222345688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=301.40 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=196.2
Q ss_pred eeeeeCceEEEEEEeC---CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
.||+|+||.||+|.++ ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999643 57889999987443 334567889999999999999999999876 45678999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc-
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI- 212 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 212 (353)
+|.+++. ....+++..+..++.|++.||.+||+. +++|+||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999983 345789999999999999999999999 99999999999999999999999999998664332211
Q ss_pred -cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 213 -STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 213 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....++..|+|||.+....++.++|+|||||++|||++ |..||........ ..... .....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i~-------------~~~~~ 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMIE-------------SGERM 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-------------CCCCC
Confidence 112233578999999988889999999999999999998 9999975433211 11111 11112
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
..+...+..+.+++.+||+.||++||++++|.+.|++
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2233445678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=305.90 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=203.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|++.+.||+|+||+||+|.. .++..+++|.+... .......+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 24678999998743 33344678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 126 VYDYMQNNSLSQTLLGEEK-------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~-------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
+|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999998843211 123578899999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 99999999997653221 112223345677999999988889999999999999999998 888986543211 1111
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
... .. ....+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 239 ~~~----~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 110 00 011222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.06 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=203.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CC----cEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DG----TVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
..+|++.+.||+|+||+||+|.+. ++ ..||+|++.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 357999999999999999999854 23 348999987443 34456788999999999999999999998765 577
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+++||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999843 234688999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcccc-ccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITHIS-TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~---~~-~--------- 225 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---IL-E--------- 225 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HH-h---------
Confidence 654322211 12234668999999999999999999999999999998 999987543221110 00 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.......+..+...+.+++.+||+.+|.+|||+.+++..|.....-
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 226 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0011111223345688999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=301.11 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=205.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|++.+.||+|+||.||++...++..+|+|.+... ......+.+|+.+++.++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35789999999999999999999877788999988743 3345678889999999999999999999887 778999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++... ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998432 345678899999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........++..|+|||.+....++.++|+|||||++|++++ |..||...+.... ....... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~-------------~ 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALERG-------------Y 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhCC-------------C
Confidence 222222345677999999998889999999999999999999 8999875432211 1111100 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
........+..+.+++.+||+.+|++||++.++++.|++
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=301.42 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=199.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||+|++|.||+|.+. +++.||+|++... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999864 6889999998754 333446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|..+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999988644 2478889999999999999999999 9999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...................... ...
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 218 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPP 218 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCC
Confidence 1233568899999999999999999999999999999999999996533221111000000000000 000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......+.++.+++.+||+.+|++||+++|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00112234568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=311.92 Aligned_cols=237 Identities=28% Similarity=0.363 Sum_probs=189.3
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHH-HHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVA-SMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68999999987432 122234445544 55778999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|..++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 g~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHL----QRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999888 3456789999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... ... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---~i~------------~~~--~~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD---NIL------------NKP--LRL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH---HHH------------cCC--CCC
Confidence 334568999999999999999999999999999999999999997544321111 110 000 011
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMS 319 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~ 319 (353)
.+..+..+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 222356688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=298.08 Aligned_cols=247 Identities=27% Similarity=0.367 Sum_probs=199.6
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChh
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLS 136 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 136 (353)
+.||+|+||.||+|...++..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888899999887543 233456888999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccc
Q 042383 137 QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216 (353)
Q Consensus 137 ~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 216 (353)
+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 98832 234688999999999999999999999 999999999999999999999999999876543322222223
Q ss_pred cCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 217 AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
.++..|+|||++.+..++.++||||||+++|++++ |..||......... ...... .....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~~~~~-------------~~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQVEKG-------------YRMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcC-------------CCCCCCCC
Confidence 44567999999988889999999999999999998 99998654322111 111110 01112223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.70 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=206.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||.|++|.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+|++++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457889999999999999999876 78899999885544 5677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999842 2223689999999999999999999999 999999999999999999999999999986633221
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
....+..|+|||.+....++.++||||||+++|++++ |..||........ ...... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~-------------~~~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVEK-------------GYR 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhc-------------CCC
Confidence 2234567999999988889999999999999999997 9999864432211 111100 011
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 112223457789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=310.61 Aligned_cols=243 Identities=20% Similarity=0.273 Sum_probs=192.1
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|... +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57889999998542 23345677899998888 699999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ ...+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~~----~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHM----QRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 9999887 3445799999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..................... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~--~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--------KP--IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--------CC--CCC
Confidence 23466899999999999999999999999999999999999999643322111111111111100 00 112
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
+...+..+.+++.+||+.||++||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22234567899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=304.97 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=195.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhc---CCCCceeeeeeEec-----CC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANI---CHENLVKLHGGCIE-----GP 121 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 121 (353)
+|++.+.||+|+||+||+|... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999876 688999999875322 2223455677776665 69999999998764 34
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..+++||++.+ +|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 88888742 2234589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+....... ......++..|+|||++.+..++.++|||||||++|+|++|.+||...........+...........+.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 98654321 1233567889999999998899999999999999999999999997654432222111111000000000
Q ss_pred cc-------cCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HL-------VDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~-------~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. ..+... ....+..+..+.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 1112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.63 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=206.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467899999999999999999754 24689999986443 33445788999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEe
Q 042383 124 IIVYDYMQNNSLSQTLLGEEK------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
++||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999854322 123578899999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhc
Q 042383 198 DFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 198 Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|++++ |..||...+..... ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHHh---
Confidence 9999876543221 12233446778999999988889999999999999999998 88998654332111 1110
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.. .....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DG---------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00 0111222336678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=306.96 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=203.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.+|.+.+.||+|+||+||+|... .+..||+|++..... .....+.+|+.++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999853 257899999875433 23456888999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 125 IVYDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
+++||+.+++|.+++.... ..+..+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999984221 1234588899999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 999999999876543221 11223445778999999988889999999999999999998 8888865432211 111
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
... .. ....+..++..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 239 i~~----~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRN----RQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHc----CC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 110 00 112233456678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=315.08 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=199.9
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP---- 121 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 121 (353)
...++|++.+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34688999999999999999999865 6889999998643 2334567789999999999999999999886543
Q ss_pred --ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 122 --CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 122 --~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 47899999976 5666551 2478899999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH-------
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW------- 272 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------- 272 (353)
|++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+............
T Consensus 168 g~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 998754322 22234568999999999999999999999999999999999999998665322211111000
Q ss_pred ---------hhc-ccc-----ccccccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 273 ---------EMH-NTD-----KLQHLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 273 ---------~~~-~~~-----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
... ... ........... ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000 00000000000 01111224568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.78 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=205.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
..++|.+.+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999742 34579999887543 33346788999999999 7999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999998432 233489999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||........... ....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~--~~~~------ 259 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK--LIKE------ 259 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH--HHHc------
Confidence 9865433221 1122345678999999998899999999999999999998 9999865443221110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
......+...+..+.+++.+||+.+|++|||+.++++.|.+.
T Consensus 260 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 -------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000111122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=303.94 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=205.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.+|.+.++||+|+||.||++... ++..+|+|.+..........+.+|+.+++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788999999999999999642 356799998876666666789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 126 VYDYMQNNSLSQTLLGEEK-----------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
+|||+++++|.+++..... ....+++..+..++.|++.|+.|||+. +++|+||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999854321 113588999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHH
Q 042383 195 KISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 272 (353)
+|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC---IT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH---HH
Confidence 9999999875533211 11222345678999999999999999999999999999998 8899864433211111 00
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
. . .....+...+..+.+++.+||+.||.+||++++|++.|+.
T Consensus 239 ~----~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 Q----G---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred c----C---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0 0 0011112334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.85 Aligned_cols=265 Identities=23% Similarity=0.373 Sum_probs=203.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC---------------CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD---------------GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLH 114 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~ 114 (353)
.++|++.+.||+|+||.||++.... ...||+|.++.. .......+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3679999999999999999987532 234899998754 333446788999999999999999999
Q ss_pred eeEecCCceEEEEEcCCCCChhhhhhhccc--------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEK--------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 115 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
+++...+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999998843211 112478899999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCcccc
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT--GQAAVHFDKELG 263 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~pf~~~~~~~ 263 (353)
+++.++.+||+|||++........ .......++..|+|||.+.++.++.++||||||+++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876533221 11222345678999999988899999999999999999998 567776443322
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
... .......... .......+...+..+.+++.+||+.+|++|||+++|++.|++
T Consensus 241 ~~~---~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIE---NTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHH---HHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111 1111111100 000011122235679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.68 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=203.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|.+.+.||+|++|.||+|.+. .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467899999999999999999865 35678999886443 33445788999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEe
Q 042383 124 IIVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKIS 197 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~ 197 (353)
++||||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999854321 123589999999999999999999999 999999999999998654 59999
Q ss_pred eccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhc
Q 042383 198 DFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 198 Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|||+++........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||......... .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~~~~~-- 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---EFVTG-- 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHc--
Confidence 99999865322111 1112233567999999998899999999999999999997 99998754332111 11000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
......+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 237 -----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 -----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 01112223345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=305.93 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=204.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999753 23568889887543 2334678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhcc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 042383 126 VYDYMQNNSLSQTLLGEE--------------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~--------------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~N 185 (353)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999875321 1124588999999999999999999999 99999999999
Q ss_pred eEECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccc
Q 042383 186 ILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELG 263 (353)
Q Consensus 186 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~ 263 (353)
|++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999998765332211 1122345678999999988889999999999999999998 999986443221
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.. ... ........+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 238 ~~---~~~-------------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LF---NLL-------------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH---HHH-------------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 111 111111222334567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.54 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=205.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CC--cEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DG--TVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.+.||+|+||.||+|..+ ++ ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999865 33 34788887742 334456788999999999 799999999999999999999
Q ss_pred EEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 127 YDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
+||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999854221 123588999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHh
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
||+|||++........ ......+..|+|||.+.+..++.++|||||||++|+|++ |..||......... ....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~---~~~~- 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY---EKLP- 232 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHh-
Confidence 9999999864322111 111223457999999988889999999999999999997 99999654332111 1100
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.......+...+..+.+++.+||+.+|.+|||++++++.|.++.....
T Consensus 233 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 233 ------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred ------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 001111222345678899999999999999999999999998887665
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=299.45 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=204.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+|++.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++|+|++++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999866 6888999998643 3344567888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999988742 2345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..... .... .... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~----~~~~---------~ 218 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI---LKVC----QGSY---------K 218 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH---HHHh----cCCC---------C
Confidence 1223356888999999999888999999999999999999999999754321111 1110 0000 1
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..+...+..+.+++.+||+.||++|||+.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1222345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=298.05 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|.+.+.||+|++|.||+|..+ +++.|++|.+... .......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 6889999998743 334456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998532 245789999999999999999999998 99999999999999999999999999988665432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||+..+..++.++|+||||+++|+|++|..||...+.... ..... .. ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~------------~~-~~ 218 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILKII------------RG-VF 218 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH------------cC-CC
Confidence 2 22334678899999999998999999999999999999999999975542111 11110 00 11
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12222445679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=303.05 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=193.6
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||+|+||+||+++.+ +|+.+|+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 68999999986421 22234556799999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+.+.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 888743 2344688999999999999999999999 99999999999999999999999999987664322 2233
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..|++.|+|||++.+..++.++||||+||++|+|++|..||............. ... ...... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~--------~~~~~~-~~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRT--------LEDEVK-FEHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH---HHh--------hccccc-ccccc
Confidence 568899999999998889999999999999999999999997543211111000 000 000000 00112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+.++.+++.+||+.||++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 35568899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.27 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=203.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-----------------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceee
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-----------------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKL 113 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~ 113 (353)
++|++.+.||+|+||+||++.+. ++..+|+|++... .......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998532 2346899998754 33345678899999999999999999
Q ss_pred eeeEecCCceEEEEEcCCCCChhhhhhhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK-------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 114 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
++++..++..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999854321 123478889999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCcccc
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT--GQAAVHFDKELG 263 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~pf~~~~~~~ 263 (353)
+++.++.++|+|||++........ .......++..|+|||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543221 11222334678999999888889999999999999999998 778886443321
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.. ............. .....+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus 242 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VI---ENTGEFFRDQGRQ------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111111000000 0011122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=298.46 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=196.8
Q ss_pred eeeeeCceEEEEEEeC---CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999754 35579999987553 2334678899999999999999999998864 57899999999999
Q ss_pred hhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc-
Q 042383 135 LSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS- 213 (353)
Q Consensus 135 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 213 (353)
|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9998842 345789999999999999999999999 999999999999999999999999999976543322111
Q ss_pred -ccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 214 -TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 214 -~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
....++..|+|||.+.+..++.++|||||||++|++++ |..||......... ... .......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~-------------~~~~~~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SFI-------------EQGKRLD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHH-------------HCCCCCC
Confidence 11223568999999988889999999999999999996 99999754322111 110 1111122
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.+..++.++.+++.+||+.+|++||++.+|++.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 3344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.92 Aligned_cols=250 Identities=20% Similarity=0.353 Sum_probs=204.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+|++.+.||+|++|.||++... ++..+++|.+..........+.+|+.+++.+.|+|++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 6889999998866555567788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999883 23578999999999999999999999 99999999999999999999999999987653321
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||........... . .. . ....
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~--~-~~---~--------~~~~ 235 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--I-AT---N--------GTPE 235 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH--H-hc---C--------CCCC
Confidence 1 12234678899999999888899999999999999999999999975543211110 0 00 0 0000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||..+|++|||+.++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1112234566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=310.29 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=197.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+++.. +++.||+|++... .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 5889999998742 2233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999832 245689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..........||+.|+|||++.. ..++.++|||||||++|+|++|..||......+.... ... ......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~---i~~---~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMN---HKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH---HHc---CCCccc
Confidence 33322333568999999999863 4578899999999999999999999975443222111 100 000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSS--LRPRMSTVIEM 324 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~ 324 (353)
+ .......+..+.+++.+||..+++ .||++.++++.
T Consensus 229 ~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011112355678888887765333 37899888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.99 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=197.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||++... +++.||+|++... .......+.+|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865 6889999998743 2233456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999998 3456799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC
Q 042383 208 DIT----------------------------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253 (353)
Q Consensus 208 ~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~ 253 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346899999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 042383 254 AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR---MSTVIE 323 (353)
Q Consensus 254 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~ 323 (353)
.||...........+. .. .. .+ .+... ...+.++.+++.+++. +|.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~~~~i~---~~--~~---~~---~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKVM---NW--KE---TL---VFPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHHH---cC--CC---ce---ecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9997655432221111 00 00 00 00000 0124567788888764 9999986 455544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=308.13 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=209.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEec
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIE 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 119 (353)
..++|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4577889999999999999999641 24579999886432 33446788999999999 89999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
....+++|||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999864321 124578889999999999999999999 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~ 265 (353)
++.++.+||+|||.+......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999876543222 1222345678999999988889999999999999999998 77887543321111
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.... .. .....+...+..+.+++.+||+.+|.+|||+.|+++.|+++..+..
T Consensus 250 ---~~~~----~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 250 ---KLLK----EG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ---HHHH----cC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 1110 00 0011223345678899999999999999999999999998877665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=299.31 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=202.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
.+|++.+.||+|++|.||++.+.++..+|+|.+.... .....+.+|+.+++.++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4678889999999999999988777889999887432 334578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++.. ....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999998832 235689999999999999999999999 9999999999999999999999999998765433222
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.++.++.++||||||+++|+|++ |..||......... .... . . ...
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~----~-~--------~~~ 220 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV---ETIN----A-G--------FRL 220 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHh----C-C--------CCC
Confidence 2222334668999999998899999999999999999998 89998754321111 1110 0 0 000
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111112467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=300.17 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=201.8
Q ss_pred CCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-----
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC----- 122 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 122 (353)
|.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999854 24679999987542 3344678899999999999999999998766554
Q ss_pred -eEEEEEcCCCCChhhhhhhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 123 -RIIVYDYMQNNSLSQTLLGEE--KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 123 -~~lv~e~~~~~sL~~~l~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
.++++||+++++|..++.... .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 2234689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccc
Q 042383 200 GLSKLFPEDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 200 g~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 9998654332211 112334668999999988899999999999999999999 888886443221 1111110
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
. .....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 231 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00112233456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=308.51 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=194.2
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+|+..+.||+|+||+||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999865 68899999987432 233456677888888885 678889999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999988 3446799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~~i~~~------------~ 217 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---QSIMEH------------N 217 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHHHhC------------C
Confidence 21 1123356899999999999989999999999999999999999999765432211 111110 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
..++...+..+.+++.+||+.+|.+|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11222334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=306.26 Aligned_cols=265 Identities=20% Similarity=0.335 Sum_probs=202.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|.+.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999865 68899999987543 2334567789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLDK-DLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9974 88888732 345689999999999999999999999 9999999999999999999999999998764432
Q ss_pred CccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC--
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD-- 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 285 (353)
... .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+..+................+..+..
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 221 1224568899999987654 578899999999999999999999976554322222111111111111111111
Q ss_pred -------cccCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 -------PMLCG----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 -------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.... ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 011223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=304.60 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=207.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC-----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-CCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIE-GPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 122 (353)
..++|++.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35789999999999999999998764 678999988743 33445678899999999999999999997665 567
Q ss_pred eEEEEEcCCCCChhhhhhhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKN----RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~----~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
.+++++|+++++|.+++...... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998543222 25689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcc
Q 042383 199 FGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 199 fg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
||+++.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |..||...+... .......
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc---
Confidence 9999865332211 1222345678999999988889999999999999999999 999986543321 1111110
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..........+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 235 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 ----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011112223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=300.57 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=204.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.+|++.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999853 23479999887542 33456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++.. ....+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999842 235689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccc--cccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITHIST--RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
........ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~~~--------- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIEEG--------- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHhCC---------
Confidence 43222211 1223467999999998899999999999999999886 99998754432111 111100
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.....+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111223356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.58 Aligned_cols=264 Identities=22% Similarity=0.354 Sum_probs=202.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999865 67889999887543 33345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ....+++..+..++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999983 346789999999999999999999973 18999999999999999999999999998754322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc-c---------
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD-K--------- 279 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~--------- 279 (353)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.................. .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1233567889999999988889999999999999999999999986443211111000000000000 0
Q ss_pred -------cccccCccc---CCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 -------LQHLVDPML---CGNFS-GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 -------~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+.+... ....+ ...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00010 1134568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.52 Aligned_cols=265 Identities=25% Similarity=0.409 Sum_probs=206.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC-----------------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCcee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD-----------------GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVK 112 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 112 (353)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4679999999999999999987542 2458999987543 344567889999999999999999
Q ss_pred eeeeEecCCceEEEEEcCCCCChhhhhhhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 042383 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK-------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185 (353)
Q Consensus 113 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~N 185 (353)
+++++..++..+++||++++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999854321 123689999999999999999999999 99999999999
Q ss_pred eEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCccc
Q 042383 186 ILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT--GQAAVHFDKEL 262 (353)
Q Consensus 186 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~pf~~~~~~ 262 (353)
|+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876533221 12233446778999999988889999999999999999998 66777543321
Q ss_pred chhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 263 GEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
. ............. .......+...+.++.+++.+||+.+|++|||+.+|++.|++
T Consensus 241 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1111111111110 011111222335679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=311.05 Aligned_cols=240 Identities=26% Similarity=0.335 Sum_probs=190.4
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHH-HHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVA-SMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|+.. +|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 68899999987432 222344455554 46778999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHL----QRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9998887 3456799999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+...... ... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---~~~------------~~~--~~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD---NIL------------HKP--LVL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH---HHH------------cCC--ccC
Confidence 234568999999999999999999999999999999999999997554322111 110 000 011
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
.+..+..+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 122345688999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=307.93 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=206.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
.++|.+.+.||+|+||.||++.+. +...+|+|.+.... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999753 23469999987542 33446788899999999 799999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999954321 123588999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
+.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987654321111 111224568999999988889999999999999999998 888886433211111
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
... .......+...+..+.+++.+||+.+|.+|||+.+|++.|+.+...
T Consensus 254 ---~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 ---LLK-------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---HHH-------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 100 0011122233456788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=303.01 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=204.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999643 24579999876442 2334567889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.++||||+++|+|.+++..... ....++...+..++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999954321 123456778899999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhh
Q 042383 197 SDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~-- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LKFVM-- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH--
Confidence 999998755332211 1122335678999999998899999999999999999998 7888864332111 11100
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
... ....+...+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 236 --~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 --DGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --cCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000 01112223467999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=301.49 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
++|.+.+.||+|+||+||+|+.+ +...+++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999854 2457999988654333 4567899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 125 IVYDYMQNNSLSQTLLGEEKN-----RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
+||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543211 12689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~----~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ----AG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH----cC
Confidence 9987543222222233455778999999988889999999999999999999 788886433211 111110 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
......+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 235 --------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 --------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00011122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=308.21 Aligned_cols=237 Identities=27% Similarity=0.364 Sum_probs=189.1
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHH-HHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVA-SMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999987432 122334445544 57788999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 81 ~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHL----QRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 9998887 3456789999999999999999999999 9999999999999999999999999998753222 122
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||...+..... .... ... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~------------~~~--~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---DNIL------------HKP--LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---HHHh------------cCC--CCC
Confidence 23456899999999999889999999999999999999999999765432111 1110 000 112
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMS 319 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~ 319 (353)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 233456788999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.45 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=198.8
Q ss_pred CCCCCeeeeeCceEEEEEEeCC-C--cEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------Cc
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQD-G--TVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG------PC 122 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 122 (353)
|.+.+.||+|+||.||+|.... + ..+|+|.++.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998754 3 26899988754 344456788999999999999999999976432 24
Q ss_pred eEEEEEcCCCCChhhhhhhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 123 RIIVYDYMQNNSLSQTLLGEE--KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
.+++|||+.+|+|.+++.... .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2234589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 201 LSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 201 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~---~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ---GN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc---CC
Confidence 99876433221 1122345678999999999999999999999999999999 788886433211 1111110 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
. ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011223355688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.19 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=200.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeE-ecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC-IEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~ 130 (353)
++|++.+.||+|++|.||++... |..+|+|.+.... ..+.+.+|+.++++++|+|++++++++ .++...++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57889999999999999999876 7789999886432 345788999999999999999999975 4556789999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999999843 2234588999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
....++..|+|||++.+..++.++|||||||++|+|++ |..||........ ..... ....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~-------------~~~~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE-------------KGYK 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh-------------cCCC
Confidence 22334567999999988889999999999999999998 8999864332111 11110 0011
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 122233456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.37 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=202.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh------hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK------QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
+|++.+.||.|+||.||+|...+++.+|+|.+..... .....+.+|+.+++.++|+||+++.+++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5788999999999999999987889999998874321 2235678899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+||+++++|.+++. ...++++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999983 345689999999999999999999999 99999999999999999999999999987543
Q ss_pred CC-----CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 207 ED-----ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 207 ~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
.. .........++..|+|||.+.+..++.++||||||+++|+|++|..||...+......... .. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~--~~--- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AH--RG--- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hc--cC---
Confidence 21 1111223457889999999998889999999999999999999999997543322111100 00 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+...+..+.+++.+||+.+|.+||++.++++
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001222334567889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.41 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=200.3
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.+++.++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999865 68899999887432 2223456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999988843 2334689999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. .....|+..|+|||++.+..++.++||||+|+++|+|++|..||................. . .
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~------------~-~ 220 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK------------E-V 220 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh------------h-h
Confidence 21 1234689999999999988999999999999999999999999975433211111111000 0 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
...++......+.+++.+||+.||++||| ++|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 01122233456889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=312.54 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=200.3
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG----- 120 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 120 (353)
...++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34689999999999999999999865 5889999998743 233446778899999999999999999988643
Q ss_pred -CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 121 -PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 121 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 346899999976 6766652 2478899999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc----
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH---- 275 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 275 (353)
|+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+...............
T Consensus 164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999865432 22234568999999999999999999999999999999999999997654322221111100000
Q ss_pred -------------ccccccccc------Cccc--CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 276 -------------NTDKLQHLV------DPML--CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 276 -------------~~~~~~~~~------~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......+. +... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000 001112234568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=301.74 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=199.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|++.+.||+|+||+||+|.+. ++. .+++|.+..... .....+..|+..+.++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 57888999999999999999864 343 478887754322 233567788888999999999999998764 45778
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999842 345789999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
..... .......++..|+|||.+.+..++.++||||||+++||+++ |..||............ . ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~---~~~---- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----E---KGE---- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----H---CCC----
Confidence 43222 12233456778999999998899999999999999999998 99998754332111111 0 000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....+..+...+.+++.+||+.+|++|||+.|+++.|..+.+
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 -----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 000111124567889999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=300.38 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=201.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
++|.+.+.||+|+||.||+|... +++.||+|+++.........+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888899999999999999865 68899999988665555567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++ ...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999988 3456799999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 211 HISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
......|++.|+|||.+. ...++.++|+|||||++|+|++|..||....+........ . .. ...+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~-~~---~~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------K-SN---FQPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------c-cC---CCCCc
Confidence 123346889999999874 4568889999999999999999999986544321111000 0 00 00000
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ....+..+.+++.+||+.+|++|||+++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0112456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=299.47 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=199.3
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|+.+++.++|+|++++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999865 68899999987432 22234567899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+.+.. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988743 2334699999999999999999999999 99999999999999999999999999987654321
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............... .....
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~--~~~~~----------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR--VLETE----------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--hhccc-----------
Confidence 123356899999999999889999999999999999999999999755432221111110 00000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
..+....+..+.+|+.+||+.||++||+ +.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1112223456789999999999999999 666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=301.40 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=203.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|++.+.||+|+||+||+|.+. ++. .||+|++... .......+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467888999999999999999853 343 5899998754 333456788899999999999999999988754 577
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999998842 245689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
........ .....+++.|+|||...+..++.++|||||||++|||++ |..||......... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~---------- 225 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLLE---------- 225 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHH----------
Confidence 65332211 122234678999999998899999999999999999998 88998643321111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.......+...+..+.+++.+||+.||++||++.++++.|......+
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 226 ---KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00111112233557889999999999999999999999998776554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=310.27 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=201.2
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
.....|++.++||+||.+.||++...+.+.+|+|.+... ......-+.+|+..|.+| .|.+|++++++-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 334669999999999999999999887777888876533 455567899999999999 49999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||-+ .+|...|.. ....++.-.+..+..|++.|+.++|.. ||||.||||.|+|+ -.|.+||+|||.|..+
T Consensus 438 vmE~Gd-~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred Eeeccc-ccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 999774 489999842 233344458889999999999999999 99999999999998 4569999999999988
Q ss_pred CCCCccc-cccccCCcCccCccccccCC-----------CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 206 PEDITHI-STRVAGTLGYLAPDYAVSGH-----------LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 206 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~-----------~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
..+.+.. .....||+.||+||.+.... .++++||||||||||+|+.|++||..-.. ..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~----- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI----- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH-----
Confidence 7765544 34578999999999887543 45789999999999999999999972110 11
Q ss_pred hccccccccccCcccCCCCChHHH-HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEA-VRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.++..+.++.-..+++.... .++.++++.||++||++|||+.|+|+.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233444433223332221 129999999999999999999999873
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=297.32 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=201.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh---------cHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ---------GEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
+|.+.+.||.|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999865 5788999988644221 22567889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++++||+++++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALL----NNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHH----HhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999998 3446789999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc-----cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 203 KLFPEDIT-----HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 203 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
+....... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~---- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---FKIGE---- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---HHHhc----
Confidence 86642211 1112245788999999999888999999999999999999999999754332111 10000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1112233344567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=309.08 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=197.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999866 6788999998742 2223345778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999842 245789999999999999999999999 999999999999999999999999999976654
Q ss_pred CCccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..........|++.|+|||++.+ +.++.++|||||||++|+|++|..||...+...... .. ........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---~i---~~~~~~~~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KI---MNHEERFQ 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH---HH---HcCCCccc
Confidence 33322334568999999998875 467889999999999999999999997544322111 11 00000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~ 323 (353)
+ +......+..+.+++.+||...+++ |++++++++
T Consensus 229 -----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 1111123466888999999865544 467877765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=315.49 Aligned_cols=262 Identities=23% Similarity=0.389 Sum_probs=205.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcC-CCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESK-QGEKEFMSEVASMANIC-HENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 121 (353)
..++|.+.+.||+|+||.||+|.+. .++.||+|++..... .....+.+|+.++.++. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888999999999999999853 346799999975432 23356889999999997 999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccc---------------------------------------------------------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEK--------------------------------------------------------- 144 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 144 (353)
..++||||+++|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999854211
Q ss_pred -------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 145 -------------------------------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 145 -------------------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
....+++..+..++.||+.||.|||+. +++|+||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 112467788899999999999999998 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~ 265 (353)
+++++.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 99999999999999986532211 11122346788999999998889999999999999999998 88898654322111
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. ..... . .....+...+..+.+++.+||+.+|.+||++++|++.|++..
T Consensus 352 ~--~~~~~----~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 Y--NAIKR----G---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HHHHc----C---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 00000 0 001122233567899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=305.45 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=201.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCc--EEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGT--VVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|+.++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999865 444 4577766532 334456788899999999 899999999999999999999
Q ss_pred EEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 127 YDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
|||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999985432 1124689999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHh
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|+| |..||...+..+... ..
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---KL-- 236 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH---HH--
Confidence 99999998643211 11111223567999999988889999999999999999998 999996543321111 10
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
. . ......+...+..+.+++.+||+.+|++||++.++++.|.++..
T Consensus 237 -~-~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 237 -P-Q---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -h-c---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 00011112234568899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.36 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=204.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.+++.+.||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999987543 33446788999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhcc------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEE------------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~------------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~N 185 (353)
++++||+++++|.+++.... .....+++..++.++.|++.||.+||+. +++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999985321 1123578899999999999999999999 99999999999
Q ss_pred eEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccc
Q 042383 186 ILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELG 263 (353)
Q Consensus 186 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~ 263 (353)
|+++.++.++|+|||.+........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11122334667999999988899999999999999999998 878886433221
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
. .... ..... ...+...+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 241 ~---~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V---IYYV----RDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---HHHH----hcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1111 01110 01122345679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=311.37 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=199.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
..++|++.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 68899999987432 22345677899999999999999999987643
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...+++++++ +++|.+++ ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 67898776 235699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+...................
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 233568999999999876 5688999999999999999999999976543222211111110000000
Q ss_pred cc--------cccCcc---cCC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 042383 280 LQ--------HLVDPM---LCG---NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGD 328 (353)
Q Consensus 280 ~~--------~~~~~~---~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 328 (353)
.. ...... ... .......+.+.+++.+||+.||++|||+.|+++. +...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 000000 000 0001123457899999999999999999999853 4443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.21 Aligned_cols=269 Identities=19% Similarity=0.207 Sum_probs=197.0
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC------CCceeeeeeEecC
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICH------ENLVKLHGGCIEG 120 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~ 120 (353)
....++|++.+.||+|+||+||+|.+. +++.||||+++... ........|+.+++.++| ++++++++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 344678999999999999999999865 57889999986432 223345567777776654 4588888888764
Q ss_pred -CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCC------
Q 042383 121 -PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNF------ 192 (353)
Q Consensus 121 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~------ 192 (353)
...|+|||++ +++|.+++. ..+.+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence 4688999988 668888883 44679999999999999999999997 6 999999999999998665
Q ss_pred ----------CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCccc
Q 042383 193 ----------NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262 (353)
Q Consensus 193 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~ 262 (353)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764321 223467899999999999999999999999999999999999999766544
Q ss_pred chhhHHHHHHhhccc--------cccccccC------ccc---------CCC--CChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 263 GEYYLVEKAWEMHNT--------DKLQHLVD------PML---------CGN--FSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~--------~~~~~~~~------~~~---------~~~--~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
+....+......... .....+.+ +.. ... ........+.+||.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 333332221110000 00000000 000 000 00012356789999999999999999
Q ss_pred HHHHHH--HhcCCC
Q 042383 318 MSTVIE--MINGDV 329 (353)
Q Consensus 318 ~~evl~--~L~~~~ 329 (353)
++|+++ .|....
T Consensus 432 a~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 432 ARQMTTHPYVLKYY 445 (467)
T ss_pred HHHHhcCccccccC
Confidence 999997 555433
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=302.10 Aligned_cols=266 Identities=25% Similarity=0.352 Sum_probs=202.1
Q ss_pred CCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRI 124 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 124 (353)
-|++.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++.+++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468899999999999999974 257889999987443 33446788999999999999999999988875 5688
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 99999999999998832 234689999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc---c
Q 042383 205 FPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD---K 279 (353)
Q Consensus 205 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 279 (353)
....... ......++..|+|||.+.+..++.++||||||+++|+|+++..|......... .......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 234 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL----KMIGPTHGQMTVTR 234 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh----hhcccccccccHHH
Confidence 6433221 12234567789999999888899999999999999999998776532211000 0000000000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
....+............+..+.+|+.+||+.+|++|||++++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000011112233467799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=302.06 Aligned_cols=260 Identities=20% Similarity=0.354 Sum_probs=210.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+|++.+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 478999999999999999999864 6889999998865555556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999883 24578999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+.+..++.++|+|||||++|++++|..||...+........ .......
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~~~ 234 (297)
T cd06656 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPE 234 (297)
T ss_pred c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCCCC
Confidence 1 122346788999999999888999999999999999999999999754432111000 0000000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDD 333 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~ 333 (353)
...+...+..+.+++.+||+.+|++||++.++++ .++...+...
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 1122334566889999999999999999999988 5555554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.19 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=205.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|.+.+.||+|++|.||+|.+.+ ...+++|...... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 3568889999999999999998643 3468999887554 44556789999999999999999999988764 5789
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999843 234689999999999999999999998 9999999999999999999999999998866
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
............++..|+|||.+....++.++||||||+++|++++ |..||......... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~---~~------ 225 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIEN---GE------ 225 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHc---CC------
Confidence 5432222222334567999999988889999999999999999986 99999755432211 11100 00
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....+...+..+.+++.+|+..+|.+|||+.++++.|.++..
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011223345679999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=295.92 Aligned_cols=250 Identities=32% Similarity=0.453 Sum_probs=203.7
Q ss_pred CeeeeeCceEEEEEEeCC----CcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQD----GTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||.||+|.... +..+++|.+...... ..+.+.+|+..++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 788999998855433 367888999999999999999999999999999999999999
Q ss_pred CChhhhhhhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 133 NSLSQTLLGEEKN-----RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 133 ~sL~~~l~~~~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
++|.+++...... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998543211 47799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 208 DIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... .......++..|+|||.+....++.++||||||+++|+|++ |..||......... .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~------------ 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRK------------ 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHc------------
Confidence 321 12233456889999999988889999999999999999999 68998765322111 11110
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
......+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223333677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=294.71 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=207.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||.|++|.||+|... +++.+++|++........+.+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999865 5788999999876666667889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998832 236799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............. . .. +...
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---~----~~---~~~~ 224 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---K----SN---FPPP 224 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h----cc---CCCc
Confidence 1 22334678889999998776 78899999999999999999999997544322211100 0 00 0000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 1122344667999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.71 Aligned_cols=263 Identities=21% Similarity=0.255 Sum_probs=200.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
..++|.+.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999865 5888999998743 233446778899999999999999999987543
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 6777662 2478899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc----
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---- 276 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 276 (353)
+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+........
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865432 122345689999999999999999999999999999999999999976654332222111000000
Q ss_pred -------------cccc-----ccccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 277 -------------TDKL-----QHLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 277 -------------~~~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+.. ..+...... ..........+.+++.+||+.||++|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000000000 01111224568899999999999999999999883
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.90 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=203.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CC---cEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DG---TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.+|++.+.||+|+||.||+|... ++ ..||+|.+... .......+..|+.+++.++||||+++.+++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999865 23 36999998754 344456889999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++.. ..+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999998842 245689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccc--ccccc--CCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 207 EDITHI--STRVA--GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 207 ~~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
...... ..... .+..|+|||.+.+..++.++|||||||++||+++ |..||...+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~~------- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQD------- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcC-------
Confidence 322211 11111 1347999999998899999999999999999886 9999875443211 1111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.....+...+..+.+++.+||+.+|.+||++++|++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111223456688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=293.71 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=199.8
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChh
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLS 136 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 136 (353)
++||.|++|.||++...+++.||+|.+...... ....+.+|+.++++++|+||+++++++.+....++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999776899999988755333 4567889999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc-cc
Q 042383 137 QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS-TR 215 (353)
Q Consensus 137 ~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-~~ 215 (353)
+++.. ....+++..+..++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||.+........... ..
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 98842 234688999999999999999999999 999999999999999999999999999876543222111 12
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCCh
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSG 294 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (353)
...+..|+|||.+.++.++.++|+||||+++|+|++ |..||........... ... ......+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~~-------------~~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IES-------------GYRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---Hhc-------------CCCCCCCc
Confidence 233567999999988899999999999999999999 7888865443211111 000 00011222
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 295 NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 295 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
..+..+.+++.+||+.+|.+|||+.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 335679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.43 Aligned_cols=248 Identities=28% Similarity=0.398 Sum_probs=197.2
Q ss_pred CeeeeeCceEEEEEEeC-C---CcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-D---GTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
++||+|+||.||+|.+. . +..+|+|.+..... ...+.+.+|+.+++.+.|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999753 2 36899999875533 34567889999999999999999999876 4568999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++. ....+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999983 334789999999999999999999999 99999999999999999999999999998664332221
Q ss_pred cc--cccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 213 ST--RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 213 ~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.. ...++..|+|||.+.+..++.++||||||+++|++++ |..||...+... ........ ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~~-------------~~ 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLESG-------------ER 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcC-------------Cc
Confidence 11 1223457999999998899999999999999999998 999986543211 11111110 00
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1122334567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.62 Aligned_cols=265 Identities=22% Similarity=0.350 Sum_probs=200.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|++|.||+|... ++..||+|.+.... ......+.+|+.++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999875 68899999987542 22346778899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
++ ++|.+++... .....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 5888877432 2235789999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc---------c
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD---------K 279 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~ 279 (353)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||....+................. .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1 12223568889999987654 57889999999999999999999998654432221111110000000 0
Q ss_pred cccccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......... .......+.++.+++.+||+.||.+|||+++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0011123566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.75 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+++.+ +++.+|+|++... .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999876 5788999998632 2223345778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999842 245689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||...+.......+. .......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh------CCCcccc
Confidence 3222233456899999999886 3457889999999999999999999997654322221111 0000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIEM 324 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 324 (353)
. +......+..+.+++.+|+..++++ |++++++++.
T Consensus 229 -----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 1111223556888888988654444 6889998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.03 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=203.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 58899999987432 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 128 DYMQNNSLSQTLLGEEK-------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~-------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
||++|++|.+++..... ....++...+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998854211 123456778899999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCc-----------------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc
Q 042383 201 LSKLFPEDIT-----------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG 263 (353)
Q Consensus 201 ~~~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~ 263 (353)
++........ .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521100 01122468999999999999999999999999999999999999997533211
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-RMSTVIEMINGDVD 330 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~ 330 (353)
.. ..... ..+.. .......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 239 i~----~~~~i---------~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS----YRDVI---------LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh----hhhhc---------cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 00000 00000 000112345688999999999999995 66777777766543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=333.68 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=204.7
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCc
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPC 122 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 122 (353)
....++|++.+.||+|+||+||+|.+. ++..+|+|++... .......+..|+.+++.++||||++++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 345678999999999999999999876 5778999988744 23345678899999999999999999998854 456
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEcCCCCCCeEECC--------
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI----KPSIVHRDIKPSNILLDQ-------- 190 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~----~~~i~H~dlk~~Nil~~~-------- 190 (353)
+++||||+++++|.++|.........+++..++.++.||+.||.|||+.. ..+|+|+||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999654444568999999999999999999999851 025999999999999954
Q ss_pred ---------CCCeEEeeccCCccCCCCCccccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 042383 191 ---------NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFD 259 (353)
Q Consensus 191 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~ 259 (353)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|+|++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654321 2234568999999998864 45889999999999999999999999754
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhcCCC
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI--EMINGDV 329 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl--~~L~~~~ 329 (353)
...... ...... .. .+. ....+..+.+||.+||+.+|.+||++.+++ ..+....
T Consensus 247 ~~~~ql--i~~lk~---~p--------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 247 NNFSQL--ISELKR---GP--------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CcHHHH--HHHHhc---CC--------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 432211 111100 00 000 011246688999999999999999999998 4555443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=299.62 Aligned_cols=252 Identities=22% Similarity=0.373 Sum_probs=202.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.+.|++.+.||.|+||.||+|+.. ++..+++|.+..........+.+|+.+++.++|||++++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999876 5889999999876666677888999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|...+. .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999988763 2345689999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 210 THISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.......+++.|+|||.+. ...++.++|||||||++|+|++|..||......... . ......
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~~~------ 231 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---L---KIAKSE------ 231 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH---H---HHhcCC------
Confidence 1123345788999999885 344678999999999999999999998754321111 1 110000
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+ ....+...+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00112233456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.61 Aligned_cols=249 Identities=20% Similarity=0.392 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.+|++.+.||.|++|+||++... +++.|++|.+........+.+.+|+.+++.++|||++++++.+.+....++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 56999999999999999999864 68899999987655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|..++. ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999872 34589999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...+......... . ..... .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~-~~~~~----------~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---T-NGTPE----------L 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-cCCcc----------c
Confidence 1223457889999999998889999999999999999999999997655432221110 0 00000 0
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...+..+.+++.+||..+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112223456889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.72 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=205.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
.++|.+.+.||+|+||.||++... ....+|+|.+... .......+..|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999742 2456899988743 233446688899999999 699999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
...+++|||+++++|.+++..... ....+++..+..++.||+.||.|||+. +++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999854321 124588999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
+.++.+||+|||.++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432111 1111223467999999998889999999999999999999 888886443221111
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
. .. .. .....+...+..+.+++.+||+.+|++|||+.++++.|.++...
T Consensus 248 ~---~~----~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 L---LR----EG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred H---HH----cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1 10 00 00112233455788999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.97 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=203.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CC---cEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DG---TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|+..+.||+|++|.||+|... ++ ..+|+|.+... .......+..|+.++..++|||++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46788899999999999999865 23 37999988754 233456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++.. ....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999998842 345789999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCccccc--cccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITHIST--RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
........ ....+..|+|||.+.+..++.++|||||||++|+|++ |..||......... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~---~~i~~---------- 225 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM---KAIND---------- 225 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---HHHhc----------
Confidence 32221111 1223457999999988889999999999999999997 99999654332111 11100
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..........+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 226 ---~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 ---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111223356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.34 Aligned_cols=249 Identities=26% Similarity=0.402 Sum_probs=199.5
Q ss_pred CeeeeeCceEEEEEEeCC--C--cEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQD--G--TVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689999986655 556788999999999999999999999988 889999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH- 211 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 211 (353)
++|.+++..... ..+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999854321 5789999999999999999999999 9999999999999999999999999999876542221
Q ss_pred -ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 212 -ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 212 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. ..... ... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~--~~~----------~ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---KKIDK--EGE----------R 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHh--cCC----------c
Confidence 1122446778999999988899999999999999999998 99998644332111 11110 000 0
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
...+...+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 11122335678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=293.83 Aligned_cols=250 Identities=20% Similarity=0.338 Sum_probs=201.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEec-CCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIE-GPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 128 (353)
+|++.+.||+|++|.||++..+ +++.+|+|.+.... ....+.+.+|+.++++++|+|++++.+.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999865 57889999987542 3344678889999999999999999998764 445789999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++.. .....+++.+++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999998843 2345689999999999999999999999 9999999999999999999999999998866432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+..... ..... ..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~----~~--------- 218 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---YRIIE----GK--------- 218 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHh----cC---------
Confidence 22 223356788999999999999999999999999999999999998744321111 00000 00
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 012233445678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=297.83 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=202.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++|||++++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999876 58899999886432 2233567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|..++ .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELE----KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998887766 3445689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc--------cc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT--------DK 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~ 279 (353)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+.............. ..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 21 1223456788999998876 45789999999999999999999999765543322222111100000 00
Q ss_pred c-ccccCcccCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 L-QHLVDPMLCGN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .....+..... ..+..+..+.+++.+||+.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000000 01122567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.84 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=198.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC------C
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEG------P 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~ 121 (353)
..+.|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+|++++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999865 58889999987543 3446778899999998 799999999998753 4
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..+++|||+.+++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 57899999999999999843 2345689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
+........ ......|+..|+|||++. +..++.++|||||||++|+|++|..||............ ..
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------~~ 230 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------PR 230 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------hc
Confidence 876543222 223456888999999886 335788999999999999999999999644322111100 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... .......+..+.+++.+||+.+|.+|||+.++++
T Consensus 231 -~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -NPAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -CCCC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 0111123456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=306.95 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=214.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc-HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
....+.++||+|-||.|.++....+..||+|.++...... .+.|.+|+++|.+++||||+.++++|..++.+++|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4456789999999999999998878999999999765444 488999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC-CCC
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP-EDI 209 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~ 209 (353)
+.|+|.+++..++... +.-....+++.||++|++||.+. ++|||||.++|+|+++++++|++|||+++.+- .+.
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999996553332 45556677999999999999999 99999999999999999999999999998443 333
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCcccchhhHHHHHHhhccc-cccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT--GQAAVHFDKELGEYYLVEKAWEMHNT-DKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 286 (353)
.....+..-+.+|+|||.+..++++.++|||+||+++||+++ .+.||....+ .+.++........ +....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~---- 765 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVV---- 765 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCccee----
Confidence 444445566789999999999999999999999999999876 6678764332 2223333332222 11111
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..-+.-++.++.+++.+||..+.++|||++++...|++..
T Consensus 766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2234456888999999999999999999999999887653
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.11 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=203.6
Q ss_pred CCCCCCeeeeeCceEEEEEEeCC--CcEEEEEEeeccC----------hhcHHHHHHHHHHHHh-cCCCCceeeeeeEec
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQD--GTVVAVKVLSVES----------KQGEKEFMSEVASMAN-ICHENLVKLHGGCIE 119 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 119 (353)
+|++.+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998764 6889999886321 2223456778887765 689999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
++..+++|||+++++|.+++.........+++..++.++.|++.||.+||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885544456679999999999999999999996 5 899999999999999999999999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~~~~~----~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---TKIVE----A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---HHHhh----c
Confidence 99998654432 223456788999999999888999999999999999999999998644322111 11100 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.. .+......+..+.+++.+||+.||++||++.|+.+++.+
T Consensus 229 ~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 229 VY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 000111234678899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.44 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+|++++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999865 68899999987553 34446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. .++++..+..++.|++.|+.+||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999832 2789999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..... ..... ...
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~-------------~~~ 215 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL---FLIPK-------------NNP 215 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH---HHhhh-------------cCC
Confidence 2 223346788899999999888999999999999999999999999754422111 10000 001
Q ss_pred CCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGN-EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... .+..+.+++.+||..+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 4556889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.33 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=201.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEec-CC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIE-GP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 121 (353)
.++|++.+.||+|+||+||+|.+ .+++.||+|+++... ......+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999973 246789999997543 23345688899999999 68999999998765 45
Q ss_pred ceEEEEEcCCCCChhhhhhhccc---------------------------------------------------------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEK--------------------------------------------------------- 144 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 144 (353)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998854211
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-ccccccc
Q 042383 145 ------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVA 217 (353)
Q Consensus 145 ------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~ 217 (353)
....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 013468888999999999999999999 999999999999999999999999999876532211 1112234
Q ss_pred CCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHH
Q 042383 218 GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNE 296 (353)
Q Consensus 218 g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..... ... ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~----~~~---------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----EGT---------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHHh----ccC---------CCCCCCCC
Confidence 5677999999988899999999999999999997 88898643321111 00000 000 00111112
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 297 AVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 297 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
++.+.+++.+||+.+|++|||+.||++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=298.67 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=201.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++||||+++++.+..+...++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 6899999988754 333446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|..++... .....+++..+..++.|++.||.|||+. .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999998887432 1234789999999999999999999963 18999999999999999999999999998765332
Q ss_pred ccccccccCCcCccCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGH------LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.............. +
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~------------~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA------------I 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH------------H
Confidence 122345788999999886543 47899999999999999999999964332211111111 0
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... .....+...+..+.+++.+||+.+|++||++++++.
T Consensus 223 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 110 012233345677889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=296.64 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=200.0
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
|++.+.||.|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++.+..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677889999999999999876 5778899998766656667788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+.. ...++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 999887732 345789999999999999999999999 999999999999999999999999999876533221 2
Q ss_pred cccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 213 STRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.....+++.|+|||++. +..++.++|||||||++|+|++|..||...+..... ....... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~---------~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSE---------PPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH---HHHhhcC---------CCC
Confidence 23356888999999874 345778999999999999999999998754322111 1110000 000
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 --LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112223467899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=299.23 Aligned_cols=265 Identities=23% Similarity=0.384 Sum_probs=205.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|++|.||+|..+ +++.||+|.++.. .......+.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999876 5889999988743 23334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++++.+.... .....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99986666554 3445689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc--------
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK-------- 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 279 (353)
.........++..|+|||++.+. .++.++||||||+++|+|++|..||......+................
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 33233345678889999999888 889999999999999999999999976543322222111111000000
Q ss_pred -cc-----cccCc-ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 -LQ-----HLVDP-MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 -~~-----~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. ..... .....++...+.++.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000 0001122233677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.12 Aligned_cols=255 Identities=20% Similarity=0.321 Sum_probs=215.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..=|.+.+.||+|-|++|-+|++- +|..||||++.... ......+.+|+..++.++|||||++|.+...+..+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 355888899999999999999854 79999999998543 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE-CCCCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL-DQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~-~~~~~~kl~Dfg~~~~~~ 206 (353)
|.-++|+|+++|..+ ...+++..+.+++.||+.|+.|+|.. .+|||||||+||.+ .+-|-|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999654 45699999999999999999999999 99999999999865 678899999999998775
Q ss_pred CCCccccccccCCcCccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLN-PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
. .....+.+|+..|-|||++.+..|+ ++.||||||||||-|.+|++||...++.+.. -.++|
T Consensus 171 P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImD 233 (864)
T KOG4717|consen 171 P--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMD 233 (864)
T ss_pred C--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhc
Confidence 4 3445668999999999999999986 6899999999999999999999866654433 33333
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
-.. ..+.....++.+||.+||..||++|.|.+||.. .|+....
T Consensus 234 CKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 234 CKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred ccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 322 355666788999999999999999999999964 4555443
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=293.06 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=205.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||.|++|.||+|.... +..+++|.+..... ...+.+|+.++++++||||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3679999999999999999999764 78999999875432 67889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999883 2346789999999999999999999999 99999999999999999999999999988665432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...... .
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~--~ 218 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPP--T 218 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCC--C
Confidence 1 223345788999999999889999999999999999999999999754332111000 000000 0
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+......+.+++.+||+.+|++|||+.+|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1122234567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=299.15 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=203.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|++|+||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 357888999999999999999865 58889999887543 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++ ...+.+++..+..++.+++.||.|||+. .+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIY----KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999887 3445789999999999999999999973 18999999999999999999999999998654322
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchh-----hHHHHHHhhccccccccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-----YLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 283 (353)
. .....++..|+|||++.+..++.++|+|||||++|++++|..||......... ........ +
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~ 225 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ---------I 225 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH---------H
Confidence 1 12356889999999998889999999999999999999999999754432110 00000000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.............+..+.+++.+||+.||.+|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000111245678899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=306.17 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=207.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
..+|++.+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 457899999999999999999742 12368999887442 33456788999999999 799999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
...++++||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 999999999999999999854321 123578889999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987654322111 122234567999999999999999999999999999998 888886443221111
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.+ .. ......+...+..+.+++.+||+.+|++|||+.|+++.|..+.....
T Consensus 248 ~~-------~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 LL-------KE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HH-------Hc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 10 00 01111223345678899999999999999999999999998885544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.86 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=202.6
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEe-----
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCI----- 118 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~----- 118 (353)
.+....++|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34456789999999999999999999865 57899999876432 2235677899999999 6999999999874
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 45578999999999999998754434456789999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||.......... .
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~------~ 240 (286)
T cd06638 168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF------K 240 (286)
T ss_pred CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh------h
Confidence 999876543221 2233468899999998753 457889999999999999999999997543321110 0
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
... . .... ...+......+.+++.+||+.+|++|||+.|+++.
T Consensus 241 ~~~-~-----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 IPR-N-----PPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccc-c-----CCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 0 0000 00111224568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.08 Aligned_cols=270 Identities=24% Similarity=0.348 Sum_probs=206.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-----CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEec--CCce
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-----DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIE--GPCR 123 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 123 (353)
+.|++.+.||+|+||.||++... ++..+|+|++...... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788899999999999999853 3678999998855443 45788999999999999999999999887 6678
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999843 233689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|..|+............. .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL 236 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence 76532221 1112334567999999988899999999999999999999999986432211000000 00000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+........+..++.++.+++.+||+.+|++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111122233457799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=311.62 Aligned_cols=261 Identities=17% Similarity=0.209 Sum_probs=199.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC---CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|+.+++.++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999987632 23457999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|++. ++|.+++ .....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 5888887 3456799999999999999999999999 999999999999999999999999999976554
Q ss_pred CCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc-----
Q 042383 208 DIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ----- 281 (353)
Q Consensus 208 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 281 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 322 22234578999999999999999999999999999999999999997654322111111111100000000
Q ss_pred -----cc---cCcccCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 282 -----HL---VDPMLCGNFS-------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 282 -----~~---~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.. ........+. ......+.+++.+||..||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 1123567889999999999999999999864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=297.58 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=204.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|+.++++++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999865 68899999987553 33346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+ +++|.+++.. ...++++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999998843 236799999999999999999999999 99999999999999999999999999988765433
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc---------c
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD---------K 279 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~ 279 (353)
........++..|+|||.+.+. .++.++||||+|+++|+|++|.+||...................... .
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2223345688899999988654 46899999999999999999988886554332222111111000000 0
Q ss_pred cccccCccc----CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 LQHLVDPML----CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+..... .....++....+.+++.+||+.+|++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 001112335788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.49 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=204.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||.|++|.||++... ++..+|+|++........+.+.+|+.++++++|||++++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357899999999999999999865 6889999999877666667888999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999998832 235799999999999999999999999 99999999999999999999999999887543321
Q ss_pred ccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 210 THISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+..... ..... ..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~---~~------ 224 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---LKILK---SE------ 224 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH---HHHhc---CC------
Confidence 1 223345788999999875 345678999999999999999999999754432111 11100 00
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+.+ ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 1122234568899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=293.58 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=196.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCce
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-----KQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCR 123 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 123 (353)
.+|++.+.||+|++|.||+|... ++..|++|.+.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999865 58899999886432 2234568889999999999999999998875 3567
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++++||+++++|.+.+. ....+++...+.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999983 345689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
....... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHh------
Confidence 6532211 1112245788999999999888999999999999999999999999754321111 0100
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......++......+..++ +||..+|++||+++||++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ---TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011222333345566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=293.54 Aligned_cols=254 Identities=23% Similarity=0.331 Sum_probs=192.7
Q ss_pred CeeeeeCceEEEEEEeC---CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||+|... ++..+|+|.++... ......+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999754 34578999887543 233457888999999999999999999999999999999999999
Q ss_pred Chhhhhhhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-
Q 042383 134 SLSQTLLGEEK-NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH- 211 (353)
Q Consensus 134 sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 211 (353)
+|.+++..... .....++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999854322 233567788889999999999999999 9999999999999999999999999998754332211
Q ss_pred ccccccCCcCccCccccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 212 ISTRVAGTLGYLAPDYAVSG-------HLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+... ... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHh----hcccCCC
Confidence 11234567889999987642 35789999999999999996 999996544322111 000 0111111
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
..+.+ ....+..+.+++.+|| .+|.+|||++||+..|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1223445778999999 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=293.34 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=202.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
+|+..+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999876 78999999987543 23446788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+||+++++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998 3345689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......... ..... ..
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~---~~------- 218 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGR---SK------- 218 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HHHHh---cc-------
Confidence 332 223456788999999987776 899999999999999999999999754421111 11000 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+......+.+++.+||+.+|.+||++.++++
T Consensus 219 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 --ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 011223334567889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.44 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=195.8
Q ss_pred CeeeeeCceEEEEEEeC-CCc--EEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGT--VVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||.||+|... ++. .+++|.+... .......+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999865 343 4688887643 334456788999999999 799999999999999999999999999
Q ss_pred CChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 133 NSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 133 ~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999854321 123578999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
++....... .......+..|+|||++.+..++.++||||||+++|+|++ |..||...+..... ... . .
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~---~-~-- 226 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKL---P-Q-- 226 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH---HHH---h-C--
Confidence 986332111 1111223567999999988889999999999999999997 99999654322111 110 0 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
......+...+..+.+++.+||+.+|.+|||+.+++..|+++.
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0011112223456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=301.94 Aligned_cols=198 Identities=25% Similarity=0.436 Sum_probs=161.4
Q ss_pred CCeeeeeCceEEEEEEeC---CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCceEEEEEcCC
Q 042383 57 SNKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCRIIVYDYMQ 131 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 131 (353)
.++||+|+||+||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.+ +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999886432 23456789999999999999999998854 456789999996
Q ss_pred CCChhhhhhhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE----CCCCCeEEeeccCC
Q 042383 132 NNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGLS 202 (353)
Q Consensus 132 ~~sL~~~l~~~~-----~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~~ 202 (353)
+ +|.+++.... .....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8887764321 1223589999999999999999999999 99999999999999 45678999999999
Q ss_pred ccCCCCCcc--ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCc
Q 042383 203 KLFPEDITH--ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDK 260 (353)
Q Consensus 203 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~ 260 (353)
......... ......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543221 22345789999999988764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=292.72 Aligned_cols=251 Identities=33% Similarity=0.473 Sum_probs=201.3
Q ss_pred CCCCCeeeeeCceEEEEEEeCC-----CcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+++.+.||.|+||.||++.... +..+|+|++...... ..+.+..|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998753 378999998755433 5678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.... ...+++..+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999984321 12289999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
..........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||......... ......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~~~~------------ 220 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYLKKG------------ 220 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhcC------------
Confidence 32222212336788999999988889999999999999999998 77887653321111 111100
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
.....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 -YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01111222466789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.84 Aligned_cols=193 Identities=22% Similarity=0.348 Sum_probs=165.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
...+|++.+.||+|+||.||+|... ++..||+|+.... ....|+.++++++||||+++++++.+....++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999876 5778999975422 22468999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
++. ++|.+++. .....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 138 ~~~-~~l~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLT---KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 996 48888873 2346789999999999999999999999 9999999999999999999999999998753322
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
.......||+.|+|||++.+..++.++|||||||++|+|+++..++.
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12233568999999999999999999999999999999999665553
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.32 Aligned_cols=248 Identities=23% Similarity=0.414 Sum_probs=204.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..|+..+.||.|++|.||+|.+. ++..||+|++.... ......+.+|+.+++.+.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999875 58899999987543 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ..++++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999999882 34689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........... ......
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~ 218 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNP 218 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCC
Confidence 1 12234578889999999888899999999999999999999999875432211100 011111
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
+......+..+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23444567789999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.17 Aligned_cols=252 Identities=22% Similarity=0.410 Sum_probs=203.7
Q ss_pred CCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccC------hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVES------KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+..++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999986 468899999987432 1234678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCcc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSKL 204 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~ 204 (353)
|+||+++++|.+++ ....++++..+..++.|++.||.+||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999988 3445789999999999999999999999 999999999999998776 599999999876
Q ss_pred CCCCCcc---ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 205 FPEDITH---ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 205 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------- 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------
Confidence 6533211 122345788999999998888999999999999999999999999654332221111110
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.........+......+.+++.+||+.+|.+|||+.++++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 --ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111123344455678999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.38 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=210.5
Q ss_pred eeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhh
Q 042383 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQ 137 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 137 (353)
+||+|++|+||.|++. +...+|||.+........+.+.+|+...+.++|.|||+++|.+.+++.+-|.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999976 466799999987777777889999999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-CCCCeEEeeccCCccCCCCCccccc
Q 042383 138 TLLGEEKNRAKF--SWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHIST 214 (353)
Q Consensus 138 ~l~~~~~~~~~l--~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 214 (353)
.+. ...+++ ++..+-.+.+||++||.|||++ .|||||||-+||||+ -.|.+|++|||-++.+. ..+....
T Consensus 662 LLr---skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TE 734 (1226)
T KOG4279|consen 662 LLR---SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTE 734 (1226)
T ss_pred HHH---hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc-cCCcccc
Confidence 993 456777 8999999999999999999999 999999999999996 47899999999998764 3455667
Q ss_pred cccCCcCccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc--CC
Q 042383 215 RVAGTLGYLAPDYAVSG--HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML--CG 290 (353)
Q Consensus 215 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 290 (353)
++.||..|||||++..+ +|+.++|||||||++.||.||++||..-..... ..+.-.++ -+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------------AMFkVGmyKvHP 798 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------------AMFKVGMYKVHP 798 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------------hhhhhcceecCC
Confidence 78899999999999865 588999999999999999999999974332111 11111122 25
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
..+.+...+...+|++|+.++|.+||+++++|+ +|+..
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 567777888999999999999999999999986 45554
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=291.17 Aligned_cols=250 Identities=21% Similarity=0.352 Sum_probs=204.8
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||.|+||.||.++.. ++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 6888999988754 344456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998432 245689999999999999999999998 99999999999999999999999999988664433
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+... ... ... .
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~---~~~----~~~--------~- 218 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---KIV----QGN--------Y- 218 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----cCC--------C-
Confidence 2 2233568899999999988889999999999999999999999997543321111 110 000 0
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......+..+.+++.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11113345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.26 Aligned_cols=261 Identities=19% Similarity=0.248 Sum_probs=206.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||.||++... +++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999876 57889999987543 223456778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||++|++|.+++ ...+.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLL----KNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999998 3446789999999999999999999999 999999999999999999999999998864211
Q ss_pred CCc--------------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 208 DIT--------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 208 ~~~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||......+. ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~---~~~~~~ 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVIS 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh
Confidence 100 011123567889999999888999999999999999999999999975432211 111000
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
... .. .......+..+.+++.+||+.+|++||+..++++.|+...-...
T Consensus 231 ----~~~---~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 ----DDI---EW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ----ccc---CC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 000 00 01111235668899999999999999998888888887654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=312.15 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=219.6
Q ss_pred CCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
+.....+||-|-||.||.|.|+. .-.||||.++ +.....++|..|..+++.++|||+|+++++|..+..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34456789999999999999874 5569999987 556677899999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
.|+|.++|. +-++..++....+.++.||.+|+.||..+ ++|||||..+|+||.++..||++|||+++++..+...
T Consensus 347 yGNLLdYLR--ecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 347 YGNLLDYLR--ECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred CccHHHHHH--HhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999993 33556678888999999999999999999 9999999999999999999999999999999776555
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......-+.-|.|||-+..+.++.|+|||+||++||||.| |-.||.+-+-. .+..++.+.++.
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------qVY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYGLLEKGYRM 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------HHHHHHhccccc
Confidence 5544555778999999999999999999999999999999 77787543322 233344455556
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
+-+..|++++.+|++.||+|+|.+||+++|+-+.|+....
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 6677789999999999999999999999999998877653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=302.51 Aligned_cols=266 Identities=20% Similarity=0.239 Sum_probs=197.3
Q ss_pred CCCeeeee--CceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 56 SSNKVGEG--GFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 56 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+.++||+| +|++||++..+ +|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 67899999865 78999999987542 333456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998432 234589999999999999999999999 999999999999999999999999986543321110
Q ss_pred ------cccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc-----
Q 042383 211 ------HISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT----- 277 (353)
Q Consensus 211 ------~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 277 (353)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~-~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EK-LNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH--HH-hcCCccccccc
Confidence 01122346678999999876 458899999999999999999999997533211110 00 000000
Q ss_pred -----ccc-----ccccCc-----------------ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 278 -----DKL-----QHLVDP-----------------MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 278 -----~~~-----~~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
+.. ....+. .............+.+++.+||+.||++|||++++++ .+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000 000000 0001122234567899999999999999999999987 45544
Q ss_pred C
Q 042383 329 V 329 (353)
Q Consensus 329 ~ 329 (353)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=301.53 Aligned_cols=252 Identities=23% Similarity=0.265 Sum_probs=203.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|++|+||+|... +++.+|+|.+..... ...+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999876 488999999875432 24456888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+.+++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999998842 2346789999999999999999999999 999999999999999999999999999875532
Q ss_pred CCcc----------------------------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 042383 208 DITH----------------------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFD 259 (353)
Q Consensus 208 ~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~ 259 (353)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 011235788899999999888999999999999999999999999755
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR----MSTVIE 323 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 323 (353)
+........ .............+..+.+++.+||+.+|++||| +++++.
T Consensus 236 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNI---------------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHH---------------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 443221110 0101111111114677999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=296.53 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=202.0
Q ss_pred CHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec-
Q 042383 43 SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE- 119 (353)
Q Consensus 43 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 119 (353)
+..++....+.|++.+.||.|+||.||+|... +++.+|+|++.... .....+..|+.++.++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44455556688999999999999999999864 68899999886543 3345678899999998 79999999998853
Q ss_pred -----CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 120 -----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 120 -----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 45789999999999999988432 234688999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHH
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE 269 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 269 (353)
+|+|||++........ ......+++.|+|||.+. ...++.++|||||||++|+|++|..||............
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~- 238 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI- 238 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH-
Confidence 9999999875532211 223356888999999876 345788999999999999999999999654322111100
Q ss_pred HHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 -----~~~------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 -----PRN------PPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----hhC------CCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 000 0111233567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=292.21 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=205.2
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 127 (353)
+|++.+.||.|++|.||++... ++..+|+|.+... .....+.+.+|+.+++.++|||++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 6888999988743 33445678889999999999999999997754 45678999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH-----EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-----~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
||+++++|.+++........++++..++.++.||+.||.+|| +. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999665455678999999999999999999999 66 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+... ...... .
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~----- 224 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIK----E----- 224 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHh----c-----
Confidence 87654322 1233568899999999998889999999999999999999999997654211 111110 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
......+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 225 ----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122333445678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.72 Aligned_cols=240 Identities=20% Similarity=0.331 Sum_probs=188.7
Q ss_pred CeeeeeCceEEEEEEeCC-------------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 58 NKVGEGGFGSVYKGKLQD-------------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
+.||+|+||.||+|...+ ...+++|++..........+.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997431 2358999887655555567888999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC-------eEEe
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN-------PKIS 197 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~-------~kl~ 197 (353)
+||||+++++|..++. .....+++..+..++.||+.||.|||+. +++|+||||+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999988873 2345689999999999999999999999 9999999999999976654 8999
Q ss_pred eccCCccCCCCCccccccccCCcCccCccccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCCcccchhhHHHHHHhhc
Q 042383 198 DFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIV-TGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 198 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.. .. .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~---~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RF---Y 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HH---H
Confidence 99998754321 2245678899999886 466889999999999999998 577877643321110 00 0
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.. .. .........+.+|+.+||+.||.+||++.+|++.|+
T Consensus 223 ~~-~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EG-QC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hc-Cc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 011112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.86 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=198.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--Cce
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-----KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCR 123 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 123 (353)
.+|++.+.||+|+||.||.+... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999865 58899999886432 22345778899999999999999999988764 467
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
+++|||+++++|.+++. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999883 345688999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
....... .......++..|+|||.+.+..++.++|||||||++|+|++|..||......... . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---H---HHhc-----
Confidence 6532111 1122345788999999998888999999999999999999999999744321111 0 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......+......+.+++.+|+. +|++||+++||++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001122344455678889999994 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.44 Aligned_cols=249 Identities=27% Similarity=0.407 Sum_probs=202.2
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|.+.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 688999999886544 3567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++ .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHH----hhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998 3445688999999999999999999999 99999999999999999999999999988765433
Q ss_pred ccccc---cccCCcCccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 210 THIST---RVAGTLGYLAPDYAVSGH---LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 210 ~~~~~---~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
..... ...++..|+|||.+.+.. ++.++||||||+++|++++|..||...+.... ....... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVGA----G----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHhc----C-----
Confidence 22211 345788999999988766 88999999999999999999999964432111 1100000 0
Q ss_pred cCcccCCCCCh--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSG--NEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+. ..+..+.+++.+||+.+|.+|||+.+++.
T Consensus 223 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 ----HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111 22566889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.84 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=200.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh----------cHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ----------GEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
+|.+.+.||.|++|.||+|... +|+.+|+|.+...... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5778899999999999999864 6889999988643111 1245778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++++|.+++. ....+++..+..++.||+.||.+||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999983 346789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccCCcCccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 202 SKLFPEDITH-ISTRVAGTLGYLAPDYAVSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 202 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
+......... ......++..|+|||.+.... ++.++|+||||+++|++++|..||......... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM------FKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH------HHhhccc
Confidence 8765432211 123345788999999887654 789999999999999999999998643322111 1111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+........+..+.+++.+||+.+|.+|||+++|++.
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111112222345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.42 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=199.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..+.+.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 3444555678999999999999855 578899999886666667788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKF--SWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLF 205 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l--~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 205 (353)
|+++++|.+++... ...+ ++..+..++.||+.||.|||+. +++|+||||+||+++. ++.++|+|||.+...
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 86 QVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred cCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999998432 2344 8888999999999999999999 9999999999999976 679999999998765
Q ss_pred CCCCccccccccCCcCccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
..... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... .....
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~--------- 226 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGM--------- 226 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhh---------
Confidence 33211 222345788999999886543 7889999999999999999999986432211100 00000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......+......+.+++.+||+.+|++|||+.++++
T Consensus 227 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 --FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00112233344567889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=297.47 Aligned_cols=263 Identities=19% Similarity=0.306 Sum_probs=198.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|++|.||+|... +|+.+|+|.++.... .....+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5788899999999999999875 688999999875422 2235677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++ +|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 78777632 345689999999999999999999999 99999999999999999999999999988654322
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchh-hHHHHHHhhccccc---ccccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDK---LQHLV 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~ 284 (353)
.. .....+++.|+|||.+.+. .++.++|||||||++|+|++|..|+......... ..+........... .....
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 21 2234568899999988764 4789999999999999999999887543322111 11110000000000 00000
Q ss_pred Cc----ccC-----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DP----MLC-----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~----~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+. ... ....+..+..+.+++.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000 1112234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.95 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=189.9
Q ss_pred CeeeeeCceEEEEEEeCC---CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQD---GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997442 4568888776443 333456788999999999999999999999999999999999999
Q ss_pred Chhhhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-c
Q 042383 134 SLSQTLLGEEKN-RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-H 211 (353)
Q Consensus 134 sL~~~l~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 211 (353)
+|.+++...... ....++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998554322 23456788899999999999999999 999999999999999999999999999865432211 1
Q ss_pred ccccccCCcCccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 212 ISTRVAGTLGYLAPDYAVS-------GHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.... ..... .....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~----~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL---KQVVR----EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---HHHhh----ccCccC
Confidence 1122345677999998643 356789999999999999999 77787644322111 11000 000111
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.. +......+..+.+++..|| .||++|||+++|++.|+
T Consensus 231 ~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1222334556778888998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.02 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=201.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|++|.||++.+. +++.+|+|++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 58899999987432 233466888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~----~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHL----RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998 3446799999999999999999999998 999999999999999999999999999887644
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..... .... ...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~~-------- 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---EKIL----EGK-------- 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----cCC--------
Confidence 3 23356789999999998888899999999999999999999999755421111 1110 000
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...+...+..+.+++.+||+.+|.+|| +++|+++
T Consensus 215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112222356788999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=291.65 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=198.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999875 47789999886432 335788999999999999999999998765 4789999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999998432 234689999999999999999999998 99999999999999999999999999987543221
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ..... ....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~-------------~~~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---ECVEK-------------GYRM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhC-------------CCCC
Confidence 12234567999999988899999999999999999998 89998654322111 11100 0111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.23 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=204.6
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE 119 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 119 (353)
++..++....++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344555556789999999999999999999864 68899999886432 2345677899999998 79999999998875
Q ss_pred C-----CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 120 G-----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 120 ~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
. ...++|+||+++++|.+++.........+++..++.++.|++.||.+||+. +++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 357999999999999998854434556789999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHH
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE 269 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 269 (353)
+|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|..||..........
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--- 243 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH---
Confidence 9999999876543221 12234578899999987643 36889999999999999999999997543321111
Q ss_pred HHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. ... ....+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 244 ~~---~~~-~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KI---PRN-PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH---hcC-CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 000 00000 011223456889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.65 Aligned_cols=239 Identities=22% Similarity=0.382 Sum_probs=187.8
Q ss_pred eeeeeCceEEEEEEeC-------------------------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceee
Q 042383 59 KVGEGGFGSVYKGKLQ-------------------------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKL 113 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 113 (353)
.||+|+||.||+|... ....|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998642 123589998875555455678889999999999999999
Q ss_pred eeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-
Q 042383 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF- 192 (353)
Q Consensus 114 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~- 192 (353)
++++.++...++||||+++++|..++. ...+.+++..+..++.||+.||.|||+. +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999988873 2345789999999999999999999999 999999999999997543
Q ss_pred ------CeEEeeccCCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHH-hCCCCCCCCcccch
Q 042383 193 ------NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIV-TGQAAVHFDKELGE 264 (353)
Q Consensus 193 ------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll-~g~~pf~~~~~~~~ 264 (353)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999987643221 12346788999998865 56899999999999999985 68999875443221
Q ss_pred hhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 265 YYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.... .. . ...+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 231 ~~~~----~~------------~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFY----EK------------K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH----Hh------------c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1100 00 0 0011112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.19 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=185.9
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhc---CCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANI---CHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
||+|+||+||+|+.. +++.||+|++..... ........|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 588999999874321 1223344566666555 699999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l----~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHL----QKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999888 3456799999999999999999999999 99999999999999999999999999987543221 12
Q ss_pred cccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 213 STRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+...... ... .... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~---~i~----~~~~------~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR---NIA----FGKV------RFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH---HHH----cCCC------CCCC-
Confidence 2345689999999988754 47899999999999999999999997544321111 110 0000 0000
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPR----MSTVIE 323 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 323 (353)
...+..+.+++.+||+.||++||+ +.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112456788999999999999984 556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.60 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=216.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC-----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
+...+.+.||.|-||.||.|.+.+ .-.||||..+.. ..+..+.|..|..++++++||||++++|+|.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 445567899999999999998532 335899999864 445568899999999999999999999999876 4899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||.++.|.|..++. .+...++......+++||+.||.|||+. +.|||||..+||||.+..-|||+|||+++.+
T Consensus 468 vmEL~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999994 4566789999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
............-+.-|+|||.+.-..++.++|||.||+.+||+++ |..||..-.. + .+...+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------s-DVI~~i 605 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------S-DVIGHI 605 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------------c-ceEEEe
Confidence 7765554444445668999999999999999999999999999988 8899975432 1 222223
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
...-+...++.|++.|..|+.+||..+|.+||++.++...|.++..
T Consensus 606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3344456788899999999999999999999999999888877654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=293.78 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=202.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------ 121 (353)
..++|++.+.||+|++|.||+|..+ +++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999975 578899999875443 346788999999999 7999999999997644
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998854433456899999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
+........ ......++..|+|||.+.. ..++.++||||||+++|+|++|..||.......... .. ..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~---~~ 232 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF---KI---PR 232 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH---Hh---hc
Confidence 876543222 2233557889999998754 346788999999999999999999997433221111 00 00
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ..+. ...+...+..+.+++.+||..||++|||+.++++
T Consensus 233 ~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000 1112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=295.98 Aligned_cols=246 Identities=23% Similarity=0.404 Sum_probs=200.8
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.|...+.||+|++|.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++.+..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556778999999999999865 57889999887443 334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999998872 35689999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... . .......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~----------~~~~~~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L----------IPKNSPP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h----------hhcCCCC
Confidence 1223457888999999998899999999999999999999999986443221110 0 0000111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+..+.+++.+||+.+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 222334567889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=289.38 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=204.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999865 67889999987442 23557789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.... ....+++..+..++.|++.||.+||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999984322 135689999999999999999999999 99999999999999999999999999987664332
Q ss_pred cc---ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 210 TH---ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 210 ~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. ......++..|+|||.+... .++.++|+||||+++|+|++|+.||........... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~---~~~~-~~-------- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML---TLQN-DP-------- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH---HhcC-CC--------
Confidence 21 22334678899999998876 788999999999999999999999975543221111 0000 00
Q ss_pred cccCCCC-ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNF-SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+.... ....+..+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0111110 1234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=291.11 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=205.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 127 (353)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 688999999875432 3456788999999999999999999988653 4689999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988755444566789999999999999999999999 999999999999999999999999999875432
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcc--cchhhHHHHHHhhccccccccccC
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE--LGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .............. . ..+.+
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~ 230 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-N---PELKD 230 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-c---hhhcc
Confidence 211 234567889999999988999999999999999999999999975532 11111111111100 0 00000
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
. .......+..+.+++.+||+.+|.+|||+.|+++ .+++..
T Consensus 231 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 231 E---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred C---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0 0101123567899999999999999999999987 554443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=288.25 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=207.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||.|++|.||+|... +++.+++|++..... .....+.+|+..+.+++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999876 589999999876543 4457789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
+++++|.+++. ...++++..++.++.|++.|+.+||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999983 33679999999999999999999999 8 9999999999999999999999999998866433
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||................. . .
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~---------~ 219 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----G---------P 219 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----C---------C
Confidence 222 2235578899999999988899999999999999999999999976543122111111110 0 0
Q ss_pred CCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGN-EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+.. .+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0112222 4567999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=290.92 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=189.7
Q ss_pred CeeeeeCceEEEEEEeCCC---cEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQDG---TVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.||+|+||+||++...++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975432 346677666443 334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC-Cccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED-ITHI 212 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 212 (353)
+|.+++..........++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999865433345577888899999999999999999 9999999999999999999999999987643211 1111
Q ss_pred cccccCCcCccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 213 STRVAGTLGYLAPDYAVS-------GHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||....+.+.. ..... +....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~----~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL---NHVIK----DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHh----hcccccC
Confidence 223457889999998753 235789999999999999997 46677543322111 11111 1111112
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
++.+ .......+.+++..|| .+|++||++++|++.|+
T Consensus 231 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 2223456788889999 57999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.46 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=204.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CC----cEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DG----TVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.+|++.+.||+|+||+||+|..+ +| ..+|+|.+.... ......+.+|+.++++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999864 23 368999887553 3344678899999999999999999999887 77899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|+||+++|+|.+++. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+...
T Consensus 86 v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999984 2344689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcccc-ccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDITHIS-TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
........ ....++..|+|||.+....++.++|+||||+++|++++ |..||......+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~----------- 225 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---DLLE----------- 225 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHh-----------
Confidence 53322111 11223567999999988889999999999999999998 99998754321111 1110
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.......+..+...+.+++.+||..+|++|||+.++++.|+.....+
T Consensus 226 --~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 226 --KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00011122223456889999999999999999999999999875433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=296.76 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=201.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 58899999876432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|..+. .....+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLE----KYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99998888766 3344589999999999999999999999 9999999999999999999999999998765433
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc-----ccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK-----LQH 282 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 282 (353)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||....................... ...
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 2 22233457889999998875 3477899999999999999999999975543222211111100000000 000
Q ss_pred ccCcccCC---------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVDPMLCG---------NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+....... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 011233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.58 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=188.4
Q ss_pred CeeeeeCceEEEEEEeCC-C----------cEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 58 NKVGEGGFGSVYKGKLQD-G----------TVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
+.||+|+||.||+|.... + ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999998753 3 25788877644333 6788899999999999999999999888 778999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-------CeEEeec
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-------NPKISDF 199 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-------~~kl~Df 199 (353)
|||+++++|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998432 23789999999999999999999998 999999999999998877 7999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccC--CCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSG--HLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
|++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.......... ...
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~----~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----FYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH----HHh---
Confidence 99886543 1223466789999998876 78999999999999999999 567775443211110 000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.. ...+......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ-----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC-----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0000111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.47 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=202.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|+||.||.+... +|+.+|+|.+... .......+.+|+.++++++||||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999865 6889999998743 233446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+.+++|.+.+.. .....+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998842 2234678999999999999999999998 99999999999999999999999999997654322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..... .... .. . .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---~~~~----~~--------~-~ 218 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV---LKII----RG--------S-Y 218 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH---HHHh----cC--------C-C
Confidence 1 122345788899999998888999999999999999999999998754321111 0000 00 0 0
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1123334567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.05 Aligned_cols=265 Identities=21% Similarity=0.347 Sum_probs=197.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|++|+||+|..+ +++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467999999999999999999876 6889999998754322 23456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.+ +|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 89888742 234789999999999999999999999 9999999999999999999999999998754322
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchh-hHHHHHHhhccccccccc---
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHL--- 283 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~--- 283 (353)
... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||......... ..................
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 111 122346788999998875 45789999999999999999999999655421111 111110000000000000
Q ss_pred ---c--------CcccCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 ---V--------DPMLCGNFS-GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ---~--------~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ...+..... ......+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000000 001256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.69 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=191.3
Q ss_pred CeeeeeCceEEEEEEeC----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEe-cCCceEEEEEcCC
Q 042383 58 NKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCI-EGPCRIIVYDYMQ 131 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 131 (353)
+.||+|+||.||+|... .+..+|+|.+... .....+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 2457999987533 3344567888999999999999999999765 4556889999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT- 210 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 210 (353)
+++|.+++.. .....++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999842 234467788899999999999999999 999999999999999999999999999875532211
Q ss_pred --cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 211 --HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG-QAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 211 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.......++..|+|||.+.+..++.++|||||||++|+|++| .+||...+.. .........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~~------------- 218 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQG------------- 218 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhcC-------------
Confidence 111123456789999999888999999999999999999995 4555433221 111111100
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001111122456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.79 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=197.8
Q ss_pred CeeeeeCceEEEEEEeCC-------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQD-------GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.||+|++|.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2578999876432 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-----CeEEeeccC
Q 042383 130 MQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-----NPKISDFGL 201 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-----~~kl~Dfg~ 201 (353)
+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 224578999999999999999999998 999999999999998877 899999999
Q ss_pred CccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~~~~----~~- 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHVT----AG- 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---HHHh----cC-
Confidence 875532211 11122345678999999999999999999999999999998 99998644332111 1110 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
.....+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111223345678899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.30 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=195.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHH-HHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVAS-MANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|+||.||++.+. +|+.||+|.+.... ......+..|+.. ++.++|||++++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999876 68999999987542 2233455556665 556689999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|++ ++|.+++.........+++..++.++.||+.||.|||+. .+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 588888755444456799999999999999999999974 28999999999999999999999999998865432
Q ss_pred CccccccccCCcCccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ ....... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~----~~----- 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLKQVVE----EP----- 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HHHHHHh----cC-----
Confidence 1 1122457888999998765 4568899999999999999999999964322111 0110000 00
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+ .....+..+.+++.+||+.+|.+|||++++++
T Consensus 225 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01123567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.57 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=201.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|++|.||++... ++..+|+|.+.... ......+.+|+.+++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999865 68889999987542 33456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~ 208 (353)
+++++|.+++.. .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999843 2245689999999999999999999999 99999999999999755 45899999999876443
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..... ..... ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~----~~--------- 217 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKIMS----GT--------- 217 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHHHh----cC---------
Confidence 2 223356788999999999888999999999999999999999999654332111 11100 00
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01122234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=294.31 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=200.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh-----cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ-----GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
+|.+.+.||+|++|.||+|... +++.||+|.+...... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 6889999998754322 335567899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999998321 23799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc------c
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD------K 279 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~ 279 (353)
..... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...................... .
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence 43221 222346778999998765 457889999999999999999988876554332221111110000000 0
Q ss_pred cccccCcccCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 LQHLVDPMLCGN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
............ .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000011 112335678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.95 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=200.2
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
|.....||.|+||.||++... ++..||+|.+........+.+.+|+..++.++|+|++++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334567999999999999865 6889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 104 ~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99998872 24589999999999999999999999 999999999999999999999999999876543222 1
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+...... .... ....... .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~~---------~~~~~~~--~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR---RIRD---------NLPPRVK--D 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh---------cCCCccc--c
Confidence 233467889999999988889999999999999999999999997544322111 1100 0111111 0
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+..+..++.+||..+|.+|||++++++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=293.66 Aligned_cols=267 Identities=21% Similarity=0.295 Sum_probs=199.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc-----
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC----- 122 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----- 122 (353)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 688999998875432 2335678899999999 46999999999887665
Q ss_pred eEEEEEcCCCCChhhhhhhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeecc
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKN-RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFG 200 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~-~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg 200 (353)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 888887543322 45789999999999999999999999 9999999999999998 8899999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...++..................
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 98765332111 122346788999998765 4578999999999999999999999976554333222211111111000
Q ss_pred cccccC-------cccC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVD-------PMLC----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~-------~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... +... ....+..+..+.++|.+||+.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=292.03 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=189.2
Q ss_pred CeeeeeCceEEEEEEeCC--------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.||+|+||.||+|.... ...+++|.+........+.+.+|..+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997542 234888887655555556788899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC--------eEEeeccC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN--------PKISDFGL 201 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~--------~kl~Dfg~ 201 (353)
+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999842 234689999999999999999999999 9999999999999977665 69999998
Q ss_pred CccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCC-CCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQ-AAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+...... ....++..|+|||.+.+. .++.++||||||+++|+|++|. .||.......... ... .
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~--~--- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYE--D--- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHH--c---
Confidence 8654321 224577889999998864 5789999999999999999995 5554332211110 000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ---------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122223456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=289.85 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=202.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||.|++|.||++..+ +++.+|+|.+.... ......+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999876 68899999987653 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
+++++|.+++... ...+++..+..++.|++.||.+||+ . +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998432 2678999999999999999999999 8 9999999999999999999999999998755322
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ....... ... .
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~---------~~~-~ 220 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYI---------VNE-P 220 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHH---------hcC-C
Confidence 11 12567889999999999899999999999999999999999997543211110 1111000 000 0
Q ss_pred CCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGN-EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+.. .+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0111111 4566899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.97 Aligned_cols=248 Identities=20% Similarity=0.354 Sum_probs=200.5
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999865 6889999998765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|...+ ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 103 ~~L~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 173 (297)
T cd06659 103 GALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 173 (297)
T ss_pred CCHHHHH-----hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence 9998876 234689999999999999999999999 999999999999999999999999999875543222 1
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||........... ... .... . ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~-~~~~--------~--~~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRD-SPPP--------K--LKN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhc-cCCC--------C--ccc
Confidence 2235688999999999988899999999999999999999999975443222111 100 0000 0 001
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+..+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11224568899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=292.48 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=206.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368999999999999999999864 6788999998755555557788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999883 23578999999999999999999999 99999999999999999999999999887554322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......+++.|+|||.+....++.++|+||||+++|++++|..||............. ......
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--------------~~~~~~ 234 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------------TNGTPE 234 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--------------cCCCCC
Confidence 2 1223457888999999988889999999999999999999999997544321110000 000000
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVD 330 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~ 330 (353)
.......+..+.+++.+||+.+|++||++.+++.. ++...+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 11122235568899999999999999999999864 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=296.14 Aligned_cols=261 Identities=20% Similarity=0.332 Sum_probs=188.2
Q ss_pred CCeeeeeCceEEEEEEeC---CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe--cCCceEEEEEcCC
Q 042383 57 SNKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI--EGPCRIIVYDYMQ 131 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 131 (353)
.++||+|+||+||+|+.. ++..||+|.+.... ....+.+|+.++++++||||+++++++. .+...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999865 35789999886432 2345678999999999999999999885 3567789999997
Q ss_pred CCChhhhhhhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE----CCCCCeEEeeccCC
Q 042383 132 NNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGLS 202 (353)
Q Consensus 132 ~~sL~~~l~~~~-----~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~~ 202 (353)
+ +|.+++.... .....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7877764221 1234589999999999999999999999 99999999999999 55678999999999
Q ss_pred ccCCCCCcc--ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchh------hHHHHHHh
Q 042383 203 KLFPEDITH--ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY------YLVEKAWE 273 (353)
Q Consensus 203 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~ 273 (353)
+........ ......+|+.|+|||++.+. .++.++|||||||++|+|+||.+||....+.... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 876543221 12335678999999988764 5789999999999999999999999754432110 00000000
Q ss_pred hcc---cccccc---------ccCcccC------------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 274 MHN---TDKLQH---------LVDPMLC------------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 274 ~~~---~~~~~~---------~~~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ...+.. ....... ..........+.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000 0000000 0011112345888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=293.04 Aligned_cols=264 Identities=20% Similarity=0.315 Sum_probs=201.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEG--PCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 126 (353)
++|++.+.||.|++|.||+|..+ +++.+|+|.++..... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999976 5889999998754322 234567899999999999999999998877 889999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+||+++ +|.+.+.. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 89888743 233689999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc--------
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT-------- 277 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 277 (353)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.........
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 2234568889999988764 4688999999999999999999999866543322221111100000
Q ss_pred ------cccccccCcccCCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 278 ------DKLQHLVDPMLCGNFSGN-EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 278 ------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111222222 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=296.52 Aligned_cols=267 Identities=21% Similarity=0.328 Sum_probs=199.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeC---CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRI 124 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 124 (353)
+|.+.+.||+|++|.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5788999999999999999865 47899999988632 33346678899999999999999999999988 8899
Q ss_pred EEEEcCCCCChhhhhhhccccC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC----CCCeEEeec
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNR-AKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ----NFNPKISDF 199 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~-~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~----~~~~kl~Df 199 (353)
+||||+++ +|.+.+....... ..+++..++.++.||+.||.|||+. +++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6777664433333 4789999999999999999999999 9999999999999999 899999999
Q ss_pred cCCccCCCCCc--cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccch------hhHHHH
Q 042383 200 GLSKLFPEDIT--HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE------YYLVEK 270 (353)
Q Consensus 200 g~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~ 270 (353)
|++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987644322 112234578889999987664 578999999999999999999999976543320 000000
Q ss_pred HHhhcc------------ccccccccCcccCCCCC-----h------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 271 AWEMHN------------TDKLQHLVDPMLCGNFS-----G------NEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 271 ~~~~~~------------~~~~~~~~~~~~~~~~~-----~------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... ........+......++ . .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00000000000000111 0 23456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.51 Aligned_cols=261 Identities=17% Similarity=0.227 Sum_probs=195.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+|.+.+.||+|+||.||++.+. +++.||+|.... ..+.+|+.++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999876 578899996432 2346899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+. ++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 588888732 234799999999999999999999999 99999999999999999999999999998654322
Q ss_pred c-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc-----hhhHHHHHHhhcc-cccccc
Q 042383 210 T-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG-----EYYLVEKAWEMHN-TDKLQH 282 (353)
Q Consensus 210 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~-~~~~~~ 282 (353)
. .......||+.|+|||++.+..++.++|||||||++|||++|..++....... ...+......... ......
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 12233568999999999999999999999999999999999887654322111 0011111111000 000000
Q ss_pred ---------ccC---cccCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 283 ---------LVD---PMLCGNFS-------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 283 ---------~~~---~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
... ........ ......+.+|+.+||+.||++|||+.|+|+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000000 0113357889999999999999999999874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.76 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=203.2
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
+|++.+.||.|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999876 68899999987542 2345778899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.+++|.+++ ....++++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l----~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998 3336899999999999999999999999 9999999999999999999999999998866443
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............... .. .
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~----------~ 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET----------A 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc----------c
Confidence 2 223355788999999998888999999999999999999999999865542111111110 00 1
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRM--STVI 322 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl 322 (353)
....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122233345778899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=288.84 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=201.5
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
-|++.+.||+|+||.||+|... ++..+|+|++.... ......+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999865 68899999876432 334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++. ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999998882 34689999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||......... .... . ....
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~----~---------~~~~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL---FLIP----K---------NNPP 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH---HHHh----c---------CCCC
Confidence 122345788899999998888999999999999999999999998643321111 1100 0 0011
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2233445678899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=296.55 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=200.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|+..+.||+|+||.||+|.+. +|. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888999999999999999864 343 578898764432 2334678899999999999999999988754 467
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+++||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999998842 344689999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccc-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITHI-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
........ .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||............ . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----~---~----- 226 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----E---K----- 226 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H---C-----
Confidence 64332211 122345678999999998899999999999999999997 88998654321111110 0 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
......+...+..+.+++.+||..+|++||+++++++.|..+..
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 227 ----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00011112234568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.82 Aligned_cols=272 Identities=22% Similarity=0.307 Sum_probs=201.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----c
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP-----C 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~ 122 (353)
..++|++.+.||+|++|.||+|... +|+.||+|++... .......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999865 6889999998643 2233456778999999999999999998766443 4
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++++||+.+ +|.+.+ ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~-----~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLI-----KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 7899999975 787766 235689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc--ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 203 KLFPEDITH--ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 203 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.................+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 765432211 1123567889999998654 5688999999999999999999999975443221111111000000111
Q ss_pred cccccCcc---------cCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCC
Q 042383 280 LQHLVDPM---------LCGN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVD 330 (353)
Q Consensus 280 ~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~ 330 (353)
+..+.... .... ..+..+..+.+++.+||+.+|++|||+.++++. |....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 11111000 0000 011235668899999999999999999999886 666554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=298.89 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=200.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 6889999998643 233345677899999999999999999988643
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...++||||+.+ +|.+.+. . .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~----~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQ----M--DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHh----h--cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 8887762 1 288999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc-----
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH----- 275 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 275 (353)
++........ .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 233457889999999999999999999999999999999999997654322221111100000
Q ss_pred -----------c------ccccccccCcccC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 276 -----------N------TDKLQHLVDPMLC----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 276 -----------~------~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
. ......+...... .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000011111110 11122346678899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=284.51 Aligned_cols=241 Identities=24% Similarity=0.288 Sum_probs=204.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|...++||+|+||.|.+++.+ +++.+|+|+++.+ .++....-..|-.+|+..+||.+..+--.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999866 7999999999865 344445556788999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||..||.|.-.+ .....+++.....+...|++||.|||+. +||+||||.+|.++|++|++|++|||+++---
T Consensus 247 MeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999888 5567899999999999999999999999 99999999999999999999999999987422
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.......+++|||.|+|||++....|+.+.|.|.+|+++|||++|+.||...+....+.++...
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------------- 383 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------------- 383 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---------------
Confidence 2233456689999999999999999999999999999999999999999877655444333211
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRP 316 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 316 (353)
- -.++....++...|+...|..||++|.
T Consensus 384 d--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 D--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0 123444455677888899999999995
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=289.24 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=199.3
Q ss_pred CCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
|.+.+.||+|+||.||+|... ++..+|+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999753 3678999998754 3344567889999999999999999999876532
Q ss_pred ceEEEEEcCCCCChhhhhhhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEE--KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
..+++++|+.+++|.+++.... .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999998874322 1223578999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccc
Q 042383 200 GLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 200 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
|.++........ ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+..... ..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---NYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH---HHHHc---C
Confidence 998865432211 1122345678999999988889999999999999999999 88888644332111 11110 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.. ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 232 ~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011123356799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=314.66 Aligned_cols=271 Identities=18% Similarity=0.235 Sum_probs=191.3
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCC--CcEEEEEEe--------------e---ccChhcHHHHHHHHHHHHhcCCCC
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQD--GTVVAVKVL--------------S---VESKQGEKEFMSEVASMANICHEN 109 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~~ 109 (353)
...++|++.+.||+|+||+||++..+. +...+.|.+ . .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987532 222222211 0 011223456789999999999999
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK-NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
|+++++++.+.+..++|++++.+ +|.+++..... .........+..++.||+.||.|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999999999999999999954 77777643221 122344677888999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCc-ccchhhH
Q 042383 189 DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDK-ELGEYYL 267 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~-~~~~~~~ 267 (353)
+.++.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|||++|..++.... ......+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765443333444678999999999999999999999999999999999886543322 2211111
Q ss_pred HHHHHhhcc-cc-------ccccccCcc-c---CCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 268 VEKAWEMHN-TD-------KLQHLVDPM-L---CGNFS-----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 268 ~~~~~~~~~-~~-------~~~~~~~~~-~---~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......... .. .+...++.. + ....+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111110000 00 000000000 0 00000 011335677899999999999999999986
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.80 Aligned_cols=270 Identities=20% Similarity=0.310 Sum_probs=203.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----Cc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----PC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 122 (353)
.++|.+.+.||+|+||+||++... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999865 6899999998743 233345677899999999999999999987654 34
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++|+||+. ++|.+++ .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQII----RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 5888887 3456799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc-
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL- 280 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 280 (353)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||...+.................+.+
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8664332 22233457889999998765 46889999999999999999999999765432222222111111110111
Q ss_pred -------ccccCccc---C---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCC
Q 042383 281 -------QHLVDPML---C---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDV 329 (353)
Q Consensus 281 -------~~~~~~~~---~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~ 329 (353)
........ . ....+..+..+.+++.+||+.+|++|||++++++. +....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 0 01112345678999999999999999999999876 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=291.96 Aligned_cols=263 Identities=21% Similarity=0.344 Sum_probs=199.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999865 68899999887443 22335788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+. ++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 588888743 2346789999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc----------
Q 042383 210 THISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD---------- 278 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 278 (353)
.. .....++..|+|||.+.+.. ++.++||||||+++|+|+||..||...++.................
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 11 22234678899999887644 5889999999999999999999997655432221111110000000
Q ss_pred ---ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 ---KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.........+ ....+.....+.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=291.28 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=201.7
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEEEEE
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRIIVYD 128 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 128 (353)
|++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999876 58899999998653 33445678899999999999999999999988 88999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++ +|.+++.. ....+++..++.++.||+.||.+||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 88888732 225789999999999999999999999 9999999999999999999999999999876544
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC--
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD-- 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 285 (353)
.........++..|+|||.+.+ ..++.++||||||+++|+|++|..||..........................+.+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222233456788999997765 4578999999999999999999999976554332222221111111111110000
Q ss_pred ------------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 ------------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+...+...++..+.+++.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000111112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=287.99 Aligned_cols=247 Identities=24% Similarity=0.432 Sum_probs=198.5
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcC---CCCceeeeeeEecCCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANIC---HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.|++.+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999864 6889999998754 3344567788999999986 999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 9999999998872 23789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......... .+.....+
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------------~~~~~~~~ 220 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------------LIPKSKPP 220 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------------ccccCCCC
Confidence 3322 2334688899999987654 56889999999999999999999997543221110 00000001
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+... ..+..+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11110 13457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=317.04 Aligned_cols=259 Identities=24% Similarity=0.439 Sum_probs=219.5
Q ss_pred CCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
...+.++||.|.||.|++|+.+ ....||||.++.. ...+..+|..|+.+|-++.||||+++.|+........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 3467899999999999999865 2357999999966 4556678999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||++|+|..+|. .+.+.|+..++.-+++.|+.|+.||-+. ++|||||..+||||+.+...|++|||+++...+
T Consensus 710 EyMENGsLDsFLR---~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLR---QNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHh---hcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999994 4557799999999999999999999999 999999999999999999999999999998866
Q ss_pred CCccccccccC--CcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 208 DITHISTRVAG--TLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 208 ~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
+.....+...| +.+|.|||.+....++.+|||||+|+++||.++ |.+||......+-...+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI---------------- 847 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI---------------- 847 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----------------
Confidence 55333333333 458999999999999999999999999999887 99999865543222222
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
++.++-.-+.+++..|.+|++.||+.|-.+||++.+|+..|.+...-|.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 2233344566778999999999999999999999999999988765544
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=293.56 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=199.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEG--PCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 125 (353)
.++|++.+.||+|++|.||+|... +|+.||+|.+...... ....+.+|+.++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 6899999998754322 223456899999999999999999998765 56899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+.+ +|.+++.. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 86 v~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 78888742 236789999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc--
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH-- 282 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 282 (353)
..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+......................
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 43321 1222345778999998865 4578999999999999999999999986654433332222111110000000
Q ss_pred -------c--cCcccC--CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 -------L--VDPMLC--GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 -------~--~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ...... .......+..+.+++.+||++||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000 0000113566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.70 Aligned_cols=247 Identities=21% Similarity=0.370 Sum_probs=200.7
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
|...+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999864 6889999998765555566788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++.. ..+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 999998832 4689999999999999999999999 9999999999999999999999999988755433221
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+...... ..... . .+.. ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~---~~~~~-~--------~~~~--~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK---RIRDN-L--------PPKL--KN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HHHhc-C--------CCCC--cc
Confidence 223457889999999988889999999999999999999999997544322111 11110 0 0000 01
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+..+.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.15 Aligned_cols=265 Identities=22% Similarity=0.386 Sum_probs=202.3
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+|++.+.||.|++|.||+|+.. +|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999976 688999999875532 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888874332 235689999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC-ccc
Q 042383 211 HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD-PML 288 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 288 (353)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+................+..+.. +.+
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1 1224467889999987654 568899999999999999999999986654333222211111111111110000 000
Q ss_pred C-----------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 C-----------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0111233567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=285.61 Aligned_cols=242 Identities=22% Similarity=0.304 Sum_probs=197.4
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||.|++|.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 48899999987432 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+++. ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99983 345689999999999999999999998 99999999999999999999999999998765432 2233
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ ..... +........++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYND------------ILKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHHH------------HhccCCCCCCCcc
Confidence 4678899999998888899999999999999999999999976553111 11111 1110111223333
Q ss_pred HHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
.+..+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3667999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.06 Aligned_cols=264 Identities=25% Similarity=0.383 Sum_probs=197.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.++|.+.+.||+|+||.||+|... ++..||+|++...... ....+.+|+.+++.++|+||+++.+++.++...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999865 6889999998754322 2345678999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+. ++|.+.+. .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 57777663 2335678889999999999999999999 999999999999999999999999999875433
Q ss_pred CCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc---c-----
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT---D----- 278 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~----- 278 (353)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ .....+..... .
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence 2111 2234468899999988754 578899999999999999999999975443211 11111110000 0
Q ss_pred -ccccccCcccCC----CC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 -KLQHLVDPMLCG----NF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 -~~~~~~~~~~~~----~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
............ .. .......+.+++.+|++.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00 0011456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=289.12 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=199.0
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
|++.+.||.|++|.||+|... +|..||+|++.... ......+.+|+.+++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677899999999999999865 68999999987543 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+ ++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 5899888322 224689999999999999999999999 999999999999999999999999999976543222
Q ss_pred cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc------cccc
Q 042383 211 HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK------LQHL 283 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 283 (353)
. .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+................... ....
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1 1223457889999987664 568899999999999999999999976554332222111100000000 0000
Q ss_pred ---cCcc---cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 ---VDPM---LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ---~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... .........+..+.+++.+||+.+|.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 001112223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.75 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=207.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|.+.+.||+|++|.||++... ++..+++|++..... .....+.+|+++++.++|||++++.+.+......++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999865 688999999875533 4556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+.+.........+++..+..++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999855433357899999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......+++.|+|||...+..++.++|+||+|+++|+|++|..||...+... ...... ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~----~~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKIL----KGQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHHh----cCC---------C
Confidence 22333567889999999988889999999999999999999999986544211 111110 000 1
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.99 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=204.8
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
+|.+.+.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++.+..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 688999999986655566788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++... ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999988432 25789999999999999999999998 999999999999999999999999999887654322
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......... . .....+.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~~~~~~------- 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T----NGPPGLR------- 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h----cCCCCcC-------
Confidence 334567889999999988889999999999999999999999997543221111100 0 0000000
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112567899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=289.84 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=197.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.+.|.+.+.||+|++|+||+|... +++.||+|.+.... ......+.+|+.+++.++|||++++.+++.+....++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999865 68899999886432 23345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+||+.+ +|.+.+. .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~g-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCLG-SASDILE---VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhCC-CHHHHHH---HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999975 7777663 2345689999999999999999999999 99999999999999999999999999987553
Q ss_pred CCCccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.. ....+++.|+|||++. ...++.++||||||+++|+|++|..||...+...... .. ....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---~~---~~~~----- 230 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HI---AQND----- 230 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH---HH---hcCC-----
Confidence 22 2345788899999874 3568889999999999999999999987544321111 00 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.........+..+.+++.+||+.+|++||++.+|+..
T Consensus 231 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 ----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0001112345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=287.01 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=209.4
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC--CCC----ceeeeeeEecCC
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC--HEN----LVKLHGGCIEGP 121 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~----iv~~~~~~~~~~ 121 (353)
....+|.+.+.+|+|+||.|-.+.+. .+..||+|+++.-. .-.+...-|+++|+++. .|+ ++++.++|+-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 34789999999999999999999865 57899999987332 23345567999999994 332 788889999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC------------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD------------ 189 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~------------ 189 (353)
+.|||+|.+ |-|+.+++. .++..+++...+..++.|++.++++||+. +++|.||||+||++.
T Consensus 165 hiCivfell-G~S~~dFlk--~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLK--ENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhc--cCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999999 559999993 34567899999999999999999999999 999999999999982
Q ss_pred --------CCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcc
Q 042383 190 --------QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261 (353)
Q Consensus 190 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~ 261 (353)
++..++++|||.|++-.+.. .....|..|+|||++.+-+|+..+||||+||||+||.+|...|...++
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 13458999999999765433 446779999999999999999999999999999999999999999887
Q ss_pred cchhhHHHHHHhhccccccccc-------------------------cCcc----cCCCCChHHHHHHHHHHhhccCCCC
Q 042383 262 LGEYYLVEKAWEMHNTDKLQHL-------------------------VDPM----LCGNFSGNEAVRFLKVGLLCVQEKS 312 (353)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~----~~~~~~~~~~~~l~~li~~cl~~~p 312 (353)
.++....+.+........+... .+.. ........+..+|.+|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 7766655554432221111100 0000 0011234456679999999999999
Q ss_pred CCCCCHHHHHH
Q 042383 313 SLRPRMSTVIE 323 (353)
Q Consensus 313 ~~RPt~~evl~ 323 (353)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999985
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.25 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=206.3
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|++|.||++... +++.+|+|.+... .......+.+|+.+++.++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788999999999999999865 6788999998753 233345677899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.........+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999865444456789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.... .... .....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~-------------~~~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKV-------------QRGKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH-------------hcCCC
Confidence 22234578899999999988899999999999999999999999975442111 1110 00111
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22333456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.25 Aligned_cols=289 Identities=22% Similarity=0.300 Sum_probs=214.7
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-CCce
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE-GPCR 123 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 123 (353)
....++|++.+.||.|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|||++++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 7889999987643 22334677889999999999999999998875 5678
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++++||+ +++|...+. ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 458887762 34688899999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc------
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN------ 276 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------ 276 (353)
..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 123456888999998765 5689999999999999999999999975543222221111100000
Q ss_pred --ccccccccCcc-cCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCCCCCccccCCcccccc
Q 042383 277 --TDKLQHLVDPM-LCGNFS-----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVDIDDDVEIWEPGLINDI 346 (353)
Q Consensus 277 --~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~~~~~~~~~~~~~~~~ 346 (353)
......+.... .....+ +..+..+.+++.+||+.+|++|||+.+++.. +....+...+ +.|...+.|..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~-~~~~~~~~~~~ 311 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE-PVAEEKFDWSF 311 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc-cCchhhcCCch
Confidence 00000000000 001111 1235678999999999999999999999876 6666555443 56766666665
Q ss_pred cccc
Q 042383 347 MDVK 350 (353)
Q Consensus 347 ~~~~ 350 (353)
.|..
T Consensus 312 ~~~~ 315 (328)
T cd07856 312 NDAD 315 (328)
T ss_pred hccc
Confidence 5543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.72 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=204.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..+.|++...||.|++|.||++... ++..+++|++..... ....+.+|+..++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999876 688999999985544 55678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++... ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999998432 13799999999999999999999998 9999999999999999999999999988755432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+........ .. .....
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~~----~~~~~------ 235 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---TT----KGIPP------ 235 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh----cCCCC------
Confidence 21 122345778999999998888999999999999999999999999754432211110 00 00000
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......+..+.+++.+||+.+|.+|||+.++++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111123567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.13 Aligned_cols=267 Identities=24% Similarity=0.361 Sum_probs=202.4
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGP---- 121 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 121 (353)
...++|++.+.||+|++|.||+|..+ +++.||+|.++... ......+.+|+.+++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678999999999999999999976 58899999987543 233356778999999999999999999887655
Q ss_pred ------ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 122 ------CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 122 ------~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 67776632 245789999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhh
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
|+|||.+...............++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999987654332222223457789999987653 5788999999999999999999999765544333333322111
Q ss_pred ccccccccccC--------------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 275 HNTDKLQHLVD--------------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 275 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+.. ....... ...+..+.+++.+||+.+|.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111100 0000001 112567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.60 Aligned_cols=262 Identities=20% Similarity=0.341 Sum_probs=203.1
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
|.+.+.||.|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999865 688999999875432 24467788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++ +|.+.+.. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 76 88887732 235789999999999999999999999 99999999999999999999999999987765433
Q ss_pred cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC----
Q 042383 211 HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD---- 285 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 285 (353)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...................+.+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 122234577889999988776 789999999999999999999999976654333222211111000011111100
Q ss_pred ---------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 ---------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...........+.++.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00001122345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=296.65 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=209.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----ceE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGP-----CRI 124 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 124 (353)
+|++.+.||.|++|.||+|... +++.+|+|.+.... ....+.+.+|+.+++.++|+||+++.+++.+.+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 58899999887543 344567889999999999999999999988775 789
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
++|||+++ +|.+.+ ....++++..++.++.||+.||.+||+. +++|+||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~~-~l~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVI----KSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999975 888887 3445899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCc--cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 205 FPEDIT--HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 205 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+...........+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 654321 122334578899999999887 78999999999999999999999997665433322222111111111100
Q ss_pred --------cccCc---cc---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 042383 282 --------HLVDP---ML---CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDD 333 (353)
Q Consensus 282 --------~~~~~---~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~ 333 (353)
..+.. .. .....+..+..+.+++.+||+.+|.+|||+.++++ .|++..+-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 00000 00 00011223567889999999999999999999998 4666655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=280.69 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRIIVY 127 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 127 (353)
+|.+.+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+..+++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 688999999875542 4457888999999999999999999999988 8899999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|++++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999983 334899999999999999999999998 999999999999999999999999999887654
Q ss_pred CCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.... ......++..|+|||.+.+...+.++||||||+++|+|++|..||...... .. ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~---~~~~~---------~~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MA---ALYKI---------GSS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HH---HHHhc---------ccc
Confidence 4321 123356788999999998888999999999999999999999999765511 11 11111 111
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+...+..+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112233334677999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=296.78 Aligned_cols=265 Identities=19% Similarity=0.301 Sum_probs=200.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEec----CCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 123 (353)
.++|++.+.||+|++|.||+|... +|..||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 68999999987542 2334667789999999999999999998763 3567
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+. ++|.+++ .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHII----HSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 5888887 3455699999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcc---ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---
Q 042383 204 LFPEDITH---ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN--- 276 (353)
Q Consensus 204 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 276 (353)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432211 1223467889999998765 4588999999999999999999999976543222211111100000
Q ss_pred -----ccccccccCcccC-CC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 -----TDKLQHLVDPMLC-GN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 -----~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+....+.... .. ..+..+..+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000000 00 11233677999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.28 Aligned_cols=266 Identities=21% Similarity=0.307 Sum_probs=199.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC--Cce
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEG--PCR 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 123 (353)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999876 5889999987532 233445677899999999 999999999988643 367
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++ +|.+++. . ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~-~L~~~~~----~-~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYMET-DLHAVIR----A-NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEeccccc-CHHHHHh----c-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 999999975 8988872 2 2788999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCc----cccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 204 LFPEDIT----HISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 204 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6643322 12233567889999998765 457889999999999999999999997554332221111111000000
Q ss_pred --------ccccccCccc------CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 279 --------KLQHLVDPML------CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 279 --------~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+++... .....+..+..+.+++.+||+.+|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000010000 011112245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.41 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=193.0
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||+|+||+||+|..+ +|+.+|+|.+.... ......+.+|+.+++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999987432 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccc
Confidence 9988432 224689999999999999999999999 9999999999999999999999999998765432 12223
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..++..|+|||.+.+..++.++||||||+++|+|++|..||.............. .. .. .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~--------~~--~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RT--------LE--MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---cc--------cc--ccccCCcc
Confidence 4577899999999888899999999999999999999999975543211111110 00 00 01122233
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
.+..+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 366788999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=286.52 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=202.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC----hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCce
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES----KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 123 (353)
+|++.+.||+|++|.||++... +++.+|+|++.... ......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999742 57889999987432 22335677899999999 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999883 345689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCccccccccCCcCccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
..............++..|+|||.+.+.. .+.++||||||+++|+|++|..||.............. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~----- 226 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILK----- 226 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--HHHc-----
Confidence 65443222223345788999999887655 78899999999999999999999964432211111110 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. ....+...+..+.+++.+||+.+|++|||+.++.+.|+...
T Consensus 227 ----~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 227 ----S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred ----c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0 01122233456889999999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=282.21 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=198.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-----ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--Cce
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-----SKQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCR 123 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 123 (353)
.+|.+.+.||+|++|.||++... ++..+|+|.+... .......+.+|+.++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999865 5889999987532 123345788899999999999999999998764 457
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++++||+++++|.+++ .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999988 3445689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
....... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~--------- 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIA--------- 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHH---------
Confidence 6532111 1112345788999999998888999999999999999999999999754322111 1110
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+..+......+.+++.+||+ +|.+||++.+++.
T Consensus 223 ---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 ---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0001122334445678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=283.45 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=201.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|.+.+.||+|++|.||++..+ +|..+|+|.+.... ....+.+.+|+.+++.++|+|++++++.+.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999876 57889999987542 23445778999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC-eEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN-PKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~ 208 (353)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999998843 2334579999999999999999999999 9999999999999988754 699999998766432
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ......|++.|+|||.+.+..++.++|+||||+++|++++|..||........ ..... ... .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~~~----~---- 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VLKIC----QGY----F---- 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHh----ccc----C----
Confidence 21 22234578899999999888899999999999999999999999864432111 11110 000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11222335678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=287.42 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=198.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|++|+||+|..+ +|+.||+|.+..... .....+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 688999998865422 233567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFPE 207 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~ 207 (353)
|+++ +|.+.+.. .....+++..++.++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9965 78777632 2233468889999999999999999999 9999999999999985 55799999999976543
Q ss_pred CCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc-----
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ----- 281 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 281 (353)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||....+.+................+.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 221 12234567899999987654 57899999999999999999999997655433222111110000000000
Q ss_pred -cccC--cccC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 -HLVD--PMLC----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 -~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... +... ....+..++++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000 0011223566889999999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.59 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=195.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999865 58899999987542 234457788999999996 99999999999999999999999
Q ss_pred CCCCChhhhhhh-ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLG-EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~-~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
+.. ++.++... .......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 66554321 112346799999999999999999999963 28999999999999999999999999998755432
Q ss_pred CccccccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||..... ........... ..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------~~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------DP 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC------CC
Confidence 11 1234578899999998776 688999999999999999999999974431 11111111100 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
+.+........+..+.+|+.+||+.+|++|||+++|++.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222223356679999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=327.47 Aligned_cols=264 Identities=28% Similarity=0.500 Sum_probs=208.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
..|.....||+|+||.||+|.. .++..||+|.+....... ..|++.+++++||||+++++++.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999987 478899999886432221 24688899999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|.+++. .+++..+..++.|++.||+|||..+..+++||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999982 37899999999999999999996555699999999999999998888775 555433211
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||...... ......+............++++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccC
Confidence 12235788999999999999999999999999999999999998533221 222333333222223334445554433
Q ss_pred --CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 291 --NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 291 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
........++.+++.+||+.+|++|||+.||++.|+++.....
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 3345567788999999999999999999999999998876554
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=288.78 Aligned_cols=266 Identities=22% Similarity=0.327 Sum_probs=197.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
.++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999875 68899999886442 222345668999999999999999999887654
Q ss_pred --ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 122 --CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 122 --~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
..++||||+.+ +|.+.+. .....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLS---NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999965 7877773 2234689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCcc---ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 200 GLSKLFPEDITH---ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 200 g~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866432211 12234567889999987664 46889999999999999999999997655433332222221111
Q ss_pred cccccccc-----cCcc-cCCCC---------ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 276 NTDKLQHL-----VDPM-LCGNF---------SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 276 ~~~~~~~~-----~~~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+..... .+.. ..... .......+.+++.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 11100000 0000 00000 0011345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=319.63 Aligned_cols=276 Identities=24% Similarity=0.301 Sum_probs=221.7
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
.++.-..++|.++++||+|+||.|..++.+ +++.||+|+++.. .......|.+|-.+|..-+.+-|+.++-.|.|+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344445689999999999999999999976 6888999998752 233446788888999888899999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
.++|+||||++||+|-.++ ....++++..+..++..|..||..||+. |+|||||||+|||+|..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLl----Sk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLL----SKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHH----hhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999998 4445899999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
.+-.+..+..-.+....|||-|.+||++.. +.|++.+|.||+||++|||+.|..||..+.-.+.|..+...
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---- 296 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---- 296 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----
Confidence 999998777777777899999999999873 56899999999999999999999999866544444333221
Q ss_pred cccccccccCcccCCCCC--hHHHHHHHHHHhhccCCCCCCCCC---HHHHHH--HhcCCC--CCCCCccccCCccc
Q 042383 276 NTDKLQHLVDPMLCGNFS--GNEAVRFLKVGLLCVQEKSSLRPR---MSTVIE--MINGDV--DIDDDVEIWEPGLI 343 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt---~~evl~--~L~~~~--~~~~~~~~~~~~~~ 343 (353)
.. . -.+| ...++...+||.+.+. +|+.|.. ++++-. ++.++. .+...+++..|+..
T Consensus 297 --k~-------~--l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs 361 (1317)
T KOG0612|consen 297 --KE-------S--LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS 361 (1317)
T ss_pred --hh-------h--cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence 11 1 1122 2246678888888775 7888888 777743 344433 34444445555543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=284.98 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=197.8
Q ss_pred CCCCCCeeeeeCceEEEEEEe----CCCcEEEEEEeeccC----hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCce
Q 042383 53 GFCSSNKVGEGGFGSVYKGKL----QDGTVVAVKVLSVES----KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 123 (353)
+|++.+.||.|+||.||.|.. .+|..||+|++.... ....+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999985 368899999987432 22345678899999999 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++|+||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999983 345789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSG--HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
..............++..|+|||.+... .++.++||||||+++|+|++|..||.............. .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~---- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS---- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH--Hhhcc----
Confidence 6644332223345688899999988753 467899999999999999999999975432211111110 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...++......+.+++.+||+.+|++|| ++.+++.
T Consensus 228 -------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112233456788999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=283.63 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=194.4
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcC-CCCceeeeeeEecC--CceEEEEE
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANIC-HENLVKLHGGCIEG--PCRIIVYD 128 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 128 (353)
|++.+.||+|++|.||+|... +++.+|+|.+.... ........+|+..+.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677889999999999999865 68899999887532 222234457888888885 99999999999987 88999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++ +|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 78877732 235789999999999999999999999 9999999999999999 99999999999865432
Q ss_pred CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc--------cc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT--------DK 279 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~ 279 (353)
.. .....++..|+|||.+.. ..++.++|||||||++|+|++|..||...+..+.............. ..
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 22 123457889999997654 55788999999999999999999999765543322211111000000 00
Q ss_pred cccccC-cccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVD-PMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~-~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... .... .......+..+.+++.+||+.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 0000 0011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=283.05 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=206.4
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
|.++.+||+|+||.||++.++ +|..+|+|.+.++ .+..++..|+.++++.+.|++|++++.+-....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 456889999999999999865 6999999988754 4567889999999999999999999988888899999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
|+..+.+. ..+++++++++..++..-+.||+|||.. .-+|||||..|||++.+|+.||+|||++-.+.+....
T Consensus 113 GSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 113 GSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred CcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 99999983 4678999999999999999999999999 8999999999999999999999999999766443332
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC-
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN- 291 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 291 (353)
..+..|||-|+|||++..-.|+.++||||||++..||..|++||..-.+.... ..+.. ...+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIPT-~PPPTF 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIPT-KPPPTF 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------EeccC-CCCCCC
Confidence 34478999999999999999999999999999999999999999744332111 11110 01111
Q ss_pred -CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 292 -FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 292 -~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+...+..+.+++++||-.+|++|-|+-.+++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 23344667999999999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.35 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=203.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 126 (353)
++|.+.+.||+|++|.||++... ++..+|+|++... .......+.+|+.+++++. ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999865 6899999998743 2233467788999999998 99999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
||++++++|.+++. ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999983 445799999999999999999999999 99999999999999999999999999988664
Q ss_pred CCCc-------------------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhH
Q 042383 207 EDIT-------------------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL 267 (353)
Q Consensus 207 ~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~ 267 (353)
.... .......++..|+|||......++.++|+||||++++++++|..||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~- 232 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ- 232 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-
Confidence 3321 12223457889999999988889999999999999999999999998655322111
Q ss_pred HHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 042383 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM----STVIE 323 (353)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~ 323 (353)
.... ....++...++.+.+++.+||+.+|.+|||+ +++++
T Consensus 233 --~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 --KILK--------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHh--------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1100 1112223336678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=281.76 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=187.7
Q ss_pred eeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHh---cCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMAN---ICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999865 58899999886432 1112233444443333 469999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+++|.+++ .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999888 3446799999999999999999999999 99999999999999999999999999987543321
Q ss_pred ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....|+..|+|||.+.+ ..++.++||||+||++|+|++|..||........... ... .. ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~---~~----------~~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRM---TL----------TVNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-HHH---hh----------cCCc
Confidence 123468999999998864 5688999999999999999999999975433211111 000 00 0111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIEM 324 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 324 (353)
..+...+..+.+++.+||+.||.+|| |++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23334456789999999999999999 59999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.39 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=197.6
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||.|++|.||++... +|+.+++|++..... .....+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 3456788899999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-----
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT----- 210 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 210 (353)
.+++. ....+++..+..++.||+.||.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~----~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99983 334789999999999999999999999 999999999999999999999999999875433211
Q ss_pred --cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 211 --HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 211 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.......++..|+|||.......+.++||||||+++|+|++|..||............ .. . .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~----~--------~- 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI---LN----G--------K- 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hc----C--------C-
Confidence 1223345778899999998888999999999999999999999999755432211110 00 0 0
Q ss_pred CCCCChH--HHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 289 CGNFSGN--EAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 289 ~~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+.. .+..+.+++.+||+.+|.+|||+.++.+.|+.-
T Consensus 218 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 218 -IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred -cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 011111 256788999999999999999997777766643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.44 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=199.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.|...+.||+|+||.||+++.. ++..+|+|.+.... ......+.+|+.+++.++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999865 68899999987432 2334568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.+ +|.+.+. ....++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCCC-CHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9975 7777763 2345689999999999999999999999 9999999999999999999999999988754321
Q ss_pred CccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 209 ITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
....+++.|+|||.+. .+.++.++|||||||++|+|++|..||............. .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~------------ 238 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---Q------------ 238 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---h------------
Confidence 2345788999999874 4568899999999999999999999987543221111100 0
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
...........+..+.+++.+||+.+|.+||++.++++.+--....+
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 00011112233556889999999999999999999998655444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=277.84 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=203.9
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|++.+.||+|++|.||++... +++.+++|.+..... .....+.+|++++++++|+|++++++++.+....++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999865 578899999875543 4556789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999983 346799999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.. .....++..|+|||...+..++.++||||+|+++|+|++|..||......... ..... ...
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~~----------~~~ 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIVQ----------DDH 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHhc----------cCC
Confidence 22 23346788999999988888899999999999999999999999754421111 01000 001
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1222333567889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=286.82 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=205.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.+.|..-++||+|+||.|+-++.+ +|+.+|+|.+... .........+|-.+|.+++.++||.+--.|+..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467888999999999999999855 7999999988643 344556678899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+..|+||+|.-.|... ....++++.+..++.+|+.||++||+. +||+|||||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999888432 346899999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
+... .....||.+|||||++.+..|+.+.|.|||||++|+|+.|+.||..........-+. +. ++.
T Consensus 339 ~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr--------~~~- 404 (591)
T KOG0986|consen 339 EGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RR--------TLE- 404 (591)
T ss_pred CCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HH--------Hhc-
Confidence 5433 233589999999999999999999999999999999999999997544322211000 00 000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMS 319 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 319 (353)
-...++...+++..++....|+.||++|.-..
T Consensus 405 -~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 -DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11345566677788999999999999996544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=280.04 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=190.4
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHH-HhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASM-ANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||.|++|.||+|... +++.||+|++..... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999865 588999999874322 1222334454444 344899999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
++|.+++ .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999988 3445789999999999999999999999 999999999999999999999999999875432
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+...... ... .... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~~~------~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD---NIL----SRRI------NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----hccc------CCCCcc
Confidence 223457889999999988888999999999999999999999997544321111 100 0000 001111
Q ss_pred ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 293 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
....+..+.+++.+||+.+|++||++.++.+.|+-
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 22345678999999999999999988766665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=290.43 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=198.9
Q ss_pred hccCCC-CCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhc--------------HHHHHHHHHHHHhcCCCCceee
Q 042383 50 ATNGFC-SSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQG--------------EKEFMSEVASMANICHENLVKL 113 (353)
Q Consensus 50 ~~~~y~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~ 113 (353)
..++|. +.+.||.|+||+||+|... +++.||+|.+....... ...+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 345665 4577999999999999865 68899999986432221 1246789999999999999999
Q ss_pred eeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 114 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
++++..++..++||||+. ++|.+++ .....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l----~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVV----DRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999999999999999997 5898888 3455689999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCC-------------ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 042383 194 PKISDFGLSKLFPEDI-------------THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFD 259 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~ 259 (353)
++|+|||.+....... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987654110 1111223467789999988764 4688999999999999999999999866
Q ss_pred cccchhhHHHHHHhhccccccccccC--------cccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVD--------PMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
++......+...........+..... .... .......+..+.+++.+||+.+|++|||++|++.
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 54333222211111111110100000 0000 0011223566889999999999999999999985
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.19 Aligned_cols=243 Identities=22% Similarity=0.400 Sum_probs=197.3
Q ss_pred CeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChh
Q 042383 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLS 136 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 136 (353)
.+||+|++|.||++..+ ++..||+|.+..........+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999864 68899999987555555667889999999999999999999999999999999999999999
Q ss_pred hhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccc
Q 042383 137 QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216 (353)
Q Consensus 137 ~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 216 (353)
+++. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 8762 34589999999999999999999999 999999999999999999999999999876543221 12234
Q ss_pred cCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHH
Q 042383 217 AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNE 296 (353)
Q Consensus 217 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (353)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............. . .....+. .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~---------~~~~~~~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---D---------NLPPKLK--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---------hCCcccC--CcccC
Confidence 57889999999988888999999999999999999999997544322211111 0 0000110 01123
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 297 AVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 297 ~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+..+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=297.81 Aligned_cols=244 Identities=25% Similarity=0.423 Sum_probs=202.4
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
|.-.+.||.|+||.||.|.+. +...||||.+....+ .....+..|+..|++++|||++.+-++|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444678999999999999865 678899999885533 3346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
|-| |-.|.+. -..+++-+..+..++.+.+.||.|||++ +.||||||..|||+++.|.|||+|||.+.....
T Consensus 108 ClG-SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 108 CLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred Hhc-cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 955 8888873 3567899999999999999999999999 999999999999999999999999999876532
Q ss_pred ccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
...+.|||.|||||++.. +.|+-++||||||++..||...++|+.+.+.....+-+... .++
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----esP-------- 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESP-------- 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----CCC--------
Confidence 244789999999999874 67999999999999999999999998766544333221111 011
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.+ -.++.+..|+.++..||+.-|.+|||.++++..
T Consensus 244 tL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11 144557789999999999999999999998753
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=278.11 Aligned_cols=248 Identities=21% Similarity=0.258 Sum_probs=192.3
Q ss_pred HHHHhccCCCCCCee--eeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 46 ELKSATNGFCSSNKV--GEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 46 ~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|||++++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334455677777776 99999999999865 688899999874322111 22222222 6999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeecc
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFG 200 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg 200 (353)
..++||||+++++|.+++. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999983 334899999999999999999999999 999999999999999988 99999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
.+...... ....++..|+|||++.+..++.++||||||+++|+|++|..||....+.. .......... .
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~--- 224 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--Q--- 224 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--c---
Confidence 98765432 22457889999999998899999999999999999999999997443321 1111110000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-MSTVIE 323 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 323 (353)
. ........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 225 -----~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -----K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 01122244667899999999999999996 688874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.47 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=205.6
Q ss_pred CCCCeeeeeCceEEEEEEeC--CC--cEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 55 CSSNKVGEGGFGSVYKGKLQ--DG--TVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++.++||+|+||.|++|.|. +| ..||||.++..... ....|.+|+.+|.+|+|+|++++||+..+ +...+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44678999999999999876 34 35899999866444 56789999999999999999999999988 678899999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
++.|||.+.|.. ..+..|.......++.||+.||.||.++ ++|||||..+|+++.....|||+|||+.+.+....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999954 4567889999999999999999999999 99999999999999999999999999999876543
Q ss_pred ccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... .....-...|+|||.+....++.++|||++||++|||+| |+.||-+....... +.+|+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL----------------~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----------------KNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------Hhccc
Confidence 322 222334568999999999999999999999999999999 78888765543222 12222
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.-.-.-+..|++.+.++++.||..+|.+||||..|.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2223345667899999999999999999999999973
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.84 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=186.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeeccChhcH-----------HHHHHHHHHHHhcCCCCceeee
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVESKQGE-----------KEFMSEVASMANICHENLVKLH 114 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~ 114 (353)
..++|++.+.||+|+||+||+|...+ +..+|+|+......... .....++..+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 44789999999999999999998653 44567776443322111 1122334455667899999999
Q ss_pred eeEecCC----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC
Q 042383 115 GGCIEGP----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ 190 (353)
Q Consensus 115 ~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~ 190 (353)
+++.... ..+++++++.. ++.+.+ ......++..+..++.|++.||.|||+. +++||||||+||+++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIF----KRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHH----HhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8765443 34678887744 666655 2233467888999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccCCccCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccch
Q 042383 191 NFNPKISDFGLSKLFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264 (353)
Q Consensus 191 ~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~ 264 (353)
++.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999866422111 11224689999999999999999999999999999999999999976533222
Q ss_pred hhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 265 YYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
........ .+..+...... ....+..+.+++..|++.+|++||+++++++.|+
T Consensus 242 ~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCD------FIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHH------HHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111100 00001111110 1122567889999999999999999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=291.34 Aligned_cols=283 Identities=22% Similarity=0.292 Sum_probs=207.1
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC---
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP--- 121 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 121 (353)
....++|++.+.||+|++|.||++... ++..||+|++... .......+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335678999999999999999999854 6899999988643 2223456789999999999999999999887654
Q ss_pred ---ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 122 ---CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 122 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
..++||||+ +++|.+++. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 358999999 668888772 35689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc-
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN- 276 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 276 (353)
||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+................
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998865432 123456889999998876 4578899999999999999999999976543222211111000000
Q ss_pred -------ccccccccC---cccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhcCCCCCCCCccccCCc
Q 042383 277 -------TDKLQHLVD---PMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI--EMINGDVDIDDDVEIWEPG 341 (353)
Q Consensus 277 -------~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl--~~L~~~~~~~~~~~~~~~~ 341 (353)
......... .... ..........+.+++.+||+.||++|||+.+++ ..++...+.+. ++-.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~--~~~~~~ 315 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED--ETEAPP 315 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc--ccCCCC
Confidence 000000000 0000 011122345688999999999999999999998 55655544433 333344
Q ss_pred cccc
Q 042383 342 LIND 345 (353)
Q Consensus 342 ~~~~ 345 (353)
+.++
T Consensus 316 ~~~~ 319 (343)
T cd07880 316 YDDS 319 (343)
T ss_pred cccc
Confidence 4443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=291.54 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=200.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
.++|.+.+.||+|++|.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 68999999886432 223356788999999999999999999887543
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++|+||+.. +|.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 666544 23689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc-
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK- 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 279 (353)
+...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...................
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8765322 123456888999998876 4688999999999999999999999986543322211111100000000
Q ss_pred -------cccccC---cccCCCC---ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 042383 280 -------LQHLVD---PMLCGNF---SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDD 333 (353)
Q Consensus 280 -------~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~ 333 (353)
...... ....... .+..+..+.+++.+||+.||++||++.+++. .+++..+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 000000 0000000 1123456889999999999999999999984 4777766544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.42 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=191.8
Q ss_pred eeeee--CceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 59 KVGEG--GFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 59 ~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
.||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999875 78999999987542 233467888999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc-
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI- 212 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 212 (353)
+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999988432 234589999999999999999999998 99999999999999999999999998654322111100
Q ss_pred -----cccccCCcCccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---------
Q 042383 213 -----STRVAGTLGYLAPDYAVSG--HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN--------- 276 (353)
Q Consensus 213 -----~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 276 (353)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||......... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccc
Confidence 1112345679999998764 4789999999999999999999999754322111 000000000
Q ss_pred ------------------cccc-----ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 ------------------TDKL-----QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 ------------------~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... .......+...........+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 0011111122223445678999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.23 Aligned_cols=267 Identities=23% Similarity=0.317 Sum_probs=202.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc----
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC---- 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 122 (353)
..++|.+.+.||+|++|.||+|... ++..||+|++... .......+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 5789999988643 23344567789999999999999999998876554
Q ss_pred --eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 123 --RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 123 --~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
.++|+||+ +++|.+++. ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 569988873 25699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN--- 276 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--- 276 (353)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99865432 233457888999998765 3678899999999999999999999976554322221111111000
Q ss_pred -----ccccccccCc---ccCCCC---ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 277 -----TDKLQHLVDP---MLCGNF---SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 277 -----~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
......++.. .....+ ....+..+.+++.+||+.+|++|||+.+|++ .+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0000001000 000000 0112567999999999999999999999987 344433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=293.83 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=198.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC---------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG--------- 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 120 (353)
..+|.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999865 6889999998866656667788999999999999999999776543
Q ss_pred -----CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCe
Q 042383 121 -----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNP 194 (353)
Q Consensus 121 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~ 194 (353)
...++|+||+++ +|.+++. ...+++..++.++.||+.||.|||+. +++|+||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 357899999974 8888772 34689999999999999999999999 9999999999999974 5678
Q ss_pred EEeeccCCccCCCCCcc--ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 195 KISDFGLSKLFPEDITH--ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
+|+|||.+......... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998765432111 1122356888999997654 56788999999999999999999999765543222211111
Q ss_pred Hhhccccccccc-------cC-cccCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhc
Q 042383 272 WEMHNTDKLQHL-------VD-PMLCGN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI--EMIN 326 (353)
Q Consensus 272 ~~~~~~~~~~~~-------~~-~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl--~~L~ 326 (353)
...........+ .. ...... ..+....++.+++.+||+.||++|||+.+++ ..++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000000000000 00 000000 1112345688999999999999999999998 4454
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.00 Aligned_cols=260 Identities=22% Similarity=0.244 Sum_probs=191.7
Q ss_pred CCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 56 SSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.+.+|.|+++.|+++.. +++.||+|++... .......+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555555554444 5889999998754 3445578899999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc---
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT--- 210 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 210 (353)
+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+........
T Consensus 85 ~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999998432 234689999999999999999999999 999999999999999999999999998865432111
Q ss_pred ---cccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---------
Q 042383 211 ---HISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN--------- 276 (353)
Q Consensus 211 ---~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 276 (353)
.......++..|+|||++.. ..++.++|+|||||++|+|++|..||......... .........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchh
Confidence 11123456778999998876 35889999999999999999999999754432211 111100000
Q ss_pred --cccccc----ccCc----ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 --TDKLQH----LVDP----MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 --~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... .... .............+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 0000 0011122334567889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=278.99 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=196.9
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhc---CCCCceeeeeeEecCCc-----
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANI---CHENLVKLHGGCIEGPC----- 122 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 122 (353)
|++.+.||+|++|.||+|+.+ +++.+|+|.+..... .....+.+|+.+++++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999976 488999999874422 2234556777777666 59999999999988776
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.+++|||+.+ +|.+++... ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 788887432 223689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc-
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ- 281 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 281 (353)
........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+....+.............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 77643322 122346888999999999899999999999999999999999987655433222111111000000000
Q ss_pred ------cccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 ------HLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........ ..........+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 1112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.69 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=203.5
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------ceEE
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP------CRII 125 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~l 125 (353)
+...+.||+|+||.||+++++ +|+.||||.++.. .....+...+|+++|++++|+|||++.++-++.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455678999999999999955 7999999999854 3445677889999999999999999999766544 4579
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC--CCC--CeEEeeccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD--QNF--NPKISDFGL 201 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~--~~~--~~kl~Dfg~ 201 (353)
|||||.||||...+.+. ++...+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999654 4567899999999999999999999999 999999999999982 323 479999999
Q ss_pred CccCCCCCccccccccCCcCccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
|+-.+++. ......||+.|++||+.. .+.|+...|.|||||++|+++||..||..........-+.+.........+
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99876654 456688999999999988 488999999999999999999999999866554322222221111111111
Q ss_pred ccccCccc------------CCCCChHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHhcCC
Q 042383 281 QHLVDPML------------CGNFSGNEAVRFLKVGLLCVQEKSSLRP--RMSTVIEMINGD 328 (353)
Q Consensus 281 ~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~evl~~L~~~ 328 (353)
.....+.- .-+.+......+...+-.+|.++|++|- .+.+....+.++
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111100 1122333445566777788889999987 555554444443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=271.73 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=196.0
Q ss_pred hccCCCCC-CeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec----CCc
Q 042383 50 ATNGFCSS-NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE----GPC 122 (353)
Q Consensus 50 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 122 (353)
.+++|.+. ++||-|-.|.|-.+..+ +++.+|+|++... ....+|++..-.. .|||||.++++|++ ..+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677764 58999999999999865 7899999998622 2345777766555 69999999998763 567
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC---CCCCeEEeec
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD---QNFNPKISDF 199 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~Df 199 (353)
+.+|||.++||.|...+.. .....+++.++..++.||+.|+.|||+. +|.||||||+|+|.. .|..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999943 3456799999999999999999999999 999999999999995 4567999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|+|+.... .....+.+.||.|.|||++....|+..+|+||+||++|-|++|.+||........ ..+-
T Consensus 209 GFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgM 275 (400)
T KOG0604|consen 209 GFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGM 275 (400)
T ss_pred ccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhH
Confidence 99986543 2334556789999999999999999999999999999999999999975443111 0111
Q ss_pred cccccCcccCCCCC----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLCGNFS----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+..... +|+ ...++...++|+.+|..+|.+|.|+.+++.
T Consensus 276 k~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 276 KRRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HhHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111111111 122 234677889999999999999999999875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=292.19 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=205.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
....|.+.+.||+|.|++|.++.+. ++..||+|.+.... ......+.+|+.+++.++|||||+++.+.+....+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3577999999999999999999865 68999999998542 22334588999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+.+|.+++++ .+.+...+..+...+.|+.+|++|+|++ +|||||||++|+|++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999 4556677799999999999999999999 99999999999999999999999999999886
Q ss_pred CCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
. ....+..+|++.|.|||++.+..| ++.+|+||+|+++|.|++|..||.+..-.... .. .+.
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~r----vl~ 269 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PR----VLR 269 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------ch----hee
Confidence 3 455677899999999999998876 58999999999999999999999743321110 00 011
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..++ .+.-...++-++++++|-.+|.+|++++++.+
T Consensus 270 gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111 11111334668888999999999999999854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=323.15 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=207.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.-++.-...||.|.||.||.|... +|.-.|+|.+.... ......+.+|..++..++|||+|+++|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346677889999999999999854 68899999887543 333467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||++|+|.+.+ ..++..++.....+..|++.|+.|||++ |||||||||.||+++.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999998 5566678888888999999999999999 999999999999999999999999999988765
Q ss_pred CCcc---ccccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 208 DITH---ISTRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 208 ~~~~---~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+... ......||+.|||||++.+. +...++|||||||++.||+||+.||...+..- .....
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--aIMy~----------- 1453 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--AIMYH----------- 1453 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--HHHhH-----------
Confidence 4322 22347899999999999864 46779999999999999999999997544321 11111
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
+...-.+.++...+.+-++++.+||+.||++|-++.++++.=-+
T Consensus 1454 --V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1454 --VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred --HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 11112234444456778899999999999999999988875433
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.82 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=196.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
.++|++.+.||+|++|.||+|... +++.+|+|.+...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 6889999988654322 2345678999999999999999999875433
Q ss_pred --ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 122 --CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 122 --~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
..++|+||+.+ +|...+. .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~---~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE---NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999975 6766663 2345799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCcc----------ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHH
Q 042383 200 GLSKLFPEDITH----------ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV 268 (353)
Q Consensus 200 g~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~ 268 (353)
|++......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 11223567889999987654 5789999999999999999999999765544333222
Q ss_pred HHHHhhcccccc------ccccCcccCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 269 EKAWEMHNTDKL------QHLVDPMLCGNFS-------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 269 ~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
............ ....+.......+ ....+.+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 221111111000 0000000000001 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.44 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=197.5
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
|.+.+.||+|++|+||+|... +++.|++|.+..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677889999999999999976 578899998874422 22334567899999998 999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+++|.+.+... ....+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 77998888432 234789999999999999999999999 99999999999999999999999999988654321
Q ss_pred cccccccCCcCccCccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc----------cc
Q 042383 211 HISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT----------DK 279 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------~~ 279 (353)
......++..|+|||++. +..++.++|+||||+++|+|++|+.||..................... ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123345788899999875 445789999999999999999999999766543332221111100000 00
Q ss_pred cccccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+..... ..........+.+++.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0011112467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=287.54 Aligned_cols=269 Identities=23% Similarity=0.289 Sum_probs=200.5
Q ss_pred CHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEec
Q 042383 43 SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIE 119 (353)
Q Consensus 43 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 119 (353)
..+++....++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++.+++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34455667799999999999999999999854 68899999987432 2234567789999999999999999998764
Q ss_pred C------CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 120 G------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 120 ~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
. ...+++++++ +++|.+.+. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888877 678988762 34689999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 194 PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+............
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998764322 233467889999998766 468899999999999999999999997554332222111111
Q ss_pred hhccccccccc-----------cCcccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 273 EMHNTDKLQHL-----------VDPMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 273 ~~~~~~~~~~~-----------~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..........+ +....... .....+..+.+++.+||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000 00000000 011234568899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=281.02 Aligned_cols=244 Identities=25% Similarity=0.399 Sum_probs=193.3
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
|...+.||+|++|+||+|+.. +++.+++|.+..... .....+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999865 688999999874322 3335678899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+.+ +|.+.+. ....++++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~~-~l~~~l~---~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CLG-SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CCC-CHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 964 7777763 2345789999999999999999999999 999999999999999999999999998864322
Q ss_pred ccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.....++..|+|||.+. ...++.++||||||+++|+|++|..||...+....... ... ..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~---~~-------- 236 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQ---ND-------- 236 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHh---cC--------
Confidence 12356788999999874 45688899999999999999999999875543221111 000 00
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.........+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 -SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112223468899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=276.09 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=187.2
Q ss_pred eeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHH---HHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 59 KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVA---SMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
.||+|+||.||++... +++.||+|.+..... .....+..|.. .+....||+|+++.+++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999998874321 11222333433 3444579999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
|++|.+++ .....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999887 3456799999999999999999999999 99999999999999999999999999987553221
Q ss_pred ccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||............... . ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------~~~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-L-------------TMAV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-h-------------ccCC
Confidence 1234688999999998754 6899999999999999999999999755332111110000 0 0011
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
..+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22223356789999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.30 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=197.4
Q ss_pred CCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeecc-----ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVE-----SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
+|.+.+.||+|++|+||++.... +..+++|+++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999998653 444555555421 122334566789999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
+||+++++|.+.+.........+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998865444567899999999999999999999999 9999999999999975 569999999987654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~~~~~------------- 219 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVLRIVE------------- 219 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHc-------------
Confidence 3222 2233557889999999888888999999999999999999999986432211 1111100
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+...+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0112233455677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=297.10 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=206.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+-|.|++.||-|+||.||+|..++ +-..|.|+|...+....+.+.-|+++|...+||+||++++.|.-++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457788999999999999998763 5556789998888888899999999999999999999999988888999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
.||-....+. .-..++.+.++.-+++|++.||.|||++ +|+|||||..|||++-+|.++|+|||++-..... .
T Consensus 112 ~GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R 184 (1187)
T ss_pred CCchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence 9998887774 4567899999999999999999999999 9999999999999999999999999998643222 2
Q ss_pred cccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 211 HISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.....+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-..-++..-. .++..... ..++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl---lKiaKSeP----PTLl- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSEP----PTLL- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH---HHHhhcCC----Cccc-
Confidence 3345588999999999865 457999999999999999999999997644432221 11111110 0111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
-+......|.+++.+||..||..||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12334566889999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=282.19 Aligned_cols=251 Identities=23% Similarity=0.375 Sum_probs=197.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.|...+.||+|++|.||+|... ++..+|+|.+... .......+.+|+.+++.++|+|++++.+++.+....++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999865 5788999988642 2233456778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+. ++|.+.+. ....++++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 57877763 2345689999999999999999999999 999999999999999999999999999876532
Q ss_pred CCccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ....+++.|+|||.+. ...++.++|||||||++|+|++|..||............. .
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~----------- 228 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---Q----------- 228 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh---h-----------
Confidence 2 2345788999999874 3467889999999999999999999986543221111000 0
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...........+..+.+++.+||+.+|++||++.++++.---..
T Consensus 229 -~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 229 -NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00001112234566889999999999999999999997644433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=280.07 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=194.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVES-KQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|++|.||+|.+++ ++.||+|.+.... ......+..|+.++.+.. ||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678899999999999999999774 8899999987543 233445666777776664 99999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ . +++|+||+|+||++++++.++|+|||.+...
T Consensus 93 ~e~~~~-~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMST-CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccCc-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999854 67766632 23478999999999999999999997 5 8999999999999999999999999998765
Q ss_pred CCCCccccccccCCcCccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGH----LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
...... ....++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... ........ .. ..
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~---~~-~~ 237 (296)
T cd06618 166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKILQ---EE-PP 237 (296)
T ss_pred cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHHhc---CC-CC
Confidence 432221 2234678899999887553 7889999999999999999999996432211 11111100 00 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
. .......+.++.+++.+||+.+|++||+++++++.
T Consensus 238 ~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 S-------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00111235678999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=285.54 Aligned_cols=263 Identities=20% Similarity=0.283 Sum_probs=193.3
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-C--CcEEEEEEeecc--ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec----CCc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-D--GTVVAVKVLSVE--SKQGEKEFMSEVASMANI-CHENLVKLHGGCIE----GPC 122 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 122 (353)
+|++.+.||+|+||.||++... + +..+|+|.+... .....+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5788899999999999999865 4 778999988743 222345678899999999 59999999986542 245
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.+++++++. ++|.+++ .....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 81 ~~~~~e~~~-~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQII----RSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 5898888 3456799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc---ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 203 KLFPEDITH---ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 203 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
......... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+.................+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1233568899999998765 468899999999999999999999997654322111111110000000
Q ss_pred ccccc-----------cCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHL-----------VDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~-----------~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+..+ ...... ....+.....+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 000000 0011122457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=267.30 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=196.4
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.+.+..||.|+.|+||+++.+ +|...|||.+... +....+++...+.++..-+ +|+||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345678999999999999976 5889999998754 5556678888888877664 999999999999999999999988
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
.. .+..++ .+..++++|..+-.+...+..||.||.+++ +++|||+||.|||+|+.|++||||||.+-++.+.
T Consensus 174 s~-C~ekLl---krik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 174 ST-CAEKLL---KRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HH-HHHHHH---HHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 54 344444 245678999999999999999999999874 9999999999999999999999999998766442
Q ss_pred cccccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 211 HISTRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.......|-+.|||||.+... .|+.++||||||++++||.||+.||...+-+ +....+... ..+ +.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln-~eP--------P~ 314 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLN-EEP--------PL 314 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHh-cCC--------CC
Confidence 233556788999999988744 5888999999999999999999999864421 222222222 001 11
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+..+ ...++.+.+++..||..|+.+||...++++
T Consensus 315 L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1111 114566999999999999999999999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=277.80 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=200.9
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ......+..|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999876 58999999988553 333466788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++ +|.+++... ...+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 84 899998432 25799999999999999999999999 999999999999999999999999999886643322
Q ss_pred cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc---------
Q 042383 211 HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL--------- 280 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 280 (353)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||.......................+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223456789999988776 7899999999999999999999999766543332221111111111000
Q ss_pred ccccCcccCC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 281 QHLVDPMLCG---NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 281 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......... ...+..+..+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0001110000 111122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.09 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=196.3
Q ss_pred CCCCeeeeeCceEEEEEEeC-CCcEEEEEEeec----cChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc--eEEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSV----ESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC--RIIVY 127 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~ 127 (353)
+...+||+|+|-+||+|.+. +|..||=-.++. .+....+.+..|+++|+.|+||||+++++.+.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999865 566665433331 234445789999999999999999999999987665 67899
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~ 206 (353)
|.+..|+|..|+ ...+.++...++.|++||+.||.|||++ .+.|+|||||.+||||+. .|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999998 4556788999999999999999999997 568999999999999976 5899999999999775
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.... ....|||.|||||+.. ..|+...||||||+.++||+|+..||..-..... +..+......+..
T Consensus 198 ~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~s------- 264 (632)
T KOG0584|consen 198 KSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAA------- 264 (632)
T ss_pred cccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHH-------
Confidence 4322 2278999999999665 8999999999999999999999999964332211 1111111111111
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
+.....+++.++|.+||.. .++|||+.|+|. +|...
T Consensus 265 -----l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 -----LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2222245688999999999 999999999985 45443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=306.16 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=190.7
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
....+|+..+.||+||||.||+++.+ +|+.||||.|.... ......+.+|+..|.+++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 35577888899999999999999987 89999999998663 34446788999999999999999998655310
Q ss_pred --------------------------------------------------------------------------------
Q 042383 121 -------------------------------------------------------------------------------- 120 (353)
Q Consensus 121 -------------------------------------------------------------------------------- 120 (353)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEEcCCCCChhhhhhhccccCCCC-CHHHHHHHHHHHHHHHH
Q 042383 121 ---------------------------------PCRIIVYDYMQNNSLSQTLLGEEKNRAKF-SWTARREIALGIARGLA 166 (353)
Q Consensus 121 ---------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~l-~~~~~~~~~~qi~~al~ 166 (353)
..+||=||||+..+|.+++.+. ... .....|+++.+|+.||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHH
Confidence 0246779999987777777322 111 47889999999999999
Q ss_pred HHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC-----------------CCCccccccccCCcCccCccccc
Q 042383 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP-----------------EDITHISTRVAGTLGYLAPDYAV 229 (353)
Q Consensus 167 ~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~ 229 (353)
|+|+. |+|||||||.|||+++++.|||+|||+++... .......+...||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998621 00111234467999999999988
Q ss_pred cCC---CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhh
Q 042383 230 SGH---LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLL 306 (353)
Q Consensus 230 ~~~---~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (353)
+.. |+.|+|+||||++++||+. ||... .+....+.... .+.+.. . ..+.....+.=.++|++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR----~g~iP~-----~-~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR----KGSIPE-----P-ADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc----cCCCCC-----C-cccccccchHHHHHHHH
Confidence 654 9999999999999999984 56532 22222221111 111110 0 22333344556788999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 042383 307 CVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 307 cl~~~p~~RPt~~evl~ 323 (353)
+++.||.+|||+.|+|.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.47 Aligned_cols=236 Identities=27% Similarity=0.348 Sum_probs=193.1
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
||+|++|.||++... +++.+|+|++..... .....+..|+.+++.++|||++++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 588999999875432 2445788899999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 215 (353)
.+++ .....+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l----~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHL----SKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9998 3344789999999999999999999998 99999999999999999999999999988654322 12234
Q ss_pred ccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 216 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
..++..|+|||...+...+.++|+||||+++|++++|..||...+.... ...... .....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~--------------~~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YEKILK--------------DPLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHhc--------------CCCCCCCC
Confidence 5678899999999888889999999999999999999999965443111 111100 01122223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRMST 320 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~~e 320 (353)
.+..+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=244.20 Aligned_cols=263 Identities=19% Similarity=0.322 Sum_probs=204.0
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+|.-.++||+|++|+|++++.+ +++.||+|.++... ..-.....+|+-+++.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999855 68899999988653 23346778999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
|+. +|..+. ..-++.++.+.+..++.|++.||.+.|++ ++.|||+||.|.+|+.+|++||+|||+++.+.-..
T Consensus 83 cdq-dlkkyf---dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYF---DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHH---HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 787776 24567899999999999999999999999 99999999999999999999999999999887654
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhC-CCCCCCCcccchhhHHHHHHhhccccccccc---c
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTG-QAAVHFDKELGEYYLVEKAWEMHNTDKLQHL---V 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 284 (353)
...+. ..-|..|++|.++.+. -|+.+.|+||-|||+.|+... .+.|.+.+-+++...+.+.......+.+..+ .
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 44333 4568899999998876 488999999999999999984 4555554444444444444444444443332 2
Q ss_pred CcccCCCCCh---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSG---------NEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
|-...+.+++ .....=++++.+.|.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222222222 12223456777888889999999998876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=265.78 Aligned_cols=271 Identities=20% Similarity=0.301 Sum_probs=203.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC---C--CcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEec-CC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ---D--GTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIE-GP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 121 (353)
....|+.++.||+|++|.||+|.-+ + .+.+|+|.++.+.. .-.....+|+.+++.++|||++.+..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3467999999999999999999533 2 23689999875421 223567899999999999999999999887 77
Q ss_pred ceEEEEEcCCCCChhhhhhhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC----CCeEE
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEK-NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN----FNPKI 196 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~----~~~kl 196 (353)
..++++||.+. +|.+.|.-++. ....++...++.++.||+.|+.|||++ =++||||||.||+|..+ |.||+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 88999999987 89998865443 346789999999999999999999998 89999999999999877 89999
Q ss_pred eeccCCccCCCCCccc--cccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccc------hhhH
Q 042383 197 SDFGLSKLFPEDITHI--STRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG------EYYL 267 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~------~~~~ 267 (353)
+|+|+++.+.+..... .....-|..|+|||.+.+. .|+++.|||+.|||+.||++.++.|......- ....
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999987655443 3446678899999998875 68999999999999999999999997654211 1111
Q ss_pred HHHHHhh---ccccccccccC---------cccCCCCChH-----------HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 268 VEKAWEM---HNTDKLQHLVD---------PMLCGNFSGN-----------EAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 268 ~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~~-----------~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..++... +....+..+.. ..-...+.+. .++.-.+|+.++|..||.+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 2222221 11111111111 1000001110 12236788999999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=284.86 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=211.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCc-EEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGT-VVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+.+.+..||-|+||.|=++..+... .+|+|+++.. ...+.+.+..|-.+|...+.|.||+++..|.++.+.|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45677889999999999999876433 4888888743 4556678899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|-|-||.|+..+ +.++.|++.....++..+++|++|||++ +|++|||||+|.+++.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999 6788899999999999999999999999 999999999999999999999999999998754
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.....+++|||.|.|||++.++..+.+.|.|+||+++|||++|.+||...++...|.++.+.....
T Consensus 573 --g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------ 638 (732)
T KOG0614|consen 573 --GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------ 638 (732)
T ss_pred --CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence 455678999999999999999999999999999999999999999999999988887776654332
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
+++........++|++....+|.+|.-
T Consensus 639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 ---EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 223333445668888999999999976
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=287.04 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=195.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.+.|.+...+|.|+|+.|-.+... +++..++|++..... ...+|+.++... +||||+++.+++.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678899999999999999999755 678899999985522 223566666555 7999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE-CCCCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL-DQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~-~~~~~~kl~Dfg~~~~~~ 206 (353)
|.+.|+-|.+.+. ....+ ...+..|+.+|+.|+.|||++ |++||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~----~~~~~-~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIR----SKPEF-CSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHH----hcchh-HHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888873 22223 377788999999999999999 99999999999999 689999999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. ....+-|..|.|||++...+|++++|+||||++||+|++|+.||...... . .+...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~----------------ei~~~ 525 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I----------------EIHTR 525 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H----------------HHHHh
Confidence 43 33345578899999999999999999999999999999999999866543 1 11111
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....++...+....+|+.+||+.||.+||++.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122333455677889999999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.08 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=199.8
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
.++||+|-||+||-|+++ +|+.||||+|... ...+...+.+|+.+|++++||.||.+.-.|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 578999999999999865 7999999999743 445567889999999999999999999999999999999999976
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeeccCCccCCCCCc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+..+.|.+ ...+.+++..-+.++.||+.||.|||.+ +|+|+||||+|||+.+ ...+||||||.|+..++.
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 66666644 4567899999999999999999999999 9999999999999954 457999999999998663
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.......|||.|+|||++.++.|+.+-|+||.|+|+|.-++|..||..+.+..++ ++.+.-+.....+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyPp~PW---------- 788 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYPPNPW---------- 788 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccCCCch----------
Confidence 3345578999999999999999999999999999999999999999865543322 1111111111111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+.....++||...|+..-++|-|...-+.
T Consensus 789 ---~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 223445778888999999999998876543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=263.63 Aligned_cols=219 Identities=19% Similarity=0.185 Sum_probs=175.9
Q ss_pred eCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhh
Q 042383 63 GGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG 141 (353)
Q Consensus 63 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 141 (353)
|.+|.||++.+. +++.+|+|.+..... ...|...+....||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-
Confidence 899999999875 688999999875432 2334455555679999999999999999999999999999999983
Q ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcC
Q 042383 142 EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221 (353)
Q Consensus 142 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~ 221 (353)
....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... .....++..
T Consensus 78 ---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 78 ---KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ---HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 334689999999999999999999999 9999999999999999999999999987655332 122345677
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHH
Q 042383 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFL 301 (353)
Q Consensus 222 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (353)
|+|||.+.+..++.++|+||+|+++|+|++|..|+...... .. .......+...+..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~----~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN----THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc----cccccCCcccCCHHHH
Confidence 99999998888999999999999999999999887532110 00 0000112233456788
Q ss_pred HHHhhccCCCCCCCCCH
Q 042383 302 KVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 302 ~li~~cl~~~p~~RPt~ 318 (353)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.70 Aligned_cols=146 Identities=27% Similarity=0.400 Sum_probs=131.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+..|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999976 68899999987432 23346788899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
|||+.+++|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~----~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999983 345689999999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.96 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=207.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC----C----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ----D----GTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
++..+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++++.+ +|+||+.+++++....
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 44456679999999999999733 1 356999998854 335567899999999999 6999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhcc---ccC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEE---KNR---------AKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~---~~~---------~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
..++|+||+..|+|.+++...+ ... ..++....+.++.||+.|++||++. .++||||..+|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence 9999999999999999996544 101 2489999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeccCCccCCCCCcccccccc--CCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 190 QNFNPKISDFGLSKLFPEDITHISTRVA--GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
++..+|++|||+++.............. -+..|+|||.+....++.++||||||++||||+| |..|+..-.....
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~-- 530 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE-- 530 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--
Confidence 9999999999999865433222212122 2446999999999999999999999999999999 7788764221111
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
+ .+.+.+..+...+..+..++.++++.||+.+|++||++.++.+.|...
T Consensus 531 l-------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 L-------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 112233334455666688899999999999999999999999999883
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=262.81 Aligned_cols=273 Identities=26% Similarity=0.345 Sum_probs=205.8
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc--CCCCceeeeeeEecCC---
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI--CHENLVKLHGGCIEGP--- 121 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~--- 121 (353)
......+..+.+.||+|.||.||+|+++ |+.||||++. ..++..+.+|.++++.. +|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3445677888999999999999999998 7889999987 34456778888888775 8999999998654332
Q ss_pred -ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCeEECCCCCeE
Q 042383 122 -CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE-----IKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 122 -~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-----~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
.+++|.+|.+.|||+|+| +...++...+.+++..+++||++||.. .++.|.|||||..||||.+++...
T Consensus 282 TQLwLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 578999999999999999 346799999999999999999999963 467999999999999999999999
Q ss_pred EeeccCCccCCCCCcc---ccccccCCcCccCccccccCC----C--CccccchhHHHHHHHHHhC----------CCCC
Q 042383 196 ISDFGLSKLFPEDITH---ISTRVAGTLGYLAPDYAVSGH----L--NPKSDIYSFGVLLLQIVTG----------QAAV 256 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~----~--~~~~DvwslG~il~~ll~g----------~~pf 256 (353)
|+|+|+|-..+..... ......||.+|||||++...- + -..+||||||.++||++.. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 9999999877654322 234578999999999886532 1 1358999999999999863 3555
Q ss_pred CCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 257 HFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.+--+.+... .++...-.++.+....-....+.+....+.++++.||..||.-|-|+--|-+.|.++...++
T Consensus 437 yd~Vp~DPs~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 437 YDVVPSDPSF-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred ccCCCCCCCH-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 4332211110 00000001111111111122345567789999999999999999999999888887775443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.13 Aligned_cols=250 Identities=21% Similarity=0.327 Sum_probs=194.4
Q ss_pred CeeeeeCceEEEEEE-eCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
+.||+|+++.|--+. ..+|..+|||++.........++.+|++++.+. .|+||++++++|+++..+|+|||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 469999999999887 568999999999987777788999999999988 599999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEeeccCCccCC--CCCc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKISDFGLSKLFP--EDIT 210 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~~~--~~~~ 210 (353)
...| ..+.-+++.++.++..+|+.||.+||.+ ||.||||||+|||-.+.. -+|||||.++.-.. .+..
T Consensus 164 LshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9998 5567799999999999999999999999 999999999999996544 48999998765432 2212
Q ss_pred cc----cccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccc-h------hhHHHHHHhh
Q 042383 211 HI----STRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG-E------YYLVEKAWEM 274 (353)
Q Consensus 211 ~~----~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~-~------~~~~~~~~~~ 274 (353)
.. ..+.+|+..|||||+.. ...|+.++|.||||+|+|-|++|.+||.+.-..+ . ....+..
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~--- 313 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK--- 313 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH---
Confidence 11 22356788999999764 2358899999999999999999999997653211 1 1111100
Q ss_pred ccccccccccCcccCCCCChHH----HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNE----AVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.+.+.+.. =+++..+ +.+..+++...|-.++.+|.++..++.
T Consensus 314 -----LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 -----LFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -----HHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000000 1233222 445667888899999999999998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=265.95 Aligned_cols=242 Identities=23% Similarity=0.284 Sum_probs=198.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
...+|..+.+||+|+||.|.++..+ +.+.+|||+++... .++.+--..|-.+|... +-|.+++++.+|..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4567889999999999999999755 56789999988542 22223334566777666 4678999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+.||+|--.+ +.-+.+.+..+..++..|+-||-+||++ ||++||||.+||+++.+|++||+|||++.-
T Consensus 427 FVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 999999999998777 4567889999999999999999999999 999999999999999999999999999873
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
--- ......+.+|||.|+|||++...+|+.+.|.||+|++||||+.|++||.+.++.+.+..+...
T Consensus 500 ni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------- 565 (683)
T KOG0696|consen 500 NIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------- 565 (683)
T ss_pred ccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------
Confidence 211 122345689999999999999999999999999999999999999999988876655433321
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP 316 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 316 (353)
. -.++...+.+...+....|..+|.+|.
T Consensus 566 --n--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 --N--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --c--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 234444566677888888999999885
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=284.34 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=208.9
Q ss_pred CCCeeeeeCceEEEEEEe-CC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 56 SSNKVGEGGFGSVYKGKL-QD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++||+|+||+||+|.+ .. +.+||+|++... ......++.+|+-+|.++.|||++++++++.... .-||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 467899999999999974 22 457999998744 3344578999999999999999999999998776 7789999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++|+|.+++. .++.++-.+..+.|..||++||.|||.+ +++||||-.+||||.+-.++|+.|||+++....+.
T Consensus 779 mP~G~LlDyvr---~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVR---EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHH---HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999994 4667889999999999999999999999 99999999999999999999999999999886554
Q ss_pred cccccc-ccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 210 THISTR-VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 210 ~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
...... ..-.+.|+|=|.+....++.++|||||||++||++| |..|+....- +.+..++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------~eI~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------EEIPDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------HHhhHHHhcc
Confidence 444332 223456999999999999999999999999999999 8888864332 2233344443
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.+-.-++.+...+..++.+||..|+..||+++++...++...
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 444556777889999999999999999999999988887644
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=265.67 Aligned_cols=273 Identities=26% Similarity=0.371 Sum_probs=204.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc--CCCCceeeeeeEecCC----ceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI--CHENLVKLHGGCIEGP----CRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~----~~~l 125 (353)
...++.+.||+|.||.||+|... ++.||||+++. ...+.+..|-+++... +|+||+++++.-.... .+.|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34455778999999999999987 58899999873 4445677777777654 7999999998766544 7899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE------IKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~------~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
|++|.+.|+|.++| ....++|....+++..++.||+|||+. ++..|+|||||..||||..+++..|+||
T Consensus 286 Vt~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999 345799999999999999999999974 3579999999999999999999999999
Q ss_pred cCCccCCCCCc-cccccccCCcCccCccccccCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHH--H
Q 042383 200 GLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGH-LN-----PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE--K 270 (353)
Q Consensus 200 g~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~ 270 (353)
|+|..+..... .......||.+|||||++.+.- +. .+.||||+|.++|||++...-+.. .+...+.+-. .
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAE 439 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHH
Confidence 99988763322 2223378999999999987642 22 368999999999999997655532 2222222111 1
Q ss_pred HHhhcccccccc-ccCcccCCCCCh-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCC
Q 042383 271 AWEMHNTDKLQH-LVDPMLCGNFSG-----NEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDD 334 (353)
Q Consensus 271 ~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~ 334 (353)
....+..+.... .+.+..++.++. .....+.+.+..||+.||+.|.|+.=+-+++.+..-+.++
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111111111 122222222222 2356688999999999999999999999999888877764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.75 Aligned_cols=262 Identities=21% Similarity=0.323 Sum_probs=196.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-----C---CCceeeeeeEe----
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-----H---ENLVKLHGGCI---- 118 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~---- 118 (353)
.+|.+.++||+|-|+|||++.+. ..+.||+|+.+ ....-.+....|+.+|++++ | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 78999999999999999999865 67899999887 33334467789999999984 2 35999999886
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-------
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN------- 191 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~------- 191 (353)
.+.+.|+|+|++ |.+|..+|.. .+.+.++...++.|++||+.||.|||..| ||+|.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 567899999999 5689888853 45678999999999999999999999986 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 042383 192 -------------------------------------------------------------------------------- 191 (353)
Q Consensus 192 -------------------------------------------------------------------------------- 191 (353)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 042383 192 -------------------------------------------------------------------------------F 192 (353)
Q Consensus 192 -------------------------------------------------------------------------------~ 192 (353)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc------hhh
Q 042383 193 NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG------EYY 266 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~------~~~ 266 (353)
.+||+|||-|+....+.+. -..|..|+|||++.+..|+..+||||++|+++||+||...|...+... +.-
T Consensus 392 ~vKIaDlGNACW~~khFT~----DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKHFTE----DIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhhhhhch----hhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 1355555555544332222 235778999999999999999999999999999999999997654322 111
Q ss_pred -HHHHHHhhcc---------------ccccccccC-------cccC--CCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042383 267 -LVEKAWEMHN---------------TDKLQHLVD-------PMLC--GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321 (353)
Q Consensus 267 -~~~~~~~~~~---------------~~~~~~~~~-------~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 321 (353)
+++.....+. .+.+..+-. ..+. =.++.+...++.+++.-||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 1111111000 111111111 1111 14677888999999999999999999999999
Q ss_pred HH
Q 042383 322 IE 323 (353)
Q Consensus 322 l~ 323 (353)
++
T Consensus 548 l~ 549 (590)
T KOG1290|consen 548 LK 549 (590)
T ss_pred hc
Confidence 85
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=270.59 Aligned_cols=230 Identities=24% Similarity=0.352 Sum_probs=187.5
Q ss_pred CCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
-|..++.||-|+||.|.++.. .+...+|+|.++... ..+......|-.||....++-||+++-.|.+.+++|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 467789999999999999974 456779999987542 3445667889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC--
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP-- 206 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~-- 206 (353)
|++||++-.+|. .-+.|+|..+..++..+.+|+++.|.. |+|||||||+|||||.+|++||+|||+++-+.
T Consensus 710 YIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 999999988884 456799999999999999999999999 99999999999999999999999999986441
Q ss_pred -------CCCcc--------------------------------ccccccCCcCccCccccccCCCCccccchhHHHHHH
Q 042383 207 -------EDITH--------------------------------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLL 247 (353)
Q Consensus 207 -------~~~~~--------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ 247 (353)
++... ......||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 00000 001246999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHH
Q 042383 248 QIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAV 298 (353)
Q Consensus 248 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
||+.|++||......+.+.. ..+++.+++--.+..++.++..
T Consensus 863 em~~g~~pf~~~tp~~tq~k---------v~nw~~~l~~~~~~~ls~e~~~ 904 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYK---------VINWRNFLHIPYQGNLSKEALD 904 (1034)
T ss_pred HHhhCCCCccCCCCCcceee---------eeehhhccccccccccCHHHHH
Confidence 99999999998776555422 2344555554455555555433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=252.30 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=192.2
Q ss_pred CceEEEEEEeC-CCcEEEEEEeeccChhc-HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhh
Q 042383 64 GFGSVYKGKLQ-DGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG 141 (353)
Q Consensus 64 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 141 (353)
+||.||+|... +++.+|+|++....... .+.+.+|+..+++++|+|++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999998655444 67889999999999999999999999999999999999999999998832
Q ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcC
Q 042383 142 EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221 (353)
Q Consensus 142 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~ 221 (353)
...+++..++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 33389999999999999999999999 99999999999999999999999999998765432 2334557889
Q ss_pred ccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHH
Q 042383 222 YLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFL 301 (353)
Q Consensus 222 y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (353)
|++||.+.+..++.++||||||+++|+|++|..||........ ....... .... . .......+..+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~~----~~~~-----~--~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIGK----PKPP-----F--PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhc----cCCC-----C--ccccccCCHHHH
Confidence 9999999888899999999999999999999999875322111 1111100 0000 0 000000346788
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 042383 302 KVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 302 ~li~~cl~~~p~~RPt~~evl~ 323 (353)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=274.65 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=209.9
Q ss_pred HHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEe---
Q 042383 44 YNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCI--- 118 (353)
Q Consensus 44 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 118 (353)
++.+..-++-|++..+||.|.+|.||+++.. +++.+|+|+... ..+..+++..|.++|+.. .|||++.++++|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3334445677899999999999999999855 688899997763 444556778899999998 6999999999886
Q ss_pred --cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 119 --EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 119 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.++.+++|||||.|||..|++.... +..+.|..+..|++.++.|+.+||.. .++|||||=.|||++.++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 4678999999999999999996554 77899999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCccccccccCCcCccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 197 SDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
+|||++......... ..+..|||.|||||++... .|+..+|+||||++..||.-|.+|+....+.....++
T Consensus 165 vDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 999999877544333 3447899999999998754 3677999999999999999999999755443221110
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+ ++-..-.-+..-.+++.++|..||..|..+||++.++++
T Consensus 241 ---pR--------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 ---PR--------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---CC--------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 111111224455788999999999999999999998875
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=251.86 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=192.5
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
...||.|+||+|++-.++ +|+..|||.++.... ...+++..|.+...+- ++||||+++|..-.++..++.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 567999999999998866 799999999986644 4556777888766554 799999999988888889999999964
Q ss_pred Chhhhhhh-ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 134 SLSQTLLG-EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 134 sL~~~l~~-~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
||..+... +.-.+..++|..+-.+......||.||... ..|+|||+||.|||++..|.+||||||.+-.+.+....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk- 224 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK- 224 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh-
Confidence 66554432 223456789999999999999999999876 49999999999999999999999999998765433222
Q ss_pred cccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 213 STRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
+.-.|-..|+|||.+.. ..|+.+|||||||++|||+.||..|+...+..-++. .. ...+.-..+....-+
T Consensus 225 -T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql-----~~-Vv~gdpp~l~~~~~~- 296 (361)
T KOG1006|consen 225 -TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL-----CQ-VVIGDPPILLFDKEC- 296 (361)
T ss_pred -hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH-----HH-HHcCCCCeecCcccc-
Confidence 33457778999998874 358999999999999999999999998665422211 11 111111111221111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
-+....+..+|.-||-.|-++||.+.++++
T Consensus 297 ---~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 297 ---VHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ---cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 223556899999999999999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=263.15 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=196.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccC-hhc------HHHHHHHHHHHHhcCCCCceeeeeeEe-cCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVES-KQG------EKEFMSEVASMANICHENLVKLHGGCI-EGP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 121 (353)
.++|-++..||+|+|+.||+|.+ ...++||+|+-.... ..+ .+...+|..+.+.|.||.||+++++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46788899999999999999974 457899999765432 111 245678999999999999999999986 667
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC---CCCCeEEee
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD---QNFNPKISD 198 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~D 198 (353)
.+|-|+|||+|.+|.-++ .....+++.++..|+.||+.||.||... +..|+|-||||.|||+- ..|.+|++|
T Consensus 542 sFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 889999999999998888 4556799999999999999999999986 67999999999999994 357899999
Q ss_pred ccCCccCCCCCcc------ccccccCCcCccCccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHH
Q 042383 199 FGLSKLFPEDITH------ISTRVAGTLGYLAPDYAVSG----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV 268 (353)
Q Consensus 199 fg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~ 268 (353)
||++..++.+... ......||..|++||.+.-+ ..+.+.||||+|||+|+.+.|+.||.......+. .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--L 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--L 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--H
Confidence 9999988765443 12335689999999987643 4688999999999999999999999754322111 1
Q ss_pred HHHHhhccccccccccCcc-cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 269 EKAWEMHNTDKLQHLVDPM-LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
+.. .++... ..-..-+....+...+|++||++--++|....++.
T Consensus 695 qeN----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QEN----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhh----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 100 011100 00011122345577889999999999988777764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=251.04 Aligned_cols=265 Identities=22% Similarity=0.362 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--------C
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE--------G 120 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~ 120 (353)
..|.-..+||+|.||.||+|+.+ +|+.||+|.+-.+ ...-.....+|+.+|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999865 5788899865433 22233566899999999999999999887652 3
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
..+|+||.+|+. +|...+. .....++...+..++.+++.||.|+|+. .|+|||+|++|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 357899999987 7888872 2236789999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCC---CccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 201 LSKLFPED---ITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 201 ~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
+++.+... .....+....|..|++||.+.+. .|+++.|||+-||++.+|+|+.+.+....+......+........
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99866432 22233445668999999988764 699999999999999999999999998877666666554433333
Q ss_pred ccccccccC-----cc-----cCCCCC--------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 TDKLQHLVD-----PM-----LCGNFS--------GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 ~~~~~~~~~-----~~-----~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+.+...-+ +. ....+. -.-.....+|+..+|..||.+|+++.+++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 222221111 00 000000 001235668888999999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=276.95 Aligned_cols=264 Identities=21% Similarity=0.260 Sum_probs=170.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-C----CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeee------Ee
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-D----GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG------CI 118 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 118 (353)
..++|.+.+.||+|+||.||+|... + +..||+|.+...... +....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999875 4 688999987632211 111111 1222222233222221 24
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEK----------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIK 182 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk 182 (353)
.+...++|+||+++++|.+++..... .........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 56678999999999999998843210 001122345678999999999999999 99999999
Q ss_pred CCCeEECC-CCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCC----------------------CCccccc
Q 042383 183 PSNILLDQ-NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH----------------------LNPKSDI 239 (353)
Q Consensus 183 ~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----------------------~~~~~Dv 239 (353)
|+|||++. ++.+||+|||++...............+++.|+|||.+.... ++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 679999999999866544444445567899999999654322 3345699
Q ss_pred hhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhh-ccccccccccCcccCCC------CChHHHHHHHHHHhhccCCCC
Q 042383 240 YSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM-HNTDKLQHLVDPMLCGN------FSGNEAVRFLKVGLLCVQEKS 312 (353)
Q Consensus 240 wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p 312 (353)
|||||++|||+++..++... ..... ...... .....+.....+....+ ..........+|+.+||+.||
T Consensus 363 wSlGviL~el~~~~~~~~~~--~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--LIQFN--RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--HHHHH--HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999976654311 11110 000000 00001111111111000 001112345589999999999
Q ss_pred CCCCCHHHHHHH
Q 042383 313 SLRPRMSTVIEM 324 (353)
Q Consensus 313 ~~RPt~~evl~~ 324 (353)
++|||+.++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999873
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=248.15 Aligned_cols=200 Identities=23% Similarity=0.354 Sum_probs=175.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|.+.++||+|+++.|..++.+ +.+-+|+|+++.+ ...+..-...|-.+..+. +||.+|.++.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368999999999999999999865 6788999999854 333444556677777666 79999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|.||++||+|--.+ +.+.+++++.+..+...|+.||.|||+. ||++||||.+|+|++..|++||+|+|+++--
T Consensus 329 vieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999997776 5667899999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHF 258 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~ 258 (353)
-. ......+++|||+|.|||++.+..|+.+.|.|+||++++||+.|+.||.-
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 22 23345668999999999999999999999999999999999999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=265.17 Aligned_cols=263 Identities=21% Similarity=0.252 Sum_probs=180.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-----------------CCCcEEEEEEeeccChhcHHH--------------HHHH
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-----------------QDGTVVAVKVLSVESKQGEKE--------------FMSE 98 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 98 (353)
..++|.+.++||+|+||+||+|.. ..++.||||.+........+. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999863 235679999987543322222 2346
Q ss_pred HHHHHhcCCCCc-----eeeeeeEec--------CCceEEEEEcCCCCChhhhhhhccc--------------------c
Q 042383 99 VASMANICHENL-----VKLHGGCIE--------GPCRIIVYDYMQNNSLSQTLLGEEK--------------------N 145 (353)
Q Consensus 99 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~ 145 (353)
+..+.+++|.++ ++++++|.. ....++||||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666677765543 666776653 3567999999999999998853210 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCc
Q 042383 146 RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225 (353)
Q Consensus 146 ~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aP 225 (353)
...+++..++.++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999 999999999999999999999999999976543222211223347899999
Q ss_pred cccccCCC----------------------CccccchhHHHHHHHHHhCCC-CCCCCcccch----hhHHHHHHhhcccc
Q 042383 226 DYAVSGHL----------------------NPKSDIYSFGVLLLQIVTGQA-AVHFDKELGE----YYLVEKAWEMHNTD 278 (353)
Q Consensus 226 E~~~~~~~----------------------~~~~DvwslG~il~~ll~g~~-pf~~~~~~~~----~~~~~~~~~~~~~~ 278 (353)
|.+..... ..+.||||+||++|+|++|.. ||........ .......+...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--- 456 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--- 456 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh---
Confidence 98764321 124799999999999999875 6643221111 00111111111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKS---SLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~ 323 (353)
......-...........+|+.++|..+| .+|+|++|+|+
T Consensus 457 -----~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 -----KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -----cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11111111122335678889999998765 78999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=248.48 Aligned_cols=266 Identities=19% Similarity=0.286 Sum_probs=204.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----Cce
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----PCR 123 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 123 (353)
.+.+..+.||-|+||.||.+.+. +|+.||+|.+..- +-...+.+.+|+..|..++|.|++..++...-. +..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45567889999999999999865 7999999987632 334457889999999999999999888765432 245
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
|.+.|.+.. +|...| -....++.+.++-+++||+.||.|||+. +|.||||||.|.|+++|+.+|+||||+++
T Consensus 133 YV~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 678888865 788887 4566789999999999999999999999 99999999999999999999999999999
Q ss_pred cCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc-
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ- 281 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 281 (353)
....+....++...-|..|+|||++.+. .|+.+.||||.|||+.||+..+-.|...++.+...++.........+..+
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 7665444445555678899999999876 58999999999999999999999998877777666665443222211111
Q ss_pred -------cccCcccC---------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 282 -------HLVDPMLC---------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 282 -------~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
.++....+ -..+.....+-..+...++..||+.|.+-.+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111 111122234566777889999999999998887654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.28 Aligned_cols=273 Identities=17% Similarity=0.180 Sum_probs=209.5
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC------CCCceeee
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC------HENLVKLH 114 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~ 114 (353)
|.+.-.+....+|.+....|+|-|++|.+|.+. .|..||||+|... ....+.=..|+++|++|+ --++++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 344444556688999999999999999999865 4779999999843 333445568999999996 23799999
Q ss_pred eeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CC
Q 042383 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FN 193 (353)
Q Consensus 115 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~ 193 (353)
..|...+++|+|+|-+.. +|.+.+.... .+-.+....+..++.|++.||..|... |++|.||||+||||++. ..
T Consensus 501 r~F~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 999999999999999954 8999996653 345688899999999999999999998 99999999999999875 56
Q ss_pred eEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 194 PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
+||||||.|....+. ..+++..+.-|+|||++.|-.|+...|+||.||+||||.||+..|.+........+......
T Consensus 576 LKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 899999999876543 23445556679999999999999999999999999999999999988766555443332211
Q ss_pred hccccc--------------------------------cccccCc------cc--CCCCC---hHHHHHHHHHHhhccCC
Q 042383 274 MHNTDK--------------------------------LQHLVDP------ML--CGNFS---GNEAVRFLKVGLLCVQE 310 (353)
Q Consensus 274 ~~~~~~--------------------------------~~~~~~~------~~--~~~~~---~~~~~~l~~li~~cl~~ 310 (353)
.+.... +...+.+ .+ +..++ ......|.+|+..|+..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 111000 0000001 00 11123 23356788999999999
Q ss_pred CCCCCCCHHHHHH
Q 042383 311 KSSLRPRMSTVIE 323 (353)
Q Consensus 311 ~p~~RPt~~evl~ 323 (353)
||++|.|.++.|.
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=270.57 Aligned_cols=245 Identities=25% Similarity=0.297 Sum_probs=186.4
Q ss_pred CCCCCeeeeeCceE-EEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEcCC
Q 042383 54 FCSSNKVGEGGFGS-VYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 54 y~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
|...+.+|.|+.|+ ||+|... |+.||||.+-. +....+.+|+..|+.- .||||+++++.-.+.+..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999987 7999987 77899998752 3345678999999998 69999999999999999999999995
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---C--CCeEEeeccCCccCC
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---N--FNPKISDFGLSKLFP 206 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~--~~~kl~Dfg~~~~~~ 206 (353)
.+|.+++...............+..+.|+++||++||+. +||||||||.||||+. + ..++|+|||+++..+
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 499999955311111112245577899999999999998 9999999999999965 2 468999999999887
Q ss_pred CCCccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITHI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG-QAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.+.... .....||-+|+|||++....-+.+.||||+||++|+.++| .+||...-+-+...+ .....+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~-- 733 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLV-- 733 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCcccee--
Confidence 554433 3346789999999999988888899999999999999996 899985432111000 0000000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
.-.-..++ +..+||.+|++++|..||++.+|+
T Consensus 734 -----~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 -----HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----eeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00011111 678899999999999999999994
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=225.06 Aligned_cols=205 Identities=25% Similarity=0.381 Sum_probs=171.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+....+..||+|++|.|-+-++. +|+-.|+|.+... +....+...+|+.+..+. .+|++|.++|..-.....++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344455678999999999888754 7999999999855 344456778888887666 7999999999888888899999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|.|+- ||..+.......++.++|..+-+++..+..||.|||++ ..++|||+||.|||++..|++|+||||.+-.+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99965 88888776667888999999999999999999999997 5999999999999999999999999999876644
Q ss_pred CCccccccccCCcCccCcccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDK 260 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~~ll~g~~pf~~~~ 260 (353)
.... +...|-..|+|||.+.. ..|+.++||||||+++.||.+++.||....
T Consensus 202 SiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 3222 22346778999998763 378999999999999999999999987543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=246.86 Aligned_cols=264 Identities=21% Similarity=0.278 Sum_probs=211.8
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeE
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGC 117 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 117 (353)
.++.....+++....+-+|+||.||.|.+. +.+.|.+|.++.. +..+...+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344555678889999999999999999654 2344667776644 445567788899999999999999999977
Q ss_pred ec-CCceEEEEEcCCCCChhhhhhh----ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 118 IE-GPCRIIVYDYMQNNSLSQTLLG----EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 118 ~~-~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
.+ ....+.++.++.-|+|..++.. .....+.++..+...++.|++.|+.|||+. +++|.||..+|++|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 64 5566888999999999999962 123345678889999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccC-CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLF-PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
++||+|-.+++.. +.+..........+..||+||.+.+..|+.++||||||+++|||+| |+.|+..-++.+.......
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999999988744 4444444444455678999999999999999999999999999999 8999987666555443332
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
. .+-.-+.+++.++..++.-||...|++||+++++..-|++
T Consensus 514 G----------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 514 G----------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred c----------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2 2222344568889999999999999999999999887754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=233.61 Aligned_cols=253 Identities=18% Similarity=0.336 Sum_probs=193.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeee-eEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHG-GCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~-~~~~~~~~~lv 126 (353)
..+.|.+.+.||+|.||.+-+++++ +++.+++|.+.. .....++|.+|+..--.| .|.||+..++ .|+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4578999999999999999999977 678899998874 344567889999877777 5899998886 57888899999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE--CCCCCeEEeeccCCcc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL--DQNFNPKISDFGLSKL 204 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~--~~~~~~kl~Dfg~~~~ 204 (353)
+||++.|+|...+ ....+.+...+.++.|+++||.|+|+. ++||||||.+|||| .+..++||||||..+.
T Consensus 101 qE~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999999887 235688999999999999999999999 99999999999999 3345899999999986
Q ss_pred CCCCCccccccccCCcCccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSG-----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.+.... ...-+..|.+||+.... ...+.+|+|.||+++|.++||..||......+..+.....|.......
T Consensus 173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 543222 22335679999976532 246789999999999999999999985544444333333333322222
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
+...+. ...+.+.++.++-|..++++|-...++.+.
T Consensus 249 ~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 249 LPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 222211 124557788889999999999666665443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=236.85 Aligned_cols=277 Identities=21% Similarity=0.246 Sum_probs=208.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEe------cCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCI------EGP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~ 121 (353)
..+|.-.+.+|.|.- .|..+-+. .+++||+|....+ +....+...+|+.++..++|+||++++.+|. +..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457777888999988 56555543 5888999987643 4455678899999999999999999999886 344
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..|+|||+|.. +|.+.+. -.++-..+..++.|++.|+.|||+. +|+||||||+||++..++.+|+.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 67899999965 8988874 3467788999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc-----
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN----- 276 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----- 276 (353)
++.-+. ....+.+..+..|+|||++.+..+...+||||+||++.||++|...|.+.+..+.+..+........
T Consensus 165 ar~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 986433 3466778889999999999999999999999999999999999999987665544433322111110
Q ss_pred ------------cc-----ccc-cccCcccCC--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCCCCC
Q 042383 277 ------------TD-----KLQ-HLVDPMLCG--NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVDIDDD 334 (353)
Q Consensus 277 ------------~~-----~~~-~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~~~~ 334 (353)
.+ ... .+.|..+.. +.+........+++.+||-.||++|.+++++|+. ++ .+-.++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~~~e 321 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYDPDE 321 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eeccccc
Confidence 00 001 111111111 1222335567789999999999999999999874 44 4433333
Q ss_pred ccccCCc
Q 042383 335 VEIWEPG 341 (353)
Q Consensus 335 ~~~~~~~ 341 (353)
++-+.|+
T Consensus 322 v~ap~pe 328 (369)
T KOG0665|consen 322 VEAPPPE 328 (369)
T ss_pred ccCCCCc
Confidence 3334455
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=224.42 Aligned_cols=259 Identities=15% Similarity=0.291 Sum_probs=194.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCC--ceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGP--CRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 125 (353)
..++|++.+++|+|.++.||.|.. .+++.+++|+++. -..+.+.+|+.+|+.+. ||||++++++..+.. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 467899999999999999999984 4678899999873 33457889999999996 999999999887654 5579
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCcc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKL 204 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 204 (353)
|+||++..+..... ..++...+..++.+++.||.|+|+. ||.|||+||.|++|+. ...++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999887665554 4678889999999999999999999 9999999999999986 45699999999998
Q ss_pred CCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCc-ccchhhHHHHHH----------
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDK-ELGEYYLVEKAW---------- 272 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~---------- 272 (353)
+... ....-...+..|--||.+.. ..|+.+-|+|||||++..|+..+.||.... ..++...+.+..
T Consensus 183 YHp~--~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 183 YHPG--KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred cCCC--ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 8543 22223445667889998765 468899999999999999999999986443 222222222111
Q ss_pred --hhccccccccccC--------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 273 --EMHNTDKLQHLVD--------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 273 --~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...-.+....++. ..+..+...-...+.++++.+.|..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0001111112111 11112222223466889999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=224.21 Aligned_cols=211 Identities=35% Similarity=0.571 Sum_probs=182.7
Q ss_pred eeeeCceEEEEEEeC-CCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhh
Q 042383 60 VGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQ 137 (353)
Q Consensus 60 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 137 (353)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999976 4889999998855432 34678899999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccCCCCCccccccc
Q 042383 138 TLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFPEDITHISTRV 216 (353)
Q Consensus 138 ~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 216 (353)
++... ...+++..+..++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 98322 14689999999999999999999999 9999999999999999 89999999999986654321 12334
Q ss_pred cCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChH
Q 042383 217 AGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGN 295 (353)
Q Consensus 217 ~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 567889999998877 788999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4578899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=249.58 Aligned_cols=196 Identities=23% Similarity=0.335 Sum_probs=169.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChh--------cHHHHHHHHHHHHhcC---CCCceeeeeeEec
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQ--------GEKEFMSEVASMANIC---HENLVKLHGGCIE 119 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 119 (353)
.+|...+.+|.|+||.|+.|.++. ...|++|.|..+.-- ..-.+..|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468899999999999999999774 566899998744210 0123457999999997 9999999999999
Q ss_pred CCceEEEEEcCC-CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 120 GPCRIIVYDYMQ-NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 120 ~~~~~lv~e~~~-~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
++++|+++|.-. |-+|.++| .....++|.++..++.|++.|+++||++ +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 999999999764 55899999 6677899999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCC
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
||.+-....+ ....+.||..|.|||++.+..| +..-|||++|++||.+.....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998765432 2345789999999999998876 567899999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=255.16 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=209.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
-.++|++...+|+|++|.||++++. +++..|+|+++.+......-+.+|+-+++..+||||+.+++.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3578999999999999999999865 689999999999988888888999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
||.||+|.+.. ...+++++.++...++..+.+++|||+. +-+|||||-.||++++.|.+|+.|||.+-.+...
T Consensus 93 ycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCccccee----eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999987 5678999999999999999999999999 9999999999999999999999999998766543
Q ss_pred CccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 209 ITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... ...+.||+.|+|||+.. .+.|...+|||++|++..|+...++|.....+.....+..+ ..+.++. +.|
T Consensus 166 i~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--S~~qpp~---lkD 239 (829)
T KOG0576|consen 166 IAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--SGFQPPT---LKD 239 (829)
T ss_pred hhh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--cCCCCCc---ccC
Confidence 322 33478999999999764 56789999999999999999998888664443322222111 1111111 111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
...-.+.|.++++.|+-.+|++|||++-+|
T Consensus 240 -------k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 -------KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -------CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 122356688999999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=221.82 Aligned_cols=198 Identities=33% Similarity=0.504 Sum_probs=172.1
Q ss_pred CCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
|.+.+.||.|++|+||++.... ++.+++|.+...... ..+.+.+|+..+++++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999998764 889999999865544 56788899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 132 NNSLSQTLLGEEKNRAK-FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~-l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+++|.+++.. ... +++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999842 233 88999999999999999999999 999999999999999999999999999887654321
Q ss_pred cccccccCCcCccCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 042383 211 HISTRVAGTLGYLAPDYA-VSGHLNPKSDIYSFGVLLLQIVTGQAAVHF 258 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~~ll~g~~pf~~ 258 (353)
.......++..|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335577889999988 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=227.58 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=196.5
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCce
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 123 (353)
...+.|.++.+||+|+|++||++... .++.||+|.+... .....+..|++.|..+ .+.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567999999999999999999743 4678999988643 3445688999999999 599999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLS 202 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~ 202 (353)
++|+||++.....+++ ..++...+..+++.++.||.++|.+ ||+||||||.|++.+. .+.-.|+|||++
T Consensus 111 ~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 9999999998888777 3467899999999999999999999 9999999999999975 567899999999
Q ss_pred ccCCCC-------------Ccc------------------------------ccccccCCcCccCccccccC-CCCcccc
Q 042383 203 KLFPED-------------ITH------------------------------ISTRVAGTLGYLAPDYAVSG-HLNPKSD 238 (353)
Q Consensus 203 ~~~~~~-------------~~~------------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~D 238 (353)
...+.. ... ......||++|+|||++... .-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 722100 000 01124699999999998765 4688999
Q ss_pred chhHHHHHHHHHhCCCCCCCCcccchhhH--HH--------HHHhhccc------ccc----------ccc-cCccc---
Q 042383 239 IYSFGVLLLQIVTGQAAVHFDKELGEYYL--VE--------KAWEMHNT------DKL----------QHL-VDPML--- 288 (353)
Q Consensus 239 vwslG~il~~ll~g~~pf~~~~~~~~~~~--~~--------~~~~~~~~------~~~----------~~~-~~~~~--- 288 (353)
|||.|+|+..++++..||....++..... +. +....... .++ ..+ .....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999976654332211 00 11111100 000 000 00000
Q ss_pred -----CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 -----CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+..+++++.+|++.||.+|.|++|.|+
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 01122223447889999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=214.97 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=198.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeCC--CcEEEEEEeeccChhcHHHHHHHHHHHHhcC----CCCceeeeeeE-ecCCceEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQD--GTVVAVKVLSVESKQGEKEFMSEVASMANIC----HENLVKLHGGC-IEGPCRII 125 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~l 125 (353)
+|.+.+.||+|+||.||.|.... ...+|+|+...........+..|..++..+. .+++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999764 3579999877554333336778888888886 25899999988 57888999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-----CCeEEeecc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-----FNPKISDFG 200 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-----~~~kl~Dfg 200 (353)
||+.+ |.+|.++..... .+.++...+..++.|++.+|++||+. |++||||||+|+.+... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 669999774322 57899999999999999999999999 99999999999999754 469999999
Q ss_pred CCc--cCCCCCcc------c-cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 201 LSK--LFPEDITH------I-STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 201 ~~~--~~~~~~~~------~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
+++ .+...... . .....||..|+++..+.+...+++.|+||++.++.+++.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33221111 1 12355999999999999999999999999999999999999999655433222111111
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
..... ... .....+..+.++...+-..+...+|....+...|++.....
T Consensus 253 ~~~~~-------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLL-------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhc-------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11000 000 22223455666666666789999999999999987765543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=252.27 Aligned_cols=194 Identities=17% Similarity=0.169 Sum_probs=136.3
Q ss_pred cCC-CCceeeeeeE-------ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042383 105 ICH-ENLVKLHGGC-------IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176 (353)
Q Consensus 105 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i 176 (353)
+.| +||+++++.| .+....+.++|++ +++|.+++.. ....+++..++.++.||+.||.|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 344 5777777776 2344677889988 5599999932 245699999999999999999999999 99
Q ss_pred EEcCCCCCCeEECCCCC-------------------eEEeeccCCccCCCCCc---------------cccccccCCcCc
Q 042383 177 VHRDIKPSNILLDQNFN-------------------PKISDFGLSKLFPEDIT---------------HISTRVAGTLGY 222 (353)
Q Consensus 177 ~H~dlk~~Nil~~~~~~-------------------~kl~Dfg~~~~~~~~~~---------------~~~~~~~g~~~y 222 (353)
+||||||+||||+..+. +|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555543211000 000113578889
Q ss_pred cCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHH
Q 042383 223 LAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLK 302 (353)
Q Consensus 223 ~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 302 (353)
+|||++.+..++.++|||||||++|||++|..|+..... ........ .+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~--------~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR--------VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh--------hcChh-----hhhcCHHHHH
Confidence 999999999999999999999999999999888652211 00000000 00000 0111234567
Q ss_pred HHhhccCCCCCCCCCHHHHHH
Q 042383 303 VGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 303 li~~cl~~~p~~RPt~~evl~ 323 (353)
++.+||+.+|.+|||+.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=199.94 Aligned_cols=167 Identities=19% Similarity=0.180 Sum_probs=125.0
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI 212 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 212 (353)
|||.+++.. .+.++++..++.++.||+.||.|||+. + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 588888832 245799999999999999999999998 6 999999999999999 99988654321
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (353)
..|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ........... .. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~------~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL--EILLNGMPADD------PR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH--HHHHHHhccCC------cc-cccc
Confidence 257899999999999999999999999999999999999996543322111 11101000000 00 0001
Q ss_pred ChHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 293 SGNEAV--RFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 293 ~~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...... .+.+++.+||+.+|++|||+.++++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 112222 689999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=205.26 Aligned_cols=167 Identities=19% Similarity=0.218 Sum_probs=130.5
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeC--CCcEEEEEEeecc-----ChhcHHHHHHHHHHHHhcCCCCcee-eeeeEe
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQ--DGTVVAVKVLSVE-----SKQGEKEFMSEVASMANICHENLVK-LHGGCI 118 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~ 118 (353)
.....++|.+.+.||+|+||+||+|.+. +++.+|+|++... .......+.+|+.++++++|+|+++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3456788999999999999999999865 5777899986532 1223466899999999999999985 443
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCeEECCCCCeEEe
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI-KPSNILLDQNFNPKIS 197 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl-k~~Nil~~~~~~~kl~ 197 (353)
....++||||++|++|.... .. . ...++.|++.||.|||+. ||+|||| ||+||+++.++.++|+
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~-----~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLAR-----PH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhC-----cc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence 24579999999999996321 11 1 146788999999999999 9999999 9999999999999999
Q ss_pred eccCCccCCCCCccc-------cccccCCcCccCccccccC
Q 042383 198 DFGLSKLFPEDITHI-------STRVAGTLGYLAPDYAVSG 231 (353)
Q Consensus 198 Dfg~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~ 231 (353)
|||+++.+....... .....+++.|.|||.+...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998765432111 1345678889999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=192.30 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=200.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.-.|+++++||+|.||.++.|+.- ++++||||.-.. ++...++..|...++.| ..++|..++-+-.++.+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 457999999999999999999843 689999997553 33445678899999888 58999999998899989999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-----CCeEEeeccCCc
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-----FNPKISDFGLSK 203 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-----~~~kl~Dfg~~~ 203 (353)
.+ |-||.|++ .-....|+.+.+..++.|++.-++++|++ .+|.|||||+|+||... ..+.++|||+|+
T Consensus 105 LL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99 56888876 23467899999999999999999999999 99999999999999643 348899999999
Q ss_pred cCCCCCccc------cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 204 LFPEDITHI------STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 204 ~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.+.+..+.. .....||..||+--.+.+.+-+.+.|+-|||-++...+-|..||.+-.....-...+++......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 876543332 22356999999999999999999999999999999999999999877655444444444443333
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+..+ |..+ ++++.+-+.-.-..+-.+-|..+-+...+.+.
T Consensus 258 T~i~~L-----c~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 258 TPIEVL-----CEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred CCHHHH-----HhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 333322 2222 34455544444456677778877765554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=182.58 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=199.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEE-eCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 127 (353)
....|.++++||+|+||.+|.|. ..+|..||+|+-+.... ...+..|..+...++ ...|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46789999999999999999998 45799999998764332 245677888998886 568888888888999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC---CCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN---FNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~~~ 204 (353)
+.+ |-||.+.+. -....++...++-++-|++.-++|+|.. +++||||||+|+|..-+ ..+.|+|||+++.
T Consensus 91 dLL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 999 668988873 2356689999999999999999999999 99999999999999643 4589999999987
Q ss_pred CCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 205 FPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 205 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
+-+..+. ......||..|++--.+.+.+-+.+.|+-|+|.++..+.-|..||.+-......+..+++.+...+-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 7543222 2233578999999888888888999999999999999999999999877666666666655443332
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 325 (353)
.+ +.+|..++.+ +.-.+.-|-..--++-|...-+.+.+
T Consensus 244 ~i-----e~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 244 PI-----EVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CH-----HHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 22 2344444443 55555666666666667665554443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=221.94 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=191.0
Q ss_pred CCHHHHHHhcc-CCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC-hhcHHHHHHHHHH--HHhcCCCCceeeeeeE
Q 042383 42 FSYNELKSATN-GFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES-KQGEKEFMSEVAS--MANICHENLVKLHGGC 117 (353)
Q Consensus 42 ~~~~~~~~~~~-~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~ 117 (353)
...+.+..... ++...+.||++.|=.|.+|++..|. |++|++-... .-..+.+.++++- ....++||.+++..+.
T Consensus 12 ~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~ 90 (1431)
T KOG1240|consen 12 SPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL 90 (1431)
T ss_pred chHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH
Confidence 34444444333 6778899999999999999998887 8999986543 2233344433333 4455899999999998
Q ss_pred ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEe
Q 042383 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 118 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
+.+...|+|-+|+.. +|+|.+ ..+..+...+.+.++.|++.||..+|.. ||+|||||.+||||+.-.-+.|+
T Consensus 91 ~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 91 VTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhh
Confidence 888899999999966 899998 5566678889999999999999999999 99999999999999999999999
Q ss_pred eccCCccC--CCCC----ccccccccCCcCccCccccccC----------C-CCccccchhHHHHHHHHHh-CCCCCCCC
Q 042383 198 DFGLSKLF--PEDI----THISTRVAGTLGYLAPDYAVSG----------H-LNPKSDIYSFGVLLLQIVT-GQAAVHFD 259 (353)
Q Consensus 198 Dfg~~~~~--~~~~----~~~~~~~~g~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~ll~-g~~pf~~~ 259 (353)
||-.-+.. +++. .....+.....+|.|||.+... . .+++.||||+||++.||++ |.+||...
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 99765422 2221 2222334445689999977542 1 5789999999999999999 57777521
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. +. .++..........+.++ . ...++.++..|++.||.+|.++++.|+.-.+..
T Consensus 243 Q------L~--aYr~~~~~~~e~~Le~I-e-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 243 Q------LL--AYRSGNADDPEQLLEKI-E-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred H------HH--hHhccCccCHHHHHHhC-c-------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1 11 11111111111112111 1 225789999999999999999999998865543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=219.38 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=188.0
Q ss_pred CCCCeeeeeCceEEEEEEeC-CCcEEEEEEeec-----cChhc-HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSV-----ESKQG-EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-----~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.....+|.|.+|.|+.+... ..+..+.|.... ..... ...+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45778999999977777543 233334443321 11111 122566777778889999998888777777676679
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||++ +|...+ .....+....+..++.|++.|+.|+|+. |+.|||+|++|+++..+|.+|++|||.+..+..
T Consensus 401 E~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998 3445788999999999999999999999 999999999999999999999999999976654
Q ss_pred CCc---cccccccCCcCccCccccccCCCCc-cccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 208 DIT---HISTRVAGTLGYLAPDYAVSGHLNP-KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 208 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
... .......|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+.... . .......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~---~~~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----T---NNYSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----h---hcccccc
Confidence 333 3445678999999999999999986 68999999999999999999986654333210 0 0000000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....-........+.....++.++|+++|.+|.|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000111223344667888999999999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-23 Score=189.09 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=197.2
Q ss_pred CCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh---cHHHHHHHHHHHHhcCCC-CceeeeeeEecCCceEEEEEc
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ---GEKEFMSEVASMANICHE-NLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 129 (353)
|.+.+.||.|+||.||.+... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999977 67899988755332 367788999999999888 799999999877778999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~ 208 (353)
+.++++.+.+...... ..++......++.|++.++.++|+. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666221111 3789999999999999999999999 999999999999999988 7999999999855443
Q ss_pred Ccc-----ccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCccc-chhhHHHHHHhhccccc
Q 042383 209 ITH-----ISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL-GEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 209 ~~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 279 (353)
... ......|+..|+|||.+.+ ...+...|+|++|++++++++|..||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 322 2355789999999999987 57889999999999999999999997655431 011111111111100
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002224567888999999999999999887764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-26 Score=189.72 Aligned_cols=246 Identities=20% Similarity=0.349 Sum_probs=192.8
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
.+..+|.+...|..|+|++. |..++.|++.... ....+.|.+|.-.|+-+.||||+++++.|....+..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34567899999999999998 4457778887553 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE-EcCCCCCCeEECCCCCeEEe--eccCCccCCCCC
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV-HRDIKPSNILLDQNFNPKIS--DFGLSKLFPEDI 209 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~-H~dlk~~Nil~~~~~~~kl~--Dfg~~~~~~~~~ 209 (353)
|||+..+. +...-..+..++.+++.+++.|+.|||+.. .++ --.|....++||++.+.++. |--++..
T Consensus 272 gslynvlh--e~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 272 GSLYNVLH--EQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred hHHHHHHh--cCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 99999994 334455678899999999999999999973 333 34588899999998887763 3222211
Q ss_pred ccccccccCCcCccCccccccCCCC---ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLN---PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.....-.|.|++||.+..++-+ .++|+|||++++|||-|...||..-.+.+-. .++.-+
T Consensus 343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkiale 404 (448)
T KOG0195|consen 343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALE 404 (448)
T ss_pred ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhc
Confidence 1123346889999998876543 5799999999999999999999865543221 223334
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.++...++..+..+.+|+.-|+.-||.+||.+..|+-.|+..
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 555667777788899999999999999999999998887754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=180.55 Aligned_cols=171 Identities=16% Similarity=0.179 Sum_probs=133.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHH---------HHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKE---------FMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
..++|++.+.||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 368899999999999999999766 46679999997543332222 57899999999999999998886643
Q ss_pred --------CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 121 --------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 121 --------~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
...+++|||++|.+|.+.. .+++ ....+++.++..+|+. |++|||++|.||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 3578999999999998764 1222 2456999999999999 999999999999999888
Q ss_pred CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHH
Q 042383 193 NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIV 250 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (353)
++|+|||........... . .+.....++.++|+|+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322111 0 1234445667999999999977654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=173.05 Aligned_cols=140 Identities=15% Similarity=0.202 Sum_probs=109.2
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh--c------------------------HHHHHHHHHHHHhcCCCCc
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ--G------------------------EKEFMSEVASMANICHENL 110 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 110 (353)
.+.||+|++|.||+|...+|+.||+|+++..... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5679999999999999878999999999754211 0 1122459999999987776
Q ss_pred eeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcCCCCCCeEEC
Q 042383 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI-HEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~L-H~~~~~~i~H~dlk~~Nil~~ 189 (353)
.....+.. ...++||||++|+++.... ....++++..+..++.|++.+|.++ |+. +++||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPR----LKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchh----hhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43332222 2248999999987776543 1335789999999999999999999 688 999999999999998
Q ss_pred CCCCeEEeeccCCccCC
Q 042383 190 QNFNPKISDFGLSKLFP 206 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~~ 206 (353)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=177.55 Aligned_cols=233 Identities=17% Similarity=0.209 Sum_probs=148.4
Q ss_pred CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCC----------CCceeeeeeE--
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICH----------ENLVKLHGGC-- 117 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~-- 117 (353)
....+.||.|+++.||.+++. +|+.+|+|++..... ...+.+.+|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999976 599999999875432 233556666555444321 1222222211
Q ss_pred -------ecC---C-----ceEEEEEcCCCCChhhhhhhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 042383 118 -------IEG---P-----CRIIVYDYMQNNSLSQTLLGEE---KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHR 179 (353)
Q Consensus 118 -------~~~---~-----~~~lv~e~~~~~sL~~~l~~~~---~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~ 179 (353)
... . +.+++|+-+.+ +|.+.+..-. .....+.......+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 34678888854 8887763211 1122344555667779999999999999 99999
Q ss_pred CCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccC--------CCCccccchhHHHHHHHHHh
Q 042383 180 DIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG--------HLNPKSDIYSFGVLLLQIVT 251 (353)
Q Consensus 180 dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~DvwslG~il~~ll~ 251 (353)
||+|+|++++.+|.+.|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999887755432111 3345779999966442 46789999999999999999
Q ss_pred CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042383 252 GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLR 315 (353)
Q Consensus 252 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 315 (353)
|..||........... .+ .... +.++.+..||..+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986543211100 11 2233 567789999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=167.15 Aligned_cols=142 Identities=15% Similarity=0.212 Sum_probs=112.0
Q ss_pred CCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh---------------------c-----HHHHHHHHHHHHhcCCCC
Q 042383 56 SSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ---------------------G-----EKEFMSEVASMANICHEN 109 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~ 109 (353)
+.+.||+|++|.||+|...+|+.||+|+++..... . ......|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999778999999998854211 0 122357889999999998
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEE
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~ 188 (353)
+.....+... ..++||||++|+++..... ....++......++.|++.++.++|+ . |++|+||||+||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 7544433332 2489999999886544321 23467888999999999999999999 8 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCC
Q 042383 189 DQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~ 207 (353)
+ ++.++|+|||++...+.
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 8 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=162.36 Aligned_cols=188 Identities=15% Similarity=0.074 Sum_probs=141.5
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc----HHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEc
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG----EKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.+...|++|+||+|+.+.. .+.+++.+.+....... ...+.+|+++|++++ ++++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 57778877776443311 135789999999995 5789999885 347999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI-KPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
+.|.+|.+.+. . ....++.|++.+|.++|+. |++|+|| ||+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99998865431 1 1134778999999999999 9999999 799999999999999999999865543
Q ss_pred Ccc----c--------cccccCCcCccCccccccC-CCC-ccccchhHHHHHHHHHhCCCCCCCCcc
Q 042383 209 ITH----I--------STRVAGTLGYLAPDYAVSG-HLN-PKSDIYSFGVLLLQIVTGQAAVHFDKE 261 (353)
Q Consensus 209 ~~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~DvwslG~il~~ll~g~~pf~~~~~ 261 (353)
... . ......++.|++|+...-- ..+ ...+.++.|+.+|.++|+..++..+.+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 321 0 1113357778888754322 233 567899999999999999998875554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=194.09 Aligned_cols=198 Identities=20% Similarity=0.250 Sum_probs=159.9
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC---CCCceeeeeeEecCCceE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC---HENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 124 (353)
....+.|.|.+.||+|++|+||+|...+|+.||+|+-+..+... |+=-.+++.+|+ -+.|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34457899999999999999999998889999999877554432 111123333443 456666777667777889
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-------CCCCeEEe
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-------QNFNPKIS 197 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-------~~~~~kl~ 197 (353)
+|+||.+.|||.+++ +..+.+++..+..+..|++..+.+||.. +|||+||||+|+++. .+..++|+
T Consensus 771 lv~ey~~~Gtlld~~----N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLI----NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhh----ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999999 5778899999999999999999999999 999999999999993 34569999
Q ss_pred eccCCccCCC-CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 042383 198 DFGLSKLFPE-DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAA 255 (353)
Q Consensus 198 Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (353)
|||.+..+.- .........++|-.+--+|...|..|+...|.|.++.+++.|+.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999864421 112233446788899999999999999999999999999999999744
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=191.05 Aligned_cols=233 Identities=23% Similarity=0.263 Sum_probs=183.9
Q ss_pred eeeeeCceEEEEEEe----CCCcEEEEEEeeccChh--cHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcCC
Q 042383 59 KVGEGGFGSVYKGKL----QDGTVVAVKVLSVESKQ--GEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|.|++|.|+++.. ..|.-+|+|++...... .......|-.++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 24677899987744211 1114456777888886 9999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
||.|...+ .....+.+.....+...++.|+.++|+. +++|+|+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99998887 5566788899999999999999999999 999999999999999999999999999986543322
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
.+||..|||||++. ....++|.||||++.+||+||..||.. +. ...++. .+..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~---------------~~~Il~--~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT---------------MKRILK--AELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH---------------HHHHhh--hccC
Confidence 27899999999987 678899999999999999999999985 00 011111 1123
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCH--HHHHHHhc
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRM--STVIEMIN 326 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl~~L~ 326 (353)
.+........+++.+++..+|..|.-. ..+.+..+
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 455556667788888999999999755 45554444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=166.08 Aligned_cols=197 Identities=19% Similarity=0.217 Sum_probs=142.2
Q ss_pred CCCCceeeeeeEec---------------------------CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHH
Q 042383 106 CHENLVKLHGGCIE---------------------------GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158 (353)
Q Consensus 106 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~ 158 (353)
+|||||++.++|.+ +..+|+||..++. +|.+++. ....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 49999999987763 2367899998865 8999983 2345666777899
Q ss_pred HHHHHHHHHHHhcCCCCeEEcCCCCCCeEE--CCC--CCeEEeeccCCccCCCCCc-----cccccccCCcCccCccccc
Q 042383 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILL--DQN--FNPKISDFGLSKLFPEDIT-----HISTRVAGTLGYLAPDYAV 229 (353)
Q Consensus 159 ~qi~~al~~LH~~~~~~i~H~dlk~~Nil~--~~~--~~~kl~Dfg~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~ 229 (353)
.|+++|+.|||.+ |+.|||+|.+|||+ +++ ..++++|||++.-.+.+.- ...-...|.-.-+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 333 3478999998864433211 1112245677789999876
Q ss_pred cCCC------CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHH
Q 042383 230 SGHL------NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKV 303 (353)
Q Consensus 230 ~~~~------~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 303 (353)
..+- -.++|.|+.|.+.||+++...||....+.-.. ... ..+..-+..+..++..+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-----------~r~----Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-----------TRT----YQESQLPALPSRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-----------hhh----hhhhhCCCCcccCChHHHHH
Confidence 4321 24799999999999999999999863321100 000 11111134455566778999
Q ss_pred HhhccCCCCCCCCCHHHHHHHhc
Q 042383 304 GLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 304 i~~cl~~~p~~RPt~~evl~~L~ 326 (353)
+...|+.||++|++.+-....|+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999999876665553
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=156.67 Aligned_cols=134 Identities=18% Similarity=0.281 Sum_probs=105.1
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-----CCCCceeeeeeEecCC---ceE-EEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-----CHENLVKLHGGCIEGP---CRI-IVY 127 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-lv~ 127 (353)
.+.||+|++|.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++++++++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 56899999999995 3234444 79988765555567889999999999 5799999999999874 333 789
Q ss_pred Ec--CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEcCCCCCCeEECC----CCCeEEeecc
Q 042383 128 DY--MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGL-AYIHEEIKPSIVHRDIKPSNILLDQ----NFNPKISDFG 200 (353)
Q Consensus 128 e~--~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al-~~LH~~~~~~i~H~dlk~~Nil~~~----~~~~kl~Dfg 200 (353)
|| +.+++|.+++.. ..+++. ..++.|++.++ +|||++ +|+||||||+||+++. ++.++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 557999999932 235555 35678888777 999999 9999999999999964 3479999954
Q ss_pred CC
Q 042383 201 LS 202 (353)
Q Consensus 201 ~~ 202 (353)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9e-21 Score=173.45 Aligned_cols=217 Identities=24% Similarity=0.383 Sum_probs=162.6
Q ss_pred HHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EEcC
Q 042383 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI-VHRD 180 (353)
Q Consensus 102 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i-~H~d 180 (353)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.|.+.. ....+++.....+.++|+.||.|||+. .+ .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999943 456789999999999999999999987 44 9999
Q ss_pred CCCCCeEECCCCCeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCC-------CCccccchhHHHHHHHHHhC
Q 042383 181 IKPSNILLDQNFNPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGH-------LNPKSDIYSFGVLLLQIVTG 252 (353)
Q Consensus 181 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslG~il~~ll~g 252 (353)
++..|++++....+|++|||+........ ........-..-|.|||.+.+.. .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987764310 01111122334689999887641 46679999999999999999
Q ss_pred CCCCCCCcccch-hhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 253 QAAVHFDKELGE-YYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 253 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
+.||........ ...+..... . ....+.+.+... .+..+.+..++.+||.-+|.+||+++.|-..+..+...
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~----~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-G----GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cCccccccccCChHHHHHHHHh-c----CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 999986443222 222222211 0 011111111100 03344788999999999999999999998888776653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=158.61 Aligned_cols=143 Identities=16% Similarity=0.126 Sum_probs=112.0
Q ss_pred cCCCCCCeeeeeCceEEEEEE--eCCCcEEEEEEeeccChh------------------------cHHHHHHHHHHHHhc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGK--LQDGTVVAVKVLSVESKQ------------------------GEKEFMSEVASMANI 105 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 105 (353)
..|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 348899999999999999998 457999999998743210 012356799999999
Q ss_pred CCCC--ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEcCCC
Q 042383 106 CHEN--LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS-IVHRDIK 182 (353)
Q Consensus 106 ~h~~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~-i~H~dlk 182 (353)
.+.. +.++++. ...++||||++|.+|.... .....+....+..++.|++.++.+||+. + ++|+|||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 7532 3444432 2358999999998887654 2234566677789999999999999999 9 9999999
Q ss_pred CCCeEECCCCCeEEeeccCCccCC
Q 042383 183 PSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 183 ~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 7899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=149.39 Aligned_cols=134 Identities=19% Similarity=0.280 Sum_probs=111.6
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChh--------cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ--------GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.||+|++|.||+|.. .|..+++|+....... ....+.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 4677999976533211 124567899999999999987777777777788999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
++|++|.+.+.. . .. ....++.+++.+|.++|+. +++|+|++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998832 1 11 7788999999999999999 999999999999999 78999999998874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-20 Score=177.22 Aligned_cols=215 Identities=20% Similarity=0.272 Sum_probs=148.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
...+|+.++.|..|++|.||.++++ +.+++|+|+ +..+- +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-----------------
Confidence 4578999999999999999999877 477888853 32211 1111 23333344444
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+-...+ .+-++++... +.|++|||+. +|+|||+||+|.+|+.-|++|++|||+.+.....
T Consensus 136 ----gDc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 2222333 2334454433 7899999999 9999999999999999999999999988644211
Q ss_pred C---------c----c-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhh
Q 042383 209 I---------T----H-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 209 ~---------~----~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
. . . .....+|||.|.|||++.-..|+...|.|++|+|+|+.+-|..||..+...+.+.......
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-- 274 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-- 274 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh--
Confidence 0 0 1 1123589999999999999999999999999999999999999998876544332111110
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
..+.+ -....+.+..+++.++|+.+|..|--...-+
T Consensus 275 ------i~wpE------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 275 ------IEWPE------EDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred ------ccccc------cCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 01111 1222345677888899999999995443333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-18 Score=145.41 Aligned_cols=139 Identities=20% Similarity=0.199 Sum_probs=109.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh----------------------cHHHHHHHHHHHHhcCCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ----------------------GEKEFMSEVASMANICHE 108 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~ 108 (353)
..-|.+.+.||+|+||.||++...+|+.||+|+++..... .......|+.++..+.++
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3348889999999999999999888999999987643210 112356788889888777
Q ss_pred C--ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 109 N--LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 109 ~--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
+ +...++ ....++||||++|++|..... ......++.+++.++.++|+. +++|+||+|+||
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 4 444443 245689999999998876541 024567889999999999998 999999999999
Q ss_pred EECCCCCeEEeeccCCccCC
Q 042383 187 LLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~ 206 (353)
+++.++.++|+|||.+....
T Consensus 157 ll~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCCcEEEEECCccccCC
Confidence 99999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=144.11 Aligned_cols=130 Identities=21% Similarity=0.293 Sum_probs=104.7
Q ss_pred eeeeeCceEEEEEEeCCCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--------QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.||+|++|+||++... +..+++|+...... .....+.+|+.++..+.|+++.....++.+....++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999854 67899998653211 11255678999999998887655555555666779999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+|++|.+.+... .. .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887321 11 7899999999999999 999999999999999 78999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-20 Score=165.51 Aligned_cols=174 Identities=24% Similarity=0.325 Sum_probs=129.7
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
+++|.|++|...+|.+++.+. ......+....+.++.|++.|+.| + +.+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999543 234456778889999999999999 6 999999999999999999999999999
Q ss_pred CccCCCCC-----ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhc
Q 042383 202 SKLFPEDI-----THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 202 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
........ ....+...||..|++||.+.+..|+.++|||+||++|+||+. -..+|... .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~----- 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------A----- 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------H-----
Confidence 98776544 334556789999999999999999999999999999999997 33332200 0
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 321 (353)
....+-+..+.+.+..+ .+.=..|+.+++...|.+||++.++
T Consensus 468 ---t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 ---TLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ---hhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 00111111111111111 1123467779999999999955444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=161.78 Aligned_cols=138 Identities=18% Similarity=0.250 Sum_probs=111.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc---C-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE---S-----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
...|...+.||+|+||+||++.+.... +++|+.... . ....+.+.+|+.++..++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445677899999999999999876443 444432211 1 1123567889999999999999887777777777
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999998872 3467899999999999999 99999999999999 6779999999998
Q ss_pred ccC
Q 042383 203 KLF 205 (353)
Q Consensus 203 ~~~ 205 (353)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=135.53 Aligned_cols=137 Identities=19% Similarity=0.235 Sum_probs=98.3
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh--cHHH----------------------HHHHHHHHHhcCCCC--c
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ--GEKE----------------------FMSEVASMANICHEN--L 110 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--i 110 (353)
.+.||+|+||+||+|...+++.||+|++...... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5679999999999999888999999998743211 1111 134566666664332 4
Q ss_pred eeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEEC
Q 042383 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~ 189 (353)
.+.+++ ...++||||++++++....... . ... ..+..++.+++.++.++|. . +++|+||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~-~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---V-RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh---h-hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444432 2358999999996543221110 0 011 5678899999999999999 7 999999999999999
Q ss_pred CCCCeEEeeccCCccCC
Q 042383 190 QNFNPKISDFGLSKLFP 206 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~~ 206 (353)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.6e-19 Score=168.44 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=189.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC--CcEEEEEEeeccC--hhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD--GTVVAVKVLSVES--KQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 125 (353)
...|.+.+.||+|+++.|-...... ...+|.|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567788889999999998886532 4456666665443 223344555777777775 9999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH-EEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSK 203 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~ 203 (353)
++++..|+++.+.+. .......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+ .+++.|||++.
T Consensus 99 ~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999988873 122225677788899999999999999 87 999999999999999999 99999999998
Q ss_pred cCCC--CCccccccccC-CcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 204 LFPE--DITHISTRVAG-TLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 204 ~~~~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
.+.. +.........| ++.|.|||...+. ...+..|+||+|+++..+++|..|+.........+
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------------- 240 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------------- 240 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------------
Confidence 7765 33333444667 9999999998884 55789999999999999999999998665432111
Q ss_pred cccccCc--ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042383 280 LQHLVDP--MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321 (353)
Q Consensus 280 ~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 321 (353)
..+... ...............+++.+++..+|..|.+.+++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 241 -SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred -eeecccccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 111111 00111112223446677778998999999998887
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-16 Score=126.67 Aligned_cols=136 Identities=21% Similarity=0.212 Sum_probs=113.4
Q ss_pred CCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC--CCceeeeeeEecCCceEEEEEcCCCC
Q 042383 56 SSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH--ENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+..+..+.+ .++++++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999864 6799998864433 4567889999999976 58899998888888899999999987
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
++... +......++.+++.++..+|.....+++|+|++|+||++++.+.++++|||.+...
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 66533 45666778999999999999863347999999999999999899999999988743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.5e-16 Score=134.92 Aligned_cols=135 Identities=19% Similarity=0.209 Sum_probs=103.3
Q ss_pred Ceee-eeCceEEEEEEeCCCcEEEEEEeeccC-------------hhcHHHHHHHHHHHHhcCCCCc--eeeeeeEecCC
Q 042383 58 NKVG-EGGFGSVYKGKLQDGTVVAVKVLSVES-------------KQGEKEFMSEVASMANICHENL--VKLHGGCIEGP 121 (353)
Q Consensus 58 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~ 121 (353)
..|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..+.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999999876 6678998875211 1223567889999999988775 66666543322
Q ss_pred -c---eEEEEEcCCC-CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 122 -C---RIIVYDYMQN-NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 122 -~---~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
. .++|+|+++| .+|.+++. ..++++. .+.+|+.+|.+||+. ||+|+||||+|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQ-----EAPLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 2599999997 68888872 2345544 357899999999999 9999999999999999889999
Q ss_pred eeccCCccC
Q 042383 197 SDFGLSKLF 205 (353)
Q Consensus 197 ~Dfg~~~~~ 205 (353)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-15 Score=130.45 Aligned_cols=205 Identities=20% Similarity=0.252 Sum_probs=144.3
Q ss_pred HHHHHHhcCCCCceeeeeeEecCC-----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 042383 98 EVASMANICHENLVKLHGGCIEGP-----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172 (353)
Q Consensus 98 e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 172 (353)
-+.-|-.+-|.|+++++.++.+.+ ...++.||+..|++..+|......+..+......+|+-||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 344555667999999999887654 46789999999999999988888888999999999999999999999985
Q ss_pred CCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC----CccccccccCCcCccCccccccCCCCccccchhHHHHHHH
Q 042383 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED----ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQ 248 (353)
Q Consensus 173 ~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 248 (353)
...++|+++..+.|++..+|-+|++- +........ .........+-++|.+||.-.....+-++|||+||+...+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 67899999999999999998888742 111111000 0011112345788999998776777889999999999999
Q ss_pred HHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 249 IVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 249 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
|..|..--..... .....+.+.. .+..+-+. .-+.++..|++..|..||++++++.
T Consensus 275 mailEiq~tnseS--~~~~ee~ia~-----~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 275 MAILEIQSTNSES--KVEVEENIAN-----VIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHheeccCCCcc--eeehhhhhhh-----heeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 9987754322211 0000000000 00101111 1124566899999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-15 Score=138.53 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=183.3
Q ss_pred ccCCCCCCeeee--eCceEEEEEEe--C-CCcEEEEEEee--ccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGE--GGFGSVYKGKL--Q-DGTVVAVKVLS--VESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
...+.+.+.+|. |.+|.||.+.. . ++..+|+|.-+ .........-.+|+.....+ .|++.++.+..++..+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 456778899999 99999999986 3 57788988733 22223334445677777777 49999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEe
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR----GLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKIS 197 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~----al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~ 197 (353)
.++-.|.+. .+|..+.. .....++...++..+.+... |+.++|+. +++|.|+||+||+..++ ...+++
T Consensus 193 lfiqtE~~~-~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeecccc-chhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999995 58888773 23344788899999999999 99999999 99999999999999998 889999
Q ss_pred eccCCccCCCCCc----cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 198 DFGLSKLFPEDIT----HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 198 Dfg~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
|||+...+....- .......|...|++||. ..+.++.++|+|++|.++.+-.+|..+......
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------------ 332 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKN------------ 332 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCC------------
Confidence 9999987764431 11222357778999994 556788999999999999999998877653311
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
..+..+-...+..++-..-..++...+.++++.+|..|++.+.+.
T Consensus 333 ----~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 333 ----SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ----CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 001111111111122222233455588899999999999988774
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-14 Score=132.17 Aligned_cols=166 Identities=14% Similarity=0.162 Sum_probs=128.7
Q ss_pred eCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHH
Q 042383 73 LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWT 152 (353)
Q Consensus 73 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~ 152 (353)
..++.+|.++..+..+........+-+..|+.++||||+++++.++..+..|+|.|.+. .|..++. .+...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk-------~l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK-------ELGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH-------HhHHH
Confidence 34678899888886666445667788899999999999999999999999999999985 3666662 12367
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCC
Q 042383 153 ARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232 (353)
Q Consensus 153 ~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 232 (353)
.+...+.||+.||.+||+.| +++|++|+.+.|+|+..|+.||++|.++.....-.. .......--.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 77888999999999999764 999999999999999999999999988765432211 111122223467777654333
Q ss_pred CCccccchhHHHHHHHHHhC
Q 042383 233 LNPKSDIYSFGVLLLQIVTG 252 (353)
Q Consensus 233 ~~~~~DvwslG~il~~ll~g 252 (353)
-..|.|.|||++++++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-14 Score=131.89 Aligned_cols=141 Identities=21% Similarity=0.295 Sum_probs=97.4
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcH----------------------------------------HHHH
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGE----------------------------------------KEFM 96 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 96 (353)
.+.||+|++|.||+|+.++|+.||||+.+....... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999999864311100 0133
Q ss_pred HHHHHHHhcC----CCCceeeeeeE-ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 042383 97 SEVASMANIC----HENLVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR-GLAYIHE 170 (353)
Q Consensus 97 ~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~-al~~LH~ 170 (353)
+|...+.++. +.+-+.+-.++ ......++||||++|++|.+..... .... ....++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 4554444442 22223332222 2244578999999999998876321 1112 23345566655 4678898
Q ss_pred cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 171 ~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
. |++|+|++|.||+++.++.++++|||++....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 99999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=110.68 Aligned_cols=131 Identities=15% Similarity=0.124 Sum_probs=95.5
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCce-eeeeeEecCCceEEEEEcCCCCCh
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV-KLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
.+.|+.|.++.||++... +..+++|+...... ....+..|+.+++.+.+.+++ +++... ....++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999876 67899998764322 223457889999988655544 444433 2345799999999877
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI--KPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
.+.- ......+.+++.+|..||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5431 011345678999999999881 12259999999999998 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-14 Score=132.62 Aligned_cols=145 Identities=18% Similarity=0.228 Sum_probs=93.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChh----------------------------------cHHH--
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQ----------------------------------GEKE-- 94 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-- 94 (353)
..|.. +.||+|++|.||+|+.++ |+.||||+.+..-.. ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999886 999999998743110 0111
Q ss_pred ----HHHHHHHHHhcC----CCCceeeeeeEec-CCceEEEEEcCCCCChhhhhhhccc--cCCCCCHHHHHHHHHHHHH
Q 042383 95 ----FMSEVASMANIC----HENLVKLHGGCIE-GPCRIIVYDYMQNNSLSQTLLGEEK--NRAKFSWTARREIALGIAR 163 (353)
Q Consensus 95 ----~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~ 163 (353)
+.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.+.-.-... ....+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 233443333332 3333333333322 4456799999999999774211100 111244444445555554
Q ss_pred HHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEeeccCCccCCC
Q 042383 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISDFGLSKLFPE 207 (353)
Q Consensus 164 al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~ 207 (353)
.. |++|+|++|.||+++.++ .++++|||++...+.
T Consensus 278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35 999999999999999887 999999999876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-12 Score=106.94 Aligned_cols=138 Identities=14% Similarity=0.123 Sum_probs=99.7
Q ss_pred CCeeeeeCceEEEEEEeCC-------CcEEEEEEeeccC----------------------hhcHHHH----HHHHHHHH
Q 042383 57 SNKVGEGGFGSVYKGKLQD-------GTVVAVKVLSVES----------------------KQGEKEF----MSEVASMA 103 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~ 103 (353)
...||.|.-+.||.|...+ +..+|||+.+... ......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999997543 4789999876210 0011222 37999999
Q ss_pred hcCC--CCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcC
Q 042383 104 NICH--ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI-HEEIKPSIVHRD 180 (353)
Q Consensus 104 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~L-H~~~~~~i~H~d 180 (353)
++.. -++...+++ ...++||||+.+..+..-.. ....++......+..+++.+|..| |+. +++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 9853 455666654 45789999997754432211 122345566777889999999999 787 999999
Q ss_pred CCCCCeEECCCCCeEEeeccCCccCC
Q 042383 181 IKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 181 lk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|++.||+++ ++.+.++|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999996 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.4e-13 Score=121.57 Aligned_cols=246 Identities=20% Similarity=0.183 Sum_probs=175.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC--CCcEEEEEEeeccChhcH--HHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ--DGTVVAVKVLSVESKQGE--KEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
...+|..+..||.|.|+.|+.+..+ ++..|++|.......... ..-..|+-+...+ .|.+++.....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567889999999999999988644 577788887764432222 2224455555555 5888888888888788888
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeeccCCc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSK 203 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~~ 203 (353)
+-.|||.++++...+ .....+.+...+++..|++.++.++|+. .++|+|++|.||++..+ +.-+++|||...
T Consensus 343 ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 999999999887766 3445678889999999999999999998 99999999999999876 778899999886
Q ss_pred cCCCCCccccccccCCcCcc--CccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYL--APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
.+... .........+. +|+......+..+.|++|||..+.+.+++...-....+ +.
T Consensus 416 ~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~ 473 (524)
T KOG0601|consen 416 RLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SL 473 (524)
T ss_pred cccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------ce
Confidence 43211 11111222333 55555566788999999999999999998755332111 11
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
.+ ........+... ..+..+...+...++..||.+.++.....
T Consensus 474 ~i-~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 TI-RSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ee-ecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 111112222222 55667777888999999999988765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-11 Score=104.10 Aligned_cols=142 Identities=20% Similarity=0.281 Sum_probs=109.0
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCC--CceeeeeeEecCC---ceEEEEEcCC
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK-QGEKEFMSEVASMANICHE--NLVKLHGGCIEGP---CRIIVYDYMQ 131 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~---~~~lv~e~~~ 131 (353)
+.|+.|..+.||++...+|..+++|....... .....+..|+.+++.+.+. .+.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999877668899998764322 1345678899999999653 4566777666542 5689999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI--------------------------------------- 172 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--------------------------------------- 172 (353)
|.++.+.+. ...+++.....++.+++.+|..||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 998877651 135677778888888888888888521
Q ss_pred --------------CCCeEEcCCCCCCeEECC--CCCeEEeeccCCcc
Q 042383 173 --------------KPSIVHRDIKPSNILLDQ--NFNPKISDFGLSKL 204 (353)
Q Consensus 173 --------------~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~ 204 (353)
...++|+|+.++||+++. ++.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999988 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-11 Score=96.08 Aligned_cols=132 Identities=20% Similarity=0.264 Sum_probs=99.4
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChh--------cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ--------GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+++|+-+.++.+.+. |.++++|.-..+... ....-.+|+.++.+++--.|.-..-++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 444777753322211 113456799999888765655555556677788999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
.+|..|.+.+... ...++..+-..+.-||.. ||+|+||.+.||.++.++ +.++|||++..-
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888322 245677788888999999 999999999999997764 999999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-12 Score=127.38 Aligned_cols=250 Identities=19% Similarity=0.232 Sum_probs=172.3
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
....+++.+.+.+-+|.++.++.+... .|...+.|+...... .+.+....+-.++...++|.++...-.+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345677888888999999999888644 343344444332111 1122223333333334567777665556667778
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
+++++|..+++|...+ .+.+..+..........+..++++||+. .+.|+|++|+|.++..+++.++.|||...
T Consensus 880 ~L~~~~~~~~~~~Skl----~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKL----HNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhh----hcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999888 3444667777777888899999999997 79999999999999999999999998432
Q ss_pred cCCC------------------------------CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC
Q 042383 204 LFPE------------------------------DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253 (353)
Q Consensus 204 ~~~~------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~ 253 (353)
.... +.........+|+.|.+||...+......+|.|+.|+++++.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2110 0001122356899999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhHHHHHHhhccccccccccCcccC-CCCChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042383 254 AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC-GNFSGNEAVRFLKVGLLCVQEKSSLRPRMS 319 (353)
Q Consensus 254 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 319 (353)
+||......... ..+...... ...+........+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~f---------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF---------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhh---------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999855442221 111111111 122233345566777788888999987766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.3e-10 Score=105.34 Aligned_cols=170 Identities=22% Similarity=0.343 Sum_probs=127.9
Q ss_pred ceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe----cCCceEEEEEcCCCC-Chhhh
Q 042383 65 FGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI----EGPCRIIVYDYMQNN-SLSQT 138 (353)
Q Consensus 65 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~~-sL~~~ 138 (353)
..+.|++..+ +|..|++|.+.............-++.++++.|+|+|++.++|. .+...++|++|.++. +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578898754 79999999994332222222334578899999999999999887 345678999999854 67666
Q ss_pred hhhcc-----------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 139 LLGEE-----------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 139 l~~~~-----------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
..... ..+...++..+|.++.|+..||.++|+. |+.-+-|.|.+|+++.+.++++...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 53322 2234678999999999999999999999 999999999999999999999998887765543
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAA 255 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (353)
+.. |.+.. -.+-|.=.||.++..|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 00111 1257888999999999999644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.7e-11 Score=92.73 Aligned_cols=143 Identities=22% Similarity=0.266 Sum_probs=104.9
Q ss_pred CCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC--------hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 56 SSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES--------KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
....+-+|+-+.|+++.+. |+.++||.-.... .-...+..+|+..|.++.--.|.-..-+|.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999987 6777777543221 122355678999998886555544444566777788999
Q ss_pred EcCCC-CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEeeccCCc
Q 042383 128 DYMQN-NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKISDFGLSK 203 (353)
Q Consensus 128 e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~ 203 (353)
||++| .++.+++...- ...........++..|-..+.-||.. +++|+||...||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 36777774321 22223333478899999999999999 999999999999996544 35899999976
Q ss_pred c
Q 042383 204 L 204 (353)
Q Consensus 204 ~ 204 (353)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-09 Score=96.28 Aligned_cols=263 Identities=11% Similarity=0.111 Sum_probs=156.1
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeee------eEecC-CceEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHG------GCIEG-PCRIIV 126 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~------~~~~~-~~~~lv 126 (353)
..++.||+|+-+.+|-.-.-. ..+.|+........... .++.|... .||-+..-+. +-.+. ...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhh--chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 457789999999999654221 23558776554433332 22333333 4554322111 01122 225577
Q ss_pred EEcCCCCChhhhhhhc---cccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGE---EKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~---~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
|..+.|.---..+.+. ++...-.+|+..++.+..++.+...||.. |.+-+|+.++|+||++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 8887765322222221 22334578999999999999999999999 99999999999999999999999865544
Q ss_pred cCCCCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCcccchh--hHHHHHHhh-
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTG-QAAVHFDKELGEY--YLVEKAWEM- 274 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g-~~pf~~~~~~~~~--~~~~~~~~~- 274 (353)
...++ ....-..|.+.|++||... +...+...|.|.||+++++++.| .+||.+-...... -....+...
T Consensus 166 i~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 INANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 43222 2222346888999999654 33456789999999999999987 8999754321110 000011000
Q ss_pred -ccccccccccCcccCCCCC-hHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHhcCC
Q 042383 275 -HNTDKLQHLVDPMLCGNFS-GNEAVRFLKVGLLCVQE--KSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 275 -~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~~ 328 (353)
....+-..-+.+-- ...+ .-.+..+..+..+|+.. ++.-|||++..+..|...
T Consensus 244 f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 244 FAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 00000000000000 0111 11133455566678753 477899999988777544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4e-10 Score=94.95 Aligned_cols=136 Identities=20% Similarity=0.192 Sum_probs=102.9
Q ss_pred CCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh----------------------hcHHHHHHHHHHHHhcCCC--C
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK----------------------QGEKEFMSEVASMANICHE--N 109 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~ 109 (353)
+.++..||-|.-+.||.|....|.++|+|.=+.... -....+.+|+++|++|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996442110 1124467899999999644 6
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
+.+.++ .+...+|||+.+|-.|...- ++......++..|+.-+..+-.. |+||+|+++-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 666665 46678999999996665432 13344455666677777666666 999999999999999
Q ss_pred CCCCeEEeeccCCccC
Q 042383 190 QNFNPKISDFGLSKLF 205 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~ 205 (353)
++|.+.++||-.+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.7e-10 Score=92.44 Aligned_cols=125 Identities=24% Similarity=0.272 Sum_probs=82.0
Q ss_pred EEEEEEeCCCcEEEEEEeeccCh--------------------------hcHHHHHHHHHHHHhcCCC--CceeeeeeEe
Q 042383 67 SVYKGKLQDGTVVAVKVLSVESK--------------------------QGEKEFMSEVASMANICHE--NLVKLHGGCI 118 (353)
Q Consensus 67 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 118 (353)
.||.|...+|..+|+|+.+.... .......+|+..|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999988899999998753110 0113467799999999755 45666544
Q ss_pred cCCceEEEEEcCC--CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 119 EGPCRIIVYDYMQ--NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY-IHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 119 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~-LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
...++||||++ |..+..+. .. .++......++.+++..+.. +|.. |++|+||++.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~-~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLK-DV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHH-HC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHH-hc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 23579999998 54454332 11 11134456677888886655 5677 99999999999999888 999
Q ss_pred EeeccCCccC
Q 042383 196 ISDFGLSKLF 205 (353)
Q Consensus 196 l~Dfg~~~~~ 205 (353)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.9e-09 Score=91.60 Aligned_cols=140 Identities=13% Similarity=0.019 Sum_probs=97.6
Q ss_pred eeeeeCceEEEEEEeCCCcEEEEEEeeccChh-----------cHHHHHHHHHHHHhcCCCCc--eeeeeeEec-----C
Q 042383 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ-----------GEKEFMSEVASMANICHENL--VKLHGGCIE-----G 120 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~ 120 (353)
.+-......|.++... |+.+.||........ ....+.+|...+.++..-+| +..+.+.+. .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3443344446666654 678999976432211 11136788888888853333 334444432 2
Q ss_pred CceEEEEEcCCCC-ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-------CC
Q 042383 121 PCRIIVYDYMQNN-SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-------NF 192 (353)
Q Consensus 121 ~~~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-------~~ 192 (353)
...++|+|++++. +|.+++.... ..+.+......++.+++..+..||+. |++|+|+++.|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3468999999886 7888874221 24456777889999999999999999 9999999999999974 46
Q ss_pred CeEEeeccCCcc
Q 042383 193 NPKISDFGLSKL 204 (353)
Q Consensus 193 ~~kl~Dfg~~~~ 204 (353)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=8.9e-11 Score=110.01 Aligned_cols=150 Identities=23% Similarity=0.364 Sum_probs=106.0
Q ss_pred HHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccc--------cccCCcCccCcccccc
Q 042383 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--------RVAGTLGYLAPDYAVS 230 (353)
Q Consensus 159 ~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~--------~~~g~~~y~aPE~~~~ 230 (353)
.+++.|+.++|.. .++||++|.|++|.++.++..|++.|+.+............ -......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999976 79999999999999999999999999987644331111000 0123457999999999
Q ss_pred CCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccC
Q 042383 231 GHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQ 309 (353)
Q Consensus 231 ~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 309 (353)
...+.++|+||+|+++|.+.. |+..+........+. .....+..-...++.+.+.++++=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHhc
Confidence 888999999999999999994 555554333222111 111112222233445667788888999999
Q ss_pred CCCCCCCCHHHHHH
Q 042383 310 EKSSLRPRMSTVIE 323 (353)
Q Consensus 310 ~~p~~RPt~~evl~ 323 (353)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-08 Score=94.20 Aligned_cols=142 Identities=17% Similarity=0.200 Sum_probs=92.0
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc----------------------------------------HHHHHH
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG----------------------------------------EKEFMS 97 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 97 (353)
..|+.++-|.||+|+.++|+.||||+.+..-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999986321100 011334
Q ss_pred HHHHHHhcC-----CCCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 042383 98 EVASMANIC-----HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172 (353)
Q Consensus 98 e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 172 (353)
|...+.++. .+++.=-.=+++-....+++|||++|-.+.+...-. ...++...+.....++.--.-+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~q~~~--d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLRQLLR--D- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHHHHHh--c-
Confidence 444444442 233221111223345678999999999888875222 13444333333333322222222 3
Q ss_pred CCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 173 ~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|+.|+|..|.||+++.+|.+.+.|||+....+.
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.3e-08 Score=79.51 Aligned_cols=139 Identities=14% Similarity=0.092 Sum_probs=101.0
Q ss_pred eeeeeCceEEEEEEeCCCcEEEEEEeecc------ChhcHHHHHHHHHHHHhcCCCC--ceeeeeeEe-c----CCceEE
Q 042383 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVE------SKQGEKEFMSEVASMANICHEN--LVKLHGGCI-E----GPCRII 125 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~-~----~~~~~l 125 (353)
.-|+||-+-|++....+ ..+-+|.-... .......+.+|+..++.+..-+ +.++. ++. . .-..+|
T Consensus 25 N~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 45678989999987764 35778865411 1335678999999999985332 44444 222 1 123579
Q ss_pred EEEcCCC-CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC--eEEeeccCC
Q 042383 126 VYDYMQN-NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN--PKISDFGLS 202 (353)
Q Consensus 126 v~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~ 202 (353)
|+|.+++ -+|.+++... ...+.+......++.+++.++.-||+. |+.|+|+.+.||+++.++. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997764 3788777321 233567888889999999999999999 9999999999999986666 999999876
Q ss_pred cc
Q 042383 203 KL 204 (353)
Q Consensus 203 ~~ 204 (353)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.4e-08 Score=82.16 Aligned_cols=107 Identities=19% Similarity=0.205 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHHhcCCCC--ceeeeeeEecC----CceEEEEEcCCCC-ChhhhhhhccccCCCCCHHHHHHHHHHHHHH
Q 042383 92 EKEFMSEVASMANICHEN--LVKLHGGCIEG----PCRIIVYDYMQNN-SLSQTLLGEEKNRAKFSWTARREIALGIARG 164 (353)
Q Consensus 92 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~a 164 (353)
.....+|...+..+..-+ +.+.+.+.+.. ...++|+|++++. +|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 346778888888775333 34455554432 2357999999874 788888432 226677788999999999
Q ss_pred HHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEeeccCCccC
Q 042383 165 LAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKISDFGLSKLF 205 (353)
Q Consensus 165 l~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~~ 205 (353)
+.-||+. |++|+|+++.|||++.++ .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.4e-07 Score=78.99 Aligned_cols=154 Identities=16% Similarity=0.200 Sum_probs=102.7
Q ss_pred cCCHHHHHHhccCCCCCC---eeeeeCceEEEEEEeCCCcEEEEEEeeccChhcH------------------------H
Q 042383 41 AFSYNELKSATNGFCSSN---KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGE------------------------K 93 (353)
Q Consensus 41 ~~~~~~~~~~~~~y~~~~---~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------~ 93 (353)
..+.+.+.....+..+.. .|++|.-+.||+|...++..+|+|+......... .
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555666666665544 4556667789999988899999999874321111 1
Q ss_pred HHHHHHHHHHhcC--CCCceeeeeeEecCCceEEEEEcCCCCCh-hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 042383 94 EFMSEVASMANIC--HENLVKLHGGCIEGPCRIIVYDYMQNNSL-SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170 (353)
Q Consensus 94 ~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 170 (353)
-...|+.-|.++. +-.+.+-+.+. .-.+||||+..... .-.| ..-++.......+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 1345777777774 33344444432 34699999965411 1111 22233344677788889999988887
Q ss_pred cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 171 ~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
. .++||+||+.-|||+. ++.+.++|||.+....
T Consensus 185 ~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 E--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred h--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2 2999999999999998 7899999999887543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.9e-07 Score=77.42 Aligned_cols=136 Identities=15% Similarity=0.190 Sum_probs=91.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHH---------HHHHHHHHhc---CCCCceeeeeeEe
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEF---------MSEVASMANI---CHENLVKLHGGCI 118 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l---~h~~iv~~~~~~~ 118 (353)
..+|.+.+++-......|.+...+ |+.+++|..+.......+.+ .+.+..+.++ .......++-+.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467888888888888888777766 67799998875543332222 2333333333 2233333332222
Q ss_pred -----cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 119 -----EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 119 -----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
-....+++|||++|..|.+.. .+++ .+...+.+++.-||+. |++|+|..|.|++++++ .
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-c
Confidence 234456899999998887654 1222 2445677889999999 99999999999999865 5
Q ss_pred eEEeeccCCc
Q 042383 194 PKISDFGLSK 203 (353)
Q Consensus 194 ~kl~Dfg~~~ 203 (353)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998755
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-07 Score=77.35 Aligned_cols=141 Identities=15% Similarity=0.180 Sum_probs=84.5
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeeeeEecCCceEEEEEcCCCCC-
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHGGCIEGPCRIIVYDYMQNNS- 134 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~s- 134 (353)
..||.|..+.||+.. +..+++|...... ......+|.++++.+..-. +.+++++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 468999999999842 4457889876322 3345688999999986433 5677777777777889999999963
Q ss_pred hhhhh--------------hhc--cccC---CCCCHHHHH-HHHH----------HHHHH-HHHHHhc-CCCCeEEcCCC
Q 042383 135 LSQTL--------------LGE--EKNR---AKFSWTARR-EIAL----------GIARG-LAYIHEE-IKPSIVHRDIK 182 (353)
Q Consensus 135 L~~~l--------------~~~--~~~~---~~l~~~~~~-~~~~----------qi~~a-l~~LH~~-~~~~i~H~dlk 182 (353)
+...+ ... .-.. ...+..... .+.. .+... ..+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 000 0000 000111000 0000 00111 1112111 12367999999
Q ss_pred CCCeEECCCCCeEEeeccCCcc
Q 042383 183 PSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 183 ~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
|.||++++++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999887 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.8e-06 Score=74.48 Aligned_cols=140 Identities=14% Similarity=0.067 Sum_probs=84.2
Q ss_pred eeeeCc-eEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcCCCCChhh
Q 042383 60 VGEGGF-GSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQ 137 (353)
Q Consensus 60 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 137 (353)
|..|.+ +.||++... +..+++|+..... ...+.+|+.+++.+. +--+.+++.+...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789999765 4678889775332 335678898888884 4446677777776667899999999987764
Q ss_pred hhh-------------------hccccCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhc----C
Q 042383 138 TLL-------------------GEEKNRAKFSWT--ARREIAL--------------------GIARGLAYIHEE----I 172 (353)
Q Consensus 138 ~l~-------------------~~~~~~~~l~~~--~~~~~~~--------------------qi~~al~~LH~~----~ 172 (353)
... .......++... ....... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 320 000000111100 0000000 011111222111 1
Q ss_pred CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 173 ~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2368999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=74.26 Aligned_cols=78 Identities=12% Similarity=0.157 Sum_probs=55.9
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCC--CceeeeeeEe---cCCceEEEEEcCC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHE--NLVKLHGGCI---EGPCRIIVYDYMQ 131 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~ 131 (353)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3579999999999999887 57999986633 4556777888888888533 2455555332 2334689999999
Q ss_pred CCChhh
Q 042383 132 NNSLSQ 137 (353)
Q Consensus 132 ~~sL~~ 137 (353)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.1e-06 Score=79.56 Aligned_cols=141 Identities=17% Similarity=0.190 Sum_probs=90.2
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc-------------------------------HHH------HHHHH
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG-------------------------------EKE------FMSEV 99 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------~~~e~ 99 (353)
.+.||.-+.|.|++|+.++|+.||||+-+..-... .+. |..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999865321110 011 22233
Q ss_pred HHHHh----cCCCC------ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH
Q 042383 100 ASMAN----ICHEN------LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169 (353)
Q Consensus 100 ~~l~~----l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 169 (353)
+-..+ +.|-+ |.+++- .-....+++||||+|..+.|.-.- ....++...+..-+.+...-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 22222 23444 223322 223457899999999988766421 2334555555444444333333333
Q ss_pred hcCCCCeEEcCCCCCCeEECC----CCCeEEeeccCCccCCC
Q 042383 170 EEIKPSIVHRDIKPSNILLDQ----NFNPKISDFGLSKLFPE 207 (353)
Q Consensus 170 ~~~~~~i~H~dlk~~Nil~~~----~~~~kl~Dfg~~~~~~~ 207 (353)
|.+|+|=.|.||++.. ++.+.+-|||+......
T Consensus 321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999983 67899999999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-05 Score=66.61 Aligned_cols=131 Identities=18% Similarity=0.296 Sum_probs=90.8
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccC----------------hhcHHHHHHHHHHHHhcC------CCCceeee
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES----------------KQGEKEFMSEVASMANIC------HENLVKLH 114 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~ 114 (353)
...||+|+.-.|| .+.++....||+..... ....+...+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 3569999999998 44455567889887554 223455667777666665 77899999
Q ss_pred eeEecCCceEEEEEcCCCC------ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 115 GGCIEGPCRIIVYDYMQNN------SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 115 ~~~~~~~~~~lv~e~~~~~------sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
|+.+.+...-+|+|..... ||.+++ ..+.++. .... .+-.-..+|-+. +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-----~~~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-----KEGGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH-----HcCCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 9999999999999876432 566766 2234554 3333 333445667777 99999999999999
Q ss_pred CCC---C-CeEEee-ccC
Q 042383 189 DQN---F-NPKISD-FGL 201 (353)
Q Consensus 189 ~~~---~-~~kl~D-fg~ 201 (353)
..+ . .+.|+| ||.
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 432 2 577777 343
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.2e-08 Score=90.12 Aligned_cols=190 Identities=17% Similarity=0.102 Sum_probs=135.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC-ceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN-LVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~ 129 (353)
+.-+..-..+++|+.+.+++.+...-+....+.+... ....-+++.|.+++||| .+..++-++.++...+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3344455668899999999887543333334444322 34556889999999999 77777777778888999999
Q ss_pred CCCC-ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 130 MQNN-SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
+.++ +-..-.. ...-.+...+...+...-..+++++|+. .-+|+| ||+.++ +..++.||+....+...
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc
Confidence 9887 2222220 1112233444455666667888999976 568888 777655 68999999998876554
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHF 258 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~ 258 (353)
. ......+++.++|||+...+.+....|+|++|.-..++.-|-+|-..
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 3 23446789999999999999999999999999887788778777543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.4e-06 Score=65.88 Aligned_cols=130 Identities=18% Similarity=0.238 Sum_probs=89.9
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCcee-eeeeEecCCceEEEEEcCCCC
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK-LHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~ 133 (353)
++.+.|++|++|.||++.+. |..+|+|+-+. .+....+..|+++|..+.-.++.+ ++.+-. -++.|||..|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 44678999999999999988 55799997653 344567889999999998666543 444322 23559999998
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC-CCCeEECCCCCeEEeeccCCccC
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIK-PSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk-~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
.|.+.-... + .+-...++.+---|... ||-|+.|. |...++..++.+.|+||..|+..
T Consensus 98 ~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 887664110 1 22334455555556666 99999987 44444445559999999988743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-05 Score=80.91 Aligned_cols=79 Identities=11% Similarity=0.237 Sum_probs=57.3
Q ss_pred CCeeeeeCceEEEEEEeCCC---cEEEEEEeeccC-hhcHHHHHHHHHHHHhcC-CCCc--eeeeeeEecC---CceEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDG---TVVAVKVLSVES-KQGEKEFMSEVASMANIC-HENL--VKLHGGCIEG---PCRIIV 126 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 126 (353)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886643 467888755322 123356789999999995 6654 7777777664 357899
Q ss_pred EEcCCCCCh
Q 042383 127 YDYMQNNSL 135 (353)
Q Consensus 127 ~e~~~~~sL 135 (353)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.8e-05 Score=68.24 Aligned_cols=76 Identities=7% Similarity=0.042 Sum_probs=56.5
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC---CCceeeeeeEec---CCceEEEEEcC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH---ENLVKLHGGCIE---GPCRIIVYDYM 130 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~ 130 (353)
.+.||.|..+.||+....+++ +++|..+. ......+..|...|+.+.. -.+.++++++.+ .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 467999999999999876564 67787432 2234578899999998853 357788877654 35689999999
Q ss_pred CCCCh
Q 042383 131 QNNSL 135 (353)
Q Consensus 131 ~~~sL 135 (353)
+|.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-05 Score=66.03 Aligned_cols=105 Identities=21% Similarity=0.202 Sum_probs=82.5
Q ss_pred HHHHHHHHhcCC-CCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 042383 96 MSEVASMANICH-ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174 (353)
Q Consensus 96 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~ 174 (353)
..|..+++.+.+ +++.+++|+|- .+++.||...+++..... ........+|..+..++.+++..+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888865 69999999884 468999998776643210 001223568999999999999999999986555
Q ss_pred CeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 175 ~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
.+...|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.9e-05 Score=66.57 Aligned_cols=73 Identities=15% Similarity=0.238 Sum_probs=45.1
Q ss_pred CeeeeeCce-EEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCC---CceeeeeeEecC---CceEEEEEcC
Q 042383 58 NKVGEGGFG-SVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHE---NLVKLHGGCIEG---PCRIIVYDYM 130 (353)
Q Consensus 58 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~ 130 (353)
+.|+.|+.. .||+.. ..+++|..+. ......+.+|..++..+... .+.+++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457767665 588762 2477786542 22345788899999888532 234444433221 2347899999
Q ss_pred CCCChh
Q 042383 131 QNNSLS 136 (353)
Q Consensus 131 ~~~sL~ 136 (353)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=66.55 Aligned_cols=74 Identities=14% Similarity=0.160 Sum_probs=49.0
Q ss_pred CeeeeeCceEEEEEEeCC--CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC-ceeeeeeEecCCceEEEEEcCCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQD--GTVVAVKVLSVESKQGEKEFMSEVASMANICHEN-LVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
+.|..|-...+|++...+ +..+++|+....... .-...+|+.+++.+...+ ..+++..+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888889999998664 678999976533221 123347888888885433 344444332 237999999877
Q ss_pred hh
Q 042383 135 LS 136 (353)
Q Consensus 135 L~ 136 (353)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=69.45 Aligned_cols=140 Identities=12% Similarity=0.073 Sum_probs=78.1
Q ss_pred eeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEcCCCCChhh
Q 042383 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDYMQNNSLSQ 137 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~ 137 (353)
.+..|-.+.+|+.... +..+++|..........-...+|..+++.+...++ .+++.... -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 3566888899988744 66788897553322211134678888888864333 33333322 368999999876542
Q ss_pred h----------h-------hhccccCCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeEEcCCCCCC
Q 042383 138 T----------L-------LGEEKNRAKFSWT-ARREIALGI---------ARGLAYIHEE-----IKPSIVHRDIKPSN 185 (353)
Q Consensus 138 ~----------l-------~~~~~~~~~l~~~-~~~~~~~qi---------~~al~~LH~~-----~~~~i~H~dlk~~N 185 (353)
. + +.......+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 0 0000111122211 111111111 1111112111 12368999999999
Q ss_pred eEECCCCCeEEeeccCCcc
Q 042383 186 ILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 186 il~~~~~~~kl~Dfg~~~~ 204 (353)
|++++++ +.++||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9998876 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5e-06 Score=72.37 Aligned_cols=135 Identities=14% Similarity=0.141 Sum_probs=97.7
Q ss_pred CCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChh----------------------cHHHHHHHHHHHHhcC-CC-C
Q 042383 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQ----------------------GEKEFMSEVASMANIC-HE-N 109 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~-h~-~ 109 (353)
+.++.+||-|.-+.||.+....|++.++|.-+..... ..-...+|+..|+.+. |- -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 5678899999999999999999999999964321100 0123456888888884 33 3
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
+.+.++ .+..++|||++.|..|.+.- ... ....+...+...+.-|..+ |+||+|..-=||++.
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~---d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVR-------HVE---DPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeee-------ecC---ChHHHHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence 444554 45688999999998776442 111 2233555666667888888 999999999999999
Q ss_pred CCCCeEEeeccCCccC
Q 042383 190 QNFNPKISDFGLSKLF 205 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~ 205 (353)
+++.++++||-.....
T Consensus 237 dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVST 252 (465)
T ss_pred cCCCEEEeechHhhcc
Confidence 9999999999765443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.7e-05 Score=79.40 Aligned_cols=195 Identities=22% Similarity=0.211 Sum_probs=136.3
Q ss_pred HHHHHHHHHhcCCCCceeeeeeEecCCceE----EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 042383 95 FMSEVASMANICHENLVKLHGGCIEGPCRI----IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170 (353)
Q Consensus 95 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 170 (353)
..-|+..+.+..|+|++.++.+-.+....- +..+++.+.++...+ ..-..++....+.+..++.+|+.++|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 345677778889999999988776554433 345677777887777 566788999999999999999999999
Q ss_pred cCCCCeEEcCCCCC---CeEECCCCCeEEe--eccCCccCCCCCccccccccCCcCccCccccccCCCCc--cccchhHH
Q 042383 171 EIKPSIVHRDIKPS---NILLDQNFNPKIS--DFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP--KSDIYSFG 243 (353)
Q Consensus 171 ~~~~~i~H~dlk~~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~DvwslG 243 (353)
. .+.|.-+... +.-++..+.+..+ ||+.....+....... ...+..+.+||......... ..|+|.+|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHH
Confidence 8 5655555554 4445666777777 8888877655433322 23455678888777666554 47999999
Q ss_pred HHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 244 VLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 244 ~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+..|..+-..... ....+...... .+.+...+|+.-++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999998766431111 01111111111 4667777999999999999999976
Q ss_pred H
Q 042383 324 M 324 (353)
Q Consensus 324 ~ 324 (353)
.
T Consensus 434 ~ 434 (1351)
T KOG1035|consen 434 H 434 (1351)
T ss_pred c
Confidence 4
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00018 Score=64.75 Aligned_cols=158 Identities=12% Similarity=0.137 Sum_probs=83.3
Q ss_pred CHHHHHHhccCCCC-----CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeee
Q 042383 43 SYNELKSATNGFCS-----SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHG 115 (353)
Q Consensus 43 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~ 115 (353)
+.+++......|.+ .+.|+.|....+|+....+| .+++|+.. . .....+..|+..+..+...+ +.+++.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 33444444344543 34577788889999987655 58889875 2 12233444556665553211 333332
Q ss_pred ------eEecCCceEEEEEcCCCCChh-----------hhhh---hcccc-------CCCCCH-HHHH------------
Q 042383 116 ------GCIEGPCRIIVYDYMQNNSLS-----------QTLL---GEEKN-------RAKFSW-TARR------------ 155 (353)
Q Consensus 116 ------~~~~~~~~~lv~e~~~~~sL~-----------~~l~---~~~~~-------~~~l~~-~~~~------------ 155 (353)
+....+..++++++++|..+. ..+. ..... ...+.+ ....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 122345578999999987542 1111 00000 000101 1100
Q ss_pred HHHHH-HHHHHHHHHh----cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 156 EIALG-IARGLAYIHE----EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 156 ~~~~q-i~~al~~LH~----~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
..+.+ +...+..+.+ ..+.++||+|+.|+||+++.+...-++||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 01111 1112222221 1245899999999999998765568999998763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.0001 Score=60.63 Aligned_cols=125 Identities=28% Similarity=0.429 Sum_probs=88.4
Q ss_pred cCCCCCCeeeeeCc-eEEEEEEeCCCcEEEEEEeec---cCh------------------hcHHHHHHHHHHHHhcC---
Q 042383 52 NGFCSSNKVGEGGF-GSVYKGKLQDGTVVAVKVLSV---ESK------------------QGEKEFMSEVASMANIC--- 106 (353)
Q Consensus 52 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 106 (353)
.+++.++.||.|.- |.||+++.. |+.+|+|++.. ... .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999987 66899999431 000 11134667777776664
Q ss_pred CCCc--eeeeeeEecC------------------CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHH
Q 042383 107 HENL--VKLHGGCIEG------------------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166 (353)
Q Consensus 107 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~ 166 (353)
+.++ ++++|+..-. ....||.||.+... .+. ..-+.+|.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 5566 8999877422 12346777665432 111 233567788889
Q ss_pred HHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 167 ~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.+|.. ||+-+|+++.|.. .=+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999986 5689999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=67.21 Aligned_cols=76 Identities=13% Similarity=0.148 Sum_probs=53.5
Q ss_pred CCeeeeeCceEEEEEEeCCC-cEEEEEEeecc-----C--hhcHHHHHHHHHHHHhcC--C-CCceeeeeeEecCCceEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDG-TVVAVKVLSVE-----S--KQGEKEFMSEVASMANIC--H-ENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~--h-~~iv~~~~~~~~~~~~~l 125 (353)
.+.||.|.+..||++...+| +.++||+-... . ....+....|.+.|+.+. . ..+.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998776 48999985411 1 123456677888888763 2 346666665 4456789
Q ss_pred EEEcCCCCC
Q 042383 126 VYDYMQNNS 134 (353)
Q Consensus 126 v~e~~~~~s 134 (353)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.7e-05 Score=66.00 Aligned_cols=144 Identities=13% Similarity=0.174 Sum_probs=84.2
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeeee------EecCCceEEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHGG------CIEGPCRIIVYD 128 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e 128 (353)
.+.+..|....+|+....++ .+++|+... .....+..|+.++..+.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677888889999876544 688898763 23445667888887774332 3444331 223445689999
Q ss_pred cCCCCChhh-----------hh---hhcccc-C------CCCCHHHH----------HHHHHHHHHHHHHHHh----cCC
Q 042383 129 YMQNNSLSQ-----------TL---LGEEKN-R------AKFSWTAR----------REIALGIARGLAYIHE----EIK 173 (353)
Q Consensus 129 ~~~~~sL~~-----------~l---~~~~~~-~------~~l~~~~~----------~~~~~qi~~al~~LH~----~~~ 173 (353)
+++|..+.. .+ +..... . ....+... ......+..++.++.+ ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 000000 0 00011100 0011112333444442 123
Q ss_pred CCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
.++||+|+.|.|+++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887778999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00035 Score=62.48 Aligned_cols=144 Identities=15% Similarity=0.243 Sum_probs=81.3
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeeee------EecCCceEEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHGG------CIEGPCRIIVYD 128 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~e 128 (353)
.+.++.|....+|++...+| .+++|+..... ....+..|++++..+...+ +.+++.. ...++..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677887889999886655 57788765321 1334556677777764222 3343331 122455689999
Q ss_pred cCCCCChhh-----------hh---hhcccc---C--C--CC-CHHHH--H----------HHHHHHHHHHHHHHh----
Q 042383 129 YMQNNSLSQ-----------TL---LGEEKN---R--A--KF-SWTAR--R----------EIALGIARGLAYIHE---- 170 (353)
Q Consensus 129 ~~~~~sL~~-----------~l---~~~~~~---~--~--~l-~~~~~--~----------~~~~qi~~al~~LH~---- 170 (353)
|++|..+.. .+ +..... . . .. .+... . .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865421 00 000000 0 0 00 00000 0 001122334444432
Q ss_pred cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 171 ~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
....++||+|+.+.|++++.++.+.++||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 124589999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00019 Score=63.85 Aligned_cols=140 Identities=16% Similarity=0.214 Sum_probs=97.2
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc-----C----------------hh-----cHHHHHHHHHHHHhcCCC
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE-----S----------------KQ-----GEKEFMSEVASMANICHE 108 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~----------------~~-----~~~~~~~e~~~l~~l~h~ 108 (353)
.+...|..|.-+.||-|...+|..+|||+.+.. . .. -.--+..|+.-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456778899999999999889999999987521 0 00 011234578888888655
Q ss_pred CceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 109 NLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 109 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
.|.-.--+.. ...+|||+|+....- . ...-..-.++...+..+-.|++.-+.-|...| ++||.||+--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw-~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGW-A---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCC-c---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 4321111111 235799999963211 1 11123445777788888889999999998876 99999999999998
Q ss_pred CCCCCeEEeeccCCc
Q 042383 189 DQNFNPKISDFGLSK 203 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~ 203 (353)
.+|.+.++|.+.+.
T Consensus 299 -hdG~lyiIDVSQSV 312 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSV 312 (520)
T ss_pred -ECCEEEEEEccccc
Confidence 56699999988664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00031 Score=62.65 Aligned_cols=74 Identities=23% Similarity=0.260 Sum_probs=48.9
Q ss_pred CeeeeeCceEEEEEEeCC-------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQD-------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 129 (353)
+.+..|-...+|++...+ ++.+++|+..... .......+|..++..+...++ .+++..+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456677788999998654 5789999866432 222455678888888853333 445555432 358999
Q ss_pred CCCCChh
Q 042383 130 MQNNSLS 136 (353)
Q Consensus 130 ~~~~sL~ 136 (353)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00062 Score=60.34 Aligned_cols=139 Identities=19% Similarity=0.266 Sum_probs=88.8
Q ss_pred CCCeeeeeCceEEEEEEeCCCcEEEEEEee--ccChhcHHHHHHHHHHHHhcCC--CCceeeeeeEecCC--ceEEEEEc
Q 042383 56 SSNKVGEGGFGSVYKGKLQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICH--ENLVKLHGGCIEGP--CRIIVYDY 129 (353)
Q Consensus 56 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~ 129 (353)
+.+.+..|....+|..... +++++++ .+ ...........+|+.+++.+.- --+...++.|.++. ..+.||++
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3445545555556666554 6778888 33 1233344556788888888743 23445566666665 66899999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHH-HHHHHHHHHHHhc-------------------------------------
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIA-LGIARGLAYIHEE------------------------------------- 171 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~-~qi~~al~~LH~~------------------------------------- 171 (353)
++|..+.+.... ...+ .+++ ..++..|..||+-
T Consensus 107 veGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 107 VEGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred ecceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 998655443310 0111 1222 3566666666641
Q ss_pred ------------------CCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 172 ------------------IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 172 ------------------~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
....++|+|+.+.|++++.++-+=+.||+++..-
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1247999999999999999888999999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0014 Score=59.60 Aligned_cols=143 Identities=15% Similarity=0.194 Sum_probs=82.5
Q ss_pred CCeeeeeCceEEEEEEeCC-----CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEcC
Q 042383 57 SNKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 130 (353)
...|..|-...+|++...+ ++.+++|+......... ...+|..+++.+..-++ .++++.+..+ .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3456568888999987532 36789998764432222 23678888888864444 4556665433 579999
Q ss_pred CCCChhhhh-----------------hhccccCC--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 042383 131 QNNSLSQTL-----------------LGEEKNRA--KFSWTARREIALGI-----------------ARGLAYI----HE 170 (353)
Q Consensus 131 ~~~sL~~~l-----------------~~~~~~~~--~l~~~~~~~~~~qi-----------------~~al~~L----H~ 170 (353)
++.+|...- +....... ...+..+..+..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 877764210 00000000 11122333333221 1112222 11
Q ss_pred -cCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCcc
Q 042383 171 -EIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKL 204 (353)
Q Consensus 171 -~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 204 (353)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12347899999999999976 46899999987764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0013 Score=57.86 Aligned_cols=73 Identities=18% Similarity=0.246 Sum_probs=47.1
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC---CCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC---HENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
.+.++.|....+|+.. .+++.+.+|+-. ......+..|.+-|+.|. --.+.+++++....+..++|+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578889999999988 557789999765 333356778888888883 335778888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0036 Score=54.97 Aligned_cols=30 Identities=30% Similarity=0.616 Sum_probs=25.3
Q ss_pred CeEEcCCCCCCeEECCCCC-eEEeeccCCcc
Q 042383 175 SIVHRDIKPSNILLDQNFN-PKISDFGLSKL 204 (353)
Q Consensus 175 ~i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~~ 204 (353)
.++|+|+.|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999987555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=1.4e-05 Score=82.09 Aligned_cols=162 Identities=14% Similarity=0.022 Sum_probs=121.8
Q ss_pred HHHHHHHHHhcCCCCceeeeeeEe--cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 042383 95 FMSEVASMANICHENLVKLHGGCI--EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172 (353)
Q Consensus 95 ~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~ 172 (353)
...|...++...|+++.....-.. +....+.+++++.+|.+.+.+.....+..+++..-+...-.+...+..-.|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 334545555668888877665443 344567899999999999999877666666666666555555467777766542
Q ss_pred --CCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHH
Q 042383 173 --KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIV 250 (353)
Q Consensus 173 --~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll 250 (353)
..-.+|+++|+-|.+|..+-.++++++|+.+... +.....+...+++-|+.|++...-.++.++|+|..|+-+|.+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2356899999999999999999999999998332 2233344466788899999888888888899999999999999
Q ss_pred hCCCCCC
Q 042383 251 TGQAAVH 257 (353)
Q Consensus 251 ~g~~pf~ 257 (353)
-|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8888774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0038 Score=56.32 Aligned_cols=73 Identities=15% Similarity=0.188 Sum_probs=48.2
Q ss_pred eeeeeCceEEEEEEeCCC-cEEEEEEee----c---cChhcHHHHHHHHHHHHhcC--CCC-ceeeeeeEecCCceEEEE
Q 042383 59 KVGEGGFGSVYKGKLQDG-TVVAVKVLS----V---ESKQGEKEFMSEVASMANIC--HEN-LVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~-~~vavK~~~----~---~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~ 127 (353)
.||-|....||++...+| +.++||+-. . .-.....+..-|.+.|+... .|. +.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999997654 589999753 1 11233455567778887763 454 444443 3455667999
Q ss_pred EcCCCC
Q 042383 128 DYMQNN 133 (353)
Q Consensus 128 e~~~~~ 133 (353)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0052 Score=55.04 Aligned_cols=32 Identities=19% Similarity=0.331 Sum_probs=28.7
Q ss_pred CCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 173 ~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+.++||+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0056 Score=56.24 Aligned_cols=73 Identities=12% Similarity=0.106 Sum_probs=49.9
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeecc----Ch---hcHHHHHHHHHHHHhcC--C-CCceeeeeeEecCCceEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE----SK---QGEKEFMSEVASMANIC--H-ENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~--h-~~iv~~~~~~~~~~~~~lv 126 (353)
.+.||.|....||++... +..++||+-... +. ....+...|...|+.+. . ..+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999999875 456999976511 11 13344455677776663 2 36777877766 446789
Q ss_pred EEcCCC
Q 042383 127 YDYMQN 132 (353)
Q Consensus 127 ~e~~~~ 132 (353)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0057 Score=55.25 Aligned_cols=142 Identities=13% Similarity=0.219 Sum_probs=79.1
Q ss_pred CeeeeeCceEEEEEEeCC----CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQD----GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.|..|-...+|++...+ +..|++|+....... .-...+|..+++.+..-++ .++++++..+ +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 456557788899886442 237899987643322 2233578888888865554 4555555322 58899887
Q ss_pred CChhhh----------h-------hhcc-ccCC-CCCHHHHHHHHHHH----------------------HHHHHHHHhc
Q 042383 133 NSLSQT----------L-------LGEE-KNRA-KFSWTARREIALGI----------------------ARGLAYIHEE 171 (353)
Q Consensus 133 ~sL~~~----------l-------~~~~-~~~~-~l~~~~~~~~~~qi----------------------~~al~~LH~~ 171 (353)
.+|... + +... .... +-.+..+..+..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 1 0000 0000 11122222222221 1112222111
Q ss_pred -----CCCCeEEcCCCCCCeEECC-CCCeEEeeccCCcc
Q 042383 172 -----IKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKL 204 (353)
Q Consensus 172 -----~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 204 (353)
...-++|+|+.+.||++++ ++.++++||..+-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1124799999999999975 57899999988753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.011 Score=53.01 Aligned_cols=29 Identities=28% Similarity=0.377 Sum_probs=25.5
Q ss_pred CCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
.+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.014 Score=52.47 Aligned_cols=141 Identities=17% Similarity=0.335 Sum_probs=83.0
Q ss_pred eeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC---cee---eee----eEecCCceEEEEE
Q 042383 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN---LVK---LHG----GCIEGPCRIIVYD 128 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~---iv~---~~~----~~~~~~~~~lv~e 128 (353)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..+..+...+ .++ .-| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 566799999887776 89987754 45567778888888884222 122 111 1222236778999
Q ss_pred cCCCCChhh-hh--------------hhccc-----cC---CCCCHH-------------HHHHHHHHHHHHHHHHHhc-
Q 042383 129 YMQNNSLSQ-TL--------------LGEEK-----NR---AKFSWT-------------ARREIALGIARGLAYIHEE- 171 (353)
Q Consensus 129 ~~~~~sL~~-~l--------------~~~~~-----~~---~~l~~~-------------~~~~~~~qi~~al~~LH~~- 171 (353)
|++|..+.. .- ....+ .. ....|. .-.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999987762 11 00000 00 011121 0001233344444444432
Q ss_pred ---CCCC---eEEcCCCCCCeEECCCCC-eEEeeccCCc
Q 042383 172 ---IKPS---IVHRDIKPSNILLDQNFN-PKISDFGLSK 203 (353)
Q Consensus 172 ---~~~~---i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~ 203 (353)
.... +||+|+.|+||+++.+.. .-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999998875 8899999775
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0015 Score=60.69 Aligned_cols=186 Identities=18% Similarity=0.232 Sum_probs=98.3
Q ss_pred EEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-CceEEEEEcCCCCChhhhhhhccccC
Q 042383 68 VYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG-PCRIIVYDYMQNNSLSQTLLGEEKNR 146 (353)
Q Consensus 68 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~ 146 (353)
++.|....|..+ ..-+.. ......+.-.+..++.+.|+|...++++-... ....+|+|++. .||.+.+....
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--- 77 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--- 77 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---
Confidence 345555545432 222222 22334566778899999999999999876543 34678899994 48998873321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCcc
Q 042383 147 AKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226 (353)
Q Consensus 147 ~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE 226 (353)
+-.... + -| ++.|-. .++.+| .++.. | |-
T Consensus 78 --l~~~s~----------~--~~-----~~~~~~------------~~~~td-~~~t~-----------------~--~~ 106 (725)
T KOG1093|consen 78 --LKDESL----------L--AH-----GVLHLN------------IIYITD-HFLTK-----------------Y--PS 106 (725)
T ss_pred --cchhhh----------c--cc-----ccceeh------------hhhccc-ccccc-----------------C--CC
Confidence 111110 0 12 333321 222233 11110 0 11
Q ss_pred ccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhh
Q 042383 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLL 306 (353)
Q Consensus 227 ~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 306 (353)
...+|+||||+|.++.++.-|...+......+....+.+... .+.......... .+.-++...+.++...
T Consensus 107 -----~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~-~d~~~~~~a~e~----~~~~~~d~~~~~~~~~ 176 (725)
T KOG1093|consen 107 -----PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYT-DDQELLSTAMEH----LIQLLADKKRLPLLKK 176 (725)
T ss_pred -----CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhcc-CchhHHHHHHHH----HHHHhhhHhHHHHhcc
Confidence 112499999999999999998877653332222211111110 000000000000 2233446678889999
Q ss_pred ccCCCCCCCCCHHHH
Q 042383 307 CVQEKSSLRPRMSTV 321 (353)
Q Consensus 307 cl~~~p~~RPt~~ev 321 (353)
|+-..|..||...+.
T Consensus 177 c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 177 CLWLEPIIRPLPMEL 191 (725)
T ss_pred CCccccccccchhHH
Confidence 999999888765443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.058 Score=48.65 Aligned_cols=94 Identities=13% Similarity=0.093 Sum_probs=54.8
Q ss_pred ccCCHHHHHHhccCCCCC---C-eeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceee
Q 042383 40 NAFSYNELKSATNGFCSS---N-KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKL 113 (353)
Q Consensus 40 ~~~~~~~~~~~~~~y~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~ 113 (353)
..++.+.+..+...+-+. + ..-.+.-..||+....++..+++|+.+. .......+..|...+..+.... ++..
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 344555555555444332 1 1223455679999888788899998752 2234556677888777773211 2221
Q ss_pred e---e--eEecCCceEEEEEcCCCCC
Q 042383 114 H---G--GCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 114 ~---~--~~~~~~~~~lv~e~~~~~s 134 (353)
. + ....++..+.++++++|..
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 1 1 2233456778999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0061 Score=51.24 Aligned_cols=29 Identities=31% Similarity=0.599 Sum_probs=21.1
Q ss_pred CeEEcCCCCCCeEE-CCCCCeEEeeccCCc
Q 042383 175 SIVHRDIKPSNILL-DQNFNPKISDFGLSK 203 (353)
Q Consensus 175 ~i~H~dlk~~Nil~-~~~~~~kl~Dfg~~~ 203 (353)
.++|+|+.+.||++ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 78999999999999 888999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0091 Score=54.60 Aligned_cols=74 Identities=14% Similarity=0.148 Sum_probs=50.2
Q ss_pred CCeeeeeCceEEEEEEeCC-CcEEEEEEee----cc--ChhcHHHHHHHHHHHHhcC--CCC-ceeeeeeEecCCceEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQD-GTVVAVKVLS----VE--SKQGEKEFMSEVASMANIC--HEN-LVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~----~~--~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 126 (353)
.+.||-|....||++...+ ++.++||+-. .. -.-..++..-|.+.|+... .|. +.+++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4578999999999999753 5679999743 11 1234466677888888763 454 444543 355567789
Q ss_pred EEcCCC
Q 042383 127 YDYMQN 132 (353)
Q Consensus 127 ~e~~~~ 132 (353)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.014 Score=48.66 Aligned_cols=117 Identities=15% Similarity=0.163 Sum_probs=72.4
Q ss_pred eCceEEEEEEeCCCcEEEEEEeeccChh-cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhh
Q 042383 63 GGFGSVYKGKLQDGTVVAVKVLSVESKQ-GEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG 141 (353)
Q Consensus 63 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 141 (353)
++.++.-.++.+-| +..+|.++.-.-. ....+..++.++.+++ .|+++..- +.-.+-++.|+|..-..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 34455555544433 3556655533222 4566788888888764 56666532 33345688898843211
Q ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 142 EEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 142 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
. .. .++..=+.+|.-.|+. ..+.+|+|-.|+||+-|+.|.+||.|-+..
T Consensus 142 -------~---~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------N---FS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------c---hh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 0 00 1111114567777854 458999999999999999999999997653
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.067 Score=55.72 Aligned_cols=143 Identities=13% Similarity=0.219 Sum_probs=79.1
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-------CCCceeeee-----eEec-CC--c
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-------HENLVKLHG-----GCIE-GP--C 122 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~~iv~~~~-----~~~~-~~--~ 122 (353)
+.|+ |..-.+|+....+|..+++|+.+... .......|...+..+. .|.+++..+ ...+ +. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45678899988778889999987432 2233444555555442 233333321 1111 12 4
Q ss_pred eEEEEEcCCCCChhhhh-----------------hh------ccccCCCCCH-----------------HHHHHHHHHHH
Q 042383 123 RIIVYDYMQNNSLSQTL-----------------LG------EEKNRAKFSW-----------------TARREIALGIA 162 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l-----------------~~------~~~~~~~l~~-----------------~~~~~~~~qi~ 162 (353)
.+-+++|++|..+.+.. .. .......+.| .....++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 56789999997765411 00 0000011111 11122233333
Q ss_pred HHHH-----HHHhcCCCCeEEcCCCCCCeEECCCC--CeE-EeeccCCcc
Q 042383 163 RGLA-----YIHEEIKPSIVHRDIKPSNILLDQNF--NPK-ISDFGLSKL 204 (353)
Q Consensus 163 ~al~-----~LH~~~~~~i~H~dlk~~Nil~~~~~--~~k-l~Dfg~~~~ 204 (353)
.... .+.+ .+.++||+|+.++||+++.++ .+. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3322 1222 245899999999999998775 555 999998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.059 Score=45.26 Aligned_cols=75 Identities=13% Similarity=0.186 Sum_probs=52.5
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC---CCCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC---HENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
+.+.-|.--..|...+. ..++.+|+- .......+..|+.-|..+. .-.+.+++.+-.+..+.|+||||++-+.
T Consensus 22 ~~v~gG~inea~~v~dg-~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRDG-TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeecC-CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 34555555566666654 456888863 3444566777877777664 3567888888889999999999998866
Q ss_pred hh
Q 042383 135 LS 136 (353)
Q Consensus 135 L~ 136 (353)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.046 Score=50.33 Aligned_cols=75 Identities=19% Similarity=0.232 Sum_probs=45.7
Q ss_pred CCeeeeeCceEEEEEEeCCC--cE-----EEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQDG--TV-----VAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 128 (353)
.+.|..|-...+|++...++ .. |.+++.... ....-.-.+|+.+++.+...++ .++++.+.. .++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 44566688899999975432 22 444432211 1111123568899999865544 556666653 58999
Q ss_pred cCCCCChh
Q 042383 129 YMQNNSLS 136 (353)
Q Consensus 129 ~~~~~sL~ 136 (353)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99988764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.043 Score=49.26 Aligned_cols=72 Identities=19% Similarity=0.182 Sum_probs=56.4
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
.+.|++|++- |+++. ......+.++..++.+.+..+.-+... ...-|||+..+||+|+ +|++-|+||-
T Consensus 299 ~y~yl~~kdh-gt~is--------~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPIS--------IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceee--------eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 3456667765 44442 123346788899999999988888876 5889999999999999 9999999999
Q ss_pred CCcc
Q 042383 201 LSKL 204 (353)
Q Consensus 201 ~~~~ 204 (353)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.13 Score=45.57 Aligned_cols=30 Identities=27% Similarity=0.411 Sum_probs=24.9
Q ss_pred CCeEEcCCCCCCeEECCC--C---CeEEeeccCCc
Q 042383 174 PSIVHRDIKPSNILLDQN--F---NPKISDFGLSK 203 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~--~---~~kl~Dfg~~~ 203 (353)
.-++|||+++.||++..+ | .++++||..++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 478999999999999554 3 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 353 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-62 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-61 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-28 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 472 bits (1218), Expect = e-169
Identities = 123/304 (40%), Positives = 184/304 (60%), Gaps = 3/304 (0%)
Query: 36 LKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG-EKE 94
L + FS EL+ A++ F + N +G GGFG VYKG+L DGT+VAVK L E QG E +
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73
Query: 95 FMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR 154
F +EV ++ H NL++L G C+ R++VY YM N S++ L +++ W R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 155 REIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
+ IALG ARGLAY+H+ P I+HRD+K +NILLD+ F + DFGL+KL TH++T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193
Query: 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAW 272
V GT+G++AP+Y +G + K+D++ +GV+LL+++TGQ A + + L++
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332
+ KL+ LVD L GN+ E + ++V LLC Q RP+MS V+ M+ GD +
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313
Query: 333 DDVE 336
E
Sbjct: 314 RWEE 317
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 423 bits (1091), Expect = e-150
Identities = 118/295 (40%), Positives = 168/295 (56%), Gaps = 4/295 (1%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
+L+ ATN F +G G FG VYKG L+DG VA+K + ES QG +EF +E+ +
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 102 MANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGI 161
++ H +LV L G C E I++Y YM+N +L + L G + SW R EI +G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE-DITHISTRVAGTL 220
ARGL Y+H +I+HRD+K NILLD+NF PKI+DFG+SK E D TH+ST V GTL
Sbjct: 149 ARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280
GY+ P+Y + G L KSD+YSFGV+L +++ ++A+ L E A E HN +L
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDV 335
+ +VDP L +F + C+ S RP M V+ + + + + V
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-142
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 21/305 (6%)
Query: 38 NINAFSYNELKSATNGF------CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLS----VE 87
++FS+ ELK+ TN F NK+GEGGFG VYKG + + T VAVK L+ +
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 88 SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRA 147
+++ +++F E+ MA HENLV+L G +G +VY YM N SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTP 128
Query: 148 KFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
SW R +IA G A G+ ++HE +HRDIK +NILLD+ F KISDFGL++ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 208 -DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266
T +++R+ GT Y+AP+ + G + PKSDIYSFGV+LL+I+TG AV D+
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DEHREPQL 242
Query: 267 LVEKAWEMH-NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
L++ E+ ++ +D + + V C+ EK + RP + V +++
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 326 NGDVD 330
Sbjct: 302 QEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-86
Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 30/308 (9%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
L + G FG V+K +L VAVK+ ++ KQ + EV S
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 102 MANICHENLVKLHGGCIEGPC----RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREI 157
+ + HEN+++ G G ++ + + SLS L SW I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 158 ALGIARGLAYIHEEI-------KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210
A +ARGLAY+HE+I KP+I HRDIK N+LL N I+DFGL+ F +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 211 HI-STRVAGTLGYLAPDYAVSGHLN-----PKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264
+ GT Y+AP+ + D+Y+ G++L ++ + A +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 265 YYLVEKAWEMHNTDKLQHLV-----DPMLCGNFSGNEAVRFL-KVGLLCVQEKSSLRPRM 318
E+ + + + +Q +V P+L + + + L + C + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 319 STVIEMIN 326
V E I
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-68
Identities = 70/319 (21%), Positives = 122/319 (38%), Gaps = 41/319 (12%)
Query: 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVAS 101
+ +E + +G G +G+VYKG L D VAVKV S ++Q +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYR 60
Query: 102 MANICHENLVKLHGGCIEGPCRI-----IVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE 156
+ + H+N+ + G +V +Y N SL + L + W +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCR 115
Query: 157 IALGIARGLAYIHEEI------KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF----- 205
+A + RGLAY+H E+ KP+I HRD+ N+L+ + ISDFGLS
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 206 --PEDITHISTRVAGTLGYLAP-------DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAV 256
P + + + GT+ Y+AP + + D+Y+ G++ +I +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 257 HFDKELGEYYLV--EKAWEMHNTDKLQHLVD-----PMLCGNFSGNEAVRFLKVGLL--C 307
+ + EY + + + +Q LV P + N + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 308 VQEKSSLRPRMSTVIEMIN 326
+ + R E +
Sbjct: 296 WDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 71/198 (35%), Positives = 109/198 (55%), Gaps = 6/198 (3%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
K+G G FG+V++ + G+ VAVK+L + + EF+ EVA M + H N+V G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ P IV +Y+ SL + LL + R + R +A +A+G+ Y+H P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
IVHR++K N+L+D+ + K+ DFGLS+L S AGT ++AP+ N
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 236 KSDIYSFGVLLLQIVTGQ 253
KSD+YSFGV+L ++ T Q
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-62
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
VG G FG V K K + VA+K + ES+ K F+ E+ ++ + H N+VKL+G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ C +V +Y + SL +L + ++ L ++G+AY+H +++
Sbjct: 71 LNPVC--LVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 178 HRDIKPSNILLDQNFN-PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
HRD+KP N+LL KI DFG + DI T G+ ++AP+ + + K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 237 SDIYSFGVLLLQIVTGQ 253
D++S+G++L +++T +
Sbjct: 184 CDVFSWGIILWEVITRR 200
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 7e-61
Identities = 69/211 (32%), Positives = 108/211 (51%), Gaps = 25/211 (11%)
Query: 58 NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGE-------KEFMSEVASMANICHEN 109
++G+GGFG V+KG+L D +VVA+K L + +GE +EF EV M+N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+VKL+G P +V +++ L LL W+ + + L IA G+ Y+
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 170 EEIKPSIVHRDIKPSNILLDQ-----NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLA 224
+ P IVHRD++ NI L K++DFGLS+ H + + G ++A
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 225 PD--YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
P+ A K+D YSF ++L I+TG+
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-57
Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
K+ E G ++KG+ Q G + VKVL V S + ++F E + H N++ + G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 116 GCIEGPCR--IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
C P ++ +M SL L E + + AL +ARG+A++H +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTL-E 131
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP---DYAVS 230
P I + ++++D++ +IS + F S ++AP
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPE 185
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+D++SF VLL ++VT +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-57
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVL----SVESKQGEKEFMSEVASMANICHENLVKL 113
+G GGFG VY+ G VAVK + Q + E A + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C++ P +V ++ + L++ L G+ + A+ IARG+ Y+H+E
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 174 PSIVHRDIKPSNILLDQNFNP--------KISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
I+HRD+K SNIL+ Q KI+DFGL++ + AG ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAP 183
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+ + + SD++S+GVLL +++TG+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 65/202 (32%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G G FG+VYKGK G VAVK+L+V + Q + F +EV + H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
I+ + + +SL L + KF +IA ARG+ Y+H S
Sbjct: 88 YSTAPQLAIVT-QWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI-THISTRVAGTLGYLAP---DYAVSG 231
I+HRD+K +NI L ++ KI DFGL+ +H +++G++ ++AP S
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ +SD+Y+FG++L +++TGQ
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-54
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG VY G+ G V A++++ +E ++ K F EV + HEN+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
C+ P I+ + +L + + R+IA I +G+ Y+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKL----FPEDITHISTRVAGTLGYLAP------ 225
I+H+D+K N+ D N I+DFGL + G L +LAP
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 226 ---DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+ SD+++ G + ++ +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-54
Identities = 70/297 (23%), Positives = 123/297 (41%), Gaps = 40/297 (13%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G+G +G V+ GK + G VAVKV + +E+ + HEN++
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAAD 100
Query: 118 IEGPCRI----IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI- 172
I+G ++ DY +N SL L + ++A GL ++H EI
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 173 ----KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI---STRVAGTLGYLAP 225
KP+I HRD+K NIL+ +N I+D GL+ F D + GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 226 ---DYAVSGHLNP---KSDIYSFGVLLLQIVTGQAA--------VHFDKELGEYYLVEKA 271
D +++ + +D+YSFG++L ++ + + + + E
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLL--CVQEKSSLRPRMSTVIEMIN 326
E+ KL+ P +S +E +R + L+ C + R V + +
Sbjct: 276 REIVCIKKLR----PSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-53
Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 34/281 (12%)
Query: 58 NKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+G+G FG K + G V+ +K L ++ ++ F+ EV M + H N++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ + +Y++ +L + +++ W+ R A IA G+AY+H +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPED-------------ITHISTRVAGTLGYL 223
+HRD+ N L+ +N N ++DFGL++L ++ V G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283
AP+ + K D++SFG++L +I+ A YL N
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-------PDYLPRTMDFGLNVRGFLDR 242
Query: 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324
P C F + + C RP +
Sbjct: 243 YCPPNC-------PPSFFPITVRCCDLDPEKRPSFVKLEHW 276
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-53
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSE--VASMANICHENLVKLHG 115
VG+G +G V++G Q G VAVK+ S + EK + E + + + HEN++
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 116 GCIEGPCRI----IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+ ++ Y + SL L + I L IA GLA++H E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 172 I-----KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI---STRVAGTLGYL 223
I KP+I HRD+K NIL+ +N I+D GL+ + + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 224 AP------DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
AP + DI++FG++L ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-52
Identities = 72/310 (23%), Positives = 133/310 (42%), Gaps = 45/310 (14%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSE--VASMANICHENLVKLHG 115
+G+G FG V++GK + G VAVK+ S + E+ + E + + HEN++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 116 GCI----EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+V DY ++ SL L NR + ++AL A GLA++H E
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 172 I-----KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF---PEDITHISTRVAGTLGYL 223
I KP+I HRD+K NIL+ +N I+D GL+ + I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 224 AP---DYAVSGHLNP---KSDIYSFGVLLLQIVTGQAAVH--------FDKELGEYYLVE 269
AP D +++ ++DIY+ G++ +I + + + VE
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLL--CVQEKSSLRPRMSTVIEMING 327
+ ++ KL+ P + + EA+R + ++ C + R + + ++
Sbjct: 279 EMRKVVCEQKLR----PNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTLS- 332
Query: 328 DVDIDDDVEI 337
+ + +++
Sbjct: 333 QLSQQEGIKM 342
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 46/282 (16%)
Query: 59 KVGEGGFGSVYKGKLQDGTV-VAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGG 116
++G G FG V+ G+L+ VAVK + +F+ E + H N+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
C + IV + +Q L A+ ++ A G+ Y+ +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY----LAPDYAVSGH 232
+HRD+ N L+ + KISDFG+S+ + + G AP+ G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYGR 291
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
+ +SD++SFG+LL + + LG Y + N + +
Sbjct: 292 YSSESDVWSFGILLWETFS----------LGASPY------PNLSNQQTREFVEKGGRLP 335
Query: 286 -PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
P LC +AV ++ C + RP ST+ + +
Sbjct: 336 CPELC-----PDAVF--RLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 57/266 (21%), Positives = 101/266 (37%), Gaps = 31/266 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G G F +VYKG + VA L +K + F E + + H N+V+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 116 ----GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
C ++V + M + +L L K R I +GL ++H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 172 IKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
P I+HRD+K NI + + KI D GL+ L V GT ++AP+
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YE 203
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290
+ D+Y+FG+ +L++ T + + + Y + + P
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RVTSGVKPASFDKVAIP---- 257
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRP 316
E ++ C+++ R
Sbjct: 258 -----EVKEIIE---GCIRQNKDERY 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 23/271 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLH 114
K+G G F VY+ L DG VA+K + + K + E+ + + H N++K +
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
IE IV + LS+ + +K + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--- 155
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
++HRDIKP+N+ + K+ D GL + F T + V GT Y++P+ N
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY-LVEKAWEMHNTDKLQHLVDPMLCGNFS 293
KSDI+S G LL ++ Q+ F + Y L +K Q P+ ++S
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKI--------EQCDYPPLPSDHYS 264
Query: 294 GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324
E + + +C+ RP ++ V ++
Sbjct: 265 -EELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 56/255 (21%), Positives = 98/255 (38%), Gaps = 31/255 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+GEGGF V + L DG A+K + +Q +E E H N+++L C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 118 IEGPCR----IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ ++ + + +L + + + + LGI RGL IH
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--------GTLGYLAP 225
HRD+KP+NILL P + D G + + T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 226 ---DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---------WE 273
++ ++D++S G +L ++ G+ +D + V A
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSIPQSP 270
Query: 274 MHNTDKLQHLVDPML 288
H++ L L++ M+
Sbjct: 271 RHSSA-LWQLLNSMM 284
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 38/247 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDG-----TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLV 111
+G G FG+VYKG VA+K L S + KE + E MA++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L G C+ ++I M L + +++ + IA+G+ Y+ E+
Sbjct: 81 RLLGICLTSTVQLIT-QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL-ED 135
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LGYLAPDYAVS 230
+ +VHRD+ N+L+ + KI+DFGL+KL + + ++A + +
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
+SD++S+GV + +++T G Y + ++ L
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT----------FGSKPY------DGIPASEISSILEKGER 237
Query: 286 ---PMLC 289
P +C
Sbjct: 238 LPQPPIC 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-39
Identities = 62/249 (24%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 58 NKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
++G+G FGSV + G VVAVK L +++ ++F E+ + ++ H+N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 113 LHGGCIEG---PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
G C ++I+ +Y+ SL L +K++ + + I +G+ Y+
Sbjct: 76 YKGVCYSAGRRNLKLIM-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDY 227
+ +HRD+ NIL++ KI DFGL+K+ P+D + G + AP+
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD- 285
+ SD++SFGV+L ++ T + + E +K +M ++ L +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 286 -----PMLC 289
P C
Sbjct: 249 GRLPRPDGC 257
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-39
Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 42/265 (15%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G+G FG V K + D A+K + ++ +SEV +A++ H+ +V+ +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 118 IEGPCRI-------------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
+E + I +Y +N +L + + I
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEA 128
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS----------- 213
L+YIH + I+HRD+KP NI +D++ N KI DFGL+K + +
Sbjct: 129 LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 214 --TRVAGTLGYLAPD-YAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL------GE 264
T GT Y+A + +GH N K D+YS G++ +++ + +
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVS 245
Query: 265 YYLVEKAWEMHNTDKLQHLVDPMLC 289
+ + + ++ ++
Sbjct: 246 IEFPPDFDD-NKMKVEKKIIRLLID 269
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-38
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 32/253 (12%)
Query: 58 NKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLV 111
+GEG FG V + G VAVK L E + E+ + N+ HEN+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 112 KLHGGCIEGPCR--IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
K G C E ++ +++ + SL + L KN+ K + + + A+ I +G+ Y+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDY 227
VHRD+ N+L++ KI DFGL+K D + + + + AP+
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT-----GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282
+ SD++SFGV L +++T F K +G + +M T +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-----GQMTVTRLVNT 255
Query: 283 LVD------PMLC 289
L + P C
Sbjct: 256 LKEGKRLPCPPNC 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 62/243 (25%), Positives = 112/243 (46%), Gaps = 37/243 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V+ G + VA+K + + E++F+ E M + H LV+L+G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+E +V ++M++ LS L R F+ + L + G+AY+ EE ++
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VI 126
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL---GYLAPDYAVSGHLN 234
HRD+ N L+ +N K+SDFG+++ +D T GT + +P+ +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------P 286
KSD++SFGVL+ ++ + G+ Y N++ ++ + P
Sbjct: 184 SKSDVWSFGVLMWEVFS----------EGKIPY------ENRSNSEVVEDISTGFRLYKP 227
Query: 287 MLC 289
L
Sbjct: 228 RLA 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 62/249 (24%), Positives = 115/249 (46%), Gaps = 24/249 (9%)
Query: 58 NKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
++G+G FGSV + G VVAVK L +++ ++F E+ + ++ H+N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 113 LHGGCIEG---PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
G C ++I+ +Y+ SL L +K++ + + I +G+ Y+
Sbjct: 107 YKGVCYSAGRRNLKLIM-EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDY 227
+ +HRD+ NIL++ KI DFGL+K+ P+D + + G + AP+
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD- 285
+ SD++SFGV+L ++ T + + E +K +M ++ L +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 286 -----PMLC 289
P C
Sbjct: 280 GRLPRPDGC 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 37/243 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V GK + VA+K++ S E EF+ E M N+ HE LV+L+G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ I+ +YM N L L + R +F E+ + + Y+ E + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 142
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL---GYLAPDYAVSGHLN 234
HRD+ N L++ K+SDFGLS+ +D T G+ + P+ + +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------P 286
KSDI++FGVL+ +I + LG+ Y N++ +H+ P
Sbjct: 200 SKSDIWAFGVLMWEIYS----------LGKMPY------ERFTNSETAEHIAQGLRLYRP 243
Query: 287 MLC 289
L
Sbjct: 244 HLA 246
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
K+GEG FG K +DG +K +++ S + +E EVA +AN+ H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
E IV DY + L + + + F + + I L ++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD------YAV 229
I+HRDIK NI L ++ ++ DFG++++ + + GT YL+P+ Y
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY-- 202
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQ 253
N KSDI++ G +L ++ T +
Sbjct: 203 ----NNKSDIWALGCVLYELCTLK 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-38
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 37/245 (15%)
Query: 59 KVGEGGFGSVYKGKLQDG---TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKLH 114
++G G FGSV +G + VA+KVL +++ + E M E M + + +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G C ++V + L + L+ R + + E+ ++ G+ Y+ EE
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-EEKN- 130
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDYAVSGH 232
VHRD+ N+LL KISDFGLSK D ++ + R AG + AP+
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
+ +SD++S+GV + + ++ G+ Y +M + + +
Sbjct: 190 FSSRSDVWSYGVTMWEALS----------YGQKPY------KKMKGPEVMAFIEQGKRME 233
Query: 286 -PMLC 289
P C
Sbjct: 234 CPPEC 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 37/242 (15%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
++G G FG V GK + VAVK++ E E EF E +M + H LVK +G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
+ IV +Y+ N L L + + E+ + G+A++ E + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FIH 127
Query: 179 RDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL---GYLAPDYAVSGHLNP 235
RD+ N L+D++ K+SDFG+++ +D GT + AP+ +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------PM 287
KSD+++FG+L+ ++ + LG+ Y N++ + + P
Sbjct: 185 KSDVWAFGILMWEVFS----------LGKMPY------DLYTNSEVVLKVSQGHRLYRPH 228
Query: 288 LC 289
L
Sbjct: 229 LA 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 47/199 (23%), Positives = 78/199 (39%), Gaps = 14/199 (7%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKV--LSVESKQGEKEFMSEVASMANIC-HENLVKLH 114
++G G +G V+K +DG + AVK + ++EV S + H V+L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
EG + + SL Q E A LA++H +
Sbjct: 124 QAWEEGGILYLQTELCGP-SLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQ--- 176
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
+VH D+KP+NI L K+ DFGL + G Y+AP+ +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQE-GDPRYMAPELLQGSY-G 233
Query: 235 PKSDIYSFGVLLLQIVTGQ 253
+D++S G+ +L++
Sbjct: 234 TAADVFSLGLTILEVACNM 252
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 37/247 (14%)
Query: 58 NKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
VG G FG V G+L+ VA+K L V + ++ +F+ E + M H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G + +IV +YM+N SL L K+ A+F+ + GIA G+ Y+ +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL--APDYAVS 230
VHRD+ NIL++ N K+SDFGL ++ +D T G + +P+
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
SD++S+G++L ++++ GE Y WEM N D ++ + +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS----------YGERPY------WEMSNQDVIKAVDEGYR 268
Query: 286 ---PMLC 289
PM C
Sbjct: 269 LPPPMDC 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 75/245 (30%), Positives = 113/245 (46%), Gaps = 41/245 (16%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V+ G T VAVK L S F++E M + H+ LV+L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ P II +YM+N SL L + + K + ++A IA G+A+I EE +
Sbjct: 78 TQEPIYIIT-EYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFI-EERN--YI 131
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL-----APDYAVSGH 232
HRD++ +NIL+ + KI+DFGL++L ++ T G AP+ G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAK--FPIKWTAPEAINYGT 186
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
KSD++SFG+LL +IVT G Y M N + +Q+L
Sbjct: 187 FTIKSDVWSFGILLTEIVT----------HGRIPY------PGMTNPEVIQNLERGYRMV 230
Query: 286 -PMLC 289
P C
Sbjct: 231 RPDNC 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 45/293 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDGTV-VAVKVLSVESKQG---EKEFMSEVASMANICHENLVKL 113
+K+G G +G VY+G + ++ VAVK L K+ +EF+ E A M I H NLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C P I+ ++M +L L E NR + S +A I+ + Y+ ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
+ +HR++ N L+ +N K++DFGLS+L D + + AP+
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLVD------P 286
+ KSD+++FGVLL +I T G Y + + + L P
Sbjct: 397 SIKSDVWAFGVLLWEIAT----------YGMSPY-----PGIDLSQVYELLEKDYRMERP 441
Query: 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMST---VIEMINGDVDIDDDVE 336
C + ++ C Q S RP + E + + I D+VE
Sbjct: 442 EGC-------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 487
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 54/247 (21%), Positives = 106/247 (42%), Gaps = 38/247 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDG-----TVVAVKVLSVES-KQGEKEFMSEVASMANICHENLV 111
+G G FG+V+KG V +KV+ +S +Q + + ++ ++ H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L G C +++ Y+ SL + ++R + IA+G+ Y+ EE
Sbjct: 79 RLLGLCPGSSLQLVT-QYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYL-EE 133
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LGYLAPDYAVS 230
+VHR++ N+LL +++DFG++ L P D + A T + ++A +
Sbjct: 134 HG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
G +SD++S+GV + +++T G Y + + L
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT----------FGAEPY------AGLRLAEVPDLLEKGER 235
Query: 286 ---PMLC 289
P +C
Sbjct: 236 LAQPQIC 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 58 NKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
+++G+G FGSV + G +VAVK L +++F E+ + + + +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 113 LHGGCI---EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
G R+++ +Y+ + L L +++RA+ + + I +G+ Y+
Sbjct: 89 YRGVSYGPGRQSLRLVM-EYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDY 227
VHRD+ NIL++ + KI+DFGL+KL P D + R G + AP+
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVT 251
+ +SD++SFGV+L ++ T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-37
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G FG V+ G T VA+K L + F+ E M + HE LV+L+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
E P I+ +YM SL L + + ++A IA G+AY+ + V
Sbjct: 332 SEEPIYIVT-EYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD++ +NIL+ +N K++DFGL++L ++ + + AP+ A+ G KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLVD------PMLCG 290
D++SFG+LL ++ T G Y M N + L + P C
Sbjct: 446 DVWSFGILLTELTT----------KGRVPY-----PGMVNREVLDQVERGYRMPCPPEC- 489
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ C +++ RP + +
Sbjct: 490 ------PESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 37/243 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G G FG V+ T VAVK + + F++E M + H+ LVKLH
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ P II ++M SL L +E +K + + IA G+A+I + + +
Sbjct: 253 TKEPIYIIT-EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG---YLAPDYAVSGHLN 234
HRD++ +NIL+ + KI+DFGL+++ ++ T G + AP+ G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 363
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------P 286
KSD++SFG+LL++IVT G Y M N + ++ L P
Sbjct: 364 IKSDVWSFGILLMEIVT----------YGRIPY------PGMSNPEVIRALERGYRMPRP 407
Query: 287 MLC 289
C
Sbjct: 408 ENC 410
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 45/213 (21%), Positives = 89/213 (41%), Gaps = 25/213 (11%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICH--ENLVKL 113
++G GG V++ + + A+K +++E Q + +E+A + + + +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ I + N L+ L K + R+ + + IH+
Sbjct: 75 Y-DYEITDQYIYMVMECGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR-VAGTLGYLAP------- 225
IVH D+KP+N L+ K+ DFG++ D T + GT+ Y+ P
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 226 ----DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+ ++PKSD++S G +L + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G FG V+ G T VA+K L + F+ E M + HE LV+L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
E P I+ +YM SL L + + ++A IA G+AY+ + V
Sbjct: 249 SEEPIYIVT-EYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD++ +NIL+ +N K++DFGL++L ++ + + AP+ A+ G KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLVD------PMLCG 290
D++SFG+LL ++ T G Y M N + L + P C
Sbjct: 363 DVWSFGILLTELTT----------KGRVPY-----PGMVNREVLDQVERGYRMPCPPEC- 406
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ C +++ RP + +
Sbjct: 407 ------PESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
+G G +G K + DG ++ K L ++ ++ +SEV + + H N+V+ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 116 GCIE--GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
I+ IV +Y + L+ + K R + + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 174 PS--IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
++HRD+KP+N+ LD N K+ DFGL+++ D + T V GT Y++P+
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
N KSDI+S G LL ++
Sbjct: 192 SYNEKSDIWSLGCLLYELCALM 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 39/246 (15%)
Query: 59 KVGEGGFGSVYKGKLQDG---TVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKL 113
++G G FG+V KG Q VAVK+L E + E ++E M + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G C ++V + + L++ L + E+ ++ G+ Y+ EE
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL-EESN 137
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPDYAVSG 231
VHRD+ N+LL KISDFGLSK D + + G + AP+
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD---- 285
+ KSD++SFGVL+ + + G+ Y M ++ L
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS----------YGQKPY------RGMKGSEVTAMLEKGERM 239
Query: 286 --PMLC 289
P C
Sbjct: 240 GCPAGC 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-37
Identities = 46/214 (21%), Positives = 90/214 (42%), Gaps = 27/214 (12%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENL--VKL 113
++G GG V++ + + A+K +++E Q + +E+A + + + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 114 HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ I +V + N L+ L K + R+ + + IH+
Sbjct: 94 Y-DYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH- 146
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR-VAGTLGYLAP------ 225
IVH D+KP+N L+ K+ DFG++ D T + GT+ Y+ P
Sbjct: 147 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 226 -----DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+ ++PKSD++S G +L + G+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 53/247 (21%), Positives = 102/247 (41%), Gaps = 38/247 (15%)
Query: 58 NKVGEGGFGSVYKGKLQDG-----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLV 111
+G G FG+VYKG VA+K L + E + E MA++ + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L G C+ ++I M L + +++ + IA+G+ Y+ E+
Sbjct: 81 RLLGICLTSTVQLIT-QLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL-ED 135
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT-LGYLAPDYAVS 230
+ +VHRD+ N+L+ + KI+DFGL+KL + + ++A + +
Sbjct: 136 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
+SD++S+GV + +++T G Y + ++ L
Sbjct: 194 RIYTHQSDVWSYGVTVWELMT----------FGSKPY------DGIPASEISSILEKGER 237
Query: 286 ---PMLC 289
P +C
Sbjct: 238 LPQPPIC 244
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 69/247 (27%), Positives = 116/247 (46%), Gaps = 38/247 (15%)
Query: 59 KVGEGGFGSVYKGKLQDGTV-----VAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
+G G FG VYKG L+ + VA+K L + ++ +F+ E M H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G + +I+ +YM+N +L + L + +FS + GIA G+ Y+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY--LAPDYAVS 230
+ VHRD+ NIL++ N K+SDFGLS++ +D T G + AP+
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
SD++SFG+++ +++T GE Y WE+ N + ++ + D
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT----------YGERPY------WELSNHEVMKAINDGFR 268
Query: 286 ---PMLC 289
PM C
Sbjct: 269 LPTPMDC 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 67/247 (27%), Positives = 111/247 (44%), Gaps = 37/247 (14%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
+G G G V G+L+ VA+K L + ++ +F+SE + M H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L G G +IV +YM+N SL L + +F+ + G+ G+ Y+ +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL--APDYAVS 230
VHRD+ N+L+D N K+SDFGLS++ +D T G + AP+
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
+ SD++SFGV++ +++ GE Y W M N D + + +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA----------YGERPY------WNMTNRDVISSVEEGYR 272
Query: 286 ---PMLC 289
PM C
Sbjct: 273 LPAPMGC 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 44/212 (20%), Positives = 87/212 (41%), Gaps = 25/212 (11%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENL--VKL 113
++G GG V++ + + A+K +++E Q + +E+A + + + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ I + N L+ L K + R+ + + IH+
Sbjct: 122 Y-DYEITDQYIYMVMECGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR-VAGTLGYLAP------- 225
IVH D+KP+N L+ K+ DFG++ D T + G + Y+ P
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 226 ----DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+ ++PKSD++S G +L + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKLH 114
K+G GG +VY + VA+K + + ++ E K F EV + + + H+N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
E C +V +Y++ +LS+ + ++ S I G+ + H+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED-ITHISTRVAGTLGYLAPDYAVSGHL 233
IVHRDIKP NIL+D N KI DFG++K E +T + V GT+ Y +P+ A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189
Query: 234 NPKSDIYSFGVLLLQIVTGQ 253
+ +DIYS G++L +++ G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 37/245 (15%)
Query: 59 KVGEGGFGSVYKGKLQDG---TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLH 114
++G G FGSV +G + VA+KVL K +E M E M + + +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G C ++V + L + L+ R + + E+ ++ G+ Y+ EE
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYL-EEKN- 456
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY--LAPDYAVSGH 232
VHR++ N+LL KISDFGLSK D ++ + R AG AP+
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
+ +SD++S+GV + + ++ G+ Y +M + + +
Sbjct: 516 FSSRSDVWSYGVTMWEALS----------YGQKPY------KKMKGPEVMAFIEQGKRME 559
Query: 286 -PMLC 289
P C
Sbjct: 560 CPPEC 564
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 36/244 (14%)
Query: 59 KVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKL 113
+GEG FG V++G VA+K + + +F+ E +M H ++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G E P I+ + L L + + A ++ LAY+ E +
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYL-ESKR 136
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
VHRDI N+L+ N K+ DFGLS+ + + +++ + ++AP+
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------ 285
SD++ FGV + +I+ G + + N D + + +
Sbjct: 195 TSASDVWMFGVCMWEILM----------HGVKPF------QGVKNNDVIGRIENGERLPM 238
Query: 286 PMLC 289
P C
Sbjct: 239 PPNC 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 22/238 (9%)
Query: 58 NKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLV 111
+GEG FG V G +VAVK L + Q + E+ + + HE+++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 112 KLHGGCIEG---PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
K G C + ++++ +Y+ SL L R A I G+AY+
Sbjct: 97 KYKGCCEDAGAASLQLVM-EYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL--GYLAPD 226
H + +HRD+ N+LLD + KI DFGL+K PE + R G + AP+
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283
SD++SFGV L +++T ++ + E + + +M + L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVLRLTELL 264
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 41/246 (16%)
Query: 58 NKVGEGGFGSVYKGKLQDGTV-VAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+K+G G +G VY+G + ++ VAVK L ++ + +EF+ E A M I H NLV+L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
C P I+ ++M +L L E NR + S +A I+ + Y+ E+
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYL-EKKN--F 132
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL-----APDYAVSG 231
+HRD+ N L+ +N K++DFGLS+L D T A AP+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYN 187
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD---- 285
+ KSD+++FGVLL +I T G Y + + + L
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT----------YGMSPY------PGIDLSQVYELLEKDYRM 231
Query: 286 --PMLC 289
P C
Sbjct: 232 ERPEGC 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 59 KVGEGGFGSVYKGKLQ----DGTVVAVKVL---SVESKQGEKEFMSEVASMANICHENLV 111
K+G+G FG V +G+ VAVK L + + +F+ EV +M ++ H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L+G + P +V + SL L K++ F A+ +A G+ Y+ +
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY--LAPDYAV 229
+HRD+ N+LL KI DFGL + P++ H + + + AP+
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 230 SGHLNPKSDIYSFGVLLLQIVT 251
+ + SD + FGV L ++ T
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGG 116
+G GGFG V++ K D A+K + + +++ +E M EV ++A + H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 117 CIEGPCRI------------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
+E I + +L + + + I L IA
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF-----------PEDITHIS 213
+ ++H + ++HRD+KPSNI + K+ DFGL P
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLL 246
T GT Y++P+ + K DI+S G++L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 42/247 (17%)
Query: 59 KVGEGGFGSVYKGKLQDG----TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKL 113
+GEG FG VY+G + VAVK + + +++FMSE M N+ H ++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G E P I+ + L L E+N+ +L I + +AY+ E I
Sbjct: 79 IGIIEEEP-TWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL---GYLAPDYAVS 230
VHRDI NIL+ K+ DFGLS+ ++ + + T +++P+
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD--- 285
SD++ F V + +I++ G+ + + + N D + L
Sbjct: 189 RRFTTASDVWMFAVCMWEILS----------FGKQPF------FWLENKDVIGVLEKGDR 232
Query: 286 ---PMLC 289
P LC
Sbjct: 233 LPKPDLC 239
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
+G+G +G VY G+ L + +A+K + + + E+A ++ H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E I + + SLS LL + K + I GL Y+H+ IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 179 RDIKPSNILLDQ-NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP---DYAVSGHLN 234
RDIK N+L++ + KISDFG SK T GTL Y+AP D G+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY-G 203
Query: 235 PKSDIYSFGVLLLQIVTGQ 253
+DI+S G ++++ TG+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 59 KVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVKL 113
+GEG FG V++G VA+K + + +F+ E +M H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G E P II+ + L L + + + A ++ LAY+ E +
Sbjct: 457 IGVITENPVWIIM-ELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYL-ESKR 511
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
VHRDI N+L+ N K+ DFGLS+ + + +++ + ++AP+
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD------ 285
SD++ FGV + +I+ G + + N D + + +
Sbjct: 570 TSASDVWMFGVCMWEILM----------HGVKPF------QGVKNNDVIGRIENGERLPM 613
Query: 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
P C + C S RPR + + ++
Sbjct: 614 PPNC-------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHG- 115
+G GGFG V+K K DG +K + ++ + EV ++A + H N+V +G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGC 72
Query: 116 ---------------GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+ C I ++ +L Q + E++ K E+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQ 130
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
I +G+ YIH + +++RD+KPSNI L KI DFGL D TR GTL
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTL 185
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLL 246
Y++P+ S + D+Y+ G++L
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLIL 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 60/298 (20%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEKEFMSEVASMANICHENLV 111
++GEG FG V+ + + +VAVK L S+ ++F E + + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTL-----------LGEEKNRAKFSWTARREIALG 160
+ G C EG ++V++YM++ L++ L GE+ +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+A G+ Y+ + VHRD+ N L+ Q KI DFG+S+ DI G
Sbjct: 167 VAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGR 219
Query: 221 GYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWE 273
L P+ + +SD++SFGV+L +I T G+ + ++
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT----------YGKQPW------YQ 263
Query: 274 MHNTDKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ NT+ + + P C + C Q + R + V +
Sbjct: 264 LSNTEAIDCITQGRELERPRAC-------PPEVYAIMRGCWQREPQQRHSIKDVHARL 314
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 61/299 (20%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLV 111
++GEG FG V+ + +D +VAVK L + K+F E + N+ HE++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE------------IAL 159
K +G C +G I+V++YM++ L++ L + R+ IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT 219
IA G+ Y+ VHRD+ N L+ N KI DFG+S+ D+ G
Sbjct: 141 QIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGG 193
Query: 220 LGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAW 272
L P+ + +SD++SFGV+L +I T G+ ++
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT----------YGKQPWF------ 237
Query: 273 EMHNTDKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
++ NT+ ++ + P +C V L C Q + R + + +++
Sbjct: 238 QLSNTEVIECITQGRVLERPRVC-------PKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 56/304 (18%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLV 111
+GEG FGSV +G L+ VAVK + ++ S++ +EF+SE A M + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 112 KLHGGCIEG-----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR--EIALGIARG 164
+L G CIE P +++ +M+ L LL + + + IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL- 223
+ Y+ +HRD+ N +L + ++DFGLSK I G + +
Sbjct: 160 MEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMP 212
Query: 224 ----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNT 277
A + KSD+++FGV + +I T G Y + N
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGMTPY------PGVQNH 256
Query: 278 DKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331
+ +L+ P C ++ C + RP S + + ++
Sbjct: 257 EMYDYLLHGHRLKQPEDC-------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
Query: 332 DDDV 335
DV
Sbjct: 310 LPDV 313
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG--EKEFMSEVASMANICHENLVKLHG 115
+G+G FG V G + G VAVK + K + F++E + M + H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 116 GCI-EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+ E IV +YM SL L + R+ + +L + + Y+
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGT---LGYLAPDYAVSG 231
+ VHRD+ N+L+ ++ K+SDFGL+K S+ + + AP+
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361
Query: 232 HLNPKSDIYSFGVLLLQIVT 251
+ KSD++SFG+LL +I +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 46/286 (16%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
+G G FG VY G L D AVK L+ + GE +F++E M + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 113 LHGGCIEG-PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
L G C+ ++V YM++ L + + L +A+G+ Y+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL-AS 146
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTL--GYLAPDYA 228
K VHRD+ N +LD+ F K++DFGL++ ++ ++ + + L ++A +
Sbjct: 147 KK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD- 285
+ KSD++SFGVLL +++T G Y +++ D +L+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT----------RGAPPY------PDVNTFDITVYLLQG 248
Query: 286 -----PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
P C +V L C K+ +RP S ++ I+
Sbjct: 249 RRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 33/217 (15%)
Query: 61 GEGGFGSVYKGKLQDGTVVAVKVLS-----------------VESKQGEKEFMSEVASMA 103
+G F + + +D A+K + K +F +E+ +
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 104 NICHENLVKLHGGCIEGPCRI-IVYDYMQN----NSLSQTLLGEEKNRAKFSWTARREIA 158
+I +E + G I + I+Y+YM+N + ++ + I
Sbjct: 99 DIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+ +YIH + +I HRD+KPSNIL+D+N K+SDFG S+ + S G
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RG 212
Query: 219 TLGYLAPDYAVSGHL---NPKSDIYSFGVLLLQIVTG 252
T ++ P+ S K DI+S G+ L +
Sbjct: 213 TYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
+G+G FG VY G+ D A+K LS ++ + F+ E M + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 113 LHGGCIEG-PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
L G + ++ YM + L Q + + + L +ARG+ Y+ E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL-AE 142
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE-DITHISTRVAGTL--GYLAPDYA 228
K VHRD+ N +LD++F K++DFGL++ + + + L + A +
Sbjct: 143 QK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 229 VSGHLNPKSDIYSFGVLLLQIVT 251
+ KSD++SFGVLL +++T
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKLH 114
+G GG V+ + L+D VAVKVL + + F E + A + H +V ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 115 -GGCIEGPCRIIVY---DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
G E P + Y +Y+ +L + + E+ + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI--STRVAGTLGYLAPDYA 228
I+HRD+KP+NI++ K+ DFG+++ + + + V GT YL+P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQ 253
++ +SD+YS G +L +++TG+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEK-EFMSEVASMANICHENL 110
++G+G FG VY+G + T VA+K ++ + E+ EF++E + M ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR------EIALGIARG 164
V+L G +G +++ + M L L A A ++A IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL- 223
+AY+ K VHRD+ N ++ ++F KI DFG+++ DI G G L
Sbjct: 151 MAYL-NANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203
Query: 224 ----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+P+ G SD++SFGV+L +I T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 45/245 (18%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG--EKEFMSEVASMANICHENLVKLHG 115
+G+G FG V G + G VAVK + K + F++E + M + H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+E + IV +YM SL L + R+ + +L + + Y+ E
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN- 137
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY--LAPDYAVSGH 232
VHRD+ N+L+ ++ K+SDFGL+K + + ST+ G L AP+
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTK----EAS--STQDTGKLPVKWTAPEALREKK 190
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD----- 285
+ KSD++SFG+LL +I + G Y + D + +
Sbjct: 191 FSTKSDVWSFGILLWEIYS----------FGRVPY------PRIPLKDVVPRVEKGYKMD 234
Query: 286 -PMLC 289
P C
Sbjct: 235 APDGC 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKV--LSVESKQGEKEFMSEVASMANIC-HENLVKLH 114
K+G G FGSV+K K DG + A+K + E+ + EV + A + H ++V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
E +I +Y SL+ + + + F +++ L + RGL YIH
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--- 134
Query: 175 SIVHRDIKPSNILLDQNFNP-------------------KISDFGLSKLFPEDITHISTR 215
S+VH DIKPSNI + + P KI D G
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191
Query: 216 VAGTLGYLAP-----DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
G +LA +Y H PK+DI++ + ++ +
Sbjct: 192 --GDSRFLANEVLQENY---TH-LPKADIFALALTVVCAAGAE 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 63/294 (21%), Positives = 119/294 (40%), Gaps = 63/294 (21%)
Query: 59 KVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL 110
+G+G F ++KG ++ T V +KVL + + F + M+ + H++L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
V +G C+ G I+V ++++ SL L +KN+ + + E+A +A + ++ E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 171 EIKPSIVHRDIKPSNILLDQNFNP--------KISDFGLSK-LFPEDITHISTRVAGTLG 221
E ++H ++ NILL + + K+SD G+S + P+DI
Sbjct: 131 ENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 222 YLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTD 278
++ P+ +LN +D +SFG L +I + G+ + +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICS----------GGDKPL------SALDSQR 226
Query: 279 KLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
KLQ D P + C+ + RP +I +N
Sbjct: 227 KLQFYEDRHQLPAPKAA---------ELANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLHG 115
G+GGF ++ V A K++ ++ Q EK E++ ++ H+++V HG
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 108
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFS-WTARREIALGIARGLAYIHEEIK 173
E + +V + + SL + K R + AR I G Y+H
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD-YAVSGH 232
++HRD+K N+ L+++ KI DFGL+ D + GT Y+AP+ + GH
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 233 LNPKSDIYSFGVLLLQIVTG 252
+ + D++S G ++ ++ G
Sbjct: 219 -SFEVDVWSIGCIMYTLLVG 237
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLV 111
+G+G FGSV + +L+ VAVK+L + + +EF+ E A M H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 112 KLHGGCIEG------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARR--EIALGIAR 163
KL G + P +++ +M++ L LL F+ + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
G+ Y+ +HRD+ N +L ++ ++DFGLS+ I G L
Sbjct: 149 GMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKL 201
Query: 224 -----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
A + SD+++FGV + +I+T
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHGG 116
G+G FG+VY + Q+ ++A+KVL +E + E + E+ +++ H N+++++
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN- 81
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFS-WTARREIALGIARGLAYIHEEIKP 174
RI ++ ++ L + L + +F + + +A L Y HE
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEE-LADALHYCHER--- 133
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
++HRDIKP N+L+ KI+DFG S P T + GTL YL P+ +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTHD 190
Query: 235 PKSDIYSFGVLLLQIVTG 252
K D++ GVL + + G
Sbjct: 191 EKVDLWCAGVLCYEFLVG 208
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGG 116
+G+G +V++G+ + G + A+KV + S + M E + + H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 117 CIEGPCRIIVY---DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
E ++ SL +L E N + + + G+ ++ E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 174 PSIVHRDIKPSNILL----DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD--- 226
IVHR+IKP NI+ D K++DFG ++ +D + GT YL PD
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 227 -----YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 71/294 (24%), Positives = 112/294 (38%), Gaps = 56/294 (19%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEK-EFMSEVASMANICHENL 110
+G G FG VY+G++ VAVK L + ++ +F+ E ++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLL---GEEKNRAKFSWTARREIALGIARGLAY 167
V+ G ++ R I+ + M L L + + +A IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 168 IHEEIKPSIVHRDIKPSNILLD---QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL- 223
+ EE +HRDI N LL KI DFG+++ DI S G L
Sbjct: 156 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLP 208
Query: 224 ----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNT 277
P+ + G K+D +SFGVLL +I + LG Y N
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYMPY------PSKSNQ 252
Query: 278 DKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ L+ + P C ++ C Q + RP + ++E I
Sbjct: 253 EVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERI 299
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 47/203 (23%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 59 KVGEGGFGSVYKGK--LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKL-- 113
+ GG G +Y +G V +K L + M+E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 114 ---HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
H P IV +Y+ SL ++ K L I L+Y+H
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+V+ D+KP NI+L + K+ D G I + GT G+ AP+
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGY-LYGTPGFQAPEIV-R 250
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+DIY+ G L +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHGG 116
G+G FG+VY + Q ++A+KVL +E E + EV +++ H N+++L+G
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG- 76
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFS-WTARREIALGIARGLAYIHEEIKP 174
R+ ++ +Y ++ + L + +KF I +A L+Y H +
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE-LANALSYCHSK--- 128
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
++HRDIKP N+LL KI+DFG S P + GTL YL P+ +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHD 185
Query: 235 PKSDIYSFGVLLLQIVTG 252
K D++S GVL + + G
Sbjct: 186 EKVDLWSLGVLCYEFLVG 203
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-34
Identities = 34/232 (14%), Positives = 64/232 (27%), Gaps = 41/232 (17%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE------------------------ 94
+G+ + + + G V V +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 95 ------FMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNN--SLSQTLLGEEKNR 146
F ++ V+L + R +Y MQ+N + + LL
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 147 AKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206
AR ++ L + R LA +H +VH ++P +I+LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 207 EDITHISTRVAGTLGYLAP-----DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
R A + D ++ G+ + I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 72/294 (24%), Positives = 114/294 (38%), Gaps = 56/294 (19%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEK-EFMSEVASMANICHENL 110
+G G FG VY+G++ VAVK L + ++ +F+ E ++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE---IALGIARGLAY 167
V+ G ++ R I+ + M L L ++ S A + +A IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 168 IHEEIKPSIVHRDIKPSNILLD---QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL- 223
+ EE +HRDI N LL KI DFG+++ DI G L
Sbjct: 197 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLP 249
Query: 224 ----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNT 277
P+ + G K+D +SFGVLL +I + LG Y N
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYMPY------PSKSNQ 293
Query: 278 DKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ L+ + P C ++ C Q + RP + ++E I
Sbjct: 294 EVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERI 340
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLHG 115
G+GGF ++ V A K++ ++ Q EK E++ ++ H+++V HG
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFHG 82
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
E + +V + + SL + K R + R I G Y+H
Sbjct: 83 -FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD-YAVSGHL 233
++HRD+K N+ L+++ KI DFGL+ D + GT Y+AP+ + GH
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH- 192
Query: 234 NPKSDIYSFGVLLLQIVTG 252
+ + D++S G ++ ++ G
Sbjct: 193 SFEVDVWSIGCIMYTLLVG 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 48/287 (16%)
Query: 58 NKVGEGGFGSVYKGKLQDG----TVVAVKVLSVESKQGEK-EFMSEVASMANICHENLVK 112
+G G FG VY G L D AVK L+ + GE +F++E M + H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 113 LHGGCI--EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
L G C+ EG +++ YM++ L + + L +A+G+ ++
Sbjct: 155 LLGICLRSEGSPLVVL-PYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL-A 209
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDITHISTRVAGTL--GYLAPDY 227
K VHRD+ N +LD+ F K++DFGL++ ++ ++ + + L ++A +
Sbjct: 210 SKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWEMHNTDKLQHLVD 285
+ KSD++SFGVLL +++T G Y +++ D +L+
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT----------RGAPPY------PDVNTFDITVYLLQ 311
Query: 286 ------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
P C +V L C K+ +RP S ++ I+
Sbjct: 312 GRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 48/227 (21%), Positives = 85/227 (37%), Gaps = 43/227 (18%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGG 116
+ EGGF VY+ + + G A+K L ++ + + EV M + H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 117 CIEGP----------------CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
G C+ + +++ S+ L + T + I
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCD--------TVLK-IFYQ 144
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--- 217
R + ++H + KP I+HRD+K N+LL K+ DFG + + +
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 218 --------GTLGYLAP---DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
T Y P D + + K DI++ G +L + Q
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 62/301 (20%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENL 110
++GE FG VYKG L VA+K L + +EF E A + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTL------------LGEEKNRAKFSWTARREIA 158
V L G + +++ Y + L + L + ++ +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
IA G+ Y+ +VH+D+ N+L+ N KISD GL + ++
Sbjct: 135 AQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLL 187
Query: 219 TLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKA 271
L AP+ + G + SDI+S+GV+L ++ + G Y
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------YGLQPY------ 231
Query: 272 WEMHNTDKLQHLVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
N D ++ + + P C + + C E S RPR + +
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDC-------PAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 326 N 326
Sbjct: 285 R 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGG 116
+G+G +V++G+ + G + A+KV + S + M E + + H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA- 74
Query: 117 CIEGPCRIIVY---DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
E ++ SL +L E N + + + G+ ++ E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 174 PSIVHRDIKPSNILL----DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD--- 226
IVHR+IKP NI+ D K++DFG ++ +D + GT YL PD
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPDMYE 188
Query: 227 -----YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+VG G FG V++ K Q G AVK + +E + + E+ + A + +V L+G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
EGP I + ++ SL Q + K GL Y+H I
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 177 VHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTR----VAGTLGYLAPDYAV-- 229
+H D+K N+LL + + + DFG + D S + GT ++AP+ V
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE--VVM 229
Query: 230 -SGHLNPKSDIYSFGVLLLQIVTGQ 253
+ K DI+S ++L ++ G
Sbjct: 230 GKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGGCI 118
G GGFG V + G VA+K E +E + E+ M + H N+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-VP 81
Query: 119 EGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+G ++ + +Y + L + L + +N R + I+ L Y+HE
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 172 IKPSIVHRDIKPSNILLDQNFNP---KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
I+HRD+KP NI+L KI D G +K + + V GTL YLAP+
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQYLAPELL 195
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQ 253
D +SFG L + +TG
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHGG 116
G+G F VY+ + + G VA+K++ + + +EV + H ++++L+
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN- 78
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAK-FS-WTARREIALGIARGLAYIHEEIK 173
E + +V + N +++ L KNR K FS AR + I G+ Y+H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMH-QIITGMLYLHSH-- 131
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
I+HRD+ SN+LL +N N KI+DFGL+ T + GT Y++P+ A
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 234 NPKSDIYSFGVLLLQIVTG 252
+SD++S G + ++ G
Sbjct: 190 GLESDVWSLGCMFYTLLIG 208
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-33
Identities = 22/227 (9%), Positives = 60/227 (26%), Gaps = 41/227 (18%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLHG- 115
G V+ + ++ A+KV ++ ++ E + A + E+ +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 116 ---------GCIEGPCRI----------------IVYDYMQNN--SLSQTLLGEEKNRAK 148
++ ++ + L TL R
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 149 FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208
A + + R A + + +VH P N+ + + + D
Sbjct: 191 EGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246
Query: 209 ITHISTRVAGTLGYLAPDYAVSGHL--NPKSDIYSFGVLLLQIVTGQ 253
+ + Y ++ + + + G+ + ++
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 58 NKVGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGEK-EFMSEVASMANI-CHEN 109
+G G FG V + VAVK+L + E MSE+ + +I H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 110 LVKLHGGC--IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE----------- 156
+V L G C GP +IV ++ + +LS L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 157 -IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215
+ +A+G+ ++ K +HRD+ NILL + KI DFGL++ DI
Sbjct: 152 CYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDY 204
Query: 216 VAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
V L AP+ +SD++SFGVLL +I +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 58 NKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEK-EFMSEVASMANI-CH 107
+GEG FG V + VAVK+L ++ + + + +SE+ M I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 108 ENLVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE---------- 156
+N++ L G C +GP +IV +Y +L + L ++S+ R
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 157 --IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
+ARG+ Y+ K +HRD+ N+L+ +N KI+DFGL++ DI +I
Sbjct: 160 VSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 212
Query: 215 RVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G L AP+ +SD++SFGVL+ +I T
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 60/258 (23%), Positives = 97/258 (37%), Gaps = 32/258 (12%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVK 112
FC + +G G G++ + D VAVK + + EV + H N+++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ + I + +L + + E+ + GLA++H
Sbjct: 83 YFCTEKDRQFQYIAIELCAA-TLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSL- 137
Query: 173 KPSIVHRDIKPSNILL-----DQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAP 225
+IVHRD+KP NIL+ ISDFGL K S R V GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 226 ---DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH-FDKEL--------GEYYLVEKAWE 273
+ DI+S G + +++ H F K L G L E
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE--GSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 274 MHNTDKLQHLVDPMLCGN 291
H + L++ M+ +
Sbjct: 254 KHEDVIARELIEKMIAMD 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 29/236 (12%), Positives = 69/236 (29%), Gaps = 52/236 (22%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE------------------------- 94
G+ + + + G V V +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 95 ---FMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRA---- 147
F+ + + + ++++ + + Y + S QT + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 148 KFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
AR ++ L + R LA +H +VH ++P +I+LDQ ++ F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 208 DITHISTRVAGTLGYLAPDYAVS-----------GHLNPKSDIYSFGVLLLQIVTG 252
+ + + G+ P+ + D ++ G+++ I
Sbjct: 259 RVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 58 NKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEK-EFMSEVASMANI-CH 107
+GEG FG V + VAVK+L ++ + + + +SE+ M I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 108 ENLVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE---------- 156
+N++ L G C +GP +IV +Y +L + L ++S+ R
Sbjct: 147 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 157 --IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
+ARG+ Y+ K +HRD+ N+L+ +N KI+DFGL++ DI +I
Sbjct: 206 VSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDY 258
Query: 215 RVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G L AP+ +SD++SFGVL+ +I T
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 58 NKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKLHG 115
+++G G G V+K G V+A K++ +E K + + E+ + +V +G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
I ++M SL Q L K + ++++ + +GL Y+ E+ K
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHK-- 152
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
I+HRD+KPSNIL++ K+ DFG+S + + + + V GT Y++P+ H +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSV 209
Query: 236 KSDIYSFGVLLLQIVTGQ 253
+SDI+S G+ L+++ G+
Sbjct: 210 QSDIWSMGLSLVEMAVGR 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEK-EFMSEVASMANI-CHEN 109
+G G FG V + VAVK+L + E+ MSE+ ++ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 110 LVKLHGGC-IEGPCRIIVYDYMQNNSL------------SQTLLGEEKNRAKFSWTARR- 155
+V L G C I GP +I +Y L + +
Sbjct: 89 IVNLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 156 -EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
+ +A+G+A++ +HRD+ NILL KI DFGL++ DI + S
Sbjct: 148 LSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSN 200
Query: 215 RVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
V L AP+ + +SD++S+G+ L ++ +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 41/227 (18%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEK-EFMSEVASMANICHENL 110
+GEG FG V K T VAVK+L + E + +SE + + H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 111 VKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE------------- 156
+KL+G C +GP +IV +Y + SL L K + +
Sbjct: 89 IKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 157 -------IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209
A I++G+ Y+ E+K +VHRD+ NIL+ + KISDFGLS+ D+
Sbjct: 148 TMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSR----DV 200
Query: 210 THISTRVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+ V + G + A + +SD++SFGVLL +IVT
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 58 NKVGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGEK-EFMSEVASMANI-CHEN 109
+G G FG V + VAVK+L + EK MSE+ M+++ HEN
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 110 LVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE----------IA 158
+V L G C GP +I +Y L L + + A +
Sbjct: 112 IVNLLGACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAG 218
+A+G+A++ +HRD+ N+LL KI DFGL++ DI + S +
Sbjct: 171 SQVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVK 223
Query: 219 TLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
L AP+ +SD++S+G+LL +I +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKLH 114
VG GG G VY+ + +VA+K++S E + + ++V +H
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 115 G-GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G I+G + + L+ L + + + I I L H
Sbjct: 101 DFGEIDG-QLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED-ITHISTRVAGTLGYLAPDYAVSGH 232
HRD+KP NIL+ + + DFG++ ++ +T + GTL Y+AP+ H
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 233 LNPKSDIYSFGVLLLQIVTGQ 253
++DIY+ +L + +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-31
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 58 NKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEK-EFMSEVASMANI-CH 107
+GEG FG V + T VAVK+L ++ + + + +SE+ M I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 108 ENLVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE---------- 156
+N++ L G C +GP +IV +Y +L + L ++S+
Sbjct: 135 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 157 --IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
A +ARG+ Y+ K +HRD+ N+L+ ++ KI+DFGL++ DI HI
Sbjct: 194 VSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246
Query: 215 RVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
T G L AP+ +SD++SFGVLL +I T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENL 110
+GEG FG V++ + T+VAVK+L E S + +F E A MA + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE-------------- 156
VKL G C G ++++YM L++ L +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLR---SMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 157 ---------IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207
IA +A G+AY+ E K VHRD+ N L+ +N KI+DFGLS+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSR---- 222
Query: 208 DITHISTRVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
+I A + P+ +SD++++GV+L +I +
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE-KEFMSEVA-SMANICHENLVKLH 114
++G G +G V K + + G ++AVK + E K + ++ SM + V +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G I + M + SL + +IA+ I + L ++H ++
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP----DYAVS 230
++HRD+KPSN+L++ K+ DFG+S +D+ AG Y+AP
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKPYMAPERINPELNQ 187
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+ KSDI+S G+ ++++ +
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 68/252 (26%), Positives = 111/252 (44%), Gaps = 36/252 (14%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+G+G FG V K G AVKV+S V+ K ++ + EV + + H N++KL
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYI 168
+ + +V + G E +R +FS I + G+ Y+
Sbjct: 92 YEFFEDKGYFYLVGEVYT---------GGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 169 HEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
H+ IVHRD+KP N+LL ++ N +I DFGLS F GT Y+AP
Sbjct: 143 HKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAP 197
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKE--------LGEYYLVEKAWEMHNT 277
+ + G + K D++S GV+L +++G + E G+Y W+ +
Sbjct: 198 E-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVS 255
Query: 278 DKLQHLVDPMLC 289
+ + L+ ML
Sbjct: 256 ESAKDLIRKMLT 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE-KEFMSEVA-SMANICHENLVKLHG 115
++G G +GSV K G ++AVK + + E K+ + ++ M + +V+ +G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
I + M + +I L + L ++ E +K
Sbjct: 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-- 146
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP----DYAVSG 231
I+HRDIKPSNILLD++ N K+ DFG+S + I TR AG Y+AP A
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQ 204
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ +SD++S G+ L ++ TG+
Sbjct: 205 GYDVRSDVWSLGITLYELATGR 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 43/228 (18%)
Query: 58 NKVGEGGFGSVYKGKLQDG------TVVAVKVLSVESKQGEK-EFMSEVASMANI-CHEN 109
+G G FG V VAVK+L ++ E+ MSE+ M + HEN
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 110 LVKLHGGC-IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE------------ 156
+V L G C + GP +I +Y L L ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIF-EYCCYGDL-LNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 157 --------IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208
A +A+G+ ++ E VHRD+ N+L+ KI DFGL++ D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLAR----D 221
Query: 209 ITHISTRVAGTLGYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
I S V L AP+ G KSD++S+G+LL +I +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 50/201 (24%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+G+G G+VY + G VA++ ++++ + ++ ++E+ M + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 117 CIEGPCRIIVYDYMQNNSLS----QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ G +V +Y+ SL+ +T + E + A + + L ++H
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALEFLHSN- 135
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
++HRDIK NILL + + K++DFG + + ST V GT ++AP+
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 233 LNPKSDIYSFGVLLLQIVTGQ 253
PK DI+S G++ ++++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 51/231 (22%), Positives = 85/231 (36%), Gaps = 44/231 (19%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASM-ANICHENLVK 112
S +G G G+V G VAVK + + E+ + + H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 113 LHGGCIEGPCRIIV--------YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
+ I D +++ ++S ++N + IA G
Sbjct: 74 YYCSETTDRFLYIALELCNLNLQDLVESKNVS------DENLKLQKEYNPISLLRQIASG 127
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLD-------------QNFNPKISDFGLSKLFPEDITH 211
+A++H I+HRD+KP NIL+ +N ISDFGL K +
Sbjct: 128 VAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 212 ISTR---VAGTLGYLAP-------DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
T +GT G+ AP + L DI+S G + I++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+GEG G V + G VAVK++ + +Q + +EV M + H N+V+++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 117 CIEGPCRIIVYDYMQNNSLS----QTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ G ++ +++Q +L+ Q L EE+ + + + LAY+H +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---------VCEAVLQALAYLHAQ- 160
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
++HRDIK +ILL + K+SDFG +D+ + V GT ++AP+
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSL 217
Query: 233 LNPKSDIYSFGVLLLQIVTGQ 253
+ DI+S G++++++V G+
Sbjct: 218 YATEVDIWSLGIMVIEMVDGE 238
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 25/246 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLH 114
K+G G +G V + A+K++ S + + EVA + + H N++KL+
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+ +V + + L ++ +R KF+ I + G+ Y+H+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH--- 155
Query: 175 SIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
+IVHRD+KP N+LL +++ KI DFGLS +F GT Y+AP+ +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRK 212
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKE--------LGEYYLVEKAWEMHNTDKLQHL 283
+ K D++S GV+L ++ G + G+Y W+ ++ + L
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDL 271
Query: 284 VDPMLC 289
+ ML
Sbjct: 272 IKQMLQ 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 56/262 (21%)
Query: 58 NKVGEGGFGSVYKGKLQDG---TVVAVKVLSVESKQGEK-EFMSEVASMANI-CHENLVK 112
+ +GEG FG V K +++ A+K + + + + +F E+ + + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 113 LHGGCIEGPCRIIVYDYMQNNSL------------SQTLLGEEKNRAKFSWTARREIALG 160
L G C + +Y + +L + S A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+ARG+ Y+ + + +HRD+ NIL+ +N+ KI+DFGLS+ +++ V T+
Sbjct: 151 VARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVY-----VKKTM 200
Query: 221 GYL-----APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE--YYLVEKAWE 273
G L A + SD++S+GVLL +IV+ LG Y
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPY------CG 244
Query: 274 MHNTDKLQHLVD------PMLC 289
M + + L P+ C
Sbjct: 245 MTCAELYEKLPQGYRLEKPLNC 266
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 54/194 (27%), Positives = 93/194 (47%), Gaps = 13/194 (6%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS-VESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+G G FG V+ + G +K ++ S+ ++ +E+ + ++ H N++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE- 87
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
E + IV + + L + ++ + S E+ + LAY H +
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H 144
Query: 176 IVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
+VH+D+KP NIL + KI DFGL++LF D ST AGT Y+AP+
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VFKRD 201
Query: 233 LNPKSDIYSFGVLL 246
+ K DI+S GV++
Sbjct: 202 VTFKCDIWSAGVVM 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 29/241 (12%)
Query: 29 TKSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE 87
+ S A+ L I+ + L+ F VG G +G VYKG+ ++ G + A+KV+ V
Sbjct: 4 SDSPARSLDEIDLSA---LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 88 SKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRI------IVYDYMQNNSLSQTLL 140
E+E E+ + H N+ +G I+ +V ++ S++ +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 141 GEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200
+ N K W A I I RGL+++H+ ++HRDIK N+LL +N K+ DFG
Sbjct: 120 NTKGNTLKEEWIA--YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 201 LSKLFPEDITHISTR---VAGTLGYLAP-----DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
+S + R GT ++AP D + KSD++S G+ +++ G
Sbjct: 175 VSA----QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 253 Q 253
Sbjct: 231 A 231
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGG 116
K+G+G FG V+KG + VVA+K++ +E + E E E+ ++ + K +G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 117 CIEGPCRIIVYDYMQNNSLS----QTLLGEEKNRAKFSWTARREIAL---GIARGLAYIH 169
++ I+ +Y+ S L E +IA I +GL Y+H
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDET------------QIATILREILKGLDYLH 136
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
E +HRDIK +N+LL ++ K++DFG++ + +T V GT ++AP+
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQA 254
+ K+DI+S G+ +++ G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEP 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS-------------VESKQGEKEFMSEVASMA 103
K+G G +G V K + A+KV+ ++ +E +E++ +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 104 NICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
++ H N++KL + +V ++ + L + ++ NR KF I I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILS 157
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
G+ Y+H+ +IVHRDIKP NILL + N KI DFGLS F +D + GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTA 212
Query: 221 GYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHF----DKEL------GEYYLVEK 270
Y+AP+ + N K D++S GV++ ++ G F D+++ G+YY
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP--FGGQNDQDIIKKVEKGKYYFDFN 269
Query: 271 AWEMHNTDKLQHLVDPMLCGNFS 293
W+ +D+ + L+ ML +++
Sbjct: 270 DWKNI-SDEAKELIKLMLTYDYN 291
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 43/211 (20%), Positives = 74/211 (35%), Gaps = 20/211 (9%)
Query: 58 NKVGEG--GFGSVYKGK-LQDGTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVK 112
+G+G +V + G V V+ +++E+ E E+ H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
I +V +M S + + A I G+ + L YIH
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDYIHHM- 147
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR------VAGTLGYLAP- 225
VHR +K S+IL+ + +S + L +L+P
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 226 --DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+ G+ + KSDIYS G+ ++ G
Sbjct: 206 VLQQNLQGY-DAKSDIYSVGITACELANGHV 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+G+G FG V K K AVKV++ ++K + EV + + H N++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKL 86
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYI 168
+ IV + G E R +FS I + G+ Y+
Sbjct: 87 FEILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 169 HEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
H+ +IVHRD+KP NILL +++ + KI DFGLS F ++ GT Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAP 192
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
+ + G + K D++S GV+L +++G
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-28
Identities = 42/264 (15%), Positives = 83/264 (31%), Gaps = 27/264 (10%)
Query: 46 ELKSATNGFCSSNKVGEGGFGSVYKGK------LQDGTVVAVKVLSVESKQGEKEFMSEV 99
E + + + +GEG F VY+ ++ +KV + +
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 100 ASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTL-LGEEKNRAKFSWTARREIA 158
+ +K + + ++V + +L + L + A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILL-----------DQNFNPKISDFGLS---KL 204
+ + + +H+ I+H DIKP N +L D + + D G S KL
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE 264
FP+ + T G+ + + N + D + + ++ G E GE
Sbjct: 236 FPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKNEGGE 292
Query: 265 YYLVEKAWEMHNTDKLQHLVDPML 288
+ + D ML
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVML 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE-KEFMSEVA-SMANICHENLVKLHG 115
++G G G V+K + + G V+AVK + + E K + ++ + + +V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
I I + M + + + ++ + I + L Y+ E+
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKHG-- 145
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP-----DYAVS 230
++HRD+KPSNILLD+ K+ DFG+S +D R AG Y+AP
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTK 203
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
+ ++D++S G+ L+++ TGQ
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKLHGG 116
+G G V VA+K +++E Q + + E+ +M+ H N+V +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE--IAL---GIARGLAYIHEE 171
+ +V + S+ ++ + + E IA + GL Y+H+
Sbjct: 82 FVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLF-PEDITHISTR--VAGTLGYLAPD- 226
+HRD+K NILL ++ + +I+DFG+S L DIT R GT ++AP+
Sbjct: 141 ---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 227 -YAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
V G+ + K+DI+SFG+ +++ TG A
Sbjct: 198 MEQVRGY-DFKADIWSFGITAIELATGAA 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGC 117
G+G F V + + G VA+K++ + ++ EV M + H N+VKL
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE-V 82
Query: 118 IEGPCRII----------VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
IE + V+DY+ + + E++ R+KF R+I + Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR----MKEKEARSKF-----RQIVSAVQ----Y 129
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
H++ IVHRD+K N+LLD + N KI+DFG S F + G Y AP+
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE- 183
Query: 228 AVSGHL--NPKSDIYSFGVLLLQIVTG 252
G P+ D++S GV+L +V+G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 26/198 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G G +G V A K + + F E+ M ++ H N+++L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 74
Query: 118 IEGPCRI-IVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHEE 171
E I +V + G E ++ F + I + +AY H+
Sbjct: 75 FEDNTDIYLVMELCT---------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 172 IKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
++ HRD+KP N L + K+ DFGL+ F + GT Y++P
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-V 179
Query: 229 VSGHLNPKSDIYSFGVLL 246
+ G P+ D +S GV++
Sbjct: 180 LEGLYGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 13/197 (6%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKV-----LSVESKQGEKEFMSEVASMANICHENLVK 112
+G+G F V + + G AVK+ + ++ E + + H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L +V+++M L ++ +S I L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 173 KPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+I+HRD+KP +LL + + K+ FG++ E RV GT ++AP+
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 230 SGHLNPKSDIYSFGVLL 246
D++ GV+L
Sbjct: 207 REPYGKPVDVWGCGVIL 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 28/200 (14%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLH 114
+G+G FG V K K AVKV++ ++K + EV + + H N++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDHPNIMKLF 87
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIH 169
+ IV + G E R +FS I + G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYT---------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 170 EEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
+ +IVHRD+KP NILL +++ + KI DFGLS F ++ GT Y+AP+
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE 193
Query: 227 YAVSGHLNPKSDIYSFGVLL 246
+ G + K D++S GV+L
Sbjct: 194 -VLRGTYDEKCDVWSAGVIL 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+GEG +GSVYK + G +VA+K + VES +E + E++ M ++VK +G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ IV +Y S+S ++ A I +GL Y+H
Sbjct: 93 YFKNTDLWIVMEYCGAGSVS-DIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHFM---RK 146
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRDIK NILL+ + K++DFG++ + + +T + GT ++AP+ N
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCV 205
Query: 237 SDIYSFGVLLLQIVTGQ 253
+DI+S G+ +++ G+
Sbjct: 206 ADIWSLGITAIEMAEGK 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 26/198 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G G F V+ K G + A+K + + +E+A + I HEN+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED-I 74
Query: 118 IEGPCRI-IVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHEE 171
E +V + G E R ++ + + + Y+HE
Sbjct: 75 YESTTHYYLVMQLVS---------GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 172 IKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
IVHRD+KP N+L ++N I+DFGLSK+ I + GT GY+AP+
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVL 179
Query: 229 VSGHLNPKSDIYSFGVLL 246
+ D +S GV+
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 45/202 (22%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
++G+G FG VYK K + G + A KV+ +S++ ++++ E+ +A H +VKL G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
I+ ++ ++ ++ E + + L ++H + I
Sbjct: 85 YYHDGKLWIMIEFCPGGAVD-AIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK---RI 138
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP-----DYAVSG 231
+HRD+K N+L+ + +++DFG+S + + + + GT ++AP +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDT 197
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ K+DI+S G+ L+++ +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIE 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 52/215 (24%), Positives = 86/215 (40%), Gaps = 44/215 (20%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS------EVASMANICHE--NLV 111
G GGFGSVY G + D VA+K + + E + EV + + ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 112 KLHGGCIEGPCRII-----------VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+L E P + ++D++ L EE R+ F ++
Sbjct: 112 RLLD-WFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFF-----WQVLEA 161
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTRVAGT 219
+ + H ++HRDIK NIL+D N K+ DFG L + + GT
Sbjct: 162 VR----HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGT 211
Query: 220 LGYLAPDYAVSGHL--NPKSDIYSFGVLLLQIVTG 252
Y P++ + H + ++S G+LL +V G
Sbjct: 212 RVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---------------------VESKQGEKEFMS- 97
G+G +G V D T A+KVLS +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 98 ----EVASMANICHENLVKLHGGCIEGPCR---IIVYDYMQNNSL----SQTLLGEEKNR 146
E+A + + H N+VKL ++ P +V++ + + + L E++ R
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVE-VLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 147 AKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206
F +++ GI Y+H + I+HRDIKPSN+L+ ++ + KI+DFG+S F
Sbjct: 141 FYF-----QDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 207 EDITHISTRVAGTLGYLAPDYAVSGHLN----PKSDIYSFGVLLLQIVTGQ 253
+S GT ++AP+ ++S D+++ GV L V GQ
Sbjct: 189 GSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 25/203 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS--------VESKQGEKEFMSEVASMANICHEN 109
+G G G V + VA++++S +E+ + + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++K+ + IV + M+ L ++ + + + + Y+H
Sbjct: 202 IIKIKN-FFDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 170 EEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP- 225
E I+HRD+KP N+LL +++ KI+DFG SK+ E + + T GT YLAP
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLAPE 311
Query: 226 --DYAVSGHLNPKSDIYSFGVLL 246
+ N D +S GV+L
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 34/209 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS---------VESKQGEKEFMSEVASMANIC-H 107
+G G V + AVK++ E ++ + + EV + + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EK--NRAKFSWTARREIALGIAR 163
N+++L +V+D M+ GE + + S R+I +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
+ +H+ +IVHRD+KP NILLD + N K++DFG S V GT YL
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYL 190
Query: 224 AP------DYAVSGHLNPKSDIYSFGVLL 246
AP + D++S GV++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 45/214 (21%), Positives = 82/214 (38%), Gaps = 42/214 (19%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVL--------SVESKQGEKEFMSEVASMANICHENLV 111
G G FG V+ + V VK + + E+A ++ + H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 112 KLHGGCIEGPCRII-----------VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
K+ E ++ ++ + L E F R++
Sbjct: 93 KVLD-IFENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIF-----RQLVSA 142
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
+ Y+ + I+HRDIK NI++ ++F K+ DFG + T GT+
Sbjct: 143 VG----YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT-FCGTI 193
Query: 221 GYLAPDYAVSGHL--NPKSDIYSFGVLLLQIVTG 252
Y AP+ + G+ P+ +++S GV L +V
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 33/207 (15%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS--------VESKQGEKEFMSEVASMANICHEN 109
+G G G V + VA+K++S +E+ + + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EK--NRAKFSWTARREIALGIARGL 165
++K+ + IV + M+ GE +K + + + +
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 166 AYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGY 222
Y+HE I+HRD+KP N+LL +++ KI+DFG SK+ E + + GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTY 182
Query: 223 LAP---DYAVSGHLNPKSDIYSFGVLL 246
LAP + N D +S GV+L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVL------SVESKQGEKEFMSEVASM----ANICHEN 109
G+GGFG+V+ G L D VA+KV+ EVA + A H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 110 LVKLHGGCIEGPCRII-----------VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIA 158
+++L E + ++DY+ LGE +R F ++
Sbjct: 100 VIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFF-----GQVV 149
Query: 159 LGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHISTRVA 217
I + H +VHRDIK NIL+D + K+ DFG L ++
Sbjct: 150 AAIQ----HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---D 199
Query: 218 GTLGYLAPDYAVSGHL--NPKSDIYSFGVLLLQIVTG 252
GT Y P++ +S H + ++S G+LL +V G
Sbjct: 200 GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 35/209 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS--------VESKQGEKEFMSEVASMANIC-HE 108
+G G V + G AVK++ + ++ + E + + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 109 NLVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGE--EK--NRAKFSWTARREIALGIAR 163
+++ L E + +V+D M+ GE + + S R I +
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRK--------GELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
++++H +IVHRD+KP NILLD N ++SDFG S + GT GYL
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYL 266
Query: 224 AP------DYAVSGHLNPKSDIYSFGVLL 246
AP + D+++ GV+L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 56 SSNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKL 113
+GEG F K + AVK++S K+ E E+ ++ H N+VKL
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKL 71
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
H + +V + + L + + + FS T I + ++++H+
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 174 PSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+VHRD+KP N+L + N KI DFG ++L P D + T TL Y AP+
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ 183
Query: 231 GHLNPKSDIYSFGVLL 246
+ D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHGG 116
G G FG V G+ G VAVK+L+ + S + E+ ++ H +++KL+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ- 78
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIARGLAYIHE 170
I P +V +Y+ L + + E + R F ++I + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF-----QQILSAVD----YCH- 128
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+ +VHRD+KP N+LLD + N KI+DFGLS + + + T G+ Y AP+ +S
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYAAPE-VIS 183
Query: 231 GHL--NPKSDIYSFGVLLLQIVTG 252
G L P+ DI+S GV+L ++ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G+G F V + G A K+++ + S + ++ E + H N+V+LH
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIH 169
I+ +V+D + G E R +S I +AY H
Sbjct: 73 -SIQEESFHYLVFDLVT---------GGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 170 EEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
IVHR++KP N+LL + K++DFGL+ + AGT GYL+P+
Sbjct: 123 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE 177
Query: 227 YAVSGHLNPKSDIYSFGVLL 246
+ DI++ GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 26/206 (12%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSE---VASMANICHENLVK 112
+G GGFG VY + D G + A+K L ++ KQGE ++E ++ ++ +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 113 LHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYI 168
+ P ++ + D M L L +F + A EI LG L ++
Sbjct: 257 MSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAA--EIILG----LEHM 308
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H +V+RD+KP+NILLD++ + +ISD GL+ F + H V GT GY+AP+
Sbjct: 309 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVL 362
Query: 229 VSGHLNPKS-DIYSFGVLLLQIVTGQ 253
G S D +S G +L +++ G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-EVASMANICHENLVKLHGGCI 118
GEG +G V VAVK++ ++ E + E+ + HEN+VK +G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HR 74
Query: 119 EGPCRI-IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ +Y L + E + F ++ +A G+ Y+H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQL---MA-GVVYLH--- 122
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT--HISTRVAGTLGYLAPDYAVS 230
I HRDIKP N+LLD+ N KISDFGL+ +F + ++ GTL Y+AP+ +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLK 180
Query: 231 GHL--NPKSDIYSFGVLLLQIVTG 252
D++S G++L ++ G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 11/191 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V++ G A K + + ++ E+ +M+ + H LV LH
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ +++Y++M L + + E K S E + +GL ++HE + V
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 178 HRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
H D+KP NI+ + K+ DFGL+ GT + AP+ A +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 236 KSDIYSFGVLL 246
+D++S GVL
Sbjct: 336 YTDMWSVGVLS 346
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/174 (29%), Positives = 93/174 (53%), Gaps = 16/174 (9%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLVK 112
KVGEG +G VYK K G +VA+K + +++ E E + E++ + + H N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L C +V+++M+ + L + L ++N+ + + + RG+A+ H+
Sbjct: 84 LIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
I+HRD+KP N+L++ + K++DFGL++ F + + V TL Y APD
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKL 113
++G G FG+VY + +++ VVA+K +S KQ ++ + EV + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIAL---GIARGLAYIHE 170
G + +V +Y S S L E ++ EIA G +GLAY+H
Sbjct: 120 RGCYLREHTAWLVMEYCLG-SASDLL---EVHKKPLQ---EVEIAAVTHGALQGLAYLHS 172
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAP--- 225
+++HRD+K NILL + K+ DFG + + ++ GT ++AP
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEVI 222
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
G + K D++S G+ +++ +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVK--VLSVESKQGEKEFMSEVASMANICHENLVKLH 114
VGEG +G V K + G +VA+K + S + K +K M E+ + + HENLV L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGE-EKNRAKFSWTARREIALGIARGLAYIHEEIK 173
C + +V++++ T+L + E + ++ I G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH-- 143
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-SGH 232
+I+HRDIKP NIL+ Q+ K+ DFG ++ VA T Y AP+ V
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVK 201
Query: 233 LNPKSDIYSFGVLLLQIVTGQA 254
D+++ G L+ ++ G+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEP 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 36/174 (20%), Positives = 62/174 (35%), Gaps = 15/174 (8%)
Query: 85 SVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK 144
+ S ++ M +N V I + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRC 156
Query: 145 NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK- 203
+ I + IA + ++H + ++HRD+KPSNI + K+ DFGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 204 ----------LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLL 247
L P T GT Y++P+ + + K DI+S G++L
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 48/175 (27%), Positives = 88/175 (50%), Gaps = 14/175 (8%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMS--EVASMANICHENLV 111
+ +GEG F +VYK + +VA+K + + + K+ + E+ + + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
L +V+D+M+ + L + + N + + + L +GL Y+H+
Sbjct: 76 GLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
I+HRD+KP+N+LLD+N K++DFGL+K F + +V T Y AP+
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPE 182
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 16/175 (9%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLV 111
K+GEG +G VYK + G VVA+K + +++ E E + E++ + + H N+V
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIV 65
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
KL +V++++ + L + + + + + +GLA+ H
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQD-LKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
++HRD+KP N+L++ K++DFGL++ F + + V TL Y AP+
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 51/223 (22%), Positives = 81/223 (36%), Gaps = 58/223 (26%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH- 114
GEG +G V + + AVK+L GE E+ + + H+N+++L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 115 ------------------GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARRE 156
G E + D + + F +
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQE------MLDSVPEKRFP-----VCQAHGYF-----CQ 117
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF----PEDITHI 212
+ G+ Y+H + IVH+DIKP N+LL KIS G+++ +D
Sbjct: 118 LIDGLE----YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 213 STRVAGTLGYLAPDYAVSGHLN---PKSDIYSFGVLLLQIVTG 252
S G+ + P+ +G K DI+S GV L I TG
Sbjct: 171 S---QGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-EVASMANICHENLVKLHGGCI 118
GEG +G V VAVK++ ++ E + E+ + HEN+VK +G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HR 74
Query: 119 EGPCRI-IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ +Y L + E + F ++ +A G+ Y+H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF-----HQL---MA-GVVYLH--- 122
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT--HISTRVAGTLGYLAPDYAVS 230
I HRDIKP N+LLD+ N KISDFGL+ +F + ++ GTL Y+AP+ +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLK 180
Query: 231 GHL--NPKSDIYSFGVLLLQIVTG 252
D++S G++L ++ G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 56/239 (23%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKV-----LSVESKQGEKEFMSEVASMANICHENLVK 112
+G+G +G V Q + A+K+ + + + + +EV M + H N+ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 113 LHGGCIEGPCRI-IVYDYMQNNSL------------------------------------ 135
L+ E I +V + L
Sbjct: 93 LYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL--DQNFN 193
E I I L Y+H + I HRDIKP N L +++F
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFE 208
Query: 194 PKISDFGLSKLF----PEDITHISTRVAGTLGYLAPD--YAVSGHLNPKSDIYSFGVLL 246
K+ DFGLSK F + ++T+ GT ++AP+ + PK D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 27/200 (13%)
Query: 59 KVGEGGFGSVYKG-KLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G+G F V + G A K+++ + S + ++ E + H N+V+LH
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIH 169
I+ +V+D + G E R +S I +AY H
Sbjct: 96 -SIQEESFHYLVFDLVT---------GGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 170 EEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
IVHR++KP N+LL + K++DFGL+ + AGT GYL+P+
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE 200
Query: 227 YAVSGHLNPKSDIYSFGVLL 246
+ DI++ GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 47/191 (24%), Positives = 80/191 (41%), Gaps = 11/191 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V++ G V K ++ + +E++ M + H L+ LH
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ +++ +++ L + E+ K S GL ++HE SIV
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIV 171
Query: 178 HRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
H DIKP NI+ + KI DFGL+ D I T + AP+ +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGF 229
Query: 236 KSDIYSFGVLL 246
+D+++ GVL
Sbjct: 230 YTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
+ +G G FG V+K + G +A K++ + ++E +E++ M + H NL++
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 113 LHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
L+ E I +V +Y+ L ++ E N + I G+ ++H+
Sbjct: 151 LY-DAFESKNDIVLVMEYVDGGELFDRIIDESYN---LTELDTILFMKQICEGIRHMHQM 206
Query: 172 IKPSIVHRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
I+H D+KP NIL KI DFGL++ + + GT +LAP+
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNF-GTPEFLAPEVVN 261
Query: 230 SGHLNPKSDIYSFGVLL 246
++ +D++S GV+
Sbjct: 262 YDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 44/173 (25%), Positives = 81/173 (46%), Gaps = 13/173 (7%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVK--VLSVESKQGEKEFMSEVASMANICHENLVKLH 114
K+GEG +G V+K + G +VA+K + S + +K + E+ + + H NLV L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGE-EKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+V++Y T+L E ++ + + I + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH-- 121
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
+ +HRD+KP NIL+ ++ K+ DFG ++L + VA T Y +P+
Sbjct: 122 -NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G GGFG V+ +++ G + A K L+ ++ ++G + M E +A + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 116 GCIEGPCRI-IVYDYM---------QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGL 165
E + +V M N E RA F +TA +I G L
Sbjct: 253 -AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--RAIF-YTA--QIVSG----L 302
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
++H+ +I++RD+KP N+LLD + N +ISD GL+ T GT G++AP
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAP 358
Query: 226 --------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
D++V D ++ GV L +++ +
Sbjct: 359 ELLLGEEYDFSV--------DYFALGVTLYEMIAAR 386
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 5e-24
Identities = 43/175 (24%), Positives = 86/175 (49%), Gaps = 17/175 (9%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLV 111
K+GEG +G+V+K K + +VA+K + ++ + E + E+ + + H+N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIV 64
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+LH +V+++ + L + + + + +GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
+++HRD+KP N+L+++N K+++FGL++ F + S V TL Y PD
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVES-KQGEKEFMS----EVA---SMANICHE 108
++G G +G+VYK + G VA+K + V + G EVA + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 109 NLVKL----HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
N+V+L + ++ +V++++ + L L ++ +++ R
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL--DKAPPPGLPAETIKDLMRQFLR 131
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF--PEDITHISTRVAGTLG 221
GL ++H IVHRD+KP NIL+ K++DFGL++++ +T V TL
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TLW 184
Query: 222 YLAPD 226
Y AP+
Sbjct: 185 YRAPE 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 5e-24
Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLVK 112
K+GEG +G VYK + G A+K + +E E E + E++ + + H N+VK
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVK 64
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
L+ ++V++++ + L + L + + L + G+AY H+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
++HRD+KP N+L+++ KI+DFGL++ F + + + TL Y APD
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-24
Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 15/176 (8%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS----EVASMANICHENLVK 112
K+G G + +VYKG G VA+K + ++S++G S E++ M + HEN+V+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVR 67
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTL--LGEEKNRAKFSWTARREIALGIARGLAYIHE 170
L+ +V+++M N+ L + + + + +GLA+ HE
Sbjct: 68 LYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
I+HRD+KP N+L+++ K+ DFGL++ F + S+ V TL Y APD
Sbjct: 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-24
Identities = 48/203 (23%), Positives = 76/203 (37%), Gaps = 25/203 (12%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCI 118
GEG V L AVK++ + EV + H N+++L
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVH 178
E +V++ M+ S+ L R F+ + +A L ++H I H
Sbjct: 82 EEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIAH 134
Query: 179 RDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTR------VAGTLGYLAP---- 225
RD+KP NIL +Q KI DF L + G+ Y+AP
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 226 --DYAVSGHLNPKSDIYSFGVLL 246
S + + + D++S GV+L
Sbjct: 195 AFSEEASIY-DKRCDLWSLGVIL 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-24
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 37/208 (17%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLHG 115
GEG FG V + VA+K +S +S + E++ + + H +++KL+
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKLYD 76
Query: 116 GCIEGPCRIIV---------YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
I P I++ +DY+ + E++ R F ++I I
Sbjct: 77 -VITTPTDIVMVIEYAGGELFDYIVEKKR----MTEDEGRRFF-----QQIICAIE---- 122
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
Y H + IVHRD+KP N+LLD N N KI+DFGLS + + + T G+ Y AP+
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYAAPE 177
Query: 227 YAVSGHL--NPKSDIYSFGVLLLQIVTG 252
++G L P+ D++S G++L ++ G
Sbjct: 178 -VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 44/199 (22%), Positives = 82/199 (41%), Gaps = 24/199 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G+G F V + + G A +++ + S + ++ E + H N+V+LH
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHE 170
E +++D + G E R +S I + + H+
Sbjct: 78 SISEEGHHYLIFDLVT---------GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 171 EIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
+VHR++KP N+LL + K++DFGL+ + GT GYL+P+
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEV 184
Query: 228 AVSGHLNPKSDIYSFGVLL 246
D+++ GV+L
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 27/198 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G VY+ K A+KVL +K +E+ + + H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKE-I 116
Query: 118 IEGPCRI-IVYDYMQNNSLSQTLLGEE-----KNRAKFSWTARREIALGIARGLAYIHEE 171
E P I +V + + G E + +S + I +AY+HE
Sbjct: 117 FETPTEISLVLELVT---------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 172 IKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
IVHRD+KP N+L + KI+DFGLSK+ + V GT GY AP+
Sbjct: 168 ---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEIL 222
Query: 229 VSGHLNPKSDIYSFGVLL 246
P+ D++S G++
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 28/204 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHGG 116
G G FG V GK G VAVK+L+ + S + E+ ++ H +++KL+
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ- 83
Query: 117 CIEGPCRI-IVYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIARGLAYIHE 170
I P I +V +Y+ L + L E+++R F ++I G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF-----QQILSGVD----YCH- 133
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+ +VHRD+KP N+LLD + N KI+DFGLS + + + T G+ Y AP+ +S
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPE-VIS 188
Query: 231 GHL--NPKSDIYSFGVLLLQIVTG 252
G L P+ DI+S GV+L ++ G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCG 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 26/199 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICH-ENLVKLHGG 116
G G F V + G A K L + E + E+A + ++ LH
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGIARGLAYIHE 170
I++ +Y GE + S + I G+ Y+H+
Sbjct: 98 YENTSEIILILEYAAG--------GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 171 EIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
+IVH D+KP NILL + KI DFG+S+ + + GT YLAP+
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIM-GTPEYLAPEI 204
Query: 228 AVSGHLNPKSDIYSFGVLL 246
+ +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 50/174 (28%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEF----MSEVASMANICHENLVK 112
+K+GEG + +VYKGK +VA+K + +E ++G + EV+ + ++ H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVT 64
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
LH +V++Y+ + L Q L + + + + RGLAY H
Sbjct: 65 LHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHR-- 118
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
++HRD+KP N+L+++ K++DFGL++ V TL Y PD
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 24/201 (11%), Positives = 53/201 (26%), Gaps = 45/201 (22%)
Query: 59 KVGEGGFGSVYKGKLQD---GTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVK 112
G ++ D VA+ + + + +E +S ++ I + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ ++V ++++ SL + S +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
+ PS + +S G L +
Sbjct: 149 --GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA------ 179
Query: 233 LNPKSDIYSFGVLLLQIVTGQ 253
NP+ DI G L ++ +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G+G FG V + D + A+K ++ VE + E+ M + H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR-NVFKELQIMQGLEHPFLVNLW 81
Query: 115 GGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK----NRAKFSWTARREIALGIARGLAYIH 169
+ + +V D + L + L + K + E+ + L Y+
Sbjct: 82 Y-SFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKL-FIC--ELVMA----LDYLQ 132
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP---- 225
+ I+HRD+KP NILLD++ + I+DF ++ + P + + +AGT Y+AP
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+G+ + D +S GV +++ G+
Sbjct: 188 SRKGAGY-SFAVDWWSLGVTAYELLRGR 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 43/195 (22%), Positives = 80/195 (41%), Gaps = 22/195 (11%)
Query: 61 GEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHG--- 115
G G G V + + G A+K+L + EV ++V +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY---DS--PKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 116 -GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
C +I+ + M+ L + E+ F+ EI I + ++H
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTEREAAEIMRDIGTAIQFLHSH--- 147
Query: 175 SIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
+I HRD+KP N+L +++ K++DFG +K ++ + T T Y+AP+
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPE 204
Query: 232 HLNPKSDIYSFGVLL 246
+ D++S GV++
Sbjct: 205 KYDKSCDMWSLGVIM 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-23
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+GEG F +V + A+K+L ++ + E M+ + H VKL+
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFVKLY 96
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEK----NRAKFSWTARREIALGIARGLAYIHE 170
+ Y +N L + + +F +TA EI L Y+H
Sbjct: 97 FTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRF-YTA--EIVSA----LEYLHG 148
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR-VAGTLGYLAPDYAV 229
+ I+HRD+KP NILL+++ + +I+DFG +K+ + GT Y++P+
Sbjct: 149 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 230 S-GHLNPKSDIYSFGVLLLQIVTGQ 253
SD+++ G ++ Q+V G
Sbjct: 206 EKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 43/214 (20%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G+GGFG V +++ G + A K L ++ ++GE ++E + + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 116 GCIEGPCRI-IVYDYMQNNSL-------SQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
E + +V M L Q E RA F + A EI G L
Sbjct: 252 -AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA--RAVF-YAA--EICCG----LED 301
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP-- 225
+H E IV+RD+KP NILLD + + +ISD GL+ PE T I RV GT+GY+AP
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 226 ------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
++ D ++ G LL +++ GQ
Sbjct: 357 VKNERYTFSP--------DWWALGCLLYEMIAGQ 382
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 57 SNKVGEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLH 114
+G G + + AVK++ +SK+ E E+ + H N++ L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTE---EIEILLRYGQHPNIITLK 82
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+G +V + M+ L +L + FS + I + + Y+H +
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ--- 135
Query: 175 SIVHRDIKPSNILL-DQNFNP---KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+VHRD+KPSNIL D++ NP +I DFG +K + + T T ++AP+
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLER 194
Query: 231 GHLNPKSDIYSFGVLL 246
+ DI+S GVLL
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 28/203 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSV------ESKQGEKEFMSEVASMANICHENLV 111
++G G F V K + G A K + +E EV+ + + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EKNRAKFSWTAR--REIALGIARGLAY 167
LH +++ + + GE + K S + I G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLFPEDITHISTRVAGTLGYL 223
+H + I H D+KP NI+L P K+ DFGL+ + + GT ++
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFV 185
Query: 224 APDYAVSGHLNPKSDIYSFGVLL 246
AP+ L ++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 28/203 (13%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE 119
G G FG + +VAVK + + E E+ + ++ H N+V+ I
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKE-VIL 86
Query: 120 GPCRI-IVYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
P + I+ +Y L + + E++ R F +++ G++ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF-----QQLLSGVS----YCH---S 134
Query: 174 PSIVHRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
I HRD+K N LLD + P KI DFG SK + + V GT Y+AP+ +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPE-VLLR 191
Query: 232 HL--NPKSDIYSFGVLLLQIVTG 252
+D++S GV L ++ G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 28/203 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSV------ESKQGEKEFMSEVASMANICHENLV 111
++G G F V K + G A K + +E EV+ + + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EKNRAKFSWTAR--REIALGIARGLAY 167
LH +++ + + GE + K S + I G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSG--------GELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLFPEDITHISTRVAGTLGYL 223
+H + I H D+KP NI+L P K+ DFGL+ + + GT ++
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEFV 185
Query: 224 APDYAVSGHLNPKSDIYSFGVLL 246
AP+ L ++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMS-----EVASMANICHENLV 111
K+GEG +G VYK VA+K + +E E+E + EV+ + + H N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNII 96
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L ++++Y +N+ L + + S + + G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEND-LKKYM----DKNPDVSMRVIKSFLYQLINGVNFCH-- 149
Query: 172 IKPSIVHRDIKPSNILLDQNFNP-----KISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
+HRD+KP N+LL + KI DFGL++ F I + + TL Y P+
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 42/202 (20%)
Query: 53 GFCSS-------NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMS--EV 99
FC K+G+G FG V+K + + G VA+K + +E+ EKE + E+
Sbjct: 11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREI 67
Query: 100 ASMANICHENLVKLHGGCIEGPCRI--------IVYDYMQNNSLSQTLLGEEKNRAKFSW 151
+ + HEN+V L C +V+D+ +++ L+ L KF+
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTL 123
Query: 152 TARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF------ 205
+ + + + GL YIH I+HRD+K +N+L+ ++ K++DFGL++ F
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 206 -PEDITHISTRVAGTLGYLAPD 226
P T+ RV TL Y P+
Sbjct: 181 QPNRYTN---RVV-TLWYRPPE 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 53/227 (23%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 52 NGFCSS-------NKVGEGGFGSVYKGK--LQDGTVVAVKVLSVESKQGEKEFMS----- 97
+G C + ++GEG +G V+K + G VA+K + V++ +E M
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIR 60
Query: 98 EVA---SMANICHENLVKL----HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKF 149
EVA + H N+V+L + ++ +V++++ + L+ L ++
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL--DKVPEPGV 117
Query: 150 SWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF--PE 207
+++ + RGL ++H +VHRD+KP NIL+ + K++DFGL++++
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+T V TL Y AP+ + D++S G + ++ +
Sbjct: 175 ALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-22
Identities = 47/205 (22%), Positives = 78/205 (38%), Gaps = 32/205 (15%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVL------SVESKQGEKEFMSEVASMANICHENLV 111
++G G F V K + G A K + S +E EV + I H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGIARGL 165
LH +++ + + GE EK + + I G+
Sbjct: 72 TLHDIFENKTDVVLILELVSG--------GELFDFLAEKE--SLTEDEATQFLKQILDGV 121
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLFPEDITHISTRVAGTLG 221
Y+H + I H D+KP NI+L P K+ DFG++ GT
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF-GTPE 176
Query: 222 YLAPDYAVSGHLNPKSDIYSFGVLL 246
++AP+ L ++D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 32/197 (16%), Positives = 70/197 (35%), Gaps = 24/197 (12%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G G FG V++ K + V + E++ + H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGIARGLAYIHEE 171
+++++++ + + + + L ++H
Sbjct: 71 ESMEELVMIFEFISG--------LDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH 121
Query: 172 IKPSIVHRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+I H DI+P NI+ + KI +FG ++ + Y AP+
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLF-TAPEYYAPEVHQ 176
Query: 230 SGHLNPKSDIYSFGVLL 246
++ +D++S G L+
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 28/203 (13%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVL------SVESKQGEKEFMSEVASMANICHENLV 111
++G G F V K + G A K + S ++ EV+ + I H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--EKNRAKFSWTAR--REIALGIARGLAY 167
LH I++ + + GE + K S T E I G+ Y
Sbjct: 78 TLHEVYENKTDVILILELVAG--------GELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 168 IHEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
+H I H D+KP NI+L KI DFGL+ + GT ++
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFV 184
Query: 224 APDYAVSGHLNPKSDIYSFGVLL 246
AP+ L ++D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 39/208 (18%)
Query: 29 TKSGAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVK-VLSV 86
K G+K+ + + + + +G G FG VY+ KL D G +VA+K VL
Sbjct: 31 DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ- 89
Query: 87 ESKQGEKEFMS-EVASMANICHENLVKLH------GGCIEGPCRIIVYDYMQNNSLSQTL 139
+K F + E+ M + H N+V+L G + +V DY+ +T+
Sbjct: 90 -----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETV 139
Query: 140 LGEEKNRAKFSWTARREIALG--------IARGLAYIHEEIKPSIVHRDIKPSNILLDQN 191
A+ A++ + + + R LAYIH I HRDIKP N+LLD +
Sbjct: 140 ----YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPD 192
Query: 192 FNP-KISDFGLSKLFPED---ITHISTR 215
K+ DFG +K +++I +R
Sbjct: 193 TAVLKLCDFGSAKQLVRGEPNVSYICSR 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 45/201 (22%), Positives = 76/201 (37%), Gaps = 33/201 (16%)
Query: 61 GEGGFGSVYKG-KLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHG--- 115
G G G V + + A+K+L K EV ++V++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYE 125
Query: 116 -GCIEGPCRIIVYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGIARGLAYI 168
C +IV + + GE ++ F+ EI I + Y+
Sbjct: 126 NLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 169 HEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
H +I HRD+KP N+L N K++DFG +K ++T T Y+AP
Sbjct: 178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPC-YTPYYVAP 232
Query: 226 DYAVSGHLNPKSDIYSFGVLL 246
+ + D++S GV++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVK-VLSVESKQGEKEFMS-EVASMANICHENLVKLH-- 114
+G G FG V++ KL + VA+K VL +K F + E+ M + H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 115 ----GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
G + +V +Y+ + + K + + + R LAYIH
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 171 EIKPSIVHRDIKPSNILLDQNFNP-KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
I HRDIKP N+LLD K+ DFG +K+ ++S + Y AP+
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIF 214
Query: 230 -SGHLNPKSDIYSFGVLLLQIVTGQA 254
+ + DI+S G ++ +++ GQ
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 37/267 (13%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVES--KQGEKE-FMSEVASMANICHENLVKLHG 115
+G G FG V KL++ V A+K+L+ K+ E F E + N + + LH
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEK----NRAKFSWTARREIALGIARGLAYIHE 170
+ + +V DY L L E A+F + A E+ + + +H+
Sbjct: 142 -AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YLA--EMVIA----IDSVHQ 193
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP----- 225
VHRDIKP NIL+D N + +++DFG ED T S+ GT Y++P
Sbjct: 194 L---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 226 -DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284
+ + P+ D +S GV + +++ G+ + + + Y + M++ ++ Q
Sbjct: 251 MEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-----MNHKERFQF-- 302
Query: 285 DPMLCGNFSGNEAVRFLKVGLLCVQEK 311
P + S A ++ L+C +E
Sbjct: 303 -PTQVTDVS-ENAKDLIR-RLICSREH 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 50/235 (21%), Positives = 99/235 (42%), Gaps = 21/235 (8%)
Query: 32 GAKILKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQD-GTVVAVK-VLSVES- 88
G+ + N A + + + F G+G FG+V GK + G VA+K V+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 89 KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR--------IIVYDYMQNNSLSQTLL 140
+ E + M + +A + H N+V+L +V +Y+ + L +
Sbjct: 63 RNRELQIMQD---LAVLHHPNIVQLQS-YFYTLGERDRRDIYLNVVMEYVPDT-LHRCCR 117
Query: 141 GEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFNPKISDF 199
+ + + + R + +H ++ HRDIKP N+L++ + K+ DF
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAV-SGHLNPKSDIYSFGVLLLQIVTGQ 253
G +K +++ + + Y AP+ + H DI+S G + +++ G+
Sbjct: 177 GSAKKLSPSEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 37/268 (13%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G G F V K++ G V A+K+++ + + F E + N + +LH
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEK----NRAKFSWTARREIALGIARGLAYIHE 170
+ + +V +Y L L + A+F + A EI + + +H
Sbjct: 129 -AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-YLA--EIVMA----IDSVHR 180
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP----- 225
VHRDIKP NILLD+ + +++DFG D T S GT YL+P
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 226 --DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283
+G P+ D ++ GV ++ GQ + D Y + +H + L
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-----VHYKEHLS-- 290
Query: 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEK 311
P++ EA F++ LLC E
Sbjct: 291 -LPLVDEGVP-EEARDFIQ-RLLCPPET 315
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V + + V A+K+LS ++ F E MA +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQLF 135
Query: 115 GGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHE 170
+ + +V +YM L L+ A+F +TA E+ L L IH
Sbjct: 136 Y-AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF-YTA--EVVLA----LDAIHS 186
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP----D 226
+HRD+KP N+LLD++ + K++DFG ++ GT Y++P
Sbjct: 187 M---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
G+ + D +S GV L +++ G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 45/189 (23%), Positives = 80/189 (42%), Gaps = 32/189 (16%)
Query: 59 KVGEGGFGSVYKGKLQD---GTVVAVKVLSVE----SKQGEKEFMSEVASMANICHENLV 111
KVG G +G VYK K +D A+K + S E + E + H N++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRE------LKHPNVI 81
Query: 112 KLHGGCIE-GPCRI-IVYDYMQNNSLSQTL-----LGEEKNRAKFSWTARREIALGIARG 164
L + ++ +++DY +++ L + K + + + I G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLF---PEDITHISTRVA 217
+ Y+H ++HRD+KP+NIL+ KI+D G ++LF + + + V
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 218 GTLGYLAPD 226
T Y AP+
Sbjct: 198 -TFWYRAPE 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEF---MSEVASMANICHENLVKLHG 115
+G+G FG V K + G A+K+L E + E ++E + N H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEE 171
+ R+ V +Y L L E +RA+F + A EI L Y+H E
Sbjct: 216 -SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGA--EIVSA----LDYLHSE 267
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
++V+RD+K N++LD++ + KI+DFGL K +D + T GT YLAP+
Sbjct: 268 K--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDN 324
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
D + GV++ +++ G+
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 60 VGEGGFGSVY----KGKLQDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKL 113
+G+G FG V+ + A+KVL + + E + + H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 114 HGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIH 169
H + ++ ++ D+++ L L E KF + A E+AL L ++H
Sbjct: 92 HY-AFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLA--ELALA----LDHLH 143
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST--RVAGTLGYLAPD- 226
I++RD+KP NILLD+ + K++DFGLSK E I H GT+ Y+AP+
Sbjct: 144 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
GH +D +SFGVL+ +++TG
Sbjct: 198 VNRRGH-TQSADWWSFGVLMFEMLTGT 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 61/273 (22%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G G + V +L+ + A+KV+ ++ Q EK + ++ H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 71
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
LV LH C + R+ V +Y+ L + + K A+F ++A EI+L L
Sbjct: 72 LVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSA--EISLA----L 123
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYL 223
Y+HE I++RD+K N+LLD + K++D+G+ K L P D T GT Y+
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYI 177
Query: 224 AP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275
AP ++V D ++ GVL+ +++ G++ +
Sbjct: 178 APEILRGEDYGFSV--------DWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QN 222
Query: 276 NTDKLQH--LVDPMLCGNFSGNEAVRFLKVGLL 306
D L L + +A LK L
Sbjct: 223 TEDYLFQVILEKQIRIPRSLSVKAASVLK-SFL 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 51/218 (23%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V + + + AVK+L VE EK ++
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PPF 403
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
L +LH C + R+ V +Y+ L + + A F + A EIA+G L
Sbjct: 404 LTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG----L 455
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYL 223
++ + I++RD+K N++LD + KI+DFG+ K ++ T T GT Y+
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT-FCGTPDYI 509
Query: 224 AP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP +V D ++FGVLL +++ GQ
Sbjct: 510 APEIIAYQPYGKSV--------DWWAFGVLLYEMLAGQ 539
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V K ++ G A+K+L V+ KQ E ++E + + LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFPFLVKLE 107
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEE 171
+ +V +Y+ + L + A+F + A +I L Y+H
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAA--QIVLT----FEYLHSL 160
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS- 230
+++RD+KP N+L+DQ +++DFG +K T + GT LAP+ +S
Sbjct: 161 ---DLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSK 213
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQ 253
G+ N D ++ GVL+ ++ G
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGY 235
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 65/275 (23%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G G + V +L+ + A++V+ ++ Q EK + ++ H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HPF 114
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIAR 163
LV LH C + R+ V +Y+ L Q L EE A+F ++A EI+L
Sbjct: 115 LVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF-YSA--EISLA--- 165
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLG 221
L Y+HE I++RD+K N+LLD + K++D+G+ K L P D T GT
Sbjct: 166 -LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPN 218
Query: 222 YLAP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273
Y+AP ++V D ++ GVL+ +++ G++
Sbjct: 219 YIAPEILRGEDYGFSV--------DWWALGVLMFEMMAGRSPFDIVGSSDNPD------- 263
Query: 274 MHNTDKLQH--LVDPMLCGNFSGNEAVRFLKVGLL 306
+ D L L + +A LK L
Sbjct: 264 QNTEDYLFQVILEKQIRIPRSLSVKAASVLK-SFL 297
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 60 VGEGGFGSVY---KGKLQD-GTVVAVKVL---SVESKQGEKEF-MSEVASMANICHENLV 111
+G+GG+G V+ K + G + A+KVL + + +E + + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 112 KLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAY 167
L + ++ ++ +Y+ L L E + A F + A EI++ L +
Sbjct: 85 DLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLA--EISMA----LGH 136
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD- 226
+H++ I++RD+KP NI+L+ + K++DFGL K D T T GT+ Y+AP+
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPEI 192
Query: 227 YAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
SGH N D +S G L+ ++TG
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 60 VGEGGFGSVY---KGKLQD-GTVVAVKVLS----------VESKQGEKEFMSEVASMANI 105
+G G +G V+ K D G + A+KVL E + E++ + +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ---- 117
Query: 106 CHENLVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGI 161
LV LH + ++ ++ DY+ L L E+ + + + EI L
Sbjct: 118 -SPFLVTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI-YVG--EIVLA- 171
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLG 221
L ++H+ I++RDIK NILLD N + ++DFGLSK F D T + GT+
Sbjct: 172 ---LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 222 YLAP---DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
Y+AP SGH + D +S GVL+ +++TG
Sbjct: 226 YMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 51/218 (23%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V + + AVKVL + E+ + + N+ H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-----NVKHPF 100
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
LV LH + ++ V DY+ L L E RA+F + A EIA L
Sbjct: 101 LVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAA--EIASA----L 152
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--GTLGYL 223
Y+H +IV+RD+KP NILLD + ++DFGL K E+I H ST GT YL
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYL 206
Query: 224 AP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP D V D + G +L +++ G
Sbjct: 207 APEVLHKQPYDRTV--------DWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 51/218 (23%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V + + + AVK+L VE EK ++
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PPF 82
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
L +LH C + R+ V +Y+ L + + A F + A EIA+G L
Sbjct: 83 LTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF-YAA--EIAIG----L 134
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYL 223
++ + I++RD+K N++LD + KI+DFG+ K ++ T T GT Y+
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FCGTPDYI 188
Query: 224 AP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP +V D ++FGVLL +++ GQ
Sbjct: 189 APEIIAYQPYGKSV--------DWWAFGVLLYEMLAGQ 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.5 bits (200), Expect = 2e-17
Identities = 48/285 (16%), Positives = 83/285 (29%), Gaps = 57/285 (20%)
Query: 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--------QGEKEFMSEVAS 101
T K+GEG FG V++ D T VA+K++++E + +E + E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 102 M---------ANICHENLVKLHGGCI----EGPCRIIVYDYMQNNSLSQ----------- 137
E + L+ P + +D+ + S
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 138 ----------TLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187
+ E+ S + I + LA HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 188 LDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLL 247
L + K+ K + + DY +S ++ +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII--------DYTLSRLERDGIVVFCDVSMDE 246
Query: 248 QIVTGQAAVHFDKELGEYYLVEKAWEMH----NTDKLQHLVDPML 288
+ TG FD W + N L +L D ML
Sbjct: 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 29/205 (14%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS----VESKQGEKEFMSEVASMANICHENLVKLH 114
+G G FG V+ + + G A+KVL V KQ E E ++ + H ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIVTHPFIIRMW 72
Query: 115 GGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK----NRAKFSWTARREIALGIARGLAYIH 169
G + +I ++ DY++ L +LL + + AKF + A E+ L L Y+H
Sbjct: 73 G-TFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKF-YAA--EVCLA----LEYLH 123
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+ I++RD+KP NILLD+N + KI+DFG +K P D+T+ T + GT Y+AP+
Sbjct: 124 SK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY--T-LCGTPDYIAPEVVS 176
Query: 230 S-GHLNPKSDIYSFGVLLLQIVTGQ 253
+ + N D +SFG+L+ +++ G
Sbjct: 177 TKPY-NKSIDWWSFGILIYEMLAGY 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V+ + + A+K L VE EK +S H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-----HPF 79
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
L + + + V +Y+ L + K +RA F + A EI LG L
Sbjct: 80 LTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAA--EIILG----L 131
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYL 223
++H + IV+RD+K NILLD++ + KI+DFG+ K + + T +T GT Y+
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT-FCGTPDYI 185
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP+ + N D +SFGVLL +++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG----EKEFMSEVASMANICHENLVKL 113
K+G G FG + GK L VA+K+ ++S+ E F ++ S I ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP-----QV 70
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ G +V + + SL L + +R FS IA+ + + Y+H +
Sbjct: 71 YYFGPCGKYNAMVLE-LLGPSLED--LFDLCDR-TFSLKTVLMIAIQLISRMEYVHSK-- 124
Query: 174 PSIVHRDIKPSNILLDQNFNPK-----ISDFGLSKLF--PEDITHISTR----VAGTLGY 222
++++RD+KP N L+ + N I DF L+K + PE HI R + GT
Sbjct: 125 -NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT--- 180
Query: 223 LAPDYA-VSGHLN----PKSDIYSFGVLLLQIVTGQ 253
Y ++ HL + D+ + G + + + G
Sbjct: 181 --ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 40/212 (18%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEF---MSEVASMANICHENLVKLHG 115
+G+G FG V + + G A+K+L E + E ++E + N H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 116 GCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEE 171
+ R+ V +Y L L E RA+F + A EI L Y+H
Sbjct: 73 -AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGA--EIVSA----LEYLHSR 124
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSK--LFPEDITHISTRVAGTLGYLAP---- 225
+V+RDIK N++LD++ + KI+DFGL K + T GT YLAP
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT-FCGTPEYLAPEVLE 178
Query: 226 ----DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AV D + GV++ +++ G+
Sbjct: 179 DNDYGRAV--------DWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 51/218 (23%)
Query: 60 VGEGGFGSVYKGKLQD-GTVVAVKVLS---------VESKQGEKEFMSEVASMANICHEN 109
+G+G FG V ++++ G + AVKVL VE EK +S + H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HPF 85
Query: 110 LVKLHGGCIEGPCRI-IVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGL 165
L +L C + P R+ V +++ L + + RA+F + A EI L
Sbjct: 86 LTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAA--EIISA----L 137
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA--GTLGYL 223
++H++ I++RD+K N+LLD + K++DFG+ K E I + T GT Y+
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYI 191
Query: 224 AP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
AP AV D ++ GVLL +++ G
Sbjct: 192 APEILQEMLYGPAV--------DWWAMGVLLYEMLCGH 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESK----QGEKEFMSEVASMANICHENLVKL 113
K+G G FG +Y G +Q VA+K+ +V++K E + + I +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP-----NV 68
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+EG ++V D + SL L +R K S +A + + ++H +
Sbjct: 69 RWFGVEGDYNVLVMD-LLGPSLED--LFNFCSR-KLSLKTVLMLADQMINRVEFVHSK-- 122
Query: 174 PSIVHRDIKPSNILLDQNFNPK---ISDFGLSKLF--PEDITHISTR----VAGTLGYLA 224
S +HRDIKP N L+ I DFGL+K + HI R + GT
Sbjct: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT----- 176
Query: 225 PDYA-VSGHLN----PKSDIYSFGVLLLQIVTGQ 253
YA V+ HL + D+ S G +L+ + G
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 21/206 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLH 114
+G G G V VA+K LS +++ K E+ M + H+N++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 115 GGCIEGPCR------IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+V + M N L Q + + + + + G+ ++
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHL 180
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H I+HRD+KPSNI++ + KI DFGL++ + T T Y AP+
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQA 254
+ DI+S G ++ ++V +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 36/214 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG----EKEFMSEVASMANICHENLVKL 113
K+G G FG +Y G + G VA+K+ V++K E + + I +
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP-----TI 70
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
EG ++V + + SL KFS +A + + YIH +
Sbjct: 71 RWCGAEGDYNVMVME-LLGPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHSK-- 124
Query: 174 PSIVHRDIKPSNILLDQNFNPK---ISDFGLSKLF--PEDITHISTR----VAGTLGYLA 224
+ +HRD+KP N L+ I DFGL+K + HI R + GT
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT----- 178
Query: 225 PDYA-VSGHLN----PKSDIYSFGVLLLQIVTGQ 253
YA ++ HL + D+ S G +L+ G
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHG 115
K+G G + V++ + + V VK+L K K+ E+ + N+ N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 98
Query: 116 GCIEGPCR---IIVYDYMQN---NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ P +V++++ N L QTL + R I + L Y H
Sbjct: 99 -IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI----------RFYMYEILKALDYCH 147
Query: 170 EEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP--- 225
I+HRD+KP N+++D ++ ++ D+GL++ F + RVA + + P
Sbjct: 148 SM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVA-SRYFKGPELL 202
Query: 226 ------DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
DY++ D++S G +L ++
Sbjct: 203 VDYQMYDYSL--------DMWSLGCMLASMIFR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 25/206 (12%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLHGG 116
+G G G V VA+K LS +++ K E+ M + H+N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 91
Query: 117 CIEGPCRI--------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+ P + IV + M N L Q + + + + + G+ ++
Sbjct: 92 -VFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHL 143
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H I+HRD+KPSNI++ + KI DFGL++ + T T Y AP+
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQA 254
+ DI+S G ++ +++ G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQ----GEKEFMSEVASMANICHENLVKL 113
++GEG FG +++G L + VA+K S E +A I +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP-----NV 71
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ EG ++V D + SL L + KFS A + + IHE+
Sbjct: 72 YYFGQEGLHNVLVID-LLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEK-- 125
Query: 174 PSIVHRDIKPSNILLDQNFNPK-----ISDFGLSKLF--PEDITHISTR----VAGTLGY 222
S+V+RDIKP N L+ + + + DFG+ K + P HI R ++GT
Sbjct: 126 -SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT--- 181
Query: 223 LAPDYA-VSGHLN----PKSDIYSFGVLLLQIVTGQ 253
Y ++ HL + D+ + G + + + G
Sbjct: 182 --ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLH 114
VG G +GSV + G VA+K LS +S+ K E+ + ++ HEN++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 115 GGCIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
+ +V +MQ + L + + KFS + + + +GL Y
Sbjct: 90 D-VFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKIQYLVYQMLKGLKY 141
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPD 226
IH +VHRD+KP N+ ++++ KI DFGL++ ++T + TR Y AP+
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 227 YAVS-GHLNPKSDIYSFGVLLLQIVTGQA 254
+S H N DI+S G ++ +++TG+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 25/173 (14%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-----EKEFMSEVASMANICHENLVK 112
K+G GGFG +Y A V+ VE ++ E +F VA I ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK--KWIE 101
Query: 113 LHGGCIEGPCRII-----VYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGI 161
G + + LG +N F + ++ + +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRM 160
Query: 162 ARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI--SDFGLSKLFPEDITHI 212
L YIHE VH DIK +N+LL ++ +D+GLS + + H
Sbjct: 161 LDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 28/182 (15%), Positives = 59/182 (32%), Gaps = 38/182 (20%)
Query: 58 NKVGEGGFGSVYKGK---------LQDGTVVAVKVLSVESKQG----EKEFMSEVASMAN 104
+ G +Y+ ++K+ ++K G E+ F A
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQNFFQRAAKPLQ 104
Query: 105 ICHENLVKLHG------------GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWT 152
+ KL+ G + R +V SL L + + S
Sbjct: 105 V--NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP-SLGRSLQSAL--DVSPKHVLSER 159
Query: 153 ARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI--SDFGLSKLFPEDIT 210
+ ++A + L ++HE VH ++ NI +D ++ + +G + +
Sbjct: 160 SVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 211 HI 212
H+
Sbjct: 217 HV 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 41/201 (20%), Positives = 70/201 (34%), Gaps = 54/201 (26%)
Query: 61 GEGGFGSVYKGK-LQDGTVVAVKVLS-VESKQGEKEFMSEVASMANICHENLVKLHG--- 115
G G G V + + A+K+L + E E + ++V++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQ-----CPHIVRIVDVYE 81
Query: 116 -GCIEGPCRIIVYDYMQNNSLSQTLLGE------EKNRAKFSWTARREIALGIARGLAYI 168
C +IV + + GE ++ F+ EI I + Y+
Sbjct: 82 NLYAGRKCLLIVMECLDG--------GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 169 HEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
H +I HRD+KP N+L N K++DFG + E G Y
Sbjct: 134 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE--------TTGE-KY--- 175
Query: 226 DYAVSGHLNPKSDIYSFGVLL 246
+ D++S GV++
Sbjct: 176 --------DKSCDMWSLGVIM 188
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 30/215 (13%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVK--VLSVESKQGEKEFMS---------EVASMANICH 107
+ G +G+V G +G VA+K +V + E+ + + H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 108 ENLVKLHGGCIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
N++ L I +V + M+ + L+Q + R S +
Sbjct: 89 PNILGLRD--IFVHFEEPAMHKLYLVTELMRTD-LAQVI---HDQRIVISPQHIQYFMYH 142
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTL 220
I GL +HE +VHRD+ P NILL N + I DF L++ D + + V
Sbjct: 143 ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVT-HR 197
Query: 221 GYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQA 254
Y AP+ + D++S G ++ ++ +A
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 40/238 (16%), Positives = 78/238 (32%), Gaps = 55/238 (23%)
Query: 59 KVGEGGFGSVYKGKLQD-GTVVAVK--------------------------VLSVESKQG 91
+G G FG V + + G A+K ++ G
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73
Query: 92 EKEFMSEVASMANICHENLVKLHGGCIEGPCRI--------IVYDYMQNNSLSQTLLGEE 143
++E + + ++ +Y+ + L + L
Sbjct: 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFI 132
Query: 144 KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP-KISDFGLS 202
++ + R + +IH I HRDIKP N+L++ N K+ DFG +
Sbjct: 133 RSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSA 189
Query: 203 KLFPEDITHISTRVAGTLGYLAP-------DYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
K ++ + + Y AP +Y P D++S G + +++ G+
Sbjct: 190 KKLIPSEPSVAY-IC-SRFYRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLHGG 116
VG G +G+V + G VA+K L +S+ K E+ + ++ HEN++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD- 91
Query: 117 CIEGPCRI--------IVYDYMQ---NNSLSQTLLGEEKNRAKFSWTARREIALGIARGL 165
+ P +V +M + LGE+ R +F + + +GL
Sbjct: 92 -VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED--RIQF-------LVYQMLKGL 141
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLA 224
YIH I+HRD+KP N+ ++++ KI DFGL++ ++T ++ TR Y A
Sbjct: 142 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRA 193
Query: 225 PDYAVS-GHLNPKSDIYSFGVLLLQIVTGQA 254
P+ ++ DI+S G ++ +++TG+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 53/270 (19%), Positives = 85/270 (31%), Gaps = 83/270 (30%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEK-------EFMSEVASMAN 104
+G G FG V + VAVK+L + E + + + N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 105 I---------------------CHENLV--------KLHGGCIEGPCRIIVYDYMQN--- 132
+ NL + +G DY+
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 133 ------------NSLSQTLLGEEKNRAKFSWTARRE--------------IALGIARGLA 166
S + + EEK+ + E + +A+G+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL--- 223
++ K +HRD+ NILL + KI DFGL++ DI V L
Sbjct: 208 FL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLK 260
Query: 224 --APDYAVSGHLNPKSDIYSFGVLLLQIVT 251
AP+ +SD++SFGVLL +I +
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLHGG 116
VG G +GSV + G VAVK LS +S K E+ + ++ HEN++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 117 CIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+ +V M + L+ + ++ + + I RGL YIH
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF-----LIYQILRGLKYIH 149
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYA 228
I+HRD+KPSN+ ++++ KI DFGL++ +++T +++TR Y AP+
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIM 201
Query: 229 VS-GHLNPKSDIYSFGVLLLQIVTGQA 254
++ H N DI+S G ++ +++TG+
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 40/178 (22%), Positives = 64/178 (35%), Gaps = 32/178 (17%)
Query: 59 KVGEGGFGSVYKG------KLQDGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENL 110
+G+GGFG +Y + VKV ++ E +F A I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI--QKW 99
Query: 111 VKLHGGCIEGPCRIIVY--------DYMQNNSLSQTLLGE------EKNRAKFSWTARRE 156
++ G + Y + G E N +FS +
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSY---RFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI--SDFGLSKLFPEDITHI 212
++L I L YIHE VH DIK SN+LL+ ++ D+GL+ + + H
Sbjct: 157 LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSV-ESKQGEKEFMSEVASMANICHENLVKLHG 115
+ +GEG +G V + VA+K +S E + + + E+ + HEN++ ++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 116 GCIEGPCRI-------IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIALGIAR 163
I I IV D M+ + L +Q L + + I R
Sbjct: 93 --IIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHL---SNDHICY-------FLYQILR 139
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS--TRVAGTLG 221
GL YIH +++HRD+KPSN+LL+ + KI DFGL+++ D H T T
Sbjct: 140 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 222 YLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQA 254
Y AP+ ++ DI+S G +L ++++ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 39/188 (20%), Positives = 77/188 (40%), Gaps = 20/188 (10%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVK-VLSVESKQGE-KEFMSEVASMANICHENLVKLHG 115
+G G +G V + + VVA+K +L V + K + E+A + + H+++VK+
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 116 GCIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
I P + +V + ++ + + + + + + G+ Y+
Sbjct: 120 --IVIPKDVEKFDELYVVLEIADSD-FKKLF----RTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H I+HRD+KP+N L++Q+ + K+ DFGL++ S
Sbjct: 173 HSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 229 VSGHLNPK 236
N K
Sbjct: 230 FPHTKNLK 237
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVL-SVES--KQGEKE-----FMSEVASMAN--ICH 107
K+G G F +V+ K + + T VA+K++ + + E E +++ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 108 ENLVKL------HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK--NRAKFSWTARREIAL 159
+++KL G +V++ L + LL K ++I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVV--MVFE-----VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 160 GIARGLAYIHEEIKPSIVHRDIKPSNILLD------QNFNPKISDFGLSKLFPEDIT-HI 212
+ GL Y+H I+H DIKP N+L++ KI+D G + + E T I
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
TR Y +P+ + +DI+S L+ +++TG
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKL---- 113
+G GG G V+ VA+K + + Q K + E+ + + H+N+VK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 114 ---HGGCIEGPCRI-------IVYDYMQ---NNSLSQTLLGEEKNRAKFSWTARREIALG 160
+ + IV +YM+ N L Q L EE A+
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE--HARL-------FMYQ 128
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHIS--TRVA 217
+ RGL YIH +++HRD+KP+N+ ++ ++ KI DFGL+++ +H +
Sbjct: 129 LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 218 GTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQA 254
T Y +P +S + D+++ G + +++TG+
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 37/162 (22%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSV-ESKQGEKEFMSEVASMANICHENLVKLHGG 116
+GEG +G V G +VA+K + + + E+ + + HEN++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN- 76
Query: 117 CIEGPCRI-------IVYDYMQ---NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
I+ P I+ + MQ + +S +L ++ ++ R +
Sbjct: 77 -IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD--HIQY-------FIYQTLRAVK 126
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208
+H +++HRD+KPSN+L++ N + K+ DFGL+++ E
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 41/186 (22%), Positives = 78/186 (41%), Gaps = 21/186 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSV--ESKQGEKEFMSEVASMANICHENLVKLHG 115
+G G +G VY VA+K ++ E K + E+ + + + +++L+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 116 GCIEGPCRI-------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
+ P + IV + ++ L + K + + I + G +I
Sbjct: 93 --LIIPDDLLKFDELYIVLEIADSD-LKKLF----KTPIFLTEEHIKTILYNLLLGENFI 145
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS-KLFPEDITHISTRVAGTLGYLAPDY 227
HE I+HRD+KP+N LL+Q+ + K+ DFGL+ + E T+I + +
Sbjct: 146 HES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 228 AVSGHL 233
+ L
Sbjct: 203 NLKKQL 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 60/224 (26%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVL-SVES--KQGEKEFMSEVASMANICHENLVKLHG 115
+G+G FG V K + VA+K++ + + +Q +E I L L
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE--------IRI----LEHLRK 152
Query: 116 GCIEGPCRII----------------------VYDYMQNNSLSQTLLGEEKNRAKFSWTA 153
+ +I +Y+ ++ N FS
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ-----------GFSLPL 201
Query: 154 RREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP--KISDFGLSKLFPEDI-T 210
R+ A I + L +H K I+H D+KP NILL Q K+ DFG S + + T
Sbjct: 202 VRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
+I +R Y AP+ + D++S G +L +++TG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 52/223 (23%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVL-SVES--KQGEKE--FMSEVASMANICHENLV 111
+ +G+G FG V K + VA+K++ + ++ Q + E + + +V
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 112 KLHGG-------CI--EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
L C+ E +YD ++N N S R+ A +
Sbjct: 120 HLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT-----------NFRGVSLNLTRKFAQQMC 167
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP--KISDFGLSKLFPEDI-THISTRVAGT 219
L ++ + SI+H D+KP NILL KI DFG S + I +I +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223
Query: 220 LGYLAP--------DYAVSGHLNPKSDIYSFGVLLLQIVTGQA 254
Y +P D A+ D++S G +L+++ TG+
Sbjct: 224 --YRSPEVLLGMPYDLAI--------DMWSLGCILVEMHTGEP 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 53/276 (19%), Positives = 94/276 (34%), Gaps = 76/276 (27%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-----EKEFMSEVASM--ANICHENL 110
K+G G F +V+ +Q VA+KV+ E + V + + E +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 111 VKLHGG-CIEGP-----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
V+L I G C +V++ + ++ L + N ++I + +G
Sbjct: 104 VQLLDDFKISGVNGTHIC--MVFEVLGHHLLK---WIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 165 LAYIHEEIKPSIVHRDIKPSNILL------------------------------------ 188
L Y+H + + I+H DIKP NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 189 -------------DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
+ KI+D G + + T T Y + + + N
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271
+DI+S + ++ TG F+ GE Y ++
Sbjct: 273 PADIWSTACMAFELATGDYL--FEPHSGEEYTRDED 306
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 43/196 (21%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS------VESKQGEKE--FMSEVASMANICHE 108
K+G+G +G V+K + G VVAVK + ++++ +E ++E++ HE
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG-----HE 69
Query: 109 NLVKLHGGCIEGPCRI----IVYDYMQNNSL-----SQTLLGEEKNRAKFSWTARREIAL 159
N+V L + +V+DYM+ + L + L E ++ +
Sbjct: 70 NIVNLLN--VLRADNDRDVYLVFDYMETD-LHAVIRANIL---EPVHKQY-------VVY 116
Query: 160 GIARGLAYIHEEIKPS--IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVA 217
+ + + Y+H S ++HRD+KPSNILL+ + K++DFGLS+ F +
Sbjct: 117 QLIKVIKYLH-----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 218 GTLGYLAPDYAVSGHL 233
L
Sbjct: 172 SINENTENFDDDQPIL 187
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 76/242 (31%)
Query: 59 KVGEGGFGSVYKG--KLQDGTVVAVKVL-SVES--KQGEKE--FMSEVASMANICHENLV 111
+GEG FG V + + + VA+K++ +V + E + ++ V
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 112 KL-----HGG--CI--E--GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
+ G CI E G +++++ N N + R +A
Sbjct: 86 LMSDWFNFHGHMCIAFELLGKN---TFEFLKEN-----------NFQPYPLPHVRHMAYQ 131
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP-------------------KISDFGL 201
+ L ++HE + H D+KP NIL + +++DFG
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 202 SKLFPEDI-THISTRVAGTLGYLAP--------DYAVSGHLNPKSDIYSFGVLLLQIVTG 252
+ E T ++TR Y P D++S G +L + G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCILFEYYRG 235
Query: 253 QA 254
Sbjct: 236 FT 237
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 51/243 (20%), Positives = 85/243 (34%), Gaps = 78/243 (32%)
Query: 59 KVGEGGFGSVYKGK--LQDGTVVAVKVL-SVES--KQGEKE--FMSEVASMANICHENLV 111
+GEG FG V + G VAVK++ +V+ + E + + + V
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 112 KLHGG-------CI--E--GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++ CI E G YD+++ N F R++A
Sbjct: 81 QMLEWFEHHGHICIVFELLGLS---TYDFIKEN-----------GFLPFRLDHIRKMAYQ 126
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP-------------------KISDFGL 201
I + + ++H + H D+KP NIL Q+ K+ DFG
Sbjct: 127 ICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG- 182
Query: 202 SKLFPED--ITHISTRVAGTLGYLAP--------DYAVSGHLNPKSDIYSFGVLLLQIVT 251
S + ++ T +STR Y AP D++S G +L++
Sbjct: 183 SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPC--------DVWSIGCILIEYYL 229
Query: 252 GQA 254
G
Sbjct: 230 GFT 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 84/248 (33%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVL-SVES--KQGEKEF-MSEVASMANICHENLVKL 113
K+G+G FG V + + + AVKV+ +++ + + E + + +I + N+VK
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101
Query: 114 HGG-------CI--E--GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIA 162
HG C+ E GP +Y+ + N N F + + I
Sbjct: 102 HGKFMYYDHMCLIFEPLGPS---LYEIITRN-----------NYNGFHIEDIKLYCIEIL 147
Query: 163 RGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP-------------------------KIS 197
+ L Y+ + S+ H D+KP NILLD + K+
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 198 DFGLSKLFPEDITH---ISTRVAGTLGYLAP--------DYAVSGHLNPKSDIYSFGVLL 246
DFG F + H I+TR Y AP D + D++SFG +L
Sbjct: 205 DFG-CATF-KSDYHGSIINTRQ-----YRAPEVILNLGWDVSS--------DMWSFGCVL 249
Query: 247 LQIVTGQA 254
++ TG
Sbjct: 250 AELYTGSL 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 8e-07
Identities = 57/344 (16%), Positives = 100/344 (29%), Gaps = 111/344 (32%)
Query: 44 YNELKSATNGFCSSNKVG-EGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEV--A 100
Y +L+ A + V +G GS GK T VA+ V Q + +F ++
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGS---GK----TWVALDVCLSYKVQCKMDF--KIFWL 187
Query: 101 SMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALG 160
++ N V +E M L Q +WT+R + +
Sbjct: 188 NLKNCNSPETV------LE----------MLQKLLYQ---------IDPNWTSRSDHSSN 222
Query: 161 IARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD-FGLS--------------KLF 205
I + I E++ + + + ++L N K + F LS L
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 206 PEDITHIST--RVAG-----TLGYLA----------PDYAVSGHLNPKSDIYSFGVLLLQ 248
THIS L P ++ + P L
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN--P---------RRLS 331
Query: 249 IVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCV 308
I+ ++ + W+ N DKL +++ L V
Sbjct: 332 IIA--ESIRDGLATWDN------WKHVNCDKLTTIIE-------------SSLN-----V 365
Query: 309 QEKSSLRPR-MSTVIEMINGDVDIDDDV-EI-WEPGLINDIMDV 349
E + R + I + + W + +D+M V
Sbjct: 366 LEPAEYRKMFDRLSV--FPPSAHIPTILLSLIWFDVIKSDVMVV 407
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 38/322 (11%), Positives = 91/322 (28%), Gaps = 102/322 (31%)
Query: 76 GTVVAVKVLSVESKQG--EKEFMSEVASMANICHENL-----------VKLHGG-CIEGP 121
+ E S + + ++L + + +G
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGL 341
Query: 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI 181
+ ++ + L+ + E +L ++P+ +
Sbjct: 342 ATWDNWKHVNCDKLTTII----------------ESSL----------NVLEPA----EY 371
Query: 182 KPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL-------- 233
+ + F+ +FP HI T + + + + +
Sbjct: 372 R-------KMFD----RLS---VFPPS-AHIPTILLSLI-WFDVIKSDVMVVVNKLHKYS 415
Query: 234 ----NPKSDIYSFGVLLLQI---VTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ----- 281
PK S + L++ + + A+H + + ++Y + K ++ +
Sbjct: 416 LVEKQPKESTISIPSIYLELKVKLENEYALH--RSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 282 ------HLVDPMLCGNFSGNEAV----RFLK-----VGLLCVQEKSSLRPRMSTVIEMIN 326
HL + + V RFL+ S L +T+ ++
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL----NTLQQLKF 529
Query: 327 GDVDIDDDVEIWEPGLINDIMD 348
I D+ +E L+N I+D
Sbjct: 530 YKPYICDNDPKYE-RLVNAILD 550
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.72 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.73 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.83 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=413.09 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=209.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|++. +|+.||+|++... .....+.+.+|+.++++++||||++++++|++++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 6899999999743 2334577899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||+||+|.+++ ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999 3456799999999999999999999999 999999999999999999999999999997754
Q ss_pred CC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+...... .+... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~i~~~----~------- 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA---KIIKL----E------- 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHT----C-------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHcC----C-------
Confidence 32 233456789999999999999999999999999999999999999998655432221 11111 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 321 (353)
..++...+.++.+||.+||+.||++|||++|+
T Consensus 251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 11222334568899999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=417.80 Aligned_cols=253 Identities=21% Similarity=0.368 Sum_probs=213.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 69999999998665555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+||+|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 154 ~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999883 24699999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+....+. ... ... .
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~~~---------~~~--~ 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPR--L 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSS---------CCC--C
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCC---------CCC--C
Confidence 3345789999999999999999999999999999999999999998655433222111 100 000 1
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
......+..+.+|+.+||+.||++|||++|+++ +|++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 112234567899999999999999999999987 4544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=420.92 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=205.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999975 6899999999754 3344577899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||+||+|.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 Ey~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999943 2345689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+... ...... .
T Consensus 178 ~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---~i~~~~----~------- 242 (350)
T 4b9d_A 178 T-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL---KIISGS----F------- 242 (350)
T ss_dssp H-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHTC----C-------
T ss_pred C-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---HHHcCC----C-------
Confidence 2 122344679999999999999999999999999999999999999998655432221 111110 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+||.+||+.||++|||++|+++
T Consensus 243 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 --PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122234567899999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=419.35 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=211.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|.+.++||+|+||+||+|++. +++.||||+++..+....+.+.+|+.++++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778899999999999999864 478899999987777777889999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 126 VYDYMQNNSLSQTLLGEEK-----------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~-----------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
|||||++|+|.+++..... ...++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999964321 235799999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHH
Q 042383 195 KISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 272 (353)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.. ....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---DCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH---HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH---HHHH
Confidence 999999998664332 223345679999999999999999999999999999999999 89999765443222 1111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.. .....+..+++++.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus 275 ~g-------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 275 QG-------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HT-------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred cC-------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11 012233445677999999999999999999999999998876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=416.33 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=215.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|.+.+.||+|+||+||+|++. ++..||||+++..+....+.+.+|+.++++++|||||++++++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999863 477899999987776677889999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhcc---------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 126 VYDYMQNNSLSQTLLGEE---------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~---------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
|||||++|+|.+++.... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999995432 2345799999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhh
Q 042383 197 SDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.. ......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---ECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHcC
Confidence 99999986543322 22334568999999999999999999999999999999999 89999865432221 111111
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
. ....+..++.++.+|+.+||+.||++|||+++|++.|+++..
T Consensus 247 ~-------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 R-------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 112334456779999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=413.38 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=213.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++++.++||+|+||+||+|.+. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667889999999999999863 4678999999754 3344578999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 125 IVYDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
+|||||++|+|.++|.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999995432 1235699999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
++||+|||+++...... ........||+.|+|||++.++.++.++|||||||++|||+| |..||...+..+ ....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 99999999998654322 223345678999999999999999999999999999999998 899997654322 1111
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
... ......+..++..+.+|+.+||+.||++|||+.||++.|+...++
T Consensus 260 i~~-------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 260 IRN-------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp HHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred HHc-------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 111 111223445567899999999999999999999999999875543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-59 Score=413.69 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=207.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888899999999999999976 689999999985432 24699999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCccCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSKLFPED 208 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~ 208 (353)
|+||+|.+++ ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ ++||+|||+++.....
T Consensus 132 ~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999 3456799999999999999999999999 999999999999999887 6999999999876543
Q ss_pred Ccc----ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 209 ITH----ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 209 ~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.. . ....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~--~~~~---- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---E--PPPI---- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---S--CCGG----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---C--CCCc----
Confidence 211 12335799999999999999999999999999999999999999986655433322211 0 0000
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...++..+..+.+++.+||+.||++|||+.|+++.|...
T Consensus 276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122334456788999999999999999999998876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-58 Score=406.11 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.+++++.++||+|+||+||+|++++ .||||+++.. +....+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3677889999999999999998763 5999998744 34455789999999999999999999998865 56899999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
||++|+|.+++.. ...++++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999842 346799999999999999999999999 9999999999999999999999999999876532
Q ss_pred C-ccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 209 I-THISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 209 ~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ........||+.|+|||++.+ +.++.++|||||||++|||+||+.||...+..... ..........+
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~~~~~~p------ 257 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVGRGYASP------ 257 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHTTCCCC------
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCC------
Confidence 2 223345689999999999864 35899999999999999999999999754432211 11111111111
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.+ ...+..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 258 --~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 258 --DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11 1233445677999999999999999999999998887553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=398.84 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=193.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|.+. +|+.||+|++... .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 6999999999754 2334567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+ +|+|.+++ ...+++++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYI----VQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHH----HHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999998 3456899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+..... .......
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~---~~i~~~~----------- 228 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF---KNISNGV----------- 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHTC-----------
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHcCC-----------
Confidence 2 22345789999999999998876 57999999999999999999999765432221 1111110
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..++...++.+.+|+.+||+.||++|||++|+++
T Consensus 229 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 ---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122233566889999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-58 Score=418.98 Aligned_cols=254 Identities=20% Similarity=0.367 Sum_probs=214.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 69999999998766556677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+||+|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 231 ~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999883 34699999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+.......+. ... ... .
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~~~---------~~~--~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPR--L 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSC---------CCC--C
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCC---------CCC--C
Confidence 3345789999999999999999999999999999999999999998655433322211 100 000 0
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
......+..+.+||.+||+.||++|||++|+++ +|++.
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 111223466889999999999999999999987 45543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-58 Score=400.84 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=198.4
Q ss_pred CCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec----CCceEEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE----GPCRIIVY 127 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 127 (353)
++.++||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.++++++|||||+++++|.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999876 6889999998744 34445678999999999999999999999875 35689999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEECC-CCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLDQ-NFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 204 (353)
|||+||+|.+++. ....+++..+..++.||+.||.|||++ + |+||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999993 456799999999999999999999998 7 999999999999974 78999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ......||+.|+|||++.+ .++.++|||||||++|||+||+.||........ ...........
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~~~~~------- 248 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKP------- 248 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCC-------
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHcCCCC-------
Confidence 4332 2345689999999998865 699999999999999999999999975433211 11111111000
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..++...++++.+|+.+||+.||++|||++|+++
T Consensus 249 -----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111222456889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-58 Score=403.54 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=201.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|++.+.||+|+||+||+|+.. +++.||+|+++... ......+.+|+.++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 47889999997432 2223467889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||||+||+|.+++ ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRL----SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999 3456799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.... .......||+.|+|||++.+..++.++|||||||++|||+||..||...+..+....+ ...
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~~~----------- 241 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI---LKA----------- 241 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC-----------
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH---HcC-----------
Confidence 4322 2234578999999999999999999999999999999999999999865543322211 110
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH--HhcCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM-----STVIE--MINGD 328 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~--~L~~~ 328 (353)
. ..++...++++.+|+.+||+.||++|||+ +|+++ .++++
T Consensus 242 -~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 -K--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -C--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 0 11223345678899999999999999985 67764 45443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=403.45 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=216.8
Q ss_pred CHHHHHHhccCCCCCCeeeeeCceEEEEEEeCC------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcC-CCCceeee
Q 042383 43 SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQD------GTVVAVKVLSVES-KQGEKEFMSEVASMANIC-HENLVKLH 114 (353)
Q Consensus 43 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~ 114 (353)
...+.+...++|++.+.||+|+||+||+|.+.. ++.||+|.+.... ....+.+.+|+.++.++. |||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334444556889999999999999999998542 3679999997543 344567899999999996 59999999
Q ss_pred eeEec-CCceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 042383 115 GGCIE-GPCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI 181 (353)
Q Consensus 115 ~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl 181 (353)
++|.+ ++..++|||||++|+|.++|..... ....+++..+..++.||+.||+|||++ +|+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 99876 4568999999999999999965332 135689999999999999999999999 9999999
Q ss_pred CCCCeEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 042383 182 KPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFD 259 (353)
Q Consensus 182 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~ 259 (353)
||+|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654332 23345678999999999999999999999999999999998 89999765
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....... ..... ......+..++.++.+++.+||+.||++|||+.||++.|+++.
T Consensus 292 ~~~~~~~--~~i~~-------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 292 KIDEEFC--RRLKE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCSHHHH--HHHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHH--HHHHc-------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 4332211 11111 1112233344667999999999999999999999999987654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=397.58 Aligned_cols=264 Identities=25% Similarity=0.334 Sum_probs=200.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----ceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP----CRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 127 (353)
++|.+.++||+|+||+||+|+++ |+.||||++..... .......|+..+.+++||||+++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46788899999999999999985 88999999874322 2223345666667889999999999998654 579999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-----KPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
|||++|+|.+++. ..++++..+..++.|++.||+|||+.+ ..+|+||||||+|||++.++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999993 346899999999999999999999752 348999999999999999999999999999
Q ss_pred ccCCCCCcc---ccccccCCcCccCccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCcccchhh-------
Q 042383 203 KLFPEDITH---ISTRVAGTLGYLAPDYAVSG------HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY------- 266 (353)
Q Consensus 203 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~------- 266 (353)
+........ ......||+.|+|||++.+. .++.++|||||||++|||+||.+||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876443222 22345799999999998764 36779999999999999999988876443221100
Q ss_pred -HHHHHHhhccccccccccCcccCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 267 -LVEKAWEMHNTDKLQHLVDPMLCGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 267 -~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....... .+....+.+.. +.+.+..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 236 ~~~~~~~~--------~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHH--------HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHH--------HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0000000 11122222222 23456789999999999999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=387.98 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=191.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCC--------
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGP-------- 121 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 121 (353)
++|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+.++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999976 689999999976543 34467899999999999999999999987654
Q ss_pred ----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEe
Q 042383 122 ----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 122 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
..|+|||||++|+|.+++.... .....++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999994321 122345677889999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCcc-----------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhh
Q 042383 198 DFGLSKLFPEDITH-----------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266 (353)
Q Consensus 198 Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~ 266 (353)
|||+|+........ ......||+.|+|||++.+..|+.++|||||||++|||++ ||....+ ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999876543211 1233579999999999999999999999999999999996 7753221 111
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
......... . +.......+.+.+|+.+||+.||++|||+.|+++ .+++
T Consensus 236 ~~~~~~~~~------------~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 236 TLTDVRNLK------------F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHHHTTC------------C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHHHhcCC------------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 111111100 0 1111223345678999999999999999999987 4544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=393.27 Aligned_cols=271 Identities=19% Similarity=0.288 Sum_probs=211.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec------CC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE------GP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 121 (353)
.++|++++.||+|+||+||+|.+. +|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 7999999999744 33445678899999999999999999998763 46
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..|+|||||+ |+|.+++ ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i----~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQII----HSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHH----TSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 5799988 4567899999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCC---ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 202 SKLFPEDI---THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 202 ~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
++.+.... ........||+.|+|||++.+. .++.++||||+||++|||++|.+||...+.......+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764321 2233457899999999998875 5699999999999999999999999877765555444433222211
Q ss_pred cccccc--------cCcccC-CC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 278 DKLQHL--------VDPMLC-GN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 278 ~~~~~~--------~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
...... +..... .. ..+..+..+.+|+.+||+.||++|||++|+++ .|++.-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 111100 000000 00 01122456889999999999999999999987 566543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=380.58 Aligned_cols=200 Identities=27% Similarity=0.400 Sum_probs=171.8
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCce
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 123 (353)
...++|++.++||+|+||+||+|+.+ +++.||+|.+.... ....+.+|+.+++.+ +||||++++++|.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999753 46789999886432 345678999999998 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeeccCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLS 202 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~ 202 (353)
|+||||+++|+|.+++ +.+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 9999999999999988 2489999999999999999999999 99999999999999876 79999999999
Q ss_pred ccCCCCCc---------------------------cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCC
Q 042383 203 KLFPEDIT---------------------------HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQA 254 (353)
Q Consensus 203 ~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~ 254 (353)
+....... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 76543211 112335799999999998875 58999999999999999999999
Q ss_pred CCCCCc
Q 042383 255 AVHFDK 260 (353)
Q Consensus 255 pf~~~~ 260 (353)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=374.22 Aligned_cols=296 Identities=41% Similarity=0.731 Sum_probs=250.4
Q ss_pred ccCccCCHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeee
Q 042383 37 KNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHG 115 (353)
Q Consensus 37 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~ 115 (353)
.....++..++....++|++.+.||+|+||+||+|...+++.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 44567899999999999999999999999999999988899999999875432 22336889999999999999999999
Q ss_pred eEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 116 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
++.+.+..++||||+++++|.+++........++++..++.++.|++.||.|||+.+..+++|+||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999966555566799999999999999999999997666999999999999999999999
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCc--ccchhhHHHHHHh
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDK--ELGEYYLVEKAWE 273 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~ 273 (353)
|+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998776554555555679999999999999999999999999999999999999996322 1112223333444
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.........+.+...........+..+.+++.+||+.||.+|||+.||++.|++.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 44455666677777777888899999999999999999999999999999999865443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=374.15 Aligned_cols=289 Identities=40% Similarity=0.642 Sum_probs=245.3
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
++..++....++|++.+.||+|+||+||+|..++++.||+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556789999999999999999999998889999999988666666778899999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999965444445799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
+....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.............+.........+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654322 22233456899999999999999999999999999999999999999876654444444444444445556
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
...+++.+........+..+.+++.+||+.||++|||+.|+++.|+.+..+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 66677777777888899999999999999999999999999999988765544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=399.74 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=214.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|.++ +|+.||+|++........+.+.+|+.+|+.++||||++++++|.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999976 6999999999877766778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC--CCeEEeeccCCccCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN--FNPKISDFGLSKLFPE 207 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~--~~~kl~Dfg~~~~~~~ 207 (353)
|+||+|.+++. .....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999983 2346799999999999999999999999 99999999999999754 8999999999998754
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .... .
T Consensus 310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~---~~~~--~-------- 374 (573)
T 3uto_A 310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---SCDW--N-------- 374 (573)
T ss_dssp T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---TTCC--C--------
T ss_pred C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---hCCC--C--------
Confidence 3 22345679999999999999999999999999999999999999998665433322111 1000 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
+........+..+.+||.+||+.||++|||+.|+++ .|+.
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~ 416 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence 001111122456889999999999999999999998 4544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=394.98 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=203.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHH---HHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMS---EVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.++||+|+||+||+|+.+ +|+.||||++.... ......+.+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999976 69999999997431 122233333 45666777899999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
|+|||||+||+|.+++ ...+.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l----~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999 3456799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..... .....+||+.|+|||++.. ..|+.++|+|||||++|||++|.+||...................
T Consensus 341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~------- 410 (689)
T 3v5w_A 341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------- 410 (689)
T ss_dssp ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-------
T ss_pred ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-------
Confidence 76543 2345689999999999964 579999999999999999999999997655433332222221110
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
..++...+.++.+||.+||+.||++|++ ++||++
T Consensus 411 -------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122334566889999999999999998 677764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=349.88 Aligned_cols=257 Identities=19% Similarity=0.354 Sum_probs=214.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 578999999999999999999864 6899999999876666677889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999983 23689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+........... .. ..
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~-----------~~ 235 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN---GT-----------PE 235 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH---CS-----------CC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CC-----------CC
Confidence 2 233467899999999999999999999999999999999999999765543222211110 00 00
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
...+...+..+.+++.+||+.||++|||+.|+++ .++....
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 1122334567889999999999999999999986 4444433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=353.97 Aligned_cols=259 Identities=23% Similarity=0.395 Sum_probs=213.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999975 6899999998766677778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999842 356799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccc-------------cccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 210 THI-------------STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 210 ~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------- 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------- 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------
Confidence 211 114578999999999999999999999999999999999999987543221110
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.......... ..+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 233 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 233 GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000001111 112223456889999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=351.06 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=208.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999997 47999999998754 344556788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++. ..+.+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999983 346799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccCCcCccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLN-PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+...... .....
T Consensus 166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~----------- 229 (328)
T 3fe3_A 166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE---RVLRG----------- 229 (328)
T ss_dssp SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHC-----------
T ss_pred CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH---HHHhC-----------
Confidence 33 223456799999999999888775 79999999999999999999997654322211 11110
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ...+...+..+.+++.+||+.||.+|||++|+++
T Consensus 230 -~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 -K--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -C--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 1112223556889999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=352.59 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=206.0
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
...++|++.+.||+|+||+||+|+.. |+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 34578999999999999999999874 7889999987543 34446788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+. + ++||||||+||+++.++.+||+|||++..
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999999999984321 122489999999999999999999998 8 99999999999999999999999999976
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~---~~~----------- 253 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA---VGF----------- 253 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---HHH-----------
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-----------
Confidence 54322 122345789999999999999999999999999999999999999976543222111 100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.......+...+..+.+++.+||+.||.+|||++++++.|+.....
T Consensus 254 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 -KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0011223334456789999999999999999999999999887654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=343.39 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=215.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|++.+.||+|+||+||+|..+++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 357899999999999999999999888899999987443 3456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999843 234699999999999999999999999 99999999999999999999999999998766544
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||........... .....
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~~~~------------- 222 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGH------------- 222 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHTTC-------------
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH---HHcCC-------------
Confidence 433444556778999999999899999999999999999999 9999975543222111 11000
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.+.+
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 01112223456889999999999999999999999999887643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=346.07 Aligned_cols=265 Identities=24% Similarity=0.389 Sum_probs=211.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999865 6889999998643 23344678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++ ...+++++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999998 3446799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
............||+.|+|||.+.+..++.++||||||+++|+|++|..||.......... .... ....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~---~~~~----~~~~---- 230 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI---KHIQ----DSVP---- 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH---HHHS----SCCC----
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhh----ccCC----
Confidence 5443333445678999999999999999999999999999999999999997654322110 0000 0000
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-RMSTVIEMINGDVDIDD 333 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~~ 333 (353)
..........+..+.+++.+||+.||.+|| +++++.+.|........
T Consensus 231 -~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 231 -NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 000112223356789999999999999998 99999999998876554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=344.21 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=213.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|+||+||+|.+.+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46789999999999999999999888899999987443 34467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++. .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHH---hcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999984 2345689999999999999999999999 999999999999999999999999999987654433
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ...... ..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~~~~~-------------~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDISTG-------------FR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTT-------------CC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHhcC-------------cc
Confidence 33344567788999999999999999999999999999999 99999765432211 111110 11
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1122223566899999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=348.40 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=207.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|+.+ +|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999976 6899999999753 233456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||++||+|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||++....
T Consensus 84 ~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999988 3456799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ .. ..
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~----~~------- 221 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LM----EE------- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH----CC-------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH---Hc----CC-------
Confidence 222 2234467999999999999999999999999999999999999999765432221111 10 00
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
..++...+..+.+++.+||+.||++|| +++|+++
T Consensus 222 ---~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 112233456789999999999999999 8999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=351.86 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=213.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|++.+.||+|+||+||+|.+. .+..||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 3556999999854 34455778999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999983 2345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 206 PEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 206 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... ....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~~~--------- 269 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS---SVEE--------- 269 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH---HHHT---------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH---HHHc---------
Confidence 543222 1222345778999999999999999999999999999999 999997654322211 1111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
......+...+..+.+++.+||+.||++|||+.+|++.|+.+...+.
T Consensus 270 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 270 ----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11122233445679999999999999999999999999998876555
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=355.02 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=214.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
.++|++.+.||+|+||+||+|.+. ++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999852 35679999997553 33456789999999999 899999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999954321 124589999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986654322 22233456789999999999999999999999999999999 999997654322211
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.... ......+...+..+.+++.+||+.||.+|||+.|+++.|+.+..+
T Consensus 317 ---~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 ---LLKE-------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ---HHHT-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhc-------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 111223334566799999999999999999999999999876644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=350.35 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=208.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh------cHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ------GEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999976 6899999999854321 35678999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEee
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISD 198 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~D 198 (353)
.++||||++||+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHH----TTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 99999999999999998 4456799999999999999999999999 999999999999998776 799999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ......
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~---i~~~~~-- 235 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---ITAVSY-- 235 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHTTCC--
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCC--
Confidence 99998765432 22446799999999999999999999999999999999999999976543322211 111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .. .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~----~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 D----FD----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C----CC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C----CC----chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00 0000122456889999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=342.49 Aligned_cols=262 Identities=22% Similarity=0.365 Sum_probs=215.2
Q ss_pred CccCCHHHHHHhccC----------CCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC
Q 042383 39 INAFSYNELKSATNG----------FCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICH 107 (353)
Q Consensus 39 ~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h 107 (353)
...++.+++..+.+. |...+.||+|+||+||+|... +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345677777766543 667789999999999999976 799999999987666667788999999999999
Q ss_pred CCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 108 ~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
|||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999872 34699999999999999999999999 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhH
Q 042383 188 LDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL 267 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~ 267 (353)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-- 250 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-- 250 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 99999999999999987654322 223467899999999999999999999999999999999999999765432211
Q ss_pred HHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....... .+.+ ......+..+.+++.+||+.||++|||+.++++
T Consensus 251 -~~~~~~~---------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 -KRLRDSP---------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHHHHSS---------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHhcCC---------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110 0000 111233566889999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=336.45 Aligned_cols=283 Identities=38% Similarity=0.613 Sum_probs=229.7
Q ss_pred CccCCHHHHHHhccCCCCC------CeeeeeCceEEEEEEeCCCcEEEEEEeecc----ChhcHHHHHHHHHHHHhcCCC
Q 042383 39 INAFSYNELKSATNGFCSS------NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE----SKQGEKEFMSEVASMANICHE 108 (353)
Q Consensus 39 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~ 108 (353)
...++..++..++++|... +.||+|+||+||+|... ++.||+|++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4668888999888888766 89999999999999874 788999998643 233456788999999999999
Q ss_pred CceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 109 NLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 109 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
||+++++++.+.+..++||||+++++|.+++... ....++++..++.++.||+.||.|||+. +++|+||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998543 2345799999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhH
Q 042383 189 DQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL 267 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~ 267 (353)
+.++.+||+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876543222 2334578999999998764 588999999999999999999999986654333222
Q ss_pred HHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 268 VEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...... .....+...+++.+ .......+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 246 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 221111 11222333344333 3456777889999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=343.92 Aligned_cols=270 Identities=21% Similarity=0.331 Sum_probs=210.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|.+.+|+.||+|++..... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4688999999999999999999998899999999875422 23467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++ +|.+.+. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHH---TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 7888773 3445699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC-
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD- 285 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 285 (353)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+....+
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 322 2233568999999999876 5689999999999999999999999987665544433333222211111111000
Q ss_pred -----cc---cC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 286 -----PM---LC----GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 286 -----~~---~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
.. .. ....+..+.++.+|+.+||+.||++|||++|+++ .+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 00 00 0011223457889999999999999999999987 4544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=350.00 Aligned_cols=270 Identities=21% Similarity=0.322 Sum_probs=209.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 122 (353)
..++|++.+.||+|+||+||+|++ .+++.||+|++........+.+.+|+.++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 357899999999999999999984 2688999999987776667889999999999999999999999864 456
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 8999999999999999843 234589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc----
Q 042383 203 KLFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---- 276 (353)
Q Consensus 203 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 276 (353)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..|+......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR----MIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH----HHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh----hhcCccccchh
Confidence 87654322 1223345677899999999999999999999999999999999998643321000 0000000
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.......+........+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00001111111122334455678999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=345.80 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=211.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|++.+.||+|+||+||++.+.++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457899999999999999999999988899999997443 3446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999843 245699999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......... ..... .
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~~-------------~ 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE---HIAQG-------------L 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHTT-------------C
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH---HHhcc-------------c
Confidence 333344556788999999999999999999999999999998 999997654322211 11110 1
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11112223467889999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=346.94 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=205.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4578999999999999999999876 789999999875432 23456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999998 4556799999999999999999999999 999999999999999999999999999986542
Q ss_pred CC-ccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 208 DI-THISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||............. . .
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~-~------------ 223 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-K-E------------ 223 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-H-T------------
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-h-c------------
Confidence 22 222344678999999999988775 778999999999999999999997655432211110 0 0
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000001112335668899999999999999999999763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=357.47 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=207.5
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
...++|++.+.||+|+||+||+|... +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999865 68999999997543 2344678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC---CCCCeEEeeccCC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD---QNFNPKISDFGLS 202 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~ 202 (353)
||||+.+|+|.+.+. ....+++..+..++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999983 456799999999999999999999999 999999999999998 5678999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .... .
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~~~-----~ 231 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK---AGAY-----D 231 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCC-----C
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---hCCC-----C
Confidence 87654322 2234679999999999999999999999999999999999999997655432221111 1000 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000111223566889999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=349.99 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=204.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|+.+ +|+.||+|+++.. .......+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999976 6899999999753 233446678899999988 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||++||+|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||++..
T Consensus 101 lv~E~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999998 3446799999999999999999999999 999999999999999999999999999985
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. .
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~---~----------- 238 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---N----------- 238 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-----------
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH---c-----------
Confidence 4322 222344679999999999999999999999999999999999999998665432221111 1
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH------HHHHH--HhcC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM------STVIE--MING 327 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~--~L~~ 327 (353)
.. ..++...+..+.+++.+||+.||++||++ +|+++ .+++
T Consensus 239 -~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 239 -DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp -CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred -CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 00 11222345668899999999999999998 77765 4444
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=350.20 Aligned_cols=254 Identities=21% Similarity=0.301 Sum_probs=208.1
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
...++|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34678999999999999999999876 6899999999754 33445678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC---CCeEEeeccCC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN---FNPKISDFGLS 202 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~~ 202 (353)
||||+++++|.+.+ .....+++..++.++.||+.||.|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDI----VAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHH----TTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999988 3456799999999999999999999999 99999999999999764 45999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... ........
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----- 248 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYD----- 248 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCCC-----
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhCCCC-----
Confidence 8765322 2234679999999999999899999999999999999999999997654322221 11110000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.........+..+.+|+.+||+.||++|||+.++++.
T Consensus 249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112235678899999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=343.71 Aligned_cols=252 Identities=15% Similarity=0.224 Sum_probs=207.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|.+. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999876 68899999987543 345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC--CCCeEEeeccCCccCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ--NFNPKISDFGLSKLFP 206 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~ 206 (353)
|+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999999983 2335799999999999999999999999 9999999999999987 7899999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........ ...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~------~~~ 224 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMNAEYT------FDE 224 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHHTCCC------CCH
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HHHcCCCC------CCh
Confidence 432 2234568999999999998889999999999999999999999997654322211 11111000 000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000122456889999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=338.36 Aligned_cols=274 Identities=20% Similarity=0.256 Sum_probs=216.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC--ceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGP--CRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 125 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3567999999999999999999976 58999999987543 334567789999999999999999999988665 7799
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE----CCCCCeEEeeccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGL 201 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~ 201 (353)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999995432 233499999999999999999999999 99999999999999 7788899999999
Q ss_pred CccCCCCCccccccccCCcCccCccccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCcccch-hhHHHHHH
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAV--------SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAW 272 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~ 272 (353)
+........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ........
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 987654322 23456899999999886 56789999999999999999999999975443222 22222222
Q ss_pred hhcccccccccc-----------CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 273 EMHNTDKLQHLV-----------DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 273 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.......+..+. .-......+......+.+++.+||+.||++|||++|+++..++..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 222111111110 011123456778889999999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=350.01 Aligned_cols=274 Identities=26% Similarity=0.348 Sum_probs=208.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc----eEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC----RII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~l 125 (353)
..++|++.+.||+|+||+||+|++. ++.||+|++.... ........|+.++++++||||+++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3478999999999999999999887 7899999987543 233455668899999999999999999987543 699
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-------KPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-------~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999832 45899999999999999999999751 23899999999999999999999999
Q ss_pred ccCCccCCCCCc-cccccccCCcCccCccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 199 FGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSG-----HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 199 fg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999987654322 223335789999999998863 45678999999999999999999997654322221111110
Q ss_pred hhcccccccc-ccCcccCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 273 EMHNTDKLQH-LVDPMLCGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 273 ~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.......+.. .......... ....+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000000000 0111111111 22456779999999999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=337.52 Aligned_cols=264 Identities=17% Similarity=0.309 Sum_probs=204.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999976 68999999997543 3334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++ +|.+.+. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 5666552 3456799999999999999999999999 9999999999999999999999999999876533
Q ss_pred CccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccch-hhHHHHHHhhccccccccccC-
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAWEMHNTDKLQHLVD- 285 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~- 285 (353)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+...........+.....
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 22 233456899999999988765 79999999999999999999888654432221 111111111111111111000
Q ss_pred -----------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 -----------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+..+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00011122344667889999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=355.54 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=216.4
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEe
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCI 118 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 118 (353)
...++|.+.+.||+|+||+||+|.+. .+..||+|++... .......+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999852 2467999998755 334457788999999999 8999999999999
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999964321 124699999999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccch
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGE 264 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~ 264 (353)
+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986653322 22333557889999999999999999999999999999999 9999975543221
Q ss_pred hhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 265 YYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
. ..... ......+...+..+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 303 ~---~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 303 F---KLLKE-------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp H---HHHHT-------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred H---HHHHc-------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 11111 11112223345679999999999999999999999999998875544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=336.21 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=197.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh----hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK----QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|.+. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 78899999875432 2346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEEcCCCCCCeEECC--------CCCeE
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS---IVHRDIKPSNILLDQ--------NFNPK 195 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~---i~H~dlk~~Nil~~~--------~~~~k 195 (353)
|||+++++|.+++ ....+++..++.++.|++.||.|||+. + ++|+||||+||+++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999988 345799999999999999999999998 7 999999999999985 77899
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|+|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....... .
T Consensus 157 l~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~---- 226 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG---V---- 226 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH---H----
T ss_pred EccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh---h----
Confidence 999999986543222 235689999999999999999999999999999999999999976543221110 0
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
.........+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 --------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011111223334456799999999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.55 Aligned_cols=256 Identities=19% Similarity=0.273 Sum_probs=207.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3567999999999999999999875 68999999987432 12457789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC---eEEeecc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN---PKISDFG 200 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg 200 (353)
++||||+++++|.+.+.........+++..++.++.||+.||.|||+. +++||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999988865544556799999999999999999999999 9999999999999976554 9999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ............
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~~~~~--- 250 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKGKYK--- 250 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHHTCCC---
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHcCCCC---
Confidence 9987654322 23345799999999999999999999999999999999999999976432 111111110000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 251 ---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 ---MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0112456889999999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=342.11 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=207.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh------hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK------QGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999976 689999999875432 135778999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEee
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISD 198 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~D 198 (353)
.++||||+++++|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHH----TTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHH----HhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999999998 4456799999999999999999999999 999999999999998877 799999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .....
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~-- 234 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---SAVNY-- 234 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HHTCC--
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---HhcCC--
Confidence 99998765322 223456899999999999999999999999999999999999999765432221111 11000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .........+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000001122456889999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=347.91 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=207.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999876 5889999998743 233456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+.||+|.+++ .....+++..++.++.||+.||.|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHL----QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHH----HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999998 4456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------- 235 (384)
T 4fr4_A 167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------- 235 (384)
T ss_dssp TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------
T ss_pred CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------
Confidence 33 22345679999999999874 45899999999999999999999999765543333222222111
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-MSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 323 (353)
...++...+..+.+|+.+||+.||.+||+ +++|++
T Consensus 236 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01223334567899999999999999998 677664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=338.43 Aligned_cols=276 Identities=19% Similarity=0.242 Sum_probs=218.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 457899999999999999999996 478999999986433 234577899999999 7999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC-----eEEeeccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN-----PKISDFGLS 202 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~-----~kl~Dfg~~ 202 (353)
||+ +++|.+++.. ...++++..++.++.||+.||.|||+. +++||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 8899999842 245699999999999999999999999 9999999999999987766 999999999
Q ss_pred ccCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 203 KLFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 203 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876543221 22346789999999999999999999999999999999999999987654433333322222111
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCccccCCccccc
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPGLIND 345 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~ 345 (353)
....... ....+..+.+++.+||+.||++|||+++|++.|+++..--. ..+...++|+
T Consensus 239 ~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~--~~~~~~~dw~ 296 (298)
T 1csn_A 239 STPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN--TTEDENFDWN 296 (298)
T ss_dssp HSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT--CCSCSCCGGG
T ss_pred CccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC--CCCCCccccC
Confidence 1111111 11224668999999999999999999999999998764333 2333444443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=344.87 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=204.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 478999999999999999999974 78999999987432 22235788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+ +|+|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 679999883 346799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. .......||+.|+|||++.+..+ ++++|||||||++|+|++|..||........ ...+..
T Consensus 160 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~ 222 (336)
T 3h4j_B 160 DG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNS 222 (336)
T ss_dssp TS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCS
T ss_pred CC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHc
Confidence 43 22344679999999999988776 7899999999999999999999975432111 111111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ....+...+..+.+++.+||+.||.+|||++|+++
T Consensus 223 ~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 C--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp S--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 11223334567889999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=356.93 Aligned_cols=258 Identities=23% Similarity=0.324 Sum_probs=210.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|.+.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999986 68999999987542 333456789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999842 334689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccc-ccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 208 DITHIS-TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||......... .....
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~~~------------ 330 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEK------------ 330 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHHHT------------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc------------
Confidence 322111 12235678999999998999999999999999999998 99999765432211 11111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
......+..++..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 331 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 331 -GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111223334567899999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=337.10 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=204.0
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||+|+||+||+|...+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999998899999999875432 2336788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++ +|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 8988883 2346799999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc-----
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL----- 283 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 283 (353)
. ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence 2 22335689999999998764 5899999999999999999999999866543333222221111111111100
Q ss_pred cCcccC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLC-------GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.++... .......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0112234567889999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=340.77 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=207.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999976 68999999997432 23456778899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~gg~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999998 3456799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~------------~ 218 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---ILN------------A 218 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH------------C
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---HHh------------C
Confidence 32 2346789999999999999999999999999999999999999976543222211 111 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
. ..++...+..+.+++.+||+.||++|| +++++++
T Consensus 219 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 112233456788999999999999999 8999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=360.34 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=210.4
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
...++|++.+.||+|+||+||+|.++++..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3457788999999999999999999888889999998543 345678999999999999999999999876 67899999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++... ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999432 335689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.........++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..... .
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~-------------~ 397 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVER-------------G 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHT-------------T
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-------------C
Confidence 3222333456788999999999999999999999999999999 99999755432211 11111 1
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.....+..++..+.+++.+||+.||++|||+++|++.|++......
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1122334456779999999999999999999999999999875544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=354.70 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=213.7
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
.++....++|++.++||+|+||+||+|+.+ +++.||+|++.... ......+.+|..++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344445689999999999999999999976 58899999997431 11223478899999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999942 246799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
+++..............||+.|+|||++. ...++.++|||||||++|||++|..||...+..+.+..+.......
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99876554444445568999999999987 4578999999999999999999999998765443332222111000
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHH--HhcCC
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIE--MINGD 328 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~--~L~~~ 328 (353)
. . +......+..+.+|+.+||..+|++ ||+++|+++ .++++
T Consensus 301 ~---~---------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 301 Q---F---------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp C---C---------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred c---C---------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 0 0 1111123456889999999988888 999999986 45543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=343.09 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=210.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+|+.+++++ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999964 789999999875432 23578899999999 99999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC-----eEEeeccCCc
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN-----PKISDFGLSK 203 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~-----~kl~Dfg~~~ 203 (353)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 8899999843 246799999999999999999999999 9999999999999998887 9999999998
Q ss_pred cCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 204 LFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 204 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76433221 123467999999999999999999999999999999999999999876544333322222211111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
... ..++. ..+ .+.+++.+||+.||.+||++++|++.|++..
T Consensus 239 ~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 239 TPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 100 00111 113 7999999999999999999999999887554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=361.15 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=216.1
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.....++|++.+.||+|+||+||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344567889999999999999999999888899999998543 45678999999999999999999999987 5678999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++... ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999432 234688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
...........+++.|+|||++....++.++|||||||++|||++ |..||......+.... ....
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~----------- 401 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERG----------- 401 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HHHT-----------
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcC-----------
Confidence 432222233456778999999999999999999999999999999 9999976543222111 1111
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.....+..++..+.+++.+||+.||++|||+++|++.|++.....
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111223344677999999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=347.15 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=210.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3578999999999999999999876 688999999987666666788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC--CCCeEEeeccCCccCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ--NFNPKISDFGLSKLFP 206 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~ 206 (353)
|+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++....
T Consensus 129 ~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999883 2345799999999999999999999999 9999999999999974 5779999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ..... .
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---i~~~~----~------ 267 (387)
T 1kob_A 203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN---VKRCD----W------ 267 (387)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHHCC----C------
T ss_pred CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH---HHhCC----C------
Confidence 432 22335689999999999999999999999999999999999999986543222211 11100 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111122335678999999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=337.50 Aligned_cols=249 Identities=23% Similarity=0.299 Sum_probs=198.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------------------------hcHHHHHHHHHHHH
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------------------------QGEKEFMSEVASMA 103 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 103 (353)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999865 688999999874421 11246789999999
Q ss_pred hcCCCCceeeeeeEec--CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 042383 104 NICHENLVKLHGGCIE--GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI 181 (353)
Q Consensus 104 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl 181 (353)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||.|||+. +++|+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56789999999999998865 345799999999999999999999999 9999999
Q ss_pred CCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCC
Q 042383 182 KPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH---LNPKSDIYSFGVLLLQIVTGQAAVHF 258 (353)
Q Consensus 182 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~pf~~ 258 (353)
||+||+++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654322 223457899999999988765 37789999999999999999999975
Q ss_pred CcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 259 DKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....... ...... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~---~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCLH---SKIKSQ------------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHHH---HHHHHC------------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHHH---HHHhcc------------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4432111 111110 0000111223456899999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=363.44 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=217.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||.||+|.++ ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467888999999999999999977 48899999987543 346788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++.. .....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 297 ~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999943 2345689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||...+....... . ...
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~-------------~~~ 435 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---L-------------EKD 435 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---H-------------HTT
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---H-------------HcC
Confidence 3333334456788999999999999999999999999999999 9999976543322111 1 111
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.....+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 112233445677999999999999999999999999999886543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=338.30 Aligned_cols=281 Identities=19% Similarity=0.299 Sum_probs=206.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999976 58999999886443 233467789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~----~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELD----RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHH----HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHH----hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999998887 4456799999999999999999999999 999999999999999999999999999987653
Q ss_pred CCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc--------c
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT--------D 278 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 278 (353)
... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..................... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 2234568999999999876 56899999999999999999999999876654443332221110000 0
Q ss_pred c-cccccCcccCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCCCccccC
Q 042383 279 K-LQHLVDPMLCGN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDDDVEIWE 339 (353)
Q Consensus 279 ~-~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~~~~~~~ 339 (353)
. ......+..... ..+..+..+.+++.+||+.||++|||++|+++ .++++.+....+...+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~ 302 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----------
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHHHHhhc
Confidence 0 000000000000 00123556889999999999999999999986 4666655554443433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=344.69 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=205.9
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
....++|++.+.||+|+||+||+|+.+ +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345688999999999999999999976 68999999997532 23456678899999887 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||++||+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 999999999999999983 345799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ...
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~~-------- 233 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMD-------- 233 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC--------
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---HhC--------
Confidence 8543221 2234567999999999999999999999999999999999999999765543222111 110
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMS-TVI 322 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl 322 (353)
...++...+..+.+++.+||+.||++||++. +|+
T Consensus 234 ------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 ------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0112223356788999999999999999998 664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=337.85 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=212.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..++|++.+.||+|+||+||+|...++..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 457899999999999999999998888899999987443 345678999999999999999999998874 458999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999998432 223689999999999999999999999 99999999999999999999999999998775543
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ...... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~-------------~ 227 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLERG-------------Y 227 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTT-------------C
T ss_pred cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHhcc-------------c
Confidence 333344556788999999998899999999999999999999 89999754432111 111110 1
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
....+...+..+.+++.+||+.||++|||+.++++.|++....
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1112233456799999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=339.30 Aligned_cols=269 Identities=23% Similarity=0.355 Sum_probs=194.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3468999999999999999999865 689999999975532 23467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 128 DYMQNNSLSQTLLGEEK--NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||++ ++|.+++..... ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 499998854322 224689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...........+....
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43322 22335689999999998764 68999999999999999999999998766544333322221111111100000
Q ss_pred -----Cccc------------CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 -----DPML------------CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 -----~~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+.. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00011123457899999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=335.47 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=212.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46789999999999999999999888899999997543 34467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999842 345789999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ...... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~i~~~-------------~~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDISTG-------------FR 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHTT-------------CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH---HHHhcC-------------Cc
Confidence 23334556788999999998999999999999999999999 89999755432111 111110 01
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122233567889999999999999999999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=353.80 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=211.8
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
++....++|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33445678999999999999999999976 58899999987421 122345778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||++||+|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999883 24689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGH----LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
+...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+....+..+........
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~- 293 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT- 293 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc-
Confidence 9876654433445678999999999998765 78999999999999999999999986654433322221110000
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHH--HhcCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL--RPRMSTVIE--MINGD 328 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~--~L~~~ 328 (353)
.......+..+.+|+.+||+.+|++ ||+++||++ .++++
T Consensus 294 ------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 294 ------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp ------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 0001122456889999999999998 999999986 35543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=343.21 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=206.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999976 68999999987432 23456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999983 345799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .... ..
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~i~~----~~------- 254 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---KIVS----GK------- 254 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHH----CC-------
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH---HHHc----CC-------
Confidence 32 234578999999999999999999999999999999999999998654322221 1111 00
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
..++...+..+.+++.+||+.||.+||+ +++|++
T Consensus 255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1122334567899999999999999998 888865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=348.37 Aligned_cols=277 Identities=24% Similarity=0.325 Sum_probs=215.3
Q ss_pred cccCccCCHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-----CCC
Q 042383 36 LKNINAFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-----HEN 109 (353)
Q Consensus 36 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~ 109 (353)
......++..+.....++|++.+.||+|+||+||+|++. +++.||+|++.. .......+..|+.+++.+. |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 344556666777777899999999999999999999975 688999999873 3344566778999999986 999
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
|+++++++...+..++||||+ +++|.+++.. .....+++..+..++.||+.||.|||+. +++||||||+||+++
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD 171 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence 999999999999999999999 8899999843 2334699999999999999999999999 999999999999997
Q ss_pred C-------------------------CCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHH
Q 042383 190 Q-------------------------NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGV 244 (353)
Q Consensus 190 ~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~ 244 (353)
. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 5 789999999999865432 23456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc--------cccc-Cccc----CCCCC----------------hH
Q 042383 245 LLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL--------QHLV-DPML----CGNFS----------------GN 295 (353)
Q Consensus 245 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~----~~~~~----------------~~ 295 (353)
++|+|++|..||...........+............ .... .... ..... ..
T Consensus 248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 327 (360)
T 3llt_A 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII 327 (360)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence 999999999999876554433332222111100000 0000 0000 00000 01
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 296 EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 296 ~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+.+|+.+||+.||++|||+.|+++
T Consensus 328 ~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 328 KHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1256889999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=346.51 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=200.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|+.+ +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3478999999999999999999976 58899999998542 22234577899999887 8999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++|+|..++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 9999999999999883 446799999999999999999999999 999999999999999999999999999985
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchh--hHHHHHHhhcccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY--YLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~ 282 (353)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~-------- 273 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------- 273 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------
Confidence 3322 22334567999999999999999999999999999999999999999643221110 000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
+.... ..++...+..+.+|+.+||+.||++||++
T Consensus 274 i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 274 ILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred Hhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000 12233345678899999999999999996
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=338.59 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=202.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHh--cCCCCceeeeeeEec----CCce
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMAN--ICHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~ 123 (353)
..++|++.+.||+|+||+||+|+. +++.||+|++... ....+..|.+++.. ++||||+++++++.+ ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999988 4889999998643 33455667777766 789999999998654 3457
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH--------EEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
++||||+++|+|.+++ ....+++..++.++.||+.||.||| +. +++||||||+||+++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHH-----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHH-----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 8999999999999998 2346999999999999999999999 77 999999999999999999999
Q ss_pred EeeccCCccCCCCCccc---cccccCCcCccCccccccC------CCCccccchhHHHHHHHHHhC----------CCCC
Q 042383 196 ISDFGLSKLFPEDITHI---STRVAGTLGYLAPDYAVSG------HLNPKSDIYSFGVLLLQIVTG----------QAAV 256 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~~ll~g----------~~pf 256 (353)
|+|||++.......... .....||+.|+|||++.+. .++.++|||||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997654332221 2334789999999998876 455799999999999999999 7888
Q ss_pred CCCcccchh-hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 257 HFDKELGEY-YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 257 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
......... ........ ..... ........+...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVC---VDQQR---PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHT---TSCCC---CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHh---ccCCC---CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 654322211 11111100 00000 00001112345678899999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=346.86 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=213.8
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
...++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999874 34789999998543 344567899999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhcccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKN--------------------RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI 181 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~--------------------~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl 181 (353)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +++|+||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 999999999999999999543211 26799999999999999999999999 9999999
Q ss_pred CCCCeEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 042383 182 KPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFD 259 (353)
Q Consensus 182 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~ 259 (353)
||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543211 22234567889999999999999999999999999999999 99999755
Q ss_pred cccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 260 KELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
...... ..... ... ...+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 281 ~~~~~~---~~~~~----~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 AHEEVI---YYVRD----GNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CHHHHH---HHHHT----TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ChHHHH---HHHhC----CCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 432211 11111 100 11223345679999999999999999999999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=341.89 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=213.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999985 24578999999754 33445778899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK--------------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIK 182 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk 182 (353)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999954322 123489999999999999999999999 99999999
Q ss_pred CCCeEECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCc
Q 042383 183 PSNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDK 260 (353)
Q Consensus 183 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~ 260 (353)
|+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866443222 2233456788999999999999999999999999999999 999997655
Q ss_pred ccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 261 ELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
........ .. ......+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 258 ~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLL---KT-------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHH---HT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHh---hc-------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43222111 11 0111223344567999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=350.24 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=200.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|.+.+.||+|+||+||+|+.. ++..||+|+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999864 4678999999754 34445678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999984 2345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcccc--ccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 206 PEDITHIS--TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 206 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
........ ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~---~~i~~--------- 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI---KAVDE--------- 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH---HHHHT---------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc---------
Confidence 54322211 12235678999999999999999999999999999998 99999755432111 11111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
......+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 266 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 266 ----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 01111223345679999999999999999999999999987653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=347.76 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=195.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999976 78999999997543 233567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC--eEEeeccCCccCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN--PKISDFGLSKLFP 206 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~~~~~ 206 (353)
|+++|+|.+++. ..+.+++..++.++.||+.||.|||+. +++||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 999999999983 445799999999999999999999999 9999999999999987665 9999999987443
Q ss_pred CCCccccccccCCcCccCccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPK-SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||................ ..
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-----------~~ 236 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-----------LS 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-----------HT
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-----------hc
Confidence 22 22234568999999999988887665 899999999999999999998655433322111110 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000001111224668899999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=338.11 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=217.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|.+. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4678999999999999999999976 4889999998743 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++.. .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999943 2346699999999999999999999999 9999999999999999999999999999877655
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+......... ..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~----------------~~ 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------------KD 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----------------TT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----------------cc
Confidence 4444445567889999999999999999999999999999999 999997654332221111 11
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.....+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1122233445679999999999999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=350.30 Aligned_cols=270 Identities=23% Similarity=0.339 Sum_probs=215.2
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceee
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKL 113 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~ 113 (353)
+.........++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44555556678999999999999999999973 246789999997543 34456789999999999 79999999
Q ss_pred eeeEecCCc-eEEEEEcCCCCChhhhhhhcccc-----------------------------------------------
Q 042383 114 HGGCIEGPC-RIIVYDYMQNNSLSQTLLGEEKN----------------------------------------------- 145 (353)
Q Consensus 114 ~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~----------------------------------------------- 145 (353)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999887554 89999999999999999653221
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 146 ---------------RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 146 ---------------~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999986643322
Q ss_pred -cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 211 -HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 211 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||............. ... .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~--~~~-------------~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--KEG-------------T 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH--HHT-------------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH--HcC-------------C
Confidence 22344567889999999999999999999999999999998 999997654332221111 000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11122233567899999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=336.44 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=198.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 45789999999999999999998642 457999998754 3344567889999999999999999999985 45688
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999842 345789999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~---~i~~~--------- 233 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENG--------- 233 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTT---------
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH---HHHcC---------
Confidence 65443333334456788999999999999999999999999999997 999997654432221 11110
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 234 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011223344567899999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=342.18 Aligned_cols=249 Identities=23% Similarity=0.271 Sum_probs=205.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|+.+ +++.||+|++... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999976 4788999999754 223456778899999888 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||++||+|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999983 345799999999999999999999999 999999999999999999999999999985
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ...
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~---i~~----------- 235 (353)
T 2i0e_A 171 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---IME----------- 235 (353)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH-----------
T ss_pred cccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH---HHh-----------
Confidence 4322 1223456799999999999999999999999999999999999999986544322211 111
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
.. ..++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 236 -~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 -HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 1122334567899999999999999995 467654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=331.62 Aligned_cols=254 Identities=30% Similarity=0.475 Sum_probs=205.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhc-------HHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQG-------EKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3478999999999999999999875 78999999987543221 167889999999999999999999987665
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEECCCCC-----e
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLDQNFN-----P 194 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~~~~~-----~ 194 (353)
++||||+++++|.+.+. .....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++. +
T Consensus 97 --~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp --EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred --eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 69999999999998884 3456799999999999999999999998 8 999999999999988776 9
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV--SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
||+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........... ....
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMIR 243 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHHH
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHHh
Confidence 9999999975433 233467899999999984 45678999999999999999999999975543322111 1111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
. .......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 244 ~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 E------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred c------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 1111223344467799999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=352.94 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=211.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||+||+|... ++..||+|++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999843 4678999998744 344556788999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEe
Q 042383 124 IIVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKIS 197 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~ 197 (353)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999965432 224689999999999999999999999 999999999999998554 59999
Q ss_pred eccCCccCCCC-CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhc
Q 042383 198 DFGLSKLFPED-ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 198 Dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|||+++..... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... ......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~i~~~- 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFVTSG- 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHTT-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcC-
Confidence 99999754221 1122233567889999999999999999999999999999998 99999765432211 111110
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.....+
T Consensus 303 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 ------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 011222334566899999999999999999999999998776443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=344.49 Aligned_cols=276 Identities=22% Similarity=0.296 Sum_probs=215.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe--cCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI--EGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 123 (353)
.++|++.+.||+|+||+||+|++ .+++.||+|++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 368899999998777677778999999999999999999999886 55668
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999998432 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 204 LFPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 204 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ...........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHH
Confidence 76543222 22335678889999999999999999999999999999999999875432110000 0000000000111
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
..+........+...+..+.+++.+||+.||++|||+.++++.|+.+..-..
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1112222233445556779999999999999999999999999998875444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=332.94 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=207.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--CceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG--PCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 126 (353)
.++|++.+.||+|+||+||+|+++ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999986 888999998854 334456789999999999999999999999887 788999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
|||+++++|.+++.. .....+++..++.++.||+.||.|||+. + ++|+||||+||+++.++.++++|||++..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999943 2233689999999999999999999998 8 99999999999999999999999988764
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNP---KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
... ....+|+.|+|||++.+..++. ++||||||+++|+|++|..||.......... ..
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~---------- 223 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM---KV---------- 223 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH---HH----------
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH---HH----------
Confidence 322 2346789999999998765544 7999999999999999999997554322111 11
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.........+...+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 224 --ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00111122333445679999999999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=338.68 Aligned_cols=267 Identities=20% Similarity=0.270 Sum_probs=212.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe----cCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI----EGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~ 124 (353)
..++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 357899999999999999999997 478999999998766677788999999999999999999999987 344788
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999976555567899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCcc--------ccccccCCcCccCccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 205 FPEDITH--------ISTRVAGTLGYLAPDYAVSGH---LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 205 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........... ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~-- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-LAV-- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-HHH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-HHh--
Confidence 5321111 012245799999999987554 68899999999999999999999853211111000 000
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
............+..+.+++.+||+.||.+|||+.++++.|+.+..-.+
T Consensus 261 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 -----------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -----------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred -----------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0011111122345679999999999999999999999999998775444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=337.90 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=201.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|++.+.||+|+||.||+|+.+ +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999976 6889999999754 333456678899999988 89999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999983 345799999999999999999999999 9999999999999999999999999999854
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc------hhhHHHHHHhhccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG------EYYLVEKAWEMHNTDK 279 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~ 279 (353)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .........
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~------- 232 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------- 232 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-------
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-------
Confidence 3221 22345679999999999999999999999999999999999999996432111 001111110
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
... ..++...+..+.+++.+||+.||++||++
T Consensus 233 -----~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 -----EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----cCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000 11233345678899999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.35 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=196.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe----CCCcEEEEEEeeccC----hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL----QDGTVVAVKVLSVES----KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999986 468999999987542 2334567889999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999983 345789999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~-------- 236 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---KILKC-------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHT--------
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhC--------
Confidence 7543221 22334678999999999999999999999999999999999999997654322211 11110
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...++...+..+.+++.+||+.||++|| ++.++++
T Consensus 237 ------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 ------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0112233456788999999999999999 7778875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=341.64 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=199.5
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCC-C---cEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQD-G---TVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
...++|++.+.||+|+||+||+|.+.. + ..||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998653 3 27999998754 34455788999999999999999999999987766
Q ss_pred e------EEEEEcCCCCChhhhhhhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 123 R------IIVYDYMQNNSLSQTLLGEEK--NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 123 ~------~lv~e~~~~~sL~~~l~~~~~--~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
. ++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 999999999999999854332 223689999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHH
Q 042383 195 KISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 272 (353)
||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.............
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--- 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI--- 253 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh---
Confidence 9999999986643322 22233456788999999999999999999999999999999 899997655432221110
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.. .....+...+..+.+++.+||+.||++|||+.++++.|+++..-++
T Consensus 254 ~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 254 GG-------------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp TT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cC-------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 00 0112233345679999999999999999999999999998875554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=344.59 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=210.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|+||+||+|.+ .++..||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999985 246689999997542 33446788999999999 8999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhcccc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKN-------------------RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIK 182 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk 182 (353)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +++|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999543211 13489999999999999999999999 99999999
Q ss_pred CCCeEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCc
Q 042383 183 PSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDK 260 (353)
Q Consensus 183 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~ 260 (353)
|+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986543322 22234557889999999999999999999999999999998 999997654
Q ss_pred ccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 261 ELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
........ .. .......+...+..+.+++.+||+.||.+|||+.++++.|+......
T Consensus 280 ~~~~~~~~--~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDANFYKL--IQ-------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHHHHHH--HH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHHHHHH--Hh-------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 33221111 00 11112223334567999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.50 Aligned_cols=275 Identities=18% Similarity=0.213 Sum_probs=208.7
Q ss_pred hccCCCCCCeeeee--CceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEG--GFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+| +||+||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999976 68999999997543 344567888999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999998432 335699999999999999999999999 999999999999999999999999998865
Q ss_pred CCCCC------ccccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh--h
Q 042383 205 FPEDI------THISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE--M 274 (353)
Q Consensus 205 ~~~~~------~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--~ 274 (353)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+............. .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42211 111223468899999999987 5789999999999999999999999976554332211110000 0
Q ss_pred cc-----ccc-------------cccccC---------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--h
Q 042383 275 HN-----TDK-------------LQHLVD---------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--I 325 (353)
Q Consensus 275 ~~-----~~~-------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L 325 (353)
.. ... ...... ...........+..+.+|+.+||+.||++|||+.|+++. +
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 00 000 000000 000011223345679999999999999999999999853 5
Q ss_pred cCCC
Q 042383 326 NGDV 329 (353)
Q Consensus 326 ~~~~ 329 (353)
+++.
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 5544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=352.97 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=200.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 6899999999743 233345677899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||+++++|.+++ .....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999988 345679999999999999999999998 7 9999999999999999999999999999864
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+. . ..
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~----~~------ 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---M----EE------ 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----CC------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---h----CC------
Confidence 3322 22344679999999999999999999999999999999999999997654432221111 0 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HhcCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE--MINGD 328 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~--~L~~~ 328 (353)
..++...+..+.+|+.+||+.||.+|| |++|+++ .++++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 112233356789999999999999999 9999986 44443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=328.88 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=211.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4688999999999999999999876 5889999998754 334456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC---eEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN---PKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~ 203 (353)
|||+++++|.+.+. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999998883 446799999999999999999999999 9999999999999976655 9999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............ ......
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~------ 225 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---KAGAYD------ 225 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHTCCC------
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---Hhcccc------
Confidence 6654322 23456899999999999999999999999999999999999999765433222111 110000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDD 333 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~ 333 (353)
.........+..+.+++.+||+.||++|||+.|+++ .+++......
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 226 ----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273 (284)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred ----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence 000111223466889999999999999999999987 5555544433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=338.28 Aligned_cols=263 Identities=21% Similarity=0.372 Sum_probs=213.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 246789999997543 34457789999999999 8999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEK--------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999954321 123589999999999999999999999 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~ 265 (353)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876543322 2233557788999999999999999999999999999999 99999765433222
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.... .. ......+...+..+.+++.+||+.||.+|||+.++++.|++...
T Consensus 258 ~~~~--~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMI--KE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHH--HH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh--cc-------------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111 00 01111222345678999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.70 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=203.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-----hcHHHHHHHHHHHHhcC---CCCceeeeeeEecC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-----QGEKEFMSEVASMANIC---HENLVKLHGGCIEG 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 120 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999964 689999999874321 12245567777777664 99999999999876
Q ss_pred C-----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 121 P-----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 121 ~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
. ..++||||+.+ +|.+++.. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 47899999975 99999843 2234499999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999998664322 2344678999999999999999999999999999999999999998766544433332222211
Q ss_pred cccccccccC---cccCC-------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 276 NTDKLQHLVD---PMLCG-------NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 276 ~~~~~~~~~~---~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+..... ..+.. ...+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111111000 00000 011233567889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=342.25 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=199.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCC--CCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICH--ENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||++...+++.||+|++... .....+.+.+|+.++.+++| |||+++++++.+++..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999888999999998754 33444678899999999976 999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||| +.+++|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++ ++.+||+|||++...
T Consensus 87 v~e-~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VME-CGNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEC-CCSEEHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEe-CCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999 5577999999 3456799999999999999999999999 999999999999997 578999999999876
Q ss_pred CCCCcc-ccccccCCcCccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 206 PEDITH-ISTRVAGTLGYLAPDYAVS-----------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 206 ~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~-- 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KL-- 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HH--
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HH--
Confidence 543222 2334679999999999865 6788999999999999999999999974332110 00
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..+++......++...+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 -------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 -------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111122223333335678899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.99 Aligned_cols=266 Identities=22% Similarity=0.240 Sum_probs=211.7
Q ss_pred HHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEec
Q 042383 44 YNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIE 119 (353)
Q Consensus 44 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 119 (353)
.++.....++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455689999999999999999999975 68999999997432 1223457889999999999999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
.+..++||||++||+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999942 234799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAV-------SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
|++...............||+.|+|||++. ...++.++|||||||++|||++|..||...+....+..+....
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 999876554333344568999999999987 3568999999999999999999999998665433332222111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCC---CCHHHHHH--HhcCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLR---PRMSTVIE--MINGD 328 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~--~L~~~ 328 (353)
.... . +......+..+.+|+.+||. +|.+| |+++|+++ +++++
T Consensus 287 ~~~~--------~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 287 EHLS--------L----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp HHCC--------C----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cCcC--------C----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 1000 0 11112234568899999999 99998 68999975 45443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.46 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=207.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-ceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP-CRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467889999999999999999986 7799999997543 4567899999999999999999999987665 78999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++|+|.+++... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999532 234579999999999999999999999 9999999999999999999999999999854322
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.....+++.|+|||++.+..++.++||||||+++|||++ |..||......+.... ... ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~-------------~~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEK-------------GY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHT-------------TC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc-------------CC
Confidence 122356889999999999999999999999999999998 9999976543322211 111 11
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12233445678999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=328.12 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=206.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|... ++..+|+|.+........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999876 577899999986656667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCccC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLF 205 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 205 (353)
|+++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999883 446699999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........... .....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~---------- 223 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK---IREGT---------- 223 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCC----------
T ss_pred cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhCC----------
Confidence 5432 2344568999999998765 489999999999999999999999976543222111 11100
Q ss_pred cccCCCCCh----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSG----NEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 224 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 12467889999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=346.63 Aligned_cols=248 Identities=27% Similarity=0.319 Sum_probs=195.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHH-HHhcCCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVAS-MANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3478999999999999999999976 58899999997542 2233455667666 46679999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||++||+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||+++.
T Consensus 116 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999999983 446789999999999999999999999 999999999999999999999999999985
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+ ..
T Consensus 189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~----------- 253 (373)
T 2r5t_A 189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI---LN----------- 253 (373)
T ss_dssp GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH---HH-----------
T ss_pred cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---Hh-----------
Confidence 4322 12234567999999999999999999999999999999999999999765543222111 11
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
.. ..++...+..+.+|+.+||+.||.+||++.+.+
T Consensus 254 -~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 254 -KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 00 112223345688999999999999999986433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=334.26 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=202.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4588999999999999999999976 68899999987542 2234678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999983 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
............+++.|+|||++.+..++.++||||||+++|+|++|..||....... ......... ..
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~--~~------ 253 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---MGAHINQAI--PR------ 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---HHHHHHSCC--CC------
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---HHHHhccCC--CC------
Confidence 5443333344668999999999999999999999999999999999999997554321 111110000 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-RMSTVIEMINGDVDIDD 333 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~~~~~~~ 333 (353)
........+..+.+++.+||+.||++|| |++++++.|+.......
T Consensus 254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0111223345688999999999999999 99999999998876655
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=344.50 Aligned_cols=268 Identities=20% Similarity=0.264 Sum_probs=205.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC------CcEEEEEEeeccChhcH-----------HHHHHHHHHHHhcCCCCcee
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGE-----------KEFMSEVASMANICHENLVK 112 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~ 112 (353)
..++|++.+.||+|+||+||+|.+.. ++.||+|++........ .....|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 47899999875542211 22344566677788999999
Q ss_pred eeeeEecC----CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 113 LHGGCIEG----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 113 ~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4589999999 8999999842 346799999999999999999999999 99999999999999
Q ss_pred C--CCCCeEEeeccCCccCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCc
Q 042383 189 D--QNFNPKISDFGLSKLFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDK 260 (353)
Q Consensus 189 ~--~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~ 260 (353)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999876432211 1123459999999999999999999999999999999999999998544
Q ss_pred ccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 261 ELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
............. ...+..+++..+.. ...+..+.+++.+||+.+|.+||++.+|++.|+++..
T Consensus 266 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPKYVRDSKIRY---RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHHHHHHHHHHH---HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHh---hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 3332221111111 11222233322211 1224568899999999999999999999999877653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=340.04 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=202.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999864 343 4688887643 3345578899999999999999999999998765 78
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+|+|++.+|+|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999843 346799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------------- 233 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------- 233 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------------
Confidence 6543222 2233456789999999999999999999999999999999 999997654432211111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.......+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 234 ---KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112223344567999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.81 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=192.3
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
...++|++.+.||+|+||+||+|... +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34678999999999999999999976 58899999987432 3456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~ 204 (353)
||+++++|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++..
T Consensus 128 e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHH----TTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999998 3456799999999999999999999999 9999999999999975 88999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......... .
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i~~~~-----~--- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRILNCE-----Y--- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHHHTTC-----C---
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHHHhCC-----C---
Confidence 5432 222345689999999999999999999999999999999999999975443211 111111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..........+..+.+|+.+||+.||++|||+.++++
T Consensus 269 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 --YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001112234567889999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=340.07 Aligned_cols=272 Identities=24% Similarity=0.347 Sum_probs=211.3
Q ss_pred hccCC-CCCCeeeeeCceEEEEEEeC-----CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEec--C
Q 042383 50 ATNGF-CSSNKVGEGGFGSVYKGKLQ-----DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIE--G 120 (353)
Q Consensus 50 ~~~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 120 (353)
..++| ++.+.||+|+||+||++.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34555 99999999999999988643 58899999998553 3445678999999999999999999999987 4
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...++||||+++++|.+++. ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred ceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence 67899999999999999983 23599999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 201 LSKLFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 201 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
++........ .......+++.|+|||++.+..++.++||||||+++|+|++|..||.......... ...........
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~ 258 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTVL 258 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhHH
Confidence 9987754332 12234557888999999999999999999999999999999999987543210000 00000000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.+...+........+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111122222233344556789999999999999999999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=338.90 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=183.8
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
.+.||+|+||+||+|.+. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999976 6899999998743 3456778999999996 9999999999999999999999999999
Q ss_pred hhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEEeeccCCccCCCCCcc
Q 042383 135 LSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 135 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 211 (353)
|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+|||++........
T Consensus 93 L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERI----KKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999 3456799999999999999999999999 999999999999997665 799999999986654322
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.................... .....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcc
Confidence 223456899999999999999999999999999999999999999765432111101111111100000 00000
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHhcCCCCCC
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI--EMINGDVDID 332 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl--~~L~~~~~~~ 332 (353)
.....+..+.+|+.+||+.||++|||+.+++ ..+++....+
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 0012356789999999999999999999997 3455554443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=330.20 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=202.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|.+.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999875 68899999987543 3345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCccC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLF 205 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 205 (353)
|+++++|.+.+.........+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999976555567899999999999999999999999 99999999999999 45678999999999865
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||.......... .... .....
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~---~~~~--~~~~~----- 244 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---KATY--KEPNY----- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHH--CCCCC-----
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh---hhcc--CCccc-----
Confidence 432 2233456899999999875 578999999999999999999999997654322111 1100 00000
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...... .+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011 2456889999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=361.79 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=215.3
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
...++|++.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788999999999999999999888889999998543 345678999999999999999999999876 67899999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.+|+|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999432 235689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.........++..|+|||++.+..++.++|||||||++|||++ |..||......+.. ..... .
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i~~-------------~ 480 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVER-------------G 480 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHHHT-------------T
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-------------C
Confidence 2222233456788999999999999999999999999999999 89999754432211 11111 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.....+..++..+.+|+.+||+.||++|||+++|++.|++......
T Consensus 481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1112233456679999999999999999999999999999875444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.72 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=197.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCC--ce
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGP--CR 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~ 123 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++... .......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999865 6899999998633 4455567889999999997 999999999997544 68
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++ +|.+.+. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~lv~e~~~~-~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCSE-EHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccCc-CHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999974 8988883 24789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCC--------------------CccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCccc
Q 042383 204 LFPED--------------------ITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262 (353)
Q Consensus 204 ~~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~ 262 (353)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112234679999999999886 67899999999999999999999999876654
Q ss_pred chhhHHHHHHhhccccccccccC------------------cccCCC------------CChHHHHHHHHHHhhccCCCC
Q 042383 263 GEYYLVEKAWEMHNTDKLQHLVD------------------PMLCGN------------FSGNEAVRFLKVGLLCVQEKS 312 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~------------~~~~~~~~l~~li~~cl~~~p 312 (353)
.....+...........+..+.. ...... .....+..+.+|+.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 44333322211111111100000 000000 001234568899999999999
Q ss_pred CCCCCHHHHHHH
Q 042383 313 SLRPRMSTVIEM 324 (353)
Q Consensus 313 ~~RPt~~evl~~ 324 (353)
++|||++|+++.
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=328.65 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=209.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeee-EecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG-CIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|.+ .+++.||+|++...... ..+.+|+.+++.++|++++..+.. ..+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999997 47899999998754332 357899999999998876665554 46677889999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~ 204 (353)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||++ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8899999842 345799999999999999999999999 99999999999999 4788999999999987
Q ss_pred CCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 205 FPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 205 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 6543221 1234678999999999999999999999999999999999999998654332222222221111110
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
... .+. ...+..+.+++.+||+.||++|||+.+|++.|+++.....
T Consensus 238 ~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 238 PIE-----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CHH-----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred chH-----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 000 011 1224568999999999999999999999999998764443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=331.30 Aligned_cols=260 Identities=29% Similarity=0.459 Sum_probs=198.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|+... .+|+|++... .....+.+.+|+.++++++||||++++++. .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45789999999999999999998653 5999998754 344457789999999999999999999965 556689999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++. .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999883 2346799999999999999999999999 999999999999999999999999999976543
Q ss_pred CC-ccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 208 DI-THISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.. ........||+.|+|||++. +..++.++||||||+++|+|++|..||......... .............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~--- 247 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGRGSLSPDL--- 247 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHHTSCCCCT---
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcccccCcch---
Confidence 21 22223456899999999886 567888999999999999999999999765432221 1111111111110
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.......+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 248 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 ------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1122344567999999999999999999999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=339.66 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=214.5
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEe
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCI 118 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 118 (353)
+.....++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999754 36789999987543 334467889999999999999999999999
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEK------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
+.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 99999999999999999999854321 125679999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHH
Q 042383 193 NPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 270 (353)
.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~ 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RF 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---HH
Confidence 999999999986543221 12233456889999999999999999999999999999999 88998754432111 11
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
... .. ....+...+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 253 ~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 VME----GG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHT----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHc----CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 110 00 011223345678999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=338.41 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=203.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|.++ +|+.||+|++...... ..+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4678999999999999999999976 6889999999754332 34688888888 7999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC----CCeEEeeccCCc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN----FNPKISDFGLSK 203 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~ 203 (353)
||+++|+|.+.+ .....+++..+..++.||+.||.|||+. +++||||||+||++... +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i----~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKI----LRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHH----HTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999998 3456799999999999999999999999 99999999999998443 359999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~------- 240 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF------- 240 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC-------
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc-------
Confidence 7644322 23346789999999999888899999999999999999999999986443322222222211100
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+........+..+.+|+.+||+.||++|||+.++++
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111122334567889999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.95 Aligned_cols=261 Identities=21% Similarity=0.220 Sum_probs=203.1
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-----ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-----SKQGEKEFMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
+....++|++.+.||+|+||+||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456788999999999999999999875 6889999998743 234456789999999999999999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhcccc------------------------------------CCCCCHHHHHHHHHHHHHH
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKN------------------------------------RAKFSWTARREIALGIARG 164 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~------------------------------------~~~l~~~~~~~~~~qi~~a 164 (353)
+..++||||+++|+|.+++...... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421111 2234678889999999999
Q ss_pred HHHHHhcCCCCeEEcCCCCCCeEECCCC--CeEEeeccCCccCCCCC---ccccccccCCcCccCcccccc--CCCCccc
Q 042383 165 LAYIHEEIKPSIVHRDIKPSNILLDQNF--NPKISDFGLSKLFPEDI---THISTRVAGTLGYLAPDYAVS--GHLNPKS 237 (353)
Q Consensus 165 l~~LH~~~~~~i~H~dlk~~Nil~~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 237 (353)
|.|||+. +++|+||||+||+++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998766 89999999998653211 112344678999999999875 6789999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 238 DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
|||||||++|+|++|..||............. .... ..........+..+.+++.+||+.||.+|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVL---NKKL----------CFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCC----------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---hccc----------ccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999997655432221111 1000 0000111123567889999999999999999
Q ss_pred HHHHHH
Q 042383 318 MSTVIE 323 (353)
Q Consensus 318 ~~evl~ 323 (353)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=349.47 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=210.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999976 79999999997432 2234678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++ ...+.+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 94 v~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999998 4456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ......
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~~i~~~---------- 231 (476)
T 2y94_A 167 SDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF---KKICDG---------- 231 (476)
T ss_dssp CTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH---HHHHTT----------
T ss_pred ccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH---HHHhcC----------
Confidence 542 22344679999999999988765 68999999999999999999999755432211 111110
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
.. ..+...+..+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 232 --~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 --IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 00 112223456889999999999999999999987 55543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=330.26 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=205.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeee-EecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG-CIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|.+ .+++.||+|++...... ..+.+|+.+++.++|++++..+.. +.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 47899999987644322 357789999999988876666554 46777889999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~ 204 (353)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 8899999842 345799999999999999999999999 99999999999999 7889999999999987
Q ss_pred CCCCCc------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 205 FPEDIT------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 205 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 654322 12234678999999999999999999999999999999999999998655433332222221111111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
... .... ..+..+.+++.+||+.||++|||+.+|++.|+++..-..
T Consensus 238 ~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 238 PIE-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp CHH-----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhh-----hhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 100 0111 124568999999999999999999999999998765433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=337.34 Aligned_cols=265 Identities=18% Similarity=0.233 Sum_probs=199.8
Q ss_pred hccCCCCC-CeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSS-NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 126 (353)
+.+.|++. +.||+|+||+||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35678885 78999999999999865 6899999999866666677889999999985 799999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC---eEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN---PKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~Dfg~~~ 203 (353)
|||+++++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++. +||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 99999999999983 345799999999999999999999999 9999999999999988766 9999999987
Q ss_pred cCCCCCc------cccccccCCcCccCcccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 204 LFPEDIT------HISTRVAGTLGYLAPDYAVS-----GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 204 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6532211 11223458999999999875 558899999999999999999999997654321000000000
Q ss_pred hhccccccccccCcccCCCCCh----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSG----NEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..........+.... ..++. ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000000000000 01111 12456889999999999999999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=327.63 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=203.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3478999999999999999999876 57789999986432 2234678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+.+. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999983 446799999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||............. .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~------------ 221 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---R------------ 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---H------------
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---h------------
Confidence 332 2234568999999999999999999999999999999999999997554322221111 1
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001122334566889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=334.70 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=194.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.++||+|+||+||+|... +|+.||||++... ..........|+..+.++ +||||+++++++.+++..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3468999999999999999999976 7899999988643 223334455566666555 89999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 6689888843 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....... .. ..
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~------------~~ 266 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ------QL------------RQ 266 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH------HH------------TT
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HH------------hc
Confidence 4322 2334568999999998875 78999999999999999999987765332110 00 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+....+..+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111111223567899999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=336.12 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=208.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecC--Cc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEG--PC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 122 (353)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999983 368899999987443 33457789999999999999999999999876 66
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999842 345699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc---c
Q 042383 203 KLFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---T 277 (353)
Q Consensus 203 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~ 277 (353)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|..|+....... ......... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCGGGHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccCCcccccCH
Confidence 87654332 22334567888999999999999999999999999999999999875322100 000000000 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 001111111112233444567799999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=338.60 Aligned_cols=252 Identities=21% Similarity=0.339 Sum_probs=199.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
..++|++.+.||+|+||.||+|++. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467999999999999999999976 78999999997543 334577899999999999999999999886543
Q ss_pred ---------------------------------------------------ceEEEEEcCCCCChhhhhhhccccCCCCC
Q 042383 122 ---------------------------------------------------CRIIVYDYMQNNSLSQTLLGEEKNRAKFS 150 (353)
Q Consensus 122 ---------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~~~~~l~ 150 (353)
..++||||+++++|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 2799999999999999995432 234456
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc-----------cccccccCC
Q 042383 151 WTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-----------HISTRVAGT 219 (353)
Q Consensus 151 ~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g~ 219 (353)
+..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778899999999999999999 999999999999999999999999999987654321 122335689
Q ss_pred cCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHH
Q 042383 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVR 299 (353)
Q Consensus 220 ~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
+.|+|||++.+..++.++|||||||++|+|++|..|+... .......... ..+.........
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~-------------~~~~~~~~~~~~ 301 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNL-------------KFPLLFTQKYPQ 301 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTT-------------CCCHHHHHHCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhcc-------------CCCcccccCChh
Confidence 9999999999999999999999999999999987764311 1111111000 001111233456
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 042383 300 FLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 300 l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+.+++.+||+.||++|||++|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 789999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=338.45 Aligned_cols=265 Identities=22% Similarity=0.342 Sum_probs=213.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEec
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIE 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 119 (353)
..++|++.+.||+|+||+||+|.+. ++..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 46789999997543 34456788999999999 89999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999954321 123589999999999999999999999 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~ 265 (353)
++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999987654322 12233456788999999998899999999999999999999 99999755432211
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
. ..... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 270 ~---~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 K---LLKEG-------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H---HHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H---HHhcC-------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 11110 0112223345678999999999999999999999999998865443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=344.49 Aligned_cols=249 Identities=20% Similarity=0.342 Sum_probs=198.2
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcC--CCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANIC--HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|...+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999998754 3344577899999999996 599999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
| +.+++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++.....
T Consensus 136 E-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56789999983 445789999999999999999999999 999999999999995 57999999999987654
Q ss_pred CCcc-ccccccCCcCccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 208 DITH-ISTRVAGTLGYLAPDYAVS-----------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 208 ~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~~------- 277 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--KL------- 277 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH-------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--HH-------
Confidence 3222 2344679999999999865 3688999999999999999999999975332110 11
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+++......++...+..+.+|+.+||+.||++|||+.|+++
T Consensus 278 -----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 -----HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111111112222233567889999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=330.94 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=207.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|.+.. +..||+|++... .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 35789999999999999999998542 346999998755 344557889999999999999999999998755 568
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999842 345689999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||............. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~~-------- 231 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGD-------- 231 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HTC--------
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cCC--------
Confidence 65443333344557889999999998999999999999999999998 999997554432221111 100
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
....+...+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01112233567899999999999999999999999998765443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.56 Aligned_cols=262 Identities=19% Similarity=0.236 Sum_probs=200.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999865 6899999999754 444567788999999999999999999999654
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 356999999986 4666652 2489999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...........+
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99866432 2234567899999999999999999999999999999999999999876654443333221111100000
Q ss_pred -------c---------------cccCcccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 281 -------Q---------------HLVDPMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 281 -------~---------------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ......+... ........+.+|+.+||+.||++|||++|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000000 01122567899999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=332.75 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=205.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CC-------cEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DG-------TVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.+.||+|+||+||+|... ++ ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999865 23 5799999987666677889999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC--------e
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN--------P 194 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~--------~ 194 (353)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999943 234489999999999999999999999 9999999999999988877 9
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
||+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+.......... .....
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--QFYED 233 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HHHHT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--HHhhc
Confidence 99999998754321 23457889999999987 678999999999999999999665554332211111 00000
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
. ...+...+..+.+++.+||+.||++|||+.++++.|+.+..-
T Consensus 234 ---~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 ---R------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ---T------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ---c------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 001111134578999999999999999999999999998763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=326.14 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=206.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999976 68999999987543 334577889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.....
T Consensus 85 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 999999999998 4456799999999999999999999999 999999999999999999999999999986542
Q ss_pred CC-ccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 208 DI-THISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||........... .... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~---~~------- 225 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DWKE---KK------- 225 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH--HHHT---TC-------
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH--Hhhh---cc-------
Confidence 21 122334568999999999987765 7789999999999999999999976543222111 0000 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000111233566889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=333.99 Aligned_cols=267 Identities=23% Similarity=0.343 Sum_probs=205.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4467999999999999999999864 6899999998753 33445678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999966555567899999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
..... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ........... .
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----~------ 254 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQC----D------ 254 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTT----C------
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcc----c------
Confidence 43322 223356899999999999999999999999999999999999999754321 11111111110 0
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.........+..+.+++.+||+.||++|||+.+|++.|+++....+
T Consensus 255 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 255 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp --SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0011112335678999999999999999999999999988765444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=340.07 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=200.3
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999865 6899999999877666677899999999999999999999999999999999999999999
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE--CCCCCeEEeeccCCccCCCCCcccc
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL--DQNFNPKISDFGLSKLFPEDITHIS 213 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~ 213 (353)
.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||++....... ..
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 998842 345689999999999999999999999 99999999999999 567889999999998765432 22
Q ss_pred ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCC
Q 042383 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293 (353)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (353)
....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ....... + .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i~~~~~~-----~-----~~~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN---ILACRWD-----L-----EDEEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHTCCC-----S-----CSGGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhccCC-----C-----Chhhh
Confidence 335689999999999988999999999999999999999999976554322211 1111000 0 00001
Q ss_pred hHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 294 GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 294 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
...+..+.+|+.+||+.||.+|||+.|+++ .|++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 123467899999999999999999999987 4443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=333.20 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=207.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh------cHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ------GEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999976 6899999998754321 35778999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEee
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISD 198 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~D 198 (353)
.++||||+++++|.+++ .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHH----HTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999998 3456789999999999999999999999 999999999999999887 799999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ........
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~-- 235 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANITSVSY-- 235 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHTTCC--
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHhccc--
Confidence 99998765432 223456899999999999999999999999999999999999999765432211 11111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 D----FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C----CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c----cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000 001122456889999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=337.69 Aligned_cols=267 Identities=20% Similarity=0.323 Sum_probs=198.9
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh--cHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ--GEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
....++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999865 6899999999754322 2456778999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-----CCCCeEEeec
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-----QNFNPKISDF 199 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-----~~~~~kl~Df 199 (353)
+||||+++ +|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++ .++.+||+||
T Consensus 110 lv~e~~~~-~L~~~~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCSE-EHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCCC-CHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 99999985 999988 3455799999999999999999999999 999999999999994 4556999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
|++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..........
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99986643322 22335679999999998875 48999999999999999999999998765543333322221111111
Q ss_pred ccccc------cC---cc----cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHL------VD---PM----LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~------~~---~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..... .. .. +........+..+.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11100 00 00 000011113467889999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=338.79 Aligned_cols=265 Identities=18% Similarity=0.231 Sum_probs=200.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccChh-----------cHHHHHHHHHHHHhcCCCCceeeee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVESKQ-----------GEKEFMSEVASMANICHENLVKLHG 115 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~ 115 (353)
.++|++.+.||+|+||+||+|... ++..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5678999998754321 1134567888899999999999999
Q ss_pred eEec----CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC
Q 042383 116 GCIE----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN 191 (353)
Q Consensus 116 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~ 191 (353)
++.+ ....++||||+ +++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9887 77899999999 889999983 334799999999999999999999999 99999999999999887
Q ss_pred C--CeEEeeccCCccCCCCCc------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc
Q 042383 192 F--NPKISDFGLSKLFPEDIT------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG 263 (353)
Q Consensus 192 ~--~~kl~Dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~ 263 (353)
+ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999987643211 11134578999999999999999999999999999999999999996432222
Q ss_pred hhhHHHH-HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 264 EYYLVEK-AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 264 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....... .........+..... ....+..+.+++.+||+.||++|||+++|++.|++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111111 101000111110000 11234579999999999999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=338.66 Aligned_cols=271 Identities=20% Similarity=0.321 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcH-HHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.+.||+|+||+||+|... +++.||+|++........ ..+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 689999999875432221 2345799999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++ +|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 975 89888842 345699999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc--
Q 042383 210 THISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP-- 286 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 286 (353)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+......
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 2 2233567999999999876 56899999999999999999999999876654443333332222222111111110
Q ss_pred -------ccCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 287 -------MLCG----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 287 -------~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
.... ...+..+..+.+|+.+||+.||++|||++|+++ .+.+..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0000 001123456889999999999999999999987 5555543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.91 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=209.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999976 68999999997432 23346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||++||+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999865444456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchh-hHHHHHHhhccccccccccC
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 285 (353)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----------- 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----------- 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----------
Confidence 4322 223457999999999999999999999999999999999999999865432211 111111110
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM-----STVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 323 (353)
...++...+..+.+++.+||+.||++||++ ++|++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 012233345678899999999999999975 56653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=337.90 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=203.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP------ 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 121 (353)
.++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999975 6899999998643 3344567889999999999999999999998653
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7799998832 4689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+.........+.+
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 234578999999999887 67999999999999999999999999876654333322221111110000
Q ss_pred c---------------cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCC
Q 042383 281 Q---------------HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDI 331 (353)
Q Consensus 281 ~---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~ 331 (353)
. ......+ .......+..+.+|+.+||+.||++|||+.|+++ .+++..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 0 0000000 1112233567899999999999999999999998 56665443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=331.57 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=210.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|.+.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4578999999999999999999976 689999999986555555678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCccC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKLF 205 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~~ 205 (353)
|+++++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999983 345799999999999999999999999 99999999999999 78889999999998764
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... ........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~--------- 224 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF---EKIKEGYY--------- 224 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHCCC---------
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHcCCC---------
Confidence 432 223356899999999999999999999999999999999999999765432211 11111100
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCCC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDIDD 333 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~~ 333 (353)
..........+..+.+++.+||+.||++|||+.++++ .+++...+..
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCCC
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcccc
Confidence 0011122234567899999999999999999999986 5666555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.22 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=209.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEe--cCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCI--EGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 124 (353)
..++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 3578999999999999999999876 6899999999754 3344567889999999999999999999874 467889
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEcCCCCCCeEECCCCCeEEeec
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS-----IVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~-----i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
+||||+++++|.+++.........+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999976555566799999999999999999999998 7 999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|.+........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ....... .
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~~~----~ 232 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKIREG----K 232 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHT----C
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHHhhc----c
Confidence 99987643322 22335689999999999998999999999999999999999999976543211 1111111 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
. ...+...+..+.+++.+||+.||++|||+.||++.+...
T Consensus 233 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 233 F---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred c---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 0 112233456789999999999999999999999866543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=341.88 Aligned_cols=276 Identities=20% Similarity=0.249 Sum_probs=216.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC--ceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGP--CRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 125 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3567999999999999999999976 58999999997543 334567789999999999999999999998765 6799
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE----CCCCCeEEeeccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL----DQNFNPKISDFGL 201 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~kl~Dfg~ 201 (353)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999985432 233499999999999999999999999 99999999999999 7778899999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCcccch-hhHHHHHH
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS--------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAW 272 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~ 272 (353)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ........
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 98765432 2234568999999998875 5678899999999999999999999975433222 22222222
Q ss_pred hhcccccccccc-----------CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 273 EMHNTDKLQHLV-----------DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 273 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.......+..+. .-......+......+.+++.+||+.||++|||+.++++.+.++.+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 221111111110 00111245577788999999999999999999999999998876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=328.91 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=209.8
Q ss_pred ccCCCCCC-eeeeeCceEEEEEEeC---CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSN-KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|.+.+ .||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999853 5788999999864 344567789999999999999999999999 4556899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999984 2345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 206 PEDITHI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 206 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i~~--------- 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQ--------- 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHT---------
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHhc---------
Confidence 5432221 223456789999999998899999999999999999998 99999765432211 11111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
......+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 229 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 229 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01122334456779999999999999999999999999987753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=336.73 Aligned_cols=270 Identities=23% Similarity=0.349 Sum_probs=214.6
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceee
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKL 113 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~ 113 (353)
+.........++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555678999999999999999999974 246889999987543 33446788999999999 79999999
Q ss_pred eeeEecCC-ceEEEEEcCCCCChhhhhhhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcC
Q 042383 114 HGGCIEGP-CRIIVYDYMQNNSLSQTLLGEEKN------------RAKFSWTARREIALGIARGLAYIHEEIKPSIVHRD 180 (353)
Q Consensus 114 ~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~------------~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~d 180 (353)
++++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +++|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 489999999999999999543221 22389999999999999999999999 999999
Q ss_pred CCCCCeEECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 042383 181 IKPSNILLDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHF 258 (353)
Q Consensus 181 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~ 258 (353)
|||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986644322 22334567889999999999999999999999999999998 9999976
Q ss_pred CcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 259 DKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
........ ...... .....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 254 ~~~~~~~~--~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 254 VKIDEEFC--RRLKEG-------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCCSHHHH--HHHHHT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhHHHH--HHhccC-------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 54332211 111110 001122233567899999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.94 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=208.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999976 6899999999743 223456678999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||++||+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++++||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999998843 2234599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----------- 404 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------- 404 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------
Confidence 432 2234579999999999999999999999999999999999999998654322211111111000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 323 (353)
...++...+..+.+|+.+||+.||.+|| +++||++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0122233456789999999999999999 7888875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=327.89 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=202.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3577999999999999999999976 7899999998854 233456788899999999 89999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC--------------
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-------------- 191 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-------------- 191 (353)
||||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999966544457899999999999999999999999 99999999999999844
Q ss_pred -----CCeEEeeccCCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchh
Q 042383 192 -----FNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY 265 (353)
Q Consensus 192 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~ 265 (353)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 479999999998765432 23589999999998866 5668999999999999999998877533211
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... ... ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 238 ---~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ---HEIR----QGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHHH----TTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHH----cCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0000 000 01222334567899999999999999999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=336.88 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=197.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce--
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR-- 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 123 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999964 68999999997543 23345788999999999999999999998765543
Q ss_pred --EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 124 --IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 124 --~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999983 445799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ . . ...
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~-~---~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--V-R---EDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--H-H---CCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--h-c---CCC
Confidence 986644322 1223356899999999999999999999999999999999999999765432211100 0 0 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHhcC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI-EMING 327 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl-~~L~~ 327 (353)
.. ... .....+..+.+++.+||+.||++||+..+++ ..|..
T Consensus 237 ~~---~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 237 IP---PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CC---HHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CC---ccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00 000 0111245688999999999999999766554 44443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=340.54 Aligned_cols=269 Identities=22% Similarity=0.323 Sum_probs=210.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe-----CCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC--ce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL-----QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP--CR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 123 (353)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 368899999998766666778999999999999999999999887644 78
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++++|.+++.. ....+++..++.++.||+.||.+||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999843 335689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc----c
Q 042383 204 LFPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN----T 277 (353)
Q Consensus 204 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----~ 277 (353)
........ ......++..|+|||++.+..++.++||||||+++|+|++|..||........ ........ .
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~----~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH----HHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH----HhhccccchhhhH
Confidence 76543221 12234567789999999988899999999999999999999999864321000 00000000 0
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..+...+........+...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001111111112233445677999999999999999999999999998653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=332.10 Aligned_cols=256 Identities=25% Similarity=0.322 Sum_probs=206.2
Q ss_pred hccCCCCCC-eeeeeCceEEEEEEeC---CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 50 ATNGFCSSN-KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 50 ~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
..++|.+.+ .||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788888 9999999999999542 46889999987543 23356789999999999999999999999 56678
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999993 345699999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 204 LFPEDITHI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 204 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~------- 235 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEK------- 235 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHT-------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHc-------
Confidence 765433221 222346788999999998889999999999999999999 99999765432211 11110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
......+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 236 ------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112223344667999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=338.47 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=211.5
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCC------CcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQD------GTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
...++|++.+.||+|+||+||+|.+.. ...||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999998642 2479999987543 34456788999999999 899999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc----------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK----------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ 190 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~----------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~ 190 (353)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 999999999999999999854321 135689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHH
Q 042383 191 NFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLV 268 (353)
Q Consensus 191 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 268 (353)
++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999986543222 12233456788999999999999999999999999999998 89999755433221111
Q ss_pred HHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 269 EKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. .. ......+...+..+.+++.+||+.||.+|||+.+|++.|++..
T Consensus 280 ~--~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 280 V--KD-------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H--HH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--hc-------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 0 00 0111122223567899999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.84 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=201.8
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhc-----HHHHHHHHHHHHhcCCCCceeeeeeEecCC
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQG-----EKEFMSEVASMANICHENLVKLHGGCIEGP 121 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 121 (353)
....++|++.+.||+|+||+||+|.+. +|+.||+|++....... ...+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999999999999975 68999999987532211 246778999999999999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++ +|.+.+. .....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHH---hcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999986 8888873 2345789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
+....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+...........+
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 98764332 223345789999999998764 5889999999999999999999999876544333222222111111111
Q ss_pred cccc---Cccc---CCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 281 QHLV---DPML---CGNFS-----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 281 ~~~~---~~~~---~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.... +... ....+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1110 0000 00111 2334679999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=332.61 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|+||+||++++. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 357889999999999999999986 788999998633 345678899999999999999999998874 478999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC-eEEeeccCCccCCCCC
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN-PKISDFGLSKLFPEDI 209 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~~ 209 (353)
++++|.+++.... ....+++..++.++.|++.||.|||+.+..+++||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999984321 2235789999999999999999999932229999999999999988876 799999999765432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ......... ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~-------------~~ 222 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNG-------------TR 222 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTT-------------CC
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcC-------------CC
Confidence 2234589999999999999999999999999999999999999975432211 111111110 01
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.......+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 112223356688999999999999999999999999877643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.10 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=203.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|++.+.||+|+||+||+|.+. +++ .||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467999999999999999999865 344 37888775332 222345678999999999999999999886 45689
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999842 245789999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||............. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~-------- 233 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KG-------- 233 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---TT--------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---cC--------
Confidence 7543322 2344567889999999999999999999999999999999 999997654332221111 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.....+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 234 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 -----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0011112223457789999999999999999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=339.98 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=205.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe----CCCcEEEEEEeeccC----hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL----QDGTVVAVKVLSVES----KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 121 (353)
.++|++.+.||+|+||+||+|+. .+++.||+|+++... ....+.+.+|+.+++.+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999987 368999999986432 22334567799999999 6999999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999983 345799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
++..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---- 281 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----
Confidence 98765444444445679999999999886 347899999999999999999999997654332222111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIEM 324 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 324 (353)
...++...+..+.+|+.+||+.||++|| |++|+++.
T Consensus 282 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1122333456688999999999999999 99999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=324.98 Aligned_cols=249 Identities=22% Similarity=0.360 Sum_probs=185.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999874 68999999987432 12346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++. ....++++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHH---TCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999984 2346799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... ......
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~ 227 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhc
Confidence 3222 123356899999999999989999999999999999999999999754432111 000000
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 1122334567889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=349.46 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=204.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999976 6899999998743 233457788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC---CCCCeEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD---QNFNPKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~ 203 (353)
|||+.+++|.+.+. ....+++..++.++.||+.||.|||+. +|+||||||+||+++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999883 346799999999999999999999999 999999999999995 45679999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+ ........
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~---- 242 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---ETGKYAFD---- 242 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHTCCCSC----
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCC----
Confidence 764432 2334578999999998875 5899999999999999999999999765543222111 11100000
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.......+..+.+++.+||+.||++|||+.++++.
T Consensus 243 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011234668899999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=336.15 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=203.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 478999999999999999999976 58999999986443 333466789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++++|.+++ .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHH----HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999998888876 3456799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc---------cc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH---------NT 277 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------~~ 277 (353)
... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||................... ..
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 222 22345689999999998875 78999999999999999999999998765443332222111000 00
Q ss_pred cccccccCcccCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 278 DKLQHLVDPMLCGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+...... .+..+..+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001111111111111 1223567999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=339.11 Aligned_cols=264 Identities=15% Similarity=0.150 Sum_probs=205.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC---------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCcee---------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD---------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK--------- 112 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------- 112 (353)
.++|++.+.||+|+||+||+|.... ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998763 788999998743 35678999999999999887
Q ss_pred ------eeeeEec-CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 042383 113 ------LHGGCIE-GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185 (353)
Q Consensus 113 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~N 185 (353)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. +++||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5666665 67889999999 89999999432 246799999999999999999999999 99999999999
Q ss_pred eEECCCC--CeEEeeccCCccCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 042383 186 ILLDQNF--NPKISDFGLSKLFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 186 il~~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
|+++.++ .+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 8999999999866432211 1233578999999999999999999999999999999999999998
Q ss_pred CCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 258 FDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
............ ..... .....+...... ....+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 270 ~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 270 NCLPNTEDIMKQ-KQKFV--DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GGTTCHHHHHHH-HHHHH--HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCcCHHHHHHH-HHhcc--CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 654222111111 11110 011111111100 012246689999999999999999999999999887643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.89 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=203.7
Q ss_pred CCCCCCeeeeeCceEEEEEEeC-C---CcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce-EEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ-D---GTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR-IIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 126 (353)
.|.+.+.||+|+||+||+|.+. + +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4666789999999999999853 2 3379999987543 34457788999999999999999999999876665 999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999842 356789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDIT---HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+......... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~--------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--THFLAQG--------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--HHHHHTT---------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--HHHhhcC---------
Confidence 3221 1223356788999999999999999999999999999999966665433222111 1111110
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....+...+..+.+++.+||+.||.+|||++++++.|+++.
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011122233567899999999999999999999999998865
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=331.36 Aligned_cols=260 Identities=19% Similarity=0.282 Sum_probs=207.4
Q ss_pred HHHHHHhccCCCCC-CeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhc-CCCCceeeeeeEe
Q 042383 44 YNELKSATNGFCSS-NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANI-CHENLVKLHGGCI 118 (353)
Q Consensus 44 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 118 (353)
+.....+.++|.+. +.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445566788887 89999999999999876 68999999987542 33457788999999999 5799999999999
Q ss_pred cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeE
Q 042383 119 EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPK 195 (353)
Q Consensus 119 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~k 195 (353)
+....++||||+++++|.+++.. .....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999832 2346799999999999999999999999 9999999999999987 78999
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. ...
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~ 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QVN 249 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTC
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hcc
Confidence 99999998764322 2234578999999999999999999999999999999999999997655432221111 100
Q ss_pred cccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...........+..+.+++.+||+.||.+|||++++++
T Consensus 250 ----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 ----------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00111122234566889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=337.27 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=203.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------QGEKEFMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999865 688999999875421 1223567799999999999999999999999
Q ss_pred CceEEEEEcCCCC-ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 121 PCRIIVYDYMQNN-SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 121 ~~~~lv~e~~~~~-sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
+..++||||+.+| +|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHH----HTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999776 999988 4556799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 9998765432 2234568999999999988876 78999999999999999999999642211
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
..... ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 -----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1111234568999999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=334.55 Aligned_cols=262 Identities=25% Similarity=0.364 Sum_probs=207.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcE--EEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTV--VAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|++.+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367999999999999999999865 5654 499988743 333446788999999999 89999999999999999999
Q ss_pred EEEcCCCCChhhhhhhcc------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 126 VYDYMQNNSLSQTLLGEE------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999995432 2235799999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHH
Q 042383 194 PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 272 (353)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~~~- 254 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKL- 254 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHG-
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH---HHh-
Confidence 999999998743321 11233456788999999998889999999999999999998 99999755432111 110
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.. ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 255 ---~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 ---PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 01112233345679999999999999999999999999987765444
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=334.63 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=203.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|++.+.||+|+||+||+|.+. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999864 344 3577777533 3445678899999999999999999999998765 78
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+|++++.+|+|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999843 346799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 205 FPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 205 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------------- 233 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------- 233 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------------
Confidence 6433222 2223456778999999999999999999999999999999 999997655433221111
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDI 331 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~ 331 (353)
.......+...+..+.+++.+||+.||.+|||+.|+++.|+.+..-
T Consensus 234 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 ---KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111122333456789999999999999999999999999877643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=340.51 Aligned_cols=266 Identities=17% Similarity=0.250 Sum_probs=203.2
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-------
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE------- 119 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 119 (353)
....++|++.+.||+|+||+||+|.+. +|+.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345688999999999999999999864 7899999998744322 2379999999999999999999843
Q ss_pred -------------------------------CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHH
Q 042383 120 -------------------------------GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168 (353)
Q Consensus 120 -------------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~L 168 (353)
....++||||+++ +|.+.+.........+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 88888866556678899999999999999999999
Q ss_pred HhcCCCCeEEcCCCCCCeEEC-CCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHH
Q 042383 169 HEEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLL 246 (353)
Q Consensus 169 H~~~~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il 246 (353)
|+. +++||||||+||+++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999997 68899999999998764432 22345689999999988765 489999999999999
Q ss_pred HHHHhCCCCCCCCcccchhhHHHHHHhhcccccc-------ccc-----cCcccCCCCChHHHHHHHHHHhhccCCCCCC
Q 042383 247 LQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL-------QHL-----VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSL 314 (353)
Q Consensus 247 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 314 (353)
|+|++|+.||......+....+...........+ ... ........++...+..+.+|+.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999876554433322221111111000 000 0000111123334567899999999999999
Q ss_pred CCCHHHHHH
Q 042383 315 RPRMSTVIE 323 (353)
Q Consensus 315 RPt~~evl~ 323 (353)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=336.31 Aligned_cols=260 Identities=19% Similarity=0.244 Sum_probs=193.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEe--------c
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCI--------E 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~ 119 (353)
...+|++.+.||+|+||+||+|.+. +++.||+|++..........+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4468999999999999999999975 68999999987666666778899999999995 999999999984 3
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEECCCCCeEEe
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
....++||||+. |+|.+++... ....++++..++.++.||+.||.|||+. + ++|+||||+||+++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 445789999996 5899888543 2345799999999999999999999998 8 9999999999999999999999
Q ss_pred eccCCccCCCCCcc-----------ccccccCCcCccCcccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCcccc
Q 042383 198 DFGLSKLFPEDITH-----------ISTRVAGTLGYLAPDYA---VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG 263 (353)
Q Consensus 198 Dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~ 263 (353)
|||++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876532221 11134589999999988 56678999999999999999999999996433211
Q ss_pred hhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 264 EYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
. .............+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 261 ~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 I-------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred h-------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 01111111111223447889999999999999999999999988765443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.70 Aligned_cols=260 Identities=24% Similarity=0.418 Sum_probs=204.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC-----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD-----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
.++|.+.+.||+|+||+||+|.... +..||+|++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999998642 346999998754 3344567889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999842 346799999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCccc--cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 205 FPEDITHI--STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 205 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~~~~------- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDG------- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTT-------
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHCC-------
Confidence 65432211 122345778999999998999999999999999999999 9999975443211 1111110
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.....+...+..+.+++.+||+.||++||++.++++.|+++....
T Consensus 267 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011122334567899999999999999999999999998765433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.31 Aligned_cols=249 Identities=19% Similarity=0.326 Sum_probs=207.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|.+.+.||+|+||+||++.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467999999999999999999976 5888999998754 23445678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++ .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 99999999999988 3445799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........... ... ..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~----~~------ 231 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKK----NE------ 231 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHT----TC------
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hhh----cc------
Confidence 43222 22335689999999999998999999999999999999999999976543221111 000 00
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+..+.+++.+||+.||++|||++++++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122233456889999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=339.82 Aligned_cols=251 Identities=18% Similarity=0.227 Sum_probs=191.5
Q ss_pred ccCCCCC-CeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec----CCce
Q 042383 51 TNGFCSS-NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 51 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~ 123 (353)
.++|.+. +.||+|+||+||++.+. +|+.||+|++... ..+.+|+.++.++ +||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567666 68999999999999876 6889999998632 3456788887554 89999999998875 6678
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeecc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFG 200 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg 200 (353)
++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 999999999999999943 2234699999999999999999999999 9999999999999987 7899999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhh-HHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY-LVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 279 (353)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .........
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~---- 283 (400)
T 1nxk_A 210 FAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---- 283 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC----
T ss_pred cccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc----
Confidence 99865432 22244678999999999999999999999999999999999999997654322110 111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 284 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 284 Y------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000011223567899999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=333.56 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=206.2
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhc-CCCCceeeee
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------QGEKEFMSEVASMANI-CHENLVKLHG 115 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~ 115 (353)
....+.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999976 699999999875431 1235678899999999 7999999999
Q ss_pred eEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 116 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
++......++||||+++++|.+++. ....+++..+..++.||+.||.|||+. |++|+||||+||+++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999983 345799999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHH
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE 269 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 269 (353)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-- 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-- 316 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH--
Confidence 99999998765432 2234678999999998864 3578899999999999999999999976543222111
Q ss_pred HHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......... .+. ....+..+.+++.+||+.||++|||+.++++
T Consensus 317 -i~~~~~~~~-----~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 -IMEGQYQFS-----SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHTCCCCC-----HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhCCCCCC-----Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111000000 000 0012456889999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=328.26 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=203.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeE-ecCCceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGC-IEGPCRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~ 124 (353)
..+|++.+.||+|+||+||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578899999999999999998542 336899988753 334457788999999999999999999985 4566789
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++++|.+++. .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHH---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999983 2356689999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCc---cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 205 FPEDIT---HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 205 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~~~----- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGR----- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHTTC-----
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhcCC-----
Confidence 644321 11233457788999999999999999999999999999999 555555433322111 111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011122234568999999999999999999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.21 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=200.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEe-CCCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.|++.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999986 478999999987542 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+. |+|.+.+. ....++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888773 2346799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
. ....||+.|+|||++. ...++.++|||||||++|+|++|..||...+...... ......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~~~~--------- 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNE--------- 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC---------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcC---------
Confidence 2 2356899999999885 5678999999999999999999999997654322211 111100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.+ .......+..+.+++.+||+.||++|||++++++
T Consensus 270 ~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0111223456889999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=347.16 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=202.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-------------hcHHHHHHHHHHHHhcCCCCceeeee
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-------------QGEKEFMSEVASMANICHENLVKLHG 115 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 115 (353)
..++|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999976 588999999875421 23467889999999999999999999
Q ss_pred eEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---
Q 042383 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF--- 192 (353)
Q Consensus 116 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~--- 192 (353)
++.+....++||||+++|+|.+.+. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999883 446799999999999999999999999 999999999999998765
Q ss_pred CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 193 NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--- 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE--- 260 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---
Confidence 69999999998765432 234467999999999876 568999999999999999999999998655432221111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......... .....+..+.+|+.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 KGKYYFDFN----------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HCCCCCCHH----------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCCcc----------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 100000000 00112456889999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=338.17 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=205.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999976 6889999999865 34445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|+++++|.+++. ....+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999983 34579999999999999999999998 5 899999999999999999999999999865422
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhh-------------
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM------------- 274 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------- 274 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..............
T Consensus 185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 1223357899999999999999999999999999999999999999765432221111000000
Q ss_pred ----------ccccc----cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 275 ----------HNTDK----LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 275 ----------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..... ...+.............+..+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000 00000011111111223567899999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=331.79 Aligned_cols=253 Identities=19% Similarity=0.324 Sum_probs=209.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|.+.+.||+|+||.||++.+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3578999999999999999999976 5789999998744 33455678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 119 v~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 999999999999883 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||............. .. .
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~----~------ 257 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK---KN----E------ 257 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HT----C------
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh---cC----C------
Confidence 43222 2234568999999999999999999999999999999999999997654322211110 00 0
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
...+...+..+.+++.+||+.||++|||++|+++ .++.
T Consensus 258 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 258 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 0112223456889999999999999999999986 4544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=324.70 Aligned_cols=248 Identities=23% Similarity=0.399 Sum_probs=207.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.+.|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999865 68899999997543 3445788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999882 35799999999999999999999999 9999999999999999999999999999866433
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... .... .
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-------------~ 235 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IPKN-------------N 235 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-------------C
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hhcC-------------C
Confidence 22 22345689999999999999999999999999999999999999975543221111 1000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11122233456899999999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=322.89 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=205.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999876 57889999987432 22346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999983 345799999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .... .
T Consensus 166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~----~-------- 227 (284)
T 2vgo_A 166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR---RIVN----V-------- 227 (284)
T ss_dssp SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHT----T--------
T ss_pred cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH---HHhc----c--------
Confidence 32 1234568999999999999999999999999999999999999997654322211 1100 0
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...++...+..+.+++.+||+.||.+|||+.++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 01122334567889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=333.80 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=204.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEec--------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIE-------- 119 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 119 (353)
.++|++.+.||+|+||+||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999974 789999999865432 234567899999999999999999999887
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
.+..++||||+++ +|.+.+. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 7777763 3345699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCC---ccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 200 GLSKLFPEDI---THISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 200 g~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998764321 222334568999999998876 458999999999999999999999998766544443333322221
Q ss_pred ccccccccc-----Ccc--cC-CCCCh-H------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 276 NTDKLQHLV-----DPM--LC-GNFSG-N------EAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 276 ~~~~~~~~~-----~~~--~~-~~~~~-~------~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
........- ... .. ..... . .+..+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111111110 000 00 00000 0 1345889999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=323.15 Aligned_cols=251 Identities=19% Similarity=0.293 Sum_probs=202.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh------hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK------QGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999976 689999999875421 2357889999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEeec
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISDF 199 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~Df 199 (353)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999983 346799999999999999999999999 999999999999998876 8999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
|.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......... ........ .
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~--~ 229 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL---TNISAVNY--D 229 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHTTCC--C
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH---HHhHhccc--C
Confidence 9998764322 223356899999999999999999999999999999999999999765432211 11100000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ......+..+.+++.+||+.||++|||+.++++
T Consensus 230 ----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 ----FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ----CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000 001122456889999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=329.81 Aligned_cols=272 Identities=24% Similarity=0.340 Sum_probs=206.6
Q ss_pred cCCHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc--CCCCceeeeeeEe
Q 042383 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI--CHENLVKLHGGCI 118 (353)
Q Consensus 41 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~ 118 (353)
..+........++|++.+.||+|+||+||+|+.. ++.||+|++.... ......|.+++... +||||+++++++.
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3444455556789999999999999999999987 8899999986332 23444555555554 8999999999998
Q ss_pred cC----CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEcCCCCCCeEEC
Q 042383 119 EG----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-----KPSIVHRDIKPSNILLD 189 (353)
Q Consensus 119 ~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-----~~~i~H~dlk~~Nil~~ 189 (353)
+. ...++||||+++|+|.+++. ...+++..++.++.|++.||.|||+.+ ..+++||||||+||+++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 77 77899999999999999983 236899999999999999999999751 23899999999999999
Q ss_pred CCCCeEEeeccCCccCCCCCccc---cccccCCcCccCccccccCCCCcc------ccchhHHHHHHHHHhC--------
Q 042383 190 QNFNPKISDFGLSKLFPEDITHI---STRVAGTLGYLAPDYAVSGHLNPK------SDIYSFGVLLLQIVTG-------- 252 (353)
Q Consensus 190 ~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslG~il~~ll~g-------- 252 (353)
.++.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|+|++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997664432221 124578999999999988776665 9999999999999999
Q ss_pred --CCCCCCCcccchh-hHHHHHHhhccccccccccCcccCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 253 --QAAVHFDKELGEY-YLVEKAWEMHNTDKLQHLVDPMLCGNFS-----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 253 --~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
+.||......... ....... .........+ ..++..+.+++.+||+.||.+|||+.+|++.
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIV-----------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHH-----------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHHH-----------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 5565433221111 1111100 0111112222 3678889999999999999999999999999
Q ss_pred hcCCCCCC
Q 042383 325 INGDVDID 332 (353)
Q Consensus 325 L~~~~~~~ 332 (353)
|+.+.+..
T Consensus 326 L~~l~~~~ 333 (337)
T 3mdy_A 326 LAKMSESQ 333 (337)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhhc
Confidence 98766443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=332.08 Aligned_cols=268 Identities=23% Similarity=0.303 Sum_probs=210.9
Q ss_pred cCCHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHh--cCCCCceeeeeeEe
Q 042383 41 AFSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMAN--ICHENLVKLHGGCI 118 (353)
Q Consensus 41 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~ 118 (353)
..+........++|++.+.||+|+||+||+|+.. ++.||+|++... ....+.+|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3444555666789999999999999999999985 889999998633 34567788888887 68999999999998
Q ss_pred cCC----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEcCCCCCCe
Q 042383 119 EGP----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH--------EEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 119 ~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--------~~~~~~i~H~dlk~~Ni 186 (353)
... ..++||||+++|+|.+++. ...+++..++.++.|++.||.||| +. +++|+||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 876 7899999999999999983 246899999999999999999999 77 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCCcc---ccccccCCcCccCccccccCC------CCccccchhHHHHHHHHHhC-----
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDITH---ISTRVAGTLGYLAPDYAVSGH------LNPKSDIYSFGVLLLQIVTG----- 252 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g----- 252 (353)
+++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999766443222 223457899999999987652 34689999999999999999
Q ss_pred -----CCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 253 -----QAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 253 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
..||............ .... +......... .......+.+++.+||+.||++|||+.+|+
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEE--MRKV--------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHH--HHHH--------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccccccCccccCcCcccHHH--HHHH--------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 6777654322111000 0000 0111111222 235677899999999999999999999999
Q ss_pred HHhcCCCC
Q 042383 323 EMINGDVD 330 (353)
Q Consensus 323 ~~L~~~~~ 330 (353)
+.|+++..
T Consensus 329 ~~L~~i~~ 336 (342)
T 1b6c_B 329 KTLSQLSQ 336 (342)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=348.18 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=199.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 68899999987542 23356788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeeccCCc
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFGLSK 203 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~ 203 (353)
|||+++|+|.+.+. ....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999883 446799999999999999999999999 9999999999999976 4459999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+. ..... .
T Consensus 188 ~~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~~~-----~ 256 (494)
T 3lij_A 188 VFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---KGKYT-----F 256 (494)
T ss_dssp ECBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HTCCC-----C
T ss_pred ECCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCC-----C
Confidence 76543 2234467999999999876 569999999999999999999999998655432221111 11000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+ .....+..+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000 00122456889999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=345.11 Aligned_cols=270 Identities=16% Similarity=0.244 Sum_probs=189.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-----CCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE-----GPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 122 (353)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999866 6899999998643 34455778899999999999999999999843 357
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.|+||||+. ++|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLF----RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhc----ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 5898888 4556799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCc--------------------------cccccccCCcCccCcccc-ccCCCCccccchhHHHHHHHHHh----
Q 042383 203 KLFPEDIT--------------------------HISTRVAGTLGYLAPDYA-VSGHLNPKSDIYSFGVLLLQIVT---- 251 (353)
Q Consensus 203 ~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~~ll~---- 251 (353)
+....... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87642211 122345789999999976 46679999999999999999999
Q ss_pred -------CCCCCCCCccc--------------------chhhHHHHHHhhcccccc--------ccccC---cccC---C
Q 042383 252 -------GQAAVHFDKEL--------------------GEYYLVEKAWEMHNTDKL--------QHLVD---PMLC---G 290 (353)
Q Consensus 252 -------g~~pf~~~~~~--------------------~~~~~~~~~~~~~~~~~~--------~~~~~---~~~~---~ 290 (353)
|.++|...+.. .....+...........+ ..... .... .
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 56666443211 000000000000000000 00000 0000 0
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
...+..+..+.+|+.+||+.||++|||++|+++ .+++.
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 011223567889999999999999999999998 45554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=329.69 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=200.8
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
...++|.+.+.||+|+||+||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999754 3458999998754 33445678899999999999999999999987553
Q ss_pred -----eEEEEEcCCCCChhhhhhhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 123 -----RIIVYDYMQNNSLSQTLLGEE--KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 123 -----~~lv~e~~~~~sL~~~l~~~~--~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
.++||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 499999999999999985432 2346799999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHh
Q 042383 196 ISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... ...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~~ 264 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LLH 264 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---HHc
Confidence 999999986643321 12233456789999999999999999999999999999999 8889876544322211 111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
. .....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 265 ~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 265 G-------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp T-------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 011222334567999999999999999999999999998765
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=324.47 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec----CCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE----GPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 124 (353)
..|++.+.||+|+||+||+|.+. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44788899999999999999875 6888999998754 34455778999999999999999999998875 45689
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEEC-CCCCeEEeeccC
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLD-QNFNPKISDFGL 201 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~-~~~~~kl~Dfg~ 201 (353)
+||||+++++|.+++ .....+++..++.++.||+.||.|||+. + ++|+||||+||+++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHH----HHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 999999999999999 3446799999999999999999999998 8 99999999999997 789999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+...... ......|++.|+|||++. +.++.++||||||+++|+|++|..||......... .........
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~----- 247 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVK----- 247 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTTTCC-----
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhccCC-----
Confidence 9765432 223456899999999776 45899999999999999999999999754432211 111110000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+...+..+.+++.+||+.||++|||++++++
T Consensus 248 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01111222356899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.88 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=206.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999976 78999999987442 3456788999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLS 202 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~ 202 (353)
||||+.+++|.+.+ .....+++..++.++.||+.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHH----HTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999988 3456799999999999999999999999 99999999999999 56789999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+....... .........
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~--- 247 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK---VEKGKYTFE--- 247 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHCCCCCC---
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHcCCCCCC---
Confidence 8765432 2234568999999998865 689999999999999999999999986554322211 111100000
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0011223567889999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=327.21 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=199.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-CceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG-PCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||++... |+.||+|++.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 478999999999999999999876 8899999987433 456788999999999999999999986544 478999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999998432 223488999999999999999999999 9999999999999999999999999998755432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .... ...
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~-------------~~~ 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE-------------KGY 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHT-------------TTC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHh-------------cCC
Confidence 122356889999999999999999999999999999998 99999755432211 1110 011
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 12233344667999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=339.61 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=193.2
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--------hhcHHHHHHHHHHHHhcCCCCceeeeeeEec
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--------KQGEKEFMSEVASMANICHENLVKLHGGCIE 119 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 119 (353)
...++|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999999999999865 68899999987432 1112347889999999999999999999865
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC---CeEE
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---NPKI 196 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---~~kl 196 (353)
+..++||||+++++|.+++ .....+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4579999999999999988 4556799999999999999999999999 999999999999996544 5999
Q ss_pred eeccCCccCCCCCccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 197 SDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQITS 359 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HHHHT
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HHHhc
Confidence 999999876532 22344678999999999864 567889999999999999999999997543322211 11100
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. .. .. .......+..+.+++.+||+.||++|||++|+++
T Consensus 360 ~~----~~-~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GK----YN-FI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TC----CC-CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC----CC-CC-----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 00 00 0000112466889999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=335.71 Aligned_cols=278 Identities=19% Similarity=0.226 Sum_probs=206.0
Q ss_pred CHHHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh-----------hcHHHHHHHHHHHHhcCCCCce
Q 042383 43 SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK-----------QGEKEFMSEVASMANICHENLV 111 (353)
Q Consensus 43 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv 111 (353)
...++....++|++.+.||+|+||+||+|...+|+.||+|++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35667788899999999999999999999988899999999864321 2236789999999999999999
Q ss_pred eeeeeEec-----CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCe
Q 042383 112 KLHGGCIE-----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNI 186 (353)
Q Consensus 112 ~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Ni 186 (353)
++++++.. ....++||||++ |+|.+.+. .....+++..++.++.||+.||.|||+. +++|+||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 99999853 346799999998 58888874 3445799999999999999999999999 999999999999
Q ss_pred EECCCCCeEEeeccCCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchh
Q 042383 187 LLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY 265 (353)
Q Consensus 187 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~ 265 (353)
+++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999754332 22234568899999998877 67899999999999999999999999876543333
Q ss_pred hHHHHHHhhcc--------ccccccccCcccCC-------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 266 YLVEKAWEMHN--------TDKLQHLVDPMLCG-------NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 266 ~~~~~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
..+........ .............. ...+..+..+.+|+.+||+.||++|||+.|+++ .++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 22221111100 00001111111100 011223466889999999999999999999986 45544
Q ss_pred C
Q 042383 329 V 329 (353)
Q Consensus 329 ~ 329 (353)
.
T Consensus 324 ~ 324 (362)
T 3pg1_A 324 F 324 (362)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=340.25 Aligned_cols=268 Identities=20% Similarity=0.270 Sum_probs=206.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc------CCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI------CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 122 (353)
...+|++.+.||+|+||+||+|.+. +++.||+|++... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999866 5899999998743 33445677888888877 47799999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC--eEEeecc
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN--PKISDFG 200 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg 200 (353)
.++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 589998843 2334599999999999999999999999 9999999999999999887 9999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc--
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD-- 278 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 278 (353)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+..........
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99765432 234578999999999999999999999999999999999999998766544333222221111100
Q ss_pred ----ccccccCcc--------------------------------cCC----CCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042383 279 ----KLQHLVDPM--------------------------------LCG----NFSGNEAVRFLKVGLLCVQEKSSLRPRM 318 (353)
Q Consensus 279 ----~~~~~~~~~--------------------------------~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~ 318 (353)
....+++.. ... .........+.+|+.+||++||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 000000000 000 0111224668999999999999999999
Q ss_pred HHHHH--HhcCC
Q 042383 319 STVIE--MINGD 328 (353)
Q Consensus 319 ~evl~--~L~~~ 328 (353)
.|+++ .|++.
T Consensus 404 ~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 404 GQALRHPWLRRR 415 (429)
T ss_dssp HHHHTSTTTC--
T ss_pred HHHhCChhhccC
Confidence 99987 44443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=326.87 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=206.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec---------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE--------- 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 119 (353)
...+|++.+.||+|+||.||+|.+. +++.||+|++..... .+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4578999999999999999999976 789999999975442 45689999999999999999998864
Q ss_pred -------CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC
Q 042383 120 -------GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF 192 (353)
Q Consensus 120 -------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~ 192 (353)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 44579999999999999999532 346799999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 193 NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..|+..... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~-- 230 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTD-- 230 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHHH--
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHHH--
Confidence 99999999998765432 22335689999999999999999999999999999999999988742111 0000
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
+....+ +...+..+.+++.+||+.||++|||+.|+++.|......+.
T Consensus 231 ----------~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 ----------LRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ----------HHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ----------hhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 001111 12234568899999999999999999999999988765544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=319.17 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=198.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999976 78999999987432 2334678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999999999983 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||......... ...... .
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~----~----- 227 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF---KKIRGG----V----- 227 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHC----C-----
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHhhcC----c-----
Confidence 4422 2234568999999999987765 68999999999999999999999754332111 111110 0
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
...+...+..+.+++.+||+.||++|||+.++++.
T Consensus 228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234568899999999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.83 Aligned_cols=200 Identities=23% Similarity=0.350 Sum_probs=168.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----C
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----P 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 121 (353)
..++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999875 6889999999743 344557889999999999999999999998766 5
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..|+||||+++ +|.+++ .....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~L~~~~----~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLF----KTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCSE-EHHHHH----HSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCCc-CHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 78999999974 999988 4456799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCc---------------------cccccccCCcCccCcccc-ccCCCCccccchhHHHHHHHHHhCCCCCC
Q 042383 202 SKLFPEDIT---------------------HISTRVAGTLGYLAPDYA-VSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 202 ~~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
++....... .......||+.|+|||++ ....++.++|||||||++|+|++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987653321 123456789999999986 56679999999999999999998655543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=333.03 Aligned_cols=270 Identities=22% Similarity=0.299 Sum_probs=208.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----Cc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----PC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 122 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999876 6889999998743 334446788999999999999999999998755 46
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++|||++.+ +|.+++. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~~-~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCSE-EHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccCc-CHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 8999999975 8998883 24699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 203 KLFPEDITH--ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 203 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 876533221 1244578999999998654 4589999999999999999999999987665544433332211111111
Q ss_pred cccccC--------cccC-CC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 280 LQHLVD--------PMLC-GN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 280 ~~~~~~--------~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
+..+.+ .... .. ..+..+..+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 110000 0000 00 11223456889999999999999999999987 45544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.23 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=200.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
++|.....||+|+||+||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555569999999999999965 68899999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeeccCCccCCCCC
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~ 209 (353)
++++|.+++... .....+++..++.++.||+.||.|||+. +++|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999998532 1234567999999999999999999999 9999999999999987 8999999999998764322
Q ss_pred ccccccccCCcCccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........... ..... .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~------------~ 242 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMF------------K 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHH------------C
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccc------------c
Confidence 1223456899999999987654 78999999999999999999999974432211110 00000 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+...+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112233344567899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=332.73 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=206.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhc-----------------HHHHHHHHHHHHhcCCCCcee
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQG-----------------EKEFMSEVASMANICHENLVK 112 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~ 112 (353)
..++|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 89999999987432211 177899999999999999999
Q ss_pred eeeeEecCCceEEEEEcCCCCChhhhhhh----ccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeE
Q 042383 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLG----EEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 113 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~----~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil 187 (353)
+++++.+.+..++||||+++++|.+++.. .......+++..++.++.||+.||.|||+ . +++|+||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998321 11225789999999999999999999999 8 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccC-CCCc-cccchhHHHHHHHHHhCCCCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNP-KSDIYSFGVLLLQIVTGQAAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslG~il~~ll~g~~pf~~~~~~~~~ 265 (353)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||.........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999875433 23446689999999999877 5666 999999999999999999999865542111
Q ss_pred hHHHHHHhhcc--ccccccccCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 266 YLVEKAWEMHN--TDKLQHLVDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 266 ~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......... ............. .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 262 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 --FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111000 0000000000000 0011334567899999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=341.02 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=210.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC-CCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICH-ENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.++| +++..+..++.+.+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 3578999999999999999999964 6899999988754332 346789999999976 56666667777888899999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE---CCCCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL---DQNFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~---~~~~~~kl~Dfg~~~~ 204 (353)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 8899999842 356799999999999999999999999 99999999999999 5889999999999987
Q ss_pred CCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 205 FPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 205 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 6543221 1224679999999999999999999999999999999999999998765544333333322221111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
.+..+. . ..+.++.+++.+||+.+|++||++.+|++.|+++..
T Consensus 236 ~~~~l~-----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 236 SIEALC-----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp CHHHHH-----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cHHHHh-----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111 1 124568999999999999999999999999988754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=331.70 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=202.4
Q ss_pred CCHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec
Q 042383 42 FSYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE 119 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 119 (353)
++..++....++|++.+.||+|+||+||+|.+. +++.||+|++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 333444456789999999999999999999975 68999999987543 3346788999999999 79999999999986
Q ss_pred ------CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC
Q 042383 120 ------GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN 193 (353)
Q Consensus 120 ------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~ 193 (353)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 56789999999999999998532 345789999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHH
Q 042383 194 PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLV 268 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~ 268 (353)
+||+|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||...........
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~- 245 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 245 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-
Confidence 99999999986643222 223356899999999987 56688999999999999999999999975543222111
Q ss_pred HHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 269 EKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
..... .. .......+..+.+++.+||+.||.+|||+.++++ .+++
T Consensus 246 --~~~~~----~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 246 --IPRNP----AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp --HHHSC----CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred --hhcCc----cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 10100 00 0011223457889999999999999999999987 4443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=354.63 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=200.8
Q ss_pred eeeeeCceEEEEEEeC---CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 59 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
.||+|+||+||+|.+. ++..||||+++.. .....+.+.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 4667999999854 33456789999999999999999999999986 56899999999999
Q ss_pred hhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccc--
Q 042383 135 LSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI-- 212 (353)
Q Consensus 135 L~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 212 (353)
|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999842 356799999999999999999999999 99999999999999999999999999998765332221
Q ss_pred cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCC
Q 042383 213 STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291 (353)
Q Consensus 213 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (353)
.....+++.|+|||++.+..++.++|||||||++|||++ |..||......+... .... .....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~---~i~~-------------~~~~~ 559 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA---FIEQ-------------GKRME 559 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH---HHHT-------------TCCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHc-------------CCCCC
Confidence 122345688999999999999999999999999999998 999998655432211 1111 11122
Q ss_pred CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 292 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 33445678999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=336.53 Aligned_cols=270 Identities=20% Similarity=0.288 Sum_probs=204.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC------ce
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP------CR 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~ 123 (353)
...+|++.+.||+|+||+||+|+...+..+|+|.+...... ..+|+.+++.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 35679999999999999999999877667999987643222 236999999999999999999986443 37
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-CCCCeEEeeccCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFNPKISDFGLS 202 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-~~~~~kl~Dfg~~ 202 (353)
++||||+++ ++...+.........+++..++.++.||+.||.|||+. +++||||||+||+++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999987 45555543334567899999999999999999999999 999999999999998 7999999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...........+.
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87643322 2345689999999988765 58999999999999999999999998766544333332221111111000
Q ss_pred c----ccC---cc-----cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCC
Q 042383 282 H----LVD---PM-----LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDV 329 (353)
Q Consensus 282 ~----~~~---~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~ 329 (353)
. ... +. +...+....+..+.+|+.+||+.||++|||+.|+++. +++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 000 00 0011222345679999999999999999999999873 55543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=325.12 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=206.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe-C-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCC------CceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL-Q-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHE------NLVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|+||+||+|.+ . +++.||+|++.. .....+.+.+|+.+++.++|+ +++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999986 3 688999999873 334456788899999988765 4999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-----------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ----------- 190 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~----------- 190 (353)
..++||||+ +++|.+++.. ....++++..++.++.||+.||.|||+. +++||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 7899999843 2334789999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCccc
Q 042383 191 --------NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262 (353)
Q Consensus 191 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~ 262 (353)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999865432 23456899999999999999999999999999999999999999876554
Q ss_pred chhhHHHHHHhhcccccccc--------------------------ccCcc-cCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042383 263 GEYYLVEKAWEMHNTDKLQH--------------------------LVDPM-LCGNFSGNEAVRFLKVGLLCVQEKSSLR 315 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~R 315 (353)
.................+.. ...+. .........+..+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 33332222211110000000 00000 0012234567889999999999999999
Q ss_pred CCHHHHHH
Q 042383 316 PRMSTVIE 323 (353)
Q Consensus 316 Pt~~evl~ 323 (353)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.84 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=191.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEG------ 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 120 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999865 6899999998643 334556788999999999999999999998654
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
...++|+|++ +++|.+++. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 679998872 25799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.........+.
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 234578999999999887 6789999999999999999999999987665443333322211111111
Q ss_pred ccc--------ccCcccC-CCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 280 LQH--------LVDPMLC-GNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 280 ~~~--------~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
+.. .+..... ... ....+..+.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 110 0000000 000 0122456889999999999999999999987 34443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=319.78 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=205.6
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---------hhcHHHHHHHHHHHHhcC-CCCceeeeeeE
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---------KQGEKEFMSEVASMANIC-HENLVKLHGGC 117 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 117 (353)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45688999999999999999999976 68999999997543 122356788999999995 99999999999
Q ss_pred ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEe
Q 042383 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 118 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
.+....++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999983 346799999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCccccccccCCcCccCccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 198 DFGLSKLFPEDITHISTRVAGTLGYLAPDYAV------SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 198 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
|||++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||........... .
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~ 241 (298)
T 1phk_A 167 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM---I 241 (298)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H
T ss_pred cccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH---H
Confidence 999998765322 223456899999999885 45678999999999999999999999976543222111 1
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.... . ..........+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~----~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGN----Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTC----C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCC----c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1100 0 0001111234567999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=337.43 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=195.1
Q ss_pred CCCCCCeeeeeCceEEEEEEeC--C--CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEe-cCCceEEE
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQ--D--GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCI-EGPCRIIV 126 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 126 (353)
.|++.+.||+|+||+||+|... + +..||+|.+... .....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999853 2 246899988643 3345578899999999999999999999865 45678999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++. .....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999983 2345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCcc---ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 207 EDITH---ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 207 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+.... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~~~------- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGR------- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHTTC-------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHcCC-------
Confidence 32211 1233456788999999999999999999999999999999 6777765443322211 11100
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112233567899999999999999999999999998876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.38 Aligned_cols=271 Identities=24% Similarity=0.377 Sum_probs=196.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHH--HHHhcCCCCceeeeeeEe-----cCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVA--SMANICHENLVKLHGGCI-----EGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~~iv~~~~~~~-----~~~~ 122 (353)
..++|++.+.||+|+||+||+|+. +++.||+|++..... ..+..|.+ .+..++||||+++++.+. ....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 357899999999999999999987 488999999874432 23333444 445579999999997543 2335
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEcCCCCCCeEECCCCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI------KPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~------~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.++||||+++|+|.+++.. ...++..++.++.||+.||.|||+.+ ..+++||||||+||+++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 6899999999999999832 34588999999999999999999752 228999999999999999999999
Q ss_pred eeccCCccCCCCC-------ccccccccCCcCccCcccccc-------CCCCccccchhHHHHHHHHHhCCCCCCCCccc
Q 042383 197 SDFGLSKLFPEDI-------THISTRVAGTLGYLAPDYAVS-------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262 (353)
Q Consensus 197 ~Dfg~~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~ 262 (353)
+|||++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998764321 112223568999999999886 45667899999999999999998877544332
Q ss_pred chhhHHHH--HHhhccccccc-----cccCcccCC--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 263 GEYYLVEK--AWEMHNTDKLQ-----HLVDPMLCG--NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 263 ~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
........ ........... ....+.+.. ......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21110000 00000000000 000111111 112346778999999999999999999999999998876
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=329.91 Aligned_cols=266 Identities=21% Similarity=0.250 Sum_probs=197.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP----- 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 121 (353)
..++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999865 6889999998753 3344567889999999999999999999997665
Q ss_pred -ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 122 -CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 122 -~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 67999999975 7887772 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc----
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---- 276 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 276 (353)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+........
T Consensus 173 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 173 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865432 223346789999999999999999999999999999999999999987654332221111000000
Q ss_pred -------------c-----cccccccCcccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 277 -------------T-----DKLQHLVDPMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 277 -------------~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
. ............+. .....+..+.+|+.+||+.||++|||++|+++ .++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 00000000100011 11223678999999999999999999999986 4443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=323.68 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=190.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhc-HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQG-EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||+||+|... +|+.||+|++.... ... .+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999974 78999999987542 222 23344555557778999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++ +|.+++.........+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999975 88888865555677899999999999999999999984 289999999999999999999999999998664
Q ss_pred CCCccccccccCCcCccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 207 EDITHISTRVAGTLGYLAPDYA----VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
.... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||......... .......
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~-------- 229 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEE-------- 229 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHHHHHS--------
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHHHhcc--------
Confidence 4322 2334689999999996 5667899999999999999999999999753321111 1111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..........+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 ----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0001111223566899999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=341.57 Aligned_cols=243 Identities=17% Similarity=0.169 Sum_probs=189.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHH---HHHhcCCCCceeee-------ee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVA---SMANICHENLVKLH-------GG 116 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~ 116 (353)
.++|++.+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467889999999999999999964 6899999999743 3345577889995 45555799999998 66
Q ss_pred EecCC-----------------ceEEEEEcCCCCChhhhhhhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042383 117 CIEGP-----------------CRIIVYDYMQNNSLSQTLLGEEKN---RAKFSWTARREIALGIARGLAYIHEEIKPSI 176 (353)
Q Consensus 117 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~~---~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i 176 (353)
+.+.+ ..++||||+ +|+|.+++...... ...+++..++.++.||+.||.|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65553 278999999 57999999543211 12234588889999999999999999 99
Q ss_pred EEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccC-----------CCCccccchhHHHH
Q 042383 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG-----------HLNPKSDIYSFGVL 245 (353)
Q Consensus 177 ~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~i 245 (353)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 246 LLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 246 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
+|+|++|..||........ ...+... ....+..+.+++.+||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999965432211 1111110 0122456889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=331.58 Aligned_cols=278 Identities=18% Similarity=0.257 Sum_probs=200.6
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC- 122 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 122 (353)
.......++|++.+.||+|+||+||+|.+. +|+.||+|++.... .......+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 444566789999999999999999999975 68999999886432 223455678888889999999999999875443
Q ss_pred ------eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEcCCCCCCeEECC-CCC
Q 042383 123 ------RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH--EEIKPSIVHRDIKPSNILLDQ-NFN 193 (353)
Q Consensus 123 ------~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~~~~i~H~dlk~~Nil~~~-~~~ 193 (353)
.++||||+++ +|...+.........+++..++.++.|++.||.||| +. +++||||||+||+++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999986 666665444456778999999999999999999999 87 9999999999999986 899
Q ss_pred eEEeeccCCccCCCCCccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 194 PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
+||+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999998765432 223456899999999887654 8999999999999999999999998766544333332211
Q ss_pred hhcccccccc---------ccC------cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 273 EMHNTDKLQH---------LVD------PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 273 ~~~~~~~~~~---------~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
.......+.. ... ...........+..+.+|+.+||+.||.+|||+.|+++ .+++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 1111000000 000 00011222335678999999999999999999999986 355543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=327.13 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=199.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC--CCc--EEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ--DGT--VVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||+||+|.+. +++ .||+|++... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 333 6899988744 2344567889999999999999999999998765 8
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999843 235689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 204 LFPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 204 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~------- 239 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDK------- 239 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHT-------
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---HHHHc-------
Confidence 76543222 1233457788999999998889999999999999999999 99999765432111 11100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.......+...+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 240 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 240 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -----cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 00111122334567999999999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.88 Aligned_cols=254 Identities=14% Similarity=0.137 Sum_probs=204.2
Q ss_pred HhccCCCCCCeeeeeCceEEEEEE------eCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC---CCCceeeeeeEec
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGK------LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC---HENLVKLHGGCIE 119 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 119 (353)
...++|.+.+.||+|+||+||+|. ..+++.||+|++.... ...+..|+.++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345779999999999999999994 3468889999987543 445677777777776 9999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC--------
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEK-NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-------- 190 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-------- 190 (353)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999964332 356799999999999999999999999 9999999999999988
Q ss_pred ---CCCeEEeeccCCccCCC-CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhh
Q 042383 191 ---NFNPKISDFGLSKLFPE-DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY 266 (353)
Q Consensus 191 ---~~~~kl~Dfg~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~ 266 (353)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999975431 12223345679999999999999999999999999999999999999986433210
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHhcCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLR-PRMSTVIEMINGDV 329 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~~~ 329 (353)
.. ....+.... ....+.+++..||+.+|.+| |+++++.+.|++..
T Consensus 293 -----------~~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 -----------CK----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -----------EE----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -----------ee----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 01 111111111 24567788889999999999 67888888777654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=329.81 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=207.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|.. .++..||+|++... .......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 357899999999999999999983 24778999998744 34455678899999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK---NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKI 196 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~---~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl 196 (353)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999954322 124589999999999999999999999 9999999999999984 456999
Q ss_pred eeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhh
Q 042383 197 SDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 197 ~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
+|||++....... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~ 261 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFVTSG 261 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHTT
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HHHhcC
Confidence 9999987543221 122233567889999999999999999999999999999998 99999754432111 111110
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.....+...+..+.+++.+||+.||.+|||+.++++.|.....-+
T Consensus 262 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 262 -------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 011122334567899999999999999999999999988765433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=338.30 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=200.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC------Cce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEG------PCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 123 (353)
..+|++.+.||+|+||+||+|++. +|+.||||++..... ...+|+.+++.++||||+++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 457999999999999999999976 689999999874322 234799999999999999999988532 236
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-CCeEEeeccCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLS 202 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-~~~kl~Dfg~~ 202 (353)
++||||+++ +|.+.+.........+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 67777655445567899999999999999999999999 99999999999999865 56899999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc-
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL- 280 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 280 (353)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+.........+.+
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87643322 2345789999999998765 7899999999999999999999999876544333222221111111111
Q ss_pred ------ccccCcccCC-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 281 ------QHLVDPMLCG-----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 281 ------~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+..+.+.. .+....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1110011100 022334567999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=323.11 Aligned_cols=256 Identities=16% Similarity=0.270 Sum_probs=201.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEec--CCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIE--GPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 126 (353)
.++|++.+.||+|+||+||+|... +++.||+|++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 478999999999999999999864 6899999998743 3467889999999996 9999999999987 6678999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~ 205 (353)
|||+++++|.+++. .+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999998872 389999999999999999999999 999999999999999766 8999999999876
Q ss_pred CCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc------
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD------ 278 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 278 (353)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..........
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l--~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH--HHHHHhcCCchhhhHH
Confidence 54322 234568999999999877 678999999999999999999999996443221111 0000000000
Q ss_pred ---------ccc--------cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 ---------KLQ--------HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ---------~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ...............+..+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 001111112222334677999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=321.62 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=204.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999876 58999999987543 34578899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++. .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||.+......
T Consensus 105 ~~~~~~L~~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999983 2356799999999999999999999999 9999999999999999999999999999766443
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... .... ... .
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-~~~--------~- 244 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM---IPTN-PPP--------T- 244 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-CCC--------C-
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HhcC-CCc--------c-
Confidence 22 22345689999999999999999999999999999999999999975543221111 1000 000 0
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
...+...+..+.+++.+||+.||.+|||+.++++ .+++.
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0112223567899999999999999999999976 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.97 Aligned_cols=266 Identities=21% Similarity=0.336 Sum_probs=190.0
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
....++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345688999999999999999999864 68899999987543 3344677899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhcc----ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 126 VYDYMQNNSLSQTLLGEE----KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~----~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999985321 1345689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCc----cccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc
Q 042383 202 SKLFPEDIT----HISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN 276 (353)
Q Consensus 202 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 276 (353)
+........ .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||........... .... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~-~ 243 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQN-D 243 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHTS-S
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---Hhcc-C
Confidence 876543211 11233568999999998876 5689999999999999999999999986554322211 1110 0
Q ss_pred ccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 277 TDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..... ............+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01000 000111122233456889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=324.58 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=201.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999976 588999999987666667888999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998842 345699999999999999999999999 9999999999999999999999999987532111
Q ss_pred CccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
........|++.|+|||++. +..++.++||||||+++|+|++|..||...+..... ........ .
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~----~-- 240 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSDP----P-- 240 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSCC----C--
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHhccCC----c--
Confidence 11122356899999999883 567889999999999999999999999765432211 11111000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
....+...+..+.+++.+||+.||++|||+.++++
T Consensus 241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112233567899999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.93 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=206.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 124 (353)
..++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3478999999999999999999976 6889999999743 223345677899999887 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999983 346799999999999999999999999 999999999999999999999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+ .
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i---~------------ 555 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---M------------ 555 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H------------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH---H------------
Confidence 43222 2234567999999999999999999999999999999999999999865543222111 1
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRM-----STVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 323 (353)
... ..++...+..+.+|+.+||+.||++||++ +||++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 110 12333445678999999999999999998 77764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=354.37 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=199.6
Q ss_pred CeeeeeCceEEEEEEeC---CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
+.||+|+||+||+|.+. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999643 46789999997542 3345789999999999999999999999975 458899999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc--
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT-- 210 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 210 (353)
|+|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l----~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999 3456799999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+ .. ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i---~~-------------~~~ 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EK-------------GER 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT-------------TCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-------------CCC
Confidence 12233456788999999999999999999999999999998 99999765543221111 11 111
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
...+..++..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223344567799999999999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=323.88 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=197.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhcCCCCceeeeeeEecC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--------QGEKEFMSEVASMANICHENLVKLHGGCIEG 120 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 120 (353)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4578999999999999999999875 588999999874321 1224578899999999999999999998766
Q ss_pred CceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC---eEEe
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN---PKIS 197 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~ 197 (353)
. .++||||+++++|.+++ .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHH----STTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 89999999999999988 4456799999999999999999999999 9999999999999987654 9999
Q ss_pred eccCCccCCCCCccccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhh
Q 042383 198 DFGLSKLFPEDITHISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 198 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 274 (353)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.......... ......
T Consensus 160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~ 235 (322)
T 2ycf_A 160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQITSG 235 (322)
T ss_dssp CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH--HHHHHT
T ss_pred cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH--HHHHhC
Confidence 99999876432 2223456899999999874 4678899999999999999999999997554322211 111110
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .. .. .......+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~----~~-~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 K----YN-FI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C----CC-CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----cc-cC-----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00 00 0000122467889999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=331.57 Aligned_cols=272 Identities=22% Similarity=0.344 Sum_probs=201.1
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
....++|++.+.||+|+||+||+|..+. .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3456889999999999999999999764 39999987542 2233456789999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++ ++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp ECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 9999999999999832 345799999999999999999999999 999999999999998 679999999998755
Q ss_pred CCCC----ccccccccCCcCccCcccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 206 PEDI----THISTRVAGTLGYLAPDYAVS---------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 206 ~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
.... ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ....
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~ 256 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---WQMG 256 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH---HHHH
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhc
Confidence 3211 112233458899999998874 34788999999999999999999999755432211 1111
Q ss_pred hhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCccccCCccccc
Q 042383 273 EMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPGLIND 345 (353)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~ 345 (353)
... .+.. .....+..+.+++.+||+.||++|||+.++++.|+.+..... ....|+..|.
T Consensus 257 ~~~---------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~--~~~~~~~~~~ 315 (319)
T 2y4i_B 257 TGM---------KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR--RLSHPGHFWK 315 (319)
T ss_dssp TTC---------CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------------
T ss_pred cCC---------CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc--cCCCCccccc
Confidence 110 0000 011123458899999999999999999999999999987665 3344555544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=321.85 Aligned_cols=273 Identities=21% Similarity=0.332 Sum_probs=207.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEe--CCCcEEEEEEeeccCh--hcHHHHHHHHHHHHhc---CCCCceeeeeeEe----
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKL--QDGTVVAVKVLSVESK--QGEKEFMSEVASMANI---CHENLVKLHGGCI---- 118 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 118 (353)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 3688999999874422 1223456777777666 8999999999987
Q ss_pred -cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEe
Q 042383 119 -EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKIS 197 (353)
Q Consensus 119 -~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~ 197 (353)
.....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999998 5999998432 234589999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 198 DFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 198 Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...........+.........
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 99999865432 2233456899999999999999999999999999999999999999876544333222221111111
Q ss_pred ccccccc-------Cc---ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 278 DKLQHLV-------DP---MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 278 ~~~~~~~-------~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
..+.... .. .....+....+..+.+|+.+||+.||++|||+.|+++ .+++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 1111000 00 0001122334567889999999999999999999994 4655543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=333.23 Aligned_cols=253 Identities=8% Similarity=0.000 Sum_probs=182.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhc--CCCCceeee-------eeEe
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANI--CHENLVKLH-------GGCI 118 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~~ 118 (353)
..|.+.+.||+|+||+||+|.+. +|+.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45889999999999999999976 789999999986532 3345677785555544 699988755 4443
Q ss_pred cC-----------------CceEEEEEcCCCCChhhhhhhccccCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 042383 119 EG-----------------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTAR------REIALGIARGLAYIHEEIKPS 175 (353)
Q Consensus 119 ~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~------~~~~~qi~~al~~LH~~~~~~ 175 (353)
.. ...++||||++ ++|.+++... ...+++..+ ..++.||+.||.|||+. +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 32 33799999998 7999999543 233455555 67889999999999999 9
Q ss_pred eEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCC
Q 042383 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQ 253 (353)
Q Consensus 176 i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~ 253 (353)
|+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999866432 113456799999999987 67999999999999999999999
Q ss_pred CCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 254 AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 254 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.||......... .......................+..+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCccccc--------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999765432110 00000000001111111112244677999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=317.10 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=202.5
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC----hhcHHHHHHHHHHHHhcCCCCceeeeeeE--ecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES----KQGEKEFMSEVASMANICHENLVKLHGGC--IEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~ 122 (353)
..++|++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999975 68899999987432 23456789999999999999999999998 45568
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||++++ |.+.+.. .....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 7776633 2346799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCC-ccccccccCCcCccCccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 203 KLFPEDI-THISTRVAGTLGYLAPDYAVSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 203 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
....... ........|++.|+|||++.+.. ++.++||||||+++|+|++|..||......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~i~~----~~ 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF---ENIGK----GS 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH----CC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---HHHhc----CC
Confidence 8764321 22233456899999999987654 377999999999999999999999765432211 11111 00
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
...+...+..+.+++.+||+.||++|||+.++++ .+++..
T Consensus 230 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 230 ----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 1122234567889999999999999999999995 465544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=325.85 Aligned_cols=270 Identities=19% Similarity=0.252 Sum_probs=206.4
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CC-----CceeeeeeE
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HE-----NLVKLHGGC 117 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~ 117 (353)
.......++|++.+.||+|+||+||+|... +++.||+|++.. .......+..|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 334445789999999999999999999876 688999999873 3344566778888888884 55 499999999
Q ss_pred ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC--CCCCeE
Q 042383 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD--QNFNPK 195 (353)
Q Consensus 118 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~k 195 (353)
...+..++||||+++ +|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+||+++ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCCC-CHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999965 999998432 335699999999999999999999942 12999999999999994 477899
Q ss_pred EeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 196 ISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999876432 234578999999999999999999999999999999999999998766544333222211111
Q ss_pred cc------cccccccCcc-----------------------------------------cCCCCChHHHHHHHHHHhhcc
Q 042383 276 NT------DKLQHLVDPM-----------------------------------------LCGNFSGNEAVRFLKVGLLCV 308 (353)
Q Consensus 276 ~~------~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~cl 308 (353)
.. +....++... -...........+.+|+.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 00 0000000000 000112234568999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 042383 309 QEKSSLRPRMSTVIE 323 (353)
Q Consensus 309 ~~~p~~RPt~~evl~ 323 (353)
+.||++|||++|+++
T Consensus 358 ~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQ 372 (382)
T ss_dssp CSCTTTSCCHHHHTT
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=325.60 Aligned_cols=268 Identities=21% Similarity=0.302 Sum_probs=199.8
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe----------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI---------- 118 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------- 118 (353)
..++|++.+.||+|+||+||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999976 58999999998777667788899999999999999999998874
Q ss_pred ----cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-CCCC
Q 042383 119 ----EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNFN 193 (353)
Q Consensus 119 ----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-~~~~ 193 (353)
+....++||||++ ++|.+++. .+++++..++.++.||+.||.|||+. +++|+||||+||+++ .++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 4467899999998 59999882 35789999999999999999999999 999999999999997 5679
Q ss_pred eEEeeccCCccCCCCCc--cccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHH
Q 042383 194 PKISDFGLSKLFPEDIT--HISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 270 (353)
+||+|||++........ .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999987643211 12233457889999998765 6789999999999999999999999987654333222211
Q ss_pred HHhhccccccccc-------cCcccC-CC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--Hhc
Q 042383 271 AWEMHNTDKLQHL-------VDPMLC-GN-----FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MIN 326 (353)
Q Consensus 271 ~~~~~~~~~~~~~-------~~~~~~-~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~ 326 (353)
............+ ...... .. ..+..+..+.+++.+||+.||++|||+.|+++ .++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 1100000000000 000000 00 11223567899999999999999999999986 454
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=329.23 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=202.7
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce---
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCR--- 123 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 123 (353)
..++|.+.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999876 6899999998754 333457788999999999999999999999877655
Q ss_pred ---EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 124 ---IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 124 ---~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
++||||+. ++|.+.+ ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 4888776 23489999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+...........
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 99865432 234568999999999887 6789999999999999999999999987654433332222111111100
Q ss_pred cccc--------cCc---ccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 042383 280 LQHL--------VDP---MLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGD 328 (353)
Q Consensus 280 ~~~~--------~~~---~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 328 (353)
...+ ... ..... ..+..+..+.+|+.+||+.||++|||+.|+++. ++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 000 00000 112235678999999999999999999999863 5543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=329.68 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=204.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC--------CCCceeeeeeEe--
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC--------HENLVKLHGGCI-- 118 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~-- 118 (353)
..++|++.+.||+|+||+||+|... +++.||+|++.. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3578999999999999999999865 688999999873 3444567889999999985 788999999987
Q ss_pred --cCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----
Q 042383 119 --EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF---- 192 (353)
Q Consensus 119 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~---- 192 (353)
+....++||||+ +++|.+.+.. .....+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 566889999999 5577777643 23467999999999999999999999852 899999999999998775
Q ss_pred ---------------------------------------------CeEEeeccCCccCCCCCccccccccCCcCccCccc
Q 042383 193 ---------------------------------------------NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227 (353)
Q Consensus 193 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~ 227 (353)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999876432 233568999999999
Q ss_pred cccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchh---hHHHHHHhhccc-------------------cccccccC
Q 042383 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEY---YLVEKAWEMHNT-------------------DKLQHLVD 285 (353)
Q Consensus 228 ~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~-------------------~~~~~~~~ 285 (353)
+.+..++.++|||||||++|+|++|..||......... ............ .....+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999765432211 111111110000 00000000
Q ss_pred cc---------cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PM---------LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. -....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 011345677888999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=323.62 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=202.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc-----
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC----- 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 122 (353)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999875 6899999998753 33345678899999999999999999999987654
Q ss_pred -eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 123 -RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 123 -~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
.++||||+. ++|.+.+ ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 4888876 23489999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+............
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 233568999999998877 67899999999999999999999999876543332222211110000000
Q ss_pred cc--------c---cCcccC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 281 QH--------L---VDPMLC---GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 281 ~~--------~---~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
.. . +..... ....+..+..+.+++.+||+.||++|||+.++++ .++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 0 000000 1122344677999999999999999999999986 455443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=322.27 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=199.0
Q ss_pred HHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcC--CCCceeeeeeEecCCc
Q 042383 47 LKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANIC--HENLVKLHGGCIEGPC 122 (353)
Q Consensus 47 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~ 122 (353)
+....++|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|+.++.+++ ||||+++++++.+.+.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34456789999999999999999999888999999998754 3345577889999999996 5999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||| +.+++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||++++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 55779999983 446789999999999999999999999 9999999999999965 79999999999
Q ss_pred ccCCCCCcc-ccccccCCcCccCcccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHH
Q 042383 203 KLFPEDITH-ISTRVAGTLGYLAPDYAVS-----------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 203 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 270 (353)
......... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||........ .
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~--- 248 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K--- 248 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--H---
Confidence 876443221 2234568999999999875 4678899999999999999999999975432111 0
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. ....+......++...+..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 249 L---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp H---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0 1111111112223333567889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=315.89 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=203.9
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
....++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999976 6889999998744 2345678889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC---CCeEEeeccC
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN---FNPKISDFGL 201 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~---~~~kl~Dfg~ 201 (353)
+||||+++++|.+.+. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999999883 345799999999999999999999999 99999999999999654 4699999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+........ .....+++.|+|||++.+ .++.++||||||+++|+|++|..||........ .............
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~- 243 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVETGKYAFDL- 243 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCCCCCS-
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHcCCCCCCc-
Confidence 986644322 223457889999998765 489999999999999999999999976543221 1111111000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+..+.+++.+||+.||++|||+.++++
T Consensus 244 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 ---------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000122456889999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=324.14 Aligned_cols=272 Identities=18% Similarity=0.266 Sum_probs=206.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecC-----Cc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEG-----PC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 122 (353)
..++|++.+.||+|+||+||+|.+. +|+.||+|++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999976 6899999998743 334456778999999999999999999987654 67
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||+. ++|.+++. ...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 48988873 24699999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCcc---------ccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHH
Q 042383 203 KLFPEDITH---------ISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAW 272 (353)
Q Consensus 203 ~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 272 (353)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 876532211 1123468999999998764 678999999999999999999999998765433322222111
Q ss_pred hhccccc-c--------ccccCcccC-C-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 273 EMHNTDK-L--------QHLVDPMLC-G-----NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 273 ~~~~~~~-~--------~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
....... . ......... . ...+..+..+.+++.+||+.||++|||+.|+++ .++....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 1111000 0 000000000 0 001233567889999999999999999999987 5665543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.68 Aligned_cols=267 Identities=19% Similarity=0.313 Sum_probs=184.6
Q ss_pred ccCCCC-CCeeeeeCceEEEEEEeC---CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEe--cCCceE
Q 042383 51 TNGFCS-SNKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI--EGPCRI 124 (353)
Q Consensus 51 ~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 124 (353)
.+.|.+ .++||+|+||+||+|+.+ +++.||+|++.... ....+.+|+.++++++||||+++++++. .....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345666 558999999999999965 57889999987432 2346789999999999999999999995 477889
Q ss_pred EEEEcCCCCChhhhhhhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE----CCCCCeE
Q 042383 125 IVYDYMQNNSLSQTLLGEEK-----NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL----DQNFNPK 195 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~-----~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~----~~~~~~k 195 (353)
+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 88887753321 223599999999999999999999999 99999999999999 6778999
Q ss_pred EeeccCCccCCCCCc--cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccc------hhh
Q 042383 196 ISDFGLSKLFPEDIT--HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELG------EYY 266 (353)
Q Consensus 196 l~Dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~------~~~ 266 (353)
|+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987654322 223446789999999998874 58999999999999999999999997554321 001
Q ss_pred HHHHHHhh---cccccccccc-------------CcccCC--------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 267 LVEKAWEM---HNTDKLQHLV-------------DPMLCG--------NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 267 ~~~~~~~~---~~~~~~~~~~-------------~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
........ .....+..+. ...... .........+.+|+.+||+.||.+|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111111 1111111100 000000 00001134688999999999999999999998
Q ss_pred H
Q 042383 323 E 323 (353)
Q Consensus 323 ~ 323 (353)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=320.82 Aligned_cols=268 Identities=18% Similarity=0.254 Sum_probs=206.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CC-cEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC------ceeeeeeEecCC
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DG-TVVAVKVLSVESKQGEKEFMSEVASMANICHEN------LVKLHGGCIEGP 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~ 121 (353)
..++|++.+.||+|+||+||+|... ++ +.||+|+++. .....+.+.+|+.++++++|++ ++.+.+++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999875 34 6899999873 3344567788999999987655 899999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE-------------
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL------------- 188 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~------------- 188 (353)
..++||||+ +++|.+.+.. .....+++..++.++.||+.||.|||+. +++||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 5677777733 2335799999999999999999999999 99999999999999
Q ss_pred ------CCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCccc
Q 042383 189 ------DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKEL 262 (353)
Q Consensus 189 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~ 262 (353)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999865432 23356899999999999999999999999999999999999999866544
Q ss_pred chhhHHHHHHhhccccccc------cccCc---------------------ccCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042383 263 GEYYLVEKAWEMHNTDKLQ------HLVDP---------------------MLCGNFSGNEAVRFLKVGLLCVQEKSSLR 315 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~------~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~R 315 (353)
................... ..... ..........+..+.+|+.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 3333222221111000000 00000 00011223446689999999999999999
Q ss_pred CCHHHHHH--HhcCC
Q 042383 316 PRMSTVIE--MINGD 328 (353)
Q Consensus 316 Pt~~evl~--~L~~~ 328 (353)
||+.|+++ .+++.
T Consensus 326 pt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 326 ITLAEALLHPFFAGL 340 (355)
T ss_dssp CCHHHHTTSGGGGGC
T ss_pred cCHHHHhcChhhcCC
Confidence 99999984 44443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=316.91 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=195.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec---------
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE--------- 119 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 119 (353)
..++|++.+.||+|+||+||+|... +++.||+|++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567999999999999999999975 789999999864 33445678899999999999999999998765
Q ss_pred ----CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeE
Q 042383 120 ----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPK 195 (353)
Q Consensus 120 ----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~k 195 (353)
....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 4567899999999999999943 345678899999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCC-------------ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcc
Q 042383 196 ISDFGLSKLFPEDI-------------THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKE 261 (353)
Q Consensus 196 l~Dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~ 261 (353)
|+|||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999998664321 1122345689999999998764 68999999999999999998 5442211
Q ss_pred cchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 262 LGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.......... ....+...++...+..+.+++.+||+.||.+|||+.++++
T Consensus 234 --~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 --RVNILKKLRS----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHHHS----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHHhccc----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111110 0111223344455677899999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=349.47 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=206.8
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
....++|++.+.||+|+||+||+|.+. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 334577899999999999999999864 2567999998754 33444678999999999999999999999854 56
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 8999999999999999842 345689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... .......
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~~~------ 609 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE------ 609 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHHTC------
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC------
Confidence 8765443333334556789999999999999999999999999999997 99999765432221 1111110
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
....+...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223344567899999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=319.58 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=192.3
Q ss_pred HHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh------cHHHHHHHHHHHHhc----CCCCceeee
Q 042383 46 ELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ------GEKEFMSEVASMANI----CHENLVKLH 114 (353)
Q Consensus 46 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~ 114 (353)
+.....++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34456789999999999999999999864 6889999998754321 223456789999998 899999999
Q ss_pred eeEecCCceEEEEEc-CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-CCC
Q 042383 115 GGCIEGPCRIIVYDY-MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QNF 192 (353)
Q Consensus 115 ~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-~~~ 192 (353)
+++.+.+..++|+|+ +.+++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 78999999983 345799999999999999999999999 999999999999998 889
Q ss_pred CeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHH
Q 042383 193 NPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN-PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271 (353)
Q Consensus 193 ~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 271 (353)
.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|..||......
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------- 245 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------- 245 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---------
Confidence 99999999998765432 2345689999999998877764 5899999999999999999999643210
Q ss_pred HhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 272 WEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
... ...++...+..+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEA--------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHT--------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhh--------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01122334566889999999999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=321.14 Aligned_cols=273 Identities=19% Similarity=0.279 Sum_probs=206.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-----------CCCceeeeeeEe
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-----------HENLVKLHGGCI 118 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 118 (353)
.++|++.+.||+|+||+||+|.+. +++.||+|++.. .......+.+|+.+++++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999974 689999999873 3344567788999998886 899999999988
Q ss_pred cCC----ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-----
Q 042383 119 EGP----CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD----- 189 (353)
Q Consensus 119 ~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~----- 189 (353)
..+ ..++|||++ +++|.+++... ....+++..++.++.||+.||.|||+.+ +++||||||+||+++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 88999998432 3456999999999999999999999842 899999999999994
Q ss_pred -CCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccch---h
Q 042383 190 -QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE---Y 265 (353)
Q Consensus 190 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~---~ 265 (353)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999876432 2335689999999999999999999999999999999999999975542111 1
Q ss_pred hHHHHHHhhccc------------------c-ccccccCc---------ccCCCCChHHHHHHHHHHhhccCCCCCCCCC
Q 042383 266 YLVEKAWEMHNT------------------D-KLQHLVDP---------MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR 317 (353)
Q Consensus 266 ~~~~~~~~~~~~------------------~-~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 317 (353)
............ . ....+... .....++...+..+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110000 0 00000000 0012356677889999999999999999999
Q ss_pred HHHHHH--HhcCCCCCCC
Q 042383 318 MSTVIE--MINGDVDIDD 333 (353)
Q Consensus 318 ~~evl~--~L~~~~~~~~ 333 (353)
++|+++ .+++......
T Consensus 328 ~~ell~hp~f~~~~~~~~ 345 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGMEE 345 (373)
T ss_dssp HHHHHTCGGGTTCTTCTT
T ss_pred HHHHhhChhhhcccCccc
Confidence 999998 6777655444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.32 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=181.1
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHH-HHHhcCCCCceeeeeeEecCCceEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVA-SMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478999999999999999999975 68999999997543 333345556665 66777999999999999999999999
Q ss_pred EEcCCCCChhhhhhhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEE-KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~-~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||+++ +|.+++.... .....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999986 8887774322 2356799999999999999999999984 28999999999999999999999999999866
Q ss_pred CCCCccccccccCCcCccCcccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYA----VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
..... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||......... . ....
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~------~~~~ 243 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----L------TQVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----H------HHHh
Confidence 43322 2334689999999998 4567899999999999999999999999754321100 0 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
......+........+..+.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000011111122234567999999999999999999999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=317.83 Aligned_cols=262 Identities=18% Similarity=0.228 Sum_probs=178.5
Q ss_pred hccCCCCCC-eeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec----CCce
Q 042383 50 ATNGFCSSN-KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 50 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 123 (353)
..++|.+.+ .||+|+||+||+|.+. +|+.||+|++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 467899855 6999999999999976 68999999987421 112223334566789999999999876 4558
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeecc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFG 200 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg 200 (353)
++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 999999999999999943 2335799999999999999999999999 9999999999999976 4559999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||............... ....
T Consensus 177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~-- 248 (336)
T 3fhr_A 177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR---IRLG-- 248 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh---hhcc--
Confidence 99865432 223456799999999998888999999999999999999999999754432111000000 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDID 332 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~ 332 (353)
............+..+.+|+.+||+.||++|||+.|+++ .+++....+
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 000011111234567899999999999999999999998 666554433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=326.26 Aligned_cols=254 Identities=21% Similarity=0.224 Sum_probs=188.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3456667899999999998777677999999998743 234667899999887 899999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCC-------------CC
Q 042383 130 MQNNSLSQTLLGEEKNRAK---FSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQN-------------FN 193 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~---l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~-------------~~ 193 (353)
++ |+|.+++......... .++..++.++.||+.||.|||+. +|+||||||+||+++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 5999999543221111 13335678999999999999999 99999999999999654 48
Q ss_pred eEEeeccCCccCCCCCcc---ccccccCCcCccCcccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCccc
Q 042383 194 PKISDFGLSKLFPEDITH---ISTRVAGTLGYLAPDYAVS-------GHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKEL 262 (353)
Q Consensus 194 ~kl~Dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~ 262 (353)
+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 999999999877543222 1234579999999999876 568999999999999999999 99999654322
Q ss_pred chhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 263 GEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. ...... ... +..........+..+.+++.+||+.||++|||+.+|++
T Consensus 247 ~~-----~i~~~~--~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ES-----NIIRGI--FSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-----HHHHTC--CCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-----HHhcCC--CCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 010100 000 01111223456788999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=321.61 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=202.6
Q ss_pred CHHHHHHhccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChh------cHHHHHHHHHHHHhcC--CCCceee
Q 042383 43 SYNELKSATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQ------GEKEFMSEVASMANIC--HENLVKL 113 (353)
Q Consensus 43 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~ 113 (353)
...+.....++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.++++++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 44455566789999999999999999999865 6899999998754221 1244567999999996 5999999
Q ss_pred eeeEecCCceEEEEEcCCC-CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC-CC
Q 042383 114 HGGCIEGPCRIIVYDYMQN-NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD-QN 191 (353)
Q Consensus 114 ~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~-~~ 191 (353)
++++.+.+..++|+|++.+ ++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++ .+
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 9999999999999999986 89999983 356799999999999999999999999 999999999999998 78
Q ss_pred CCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHH
Q 042383 192 FNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270 (353)
Q Consensus 192 ~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 270 (353)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------- 255 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------- 255 (320)
T ss_dssp TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------
Confidence 899999999998765322 233568999999999887766 67899999999999999999999643210
Q ss_pred HHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
.. . . .......+..+.+++.+||+.||++|||++++++ .+++.
T Consensus 256 -~~---~-~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 256 -IR---G-Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -HH---C-C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -hc---c-c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 00 0 0 0011223456889999999999999999999987 44443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.11 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=179.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hc-HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QG-EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.++|++.+.||+|+||+||+|.+. +|+.||+|++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999976 689999999975432 22 233444555678889999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
||+ ++.+..... .....+++..++.++.||+.||.|||+ . +++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 444544432 235679999999999999999999998 6 99999999999999999999999999997654
Q ss_pred CCCccccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
... ......+++.|+|||++. ...++.++||||||+++|+|++|..||........ ..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~----- 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKVLQEEP----- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHHSCC-----
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHHhccCC-----
Confidence 322 223456899999999984 45688999999999999999999999975332111 1111111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..+ ......+..+.+++.+||+.||.+|||++++++
T Consensus 248 ----~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 001123456889999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.14 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=187.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
..+|.+.+.||+|+||+|+.....+++.||||++...... .+.+|+.+++++ +||||+++++++.+....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568889999999999977665667899999998744322 245799999999 799999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-----CCCeEEeeccCCcc
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-----NFNPKISDFGLSKL 204 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-----~~~~kl~Dfg~~~~ 204 (353)
+.+ +|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||+++. ...+||+|||++..
T Consensus 100 ~~g-~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CAA-TLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CSE-EHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 974 99999843 233455566788999999999999999 9999999999999953 33588999999987
Q ss_pred CCCCCc--cccccccCCcCccCccccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 205 FPEDIT--HISTRVAGTLGYLAPDYAV---SGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 205 ~~~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
...... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||......... . .....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~---~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----I---LLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----H---HTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----H---HhccC
Confidence 653321 2233467999999999987 4567889999999999999999 89998643321111 0 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .............+.+|+.+||+.||++|||+.+|++
T Consensus 246 ~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0001122344667889999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.27 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=200.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec------CCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIE------GPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 122 (353)
.++|++.+.||+|+||+||+|.+. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999875 6889999998754 34455778999999999999999999998765 677
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCC---eEEeec
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFN---PKISDF 199 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~---~kl~Df 199 (353)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 89999999999999998542 2234689999999999999999999999 9999999999999987665 999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhH---HHHHHhhcc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYL---VEKAWEMHN 276 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~ 276 (353)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .........
T Consensus 169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9998765432 22446789999999999999999999999999999999999999975432111000 000000000
Q ss_pred cccccc---ccCc-ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042383 277 TDKLQH---LVDP-MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTV 321 (353)
Q Consensus 277 ~~~~~~---~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 321 (353)
...... +... ..........+..+.+++.+||++||++|||+.++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 0000 11123556678899999999999999999999773
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.22 Aligned_cols=234 Identities=12% Similarity=0.091 Sum_probs=185.4
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+..+.+++||||+++++++.+++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999976 58999999998553 2334678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||++|++|.+++. . + .....+..++.||+.||.|||+. +++||||||+||+++.++.+||++++
T Consensus 109 v~e~~~g~~L~~~l~----~-~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVAD----T-S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHT----T-C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHh----c-C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999982 2 2 35567889999999999999999 99999999999999999999997443
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
|++| ++.++|||||||++|+|++|..||...+...... .......
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~ 219 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTA 219 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTT
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhc
Confidence 3332 6789999999999999999999998654321100 0000000
Q ss_pred cccC--CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 286 PMLC--GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 286 ~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
.... .......+..+.+++.+||+.||++| |+.|+++.|+.......
T Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000 01112335678999999999999999 99999999998665433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=332.62 Aligned_cols=239 Identities=20% Similarity=0.255 Sum_probs=193.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC--CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc----
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ--DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC---- 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 122 (353)
..++|++.+.||+|+||+||+|.+. +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4578999999999999999999975 5899999998644 33445678899999999999999999999987766
Q ss_pred -eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 123 -RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 123 -~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
.|+||||++|++|.+.+. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999988762 2699999999999999999999999 99999999999999886 999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
+...... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------- 282 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------- 282 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-------------------
Confidence 9876432 345689999999988765 488999999999999999999887632110
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhcC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-MSTVIEMING 327 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~ 327 (353)
...........+..+.+++.+||+.||++||+ ++++...|.+
T Consensus 283 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 ----GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00000111123457889999999999999995 5556555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.64 Aligned_cols=234 Identities=18% Similarity=0.255 Sum_probs=181.6
Q ss_pred ccCCCCC-CeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHH-HhcCCCCceeeeeeEec----CCce
Q 042383 51 TNGFCSS-NKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASM-ANICHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 51 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~ 123 (353)
.++|.+. +.||+|+||+||+|... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.+ ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4667776 78999999999999875 688999999863 23456788887 55589999999999886 6778
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeecc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFG 200 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg 200 (353)
++||||+++++|.+++.. .....+++..++.++.||+.||.|||+. +++|+||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999943 2335799999999999999999999999 9999999999999988 7889999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
++.... +..++.++|||||||++|+|++|..||......... ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~ 211 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK 211 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence 986432 234677899999999999999999999754321110 0000
Q ss_pred ccccCcccCCCCC----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 281 QHLVDPMLCGNFS----GNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 281 ~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
..+.... ...+ ...+..+.+++.+||+.||++|||+.|+++ .+++...
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 0000000 1111 223567999999999999999999999987 4555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=309.31 Aligned_cols=241 Identities=16% Similarity=0.152 Sum_probs=180.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---hcHHHHHHHHHHHHhcCC-CCceee---------e---
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---QGEKEFMSEVASMANICH-ENLVKL---------H--- 114 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~iv~~---------~--- 114 (353)
..|...+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+++.+.| +|...+ .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34778889999999999999965 689999999874322 234678899999999976 322111 1
Q ss_pred ---------eeEec-----CCceEEEEEcCCCCChhhhhhhc---cccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 042383 115 ---------GGCIE-----GPCRIIVYDYMQNNSLSQTLLGE---EKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177 (353)
Q Consensus 115 ---------~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~ 177 (353)
.++.. ....+++|+.+ +++|.+++... ......+++..+..++.||+.||.|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11111 22456777766 56999888422 22345678889999999999999999999 999
Q ss_pred EcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCcccc----------ccCCCCccccchhHHHHHH
Q 042383 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA----------VSGHLNPKSDIYSFGVLLL 247 (353)
Q Consensus 178 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DvwslG~il~ 247 (353)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865432 344567 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 248 QIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 248 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
+|++|..||........ ...++... ... +..+.+|+.+||+.||++|||+.+++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975443211 11111111 122 36689999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=303.04 Aligned_cols=242 Identities=18% Similarity=0.167 Sum_probs=183.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccC--------hhcHHHHHHHHHHHHhcC---------CCCceee
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVES--------KQGEKEFMSEVASMANIC---------HENLVKL 113 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~~ 113 (353)
.++|++.+.||+|+||+||+|++ +|+.||+|++.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 58999999998542 223367889999998886 6666555
Q ss_pred eee-----------------Eec-------------CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHH
Q 042383 114 HGG-----------------CIE-------------GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163 (353)
Q Consensus 114 ~~~-----------------~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~ 163 (353)
.++ +.+ .+..++||||+++|++.+.+. ...+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 554 433 678999999999998777762 256899999999999999
Q ss_pred HHHHHH-hcCCCCeEEcCCCCCCeEECCCC--------------------CeEEeeccCCccCCCCCccccccccCCcCc
Q 042383 164 GLAYIH-EEIKPSIVHRDIKPSNILLDQNF--------------------NPKISDFGLSKLFPEDITHISTRVAGTLGY 222 (353)
Q Consensus 164 al~~LH-~~~~~~i~H~dlk~~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y 222 (353)
||.||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999998887 8999999999865432 34789999
Q ss_pred cCccccccCCCCccccchhHHHH-HHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHH
Q 042383 223 LAPDYAVSGHLNPKSDIYSFGVL-LLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFL 301 (353)
Q Consensus 223 ~aPE~~~~~~~~~~~DvwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 301 (353)
+|||++.+.. +.++||||+|++ .+++++|..||...... ........... ..............+..+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQM-------TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTC-------CCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhh-------ccCcccchhhhhhcCHHHH
Confidence 9999998766 889999998777 78888899998421100 00011110000 0001111112345678899
Q ss_pred HHHhhccCCCCCCCCCHHHHH
Q 042383 302 KVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 302 ~li~~cl~~~p~~RPt~~evl 322 (353)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999866 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.7e-34 Score=271.45 Aligned_cols=185 Identities=14% Similarity=0.132 Sum_probs=130.1
Q ss_pred eeeeCceEEEEEEe-CCCcEEEEEEeeccC----------hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEEE
Q 042383 60 VGEGGFGSVYKGKL-QDGTVVAVKVLSVES----------KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 60 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+.|+.|.+..++. -.|+.+++|++.... ....+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 44555555554432 246779999987431 22336689999999999 7999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||++|++|.+.| ...+++++. .++.||+.||.|+|++ ||+||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i----~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDML----AAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHH----HTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHH----HhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999 445677765 4789999999999999 999999999999999999999999999987654
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAV 256 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf 256 (353)
... ......||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 2344679999999998865 4677899999999998887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=235.42 Aligned_cols=184 Identities=16% Similarity=0.154 Sum_probs=144.4
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh--------hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--------QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
...+.||+|+||+||++... +..+++|....... ...+.+.+|+.++++++||||+++..++.+.+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44668999999999999544 67889997653221 1134578999999999999999666666677788999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+||+++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999832 568999999999999999 9999999999999998 99999999999875
Q ss_pred CCCccc------cccccCCcCccCcccccc--CCCCccccchhHHHHHHHHHhCCCCC
Q 042383 207 EDITHI------STRVAGTLGYLAPDYAVS--GHLNPKSDIYSFGVLLLQIVTGQAAV 256 (353)
Q Consensus 207 ~~~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~~ll~g~~pf 256 (353)
...... .....||+.|+|||++.. ..|+..+|+|+..+-..+-..++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 432211 234679999999999987 66888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-26 Score=199.36 Aligned_cols=148 Identities=15% Similarity=0.070 Sum_probs=119.1
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh------------------hcHHHHHHHHHHHHhcCCCCc
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK------------------QGEKEFMSEVASMANICHENL 110 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i 110 (353)
.....|.+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 33455667799999999999999997799999999864321 13456889999999998 4
Q ss_pred eeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC
Q 042383 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ 190 (353)
Q Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~ 190 (353)
+++.+++.. +..++||||++|++|.+ +. . .....++.|++.||.+||+. +++||||||+||+++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR----V------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----C------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc----h------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence 666665544 55699999999999988 41 1 22346999999999999999 999999999999999
Q ss_pred CCCeEEeeccCCccCCCCCccccccccCCcCccCccccc
Q 042383 191 NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229 (353)
Q Consensus 191 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 229 (353)
++.+||+|||++.. +..+.|||.+.
T Consensus 228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999873 34478899764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=169.56 Aligned_cols=136 Identities=14% Similarity=0.145 Sum_probs=105.8
Q ss_pred CCCCCeeeeeCceEEEEEEe-CCCcE--EEEEEeeccChh------------------------cHHHHHHHHHHHHhcC
Q 042383 54 FCSSNKVGEGGFGSVYKGKL-QDGTV--VAVKVLSVESKQ------------------------GEKEFMSEVASMANIC 106 (353)
Q Consensus 54 y~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 106 (353)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999997 67888 999987543111 1135788999999998
Q ss_pred CCCc--eeeeeeEecCCceEEEEEcCCC-C----ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEE
Q 042383 107 HENL--VKLHGGCIEGPCRIIVYDYMQN-N----SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH-EEIKPSIVH 178 (353)
Q Consensus 107 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~~~~i~H 178 (353)
|+++ ..+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.+|| +. +++|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8764 333332 356899999942 4 55554411 234567889999999999999 88 9999
Q ss_pred cCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 179 RDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 179 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=163.32 Aligned_cols=139 Identities=14% Similarity=0.160 Sum_probs=101.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh--------------hcH--------HHHHHHHHHHHhcCCCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--------------QGE--------KEFMSEVASMANICHEN 109 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~h~~ 109 (353)
.-|.+.+.||+|++|.||+|...+|+.||||+++.... ... -....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999998999999998753210 000 11235667777775544
Q ss_pred ceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC
Q 042383 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD 189 (353)
Q Consensus 110 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~ 189 (353)
+.-..-+.. ...++||||++|++|.+... . .....++.||+.+|.+||+. |+|||||||.|||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 321111111 23479999999988876541 1 23356789999999999998 999999999999998
Q ss_pred CCC----------CeEEeeccCCccC
Q 042383 190 QNF----------NPKISDFGLSKLF 205 (353)
Q Consensus 190 ~~~----------~~kl~Dfg~~~~~ 205 (353)
+++ .+.++||+.+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 766 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.3e-14 Score=123.06 Aligned_cols=146 Identities=14% Similarity=0.024 Sum_probs=113.8
Q ss_pred HHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEE
Q 042383 48 KSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 48 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 126 (353)
.....+|.+...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888889999999999999865 6789999987432223345788999999984 67788899999888899999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI---------------------------------- 172 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---------------------------------- 172 (353)
||+++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999877541 11223467889999999999810
Q ss_pred ----------------------CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 173 ----------------------KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 173 ----------------------~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799998765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=5.7e-13 Score=114.89 Aligned_cols=137 Identities=15% Similarity=0.091 Sum_probs=99.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++.+....+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +.+++.+..+++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333456669999998777788999987643 2245678999998885444 55688888888889999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI------------------------------------- 172 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~------------------------------------- 172 (353)
++|.+|. .. . .+ ...++.+++.+|..||+..
T Consensus 97 i~G~~l~--~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 21 0 11 1256777888888888641
Q ss_pred ------------------CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 173 ------------------KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 173 ------------------~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=3.9e-11 Score=108.55 Aligned_cols=144 Identities=17% Similarity=0.166 Sum_probs=107.3
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEee--ccC-hhcHHHHHHHHHHHHhcC--CCCceeeeeeEecC---CceEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLS--VES-KQGEKEFMSEVASMANIC--HENLVKLHGGCIEG---PCRIIV 126 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv 126 (353)
...+.|+.|.++.||++...+ ..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346789999999999998764 568888765 222 122356788999999996 45578888888766 347899
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI---------------------------------- 172 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---------------------------------- 172 (353)
||+++|.++.+.. ...++......++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999998775432 134678888899999999999999731
Q ss_pred ---------------------CCCeEEcCCCCCCeEECCCCC--eEEeeccCCccC
Q 042383 173 ---------------------KPSIVHRDIKPSNILLDQNFN--PKISDFGLSKLF 205 (353)
Q Consensus 173 ---------------------~~~i~H~dlk~~Nil~~~~~~--~kl~Dfg~~~~~ 205 (353)
...++|+|++++||+++.++. +.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999987653 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=3.3e-11 Score=106.41 Aligned_cols=187 Identities=18% Similarity=0.212 Sum_probs=121.6
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCC--ceeeeeeEecCC---ceEEEEEcC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HEN--LVKLHGGCIEGP---CRIIVYDYM 130 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~ 130 (353)
.+.++.|.+..||++. ..+++|+.. .......+.+|+.+++.+. +.. +.+++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999864 348889754 2234567889999998883 333 344444433332 347899999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-------------------------------------- 172 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~-------------------------------------- 172 (353)
+|.+|.+... ..++..+...++.+++..+..||+..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865431 24677778888888888888888621
Q ss_pred -----------------CCCeEEcCCCCCCeEECC--CCCeEEeeccCCccCCCCCccccccccCCcCccCcccccc---
Q 042383 173 -----------------KPSIVHRDIKPSNILLDQ--NFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS--- 230 (353)
Q Consensus 173 -----------------~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--- 230 (353)
...++|+|++|.||+++. +..+.++||+.+...+....- ....... .-..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~-~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDD-EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTT-TSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhc-cccCHHHHHHHHH
Confidence 135799999999999988 556789999988654321100 0000000 0012221110
Q ss_pred --CCC---------CccccchhHHHHHHHHHhCCCCCC
Q 042383 231 --GHL---------NPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 231 --~~~---------~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
+.. ..-.+.|++|.++|.+.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 011 112589999999999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=6.5e-08 Score=83.57 Aligned_cols=134 Identities=13% Similarity=0.072 Sum_probs=97.3
Q ss_pred eeeeeCce-EEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 59 KVGEGGFG-SVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 59 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
.+..|..+ .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68988765 466789997652 33456788999998884 33467788888888999999999999887
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI------------------------------------------- 172 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~------------------------------------------- 172 (353)
.+.... .......+..++...|..||+..
T Consensus 108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 765421 11223356667777777777521
Q ss_pred ------------CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 173 ------------KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 173 ------------~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1147999999999999987777799998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.3e-07 Score=83.31 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=93.9
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCC---CceeeeeeEe-cCCceEEEEEcCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHE---NLVKLHGGCI-EGPCRIIVYDYMQN 132 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 132 (353)
.+.++.|....||+. |..+++|+.. .......+.+|..+++.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888999988 4558888743 333456788999999999642 2455555553 44567899999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE----------------------------------------- 171 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----------------------------------------- 171 (353)
.+|.+... ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88865321 1234455555556666666655542
Q ss_pred ----------------CCCCeEEcCCCCCCeEECC---CCC-eEEeeccCCcc
Q 042383 172 ----------------IKPSIVHRDIKPSNILLDQ---NFN-PKISDFGLSKL 204 (353)
Q Consensus 172 ----------------~~~~i~H~dlk~~Nil~~~---~~~-~kl~Dfg~~~~ 204 (353)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 47999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.8e-07 Score=84.23 Aligned_cols=80 Identities=8% Similarity=-0.006 Sum_probs=54.7
Q ss_pred Cee-eeeCceEEEEEEeC-------CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcC-C--CCceeeeeeEecC---
Q 042383 58 NKV-GEGGFGSVYKGKLQ-------DGTVVAVKVLSVES---KQGEKEFMSEVASMANIC-H--ENLVKLHGGCIEG--- 120 (353)
Q Consensus 58 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--- 120 (353)
+.| +.|..+.+|++... ++..+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998754 25678999765322 001245678888888874 3 3466777776655
Q ss_pred CceEEEEEcCCCCChhh
Q 042383 121 PCRIIVYDYMQNNSLSQ 137 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~ 137 (353)
...++|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=4.4e-06 Score=74.47 Aligned_cols=142 Identities=15% Similarity=0.208 Sum_probs=79.1
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC--CCCceeeee------eEecCCceEEEEEc
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC--HENLVKLHG------GCIEGPCRIIVYDY 129 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~------~~~~~~~~~lv~e~ 129 (353)
+.|+.|..+.||++...+| .+++|+.... ...+..|..+++.+. .-.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987655 4889988742 233344555555553 112333332 12345678899999
Q ss_pred CCCCChh-----------hh---hhhccccCC-C---------CCHHH-------------------------------H
Q 042383 130 MQNNSLS-----------QT---LLGEEKNRA-K---------FSWTA-------------------------------R 154 (353)
Q Consensus 130 ~~~~sL~-----------~~---l~~~~~~~~-~---------l~~~~-------------------------------~ 154 (353)
++|.++. .. ++....... + ..+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 01 111000000 0 11111 1
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 155 REIALGIARGLAYIHE----------EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 155 ~~~~~qi~~al~~LH~----------~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
..+..++..++..|++ .....++|+|+++.||+++.++.+.++||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 0134899999999999998888999999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.1e-06 Score=78.38 Aligned_cols=75 Identities=12% Similarity=0.137 Sum_probs=48.9
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-------hcHHHHHHHHHHHHhcCC--CCc-eeeeeeEecCCceEE
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-------QGEKEFMSEVASMANICH--ENL-VKLHGGCIEGPCRII 125 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~~l 125 (353)
.+.||.|..+.||++... +++.+++|....... .....+..|.++++.+.. +.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899998653211 122456778888888742 433 345433 3455689
Q ss_pred EEEcCCCC
Q 042383 126 VYDYMQNN 133 (353)
Q Consensus 126 v~e~~~~~ 133 (353)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.25 E-value=7.6e-06 Score=71.22 Aligned_cols=79 Identities=16% Similarity=0.244 Sum_probs=57.2
Q ss_pred CCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCC---CceeeeeeEecCCceEEEEEc
Q 042383 53 GFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHE---NLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 53 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~ 129 (353)
...-.+.+|.|..+.||+++..+|+.+++|+-..........+..|+..|+.+... -+.+++.+ + ..++|||+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 34456789999999999999999999999986644433445678899999988422 23444443 2 24789999
Q ss_pred CCCCCh
Q 042383 130 MQNNSL 135 (353)
Q Consensus 130 ~~~~sL 135 (353)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.7e-05 Score=69.70 Aligned_cols=75 Identities=13% Similarity=0.102 Sum_probs=59.3
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC---CCCceeeeeeEecCCceEEEEEcCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC---HENLVKLHGGCIEGPCRIIVYDYMQNN 133 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 133 (353)
.+.|+.|....+|+.... +..+++|+.... ....+..|+..|+.+. ...+.+++.+....+..++|||+++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 457899999999999864 567889986532 3566788999998884 256778888887778899999999988
Q ss_pred Ch
Q 042383 134 SL 135 (353)
Q Consensus 134 sL 135 (353)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.8e-05 Score=70.57 Aligned_cols=78 Identities=14% Similarity=0.094 Sum_probs=46.3
Q ss_pred CCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCC---CCccccchhHHHHHHHHH
Q 042383 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH---LNPKSDIYSFGVLLLQIV 250 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~~ll 250 (353)
..++|+|++|.||+++.++ +.++||+.+...+....-...-..-...|.+|+...... .....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4899999999999998776 999999988754311110000000012455655443111 112344557777788777
Q ss_pred hC
Q 042383 251 TG 252 (353)
Q Consensus 251 ~g 252 (353)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.92 E-value=4e-05 Score=62.55 Aligned_cols=102 Identities=13% Similarity=0.076 Sum_probs=66.8
Q ss_pred ChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcccc
Q 042383 134 SLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS 213 (353)
Q Consensus 134 sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 213 (353)
||.+.|. ..+.+++++++|.++.|.+.+|..+-.. . .-...=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARR-R-QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT-T-CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhc-c-cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 6888883 4578999999999999999999877221 0 111333457899999999988864 1110
Q ss_pred ccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCC
Q 042383 214 TRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAA 255 (353)
Q Consensus 214 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~p 255 (353)
.....+.|||... ...+.+.-|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888653 3456778899999999999875555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=8.9e-05 Score=65.37 Aligned_cols=159 Identities=11% Similarity=0.146 Sum_probs=86.1
Q ss_pred CCHHHHHHhccCCCCC-----CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeee
Q 042383 42 FSYNELKSATNGFCSS-----NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLH 114 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~ 114 (353)
.+.+++......|.+. +.|+.|....+|++...+| .+++|+.... .....+..|+.++..+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4555666666666552 3466788889999987766 5788987642 12234556777777764212 23333
Q ss_pred ee------EecCCceEEEEEcCCCCChhh-----------h---hhhcccc-CCC----CC---HHHHHH----------
Q 042383 115 GG------CIEGPCRIIVYDYMQNNSLSQ-----------T---LLGEEKN-RAK----FS---WTARRE---------- 156 (353)
Q Consensus 115 ~~------~~~~~~~~lv~e~~~~~sL~~-----------~---l~~~~~~-~~~----l~---~~~~~~---------- 156 (353)
.. ....+..++++++++|..+.. . ++..... ..+ .. +.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122355789999999865421 0 1100000 000 11 111000
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 157 --IALGIARGLAYIHEE----IKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 157 --~~~qi~~al~~LH~~----~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
+...+...+..+... ...+++|+|+.++||++++++.+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133444555431 13489999999999999887656899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.79 E-value=9.1e-05 Score=64.76 Aligned_cols=72 Identities=8% Similarity=0.111 Sum_probs=44.9
Q ss_pred CCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEcC-CCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDYM-QNNS 134 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~s 134 (353)
.+.|+.|....+|++ ..+++|+........ ....+|+.+++.+...++ .+++.. +.+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999999 348889876432111 123467777777743233 455543 333457899999 6655
Q ss_pred hh
Q 042383 135 LS 136 (353)
Q Consensus 135 L~ 136 (353)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00012 Score=66.00 Aligned_cols=143 Identities=19% Similarity=0.194 Sum_probs=84.4
Q ss_pred CCeeeeeCceEEEEEEeC--------CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQ--------DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+.|..|-...+|++... ++..+++|+... .........+|..+++.+. +.-..++++.+.++ +||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEE
Confidence 456777888999999864 246899998542 2223456678999998884 33345666665542 899
Q ss_pred EcCCCCChhhhh-----------------hhcc-ccCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 042383 128 DYMQNNSLSQTL-----------------LGEE-KNRAKFS--WTARREIALGIAR-------------------GLAYI 168 (353)
Q Consensus 128 e~~~~~sL~~~l-----------------~~~~-~~~~~l~--~~~~~~~~~qi~~-------------------al~~L 168 (353)
||++|.+|...- +... ....... +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999987654211 0000 0011122 3455555544422 12333
Q ss_pred Hh----c-CCCCeEEcCCCCCCeEECCC----CCeEEeeccCCcc
Q 042383 169 HE----E-IKPSIVHRDIKPSNILLDQN----FNPKISDFGLSKL 204 (353)
Q Consensus 169 H~----~-~~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~~ 204 (353)
.+ . ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 1 23478999999999999876 7899999988753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00046 Score=60.88 Aligned_cols=143 Identities=11% Similarity=0.108 Sum_probs=80.9
Q ss_pred CeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC--ceeeeee-----EecCCceEEEEEcC
Q 042383 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN--LVKLHGG-----CIEGPCRIIVYDYM 130 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e~~ 130 (353)
..++ |....||++...+|+.+++|..... ......+..|..++..+.... +.+++.. ...++..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3566 8888999988777777999987632 123456667888887774222 3444432 22244567899999
Q ss_pred CCCChhh-----------h---hhhcccc-----CCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 042383 131 QNNSLSQ-----------T---LLGEEKN-----RAKFSWTAR----------------------REIALGIARGLAYIH 169 (353)
Q Consensus 131 ~~~sL~~-----------~---l~~~~~~-----~~~l~~~~~----------------------~~~~~qi~~al~~LH 169 (353)
+|.++.. . ++..... ....+.... ...+..++..+..+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865421 0 0000000 011111110 111122222222221
Q ss_pred h-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 170 E-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 170 ~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234789999999999998 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=67.89 Aligned_cols=73 Identities=16% Similarity=0.218 Sum_probs=49.8
Q ss_pred CCeeeeeCceEEEEEEeCC--------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 127 (353)
.+.|+.|....+|++...+ +..+++|+.... .....+..|+.+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888899999998653 478999987432 122445579888888853333 566665543 2899
Q ss_pred EcCCCCCh
Q 042383 128 DYMQNNSL 135 (353)
Q Consensus 128 e~~~~~sL 135 (353)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00025 Score=62.90 Aligned_cols=143 Identities=13% Similarity=0.056 Sum_probs=72.3
Q ss_pred CeeeeeCceE-EEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-C-CCceeeeeeEecCCceEEEEEcCCCCC
Q 042383 58 NKVGEGGFGS-VYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-H-ENLVKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 58 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~iv~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+. + -.+.+++.+..+. -+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665554 6677654466778886543221 23345667776663 2 2244555543333 378999998766
Q ss_pred hhhhhhhccc----------------------cCCCCCHHHHH-------HHH-------------HHHHHHHHHHH---
Q 042383 135 LSQTLLGEEK----------------------NRAKFSWTARR-------EIA-------------LGIARGLAYIH--- 169 (353)
Q Consensus 135 L~~~l~~~~~----------------------~~~~l~~~~~~-------~~~-------------~qi~~al~~LH--- 169 (353)
+.+.+..... ....++..... .+. ..+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6544321100 00112221110 000 01111222221
Q ss_pred hcCCCCeEEcCCCCCCeEECCC----CCeEEeeccCCccC
Q 042383 170 EEIKPSIVHRDIKPSNILLDQN----FNPKISDFGLSKLF 205 (353)
Q Consensus 170 ~~~~~~i~H~dlk~~Nil~~~~----~~~kl~Dfg~~~~~ 205 (353)
......++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123489999999999999874 67899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00031 Score=65.06 Aligned_cols=74 Identities=11% Similarity=0.017 Sum_probs=47.9
Q ss_pred CCeeeeeCceEEEEEEeCC-CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc-eeeeeeEecCCceEEEEEcCCCCC
Q 042383 57 SNKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENL-VKLHGGCIEGPCRIIVYDYMQNNS 134 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~s 134 (353)
.+.|+.|-...+|++...+ +..+++|+........ -...+|+.+++.+...++ .++++.+.. .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3567888889999998764 4778999865322111 112578899988865444 566666632 25999998865
Q ss_pred h
Q 042383 135 L 135 (353)
Q Consensus 135 L 135 (353)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00028 Score=63.48 Aligned_cols=74 Identities=11% Similarity=0.137 Sum_probs=44.3
Q ss_pred CCeeeeeCceEEEEEEeCC---------CcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC-ceeeeeeEecCCceEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQD---------GTVVAVKVLSVESKQGEKEFMSEVASMANICHEN-LVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 126 (353)
.+.|+.|....+|++...+ +..+++|+....... ......|..+++.+...+ ..++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567788889999998653 267899986533221 112357888888774333 34566544 2 3689
Q ss_pred EEcCCCCCh
Q 042383 127 YDYMQNNSL 135 (353)
Q Consensus 127 ~e~~~~~sL 135 (353)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0016 Score=57.77 Aligned_cols=31 Identities=26% Similarity=0.345 Sum_probs=27.6
Q ss_pred CCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.01 Score=54.21 Aligned_cols=142 Identities=8% Similarity=0.108 Sum_probs=84.1
Q ss_pred CCeeeeeCceEEEEEEeCC--------CcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 127 (353)
.+.+..|-...+|++...+ +..+++|+...... ..-...+|..+++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778889999998653 57799998653321 1112357888888874 333445555332 26899
Q ss_pred EcCCCCChhhh-h----------------hhccc---------cCCCCCHHHHHHHHHHHH-------------------
Q 042383 128 DYMQNNSLSQT-L----------------LGEEK---------NRAKFSWTARREIALGIA------------------- 162 (353)
Q Consensus 128 e~~~~~sL~~~-l----------------~~~~~---------~~~~l~~~~~~~~~~qi~------------------- 162 (353)
+|++|.+|... + +.... ...+.-+..+..+..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765311 0 00000 111212444444443322
Q ss_pred HHHHHHHh---------------------cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 163 RGLAYIHE---------------------EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 163 ~al~~LH~---------------------~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
..+..|.+ .....++|+|+.++||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 12222221 11347899999999999 7788999999988763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.033 Score=50.54 Aligned_cols=30 Identities=30% Similarity=0.432 Sum_probs=25.2
Q ss_pred CeEEcCCCCCCeEE------CCCCCeEEeeccCCcc
Q 042383 175 SIVHRDIKPSNILL------DQNFNPKISDFGLSKL 204 (353)
Q Consensus 175 ~i~H~dlk~~Nil~------~~~~~~kl~Dfg~~~~ 204 (353)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999988763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.12 E-value=0.26 Score=40.05 Aligned_cols=116 Identities=12% Similarity=0.095 Sum_probs=78.5
Q ss_pred CCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCC
Q 042383 106 CHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSN 185 (353)
Q Consensus 106 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~N 185 (353)
.||++++. .+-.+.+.+.+.++.-+.+ ..+- .-...+....++++.+|+....++++ =+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 68888877 4566666666666654422 2221 12357889999999999998866663 4788899999
Q ss_pred eEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 042383 186 ILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 186 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
++++.++.+++.-.|+-.. ++|. ..+...=.-.+=|++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987665332 2222 11112223467788888999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.83 E-value=0.4 Score=39.12 Aligned_cols=115 Identities=11% Similarity=0.119 Sum_probs=77.2
Q ss_pred CCCCceeeeeeEecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEcCCCCC
Q 042383 106 CHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA-YIHEEIKPSIVHRDIKPS 184 (353)
Q Consensus 106 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~-~LH~~~~~~i~H~dlk~~ 184 (353)
.||++ -..+-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 57888 333446677777777765443222333 35788999999999988777 665 4578889999
Q ss_pred CeEECCCCCeEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 042383 185 NILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVH 257 (353)
Q Consensus 185 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~ 257 (353)
|++++.++.+++.-.|+-.. ++|..+ +...=+-++=|++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987765332 333321 111113366778888888877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 353 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-68
Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
++G G FG+VYKGK VAVK+L+V + Q + F +EV + H N++ G
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
P IV + + +SL L KF +IA A+G+ Y+H S
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLH---AKS 124
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPE-DITHISTRVAGTLGYLAPDYAV---SG 231
I+HRD+K +NI L ++ KI DFGL+ + +H +++G++ ++AP+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGN 291
+ +SD+Y+FG++L +++TGQ + + + + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------RGYLSPDL-SK 233
Query: 292 FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
N ++ C+++K RP ++ I
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-67
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 22/268 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V+ G T VAVK L + F++E M + H+ LV+L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ P I+ +YM+N SL L + + K + ++A IA G+A+I E + +
Sbjct: 78 TQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD++ +NIL+ + KI+DFGL++L ++ + + AP+ G KS
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEA 297
D++SFG+LL +IVT + E + N ++ +V P C
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRPDNCPE------ 237
Query: 298 VRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
++ LC +E+ RP + ++
Sbjct: 238 -ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-67
Identities = 64/268 (23%), Positives = 120/268 (44%), Gaps = 22/268 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V+ G + VA+K + E E++F+ E M + H LV+L+G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+E +V+++M++ LS R F+ + L + G+AY+ E ++
Sbjct: 70 LEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD+ N L+ +N K+SDFG+++ +D ST + + +P+ + KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEA 297
D++SFGVL+ ++ + + ++ E + L P L
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVV--------EDISTGFRLYKPRLAST------ 229
Query: 298 VRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
++ C +E+ RP S ++ +
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (523), Expect = 8e-65
Identities = 64/306 (20%), Positives = 130/306 (42%), Gaps = 39/306 (12%)
Query: 39 INAFSYNELKSATNGFCSS---------NKVGEGGFGSVYKGKL----QDGTVVAVKVLS 85
I+ F++ + A F +G G FG V G L + VA+K L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 86 VE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEK 144
+++ ++F+SE + M H N++ L G + +I+ ++M+N SL +
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQ 120
Query: 145 NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204
N +F+ + GIA G+ Y+ + VHRD+ NIL++ N K+SDFGLS+
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 205 FPEDITHISTRVA----GTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDK 260
+D + + A + + AP+ SD++S+G+++ ++++
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG------- 230
Query: 261 ELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMST 320
E+ + + + ++ + ++ L C Q+ + RP+
Sbjct: 231 --------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 321 VIEMIN 326
++ ++
Sbjct: 283 IVNTLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 1e-64
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 25/283 (8%)
Query: 58 NKVGEGGFGSVYKGKLQD-GTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
+K+G G +G VY+G + VAVK L ++ + E EF+ E A M I H NLV+L G
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 81
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
C P I+ ++M +L L E NR + S +A I+ + Y+ K +
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRD+ N L+ +N K++DFGLS+L D + + AP+ + K
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 237 SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNE 296
SD+++FGVLL +I T + + ++ L++
Sbjct: 197 SDVWAFGVLLWEIATYG---------------MSPYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 297 AVRFLKVGLLCVQEKSSLRPRMSTVIEMING---DVDIDDDVE 336
+ ++ C Q S RP + + + + I D+VE
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-64
Identities = 66/268 (24%), Positives = 112/268 (41%), Gaps = 22/268 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V GK + VA+K++ E E EF+ E M N+ HE LV+L+G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ I+ +YM N L L + R +F E+ + + Y+ +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD+ N L++ K+SDFGLS+ +D S + + P+ + + KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEA 297
DI++FGVL+ +I + + +E + + L +
Sbjct: 183 DIWAFGVLMWEIYSLG---------------KMPYERFTNSETAEHIAQGLRLYRPHLAS 227
Query: 298 VRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ + C EK+ RP ++ I
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-63
Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 22/268 (8%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G+G FG V+ G T VA+K L + F+ E M + HE LV+L+
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
E P IV +YM SL + + ++A IA G+AY+ + + V
Sbjct: 82 SEEPI-YIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 135
Query: 178 HRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKS 237
HRD++ +NIL+ +N K++DFGL++L ++ + + AP+ A+ G KS
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195
Query: 238 DIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEA 297
D++SFG+LL ++ T + ++ V+
Sbjct: 196 DVWSFGILLTELTTKG---------------RVPYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 298 VRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ C +++ RP + +
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-63
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 13/210 (6%)
Query: 46 ELKSATNGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-EKEFMSEVASMA 103
ELK + F +++G G G V+K G V+A K++ +E K + + E+ +
Sbjct: 2 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 104 NICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIAR 163
+V +G I ++M SL Q L K + ++++ + +
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIK 115
Query: 164 GLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYL 223
GL Y+ E K I+HRD+KPSNIL++ K+ DFG+S + + GT Y+
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYM 170
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQ 253
+P+ H + +SDI+S G+ L+++ G+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-63
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 30/291 (10%)
Query: 59 KVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCI 118
+G+G FG V++GK G VAVK+ S ++ +E+ + HEN++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 119 EG----PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI-- 172
+ +V DY ++ SL L NR + ++AL A GLA++H EI
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 173 ---KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED---ITHISTRVAGTLGYLAPD 226
KP+I HRD+K NIL+ +N I+D GL+ I GT Y+AP+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 227 Y------AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY----LVEKAWEMHN 276
++DIY+ G++ +I + ++ Y + + E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 277 TDKLQHLVDPMLCGNFSGNEAVRFL-KVGLLCVQEKSSLRPRMSTVIEMIN 326
+ + P + + EA+R + K+ C + R + + ++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 63/291 (21%), Positives = 133/291 (45%), Gaps = 29/291 (9%)
Query: 54 FCSSNKVGEGGFGSVYKGKLQDGT-----VVAVKVLSVESKQGEK-EFMSEVASMANICH 107
+G G FG VYKG L+ + VA+K L + ++ +F+ E M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
N+++L G + +I+ +YM+N +L + + +FS + GIA G+ Y
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI--THISTRVAGTLGYLAP 225
+ + VHRD+ NIL++ N K+SDFGLS++ +D T+ ++ + + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285
+ SD++SFG+++ +++T E+ + + ++ ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYG---------------ERPYWELSNHEVMKAIN 227
Query: 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVE 336
+ ++ + C Q++ + RP+ + ++ +++ + D ++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 7e-59
Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENL 110
+GEG FG V++ + + T+VAVK+L E S + +F E A MA + N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKN--------------------RAKFS 150
VKL G C G ++++YM L++ L + S
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 151 WTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK-LFPEDI 209
+ IA +A G+AY+ E VHRD+ N L+ +N KI+DFGLS+ ++ D
Sbjct: 139 CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195
Query: 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVE 269
A + ++ P+ +SD++++GV+L +I + ++
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG---------- 245
Query: 270 KAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
M + + + ++ D + N + + LC + + RP ++ ++
Sbjct: 246 ----MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-58
Identities = 59/274 (21%), Positives = 116/274 (42%), Gaps = 28/274 (10%)
Query: 59 KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKLH 114
++G G FGSV +G + VA+KVL +++ + +E M E M + + +V+L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
G + ++V + L + L+G+ + + + E+ ++ G+ Y+ +
Sbjct: 76 G-VCQAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLE---EK 128
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAPDYAVSGH 232
+ VHRD+ N+LL KISDFGLSK D ++ + R L + AP+
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292
+ +SD++S+GV + + ++ +K ++ ++ ++
Sbjct: 189 FSSRSDVWSYGVTMWEALSYG---------------QKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ C K RP TV + +
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-58
Identities = 58/274 (21%), Positives = 106/274 (38%), Gaps = 31/274 (11%)
Query: 58 NKVGEGGFGSVYKGKL-QDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLH 114
++G G F +VYKG + VA L +K + F E + + H N+V+ +
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 115 GGCIE----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
C ++V + M + +L L K R I +GL ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 171 EIKPSIVHRDIKPSNILL-DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
P I+HRD+K NI + + KI D GL+ L V GT ++AP+
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM-Y 185
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289
+ D+Y+FG+ +L++ T + + + Y ++ V P
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-----------RRVTSGVKPASF 234
Query: 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
+ E ++ C+++ R + ++
Sbjct: 235 DKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 56/295 (18%), Positives = 111/295 (37%), Gaps = 40/295 (13%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEKE-FMSEVASMANIC-HEN 109
+G G FG V + VAVK+L + E+E MSE+ ++ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE--------------EKNRAKFSWTARR 155
+V L G C G +++ +Y L L + E +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 156 EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH-IST 214
+ +A+G+A++ + + +HRD+ NILL KI DFGL++ D + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274
+ ++AP+ + +SD++S+G+ L ++ + ++ + M
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--------------PGM 251
Query: 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329
K ++ + + C RP ++++I +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-57
Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 24/273 (8%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLH 114
+G G +G K + DG ++ K L S + ++ +SEV + + H N+V+ +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 115 GGCIEGPCRI--IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-- 170
I+ IV +Y + L+ + K R + + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+ +++HRD+KP+N+ LD N K+ DFGL+++ D T + GT Y++P+
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290
N KSDI+S G LL ++ + K++ +
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALM------------PPFTAFSQKELAGKIREGKFRRIPY 236
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
+S +E + + K RP + ++E
Sbjct: 237 RYS-DELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-57
Identities = 48/219 (21%), Positives = 102/219 (46%), Gaps = 13/219 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
++G+G FG VYK + + + A KV+ +S++ +++M E+ +A+ H N+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
I+ ++ ++ + + + + + + L Y+H+ I
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-----G 231
+HRD+K NIL + + K++DFG+S I + + GT ++AP+ +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 232 HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
+ K+D++S G+ L+++ + H + + K
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-57
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 30/279 (10%)
Query: 57 SNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLV 111
+ +G G FG VY G L D AVK L+ + GE +F++E M + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 112 KLHGGCIEGP-CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
L G C+ ++V YM++ L + L +A+G+ ++
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLA- 147
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE---DITHISTRVAGTLGYLAPDY 227
VHRD+ N +LD+ F K++DFGL++ + D H T + ++A +
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287
+ KSD++SFGVLL +++T A + D + + + + ++ DP+
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGRRLLQPEYCPDPL 263
Query: 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+V L C K+ +RP S ++ I+
Sbjct: 264 -------------YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 63/269 (23%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G+G FG V G G VAVK + + + F++E + M + H NLV+L G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 118 IEGPCRI-IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+E + IV +YM SL L + R+ + +L + + Y+ +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
VHRD+ N+L+ ++ K+SDFGL+K + + AP+ + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTK 180
Query: 237 SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNE 296
SD++SFG+LL +I + + L + +V + + + D
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDAPDGCPP----------- 227
Query: 297 AVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+V C +++RP + E +
Sbjct: 228 --AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-57
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 30/276 (10%)
Query: 58 NKVGEGGFGSVYKGKLQD---GTVVAVKVLSVESKQGE--KEFMSEVASMANICHENLVK 112
++G G FG+V KG Q VAVK+L E+ E ++E M + + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ G E ++V + + L++ L + E+ ++ G+ Y+
Sbjct: 73 MIG-ICEAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR--VAGTLGYLAPDYAVS 230
+ + VHRD+ N+LL KISDFGLSK D + + + + AP+
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290
+ KSD++SFGVL+ + + +K + ++ +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERM 229
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ LC RP + V +
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 4e-57
Identities = 57/277 (20%), Positives = 118/277 (42%), Gaps = 34/277 (12%)
Query: 54 FCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHEN 109
F ++G G FG+VY + +++ VVA+K +S KQ ++ + EV + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
++ G + +V +Y ++ ++ + G +GLAY+H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
+++HRD+K NILL + K+ DFG + + + GT ++AP+ +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184
Query: 230 S---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286
+ G + K D++S G+ +++ + + + Y + Q+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----------AQNESPA 233
Query: 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
+ G++S F+ C+Q+ RP +++
Sbjct: 234 LQSGHWS-EYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-56
Identities = 60/275 (21%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG 116
K+G+G G+VY + G VA++ ++++ + ++ ++E+ M + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
+ G +V +Y+ SL+ + + + L ++H +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 177 VHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPK 236
+HRDIK NILL + + K++DFG + + ST V GT ++AP+ PK
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 237 SDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM------HNTDKLQHLVDPMLCG 290
DI+S G++ ++++ G+ + L YL+ + + ++ L
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 291 N----FSGNEAVR--FLKVGLLCVQEKSSLRPRMS 319
+ S E ++ FLK+ + SSL P ++
Sbjct: 257 DVEKRGSAKELLQHQFLKIA----KPLSSLTPLIA 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-56
Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 58 NKVGEGGFGSVYKGKL-QDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+G+G FG+VY + Q ++A+KVL +E E + EV +++ H N+++L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+G + ++ +Y ++ + L + +KF +A L+Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK-- 125
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
++HRDIKP N+LL KI+DFG S P + GTL YL P+
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMH 181
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---WEMHNTDKLQHLVDPMLCG 290
+ K D++S GVL + + G+ + Y + + + T+ + L+ +L
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 291 N 291
N
Sbjct: 242 N 242
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-55
Identities = 62/296 (20%), Positives = 107/296 (36%), Gaps = 45/296 (15%)
Query: 59 KVGEGGFGSVYKGKLQD------GTVVAVKVLSVESKQGEKE-FMSEVASMANIC-HENL 110
+G G FG V VAVK+L ++ E+E MSE+ M + HEN+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTL-------------------LGEEKNRAKFSW 151
V L G C ++++Y L L L EE++ ++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 152 TARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211
A +A+G+ ++ S VHRD+ N+L+ KI DFGL++ D +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 212 -ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
+ + ++AP+ G KSD++S+G+LL +I + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------------- 267
Query: 271 AWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ L+ + + C S RP + +
Sbjct: 268 -PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-55
Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 52 NGFCSSNKVGEGGFGSVYKGKLQDG---TVVAVKVLS-VESKQGEKEFMSEVASMANIC- 106
N + +GEG FG V K +++ A+K + SK ++F E+ + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGE------------EKNRAKFSWTAR 154
H N++ L G C + +Y + +L L + S
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 155 REIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIST 214
A +ARG+ Y+ + +HRD+ NIL+ +N+ KI+DFGLS+ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 215 RVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274
+ ++A + SD++S+GVLL +IV+ + E L EK +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQG 242
Query: 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ +K + D + + C +EK RP + ++ +N
Sbjct: 243 YRLEKPLNCDDEV-------------YDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-55
Identities = 60/277 (21%), Positives = 107/277 (38%), Gaps = 30/277 (10%)
Query: 58 NKVGEGGFGSVYKGKL----QDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENL 110
K+G+G FG V +G+ VAVK L + + +F+ EV +M ++ H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
++L+G + P ++ V + SL K++ F A+ +A G+ Y+
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH--ISTRVAGTLGYLAPDYA 228
+HRD+ N+LL KI DFGL + P++ H + + AP+
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288
+ + SD + FGV L ++ T ++ + L +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------------LNGSQILHKIDKEGE 232
Query: 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMI 325
+ V + C K RP + + +
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-54
Identities = 53/276 (19%), Positives = 113/276 (40%), Gaps = 29/276 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVL-----SVESKQGEKEFMSEVASMANICHENLV 111
+G G FG+VYKG + +G V + V S + KE + E MA++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
+L G C+ ++I L +++ + IA+G+ Y+
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE-- 128
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF-PEDITHISTRVAGTLGYLAPDYAVS 230
+VHRD+ N+L+ + KI+DFGL+KL E+ + + + ++A + +
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290
+SD++S+GV + +++T K ++ ++ +++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISSILEKGERL 232
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ + + C + RP+ +I +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-54
Identities = 58/242 (23%), Positives = 103/242 (42%), Gaps = 17/242 (7%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHG 115
+GEG +G V VAVK++ ++ + + E+ + HEN+VK +G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
EG + + +Y L + + + + G+ Y+H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLF-PEDITHISTRVAGTLGYLAPDYAVSGHLN 234
I HRDIKP N+LLD+ N KISDFGL+ +F + + ++ GTL Y+AP+ +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 235 -PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN------TDKLQHLVDPM 287
D++S G++L ++ G+ + + Y K + + L+ +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 288 LC 289
L
Sbjct: 244 LV 245
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-53
Identities = 54/273 (19%), Positives = 102/273 (37%), Gaps = 27/273 (9%)
Query: 59 KVGEGGFGSVYKGKL----QDGTVVAVKVLSVESKQGEKE-FMSEVASMANICHENLVKL 113
+GEG FG V++G VA+K + +E F+ E +M H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G E I+ + L + + + A ++ LAY+
Sbjct: 74 IGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
VHRDI N+L+ N K+ DFGLS+ + + +++ + ++AP+
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFS 293
SD++ FGV + +I+ + + ++++ + N
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------GRIENGERLPMPPNCP 235
Query: 294 GNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ C S RPR + + ++
Sbjct: 236 -PTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-51
Identities = 64/287 (22%), Positives = 126/287 (43%), Gaps = 32/287 (11%)
Query: 58 NKVGEGGFGSVYKGKL------QDGTVVAVKVLSVESKQGEK-EFMSEVASMANICHENL 110
++G+G FG VY+G + T VA+K ++ + E+ EF++E + M ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 111 VKLHGGCIEGPCRIIVYDYMQNNSLSQTL------LGEEKNRAKFSWTARREIALGIARG 164
V+L G +G +++ + M L L + A S + ++A IA G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE-DITHISTRVAGTLGYL 223
+AY++ VHRD+ N ++ ++F KI DFG+++ E D + + ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 224 APDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283
+P+ G SD++SFGV+L +I T E+ ++ + +++
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGLSNEQVLRF 247
Query: 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330
V + N ++ +C Q +RP +I I +++
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 1e-50
Identities = 51/242 (21%), Positives = 103/242 (42%), Gaps = 20/242 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V++ G A K + + ++ E+ +M+ + H LV LH
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ +++Y++M L + + K S E + +GL ++HE + V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 178 HRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
H D+KP NI+ + K+ DFGL+ + T GT + AP+ A +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 236 KSDIYSFGVLLLQIVTGQ--------AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287
+D++S GVL +++G + + ++ + + A+ ++ + + +
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS-GISEDGKDFIRKL 263
Query: 288 LC 289
L
Sbjct: 264 LL 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-49
Identities = 62/292 (21%), Positives = 113/292 (38%), Gaps = 41/292 (14%)
Query: 58 NKVGEGGFGSVYKGKL--------QDGTVVAVKVLSVE-SKQGEKEFMSEVASMANIC-H 107
+GEG FG V + T VAVK+L + +++ + +SE+ M I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTL------------LGEEKNRAKFSWTARR 155
+N++ L G C + ++ +Y +L + L + S
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 156 EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTR 215
A +ARG+ Y+ +HRD+ N+L+ ++ KI+DFGL++ + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 216 V-AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM 274
+ ++AP+ +SD++SFGVLL +I T +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG---------------GSPYPG 240
Query: 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
++L L+ + N + C S RP ++E ++
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-49
Identities = 65/291 (22%), Positives = 120/291 (41%), Gaps = 39/291 (13%)
Query: 58 NKVGEGGFGSVYKG------KLQDGTVVAVKVLSVESKQGE-KEFMSEVASMANICHE-N 109
+G G FG V + K VAVK+L + E + MSE+ + +I H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 110 LVKLHGGCIE-GPCRIIVYDYMQNNSLSQTL------------LGEEKNRAKFSWTARRE 156
+V L G C + G +++ ++ + +LS L E+ + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI-STR 215
+ +A+G+ ++ +HRD+ NILL + KI DFGL++ +D ++
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 216 VAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275
L ++AP+ +SD++SFGVLL +I + A+ + ++ E + + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRLKEG 253
Query: 276 NTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
+ P + L C + S RP S ++E +
Sbjct: 254 TRMRAPDYTTP------------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-49
Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 15/240 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+GEG F +V + L A+K+L + + E M+ + H VKL
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ + Y +N L + + + F T R I L Y+H
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHG--- 126
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLF-PEDITHISTRVAGTLGYLAPDYAVSGH 232
I+HRD+KP NILL+++ + +I+DFG +K+ PE + GT Y++P+
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---WEMHNTDKLQHLVDPMLC 289
SD+++ G ++ Q+V G E + + K + K + LV+ +L
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 2e-48
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 11/215 (5%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
++G G FG V++ G V K ++ + +E++ M + H L+ LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+ +++ +++ L + K S GL ++HE SIV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 178 HRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
H DIKP NI+ + KI DFGL+ D I T + AP+ +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGF 207
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
+D+++ GVL +++G + + +L V++
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 9e-47
Identities = 58/279 (20%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G G FG +Y G + G VA+K+ V++K + E + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 118 I-EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
EG ++V + + + KFS +A + + YIH + +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 177 VHRDIKPSNIL---LDQNFNPKISDFGLSKLFPEDITHI------STRVAGTLGYLAPDY 227
+HRD+KP N L + I DFGL+K + + TH + + GT Y + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287
+ + + D+ S G +L+ G K + E+ E + + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----EV 239
Query: 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
LC + +E +L C + +P S + ++
Sbjct: 240 LCKGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (406), Expect = 9e-47
Identities = 66/252 (26%), Positives = 111/252 (44%), Gaps = 24/252 (9%)
Query: 52 NGFCSSNKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEV---ASMAN 104
N F +G GGFG VY + G + A+K L ++ KQGE ++E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 105 ICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARG 164
+V + + D M L L FS R A I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILG 119
Query: 165 LAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLA 224
L ++H +V+RD+KP+NILLD++ + +ISD GL+ F + H S GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 225 PDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN------T 277
P+ G + +D +S G +L +++ G + K ++ + M +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 278 DKLQHLVDPMLC 289
+L+ L++ +L
Sbjct: 234 PELRSLLEGLLQ 245
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-45
Identities = 40/242 (16%), Positives = 92/242 (38%), Gaps = 21/242 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
+G G FG V++ K + V+ + E++ + H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIV 177
+++++++ + + + + + + + L ++H +I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 178 HRDIKPSNILLDQNFNP--KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
H DI+P NI+ + KI +FG ++ + Y AP+ ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKEL--------GEYYLVEKAWEMHNTDKLQHLVDPM 287
+D++S G L+ +++G + EY E+A++ + + VD +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK-EISIEAMDFVDRL 241
Query: 288 LC 289
L
Sbjct: 242 LV 243
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 6e-45
Identities = 61/286 (21%), Positives = 120/286 (41%), Gaps = 29/286 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG-EKEFMSEVASMANICHENLVKLHG 115
+ +G G F V + + +VA+K ++ ++ +G E +E+A + I H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
G ++ + L + + ++ + + + Y+H+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLG--- 127
Query: 176 IVHRDIKPSNILL---DQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
IVHRD+KP N+L D++ ISDFGLSK+ ED + + GT GY+AP+
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 233 LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNF 292
+ D +S GV+ ++ G + + + + + KA ++ + D
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD------- 238
Query: 293 SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVDIDDDVE 336
A F++ +++ R ++ I GD +D ++
Sbjct: 239 ---SAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (387), Expect = 6e-45
Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 35/257 (13%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSV---------ESKQGEKEFMSEVASMANI-C 106
+G G V + AVK++ V E ++ + + EV + +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 107 HENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
H N+++L +V+D M+ L L + S R+I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVIC 124
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPD 226
+H+ +IVHRD+KP NILLD + N K++DFG S V GT YLAP+
Sbjct: 125 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPE 179
Query: 227 YAVSGHL------NPKSDIYSFGVLLLQIVTGQAAVHFDKEL--------GEYYLVEKAW 272
+ D++S GV++ ++ G K++ G Y W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 273 EMHNTDKLQHLVDPMLC 289
+ +D ++ LV L
Sbjct: 240 D-DYSDTVKDLVSRFLV 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 8e-45
Identities = 55/239 (23%), Positives = 107/239 (44%), Gaps = 18/239 (7%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+G G FG V+ + +G A+KVL V + + E ++ + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
G + ++ DY++ L + +F + A + L Y+H
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFS----LLRKSQRFPNPVAKFYAAEVCLALEYLHS--- 122
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
I++RD+KP NILLD+N + KI+DFG +K P+ + GT Y+AP+ +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPY 178
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---WEMHNTDKLQHLVDPMLC 289
N D +SFG+L+ +++ G + + Y + A + + ++ L+ ++
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 3e-44
Identities = 47/230 (20%), Positives = 97/230 (42%), Gaps = 9/230 (3%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHG 115
K+GEG +G VYK + G A+K + +E + + E++ + + H N+VKL+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
++V++++ + + L + G+AY H+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
++HRD+KP N+L+++ KI+DFGL++ F + + + S +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285
DI+S G + ++V G E + + + N+ ++ +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (382), Expect = 3e-44
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE---KEFMSEVASMANICHENLVKLH 114
+G GG V+ + L+ VAVKVL + + F E + A + H +V ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 115 GGCIE----GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE 170
GP IV +Y+ +L + + E+ + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 171 EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHI--STRVAGTLGYLAPDYA 228
I+HRD+KP+NI++ K+ DFG+++ + + + V GT YL+P+ A
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 229 VSGHLNPKSDIYSFGVLLLQIVTGQ 253
++ +SD+YS G +L +++TG+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-44
Identities = 52/220 (23%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE-----FMSEVASMANICHENLV 111
+ +GEG F +VYK + +VA+K + + + K+ + E+ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
L +V+D+M+ + + N + + + L +GL Y+H+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 172 IKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSG 231
I+HRD+KP+N+LLD+N K++DFGL+K F + +V T Y AP+
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 232 HL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
+ D+++ G +L +++ + D +L + + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-44
Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 9/216 (4%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLH 114
K+GEG +G VYK + G VVA+K + E++ + E++ + + H N+VKL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+V++++ + + + + +GLA+ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 122
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
++HRD+KP N+L++ K++DFGL++ F + + V + +
Sbjct: 123 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
DI+S G + ++VT +A D E+ + + + +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-43
Identities = 54/237 (22%), Positives = 100/237 (42%), Gaps = 9/237 (3%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE-KEFMSEVASMANICHENLVKLHG 115
+ +GEG +G V + VA+K +S Q + + E+ + HEN++ ++
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
+ Y+ + + L K + S I RGL YIH +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHIS--TRVAGTLGYLAPDYAVSGHL 233
++HRD+KPSN+LL+ + KI DFGL+++ D H T T Y AP+ ++
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 234 -NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289
DI+S G +L ++++ + L + + + + L +++
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-43
Identities = 51/235 (21%), Positives = 100/235 (42%), Gaps = 21/235 (8%)
Query: 53 GFCSSN-------KVGEGGFGSVYKGK--LQDGTVVAVKVLSVESKQG--EKEFMSEVAS 101
G C ++ ++GEG +G V+K + G VA+K + V++ + + EVA
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60
Query: 102 M---ANICHENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLG--EEKNRAKFSWTARRE 156
+ H N+V+L C + + Q L ++ ++
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 157 IALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRV 216
+ + RGL ++H +VHRD+KP NIL+ + K++DFGL++++ + T V
Sbjct: 121 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 217 AGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA 271
TL Y AP+ + D++S G + ++ + ++ + +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-43
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMSEVASMANIC-HENLVK 112
+G+G FG V+ + + A+K L + + + M E ++ H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 113 LHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI 172
+ V +Y+ L + ++ KF + A I GL ++H
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLH--- 120
Query: 173 KPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGH 232
IV+RD+K NILLD++ + KI+DFG+ K +T GT Y+AP+ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQK 179
Query: 233 LNPKSDIYSFGVLLLQIVTGQ 253
N D +SFGVLL +++ GQ
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 1e-42
Identities = 52/281 (18%), Positives = 103/281 (36%), Gaps = 31/281 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH-ENLVKLHGG 116
++GEG FG +++G L + VA+K S + E + + + ++
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSI 176
EG ++V D + + + KFS A + + IHE S+
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 177 VHRDIKPSNILLDQNFNP-----KISDFGLSKLFPEDITHI------STRVAGTLGYLAP 225
V+RDIKP N L+ + + + DFG+ K + + +T ++GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 226 DYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285
+ + + + D+ + G + + + G K E+ E + L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL----- 237
Query: 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326
LC F E +++ P + + +
Sbjct: 238 RELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-41
Identities = 60/259 (23%), Positives = 104/259 (40%), Gaps = 19/259 (7%)
Query: 54 FCSSNKVGEGGFGSVYKGKL-QDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVK 112
+ + +G G FG VY+ KL G +VA+K + Q ++ E+ M + H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 113 LHGGCIEG------PCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLA 166
L +V DY+ + + + + + R LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 167 YIHEEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTRVAGTLGYLAP 225
YIH I HRDIKP N+LLD + K+ DFG +K ++S + Y AP
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAP 191
Query: 226 DYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284
+ D++S G +L +++ GQ D + + + K ++++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 285 DPMLCGNFSGNEAVRFLKV 303
F +A + KV
Sbjct: 252 PNYTEFKFPQIKAHPWTKV 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-41
Identities = 52/242 (21%), Positives = 92/242 (38%), Gaps = 23/242 (9%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE------FMSEVASMANI--CHEN 109
+G GGFGSVY G + D VA+K + + E EV + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 110 LVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
+++L +++ + + + R R + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 170 EEIKPSIVHRDIKPSNILLDQN-FNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDY- 227
++HRDIK NIL+D N K+ DFG L + + T GT Y P++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287
+ + ++S G+LL +V G D+E+ + + + + QHL+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF---FRQRVSSECQHLIRWC 238
Query: 288 LC 289
L
Sbjct: 239 LA 240
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-40
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 15/239 (6%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS---VESKQGEKEFMSEVASMANICHENLVKL 113
+G+G FG V + G A+K+L + +K ++E + N H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 114 HGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
V +Y L L F+ R I L Y+H
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL 233
+V+RDIK N++LD++ + KI+DFGL K D + T GT YLAP+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 182
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA---WEMHNTDKLQHLVDPMLC 289
D + GV++ +++ G+ + + L+ + + + + L+ +L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-39
Identities = 39/199 (19%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLH 114
K+GEG +G+V+K K + +VA+K + ++ + + E+ + + H+N+V+LH
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+V+++ + + + + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
+++HRD+KP N+L+++N K+++FGL++ F + S V + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 235 PKSDIYSFGVLLLQIVTGQ 253
D++S G + ++
Sbjct: 181 TSIDMWSAGCIFAELANAG 199
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 20/206 (9%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGE------KEFMSEVASMANICHENLV 111
++G G F V K + G A K + + ++ EV+ + I H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 112 KLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE 171
LH I++ + + L + + E I G+ Y+H
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 172 IKPSIVHRDIKPSNILLDQNFNP----KISDFGLSKLFPEDITHISTRVAGTLGYLAPDY 227
I H D+KP NI+L P KI DFGL+ + + GT ++AP+
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 187
Query: 228 AVSGHLNPKSDIYSFGVLLLQIVTGQ 253
L ++D++S GV+ +++G
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-38
Identities = 54/239 (22%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 54 FCSS-------NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQG--EKEFMSEVASMA 103
FC K+G+G FG V+K + + G VA+K + +E+++ + E+ +
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 104 NICHENLVKLHGGCIEGPCRI--------IVYDYMQNNSLSQTLLGEEKNRAKFSWTARR 155
+ HEN+V L C +V+D+ +++ KF+ + +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIK 120
Query: 156 EIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF---PEDITHI 212
+ + GL YIH I+HRD+K +N+L+ ++ K++DFGL++ F +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 213 STRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
T TL Y P+ + P D++ G ++ ++ T + + E + L+ +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-38
Identities = 48/273 (17%), Positives = 100/273 (36%), Gaps = 30/273 (10%)
Query: 60 VGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHG-- 115
+G G G V + + A+K+L Q + EV ++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 116 --GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
C +IV + + L + +++ F+ EI I + Y+H
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 174 PSIVHRDIKPSNILLDQNFNP---KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS 230
+I HRD+KP N+L K++DFG +K + + T Y+AP+
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187
Query: 231 GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290
+ D++S GV++ ++ G + + L + M ++ P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPGMKTRIRMGQYEFPNPEW 241
Query: 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323
+ E ++ ++ + + R ++ +
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-38
Identities = 53/239 (22%), Positives = 93/239 (38%), Gaps = 9/239 (3%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVL--SVESKQGEKEFMSEVASMANICHENLVKLHG 115
VG G +G+V + G VA+K L +S+ K E+ + ++ HEN++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 116 GCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS 175
D+ T LG+ K + + + +GL YIH
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 176 IVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNP 235
I+HRD+KP N+ ++++ KI DFGL++ ++T V
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYTQ 198
Query: 236 KSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSG 294
DI+S G ++ +++TG+ L + + K + +Q L G
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 2e-37
Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 18/238 (7%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKE---FMSEVASMANICHENLVKLH 114
+G G FG V K + G A+K+L + K+ ++E + + LVKL
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
+ +V +Y+ + L + +FS R A I Y+H
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL--- 160
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLN 234
+++RD+KP N+L+DQ +++DFG +K + GT LAP+ +S N
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYN 216
Query: 235 PKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEM---HNTDKLQHLVDPMLC 289
D ++ GVL+ ++ G D+ + Y + H + L+ L+ +L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-33
Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 25/250 (10%)
Query: 58 NKVGEGGFGSVYKGKL----QDGTVVAVKVLS----VESKQGEKEFMSEVASMANICHE- 108
+G G +G V+ + G + A+KVL V+ + + +E + +I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 109 NLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYI 168
LV LH ++ DY+ L L R +F+ + I L ++
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHL 145
Query: 169 HEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYA 228
H+ I++RDIK NILLD N + ++DFGLSK F D T + GT+ Y+APD
Sbjct: 146 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 229 VSGH--LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKA-------WEMHNTDK 279
G + D +S GVL+ +++TG + D E + + + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 280 LQHLVDPMLC 289
+ L+ +L
Sbjct: 263 AKDLIQRLLM 272
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-32
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 11/217 (5%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLH 114
+ VG G +GSV + G VAVK LS +S K E+ + ++ HEN++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 115 GGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKP 174
D L L K + + + I RGL YIH
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 175 SIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-GHL 233
I+HRD+KPSN+ ++++ KI DFGL++ +++T T Y AP+ ++ H
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHY 196
Query: 234 NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEK 270
N DI+S G ++ +++TG+ + + L+ +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (299), Expect = 9e-32
Identities = 40/202 (19%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 58 NKVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHG 115
K+G G + V++ + + V VK+L K K+ E+ + N+ N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 97
Query: 116 GCIEGPCR--IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIK 173
+ R +V++++ N Q + R I + L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---S 147
Query: 174 PSIVHRDIKPSNILLD-QNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVS-G 231
I+HRD+KP N+++D ++ ++ D+GL++ + + + + P+ V
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQ 205
Query: 232 HLNPKSDIYSFGVLLLQIVTGQ 253
+ D++S G +L ++ +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRK 227
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 1e-31
Identities = 48/234 (20%), Positives = 90/234 (38%), Gaps = 21/234 (8%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLS--VESKQGEKEFMSEVASMANICHENLVKLHG 115
+G G G V VA+K LS +++ K E+ M + H+N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 116 GCI------EGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIH 169
E +V + M N + + + + + G+ ++H
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLC-------QVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 170 EEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAV 229
I+HRD+KPSNI++ + KI DFGL++ T T Y AP+ +
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVIL 191
Query: 230 SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283
DI+S G ++ ++V + + ++ V + + ++ L
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 2e-29
Identities = 50/249 (20%), Positives = 101/249 (40%), Gaps = 28/249 (11%)
Query: 59 KVGEGGFGSVYKGK-LQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGC 117
K+G G F +V+ K + + T VA+K++ K + E+ + + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 118 IEGPCRII-VYDYMQNNSLSQTLLGEE-----------KNRAKFSWTARREIALGIARGL 165
+++ +++ N + ++ E ++I+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 166 AYIHEEIKPSIVHRDIKPSNILLDQNFNP------KISDFGLSKLFPEDITHISTRVAGT 219
Y+H + I+H DIKP N+L++ +P KI+D G + + E T+ T
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQT 192
Query: 220 LGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279
Y +P+ + +DI+S L+ +++TG F+ + G Y + +
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIEL 250
Query: 280 LQHLVDPML 288
L L +L
Sbjct: 251 LGELPSYLL 259
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 98.7 bits (245), Expect = 3e-25
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 29/196 (14%)
Query: 58 NKVGEGGFGSVYKGKLQDGTVVAVKVLSVES----------KQGEKEFMSEVASMANICH 107
+GEG +V+ + VK V G+ F A
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 108 ENLVKLHGGCIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAY 167
L KL G + VY + N L + L + K + E+ I +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 168 IHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF--PEDITHISTRVAGTLGYLAP 225
+ IVH D+ N+L+ I DF S + V + Y +
Sbjct: 119 FYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 226 DYAVSGHLNPKSDIYS 241
Y + DI S
Sbjct: 175 TY------RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 353 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.24 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=399.81 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=206.6
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.++|++.+.||+|+||+||+|+++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3578999999999999999999975 689999999975532 33457889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 Ey~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 999999999998 4556799999999999999999999999 999999999999999999999999999987643
Q ss_pred CC-ccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 208 DI-THISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.............. .
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~------------ 221 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--E------------ 221 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--T------------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--c------------
Confidence 32 223445779999999999988876 5789999999999999999999976543322211110 0
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...........+..+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00001111223466889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=398.61 Aligned_cols=255 Identities=20% Similarity=0.350 Sum_probs=213.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
++|++.+.||+|+||+||+|.+. +|+.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999865 69999999998666566678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
+||+|.+++. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++++||+|||+++......
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 9999998772 34699999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......... .. ....
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~-----------~~~~ 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NG-----------TPEL 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HC-----------SCCC
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CC-----------CCCC
Confidence 223456799999999999999999999999999999999999999976554322211111 00 0001
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
..+...+..+.+|+.+||+.||++|||++|+++ +|+...
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 122334567899999999999999999999986 454433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=392.80 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=208.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|+++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999976 6889999998743 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+++|+|.+++ .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l----~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999998 3456799999999999999999999999 999999999999999999999999999986643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... .....
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i~~~------------- 219 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---RISRV------------- 219 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTT-------------
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH---HHHcC-------------
Confidence 2 2334679999999999999999999999999999999999999997654322221 11110
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...++...++++.+|+.+||+.||++|||++|+++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01122334567889999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-58 Score=398.94 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=201.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.+.||+|+||+||+|.+.+++.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578899999999999999999988889999999743 3445679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+|+|.+++. .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999884 3446789999999999999999999999 9999999999999999999999999999877654444
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ-AAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......||+.|+|||++.+..++.++|||||||++|||+|+. +||......+ ........ ...
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~-------------~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-------------FRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHT-------------CCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHhc-------------CCC
Confidence 444567899999999999999999999999999999999964 4444332211 11111111 111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..+..++.++.+|+.+||+.||++|||++||++.|+++.
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 222334567899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-58 Score=403.36 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=217.3
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
..++|++.+.||+|+||+||+|.++ +|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467889999999999999999976 5889999998744 3445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++.. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999843 3456799999999999999999999999 9999999999999999999999999999987655
Q ss_pred CccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.........|++.|+|||++.+..++.++|||||||++|||++|..||......... .... ....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~--~~~i-------------~~~~ 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL-------------EKDY 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HHHH-------------HTTC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH--HHHH-------------hcCC
Confidence 444445566889999999999999999999999999999999987776543322111 1111 1111
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
....+...+..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 223344456779999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=395.90 Aligned_cols=256 Identities=23% Similarity=0.340 Sum_probs=199.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--CCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE--GPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 125 (353)
.++|++.+.||+|+||+||+|+.+ +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 467999999999999999999875 6899999998754 33445678899999999999999999999865 456899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI--KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
||||+++|+|.+++.........+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999999766566778999999999999999999999871 1139999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.. ...... ..
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~---~~i~~~----~~--- 231 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---GKIREG----KF--- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHT----CC---
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH---HHHHcC----CC---
Confidence 765432 2234467999999999999999999999999999999999999999765432211 111111 10
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 ------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122234567899999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=395.54 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=210.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 4678889999999999999999988889999999743 3445679999999999999999999998765 4578999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|.+++.. ....++++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999998743 2334699999999999999999999999 999999999999999999999999999998765544
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+........ ....... ....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i~~-------------~~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLER-------------GYRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT-------------TCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh-------------cCCC
Confidence 444556789999999999999999999999999999999997665543322111 1111111 1112
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
..+...+..+.+|+.+||+.||++|||+++|++.|++
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2233445678999999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-57 Score=387.55 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=216.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQ 131 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 131 (353)
++|++.++||+|+||+||+|++++++.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999998543 345689999999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc
Q 042383 132 NNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH 211 (353)
Q Consensus 132 ~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 211 (353)
+|+|.+++. .....+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999874 3456789999999999999999999999 9999999999999999999999999999877655444
Q ss_pred ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 212 ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 212 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+.. ...... ...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~~~-------------~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQG-------------LRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHTT-------------CCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---HHHHhC-------------CCC
Confidence 4445678999999999999999999999999999999998 89999765543222 111111 111
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
..+...+..+.+|+.+||+.||++|||+++|++.|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22333456799999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-57 Score=393.47 Aligned_cols=251 Identities=20% Similarity=0.328 Sum_probs=209.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+.|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999975 68999999998766666678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|.+++. ....++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...... .
T Consensus 92 ~~g~L~~~~~---~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 9999999873 2346799999999999999999999999 9999999999999999999999999999765322 1
Q ss_pred cccccccCCcCccCccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccC
Q 042383 211 HISTRVAGTLGYLAPDYAV-----SGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVD 285 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
.......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+..+....+ .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i---~~~~~--------- 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---AKSEP--------- 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH---HHSCC---------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH---HcCCC---------
Confidence 1233467999999999884 456889999999999999999999999866543332211 11100
Q ss_pred cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 286 PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 286 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 233 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 --PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122334567899999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=392.44 Aligned_cols=247 Identities=22% Similarity=0.315 Sum_probs=205.5
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 6899999998743 2234467899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||++||+|.+++ ...+.+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 88 Ey~~gg~L~~~~----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhh----hccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999988 4556899999999999999999999999 999999999999999999999999999987754
Q ss_pred CC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 208 DI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 208 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+...... .....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i~~~------------ 225 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---KIIKL------------ 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHTT------------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---HHHcC------------
Confidence 32 223344679999999999999999999999999999999999999998654332221 11110
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVI 322 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 322 (353)
...++...++.+.+||.+||+.||++|||++|++
T Consensus 226 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 226 --EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 0112233456688999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=388.61 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=204.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|+.+. .||||+++.. .....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4679999999999999999998653 5999998744 34455788999999999999999999998754 56899999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999842 345799999999999999999999999 9999999999999999999999999999876533
Q ss_pred Cc-cccccccCCcCccCccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 209 IT-HISTRVAGTLGYLAPDYAVSG---HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 209 ~~-~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.. .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.......... .........+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~p~~---- 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYLSPDL---- 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSCCCCG----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCCCCcc----
Confidence 22 233456799999999998643 47899999999999999999999997654332221 111111111111
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...+..+++.+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123334567999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-57 Score=403.39 Aligned_cols=270 Identities=22% Similarity=0.338 Sum_probs=210.2
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..++|++.+.||+|+||+||+|++. +|+.||+|+++... ......+.+|+.++++++||||++++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999975 68999999997553 334567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
||++||+|.+++. ..+.+++..+..++.||+.||.|||+ + +|+||||||+|||++.++++||+|||+|....
T Consensus 84 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999993 44679999999999999999999996 6 89999999999999999999999999998653
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcc----------
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHN---------- 276 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 276 (353)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+................
T Consensus 157 ~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 D---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 223446899999999999999999999999999999999999999976543322111000000000
Q ss_pred -------------ccc----cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCC
Q 042383 277 -------------TDK----LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDV 329 (353)
Q Consensus 277 -------------~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~ 329 (353)
... ...+.............+.++.+|+.+||+.||++|||++|+++ .|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000 00000000000011122456889999999999999999999988 465544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=390.36 Aligned_cols=267 Identities=25% Similarity=0.379 Sum_probs=212.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
.++|++.+.||+|+||+||+|.+++++.||||+++.. ....+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 3679999999999999999999988888999999744 3445789999999999999999999999865 4578999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|..++.. .....+++..++.++.||+.||.|||+. +++||||||+|||++.++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999988843 2345699999999999999999999999 999999999999999999999999999987654443
Q ss_pred cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcccCC
Q 042383 211 HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLCG 290 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (353)
.......||+.|+|||++..+.++.++|||||||++|||++|..|+......... ..... .....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~--~~~i~-------------~~~~~ 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVE-------------RGYRM 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHH-------------TTCCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH--HHHHH-------------hcCCC
Confidence 3444467899999999999999999999999999999999977666543322111 11111 11122
Q ss_pred CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCccccCCc
Q 042383 291 NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDDDVEIWEPG 341 (353)
Q Consensus 291 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~~~~~~~~~ 341 (353)
..+...++++.+++.+||+.||++|||+++|++.|++...... +.++|+
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~--p~~~p~ 282 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE--PQYQPG 282 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC--CCCCCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC--CCCCCC
Confidence 3344556789999999999999999999999999998775544 466664
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-56 Score=392.21 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=198.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
..+.|++.+.||+|+||+||+|+++ +|+.||||++..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999976 689999999975432 23456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC---CCCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD---QNFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~---~~~~~kl~Dfg~~~~ 204 (353)
||++||+|.+++ ...+.+++..+..++.||+.||.|||+. +++||||||+||++. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHH----HTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhh----hcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 999999999999 4567899999999999999999999999 999999999999994 578999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 160 ~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~~~--------- 225 (307)
T d1a06a_ 160 EDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQILKAE--------- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHTTC---------
T ss_pred ccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHhccC---------
Confidence 5432 2234467999999999999999999999999999999999999999765432221 1111100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDID 332 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~ 332 (353)
...........++.+.+|+.+||+.||++|||++|+++ .|++....+
T Consensus 226 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 274 (307)
T d1a06a_ 226 -YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274 (307)
T ss_dssp -CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCC
T ss_pred -CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccc
Confidence 01111222334567899999999999999999999998 576544433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-56 Score=393.66 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=202.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CC---cEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DG---TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.+.||+|+||+||+|.++ ++ ..||||.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888899999999999999875 22 36899988754 444557899999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++. ...+.+++..+..++.||+.||.|||+. +++||||||+|||++.++++||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999873 3355799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccc----cccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 207 EDITHI----STRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 207 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |..||......+.. .....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~---~~i~~-------- 248 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---NAIEQ-------- 248 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHT--------
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH---HHHHc--------
Confidence 432221 122457899999999999999999999999999999998 89999765432211 11111
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
......+...+..+.+|+.+||+.||++|||+.||++.|+.+..-+
T Consensus 249 -----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 249 -----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1112233445677999999999999999999999999998765433
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=383.11 Aligned_cols=244 Identities=22% Similarity=0.363 Sum_probs=197.6
Q ss_pred CCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec----CCceEEEE
Q 042383 55 CSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE----GPCRIIVY 127 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 127 (353)
++.++||+|+||+||+|.+. +++.||+|.+... .....+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999976 6889999998754 34445678999999999999999999999875 34678999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEcCCCCCCeEEC-CCCCeEEeeccCCcc
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPS--IVHRDIKPSNILLD-QNFNPKISDFGLSKL 204 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~--i~H~dlk~~Nil~~-~~~~~kl~Dfg~~~~ 204 (353)
||+++|+|.+++ .....+++..+..++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+++.
T Consensus 92 E~~~~g~L~~~l----~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHH----hccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999998 3456799999999999999999999998 7 99999999999996 578999999999986
Q ss_pred CCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 205 FPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 205 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...........
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~~~~~------- 231 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKP------- 231 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCCC-------
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHcCCCC-------
Confidence 5432 2345679999999998865 699999999999999999999999975433211 11111110000
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..++...++++.+|+.+||+.||++|||++|+++
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111223456889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-55 Score=394.64 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=214.0
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 6899999999877666678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC--CCCCeEEeeccCCccCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD--QNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~ 207 (353)
|+||+|.+++. ...+.+++..+..++.||+.||.|||++ +++||||||+|||++ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999883 2346799999999999999999999999 999999999999995 467899999999987654
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.... ...... .
T Consensus 179 ~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~~~----------~ 243 (350)
T d1koaa2 179 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VKSCDW----------N 243 (350)
T ss_dssp T--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHTCC----------C
T ss_pred c--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCC----------C
Confidence 3 223456799999999999999999999999999999999999999976544322211 111100 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 328 (353)
.........++.+.+|+.+||+.||++|||++|+++. |++.
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0011112234668899999999999999999999984 5543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-55 Score=393.22 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=214.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.........+.+|+.++++++||||++++++|.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999975 6999999999877666667888999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEEC--CCCCeEEeeccCCccCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLD--QNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~ 207 (353)
|+||+|.+.+. ....++++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998873 3345799999999999999999999999 999999999999997 678999999999987754
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ...... .
T Consensus 182 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i~~~~~----------~ 246 (352)
T d1koba_ 182 D--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN---VKRCDW----------E 246 (352)
T ss_dssp T--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHHCCC----------C
T ss_pred C--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhCCC----------C
Confidence 3 233456789999999999999999999999999999999999999976554322211 111100 0
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
.........+..+.+|+.+||+.||.+|||++|+++ .|++.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 111122234566889999999999999999999988 36553
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=386.06 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=210.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC------hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES------KQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3478999999999999999999975 68999999987432 2235788999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC----CeEEee
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF----NPKISD 198 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~----~~kl~D 198 (353)
.++|||||++|+|.+++ ...+.+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+|++|
T Consensus 88 ~~iv~E~~~gg~L~~~i----~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchh----ccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999998 3446799999999999999999999999 999999999999998766 499999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+... .......
T Consensus 161 fG~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i~~~~~-- 233 (293)
T d1jksa_ 161 FGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVSAVNY-- 233 (293)
T ss_dssp CTTCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHTTCC--
T ss_pred hhhhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH---HHHhcCC--
Confidence 9999876543 22344678999999999999999999999999999999999999998655432221 1111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
..........+..+.+|+.+||+.||++|||++|+++ .+++
T Consensus 234 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 234 --------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp --------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred --------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000011123456889999999999999999999987 4544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=383.65 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=208.2
Q ss_pred cCCCCCC-eeeeeCceEEEEEEeC---CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSN-KVGEGGFGSVYKGKLQ---DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|.+.. +||+|+||+||+|.++ ++..||||+++.. .....+.+.+|+.++++++||||+++++++.++ ..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence 4566666 4999999999999764 3567999999754 344557899999999999999999999998754 58899
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++. ..+..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999873 3446799999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 207 EDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 207 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
..... ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+.. .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~~i~~---------- 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQ---------- 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHT----------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----------
Confidence 43222 2233568899999999999999999999999999999998 89999765432221 11111
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
......+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 228 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 228 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111233444567799999999999999999999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-55 Score=389.88 Aligned_cols=245 Identities=22% Similarity=0.389 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
+.|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999865 68899999997543 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
|||.+|+|..++ ....++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999887665 3456899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcCccCcccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVS---GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
.....||+.|+|||++.+ +.++.++|||||||++|+|++|..||.......... ......
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~---~i~~~~--------- 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNE--------- 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC---------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhCC---------
Confidence 234579999999999864 458999999999999999999999997654322211 111100
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.....+...++.+.+|+.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 000111223567899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=382.73 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=200.1
Q ss_pred CeeeeeCceEEEEEEeC---CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcCCC
Q 042383 58 NKVGEGGFGSVYKGKLQ---DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYMQN 132 (353)
Q Consensus 58 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 132 (353)
++||+|+||+||+|.++ +++.||||+++... ....+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999754 35689999987442 33356789999999999999999999998754 57899999999
Q ss_pred CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCcc-
Q 042383 133 NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDITH- 211 (353)
Q Consensus 133 ~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 211 (353)
|+|.+++ .....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 92 g~L~~~l----~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHH----HHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHH----hhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999998 4556799999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCcccC
Q 042383 212 -ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPMLC 289 (353)
Q Consensus 212 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (353)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+.. ..... ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~---~~i~~-------------~~~ 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEK-------------GER 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHT-------------TCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH---HHHHc-------------CCC
Confidence 2233568999999999999999999999999999999998 89999865432211 11111 111
Q ss_pred CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 042383 290 GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMING 327 (353)
Q Consensus 290 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 327 (353)
...+...+.++.+|+.+||+.||++|||+++|++.|+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22334456779999999999999999999999988865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=392.95 Aligned_cols=258 Identities=22% Similarity=0.360 Sum_probs=207.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC------CcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD------GTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.++||+|+||+||+|++.. ...||+|.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678999999999999999998642 236999988644 233346788999999998 89999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhccc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEK-------------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKP 183 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~ 183 (353)
.++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999954321 124689999999999999999999999 999999999
Q ss_pred CCeEECCCCCeEEeeccCCccCCCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcc
Q 042383 184 SNILLDQNFNPKISDFGLSKLFPEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKE 261 (353)
Q Consensus 184 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~ 261 (353)
+||+++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||...+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865443222 2334668999999999999999999999999999999998 8999976544
Q ss_pred cchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 042383 262 LGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMIN 326 (353)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 326 (353)
......+ +........+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~~~~~~~---------------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKL---------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHH---------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHH---------------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3222111 1111122334445677999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=385.02 Aligned_cols=261 Identities=24% Similarity=0.431 Sum_probs=205.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCC-----cEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDG-----TVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
..|+..++||+|+||+||+|.++.. ..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999986532 47999998754 33444678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+.++++.+.+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999988773 3446799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
...... ......||+.|+|||++.++.++.++|||||||++|||++|..|+........ .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i------------ 226 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI------------ 226 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH------------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHH------------
Confidence 543222 22335689999999999999999999999999999999997666543322111 11111
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDIDD 333 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~~ 333 (353)
........+...+..+.+|+.+||+.||++|||+.||++.|+.+...++
T Consensus 227 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp -HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 1112233344456779999999999999999999999999987765544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=386.20 Aligned_cols=248 Identities=24% Similarity=0.288 Sum_probs=209.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
.++|++++.||+|+||+||+|+.+ +|+.||+|+++.. .....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999975 7999999999743 233457788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||++||+|.+++ ...+.+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~----~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhh----hcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999998 4556899999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||...+....... ... ..
T Consensus 157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---i~~----~~------- 221 (337)
T d1o6la_ 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---ILM----EE------- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH----CC-------
T ss_pred cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH---Hhc----CC-------
Confidence 332 233457899999999999999999999999999999999999999987654322211 111 00
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
..++...+.++.+||.+||+.||++||+ ++|+++
T Consensus 222 ---~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122334556889999999999999995 788876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-54 Score=380.98 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=210.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++.+.||+|+||+||+|+++ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 6899999999743 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||++||+|...+ .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999988 5567789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.... ....
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~~~------------- 216 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---ILNA------------- 216 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHC-------------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH---HHcC-------------
Confidence 2 2346799999999999999999999999999999999999999986554322211 1110
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HhcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE--MINGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~--~L~~~ 328 (353)
...++...++.+.+++.+||+.||.+|| |++++++ .++++
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 0112233356688999999999999996 8999987 35554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-53 Score=369.67 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=207.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh---------hcHHHHHHHHHHHHhcC-CCCceeeeeeEec
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK---------QGEKEFMSEVASMANIC-HENLVKLHGGCIE 119 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 119 (353)
.++|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999975 689999999975421 12246788999999996 9999999999999
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
++..|+||||+++|+|.+++ ...+++++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999999 3456899999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCccccccccCCcCccCcccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVS------GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
|+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+ ..
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---~~ 229 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---MS 229 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH---Hh
Confidence 9998775432 2344679999999998864 34688999999999999999999999866543222111 11
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
. .. ..........++++.+|+.+||+.||++|||++||++
T Consensus 230 ~----~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 G----NY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp T----CC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C----CC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 00 0111122334567999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=376.00 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=199.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
.++|++.+.||+|+||+||+|.+.. +..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3679999999999999999998642 456899988644 33445678999999999999999999999964 57899
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
||||+++|+|.+++. ....++++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999998873 3456799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhcccccccccc
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV 284 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
............||+.|+|||++.+..++.++|||||||++|||++ |.+||......+... .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~---~i~~~---------- 225 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIENG---------- 225 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHTT----------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH---HHHcC----------
Confidence 6544444455678999999999999999999999999999999998 888987655433221 11111
Q ss_pred CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 285 DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 285 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....++..+..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 226 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111233445677999999999999999999999999987653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=373.71 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=203.3
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhc-----HHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEcC
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQG-----EKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDYM 130 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 130 (353)
+++||+|+||+||+|+++ +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 68999999987543221 246789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
.++++.... .....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988776665 4567799999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc---
Q 042383 211 HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP--- 286 (353)
Q Consensus 211 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (353)
. .....||+.|+|||++... .++.++|||||||++|+|++|..||......+....+...........+......
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence 2 2345789999999988754 5799999999999999999999999876654443333322211111111111000
Q ss_pred c-c--CCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 287 M-L--CGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 287 ~-~--~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
. . .... ....++.+.+|+.+||+.||++|||++|+++ .|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 0 0001 1123467899999999999999999999997 57643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-53 Score=381.63 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=209.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++|++++.||+|+||+||+|+++ +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999975 6999999998743 2234467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPE 207 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 207 (353)
||+.+|+|.+.+ ...+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHH----HHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhH----hhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998 3446799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..... .......
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~~~~------------ 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EKIVSGK------------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCC------------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---HHHhcCC------------
Confidence 2 23467999999999999999999999999999999999999999765432222 1111110
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HhcCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE--MINGD 328 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~--~L~~~ 328 (353)
...+...+..+.+++.+||+.||.+|+ |++++++ .++++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 112223356688999999999999994 8999987 45543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-53 Score=372.15 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=201.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----c
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMSEVASMANICHENLVKLHGGCIEGP----C 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 122 (353)
.++|++.+.||+|+||+||+|.+. +|+.||||+++... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999975 79999999997543 333467889999999999999999999987654 3
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.|+||||++|++|.+++ ...+++++..+..++.||+.||.|||+. +++||||||+||+++.++.++++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~----~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhh----cccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 78999999999999988 4456799999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc--cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 203 KLFPEDIT--HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 203 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
........ .......||+.|+|||++.+..+++++|||||||++|+|+||+.||...+..+.... ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---~~~---~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---HVR---EDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH---CCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH---HHh---cCCC
Confidence 76543222 233446799999999999999999999999999999999999999976544322111 110 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcC
Q 042383 281 QHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-RMSTVIEMING 327 (353)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~ 327 (353)
.........++++.+++.+||+.||++|| |++++++.|..
T Consensus 233 -------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 00111122346788999999999999999 89999887764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-53 Score=375.69 Aligned_cols=255 Identities=14% Similarity=0.222 Sum_probs=208.4
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
-++|++.+.||+|+||+||+|.+. +|+.||+|+++.... ....+.+|+.+|+.++||||++++++|.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999976 688999999986543 345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC--CCCeEEeeccCCccCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ--NFNPKISDFGLSKLFPE 207 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~ 207 (353)
|+||+|.+++. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||++.....
T Consensus 83 ~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999983 2344799999999999999999999999 9999999999999975 45799999999987643
Q ss_pred CCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 208 DITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 208 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. .......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+. .... . ....
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~---~~~~--~----~~~~ 225 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM---NAEY--T----FDEE 225 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HTCC--C----CCHH
T ss_pred C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCC--C----CChh
Confidence 2 22344678999999999999999999999999999999999999998665432221111 1000 0 0000
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
.....+.++.+|+.+||+.||++|||++|+++ .+++
T Consensus 226 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ----hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 00112456889999999999999999999997 3543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.1e-53 Score=380.70 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=201.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC---hhcHHHHHH---HHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES---KQGEKEFMS---EVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+ ++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999976 68999999986431 222233334 46677777899999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
|+||||++||+|.+++ .....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++
T Consensus 83 ~ivmE~~~gg~L~~~l----~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHH----HhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999998 3456789999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccc
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQH 282 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (353)
..... ......||+.|+|||++.. ..++.++|||||||++|+|+||+.||............... ..
T Consensus 156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----~~----- 223 (364)
T d1omwa3 156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----LT----- 223 (364)
T ss_dssp ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS----SS-----
T ss_pred ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----cc-----
Confidence 76543 2344679999999999875 56899999999999999999999999865543332211110 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042383 283 LVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPR-----MSTVIE 323 (353)
Q Consensus 283 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 323 (353)
.....+...++++.+||.+||+.||++||| ++|+++
T Consensus 224 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 -----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001122234567899999999999999999 688875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=370.53 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=199.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-CCceEEEEEc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE-GPCRIIVYDY 129 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 129 (353)
.++|++.+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356888999999999999999986 788999999743 344678999999999999999999998865 4568999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+++|+|.+++... ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999998432 234589999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccccCccc
Q 042383 210 THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPML 288 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
.....+++.|+|||++.++.+++++|||||||++|||+| |.+||......+.. ... ....
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i-------------~~~~ 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV-------------EKGY 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHH-------------TTTC
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HHH-------------HcCC
Confidence 233457889999999999999999999999999999998 67777654332221 111 1112
Q ss_pred CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 289 CGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 289 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
....+...+.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2334445567899999999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=373.44 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=198.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC--C--CcEEEEEEeecc---ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ--D--GTVVAVKVLSVE---SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 124 (353)
++|++.+.||+|+||+||+|+.. + ...||||++... .....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56999999999999999999853 2 246899988743 233446789999999999999999999999764 678
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
+||||+++|+|.+.+.. ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999988743 345699999999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCcc--ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccc
Q 042383 205 FPEDITH--ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQ 281 (353)
Q Consensus 205 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
....... ......|+..|+|||++.+..++.++|||||||++|||+| |..||...+..+.. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i~--------- 228 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKID--------- 228 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHH---------
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHHH---------
Confidence 7554332 2234567889999999999999999999999999999998 89999755443221 1111
Q ss_pred cccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 282 HLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
........+...+..+.+|+.+||+.||++|||+++|.+.|++.
T Consensus 229 ---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 ---KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111223334456799999999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=376.24 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=204.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc---ChhcHHHHHHHHHHHH-hcCCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE---SKQGEKEFMSEVASMA-NICHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.+.||+|+||+||+|++. +|+.||||+++.. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999976 6899999999743 2233455666766665 67999999999999999999999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFP 206 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 206 (353)
|||+++|+|.+++ .....+++..+..++.||+.||.|||++ +++||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i----~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHH----HHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999998 4556799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCc
Q 042383 207 EDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDP 286 (353)
Q Consensus 207 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (353)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... ....
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~---i~~~------------ 218 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS---IRMD------------ 218 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHC------------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHcC------------
Confidence 332 233446799999999999999999999999999999999999999986554322211 1110
Q ss_pred ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042383 287 MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMS-TVIE 323 (353)
Q Consensus 287 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 323 (353)
...++...+..+.+|+.+||+.||++|||+. ++++
T Consensus 219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0112223356689999999999999999996 7764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-53 Score=375.43 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=210.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeeccCh-hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCce
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVESK-QGEKEFMSEVASMANICHENLVKLHGGCIEGPCR 123 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 123 (353)
.++|++.+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 467999999999999999999864 357899999975533 3456799999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhhhcc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCC
Q 042383 124 IIVYDYMQNNSLSQTLLGEE--------------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKP 183 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~--------------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~ 183 (353)
+++|||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 99999999999999985321 1224589999999999999999999999 999999999
Q ss_pred CCeEECCCCCeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCcc
Q 042383 184 SNILLDQNFNPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ-AAVHFDKE 261 (353)
Q Consensus 184 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~pf~~~~~ 261 (353)
+|||++.++.+||+|||+++...... ........+++.|+|||.+.+..++.++|||||||++|||++|. +||...+.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999998654332 22334467889999999999999999999999999999999986 56665443
Q ss_pred cchhhHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 262 LGEYYLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.+.. ..... .. ....+...+.++.+|+.+||+.+|++|||+.||++.|+.+.
T Consensus 249 ~e~~---~~v~~----~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVI---YYVRD----GN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHH---HHHHT----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHH---HHHHc----CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3221 11111 10 11223344567899999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=375.32 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=203.4
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCc----EEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGT----VVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRII 125 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 125 (353)
++|+++++||+|+||+||+|.+. +|+ .||+|.++.. .....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999865 343 6899988643 334567899999999999999999999999875 4678
Q ss_pred EEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccC
Q 042383 126 VYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLF 205 (353)
Q Consensus 126 v~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 205 (353)
++|++.+++|.+.+. .....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 889999999998874 3466799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc-ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhhHHHHHHhhccccccccc
Q 042383 206 PEDITH-ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL 283 (353)
Q Consensus 206 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||...+..+....+. .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~---------- 228 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K---------- 228 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---H----------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c----------
Confidence 543332 2233568999999999999999999999999999999998 788887554432221111 1
Q ss_pred cCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 042383 284 VDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGD 328 (353)
Q Consensus 284 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~ 328 (353)
......+..++..+.+|+.+||+.||++|||+.||++.|..+
T Consensus 229 ---~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 229 ---GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111223344567799999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=374.35 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=200.6
Q ss_pred HhccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec-
Q 042383 49 SATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIE- 119 (353)
Q Consensus 49 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 119 (353)
...++|++.+.||+|+||+||+|.+. +++.||+|+++.. .....+.+.+|...+.++ +|+||+.+++++.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999853 3468999998754 334456677888888877 68999999998765
Q ss_pred CCceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeE
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNIL 187 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil 187 (353)
+...++|||||++|+|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 4568999999999999999964332 234589999999999999999999999 9999999999999
Q ss_pred ECCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCcccchh
Q 042383 188 LDQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ-AAVHFDKELGEY 265 (353)
Q Consensus 188 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~pf~~~~~~~~~ 265 (353)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|. +||.........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986654332 2334467999999999999999999999999999999999975 567654433222
Q ss_pred hHHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 266 YLVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.. .... ......+...+.++.+++.+||+.||++|||++||++.|+++.
T Consensus 247 ~~--~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CR--RLKE-------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HH--HHHH-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HHhc-------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1111 1111223334567899999999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=372.71 Aligned_cols=257 Identities=18% Similarity=0.210 Sum_probs=202.0
Q ss_pred ccCCCCCC-eeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhc-CCCCceeeeeeEec----CCce
Q 042383 51 TNGFCSSN-KVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANI-CHENLVKLHGGCIE----GPCR 123 (353)
Q Consensus 51 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~ 123 (353)
.++|.+.+ .||+|+||+||+|++. +++.||||+++. ...+.+|+.++.++ +||||++++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46888875 5999999999999874 689999999863 23567899887655 89999999999875 4678
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeecc
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFG 200 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg 200 (353)
|+|||||+||+|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999942 2235799999999999999999999999 9999999999999975 5679999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL 280 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||............ .
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-----------~ 226 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----------K 226 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----------H
Confidence 998765432 234567999999999999999999999999999999999999999755432221100 0
Q ss_pred ccccCcccC--CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCC
Q 042383 281 QHLVDPMLC--GNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVD 330 (353)
Q Consensus 281 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~ 330 (353)
..+...... .......++++.+|+.+||+.||++|||+.|+++ .+.+...
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 011111111 1111234567999999999999999999999988 3554443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-52 Score=365.21 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=205.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEEc
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYDY 129 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 129 (353)
++|++.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999999999999999975532 2347889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCC
Q 042383 130 MQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDI 209 (353)
Q Consensus 130 ~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 209 (353)
+.++.+.... ...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887666655 4567899999999999999999999999 99999999999999999999999999998765432
Q ss_pred ccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccccccc----
Q 042383 210 THISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLV---- 284 (353)
Q Consensus 210 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 284 (353)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+................
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 2 22335689999999998765 56899999999999999999999997665433332222221111111111000
Q ss_pred --------CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 285 --------DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 285 --------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
............+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001122233567889999999999999999999984
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=370.13 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=206.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeCC--------CcEEEEEEeeccCh-hcHHHHHHHHHHHHhc-CCCCceeeeeeEecC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESK-QGEKEFMSEVASMANI-CHENLVKLHGGCIEG 120 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 120 (353)
.++|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4688999999999999999997532 34799999976543 4456788899999888 799999999999999
Q ss_pred CceEEEEEcCCCCChhhhhhhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 121 PCRIIVYDYMQNNSLSQTLLGEEK------------NRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 121 ~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999954321 235689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCC-ccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDI-THISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVT-GQAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~-g~~pf~~~~~~~~~~ 266 (353)
+.++.+||+|||+++...... ........+++.|+|||.+.++.++.++|||||||++|||++ |.+||.........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~- 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-
Confidence 999999999999998664432 223344678999999999999999999999999999999998 68888654432211
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..... ......+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 248 --~~i~~-------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 248 --KLLKE-------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp --HHHHT-------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHc-------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 11111 1112223334567999999999999999999999999998654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=370.22 Aligned_cols=261 Identities=20% Similarity=0.368 Sum_probs=211.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEe------CCCcEEEEEEeeccC-hhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKL------QDGTVVAVKVLSVES-KQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 122 (353)
.++|++.++||+|+||.||+|++ .+++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46888999999999999999975 246789999997543 34456788999999999 69999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhcc--------------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEE--------------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILL 188 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~--------------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~ 188 (353)
.++||||+++|+|.+++.... .....+++..+..++.||+.||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999985432 1234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCcccchhh
Q 042383 189 DQNFNPKISDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTG-QAAVHFDKELGEYY 266 (353)
Q Consensus 189 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g-~~pf~~~~~~~~~~ 266 (353)
+.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987764332 233446789999999999999999999999999999999995 55554433322221
Q ss_pred HHHHHHhhccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 267 LVEKAWEMHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.. +........+...+..+.+|+.+||+.||++|||+++|++.|+...
T Consensus 259 ~~---------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KM---------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HH---------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---------------HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 1111122233334567999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=365.27 Aligned_cols=270 Identities=21% Similarity=0.328 Sum_probs=206.1
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh--hcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK--QGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|++.+.||+|+||+||+|.+. +|+.||||+++.... .....+.+|+.++++++||||+++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 689999999975432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
|+.++ +.+.+. ......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~-~~~~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhh--hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 444442 23456799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccc---c
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHL---V 284 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 284 (353)
.. ......||+.|+|||++.... ++.++||||+||++|+|++|+.||...+..+....+............... .
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence 22 234457999999999877665 578999999999999999999999866543333222221111111111100 0
Q ss_pred C------cccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCC
Q 042383 285 D------PMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGD 328 (353)
Q Consensus 285 ~------~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~ 328 (353)
+ ...... .....+..+.+|+.+||+.||++|||++|+++. |+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0 000000 011224678899999999999999999999984 6543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=371.27 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=206.8
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCc--EEEEEEeecc-ChhcHHHHHHHHHHHHhc-CCCCceeeeeeEecCCceEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGT--VVAVKVLSVE-SKQGEKEFMSEVASMANI-CHENLVKLHGGCIEGPCRIIV 126 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 126 (353)
++|++.++||+|+||+||+|.++ +|. .||||.++.. .....+.+.+|+.+++++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67888999999999999999875 444 4778877633 334456789999999998 799999999999999999999
Q ss_pred EEcCCCCChhhhhhhc------------cccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCe
Q 042383 127 YDYMQNNSLSQTLLGE------------EKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNP 194 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~------------~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~ 194 (353)
|||+++|+|.+++... ......+++..+..++.||+.||.|||+. +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998543 12346799999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCC-CCCCCcccchhhHHHHHHh
Q 042383 195 KISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQA-AVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 195 kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~~~~ 273 (353)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+..+. .....
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~i~- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP- 240 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHGG-
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHHHH-
Confidence 999999998654322 2233568999999999999999999999999999999999765 5654432211 11111
Q ss_pred hccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVDID 332 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~~~ 332 (353)
.......+...+.++.+|+.+||+.||++|||++||++.|+++.+..
T Consensus 241 ------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 ------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ------------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11122334445678999999999999999999999999988876433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=363.34 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=202.4
Q ss_pred CCeeeeeCceEEEEEEeCC----CcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-CCceEEEEEcC
Q 042383 57 SNKVGEGGFGSVYKGKLQD----GTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIE-GPCRIIVYDYM 130 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 130 (353)
.++||+|+||+||+|.+.. ...||||.++.. .....+.+.+|+.++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999998643 236899998743 45556789999999999999999999999765 45789999999
Q ss_pred CCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCCCc
Q 042383 131 QNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPEDIT 210 (353)
Q Consensus 131 ~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 210 (353)
++|+|.+++. .....+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999883 3455678889999999999999999999 999999999999999999999999999987654322
Q ss_pred c---ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccccccccCcc
Q 042383 211 H---ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKLQHLVDPM 287 (353)
Q Consensus 211 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......... .......
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~~i~~g------------- 250 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQG------------- 250 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HHHHHTT-------------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HHHHHcC-------------
Confidence 2 223356899999999999999999999999999999999988887644322111 1111110
Q ss_pred cCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 288 LCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 288 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.....+...+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 011222334567999999999999999999999999998875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=368.68 Aligned_cols=271 Identities=23% Similarity=0.286 Sum_probs=198.6
Q ss_pred cCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----ceEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIEGP----CRIIVY 127 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 127 (353)
++|.+.+.||+|+||+||+|+.+ |+.||||+++..... ......|+..+..++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 56788899999999999999975 789999998743221 222334555556789999999999988654 578999
Q ss_pred EcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 128 DYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE-----IKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 128 e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-----~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
||+++|+|.+++.. .++++..+..++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999932 3689999999999999999999962 1239999999999999999999999999999
Q ss_pred ccCCCCCcc---ccccccCCcCccCccccccCC------CCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHh
Q 042383 203 KLFPEDITH---ISTRVAGTLGYLAPDYAVSGH------LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWE 273 (353)
Q Consensus 203 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 273 (353)
......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876443222 234467999999999887643 56789999999999999999988864432211100000000
Q ss_pred hccccccccccCcccCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 274 MHNTDKLQHLVDPMLCGNF-----SGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
...........+..+.+.. +.+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0000000011112222222 2345677999999999999999999999999998654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-52 Score=368.09 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=213.0
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC------CCcEEEEEEeecc-ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCc
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ------DGTVVAVKVLSVE-SKQGEKEFMSEVASMANICHENLVKLHGGCIEGPC 122 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 122 (353)
..++|++.+.||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3478889999999999999999763 3578999999754 33444578999999999999999999999999999
Q ss_pred eEEEEEcCCCCChhhhhhhcc------ccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 123 RIIVYDYMQNNSLSQTLLGEE------KNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~------~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
.++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 999999999999999885432 1224578999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCc-cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCcccchhhHHHHHHhh
Q 042383 197 SDFGLSKLFPEDIT-HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQ-AAVHFDKELGEYYLVEKAWEM 274 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~ 274 (353)
+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+||. +||...+..+.... ...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~---i~~- 250 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VME- 250 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH---HHT-
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHh-
Confidence 99999986644322 2233456899999999999999999999999999999999985 66654443222211 111
Q ss_pred ccccccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 042383 275 HNTDKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDVD 330 (353)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~~ 330 (353)
. .....+...+..+.+++.+||+.||++|||+++|++.|++..+
T Consensus 251 ---~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 ---G---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---C---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 0122233445679999999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=363.36 Aligned_cols=270 Identities=19% Similarity=0.320 Sum_probs=205.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-C-CcEEEEEEeeccC--hhcHHHHHHHHHHHHhc---CCCCceeeeeeEec----
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-D-GTVVAVKVLSVES--KQGEKEFMSEVASMANI---CHENLVKLHGGCIE---- 119 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 119 (353)
.++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999874 4 6779999987542 22223456777777666 79999999998853
Q ss_pred -CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEee
Q 042383 120 -GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISD 198 (353)
Q Consensus 120 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~D 198 (353)
....+++||++.++++.... ......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH---HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhh---hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34678999999987665443 23556789999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 199 FGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 199 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
||++..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+..........
T Consensus 160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 999886543 233455779999999999999999999999999999999999999998766544433332222111111
Q ss_pred ccccc-------cC---cccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 279 KLQHL-------VD---PMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 279 ~~~~~-------~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
.+... .. ......+....++.+.+|+.+||+.||++|||++|+++ +|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 11000 00 00001122334567889999999999999999999987 35554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=363.40 Aligned_cols=245 Identities=21% Similarity=0.329 Sum_probs=199.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccCh------hcHHHHHHHHHHHHhcC--CCCceeeeeeEecCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESK------QGEKEFMSEVASMANIC--HENLVKLHGGCIEGP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 121 (353)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 568999999999999999999975 689999999874321 11233568999999986 899999999999999
Q ss_pred ceEEEEEcCCC-CChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-CCCeEEeec
Q 042383 122 CRIIVYDYMQN-NSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-NFNPKISDF 199 (353)
Q Consensus 122 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-~~~~kl~Df 199 (353)
..++||||+.+ +++.+++ .....+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~----~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHH----HHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 5777777 3456799999999999999999999999 9999999999999985 478999999
Q ss_pred cCCccCCCCCccccccccCCcCccCccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc
Q 042383 200 GLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHL-NPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD 278 (353)
Q Consensus 200 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 278 (353)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. .... .
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~~~--~- 220 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRG--Q- 220 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHC--C-
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hhhc--c-
Confidence 999865432 2344679999999999987765 5679999999999999999999974321 0000 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCC
Q 042383 279 KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGD 328 (353)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~ 328 (353)
..++...+.++.+|+.+||+.||++|||++|+++ .|+++
T Consensus 221 -----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 -----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp -----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0111223456889999999999999999999987 45543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=357.15 Aligned_cols=267 Identities=20% Similarity=0.285 Sum_probs=203.3
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec--------
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE-------- 119 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 119 (353)
.++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 7999999998644 23344678899999999999999999998865
Q ss_pred CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeec
Q 042383 120 GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDF 199 (353)
Q Consensus 120 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Df 199 (353)
....++||||+.++++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34678999999887665444 4566799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCc---cccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhc
Q 042383 200 GLSKLFPEDIT---HISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMH 275 (353)
Q Consensus 200 g~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 275 (353)
|++........ .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||....+......+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99986653322 122335689999999998765 68999999999999999999999998766554444444333222
Q ss_pred cccccccccCcc--------cCCCCCh-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 276 NTDKLQHLVDPM--------LCGNFSG-------NEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 276 ~~~~~~~~~~~~--------~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
............ ....... .....+.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 221111111100 0000111 113456789999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=359.49 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=212.1
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC----CCcEEEEEEeeccC----hhcHHHHHHHHHHHHhcCC-CCceeeeeeEecCC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ----DGTVVAVKVLSVES----KQGEKEFMSEVASMANICH-ENLVKLHGGCIEGP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 121 (353)
.++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 367999999999999999999852 47899999986431 2234567889999999965 89999999999999
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..+++|||+.+|+|.+++ ...+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i----~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHH----HHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHH----HhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 999999999999999998 4556788999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSG--HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+..+............|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--- 252 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--- 252 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC---
Confidence 987765555555667899999999998765 468899999999999999999999987665444333322211111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HhcCCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRP-----RMSTVIE--MINGDV 329 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~--~L~~~~ 329 (353)
...+...+.++.+|+.+||++||++|| |++|+++ +++++.
T Consensus 253 ----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 253 ----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 122334467799999999999999999 4789986 576644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=360.12 Aligned_cols=269 Identities=21% Similarity=0.289 Sum_probs=201.9
Q ss_pred hccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC-----
Q 042383 50 ATNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIEGP----- 121 (353)
Q Consensus 50 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 121 (353)
..++|+++++||+|+||+||+|.+. +|+.||||+++.. +....+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3578999999999999999999975 6999999999743 3344567889999999999999999999998655
Q ss_pred -ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeecc
Q 042383 122 -CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFG 200 (353)
Q Consensus 122 -~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg 200 (353)
..++||||+ +.+|...+ ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 469999999 55777665 235799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 201 LSKLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 201 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
+++..... .....||+.|+|||++.+. .++.++||||+||++|+|++|..||...+...................
T Consensus 167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 99876543 2346789999999998764 568999999999999999999999987654433322222111110000
Q ss_pred ---------------cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 042383 280 ---------------LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDID 332 (353)
Q Consensus 280 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~ 332 (353)
........+ .......+..+.+|+.+||+.||++|||++|+++ .|+++.+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 000000000 1111223456889999999999999999999998 477765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=359.24 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=199.3
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeeeEec------CCceE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGGCIE------GPCRI 124 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~ 124 (353)
.+|+..++||+|+||+||+|++. +|+.||||++...... ..+|+.++++++||||++++++|.. ..+.+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 36888899999999999999976 6899999999754322 2479999999999999999999853 33578
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSK 203 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~ 203 (353)
+||||++++ +.+.+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus 96 lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 999999865 4444443345667899999999999999999999999 999999999999998765 89999999998
Q ss_pred cCCCCCccccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccc----
Q 042383 204 LFPEDITHISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTD---- 278 (353)
Q Consensus 204 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---- 278 (353)
...... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.......+..........
T Consensus 172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 765432 2344678999999998775 578999999999999999999999998766543333222211100000
Q ss_pred --------ccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 279 --------KLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 279 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
..................++.+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000011122234567899999999999999999999996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=347.37 Aligned_cols=268 Identities=17% Similarity=0.290 Sum_probs=209.7
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC--hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCCceEEEEE
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES--KQGEKEFMSEVASMANICHENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 128 (353)
++|+++++||+|+||+||+|++. +|+.||||+++... ......+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 78999999997543 3345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCccCCCC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKLFPED 208 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 208 (353)
++.+++|..++ ...+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99998888776 4567889999999999999999999999 9999999999999999999999999999876543
Q ss_pred CccccccccCCcCccCccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCcccch-hhHHHHHHhhcccccccc---c
Q 042383 209 ITHISTRVAGTLGYLAPDYAVSGH-LNPKSDIYSFGVLLLQIVTGQAAVHFDKELGE-YYLVEKAWEMHNTDKLQH---L 283 (353)
Q Consensus 209 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~---~ 283 (353)
... .....+++.|+|||++.+.. ++.++||||+||++|+|++|..||........ ...+.............. .
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 322 23345778899999887665 68999999999999999999999765433222 221111111111110000 0
Q ss_pred c---------CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcC
Q 042383 284 V---------DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MING 327 (353)
Q Consensus 284 ~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 327 (353)
. ............++.+.+|+.+||+.||++|||++|+++ .|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0 000111222334567889999999999999999999987 4543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=357.68 Aligned_cols=273 Identities=20% Similarity=0.255 Sum_probs=202.8
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccC-hhcHHHHHHHHHHHHhcCCCCceeeeeeEecCC----ceE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVES-KQGEKEFMSEVASMANICHENLVKLHGGCIEGP----CRI 124 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 124 (353)
..+|++++.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999865 79999999997543 344567889999999999999999999987643 234
Q ss_pred EEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 125 IVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 125 lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
++++++.+|+|.+++. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5556677899999983 24699999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCc--cccccccCCcCccCcccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhcccccc-
Q 042383 205 FPEDIT--HISTRVAGTLGYLAPDYAVS-GHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDKL- 280 (353)
Q Consensus 205 ~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 280 (353)
...... .......||+.|+|||++.. ..++.++||||+||++|+|++|..||...+....................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 643322 22344678999999998854 46789999999999999999999999766543333222221111100000
Q ss_pred -------ccc---cCcccCC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--hcCCCCC
Q 042383 281 -------QHL---VDPMLCG---NFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM--INGDVDI 331 (353)
Q Consensus 281 -------~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~~~~~ 331 (353)
... ....... ...+..+.++.+|+.+||+.||++|||++|+++. |+...+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 000 0000000 0011223568899999999999999999999984 6655443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-49 Score=346.19 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=207.9
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+. |+|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999976 689999998864432 234678899999996 4899999999999999999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC-----CCCeEEeeccCCc
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ-----NFNPKISDFGLSK 203 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~-----~~~~kl~Dfg~~~ 203 (353)
|+ +++|.+++. .....+++..+..++.|++.||+|||+. |++||||||+||+++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~---~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHH---hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 679988873 3345799999999999999999999999 9999999999999964 5789999999998
Q ss_pred cCCCCCcc------ccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc
Q 042383 204 LFPEDITH------ISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT 277 (353)
Q Consensus 204 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 277 (353)
.+...... ......||+.|+|||++.+..+++++|||||||++|+|++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 76533211 223467999999999999999999999999999999999999999865544333322222221111
Q ss_pred cccccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 278 DKLQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
..... +... .++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 235 ~~~~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 1122 2456889999999999999999999988877654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-49 Score=349.31 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=200.5
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCC-ceeeeeeEecCCceEEEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANICHEN-LVKLHGGCIEGPCRIIVYD 128 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 128 (353)
.++|++.+.||+|+||+||+|++. +|+.||||++..... ...+..|+++++.++|++ |+.+..++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999875 689999999875433 235778999999997665 5555667788888999999
Q ss_pred cCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECC---CCCeEEeeccCCccC
Q 042383 129 YMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQ---NFNPKISDFGLSKLF 205 (353)
Q Consensus 129 ~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~---~~~~kl~Dfg~~~~~ 205 (353)
|+. ++|.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+||+++. +..++|+|||+++..
T Consensus 84 ~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 46666652 3456799999999999999999999999 9999999999999854 557999999999876
Q ss_pred CCCCc------cccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc
Q 042383 206 PEDIT------HISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK 279 (353)
Q Consensus 206 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 279 (353)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 54322 123346799999999999999999999999999999999999999986654433332222211111111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 042383 280 LQHLVDPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEMINGDV 329 (353)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~~~ 329 (353)
.. .+ ....+.++.+++.+||+.+|++||++.++.+.|+...
T Consensus 237 ~~-----~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 IE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HH-----HH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hh-----Hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 11 1122456889999999999999999999988887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-48 Score=348.48 Aligned_cols=258 Identities=17% Similarity=0.278 Sum_probs=199.7
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEec--CCceEEE
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIE--GPCRIIV 126 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 126 (353)
.++|+++++||+|+||+||+|++. +|+.||||+++.. ..+.+.+|+.+|++++ ||||++++++|.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999975 6899999998743 3457789999999995 9999999999974 4568999
Q ss_pred EEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCC-CeEEeeccCCccC
Q 042383 127 YDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNF-NPKISDFGLSKLF 205 (353)
Q Consensus 127 ~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~-~~kl~Dfg~~~~~ 205 (353)
|||+.+++|.... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987654 3589999999999999999999999 999999999999998654 6999999999876
Q ss_pred CCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhh-HHHHHH---------hh
Q 042383 206 PEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY-LVEKAW---------EM 274 (353)
Q Consensus 206 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~---------~~ 274 (353)
.... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.......... .+.... ..
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 5432 23446789999999998765 47999999999999999999999997654322211 111100 00
Q ss_pred cc---cccccccc--------CcccCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042383 275 HN---TDKLQHLV--------DPMLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE 323 (353)
Q Consensus 275 ~~---~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 323 (353)
.. ........ ............+.++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000 011111122334567899999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=351.81 Aligned_cols=262 Identities=19% Similarity=0.219 Sum_probs=194.2
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec------CC
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE------GP 121 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 121 (353)
.++|+++++||+|+||+||+|.+. +|+.||||++... +......+.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999976 6999999999754 34445678899999999999999999999963 46
Q ss_pred ceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccC
Q 042383 122 CRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGL 201 (353)
Q Consensus 122 ~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~ 201 (353)
..|+||||+.++.+ +.+ ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++++|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 78999999977544 443 24589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccc----
Q 042383 202 SKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNT---- 277 (353)
Q Consensus 202 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 277 (353)
++..... .......+|+.|+|||++.+..+++++||||+||++|+|++|+.||...+.......+.........
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8865432 2334467899999999999999999999999999999999999999866543322222111100000
Q ss_pred ------------------cccccccCcccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042383 278 ------------------DKLQHLVDPMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIEM 324 (353)
Q Consensus 278 ------------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 324 (353)
.............. .....+..+.+|+.+||+.||++|||++|+|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000111111111 123346788999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=352.71 Aligned_cols=270 Identities=23% Similarity=0.283 Sum_probs=204.6
Q ss_pred ccCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeecc--ChhcHHHHHHHHHHHHhcCCCCceeeeeeEec-----CCc
Q 042383 51 TNGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE--SKQGEKEFMSEVASMANICHENLVKLHGGCIE-----GPC 122 (353)
Q Consensus 51 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 122 (353)
.++|++.++||+|+||+||+|++. +|+.||||+++.. +....+.+.+|+.+|++++|||++++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999965 7999999999754 33445678899999999999999999999863 334
Q ss_pred eEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEEeeccCC
Q 042383 123 RIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKISDFGLS 202 (353)
Q Consensus 123 ~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~ 202 (353)
.+++++++.+|+|.+++ ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~-----~~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIV-----KCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhc-----ccccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46677788899999988 234699999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccCCcCccCccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCcccchhhHHHHHHhhccccc--
Q 042383 203 KLFPEDITHISTRVAGTLGYLAPDYAVSG-HLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYYLVEKAWEMHNTDK-- 279 (353)
Q Consensus 203 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 279 (353)
..... ......|++.|+|||+..+. .++.++|||||||++|+|++|..||...+.......+...........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 75432 23446788999999987765 468899999999999999999999987665444333322211111000
Q ss_pred ------cccccC---cccCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 042383 280 ------LQHLVD---PMLCGN---FSGNEAVRFLKVGLLCVQEKSSLRPRMSTVIE--MINGDVDID 332 (353)
Q Consensus 280 ------~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~~~~~~ 332 (353)
...... ...... .....+..+.+|+.+||+.||++|||++|+++ .|++..+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~ 311 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence 000000 000000 00122456889999999999999999999998 677665433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-42 Score=312.35 Aligned_cols=285 Identities=19% Similarity=0.231 Sum_probs=202.9
Q ss_pred cCCCCCCeeeeeCceEEEEEEeC-CCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-----------CCCceeeeeeEec
Q 042383 52 NGFCSSNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVESKQGEKEFMSEVASMANIC-----------HENLVKLHGGCIE 119 (353)
Q Consensus 52 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 119 (353)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 79999999997443 33456778888888775 5789999988764
Q ss_pred --CCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCC---
Q 042383 120 --GPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFN--- 193 (353)
Q Consensus 120 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~--- 193 (353)
....+++++++..+....... .......+++..++.++.||+.||.|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 345667777765554333322 22456678999999999999999999998 6 9999999999999976543
Q ss_pred ---eEEeeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHHHHHHhCCCCCCCCcccchhh----
Q 042383 194 ---PKISDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLLLQIVTGQAAVHFDKELGEYY---- 266 (353)
Q Consensus 194 ---~kl~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~~ll~g~~pf~~~~~~~~~~---- 266 (353)
++++|||.+..... ......||+.|+|||++.+..++.++||||+||++++|++|+.||..........
T Consensus 168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999875532 2244678999999999999999999999999999999999999997554321111
Q ss_pred HHHHHHhh-----------------ccccccccccCc----------ccCCCCChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042383 267 LVEKAWEM-----------------HNTDKLQHLVDP----------MLCGNFSGNEAVRFLKVGLLCVQEKSSLRPRMS 319 (353)
Q Consensus 267 ~~~~~~~~-----------------~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 319 (353)
........ ............ ..........+..+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11100000 000000000000 011234566788899999999999999999999
Q ss_pred HHHH--HhcCCCCCCCCccccCCcccccc
Q 042383 320 TVIE--MINGDVDIDDDVEIWEPGLINDI 346 (353)
Q Consensus 320 evl~--~L~~~~~~~~~~~~~~~~~~~~~ 346 (353)
|+|+ .|++....+. +..|+.++....
T Consensus 324 e~L~Hp~f~~~~~~~~-~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEE-IRVPDRELYGSG 351 (362)
T ss_dssp HHHTCGGGTTCTTCTT-CCCTTSCTTCBS
T ss_pred HHhcCcccCCCCCccc-CCCCCcccCCCC
Confidence 9998 4775554433 444555555443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1e-25 Score=184.25 Aligned_cols=169 Identities=17% Similarity=0.092 Sum_probs=120.8
Q ss_pred CCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccCh------------------hcHHHHHHHHHHHHhcCCCCceeeeee
Q 042383 55 CSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESK------------------QGEKEFMSEVASMANICHENLVKLHGG 116 (353)
Q Consensus 55 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 116 (353)
.+.++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999988899999998763211 111334568889999999999888765
Q ss_pred EecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCCCCCCeEECCCCCeEE
Q 042383 117 CIEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDIKPSNILLDQNFNPKI 196 (353)
Q Consensus 117 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dlk~~Nil~~~~~~~kl 196 (353)
. ..+++|||+++..+.+ +++.....++.|++.++.+||+. +++||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998865433 33445567899999999999999 99999999999999865 5899
Q ss_pred eeccCCccCCCCCccccccccCCcCccCccccccCCCCccccchhHHHHH
Q 042383 197 SDFGLSKLFPEDITHISTRVAGTLGYLAPDYAVSGHLNPKSDIYSFGVLL 246 (353)
Q Consensus 197 ~Dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il 246 (353)
+|||.+.............. ... .-.+ +....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~r--d~~-~~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILER--DVR-NIIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHH--HHH-HHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHH--HHH-HHHH-HHcCCCCCcccHHHHHHHH
Confidence 99999976543221110000 000 0001 1235678899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.92 E-value=3.3e-09 Score=89.22 Aligned_cols=149 Identities=15% Similarity=0.039 Sum_probs=102.9
Q ss_pred HHHHHhccCCCCCCeeeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCce
Q 042383 45 NELKSATNGFCSSNKVGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCR 123 (353)
Q Consensus 45 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 123 (353)
.++....+.|++.+..+.++.+.||+.... ++.+++|............+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 345555677777776555556789998754 5567888776444334445678888888774 43467778888888889
Q ss_pred EEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 042383 124 IIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEI------------------------------- 172 (353)
Q Consensus 124 ~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~------------------------------- 172 (353)
++||++++|.++.+... +......++.+++..+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999988765441 11122334566666666776421
Q ss_pred -------------------------CCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 173 -------------------------KPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 173 -------------------------~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0147999999999999887667799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=6.3e-07 Score=74.45 Aligned_cols=130 Identities=15% Similarity=0.104 Sum_probs=86.8
Q ss_pred eeeeeCc-eEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC--CCceeeeeeEecCCceEEEEEcCCCCCh
Q 042383 59 KVGEGGF-GSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH--ENLVKLHGGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 59 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL 135 (353)
.+..|.. +.||+....++..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 679999988788889997654332 245678888877743 2356678888888889999999998766
Q ss_pred hhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 042383 136 SQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEE-------------------------------------------- 171 (353)
Q Consensus 136 ~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-------------------------------------------- 171 (353)
.+.. .+.. ..+.++...|..||+.
T Consensus 94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4321 1111 1223444444444431
Q ss_pred -----------CCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 172 -----------IKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 172 -----------~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01247999999999999887667899998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=6.5e-06 Score=72.81 Aligned_cols=77 Identities=9% Similarity=0.072 Sum_probs=48.7
Q ss_pred CCeeeeeCceEEEEEEeC-CCcEEEEEEeecc-------ChhcHHHHHHHHHHHHhcC--CC-CceeeeeeEecCCceEE
Q 042383 57 SNKVGEGGFGSVYKGKLQ-DGTVVAVKVLSVE-------SKQGEKEFMSEVASMANIC--HE-NLVKLHGGCIEGPCRII 125 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~l 125 (353)
.+.||.|....||++... +++.+++|.-... -.....+...|.+.|+.+. .| .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 4678999975421 1112334566888887763 23 34445443 4556789
Q ss_pred EEEcCCCCCh
Q 042383 126 VYDYMQNNSL 135 (353)
Q Consensus 126 v~e~~~~~sL 135 (353)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.69 E-value=9.2e-05 Score=63.39 Aligned_cols=139 Identities=14% Similarity=0.088 Sum_probs=80.1
Q ss_pred eCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCc--eeee-----eeEecCCceEEEEEcCCCCCh
Q 042383 63 GGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENL--VKLH-----GGCIEGPCRIIVYDYMQNNSL 135 (353)
Q Consensus 63 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~sL 135 (353)
+.-..||++...+|..+++|+.+.. ....+.+..|...+..|...++ +..+ ..+..+...+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3346899999989999999987633 3345677888888888752222 1111 133456667889999877543
Q ss_pred hh-----------hh-------hhcc-ccC-------------------CCCCHH---HHHHHHHHHHHHHHHHH-hcCC
Q 042383 136 SQ-----------TL-------LGEE-KNR-------------------AKFSWT---ARREIALGIARGLAYIH-EEIK 173 (353)
Q Consensus 136 ~~-----------~l-------~~~~-~~~-------------------~~l~~~---~~~~~~~qi~~al~~LH-~~~~ 173 (353)
.. .+ .... ... ..++.. .....+.++...+...- +..+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 20 00 0000 000 111111 12222333333332221 2224
Q ss_pred CCeEEcCCCCCCeEECCCCCeEEeeccCCcc
Q 042383 174 PSIVHRDIKPSNILLDQNFNPKISDFGLSKL 204 (353)
Q Consensus 174 ~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~~ 204 (353)
.++||+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 589999999999999744 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.68 E-value=0.00018 Score=61.11 Aligned_cols=159 Identities=12% Similarity=0.055 Sum_probs=85.6
Q ss_pred CCHHHHHHhccCCCCCCeee-----eeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCC-----CCce
Q 042383 42 FSYNELKSATNGFCSSNKVG-----EGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICH-----ENLV 111 (353)
Q Consensus 42 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv 111 (353)
.+.+++.....+|.+++... .|.-.+.|+++..+|+ +++|+..... ..+.+..|+..+..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 56778888888898765543 5666789999887665 8899876331 22345566777777642 2222
Q ss_pred eeee---eEecCCceEEEEEcCCCCChhhhh--------------hhc-c----------------------ccCCCCCH
Q 042383 112 KLHG---GCIEGPCRIIVYDYMQNNSLSQTL--------------LGE-E----------------------KNRAKFSW 151 (353)
Q Consensus 112 ~~~~---~~~~~~~~~lv~e~~~~~sL~~~l--------------~~~-~----------------------~~~~~l~~ 151 (353)
...+ +.........++.+..+......- ... . ........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 2111 122234455666666554321100 000 0 00000011
Q ss_pred HHHHHHHHHHHHHHHHHHh-cCCCCeEEcCCCCCCeEECCCCCeEEeeccCCc
Q 042383 152 TARREIALGIARGLAYIHE-EIKPSIVHRDIKPSNILLDQNFNPKISDFGLSK 203 (353)
Q Consensus 152 ~~~~~~~~qi~~al~~LH~-~~~~~i~H~dlk~~Nil~~~~~~~kl~Dfg~~~ 203 (353)
......+..+...+...+. ..+.++||+|+.++||+++++...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222333333222 124589999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=0.00019 Score=63.17 Aligned_cols=74 Identities=16% Similarity=0.187 Sum_probs=50.8
Q ss_pred CCeeeeeCceEEEEEEeCC--------CcEEEEEEeeccChhcHHHHHHHHHHHHhcC-CCCceeeeeeEecCCceEEEE
Q 042383 57 SNKVGEGGFGSVYKGKLQD--------GTVVAVKVLSVESKQGEKEFMSEVASMANIC-HENLVKLHGGCIEGPCRIIVY 127 (353)
Q Consensus 57 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 127 (353)
++.|+.|-.-.+|++...+ ...|++++.. .. .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578888899999998653 3567777765 22 22345568899998885 4334577777653 5899
Q ss_pred EcCCCCChh
Q 042383 128 DYMQNNSLS 136 (353)
Q Consensus 128 e~~~~~sL~ 136 (353)
||++|.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876543
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.24 E-value=3.7 Score=33.25 Aligned_cols=136 Identities=11% Similarity=0.125 Sum_probs=76.7
Q ss_pred eeeeCceEEEEEEeCCCcEEEEEEeeccChhcHHHHHHHHHHHHhcCCCCceeeeee-----------------E-----
Q 042383 60 VGEGGFGSVYKGKLQDGTVVAVKVLSVESKQGEKEFMSEVASMANICHENLVKLHGG-----------------C----- 117 (353)
Q Consensus 60 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-----------------~----- 117 (353)
+..+|.+-|+-+..++| .+++|. .+....+.+-.++...-.+..|...-+... .
T Consensus 76 ~s~~Gs~Gv~FV~~e~g-aiVlK~---s~tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~~e~d~~I~s 151 (342)
T d1cjaa_ 76 RSEKGTEGLFFVETESG-VFIVKR---STNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVITT 151 (342)
T ss_dssp ECCSTTSCEEEEEESSC-EEEEEC---CTTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHHHH
T ss_pred EeecCCceEEEEEcCCc-eEEEec---CCchHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHhcCCChhHHHHH
Confidence 33445555555665544 477785 233444666777777777778876554310 0
Q ss_pred ecCCceEEEEEcCCCCChhhhhhhccccCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcCC-CCCCeEECCCC-CeE
Q 042383 118 IEGPCRIIVYDYMQNNSLSQTLLGEEKNRAKFSWTARREIALGIARGLAYIHEEIKPSIVHRDI-KPSNILLDQNF-NPK 195 (353)
Q Consensus 118 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~~~~i~H~dl-k~~Nil~~~~~-~~k 195 (353)
......+++|||.+|.+|.+.-... ....++...+..+.+ |+-.=.++++..+.++.+++- .+.|++++.++ .+.
T Consensus 152 el~~A~~liMeYvpG~~l~e~~~~~--a~~~fs~~~l~~LGk-IiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~ 228 (342)
T d1cjaa_ 152 LANQANILLMELVRGITLNKLTTTS--APEVLTKSTMQQLGS-LMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVV 228 (342)
T ss_dssp HTTCSEEEEEECCCEEESTTCCSSS--HHHHSCHHHHHHHHH-HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEE
T ss_pred HHhcccceeeeccCCcccccccccc--chhhhcHHHHHHhhh-HHHHHHHHcCCccccccccCCCCccceEEecCCcEEE
Confidence 0124567999999988775543110 011122232222111 222234667666667777632 78999998776 677
Q ss_pred EeeccCC
Q 042383 196 ISDFGLS 202 (353)
Q Consensus 196 l~Dfg~~ 202 (353)
.+|=|..
T Consensus 229 ~IDs~i~ 235 (342)
T d1cjaa_ 229 PIDSKII 235 (342)
T ss_dssp ECSCCCC
T ss_pred EecCCcc
Confidence 8886554
|